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Summary
With the recent, rapid advances in recombinant DNA technology, it
has become possible to consider the use of nucleic acid probes in diagnosis
of human viral diseases. Several examples are discussed which employ
techniques of dot blot hybridization, sandwich hybridization and in situ
hybridization. Typing of viral strains using restriction endonuclease digestion
as an epidemiological tool is considered. Finally, the present limitations of
molecular hybridization are discussed, and future developments including
the production of non-radio actively labeled probes, are assessed.
Introduction
Recent advances in the area of recombinant DNA technology have led
to the possibility of using nucleic acid probes in the diagnosis of viral
infections in man. Integrated viral sequences may be assayed, viral nucleic
acids quantitated and epidemiology carried out on a molecular level. Hybrid¬
ization methods may be applied to aetiopathogenic studies particularly to
viral infections where viral genome is the only remaining evidence of virus
infection acquired in the distant past. In addition, techniques of in situ
hybridization permit viral nucleic acid to be detected in specific cells of a
tissue section. The specificity and speed of hybridization should allow this
method to be a valuable adjunct to the conventional methods used at present,
such as infection of susceptible cells and growth of virus in tissue culture,
electron microscopy of specimens, examination for viral antigens by using
immunofluorescence or immunoenzyme conjugates, radioimmunoassay or
ELISA, and serological assays (1, 16).
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Three methods of recombinant RNA technology have important appli¬
cations for viral diagnosis. These are molecular cloning, nucleic acid hybrid¬
ization and the use of restriction enzymes to cut DNA at specific sites (20,
34). This paper outlines some of the methods currently used to prepare the
viral nucleic acid probes; then consideration is given to several methods of
rapid diagnosis, viral histopathology and epidemiological studies using such
reagents. Finally, the future of such a molecular approach is discussed.
Preparation of Nucleic Acid Probes
Molecular cloning procedures have been especially useful for obtaining
abundant supplies of those viral nucleic acid probes which cannot be
propagated in tissue culture systems, such as hepatitis B virus (HBV) and
human papilloma virus (HPV). These two viruses which have genomes of
less than 10 kilobases have been cloned using plasmid vectors (5, 12, 17, 30).
With larger M.W. viral DNAs, a collection of recombinant plasmids, bacteri¬
ophage or cosmid clones have been made containing viral DNA fragments
which collectively represent the entire genome. Some of the human viral
genomes that have been cloned in this way are vaccinia (3), cytomegalovirus
(CMV) (21), PLerpes simplex virus type 1 (HSV-1) (25) and type 2 (HSV-2)
(24), Epstein-Barr virus (EBV) (57) and adenovirus (50). The cloned viral
DNA fragments can be further digested with restriction endonucleases and
then sub-cloned into plasmid vectors. The collection of different cloned
fragments, called genomic libraries, are an important source of defined and
undefined DNA sequences for mapping and use as diagnostic probes.
Whereas plasmids, most bacteriophages and cosmids yield double-stranded
(ds) recombinant probes, single-stranded (ss) recombinant probes can be
obtained using M13 phage systems (41).
DNA probes also have been obtained from RNA viruses such as rota¬
virus (51) and influenza A (13) by synthesizing a complementary DNA
(cDNA) from the viral RNA using the enzyme "reverse transcriptase".
After synthesizing the homologous strand, the cDNA can be inserted into
a bacterial plasmid or phage and molecularly cloned to produce recombinant
DNA probes.
Viral diagnostic probes are also prepared directly from viruses which
have been propagated in eukaryotic cell-culture systems (43). However, the
disadvantages of using eukaryotic cells are that the yield of virus from
productive infections may be very low and viral nucleic acids may be
contaminated with cellular nucleic acids during the isolation procedure.
Extensive genomic drift also may occur on prolonged maintenance of virus
in culture especially for RNA viruses (27).
Applications to Rapid Diagnosis
Several methods have been published recently which illustrate the
potential of using nucleic acid probes in viral diagnosis. In all of these,
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Table 1. Comparison of conventional detection methods and hybridization
Detection by hybridization
Virus group Conventional detection and RE fragment analysis Refs.
Growth in tissue culture
(several weeks) or EM. No
method of distinguishing
types.
Growth in tissue culture
(several days), EM, IF,





cytes, IF and CF.
Growth in tissue culture
(several days), RIA or IF.
Types distinguished by
neutralization or CF.
Antigens and antibodies de¬
tected by RIA and ELISA.
No cell culture system
available to propogate virus.
Free virus detected by EM
or IF but difficult to find.
No cell culture system
available to propogate virus.
Detection by EM, PAGE,
RIA or ELISA.
Dot blot hybridization (24
hours), 5pg vDNA detect¬
able, quantitative. Analysis
of type by RE digestion.
Dot blot hybridization (20
hours), vDNA from less
than 103 cells detectable.
Analysis of type by RE
digestion or by membrane
hybridization under differ¬
ent conditions.




(several hours), 0.2 ng
vDNA detectable. Analysis
of type by RE digestion or
by hybridization under dif¬
ferent conditions.
Dot blot hybridization (24
hours).
1—10 pg vDNA detectable,
quantitative.
Southern blotting and hy¬
bridization after RE di¬
gestion (48 hours).
Integrated and free vDNA
detectable.
Analysis of type by RE
digestion.
Southern blotting and hy¬
bridization under different
conditions.
Dot blot hybridization (sev¬
eral hours), 8 pg vRNA
detectable, 10—100X more
sensitive thanELISA. Anal¬















v viral; EM electron microscopy; ELISA enzyme linked immunosorbent assay;
IF immunofluorescence; RIA radioimmunoassay; CF complement fixation; RE
restriction endonuclease; PAGE polyacrylamide gel electrophoresis
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radioactively labeled probes have been prepared and used for DNA-DNA
hybridization in solution or on a solid support. A comparison of conventional
and hybridization procedures for the detection of several different viral
groups is summarized in Table 1.
One of the first reports on the use of hybridization to type HSV isolates
was by Brautigam et al. (7); DNA-DNA hybridization was performed in
solution with the products being analyzed by hydroxyapatite chromato¬
graphy. A simpler hybridization method which can detect and type HSV
DNA from less than a 1000 infected cells has since been described (49). DNA
extracted from cells grown in one roller tube was alkali-denatured and
immobilized on nitrocellulose membranes by dot blotting. This enabled a
large number of samples to be processed simultaneously. A probe was made
from 32P-labeled DNA fragment of HSV-1. Low stringent washing of mem¬
branes after hybridization permitted the detection of both HSV-1 and HSV-2.
Rewashing of membranes under conditions of high stringency, where only
a few base mis-matches are tolerated (1), allowed discrimination between
types 1 and 2 as no hybridization occurred with the latter. In this study, a
Hindlll-Eco^il DNA fragment was used as probe although its precise
location in the HSV genome was not known (49). HSV probes for hybridization
need to be selected with care as HSV-1 fragments cross-hybridize to HSV-2
with varying degrees (37) and homologies may occur between viral DNA
of the herpes group and cellular DNA (and mRNAs) (38). Traditionally,
HSV isolates are typed by determining differences in biological properties
which are not always clear cut. Serological assays are also used and recently,
monoclonal antibodies have been produced that can distinguish between
HSV types 1 and 2 (35).
Other dot blot hybridizations have been carried out successfully. In
1980, Brandsma and Miller reported the screening of lymphoid cells for
the presence of EBV (6). The cells were spotted on nitrocellulose filters, the
DNA denatured and hybridization carried out with EBV-DNA, radiolabeled
by nick translation. The sensitivity was 0.06 to 0.6 genome equivalents per
cell and the method quantitative. Hybridizations are of particular importance
in the study of viral infections such as EBV in which the infection is either
nonproductive or virions are released in low quantity.
Flores et al. (22) described a dot blot technique for rotaviruses which are
normally detected by electron microscopy, analysis of RNA on poly-
acrylamide gel electrophoresis, RIA or ELISA. The stool specimens were
pre-treated with fluorocarbon and extracted with phenol before denaturation
by boiling and dotting on nitrocellulose membranes. However, it was also
shown that the pre-treatment procedures, apart from boiling, were not
essential. Hybridization was carried out using ss rotavirus RNA labeled
with 32P-GTP by in vitro transcription or with 125I by chemical iodination.
Good correlation was obtained with diagnosis by other methods. There was
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sufficient cross-homology between different strains of rotavirus that detection
of unknown strains in the specimens was possible. Asymptomatic carriers
were found. The limit of detection of 8 pg of viral RNA was 10 to 100 times
more sensitive than the ELISA test. Although the dot blot was very sensitive
and enabled rapid screening of a large number of samples, it lacked specificity
within the rotavirus genus (22). Information on the diversity of strains can
be further obtained by polyacrylamide gel electrophoresis and Northern blot
hybridization as human strains differ in their RNA migration patterns (51).
Increasingly, programs are being undertaken to screen for the presence
of CMV in urine or other specimens from immunosuppressed patients who
are receiving bone marrow, heart and kidney transplants. By conventional
methods of in vitro culture, clinical CMV isolates often produce recognizable
cytopathic effects only after several weeks and quantitation by plaque assay
is too slow to be of any benefit to a patient receiving therapy. Recently, a
dot blot technique has been used to detect human CMV in urine samples
that were clarified, then ultracentrifuged to deposit any virus (1, 15). The
pellet was alkali-denatured, neutralized and immobilized on nitrocellulose
filters before hybridization was carried out with a 32P-labeled CMV DNA
probe containing an EcoRI fragment representing 1/10 of the viral genome.
This assay was rapid (being completed in one day), sensitive (detecting
5 pg viral DNA) and quantitative so that the impact of antiviral therapy on
the patient could be easily measured. A similar dot blot procedure has been
used to detect adenovirus types (1, 14), HSV types (49), HBV (4) and entero¬
viruses (29) in biological specimens.
A different hybridization system has been described to detect HBV
UNA in liver and serum and to determine the presence of integrated and
free viral DNA in liver cells (8). DNA was extracted from needle biopsies
of liver; some was digested with the restriction endonuclease Hind III, and
the fragments separated by electrophoresis on agarose before being transferred
to a nitrocellulose membrane by the Southern blot technique (47). The
hybridization was carried out using cloned HBV HNA labeled with 32P by
nick translation and denatured. One band (3.2 kilobase position) was found
in the Hind III digested and undigested sam ples from all HBe antigen-
positive patients which demonstrated unintegrated viral DNA. In addition,
bands corresponding to high M.W. DNA were found in some digested
samples indicating integration of HBV sequences. Serum samples were
phenol extracted and assayed in a similar manner for free viral DNA. This
was a more sensitive assay for serum infectivity than radioimmunoassay
for HBe antigen. Thus, viral DNA replication, serum infectivity, integration,
and the early stages of infection and its progression may be studied using
hybridization. Also, the selection and monitoring of patients for antiviral
therapy can be better assessed as it seems unlikely that drugs such as adenine
arabinoside or interferon could affect integrated viral genomes. Recently,
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the state of HBV DNA in various childhood liver diseases has been examined
in a similar way (44).
A new test called sandwich hybridization has been described which is
an adaptation of the dot blot hybridization (1, 39, 52). This has been applied
to the detection of adenovirus in nasopharyngeal mucus aspirates. To test
for subgroup C viruses, a fragment (29—42 per cent map position) of cloned
adeno-2 was denatured and immobilized on nitrocellulose filters. It was
hybridized with denatured DNA from the aspirate in the presence of the
probe, 125I-labeled ss adeno-2 fragment (42—45.3 per cent map position)
which had been cloned in the phage M13 mp7 (39). Where the aspirate DNA
was homologous to adeno-2, it annealed to both filter and probe, thus
binding the probe to the filter. The sensitivity of the technique (5 X 10®
molecules or 0.2 ng of adenovirus DNA) was similar to that of a radio¬
immunoassay for viral hexon protein (1). It is possible to manipulate the
probes so that reagents may be prepared with either group or strain specificity
and the technique is quantitative if suitable standards are available (1, 39,52).
Human leukemias and lymphomas are currently being surveyed for
sequences homologous to human T-cell leukemia virus DNA using probes
prepared from the viral genome and provirus (56).
Applications to Viral Histopathology
Although in situ hybridization is not applied at the moment to rapid
viral diagnosis, several examples illustrate its potential and its present use
in histopathology. It is of particular value where a small proportion of cells
in a population is infected or where the histological and pathological picture
can be correlated with the distribution of viral genomes. In addition to loca¬
lization of viral genomes, expression of viral mRNA may be monitored.
Burrell et al. (11) used in situ hybridization to examine the replication
of HBV in liver sections from patients with chronic hepatitis. 3H-labeled
cloned HBV DNA was used as a probe to detect HBV DNA in single cells.
They were able to show focal infection suggesting cell-to-cell spread of virus,
and an association between HBV replication and hepatocyte injury at the
cellular level. From these residts they suggested that patients showing spread
of virus would be the ones most likely to benefit from treatment with anti¬
viral agents.
Some work has been done to detect viral genomes in various neurological
conditions of unknown etiology using in situ hybridization. Sequiera et
al. (45) showed that HSV type 1 DNA was present in cells from brain smears
of several patients who had died with chronic psychiatric illness and neuro-
pathological changes. In a similar way HSV mRNA was detected in ganglion
cells in sections of paravertebral sympathetic ganglia at autopsy (23). Only
a small percentage of neurons within the ganglia were positive. In situ
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hybridization has also been used to detect viral DNA or mRNA in various
neoplasms such as epidermodyplasia verruciformis (36), Burkitt's lymphoma
(58), nasopharyngeal carcinoma (55) and cervical carcinoma (19).
The biggest drawback at the moment to using in situ hybridization as a
tool for rapid viral diagnosis is the time taken for the autoradiograph to
develop to visualize viruses in tissue sections. This may be in the order of
several days for 125I and 32P probes, and up to several months for 3H probes.
If labeling with non-radioactive reagents such as antisera to nucleic acid
hybrids (40), biotin (31) or flnorochrome (2) can be further developed, then
more applications for in situ hybridization would become apparent. A start
has been made in this direction by Brigati et al. (9) who reported the use
of biotin-labeled DNA or RNA probes to detect viral genomes both in tissue
culture (parvovirus, polyomavirus, HSV, adenovirus, retrovirus) and in
paraffin sections of tissue (HSV and adenovirus). The whole procedure was
completed in less than 24 hours, although the sensitivity was not equal, as
yet, to autoradiographic methods.
Applications to Viral Epideiniology
It is often important to be able to trace the source of a virus which causes
an infection, to test the relatedness of different strains or to follow the
genomic changes over a period of time. Restriction endonuclease digestion
followed by electrophoretic separation of fragments has allowed such studies
to be made in recent years. This may be allied to Southern and Northern
blotting, and subsequent hybridization with nucleic acid probes.
As serological reagents which are able to distinguish between types of
CMV are not available, molecular epidemiological studies have provided
valuable information in this area. Restriction endonuclease digestion of
CMV from random clinical isolates has indicated that no 2 viruses generate
the same pattern of DNA fragments, if more than one enzyme is used. Thus,
Huang et al. (28) showed that endogenous virus carried by mothers during
pregnancy was the most frequent source of recurrent infection, and of
transmission to their babies. Re-infection with another strain occurred
rarely. In much the same way Spector (48) demonstrated that CMV could
be spread from one baby who had viruria to another in a hospital environ¬
ment. This result has obvious implications for management of patients in
renal and bone marrow transplant units and in pediatric wards.
HSV isolates have also been typed (32) and classified using restriction
endonuclease digestion (1) as have some adenoviruses which are not clearly
identified by serological methods (53). Genome mapping has provided
valuable information about the source of herpetic infection in nosocomial
outbreaks (10) in temporal clusters of encephalitis cases (26) and in moni¬
toring transmission of virus from one patient to another (46).
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The analysis of diversity in strains of viruses has been illustrated by
human rotaviruses isolated over a period of several years (51). The segmented
viral RNAs were separated by polyacrylamide gel electrophoresis, transferred
by Northern blotting to diazobenzyloxymethyl (I ) BM) paper and hybridized
with cDNA probes under conditions of low stringency (34 per cent base
mis-match tolerated) and high stringency (no more than 8 per cent base
mis-match tolerated). A distinct advantage of using J)BM paper instead
of nitrocellulose paper is that it may be used with various probes. This
method permits strains to be compared in retrospect or as new clones become
available. In addition, RNA electrophoretic patterns of viral isolates can
be visualized directly on gels by using ethidium bromide or a sensitive silver
staining procedure (54).
A further example of the use of hybridization and restriction endo-
nuclease analysis has been to distinguish human papilloma virus (HPV)
types of which 25 are presently recognized and to associate each with a
particular type of lesion (18, 33). The recent discovery of HPV-16 in cervical
tumors of women using molecularly cloned viral DNA probes, HPV-6 or
HPV-11, demonstrates the value of employing hybridization conditions of
varying stringencies to detect and isolate new types of virus (18). Free HPV
has not been found in cervical tumors using traditional techniques of viral
diagnosis, such as EM, immunofluorescence or cell culture systems to
propogate virus. On the other hand, many cases of non-productive viral
infection and new types of virus (HPV-6, 10, 11, 16 and 18) have been
identified in cervical disease using recombinant DNA procedures (42).
Present Limitations and Future Developments
This review has illustrated the significant contribution which molecular
hybridization and restriction enzyme fragment analysis can make to diagnostic
virology and the examples given indicate the wide ranging applications in
this area, especially when allied with other techniques. Cloning and charac¬
terization of the recombinant DNAs for use as diagnostic probes involve
methods which are complex and time-consuming. It is clear that their
preparation will be done in research centers and molecular biology companies.
The availability of commercial diagnostic kits should enable hybridization
techniques to become valuable adjuncts to the more traditional diagnostic
methods.
At the moment, probes are normally radio-labeled to high specific
activity with y-emitters. This procedure is expensive, produces probes of
short half-life and creates difficidties in handling in a routine diagnostic
laboratory. The replacement of the radioactive label by other tracer
substances of at least equal sensitivity is an obvious area for development.
This should enable preparations of safer and more convenient reagents which
are better suited to a diagnostic laboratory. Three alternatives are currently
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being tested. The first is to use antibodies against the nucleic acid hybrids
which would then be detected by imraunocytochemistry or ELISA (40).
Secondly, biotin can be covalently attached to the C-5 of pyrimidine and
incorporated into the probe in vitro. This may then be detected using
immunofluorescence, immunoperoxidase, avidin conjugated to an enzyme
or affinity chromatography, based on the specific interaction between
biotin and antibiotin IgG or avidin (31). Thirdly, fluorescein and rhodamine
have been coupled to the 3'-terminus of the probe giving advantages in
speed and resolving power for in situ hybridizations (2).
It would be useful if nucleic acid probes could be generated with various
specificities, such as group, type or "virulence", and these quantitated under
hybridization conditions of varying stringencies. Such methods are of
special interest when viruses cannot be cultured in vitro, when they grow
very slowly, when there are no antigenic markers to type them or when
numbers of samples are very large. Dots of specimen DNAs or RNAs may
be prepared in countries not equipped to do hybridizations and then posted
to some central laboratory where the probes are available. Pre-treatment of
samples before application to nitrocellulose paper leads to some extra work but
has not proved essential in some systems. A distinct advantage of dot blotting
is that it allows viral sequences to be assayed either singly or as numerous
samples, simultaneously. In situ hybridization techniques may have
important applications in the field of histopathology, especially if paraffin
embedded sections of tissue can be used. Integrated viral genomes can be
detected which may not be expressed and therefore not demonstrable by
other methods. Such studies, including the ability to characterize single
cells in a tissue section, may be particularly useful in the area of tumor
etiology and in disorders of unknown etiology.
Epidemiology using restriction endonuclease digestion and molecular
hybridization has revealed important information for virus groups which
cannot readily be typed in other ways or for which detailed genetic analysis
is required. The way is now clear for antigenic relatedness, genetic mapping
and pathogenesis to be compared and correlated.
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ABSTRACT
Norval, M., Michie, J.R., Apps, M.V., Head, K.W. and Else, R.E., 1985. Rumen papillomas
in sheep. Vet. Microbiol., 10: 219—229.
Out of a sample of 200 rumens from sheep slaughtered in Edinburgh, papillomas
were found in 25. They occurred as fibro-papillomas, mostly along the pillar of muscle
between the dorsal and ventral rumen, and were often multiple. No inclusion bodies
were seen in the lesions or papilloma virus particles on electron microscopy. Homoge-
nisation of papillomatous tissue followed by various methods of purification did not
yield identifiable virus particles, and viral DNA was not detected. Immunoperoxidase
staining showed a very small number of positive cells at or on the surface of 6 out of
10 lesions examined. Thus, it seems probable that virus particles are not found in large
numbers in the rumen papillomas of sheep, unlike the situation in ovine skin warts,
but are present in a few epithelial cells which are rapidly shed from the surface of the
mucous membrane.
INTRODUCTION
Cutaneous papillomas have been reported in a wide variety of species,
including man, and are particularly common in cattle. In sheep from the
British Isles they are very rare, but have been described in one report (Gibbs
et al., 1975). Warts were found on the limbs of 3 sheep and the muzzle
of another, and electron microscopic examination identified virus particles
in the lesions with typical papilloma morphology and size. In areas of
Australia with high sunlight levels, papillomas resembling verrucae vulgaris
and cornified horns have been described on the unwoolled areas of the
face and ears of sheep (Lloyd, 1961; Ladds and Entwistle, 1977; Vanselow
et al., 1982). Virions resembling papilloma virus particles have been detected
by electron microscopy after homogenisation of lesions (Vanselow et al.,
1982). In addition, hyperkeratotic scales which contained similar papilloma
0378-1135/85/$03.30 © 1985 Elsevier Science Publishers B.V.
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virus particles have been reported on the perineum of sheep (Vanselow and
Spradbrow, 1983).
There is now good evidence to link specific papilloma viruses with con¬
version of papillomas to carcinomas such as in the digestive tract of cattle
(Jarrett et al., 1978a), eyes of cattle (Ford et al., 1982) and cervix of man
(Durst et al., 1983). In sheep, cutaneous carcinomas are considered to
have similar precursor lesions, with sunlight as a possible co-factor in the
conversion (Vanselow et al., 1982; Vanselow and Spradbrow, 1983).
In addition to the skin, papillomas have been described in the rumen
of sheep where they occur as fibropapillomas with an epithelial component
and with complex branching and reuniting of rete pegs (Head, 1976). Papil¬
lomas are found in the alimentary tract only at this site, mainly in older
sheep and seldom undergo malignant transformation (Head, 1976); this
is unlike the situation in cattle. The ovine rumen is not often examined
in Britain during routine meat inspection, so the prevalence of papillomas
in this site is not known, nor is the cause. In a study of a flock of sheep
from N.E. Yorkshire, McCrea and Head (1978) noted rumen papillomas
in groups of up to 8 lesions, sometimes occurring with other types of
tumours.
The present investigation was undertaken to ascertain the frequency
of occurrence of sheep rumen papillomas, and to look for a papilloma
virus in these lesions.
MATERIALS AND METHODS
Clinical material
Rumens containing 1 or several papillomas were obtained from a variety
of sheep slaughtered in Edinburgh including Blackface, Halfbred and Border
Leicester breeds. Normally, these rumens were selected after washing by
the tripery attendant and transported to the laboratory 2—3 h later. A
macroscopic examination was then made and sections of suspected papil¬
lomas retained for histological tests. The remainder was stored at -70°C
until required. In a few cases the rumens were examined within a few min¬
utes of slaughter. Small pieces (about 2 mm3) of any papillomas found
were fixed immediately in 2.5% glutaraldehyde for subsequent ultra-struc¬
tural studies using a Philips 400 TEM, while the remainder was frozen
immediately in liquid nitrogen.
Preparation of homogenates and attempted purification of virus
The methods outlined by Gissmann and zur Hausen (1976) and Lancaster
et al. (1976) were used. About 15 g wet weight of warts, which usually
comprised 3 or 4 warts, was used. The same weight of normal tissue from
a different site in the same rumens acted as a negative control. After cen-
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trifugation in CsCl, the fractions with density 1.31—1.33 and 1.33—1.35
g ml"1 were pooled, diluted and centrifuged at 80 000 g for 2.5 h. The
drained pellet was suspended in 1 drop distilled water and stained with
uranyl acetate for examination in the electron microscope.
In addition to these methods, the procedure of Jarrett (W.F. Jarrett,
personal communication, 1981) for purification of bovine papilloma virus
was used. After homogenisation in Tris buffer containing 0.5% deoxycholate
and 0.5% NP-40, the suspension was layered on top of a 10—20% sucrose
gradient with a pad of CsCl of density 1.50 g ml"1 in the base, and cen¬
trifuged at 170 000 g for 20 min. The visible band at the interface was
collected and viewed in the electron microscope after dialysis or after
pelleting.
A further method used was to treat finely-minced wart tissue with
guanidine thiocyanate (Chirgwin et al., 1979). Wart tissue (6 g) from 1
specimen or several pooled together, or tissue from normal rumen was
homogenised by hand for a few seconds in 40 ml guanidine thiocyanate
solution and dialysed immediately against a large volume of 0.01 Tris-HCl,
0.15 M NaCl, 0.1 M EDTA, pH 8.0, at room temperature. The mixture
was centrifuged at 10 000 g for 10 min before being layered on the sucrose-
CsCl gradient as above. The band at the interface was collected and cen¬
trifuged in CsCl also as above. The fractions with density 1.32—1.34 gml"1
were pooled, diluted and centrifuged at 80 000 g for 2.5 h. The pellet was
suspended in 0.1 ml distilled water and stained with uranyl acetate for
examination in the electron microscope.
Extraction of viral DNA from warts
Viral DNA was extracted selectively from individual warts or pooled
warts (up to 5 g wet weight) using a modified Hirt procedure (Hirt, 1967)
as outlined by Orth et al. (1978), and purified by agarose gel electrophoresis.
In addition, the guanidine thiocyanate procedure of Chirgwin et al. (1979)
was tried. Viral DNA extracted from bovine skin warts was used as a positive
control and purified SV-40 DNA (a kind gift from Dr. A. Wyllie) as a mol¬
ecular weight marker.
Preparation of antisera
The method of Jensen et al. (1980) was followed using the CsCl-purified
material from 5 g pooled ovine warts or normal ovine rumen to act as a
negative control for each injection. New Zealand white rabbits were im¬
munised subcutaneously 3 times at fortnightly intervals; for the first in¬
jection the material was emulsified with Freund's complete adjuvant and
for the next 2 with Freund's incomplete adjuvant. The rabbits were bled
2 weeks after the final injection. Removal of cross-reacting antibodies




Paraffin sections of ovine rumen warts and normal rumen from the
same animal were prepared and the immunoperoxidase method carried
out as outlined by Mukai and Rosai (1980). Endogenous peroxidase was
blocked with 3% H202 in absolute methanol and non-specific background
reactions were blocked with normal porcine serum at a dilution of 1/5.
The rabbit antisera were used at dilutions of 1/50. The immunoperoxidase
staining was done using a DAKO PAP kit followed by a counterstain with
Harris's haematoxylin.




Incidence and morphology of rumen papilloma
A survey of 200 rumens from a variety of adult ewes slaughtered in
Edinburgh showed that 25 had papillomas. Due to the system of killing,
it was not possible to break down these figures into distribution in individual
flocks, geographical areas and breeds.
One hundred rumens containing papillomas have been examined in
detail to ascertain the nature and number of lesions. Most (88%) occurred
along a pillar of muscle between the dorsal and ventral rumen (Fig. 1) and
the remaining 12% were found elsewhere in the rumen, especially in areas
showing evidence of either current or past-healed rumenitis. Papillomas
occurred singly or in multiple numbers. The average number per rumen,
of those which contained papillomas, was 4.9 and the distribution is shown
in Fig. 2. In 21 cases out of the 100 examined there was a prominent papil¬
loma and several smaller ones nearby. Macroscopically the papillomas were
classified as pedunculate (joined by a stalk to the mucosa of the rumen)
or sessile (no stalk), and were found in the proportion of 2 : 1 approxi¬







Fig. 2. The number of papillomas per rumen found in a survey of 100 papilloma-con-
taining rumens of sheep.
Sections were cut for histological studies from a variety of 500 papil¬
lomas. In all but 4 instances, these were found to be fibro-papillomas with
a branching central core of coarse collagenous connective tissue. The epi¬
thelium overlying the stroma was of similar thickness to that of the normal
rumen, but showed excessive complex branching and reuniting of the rete
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Fig. 3. Paraffin section of typical ovine rumen papilloma (haematoxylin and eosin,
X 125).
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pegs (Fig. 3). Epithelial cells seemed normal except for a few showing
hydropic change. Keratinization was similar to the rest of the rumen as
was a light and patchy infiltration of various leukocytes under the epi¬
thelium. Eosinophilic inclusion bodies were seen in over 30% papillomas
examined, being present in cytoplasmic vacuoles within epithelial cells
which showed hydropic change. No intranuclear inclusion bodies char¬
acteristic of papilloma virus infection were present. Normal papillae showed
delicate connective tissue with large thin-walled blood and lymphatic vessels.
The epithelium was thin with short stubby rete pegs. Small papillomas
with diameters less than 4 mm were found to have similar structure to
large, apparently normal, papillae suggesting a possible transition from
these to papillomas.
In one specimen, an early squamous cell carcinoma was present in a
lesion which grossly resembled a typical fibropapilloma. In 3 cases from
different rumens, a squamous papilloma was present in addition to the
fibropapillomas. These had very small delicate connective tissue cores
which branched markedly giving long finger-like projections which were
covered by stratified squamous epithelium. No mitotic figures or inclusions
were seen.
Electron microscopic examination of thin sections of 30 rumen papil¬
lomas demonstrated enlarging and actively growing epithelial cells in
the germinal and spinous layers with increase in tonofibrils and desmo-
somes. The degenerating cells in the spinous layer showed a loss of tono¬
fibrils, detachment of desmosomes, focal necrosis, vacuoles in the cyto¬
plasm and condensed marginated chromatin. These changes were more
evident in the stratum corneum. Particles with the structure of papilloma
viruses were never seen, either in crystalloid arrays or singly.
Purification ofpapilloma viruses and viral DNA
The papillomatous tissue from the rumen was found to be very tough,
fibrous and difficult to disaggregate. Several methods were used, and a
total of 20 preparations made. In addition, in case the conditions of col¬
lection and storage of the specimens were not optimal, one preparation
used papillomas obtained within a few minutes of slaughter, frozen im¬
mediately in dry ice and stored at -70°C until homogenised. Particles were
never observed with the morphology of papilloma viruses in the electron
microscope after negative staining with uranyl acetate.
If guanidine thiocyanate was used to disaggregate the tissue, 2 out of
5 rumen papilloma preparations were found to contain very small numbers
of particles. These had a consistent diameter of about 35 nm, but were
apparently without capsomeres on the surface. They were not thought
to represent papilloma virus particles although no such particles were found
in the other 3 specimens, or in preparations from normal rumen treated
in the same way. Human papilloma virus type 1, purified on CsCl gradients
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from skin scrapings of plantar warts, showed some disruption of structure
on electron microscopy after guanidine thiocyanate treatment for 10 s,
followed by dialysis, although the particles were still recognisable as ico-
sahedral and had indentifiable capsomeres.
DNA has been extracted from a few human genital warts and supercoiled
DNA with molecular weight typical of papillomas isolated on agarose gels
(Gissmann and zur Hausen, 1980). This was tried with individual warts,
ovine rumen warts of varying morphology and with pooled warts, altogether
over thirty being examined. No DNA with molecular weight of papillomas
was detected on agarose gels. Viral DNA extracted by the same methods
from bovine skin warts gave bands of Form I, II and III DNA on agarose
gels after ethidium bromide staining.
Fig. 4. Section of ovine rumen papilloma (immunoperoxidase and haematoxylin, X 675).
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Immunoperoxidase staining of ovine rumen papillomas
An antiserum was prepared to the putative ovine rumen papilloma virus
and used in an immunoperoxidase test on paraffin sections of rumen papil¬
lomas and normal rumen tissue. Ten specimens of warts were used, and
4 sections from each were examined. The warts varied in their pathology
from sessile to pedunculate and in size from 2 to 35 mm. Six showed some
reaction with the antiserum prepared against the ovine rumen papillomas
and none stained with the antiserum against the normal rumen. On average,
1—3 peroxidase-stained dark brown epithelial cells were seen in each section
in the keratinized upper layer on the surface of the papilloma section (Fig.
4). In addition, there were also clusters of 3—5 cells showing light brown
cytoplasmic staining in the upper layers of the epithelium. Often these were
found in areas where there was hydropic change. No brown cells were found
in the deeper epithelial layer or in the central core of connective tissue.
Papillomas which showed a positive immunoperoxidase result could not be
distinguished from those giving no staining on the basis of their size, shape or
histopathology. There was no staining of sections of normal rumen using
either antiserum.
DISCUSSION
Only one report has indicated the presence of cutaneous warts in sheep
in Britain and such lesions are known to be rare (Gibbs et al., 1975). This
present survey of sheep slaughtered in Edinburgh showed the incidence
of papillomas in the rumen to be 12.5%. The most common site was at
the entrance of the ventral rumen where cuts and abrasions are most likely
to occur. Multiple foci of papillomas were found frequently, there often
being one large wart and several smaller ones. These observations may
suggest an infectious aetiology for rumen papillomas with transmission
by direct inoculation through minute abrasions of the surface as has been
postulated for other papilloma viruses (Andrewes et al., 1978), and poten¬
tial spread from an initial site of infection.
The histopathology of these warts showed them to be predominantly
fibropapillomas and thus similar to the bovine oesophageal papillomas
(Jarrett et al., 1978b). In cattle there is frequent conversion of multiple
alimentary papillomas to carcinomas if bracken fern (Pteridium aquilinum),
which may contain carcinogens or act as an immunosuppressive agent,
is present in the diet (Jarrett et al., 1978a). The majority of sheep slaugh¬
tered in Edinburgh are grazed on bracken-infected moorlands in Scotland
and the north of England but, during this work, conversion of rumen papil¬
lomas to carcinomas was found on only 1 occasion. However, it is interesting
to note that the prevalence of adenocarcinoma of the small intestine in
sheep slaughtered in Edinburgh has been estimated at 0.2% (J. Norval,
personal communication, 1981). Also a survey of tumours occurring in
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sheep grazing on the moors in North England has revealed several cases
of rumen papillomas occurring in conjunction with adenocarcinoma of
the small intestine (McCrea and Head, 1978).
In this study, no virus particles were detected after electron microscopy
of thin sections of ovine rumen warts or after mechanical homogenisation
and purification on CsCl gradients. After disruption of the tissue with
guanidine hydrochloride, very small numbers of particles were seen in 2
instances which were not thought to represent papilloma viruses. In several
other papillomas, such as human laryngeal warts (Lack et ah, 1980) and
Condylomata acuminata (Oriel and Almeida, 1970), virus particles have
either not been seen at all or are present in very small numbers.
Viral DNA was not detected in any lesion. In 6 out of 10 papillomas,
a few cells reacted with an antiserum raised against the putative ovine rumen
papilloma virus. These cells were found on or near the surface of the epi¬
thelium, a situation similar to that found by Quick et al. (1980) and by
Woodruff et al. (1980), when looking at human genital warts.
It is possible that a virus-producing cell may be shed rapidly from the
surface of the mucous membrane. This would result in low quantities of
viral nucleic acid and low numbers of virions being present at any one
time, and would explain the results obtained here. It may be necessary
in the future to resort to the sensitivity of restriction endonuclease digestion
of cellular DNA followed by Southern blot techniques to detect viral DNA
in ovine rumen papillomas. For this a specific ovine papilloma viral genome
would be preferred as a nucleic acid probe, which could be prepared from
cutaneous papillomas on sheep from Australia. This could also be used
to examine the rumen papillomas for the presence of viral nucleic acid
in the various layers of the epithelium and in the adenocarcinomas of the
small intestine by in situ hybridization.
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Short title: Urocanic acid suppresses DTH to HSV-1 in mice.
Abstract
UV-radiation is known to induce a transient defect in
epidermal antigen presentation which leads to the generation of
antigen-specific suppression of the delayed type
hypersensitivity response. The putative receptor in skin for
the primary event in UV-suppression is urocanic acid which may
then interact locally, or systemically, with antigen presenting
cells or initiate a cascade of events resulting in suppression.
We present the first direct evidence that urocanic acid, when
_2
irradiated with a dose (96mJcm ) of UV-B light known to
suppress the DTH response to HSV-1 in mice, can induce
suppression following epidermal application or subcutaneous
injection of the irradiated substance. This suppression is
transferable with nylon wool-passed spleen cells.
Abbreviations used:
UV ultraviolet, CMI cell mediated immunity, LC Langerhans
cell, DTH delayed type hypersensitivity, UCA urocanic acid, TNCB
trinitrochlorobenzene, HSV-1 herpes simplex virus, type 1, APC
antigen presenting cell, DMSO dimethylsulphoxide, UV-UCA




Ultraviolet (UV)-B irradiation has been shown to depress
cell-mediated immunity (CMI) to tumour (1), skin sensitising (2)
and viral (3) antigens encountered epidermally within a critical
period after exposure. Although both the numbers and
morphology of Langerhans cells (LC) in the skin are affected by
UV-irradiation (4) and therapeutic UV-regimes (5), recent work
has indicated that maximum suppression of the delayed type
hypersensitivity (DTH) response occurs at different wavelengths
from those directly affecting LC (6,7). These findings have been
employed as support for the proposal of De Fabo and Noonan (8)
that there is release of a photoproduct, the cis-isomer of
urocanic acid (UCA), following UV irradiation of skin which may
then interact with the cells of the immune system to induce
suppression. Preliminary evidence from these workers (9)
indicates that the DTH response to the contact sensitising agent
trinitrochlorobenzene (TNCB) in mice deficient in epidermal
urocanic acid cannot be suppressed by UV-B irradiation.
Previous reports from this laboratory have indicated that
the DTH response to herpes simplex virus, type 1 (HSV-1) in a
murine model can be suppressed by irradiation of the mice with 96
-2
mJcm of UV-B light 3 days before sensitisation with live virus
(3). The suppression of the efferent DTH response is mediated
by two phenotypically distinct, Lyl+2 and Lyl 2+, T cells (10).
Epidermal APC from such mice have a reduced ability to present
HSV-1 antigens to T helper cells in vitro (11). In this paper
we investigate the possible role of urocanic acid as a factor in
2.




Mice - The two initial experiments were carried out using female
CBA/CA mice aged 10-12 weeks obtained from the Faculty of Medicine
Animal House. In all subsequent experiments C3Hf Bu/Kam male
mice aged 10-12 weeks were used. The C3H mice were bred in the
Department of Bacteriology animal house and all the mice
maintained there.
Virus - The virus used throughout was a clinical isolate of HSV-1
whose DNA has been analysed using restriction endonucleases.
The virus was cultured in Vero cells and assayed for
plaque-forming units (pfu) per ml as described previously (3,10).
DTH assay - This has been described previously (3, 10).
Briefly, mice were sensitised by subcutaneous injection in the
right flank with 5 x 10^ pfu HSV-1 grown in Vero cells. Control
4
mice were either sensitised with an equivalent number (10 ) of
sonicated, uninfected Vero cells or, in some experiments, not
sensitised. The mice were tested for DTH to HSV-1 between 8 and
10 days after sensitisation. Ear thicknesses were measured
before the mice were challenged by injecting 10pl (10^ pfu) of
UV-inactivated virus into each ear pinna. The ear thicknesses
were again measured twenty-four hours later and the DTH
calculated as the average ear increase per mouse. Suppression
of DTH was determined by the formula:
% suppression = 100 - 100 x net increase of experimental mice
net increase of control mice
as described by Noonan et al (6).
Induction of suppression - To induce suppression of DTH to HSV-1,
mice were irradiated for 20 minutes under two Philips TL20W/12
2
bulbs which gave a dose of 96mj/cm on the shaved backs of the
mice as described previously (3).
Urocanic acid (Sigma (UK) Ltd.) was dissolved in a small
volume of dimethylsulphoxide (DMSO) at 37°C for 5 minutes at a
maximal concentration of 40 mg/ml, then diluted 10-40 fold in
sterile physiological saline. This solution was poured into a
large Petri dish to give a thin layer and irradiated for 20 min
as for the mice. The irradiated solution was then diluted in
saline as required. The UV-irradiated UCA (UV-UCA) was either
painted onto the shaved, tape-stripped flanks of mice or
injected subcutaneously. Four tape strips were administered
using a single batch of Sellotape. The same site was used for
the administration of the sensitising dose of HSV. Other mice
were treated in a similar manner but using non-irradiated UCA,
the vehicle or irradiated vehicle only.
Isomerisation of UCA - Nuclear magnetic resonance (NMR)
spectroscopy was employed to determine the amount of UCA
isomerised from the trans to cis form on irradiation as above.
For this procedure the UCA was dissolved in a small volume of
deuteriated DMSO at 37°C for 5 minutes then diluted in a large
volume of deuterium oxide (D^O) to a final concentration of 1
mg/ml before irradiation. The two isomers were identified
from the coupling constants of the olefinic protons and their
amount from the changes in the amplitude of the olefinic
proton signals in the NMR. The samples were run on
5.
a Bruker WP 80 SY nuclear magnetic resonance spectrophotometer.
Cell transfers - Cells from spleens of HSV-1 sensitised mice which
had been injected with UV-UCA 5 hours before sensitisation were
enriched for T cells by passage over nylon wool columns (12).
The collected cells were injected intravenously into recipient
mice 24 hours before ear challenge with HSV-1 as described
previously (10).
Results
1. UV-induced isomerisatlon (trans-cis) of PCA
A time course for the isomerisation of UCA on irradiation is
shown in Fig. 1. Initially there was no detectable cis-form but
this was present at 24% after 20 minutes, rising to 45% at 1
hour and 74% at 4 hours. The isomer was stable on storage at
room temperature, there being no reversal to the trans-form after
6 weeks. In subsequent experiments UCA irradiated for 20
minutes was used.
2. UV-irradiated urocanic acid suppresses DTH to HSV-1
This first experiment was to determine whether UV-UCA could
induce suppression of the DTH response when administered 3 days
or 5 hours before sensitisation with the amount normally present
in the irradiated area of skin (13). Table 1 shows that UV-UCA
induced marked suppression in CBA mice whether the chemical was
painted onto shaved, tape-stripped skin or injected
subcutaneously 5 hours or 3 days before sensitisation. Maximum
suppression (57%) of the DTH response occurred when UV-UCA was
injected 5 hours before a sensitising dose of HSV-1 administered
at the same site. Injecting the vehicle in which the UCA was
dissolved had no effect.
3. Spleen cells can transfer the UV-UCA suppression of efferent
DTH to HSV-1
In order to determine the nature of the suppression induced
by UV-UCA, nylon wool-passed spleen cells from UV-UCA suppressed
mice (Group 5, Table 1) were transferred to syngeneic animals
which had been sensitised with live virus 8 days previously.
7.
Table 2 indicates that UV-UCA induced suppression of DTH to HSV-1
was transferable with nylon wool-passed spleen cells.
4. Comparison of UV-UCA and non-irradiated PCA
The effects of injecting the trans-form of UCA and of
supplementing UV-irradiation of C3H mice with UV-UCA on the DTH
response were examined. Table 3 indicates that there was no
increase in suppression over UV-UCA alone when both UV and
UV-UCA were administered together. Non-irradiated UCA had a
suppressive effect on the DTH response to HSV-1 but to a lesser
extent than the same quantity of UV-UCA.
5. Calibration of the suppressive effect of UV-UCA on the DTH
response to HSV-1
To determine whether there was a relationship between the
amount of UCA or UV-UCA administered and the quantity of
suppression achieved, a series of dose response experiments were
carried out. Representative experiments are shown in Table 4.
Experiment 1 indicates that the suppression achieved by
injecting UV-UCA was titratable but there was reduced suppression
at the highest concentration of UV-UCA used. As before there
was a lesser suppression of DTH using non-irradiated UCA compared
to UV-UCA. The suppression of the DTH response generated by
UV-B and 100 pg of UV-UCA was of a similar order.
Experiment 2 indicates that there was a titratable
suppressive effect using small doses of UV-UCA (3 pg - 100 pg) .
Again, non-irradiated UCA had a suppressive effect but less than
the same dose of UV-UCA. The amount of suppression achieved by
100 pg of UCA was similar to that induced by 3 pg of UV-UCA.
8.
Nylon wool-passed spleen cells from UV-UCA treated mice from a
previous experiment could transfer efferent suppression of the
DTH response. The irradiated vehicle on its own had no effect
on the DTH response (data not shown).
9.
Discussion
Although UV-B irradiation is known to affect the APC
function of the skin (11, 14, 15) and other organs (16) the
mechanism by which the alteration in antigen handling occurs is
unknown. Urocanic acid, a major component of the stratum
corneum, is formed through the deamination of histidine by the
enzyme histidase. Further catabolism of UCA does not occur in
skin (13) as the enzyme urocanase, present in liver, is absent.
UCA undergoes a UV-dependent trans to cis isomerisation (17).
The action spectrum of this isomerisation shows a close fit with
the action spectrum for the UV-induction of systemic suppression
of contact hypersensitivity (8) and has implicated UCA in the
mechanism of UV-suppression. The present paper provides the
first direct evidence that the cutaneous or subcutaneous
administration of the cis-isomer of urocanic acid can influence the
DTH response of mice to antigens which are encountered
epidermally shortly thereafter. Early evidence also indicates
that this suppression is transferable with nylon wool-passed
spleen cells. The evidence lends support to the hypothesis of
De Fabo and Noonan (8) that the putative photoreceptor for UV-B
suppression in skin is UCA. This evidence, however, does not
preclude the influence of several interacting factors in the
mechanism of UV-suppression.
Noonan and colleagues (6) and Morison et al (7) have
elegantly demonstrated that systemic suppression of DTH to a
contact sensitiser is almost certainly not generated by a
UV-induced loss of LC from the UV-irradiated site or by an
10.
alteration in LC morphology. However, it is possible that
there may be a local interaction of UV-UCA with APC in the skin
resulting in altered handling of antigens. This is attractive
from the point of view that the soluble photoisomer, cis-UCA,
must presumably be released from the cells of the stratum
corneum and could interact locally with APC which would then
generate a systemic suppressive response. An alternative
possibility is that UV-UCA may diffuse from the epidermis to
interact with the immune system at a distant site.
Our previous work indicates that a lapse of 5 hours between
UV-B irradiation and sensitisation with HSV-1 is not sufficient
for the initiation of a suppressed response whereas the
application or injection of UV-UCA 5 hours before sensitisation
is sufficient for the generation of a suppressed DTH response.
We are at present addressing the question of the direct effect
of UV-UCA on the functional ability of APC in vitro and in vivo.
NMR spectroscopy indicates that less than 1% of UCA as
supplied is of the cis-form; this proportion, however, may be
physiologically relevant although it is at the limit of
resolution of the NMR technique. Also, increasing doses of
non-irradiated UCA can increase the suppression induced. UV
irradiation for 20 minutes significantly increases the proportion
of the cis-form of UCA yet when very large doses (800 pg) of
UV-UCA are administered the suppression is less than when lower
doses (100 - 200 pg) are employed. Here, competitive inhibition
may be important when very large amounts of trans-UCA are
present.
11.
Unlike Baden and Pathak (13) and others (17) whose early
work indicated that the UV-induced isomerisation of UCA tails off
as the amount of cis- and trans-isomers approaches equality our
NMR spectra indicate that isomerisation under the conditions we
describe continues until, at 4 hours, 74% of the UCA is of the
cis- form. We propose to purify this cis- UCA and to employ it
to investigate further its interaction with the cells of the
immune system in the physiological range with less interference
from exogenous trans-UCA. Adoptive transfer experiments are
also in progress to further characterise any population of
immune cells generated by UV-UCA treatment.
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Fig. 1 A representative experiment showing the time course for
the isomerisation (trans- cis) of urocanic acid.
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1.
Antigens encountered by the skin induce delayed
hypersensitivity (DH) reactions on subsequent exposure. DH to the
epidermal virus herpes simplex type one (HSV-1) protects animals
1 2
from lethal infection ' . We have been studying the role of
antigen presenting cells (APCs) in the generation of DH to HSV-1 and
its modulation by the environmentally encountered epidermal stimulus
ultraviolet-B (UV-B) irradiation. Experimentally UV-B affects APCs
3 A- 5 6
locally and systemically , induces T suppressor (Ts) cells for DH '
and alters HSV-1 pathogenesis by acting as a trigger for
7 8
recrudescence in experimental and natural infections. In a
murine model we reported that UV-B irradiation followed by HSV-1
9
infection suppresses DH to the virus in vivo and decreases the
ability of epidermal cells to present HSV-1 in vitro^. Here we
report that transfer of epidermal cells from UV-B irradiated
animals to naive syngeneic recipients together with live HSV-1 is
sufficient to induce T cell mediated suppression of DH.
The first set of experiments (shown in Table 1) demonstrate
that epidermal cells from mice irradiated 3 days previously and
transferred to naive syngeneic recipients together with live HSV-1
at the same site induced suppression of DH to the virus. The
same cells given simultaneously with the virus but at a different
site did not cause suppression, nor did the administration of
epidermal cells from non-irradiated mice. Thus it appears that
external modulation of the cells involved in local antigen
presentation to the immune system can determine whether DH or
suppression of DH to HSV-1 is generated in otherwise untreated
2.
animals.
Table 2 shows that the suppression generated in this way is
transferable by nylon wool passed spleen cells. The
suppression is of the efferent DH to HSV-1 and is specific for
HSV as the response to the unrelated Semliki Forest virus (SFV)
is not affected. The fine specificity of the suppression
against other herpes viruses is under investigation and will be
reported elsewhere.
To determine the nature of the T suppressor (Ts) cell(s), two
sets of cell transfer experiments were performed. The first set
utilised the monoclonal antibodies TIB104 (anti-Lyl) and TIB105
(anti-Ly2) and the results are shown in Table 3. As these antibodies
are not cytotoxic, an indirect killing system was employed. Using
the same system we have previously reported that the Ts cells induced
by UV-B irradiation followed 3 days later by infection with HSV-1 are
of two phenotypically distinct subclasses (Lyl+2 and Lyl 2"1")''''''.
Interestingly, the suppressor cells induced by transfer of UV-B
irradiated epidermal cells belonged only to the Lyl+2 subclass - the
more "classical" Ts cell population Lyl 2+ was absent.
To further clarify the nature of the suppressor cells a series
of monoclonal antibodies directed against L3T4 (the "helper cell"
determinant), Ly2 and Thyl was employed. These antibodies are all
directly cytotoxic. The results of these experiments can be seen
in Table 4. The Ts population was defined as Thyl+, L3T4+, Ly2 .
Other workers have described Ts cells for DH to HSV-1 induced
by intravenous injection of either temperature sensitive mutants of
3.
HSV-1, where Lyl+2 Ts cells suppressed afferent DH to HSV-1^ or
thymidine kinase deficient mutants of HSV-1 where both Lyl+2 and
Lyl 2+ Ts cells suppressed afferent DH to the virus'''. DH to
HSV-1 in both systems was induced by subcutaneous infection with
live unattenuated HSV-1.
12
Shrier et al also demonstrated that different populations of
Ts for DH to HSV-1 could be induced by different presentations of
antigen. A temperature sensitive mutant of HSV-1 injected
intravenously induced Ts cells which would only suppress afferent DH
to the virus. However, intravenously injected syngeneic spleen cells
infected with the same virus in vitro induced Ts cells capable of
suppressing both afferent and efferent DH to HSV-1. We are
investigating whether Ts cells generated in our system suppress
afferent as well as efferent DH to HSV-1 and the results will be
reported elsewhere.
2
High dose (660 mj/cm ) in vitro UV-B irradiation of
dissociated epidermal cells has been used to reveal the presence
of I-J+ cells which act as APCs for the generation of Ts cells
13
of DH to the hapten ABA . However, in this system the Ts
cells suppressed afferent but not efferent DH to ABA. We are
currently investigating the cells in the epidermis of UV-B
irradiated and normal mice using flow cytometry in an attempt to
elucidate the nature of the APCs in our system.
In conclusion we have previously demonstrated that UV-B
irradiation in vivo alters antigen handling by the epidermis such
that Ts cells for DH to HSV-1 are generated. Two suppressor T cell
populations Lyl+2 and Lyl 2+ were demonstrated. The present
report demonstrates that the ability to induce the Lyl+2 but not the
Lyl 2+ population can be transferred by inoculating naive syngeneic
recipients with UV-B irradiated epidermal cells at the same site and at
the same time as HSV-1. The full phenotype of this Ts cell is Lyl+2
L3T4+ Thyl+. We are presently investigating the nature of UV-B induced
signal which may induce the other Ts population as well as the nature of
the APCs involved in the Ts generation.
Our model is unique in that the same virus was used to induce
either DH or Ts for DH and represents a wild type clinical isolate
of HSV-1. Similarly, in the epidermal cell transfer experiments
reported here the recipient mice in which DH or Ts for DH to HSV-1
are induced are identical and otherwise untreated. The only
experimental parameter which varies is the application of an
external suberythemal dose of UV-B light. This irradiation is
sufficient to alter the antigen handling by epidermal cells in such
a way that the immune system specifically generates Ts for DH rather
than DH itself. The implications of such a mechanism affecting the
generation of specific immunity to epidermal pathogens particularly
those which, like HSV-1, persist in the host after initial infection
may be profound.
This work was funded by the Medical Research Council of
which S.H. is a Senior Fellow.
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Table 1 UV-B irradiated epidermal cells inoculated at the same site as HSV-1
induces suppression of DH to the virus.
Animals sensitised Increase in ear thickness
_2
(units x 10 mm) and % suppression of DH
with (day 0) Experiment 1 Experiment 2 Experiment 3
104 Vero 3.02+0.40 (n=ll) 5.10+0.73 (n=5) 3.04+0.41(n=ll)












R flank 15.13+1.30 (n= 4) 0% 10.81+1.28e(n=4) 33% 14.70+1.47(n=6)
UV-B EC L flank3
+ 10 HSV-1 R flank 14.70+1.09 (n= 5) 0% 10.35+0.82e(n=5) 29% ND
UV-B EC R flank3
+ 10 HSV-1 R flank 7.80+0.46° (n= 5) 57% 6.00+0.73°(n=5) 88% 6.83+1.64d(n=3) f
All mice challenged on Day 8. Results expressed as arithmetic mean + 1 standard error,
n = number of experimental animals per group
a, number of epidgrmal cells (EC) transferred in Experiment 1 = 5 x 10^, in
Experiment 2 = 10 , in Experiment 3 = 5 x 10 .
b, significantly different from control group, p <0.01 by t test
c, as for b, p <0.001
d, as for b, p <0.02
e, not significantly different from control group
LEGEND TO TABLE 1
Inbred female C3Hf Bu/Kam mice aged between 10-16 weeks, bred and maintained in
the Departmental Animal House were used in all experiments.
The methods for determining DH and for separating epidermal cells have all
9 10
been published elsewhere ' . Briefly HSV-1 grown in Vero cells (control
group) or an equivalent number of uninfected cells (background group) were
injected into mice subcutaneously in the right flank. 8-10 days later ear
thickness was measured and the animals challenged by injection of 10pl
6
containing 10 plaque forming units (pfu) of UV inactivated HSV-1 into each ear
pinna. After 24 hrs. ears were again measured and the increase in thickness
calculated. To induce UV-B suppression of DH mice were irradiated with 96
_2
mJcm UV-B (equivalent to 20 minutes exposure under two Philips TL20/12 bulbs
in our system) 3 days before infection with HSV-1. For EC transfers ears were
removed from normal animals or from animals which had been irradiated as above
3 days previously. The ears were split open and floated on 0.3% trypsin for 1
hr at 37°C. The trypsin was then removed by washing in phosphate buffered
saline (PBS) and inactivating with 10% FCS. The epidermal sheets were
separated using forceps. Single cell suspensions were made by shaking the
epidermal sheets vigorously in PBS + 10% FCS in universal tubes containing
glass beads. The resulting cell suspension was strained through a wire mesh.
The cells were washed in PBS + 10% FCS and layered onto a discontinous
20%/50%/70% Percoll gradient. The cells at the 20%/50% interface were 80-85%
viable by trypan blue exclusion and were used for the cell transfers. The
cells were either mixed with HSV-1 immediately before injection into the right
flank or were injected into the left flank while HSV-1 was injected into the
right flank. DH was measured as above. Suppression of DH was calculated
according to the formula :
% suppression = 100 - 100 x net increase in experimental mice
net increase in control mice
Table 2 The DH suppression induced by EC transfer is transferable by nylon
wool passed spleen cells and is HSV specific.
Animals sensitised Animals transferred Animals challenged Increase in ear thicknes
with (Day 0) with (Day 9) with (Day 10) (units x 10 mm) and %
suppression of DH
104 Vero NIL HSV-la 4.03 + 0.63 (n = 8)
1.5 x 106 pfu HSV-1 NIL HSV-1 15.82 + 0.62 (n = is:
UV-B 3 days previously
1.56 x 10 HSV-1 NIL HSV-1 7.22 + 0.39b(n = 8)
5 x 105 UV-B EC R flank
1.5 x 10 HSV-1 R flank NIL HSV-1 7.25 + 0.69b(n = 6)
1.5 x 106 HSV-1 107 NW spleen0
(UV-B EC + HSV-1)
HSV-1 8.59 + 0.58b(n = 8)
104 BHK NIL SFVd 5.59 + 0.62 (n = 8)
5 x 106 pfu SFVe NIL SFV 16.16 + 0.64 (n = 14:
UV-B 3,days previously
5 X 106 SFV NIL SFV 6.09 + 0.37b(n = 8)
5 x l(n UV-B EC R flank
5 x 10 SFV R flank NIL SFV 7.06 + 0.54b(n = 8)
5 x 106 SFV 107 NW spleen0
(UV-B EC + HSV-1)
SFV 16.31 + 0.52 (n = 8)
a - mice challenged with
0
10 pfu UV-inactivated HSV-1 in both ear pinnae
b - significantly different from control group (p < 0.001 by t test)
c - mice injected with spleen cells from mice suppressed for HSV-1 DH by epidermal cell ti
(cells passed through nylon wool)
d - mice challenged with 5 x 10b pfu UV-inactivated SFV in both ear pinnae
0
e - mice sensitised with 5 x 10 pfu UV-inactivated SFV subcutaneously in the right flank
LEGEND TO TABLE 2
DH for HSV-1 was induced and suppressed by either UV-B exposure 3 days
before infection or by transfer of UV-B exposed EC at the same site and
time as HSV-1 infection as described in Table 1. DH to Semliki Forest
virus (SFV) was induced in an identical fashion with the exception that
UV-inactivated rather than live virus was used to sensitise the mice. The
SFV was passaged in vitro in BHK cells. Spleens were removed from mice
suppressed for DH to HSV-1 by UV-B EC transfer as above 9 days after
sensitisation. The spleens were homogenised and the cells passed over
14
nylon wool columns using the method of Julius et al . The cells
recovered from the columns were > 95% Thy-1 positive by immunofluoresence.
The nylon wool passed spleen cells were injected intravenously into mice
sensitised with either HSV-1 or SFV and the mice were challenged with the
appropriate virus within 24 hours. DH to SFV and HSV-1 was measured 24
hours after challenge.
Table 3 The suppression of efferent DH induced by EC transfer is transferable
by nylon wool passed (NW) spleen cells of the Lyl 2 phenotype.
Animals sensitised Animals transferred
with (day 0) with (day 9)
_2
Increase in ear thickness (units x 10 mm)
and % suppression of DH
Experiment 1 Experiment 2
10 Vero NIL 1.84+0.35 (n=8) 3.48+0.48 (n= 6)
3 x 10 pfu HSV-1 NIL 16.10+1.08 (n=8) 14.61+1.12 (n= 9)
UV-B 3fidays previously
3 x 10 HSV-1 NIL 6.80+1.04e(n=8) 65% 5.23+0.45e(n=ll) 84%
10 UV-B EC R flank
3x10 HSV-1 R flank NIL 7.80+1.24e(n=8) 58% 6.33+0.69e(n= 6) 74%
3 x 10 HSV-1 5 x 10^ NW spleen3
RIG + C only 8.40+1.16e(n=8) 54% 7.22+0.69e(n= 8) 66%
3 x 10 HSV-1 5 x 10^ NW spleen^*
Ly 1 (TIB 104) 14.56+1.03 (n=8) 11% 13.62+0.68 (n= 8) 9%
3 x 10 HSV-1 5 x 10^ NW spleenC
Ly 2 (TIB 105) 8.25+0.90e(n= 8) 55% 7.68+0.85e(n= 7) 62%
3 x 10 HSV-1 5 x 10^ NW spleen^
Lyl + Ly2 ND 15.84+1.16 (n= 8) 0%
All mice challenged on Day 10.
n = number of experimental animals per group
a, mice injected with spleen cells from mice suppressed by epidermal-cell-transfei
all passed through nylon wool and treated with anti-rat immunoglobulin and compleme
alone.
b, as in a, but cells also treated with anti Ly 1 monoclonal antibody TIB104
c, as in a, but cells also treated with anti Ly 2 monoclonal antibody TIB105
d, as in a, but cells also treated with both TIB104 and TIB105
e, significantly different from control group, p <0.001 by t test.
LEGEND TO TABLE 3
DH and UV-B or UV-B-irradiated-epidermal-cell-transfer
suppression of DH was induced and measured as in Table 1. The
methods used for treating nylon wool passed spleen cells with the
monoclonal antibodies TIB104 and TIB105 (from the American Type
Culture Collection) have been published elsewhere"'''''. Briefly,
since these rat monoclonal antibodies are not directly cytotoxic
an indirect killing method was used. Nylon wool passed spleen
cells were incubated with the appropriate monoclonal(s) or in
PBS containing 5% FCS for 1 hr on ice, the cells were then
washed x 3 and incubated with anti-rat immunoglobulin antiserum
for 45 minutes on ice, the cells were again washed extensively
and finally incubated with complement for 30 minutes at 37°C.
After the final incubation the cells were washed and the number
of viable cells counted by trypan blue exclusion. Viable cells
were injected intravenously into mice which had been infected
with HSV-1 nine days previously.
Table 4 The transferable suppressor cell is a T cell of the L3T4+Ly2 Thyl+
phenotype.
_2
Animals sensitised Animals transferred Increase in ear thickness (units x 10 mm)
with (day 0) with (day 9) and % suppression of DH
Experiment 1 Experiment 2
104 Vero NIL 4.56+0.79 (n=8) 3.33+0.17 (n=6)
3 x 106 pfu HSV--1 NIL 15.05+0.84 (n=10) 14.15+1.10 (n=5)
UV-B 3 days previously
3 x 10 HSV-1 NIL 6.95+1.13f(n= 5) 77% 6.54+0.75S(n=6) 70%
5xl05 UV-B EC R
3 x 10 HSV-1 R
flank
flank NIL 7.20+0.45s(n= 6) 75% 8.35+0.23g(n=5) 54%
3 x 106 HSV-1 5 x lO^NW spleen3
untreated 7.14+1.1lg(n=7) 75% 7.86+0.62s(n=7) 58%
3 x 106 HSV-1 5 x lO^NW spleen^
L3T4 (YTS 191.1) 13.47+1.llS(n=8) 15% 13.30+1.28 (n=7) 8%
3 x 106 HSV-1 5 x lO^NW spleenC
Ly2 (YTS 169.4) 6.38+0.48g(n=8) 83% 7.96+0.49g(n=6) 57%
3 x 106 HSV-1 5 x lO^NW spleen^
L3T4 + Ly2 14.64+0.95 (n=7) 10% 14.42+0.66 (n=6) 0%
3 x 106 HSV-1 5 x lO^NW spleen6
Thy-1 (YTS154.7) ND 14.58+0.95 (n=6) 0%
All mice challenged on Day 10.
n = number of experimental animals per group.
a, mice injected with spleen cells from mice suppressed by epidermal-cell-
transfer; cells passed through nylon wool.
b, as in a, but cells treated with anti-L3T4 monoclonal antibody YTS191.1
c, as in a, but cells treated with anti-Ly2 monoclonal antibody YTS169.4
d, as in a, but cells treated with anti-L3T4 and anti-Ly2
e, as in a, but cells treated with anti-Thyl monoclonal antibody YTS154.7
►
f, significantly different from control group, p <0.01 by t test
g, significantly different from control group, p<0.001 by t test
LEGEND TO TABLE 4
For induction and suppression of DH and cell transfer protocols
see Tables 1, 2 and 3. After passage through nylon wool columns
spleen cells from epidermal-cell-transfer-suppressed mice were
treated with the directly cytotoxic monoclonal antibodies YTS191.1,
YTS169.4 and YTS154.7 (from SERA-LAB Ltd., Crawley Down, Sussex,
U.K.) or with PBS containing 5% FCS for one hour at room
temperature. The cells were then extensively washed with PBS and
the number of viable cells determined by trypan blue exclusion.
The cells were then injected intravenously into syngeneic mice which
had been infected 9 days previously with HSV-1. After 24 hours the
mice were challenged with UV-B inactivated HSV-1 as described and
the 24 hour DH reaction measured.
 
Two phenotypically distinct T cells are involved
in UV-irradiated urocanic acid induced suppression
of the efferent DTH response to HSV-1 in vivo.
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When UV-B irradiated urocanic acid, the putative photoreceptor/
mediator for UV-B suppression, is administered to mice it induces a
dose dependent suppression of the delayed type hypersensitivity
response to herpes simplex virus type 1 (HSV-1), of similar
magnitude to that induced by UV irradiation of mice. In this
study, the efferent suppression of delayed type hypersensitivity by
UV-irradiated urocanic acid is demonstrated to be due to two
phenotypically distinct T cells, (Thyl+, L3T4 , Ly2+) and (Thyl ,
L3T4+, Ly2 ). The suppression is specific for HSV-1. This
situation parallels the generation of two distinct T suppressor
cells for HSV-1 by UV irradiation of mice and provides further
evidence for the involvement of urocanic acid in the generation of
UV-B suppression.
Abbreviations used:
UV ultraviolet; DTH delayed type hypersensitivity; HSV-1 herpe
simplex virus, type 1; APC antigen presenting cell; SFV Semlik
Forest virus; UCA urocanic acid; UV-UCA ultraviolet-irradiated
urocanic acid; DMSO dimethylsulphoxide; NMR nuclear magnetic
resonance; LC Langerhans cell.
INTRODUCTION
Urocanic acid (UCA), a substance present in the stratum
corneum of skin, has been implicated as the photoreceptor/mediator
for ultraviolet(UV)-B induced suppression of the immune response by
De Fabo and Noonan (1). Urocanic acid is formed in a single step
deamination of histidine by the enzyme histidase and undergoes a
UV-dependent trans - cis isomerization. The photochemical
properties of urocanic acid, including the ability to form photo-
dimers and a capacity to bind to DNA in a UV-dependent manner,
have recently been reviewed by Morrison (2).
We have previously reported the first direct evidence that UV-B
irradiated urocanic acid (UV-UCA) induced suppression of the delayed
type hypersensitivity (DTH) response to a subsequently encountered
antigen, herpes simplex virus (HSV-1), in normal mice (3). This
suppression was achieved by painting the skin with UV-irradiated UCA
(UV-UCA), or by injecting UV-UCA subcutaneously, shortly before
sensitisation with virus. Transfer of suppression to sensitised
mice was performed using nylon wool-passed spleen cells from mice
previously treated with UV-UCA prior to sensitisation. Preliminary
evidence from Noonan, De Fabo and Morrison (4) indicates that
intraperitoneal injection of cis-UCA into mice prior to
sensitisation caused suppression of contact hypersensitivity on
subsequent challenge.
In this paper, we investigate the nature of the suppressor cells
generated by UV-UCA in a murine model of HSV infection and discuss
its relevance to the mechanism of UV-B suppression.
2.
MATERIALS AND METHODS
Mice - CH3f Bu/Kam mice aged 10-12 weeks were used throughout and
each experiment comprised either all male or all female mice. The
mice were bred and maintained in the Department of Bacteriology
animal house.
Viruses - HSV-1. The virus used throughout was a clinical isolate
of HSV-1 cultured in Vero cells and assayed for plaque forming units
(pfu) per ml, as described previously (5).
Semliki Forest Virus (SFV) - Semliki Forest Virus was the
generous gift of Dr A.G. Morris of the Department of Biological
Sciences at Warwick University. It was maintained by in vitro
passage in BHK cells. For the DTH experiments, SFV of known
pfu per ml was irradiated with ultraviolet light for 75 minutes to
inactivate the virus whilst preserving its antigenicity. This
protocol induces a DTH response to SFV (unpublished results) and
was used in preference to live virus inoculation.
DTH assay - This has been described previously (3,6,7). Briefly,
mice were sensitised in the right flank by subcutaneous injection of
a known number of pfu of HSV-I grown in Vero cells or UV-inactivated
SFV grown in BHK cells. Control mice were injected with an
equivalent number of sonicated, uninfected Vero cells or
UV-irradiated BHK cells. The mice were measured for DTH to HSV-1 or
SFV between 8 and 14 days after sensitisation. Ear thicknesses
were measured immediately before the mice were challenged by
£
injecting 10 pi (10 pfu) of UV-inactivated virus into each ear
pinna. The ear thicknesses were again measured 24 hours later and
3.
the DTH calculated as the average ear increase per mouse.
Suppression of DTH was determined by the formula:
100 x net increase of experimental mice% suppression = 100 - -
net increase of control mice
as described by Noonan et al (8).
Isomerization of UCA - This has been described previously (3).
Briefly, a thinly spread solution of urocanic acid (Sigma (UK) Ltd),
at a concentration of 20-40 mg/ml in dimethylsulphoxide (DMS0), was
irradiated under two Philips TL20W/12 UV lamps for 20 minutes giving
_ 2
a dose of 96 mJcm of UV in the range 270-350 nm. NMR spectroscopy
previously indicated that this dose induces a 23% isomerization of
UCA to the cis form (3).
Induction of suppression - This solution of UV-UCA in DMS0 was then
either diluted in absolute ethanol to the desired concentration and
painted onto the shaved, gently tape-stripped (x4) flanks of the
mice, or diluted in sterile physiological saline and injected
subcutaneously. The same site was used for the administration of
the sensitising dose of HSV or SFV 5 hours later. Other mice were
treated in a similar manner but using the vehicle or irradiated
vehicle only.
Cell transfers - Cells from the spleens of HSV-1 sensitised mice
which had been painted or injected with UV-UCA 5 hours before
sensitisation were enriched for T cells by passage over nylon wool
columns (9). The collected cells were treated appropriately (see
below) and injected intravenously into sensitised recipient mice
24 hours before ear challenge.
4.
Cell depletions - The rat (lgG2b) monoclonal antibodies YTS 191.1
(anti-L3/T4), YTS 169.4 (anti-Lyt2) and YTS 154.7 (anti-Thy-1)
(SeraLab Ltd, Crawley Down, Sussex, UK) are able to eliminate cells
without adding complement in vitro by coating the cells and
employing in vivo opsonisation . The nylon wool-passed spleen
cells were incubated with these antibodies at a final dilution of
1:50 and at a concentration of up to 5 x 10^ cells/ml for 30
minutes at room temperature. The cells were then washed twice in
serum free medium, resuspended in PBS and transferred to recipient
animals.
RESULTS
1 . Spleen cells transfer the UV-UCA induced suppression of efferent
DTH to HSV-1
The first experiment, shown in Table 1, confirms the previous
finding (3) that suppression was induced by injecting 200 pg of
UV-UCA (23% cis) 5 hours before sensitisation with HSV-1 at the same
site. Nylon wool passed spleen cells from a parallel group of mice
mediated suppression when transferred intravenously to HSV
sensitised mice 24 hours before ear challenge. The efferent
suppression achieved by injecting 200 pg of UV-UCA before
sensitisation or transferring spleen cells from this group of mice
24 hours before challenge was comparable.
5.
2. (L3T4+, Ly2 ) and (L3T4 , Ly2+) T cells are responsible for the
transfer of UV-UCA induced suppression of DTH to HSV-1
In order to determine the phenotype of the transferable T
suppressor cells, nylon wool passed spleen cells from UV-UCA
suppressed mice were treated with (a) no antibodies, (b) anti-L3/T4
monoclonal antibody, (c) anti-Ly2 monoclonal antibody, or (d) both
anti~L3/T4 and anti-Ly2 antibodies simultaneously. Two represent¬
ative experiments are shown in Table 2. Suppression of the DTH
response was only abrogated by simultaneous treatment with both
anti-Ly2 and anti-L3/T4 antibodies.
3. Specificity of the UV-UCA induced T suppressor cells DTH
to HSV- 1
Table 3 confirms that the suppression is due to transferable T
cells of two distinct phenotypes. Suppression was only abrogated
by anti-Thy-1 treatment or by a combination of anti-Ly2 and
anti-L3/T4 antibody treatment. Transferring spleen cells from
UV-UCA treated mice subsequently sensitised with HSV-1 5 hours
later had no effect on the DTH response to an unrelated virus
(SFV). The suppressor cells were therefore specific for HSV.
Table 3 also indicates that UV-UCA can induce suppression of the
DTH response to other viral antigens (SFV). Painting on the




Our recent work suggests that a temporary alteration in
epidermal antigen presentation due to ultraviolet light may lead to
the ineffective, inadequate or inappropriate processing and
presentation of viral antigens (6,7,10). This may have long term
consequences for the host, particularly in the case of persistent
viral infections such as herpes simplex. Irradiation with UV in
the range 250-320 nm (UV-B) has been shown to influence cell-
mediated immunity to tumour (11), skin sensitising (12) and viral
antigens (3,6,7,10) in such a way that there is preferential
generation of T cell mediated suppression for the particular
antigen. The influence of UV on the generation of antigen specific
responses occurs in a critical period following exposure (6).
Recent work by Noonan et al (8) and Morison et al (13) indicates
that significant suppression of the DTH response occurs at
different wavelengths from those directly affecting the morphology
and distribution of Langerhans cells (LC). These findings provide
evidence that UV-immunosuppression is not due solely to a direct
effect on antigen presenting cells (APC) and further implicates the
photoreceptor, urocanic acid, in the mechanism of UV-B suppression
(1).
Recently we have used UV-UCA (23% cis form) painted on the
skin or injected subcutaneously and shown that suppression of the
DTH response to the virus occurs. This UV-UCA induced suppression
is dose related and of a similar magnitude to that obtained by
UV-irradiation of the mice (3). In another system, Noonan and
7.
colleagues (4) have preliminary evidence that intra-peritoneal
injection of UV-UCA induces a dose-related suppression of contact
hypersensitivity to 2,4,6-trinitrochlorobenzene in mice, again
similar to that observed after UV-irradiation of mice.
We have now shown that two suppressor cells (L3T4+, Ly2 ) and
(L3T4 , Ly2+) are involved in urocanic acid induced suppression of
the DTH response to HSV. The suppression is specific for HSV as
transferring these suppressor cells has no effect on the DTH
response to an unrelated virus (SFV). This parallels our previous
_2
finding using a suberythemal dose (96 mJcm ) of UV-B where two
UV-induced T suppressor cells (7) (Lyl+, Ly2 and Lyl , Ly2+), one
of which has subsequently been shown to be L3T4+, Ly2 (14), are
involved in the efferent suppression of DTH to HSV-1. Thus the T
_2
suppressor cell subsets generated by UV-B (96 mJcm ) and by UV-UCA
_ 2
(96 mJcm ) are of similar phenotype, providing further evidence
that urocanic acid may be the photoreceptor/mediator for
UV-B suppression.
Current work (14) indicates that only one of the UV-induced
suppressor cell phenotypes (Thy 1+, Lyl+, L3T4+, Ly2 ) is generated
via the epidermal route and is presumably associated with a unique
antigen presentation event occurring locally in the skin at the
site of infection following UV-irradiation. The hypothesis that
the other suppressor cell phenotype is generated systemically
is being investigated using both UV irradiation and UV-UCA
protocols. This presentation event may be associated with APC,
possibly in the spleen or lymph nodes under the influence of the
cis isomer of UCA. Both spleen and lymph node APC function is
known to be affected by UV-irradiation in vivo (15).
Urocanic acid and the immunomodulatory substance histamine are
both formed in one step reactions from histidine and are structur¬
ally closely related. The use of synthetic histamine agonists (16)
has indicated that histamine may activate both suppressor and
contrasuppressor T cell subsets: H2 receptor agonists tend to
activate suppressor cells while Hj receptor agonists activate
contrasuppressor cells. We have previously reported that urocanic
acid promotes a biphasic response (3), where high concentrations of
UV-UCA induce less suppression than more physiological doses,
similar to that with histamine which is dependent on concentration.
It is possible that urocanic acid may fit similar receptors or
utilise histamine receptors, both in the epidermis and
systemically, to exert its effect, or exert part of its effect, on
the immune response. This is currently being investigated as is
the intriguing hypothesis that UCA in either its cis or trans form
may interfere with the binding of histamine to its receptor in skin
and thus may further affect the types of response generated to
epidermal antigens and pathogens.
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TABLE2L3T4+ y2and3T4Ly2+ cellsreresponsibleforthansfer ofUV-UCAinducedsuppr ssionDTHtoHSV-1.
UV-UCA painted (onDay0)
Sensitisation (onDay0, 5hourslater)







200pg NIL NIL NIL NIL
10Verocells 1 .5x10HSV 1 .5x10HSV 1.5x10HSV 1 .5x10HSV 1.5x10HSV 1 .5x10HSV
NIL NIL NIL UNTREATED3 ..tOb anti-Ly2 anti-L3/T4C -•TOd anti-Ly2
+anti-L3/T4
3.32-0.50(n=7)
12.-0.70(n=7) 3.21-1.33(n=7) 5.31-1,24(n=4) 10.04-0.54(n=7) 8.67-0.81(n=7) 11.00^0.48(n=6)
100* 77*** 24** 39** ,3NS
4.07-0.90(n=7) 16.95-0.86(n=5) ND 5.15—0.93(n=5) 9.50-1.17(n=4) 11.50-1.37(n=4) 16.45-1.29(n=5)
ND 92* 58** 42**** ,NS




















































































































































































































































ON THE NATURE OF THE DEEP CELLULAR
DISTURBANCES IN HUMAN-PAPILLOMA-VIRUS
INFECTION OF THE SQUAMOUS CERVICAL -
EPITHELIUM
Stewart Fletcher MaryNorval
. Departments of Pathology and Bacteriology, University of Edinburgh
Summary -In the squamous epithelium of the cervix,
disturbed deep cells, usually regarded as
dysplastic, often underlie superficial koilocytes. Recognition
ofkoilocytosis as a cytopathic effect ofhuman papilloma virus
(HPV) prompts reconsideration of the state of the deep cells,
. which could be non-dysplastic or dysplastic. In the dysplastic
states HPV could be non-causative or causative. For
dysplastic causation by HPV, a cell-differentiation
hypothesis reconciles the coexistence in the epithelium of a
permissive HPV infection of the superficial layers
(koilocytosis) and a non-permissive cellular infection of the
deep layers, which may undergo transformation to dysplasia.
''
. ■ introduction
In general, cells may respond to virus infections in several
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ways.1 They may be resistant and show no change or evidence
of infection. In a productive infection, however, a cytopathic
effect usually develops during the replication of many
complete virions which, in the case of naked viruses like
human papilloma virus (HPV), are released during cell
autolysis.2 In the cervix, the superficial koilocytes are
thought to die from the cytopathic effects of a productive
(permissive) papilloma-virus infection: they cannot,
therefore, be progenitors of a malignant cell line.
. In most non-productive (non-permissive) infections, the
virus enters and infects the cell. Viral reproduction stops at
the stage ofviral nucleic-acid replication, and virus remains as
"incomplete" naked genome which ranges numerically from
part of 1 genome to, perhaps, 200 genomes. With oncogenic
viruses about 1 in 105 of infected non-permissive cells
undergo transformation: in vitro their morphology becomes
distinctive and they can grow in suspension and form foci
over the monolayer ofuntransformed cells. In vivo they may
be tumorigenic in susceptible animals.3
Y'\
j 8. • ijrf? .*v • - .**
Superficial "koilocytes, a presumptive sign of an HPV productive
infection.
a, basal cells with minimal disturbance, b, deep dells with disturbances
indistinguishable from moderate dysplasia. (Haemalum and eosin, reduced by
a third from x 250.)
In transformation the viral genome may be integrated into
the host-cell genome4 or remain non-integrated, as free
covalently closed circles. Integrated and non-integrated states
may coexist. In either state the viral genome, or part of it, can
be transmitted to the daughter cells on division without
release ofvirus, thus perpetuating the transformation and any
of its cellular effects. Some of the viral genome may be
transcribed and translated, and "early" viral proteins may be
. expressed on the cellular or nuclear membranes and serve as
markers of cellular transformation or neoplasia.
The non-permissive stateuf the transformed cells prevents
replication of complete virus and concomitant cell death:
transformed cells are thus enabled to generate malignant cell
lines.
A mixed, semipermissive, type of infection is also
recognised in cell culture. Here some cells are non-
permissive, or transformed, whereas others are permissive
and undergo a productive infection causing, where
appropriate, cell death. Probably differences in the cells
rather than differences in the virus determine the type of
infection.
The in-vitro patterns of permissive and non-permissive
viral replication and of transformation suggest hypotheses
. about the nature of the cellular changes in the squamous
epithelium of the cervix in HPV infections. • ■
SQUAMOUS-EPITHELIAL-CELL CHANGES IN
PAPILLOMA-VIRUS INFECTION
In the squamous epithelium of the cervix productive HPV
infection is commonplace in the form of koilocytes in the
upper strata.5"7 They may or may not be associated with
disturbances of the deep cells indistinguishable
microscopically from dysplasia (see figure).
Before the viral cause of koilocytic change was
established5'3"11 the nature of the disturbed cells would not
have been questioned and they would have been regarded as
one of the grades of dysplasia or as carcinoma-in-situ. In our
present imperfect state ofknowledge, that very practical view*
is still necessary to ensure that the patient is adequately
treated.12 However, the confirmation ofHPV infection in the
epithelium now creates additional possibilities for the nature
■of the deep cells.
I. THE DEEP CELLS ARE NON-DYSPLASTIC
It is possible that the morphologically disturbed deep cells
are not destined for dysplastic behaviour, and this could
perhaps explain the regression of some cervical dysplasias.13
They may thus represent early non-koilocytic or pre-
koilocytic stages of a productive infection that ultimately
leads to koilocytosis and death of the maturing cells with a
negligible risk of malignant transformation. When the
infection declines, a return to normal appearances would be
expected.
II. THE DEEP CELLS ARE DYSPLASTIC
Dysplasia in the deep cells could be either causally
unrelated or causally related to HPV infection. . ,
A. Dysplasia Not Causally Related to HPV
Dysplasia due to any cause might be established in the
cervix before the onset of HPV infection. The association
between koilocytes and disturbed deep cells might reflect
merely the contingency in space and time of two quite
unrelated states. Indeed, the relationship might be in the
548
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opposite direction since dysplastic cells would be killed by
koilocytosis and might regress.
B. Dysplasia Possibly Causally Related to HPV
Dysplasia due to HPV alone.—Here we postulate that the
deep cells are dysplastic and that papilloma-virus infection is
causative. In doing so we have to explain certain difficulties.
The epithelium at first sight (figure b) appears to be
undergoing a productive (koilocytic) infection, in which
transformation ofthe koilocytes to a proliferative malignancy
is impossible. Is it then possible that the deep cells may have a
different non-permissive viral association? The question
remains unanswered, but a plausible hypothesis and some
findings support the possibility. With an invariant strain of
oncogenic virus the establishment ofa non-permissive rather
than a permissive infection usually entails a significant
change in the. nature of the host cell—eg, a change ofspecies.
However, cervical squamous epithelium contains a broad
spectrum of morphological and functional cellular
differences, ranging from immature basal cells through
actively mitotic parabasal cells to the rounded cells of the
stratum spinosum and the flattened superficial glycogenated
squames. Virions released from the productively infected
koilocytes could find their way through the intercellular
spaces to the deeper strata and could well strike up a non-
permissive infection in them. The non-permissive association
would be largely determined by the different nature of the
deep cells, but mutations in the "productive" virions might
assist. Transformation to dysplasia in multiple foci would be
consistent with the common association between koilocytes
and dysplasia. The epithelium might then be thought of as
semi-permissive, with the unusual property' that the
distribution of permissive and non-permissive cells is not
random as in a cell culture but topographically predictable,
with koilocytes ,in the superficial strata and transformed
dysplastic cells in the deeper zones. Our hypothesis that
cervical epithelial cells ofdifferent degrees ofdifferentiation
may relate differently to virus is supported by studies
suggesting that the nature of virus growth in cells can be
altered by organ, or even functional, differentiation rather
than by a change of species. Thus, susceptibility of mouse
organs to polyoma infection was determined pot only by
organ differentiation (salivary gland or metanephros) but also
by the metanephric epithelium, mesenchyme, and stage of
development.14 In SV-40 infection of murine
teratocarcinoma cells undifferentiated cells were resistant but
differentiated cells supported SV-40 non-permissively.15
Stem cells transfected with a plasmid bearing SV-40 genome
did not express early protein until induced to differentiate by
retinoic acid.16 In murine cytomegalovirus infection of
teratocarcinoma cell lines differentiated cells were permissive
but undifferentiated cells supported only a latent infection
until induced to differentiate with dimethylacetamide, when
viral production began.17 In addition, purely functional
differences in related morphologically similar cells have been
shown to alter virus growth patterns, as with herpes-simplex
infection of lymphoid cells maturing from the "null" state
through the different stages of the divergent B and T cell
paths to mature lymphocytes.18
Dysplasia due to viruses other than • papilloma
virus.—Herpes-simplex type-2 virus (HSV-2) has for long
been linked by circumstantial evidence to cervical carcinoma.
Inactivated virus can transform rodent cells to malignancy in
vitro,19 and antibodies against it20 are found in higher titre
and are more common in women with cervical cancer than in
. • >
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controls, although there is considerable geographical •
variation.21 HSV-2-specific mRNA has been detected in
premalignant and malignant cervical tissue.22"24 Direct l-
evidence for a causal connection between HSV-2 and cervical ;
cancer has not been forthcoming, and HSV-specific DNA has j
only rarely been found in cervical malignancy even with 1
highly sensitive hybridisation techniques.25 HSV-2 as a sole *
cause ofcervical cancer remains in great doubt. On the other «
hand, dysplasia brought about by HSV-2 in synergism with 1
< other agents, notably human papilloma virus, is plausible. .3
Viral synergism as a cause of dysplasia.—zur Hausen '■
. proposes a synergism between HSV and HPV which leads to I
cervical neoplasia.26 The hypotnesis resolves the conflict 4
between the serological evidence, favouring past HSV i
infections and the general failure to detect HSV-2 DNA in the 1
neoplasms. It proposes that a transient cervical epithelial ■
infection with HSV raises the antibody level and "initiates" |
the malignancy. Initiation of the cellular genetic change to
neoplasia is not brought about directly by integration ofHSV
oncogene but indirectly by DNA repair enzymes transcribed
from the virus early in the infection. The viral enzymes
(deoxyribonuclease or a DNA polymerase with additional
exonuclease activity) bring about chromosomal aberrations
or gene amplification in the cellular genome—a known
mechanism of physical and chemical carcinogensis. The
cellular mutation is, ofcourse, transmissible to daughter cells
but need not be accompanied by virus—thus explaining the
absence ofHSV-2 DNA from the neoplasms. HSV thus acts
as a "hit and run" type of initiator of neoplasia, zur Hausen
further postulates that cells initiated by HSV could be
promoted by a superimposed HPV infection to recognisable
dysplasia. •
Dysplasia due to synergism between virus and other
carcinogens.—Synergism with papilloma or other viruses
could provide the component necessary to give expression to
some of the other risk factors ofcervical carcinoma—eg, the
tenuous association with smoking27 or nitrosamines28,29 or
other substances so far undetermined. To test the hypotheses
, outlined above, it would be necessary to purify the virus from
cervical koilocytes and to compare it with the 15 known types
and several subtypes of HPV. As papilloma virions are
probably present in very small numbers and cannot be
cultured productively in vitro, the viral DNA could be cloned
in a suitable vector, as has been achieved with bovine
papillomavirus genomes.30 Thereafter in-situ hybridisation
experiments should reveal which cells of the koilocytic
epithelium contain HPV nucleic acid, and perhaps shed light
on what is happening in the deeper layers.
Correspondence should be addressed to S. F., Pathology Department,
University of Edinburgh, Teviot Place, Edinburgh EH8 9AG. . •.
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1. INTRODUCTION
Papilloma viruses are known to infect a variety of species
including man, dogs, horses, rabbits, deer, sheep, cattle, mice
and birds, and to induce papillomatosis (warts) in these animals
(reviewed by Lancaster and Olson, 1982). Warts have been
recognised for centuries and were experimentally transmitted
almost eighty years ago (Ciuffo, 1907). Traditionally warts
were thought of as benign or even hyperplastic lesions of
cutaneous or mucosal tissues but gradually their potential for
transformation to carcinomas was recognised. In particular, in
recent years, an association between human papilloma viruses
(HPV) and the development of genital neoplasias has been found,
which has fostered interest in the papilloma viruses and their
detection. Concomitantly, significant advances in the molecular
cloning of papilloma viruses have partly compensated for our
inability to culture the viruses in vitro and have made possible
some studies on their behaviour.
In this chapter, the biology of HPV types is introduced
followed by a review of genital warts and the association of HPV
with genital carcinomas. Methods for the detection of HPV in
genital lesions are then given and assessed. The relevance of
monoclonal and polyclonal antibodies is discussed.
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2. HUMAN PAPILLOMA VIRUSES
A. Papilloma virus types
Papilloma viruses belong to the genus A of the family
Papovaviridae. The virions are naked, about 50 nm in diameter,
with icosahedral symmetry and containing 72 capsomeres.
Particles of HPV prepared from plantar warts by grinding skin
scrapings followed by equilibrium centrifugation in CsC1 are
shown in Fig. 1.
In the past few years it has become clear that there are
many types of papilloma viruses which infect particular species
in preferential sites and with typical clinical manifestations.
In man, the number of types has risen to 35 and more are still
being discovered. Types I to 18 and their associated clinical
lesions are outlined in Table I.
9
A new type is designated if it shares less than 502 sequence
homology with other papilloma viruses as tested by reassociation
kinetics under stringent conditions of nucleic acid hybridisation
(Coggin and zur Hausen> 1979 ; see Section 6E below for an
explanation of hybridisation conditions). There should also be
significant antigenic variation from any other type although this
is often not possible to test if virus particles are either not
present or are present in low numbers. Furthermore, viral
protein products are not well defined at the present time either
in terms of molecular weight or function. In practice, typing
is based on molecular cloning of viral DNA, followed by blot
hybridisation with known human types under different stringency
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conditions. A subtype has less than 100% but more than 50%
sequence homology with known types. Perhaps it is surprising
that typing without characterisation of viral mRNA and viral
proteins should lead to such good concordance with clinical
lesions. Recombination between different types has been
suggested to occur (Gissmann, 1984).
6.
B. Genomic organisation
The genome of HPV types consists of a double-stranded,
covalently closed, circular DNA molecule containing about 7900
base pairs. As papilloma viruses cannot be cultured in vitro it
is important to ascertain their genomic organisation from
nucleotide sequence analysis so that predictions can be made
about their possible protein products, control elements and
associations with different types of cells.
Some HPV types are found in small numbers only in wart
lesions, as in genital warts, and some are present only in the
form of viral DNA, not as mature virus particles, as in cervical
carcinomas. Thus sequencing in these cases depends on
successful molecular cloning of papilloma virus DNA. Where
possible, the cloning methods depend on the isolation and
purification of viral DNA followed by linearisation either at
the single BamHI or ECoRI site, making recombinant plasmids,
often with pBR322, and cloning in suitable bacterial strains.
Where viral particles are not found, a genomic library of the
appropriate tissue is made by cleaving cellular DNA with a
restriction endonuclease using bacteriophage X as vector.
Recombinant phages containing viral DNA are then cloned. These
strategies are reviewed by Gissmann and Schwarz (1984).
Initial studies led to the elucidation of the nucleotide
sequence of bovine papilloma virus type 1 (BPV 1, Chen et al,
1982) and subsequently the sequence of HPV la, (Danos et al,
1982; Clad et al, 1982), 6b (Schwarz et al, 1983) and 16
(Seedorf et al, 1985) have been found. The general organisation
is very similar in all these types and is illustrated in Fig. 2
for HPV 6b and 16.
Intracellular replication of DNA viruses is often split into
three phases: firstly, early proteins are synthesized which are
predominantly non-structural in function, then viral DNA is
replicated and finally late proteins are synthesized which are
mostly structural, making up the capsomere sub-units of the virus
particle. The proteins are coded for by open reading frames on
the viral DNA. All significant open reading frames (ORFs) are
on one DNA strand. These potentially encode polypeptides
greater than 90 amino acids. There are several presumptive
early ORFs, designated El to E7, on the basis of size, and two
late ORFs, LI and L2. Between LI and E6 is a non-coding region o
about 1000 base pairs which is thought to contain the origin of
* . .
DNA replication and the promoter for early gene transcription.
Transcriptional enhancer elements functioning in a position- and
orientation-independent manner have been mapped within this
region and also in the other region between the E and L parts of
the genome (Spalholz et al, 1985; Lusky et al 1983).
An in vitro transforming system is available for BPV 1 and
had yielded interesting results on genomic organisation. A
segment containing 69% of the viral genome was found to be
necessary for transformation of certain mouse cells to focus
formation, growth in soft agar and tumorigenicity in athymic
nude mice (Lowy et al, 1980); further, the genetic information
encoded by E2, E3, E4 and E5 was sufficient to induce
transformation (Yang et al, 1985a; Lusky and Botchan, 1985).
El function is involved in extrachromosomal viral DNA maintenance
in transformed cells (Lusky and Botchan, 1984). E2 is
responsible for the transactivation of the enhancer located in
the non-coding region (Yang et al, 1985b). This could lead to a
direct effect on transformation as well as increased expression
of other ORFs including E6, E7 and El. E5 may be involved in
inducing proliferation of dermal fibroblasts in fibropapillomas.
It will be interesting to see if the early ORFs of HPV have
similar functions, despite their lack of homology with BPV I and
their biological differences in inducing epithelial
proliferation rather than fibropapillomas.
Differences in coding potential between different HPV types
may be of functional significance. For example, HPV 16 which is
associated mainly with genital carcinomas, is not like HPV la and
6b in some respects. The ORFs for El of HPV 16 is split into 2
reading frames, and E4 and E5 do not have a translation
initiation codon (Seedorf et al, 1985). The importance of these
changes is not known at the present time. By studying HPV 16
and 18 sequences in various cervical cell lines derived from
carcinomas, the presence of El but probably not E2 was thought to
be necessary for expression of the malignant phenotype (Pater and
Pater, 1985).
Viral mRNA synthesis has been examined mainly in BPV 1 and
cotton tail rabbit papilloma virus (CRPV) systems (reviewed by
Pfister, 1984). Some interesting results with CRPV show that
transcription differs in virus-producing benign tumours from
malignant non-productive tumours (Phelp et al, 1985). The
regions of the genome containing the ORFs, once transcribed to
RNA, probably undergo excision and splicing to make the mRNAs.
Work has begun on analysing viral mRNAs in cervical cell lines to
find out which regions of the genome are transcribed, whether or
not splicing occurs and whether co-transcribed host sequences are
important (Schwarz et al, 1985). In one report, HPV 16 mRNA was
found only rarely in cervical carcinoma biopsies containing HPV
16 DNA (Lehn et al, 1985). Thus continuous expression of HPV
may not be necessary for the maintenance of a transformed state.
The implications for detection methods, such as assaying for HPV
protein products are obvious.
I
C. Viral protein products
To date, none of the early gene products of HPV types have
been identified in in vitro transforming systems or in warts, and
no specific tumour antigens are characterised in vivo. It is
likely that such proteins are, in fact, synthesized as shown by
the conservation of the amino acid sequences coded for by the
early regions of different papilloma virus genomes. However
they may be present only in small quantities or be weakly
antigenic so that new methods may have to be developed to detect
them. One approach may be to translate viral mRNAs in vitro.
Another may be to take segments of ORFs, especially the early
ORFs, and to insert these into bacterial expression vectors under
the control of inducible promoters, in the hope of getting
translation of viral products.
LI and L2 are expected to code for the viral structural
polypeptides. Major polypeptides of molecular weight 57,000,
54,000 and 44,000 have been described in purified HPV 1, 2 and 3,
in association with other minor polypeptides of smaller molecular
weights and which varied between isolates (Gissmann et al, 1977).
Such work has been dogged by difficulties in the preparation of
adequately purified virus particles from pooled clinical material
and in sufficient quantity for analysis. However it should be
possible to obtain a sufficient quantity for the preparation of
monoclonal antibodies. In BPV 2, LI codes for the major
polypeptide of the capsid which has molecular weight 55,000; L2
probably codes for a polypeptide of molecular weight 50,000
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(Potter and Meinke, 1985).
Antisera have been prepared against purified HPV, where
feasible, i.e. types 1, 2, 3, 5, 8 and 9 (Jablonska et al 1982;
Gissmann et al, 1977). These are type-specific and detect viral
capsid antigens in the nuclei of infected cells. If the antisera
are prepared using virus particles disrupted with sodium dodecyl
sulphate (SDS) then the type specificity is lost and the antisera
cross react, not only with the capsid antigens of other HPV
types, but also with papilloma viruses from other species, such
as cattle, dogs, horses and deer (Jenson et al, 1980). Again
the antigen is located in the nuclei of infected cells.
Probably there are amino acid sequences shared between all
papilloma viruses which lie in a part of the capsid protein not
normally exposed on the surface of virions, which then account
for the genus-specific reactivity. As will be outlined in
Section 6D, both the genus-specific and type-specific antisera to
the capsid antigens are of use in screening tissues for evidence
of papilloma virus infection.
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3. HUMAN WARTS
Wart lesions induced by HPV infection are primarily
epithelial proliferations of the skin or mucosa. This results in
overgrowth of sub-epithelial capillaries (papillomatosis), and in
thickening of the stratum spinosum (acanthosis) and stratum
corneum (hyperkeratosis). Eventually, probably to accomodate
the epithelial proliferation on a limited base, the basement
membrane and the overlying strata corrugate creating strands or
outgrowths whose vessels (which grow correspondingly) nourish the
epithelium. The lesion is thus essentially fibro-epithelial
with, usually, some (limited) branching of the processes or
"asperities".
Warts are benign, in most instances, showing limited growth
and generally regress spontaneously after several weeks or
months. They can persist, however, and can rlcur. Abrasion to
the skin is probably required before the virus is able to infect
a new host and the incubation period is thought to be between 3
and 18 months (Rowson and Mahy, 1967). It is not known what is
happening during this period, how infective HPV types are and
whether infections are sometimes sub-clinical.
A few cells of the basal layer contain HPV DNA in their
nuclei (Beckmann et al, 1985) and many more in the first or
second suprabasal layer of the stratum corneum (Grussendorf and
zur Hausen, 1979). The viral DNA may be integrated or
extra-chromosomal, although the latter is the more commonly found
state with most, but not all, types. The parabasal cells
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probably represent the first target for the virus. The
structural proteins begin to appear in the cells of the upper
layers of the stratum spinosum and virus particles, when present,
in this layer and the stratum granulosum. The virions can
sometimes be seen in paracrystalline arrays in the nuclei and
enmeshed in keratin in the stratum corneum. Fig. 3 shows a
diagram of the epidermis infected with HPV, and Fig. 4 an array
of HPV 1 in the stratum granulosum of a plantar wart.
The cells of the basal and suprabasal layers may be non-
permissive for HPV and the association with virus a transforming
one (Fletcher and Norval, 1983). In vitro HPV fails to
replicate productively even in cultures of keratinocytes which
are forming a granular layer and is found only as viral DNA, 50
to 250 copies per cell, present as stable non-integrated genomes
(Taichman et al, 1983). As the keratinocytes become more
differentiated in the stratum spinosum, the association with
virus probably becomes a permissive one. The productive
infection in the superficial cells is marked by the presence of
koilocytic cells, first noted by Koss and Durfee (1956). In
brief, these can be described as having densely staining,
irregular,indented or folded nuclei and a ballooned cytoplasm
with a clear, glycogen-free perinuclear halo. Sometimes there
are basophilic nuclear inclusions which consist of arrays of
virus particles. The koilocytes are considered pathogonomic of
HPV infection. Different types of koilocytes have been described
by their histopathological appearance (Crum et al, 1985) but
whether these represent separate clinical entities, infection
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with different HPV types or stages or permissiveness for HPV
replication is not known.
There is increasing evidence that HPV can become latent and
may be present in the epidermis without clinical lesions and
morphological signs. The cervix, in particular, may be subject
to latency which may be significant for the diagnosis and




It has become increasingly evident that papilloma viruses
associated with infections of the male and female genital areas
are spread predominantly by sexual transmission. There is
probably no correlation between genital and skin warts. Genital
warts are found in populations of high promiscuity (Waugh, 1972),
in age groups of sexual maturity and where sexual activity is
highest (zur Hausen, 1977). The sites of genital warts are
commonly those of frequent contact during coitus. Horizontal
spread can be traced from subjects with the disease (Oriel,
1971). The incidence of genital HPV infection increased during
the last decade and now represents at least 6% of all cases seen
in Genito-Urinary Medical Departments in Britain (Adler, 1984).
In Edinburgh 13% of male patients (out of 5,013) and 13% of
female patients (out of 3,230) attended the Genito-Urinary
Medical Department with genital warts in 1984 (A. McMillan;
personal communication).
In men, genital warts are found on the glans and body of the
penis, prepuce, fraenum and coronal sulcus, urethral meatus,
scrotum, anus and rectum. In women, they are present on the
introitus, vulva, vagina, cervix, perineum, anus and rectum.
Until 1976, only one type of genital warts was described, the
condyloma acuminatum, but now several others are recognised, the
most important being the flat condyloma and Bowenoid papulosis.
A. Condyloma acuminatum
The classical exophytic genital wart or condyloma acuminatum
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is characterised by papillomatosis, acanthosis, elongation and
thickening of the rete pegs and koilocytosis (Woodruff and
Peterson, 1958). Its growth pattern is illustrated in Fig. 5a
and a clinical example in Fig. 6b. It is found on the penis,
anus, vulva, perineum and cervix (zur Hausen, 1977). Virus
particles are seen in some lesions, around 50% in most surveys,
although not normally in high numbers. Viral antigens have also
been detected and viral DNA, predominantly types 6 and 11
(Gissmann et al, 1983). Malignant conversion into carcinomas of
the penis and vulva is rare (zur Hausen, 1977).
Giant condylomata located on the penis were described by
Buschke and Lowenstein in 1931. They have invasive growth
properties after long periods of time but without metastases.
They are associated with HPV 6 and 11 (Zachow et al, 1982).
B. Flat condyloma (flat koilocytosis)
In the cervix, predominantly, HPV infections assume a less
exophytic form and flat lesions are found. They appear often as
white epithelium in the transformation zone of cervical ectropion
where subcolumnar reserve cells are proliferating and
re-differentiating into squamous epithelium. It is not known
why there should be a predilicted site for this type of wart, but
perhaps the rate of cell or tumour production is highest here, or
the keratin pattern may be unusual. Flat condylomata were only
recognised as being wart lesions in 1976 (Miesels and Fortin,
1976) and, on colposcopy, are often very difficult to distinguish
from lesions of cervical intra-epithelial neoplasia (CIN), being
classified traditionally as CIN grade 1 (mild dysplasia). They
are also found in the vulva and penile glans (Gross et al,
1985b). The growth pattern of flat condyloma is shown in Fig.
5b, and a clinical lesion in the cervix in Fig. 6c. The
nomenclature of this type of wart is confusing as it has been
called variously a flat wart, a non-condylomatous cervical wart,
subclinical HPV, flat koilocytic lesion and atypical condyloma,
but the term flat condyloma is being used increasingly despite
the inherent contradiction in this description (condyloma is
derived from Greek kondylos : knuckle; see Fletcher, 1983, for a
critical review of nomenclature and classification).
In this decade flat condylomata of the uterine cervix have
become recognised as common infections. It has been estimated
that 1.3% of unselected women show cytological changes consistent
with HPV infections on routine Papanicolaou smears and 25% of
colposcopically directed punch biopsies also show similar changes
(Reid et al, 1980). There is evidence tb suggest that the
incidence of flat condylomata of the cervix is increasing
although there is more awareness of this condition and better
detection methods than formerly (Oriel, 1983). As with
condylomata acuminata, flat condylomata show koilocytic cells on
histology; genus-specific viral antigen is present in about half
the cases although its distribution is often patchy and sparse
compared to exophytic genital warts (Woodruff et al, 1980).
HPV 6 and 11 DNA are found in 50-60% flat condylomata (Gissmann
et al, 1982; Gross et al, 1985b).
In addition to the flat condyloma, an endophytic or inverted
condyloma has been described (Meisels et al, 1976). Here
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squamous epithelium has proliferated in the necks of the
endocervical glands with superficial koilocytosis. It is
possible that this is merely a papilloma virus infection of a
branching epidermidised gland and Fletcher ( 1983) has suggested
that it should not be considered as different from flat
condyloma.
C. Bowenoid papulosis
Classically this is described as flat, multifocal, slightly
pigmented papules, often verrucoid, in the body of the penis,
first noted in 1970 (Lloyd, 1970) and affecting young adults.
Although appearing to be benign macroscopically and often
regressing spontaneously, these papules show histological changes
of squamous cell carcinomas-in-situ. They assume a flat,
papillary endophytic or papillomatous exophytic form (Gross et
al, 1985). Only 5% of lesions show the genus-specific antigen
of HPV but over 50% contain HPV 16 DNA (Ikenberg et al, 1983;
Braun et al, 1983; Gross et al, 1985a). This is taken to
indicate low productive infection with HPV 16 in epithelial cells
predominantly non-permissive for the virus and transformed to
some extent by the presence of viral DNA. Bowenoid papulosis of
men may represent an important reservoir of HPV 16.
Genital Bowen's disease is found histologically to be very
similar to Bowenoid papulosis except lesions are not multifocal
and they occur on the glans of the penis (Wade, 1978). The
average age of patients is 50, and HPV 16 is found in 80% cases
(Ikenberg et al, 1983).
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5. ASSOCIATION OF HPV WITH GENITAL CARCINOMAS
Almost 150 years ago Rigoni-Stern ( 1842) observed that
uterine cancers were more prevalent in married than in unmarried
women, and were almost absent in certain orders of nuns.
Confirmation of these findings indicating that sexual behaviour
and cervical cancer were associated was published in 1973
(Rotkin), and since then a sexually transmitted agent has been
sought. In addition, based on epidemiological data, a
progression from a pre-malignant change in the cervix to a truly
malignant state is suggested (Meisels et al, 1982). These
stages are recorded histologically as CIN 1 (mild dysplasia), CIN
2 (moderate dysplasia), CIN 3 (severe dysplasia/carcinoma-in-
situ) and invasive carcinoma. Various viruses such as herpes
simplex type 2 and cytomegalovirus have been implicated as
possible agents in)this neoplastic process and HPV suggested only
a few years ago (zur Hausen, 1976). However the association
between HPV and abnormalities of the uterine cervix gained ground
rapidly after it was realised that CIN often occurred in
conjunction with koilocytosis (Meisels et al, 1982).
Various groups soon added data in support of HPV infections
being important in CIN. Most notably, techniques have included
histopathology looking for features of papilloma virus
infection, screening for HPV antigen using an antiserum against
the genus-specific papilloma antigen, and detection of HPV DNA
by nucleic acid hybridisation. Some selected results and
references are summarised in Table 2. In addition to this
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data HPV 16 is found in CIN lesions where there are abnormal
mitotic figures and nuclear atypia in all layers of the squamous
epithelium. These lesions have an aneuploid nuclear DNA content
and a high risk of progression to malignancy (Crum et al, 1984;
Crum et al, 1985).
Similar results to that found in the cervix have been
obtained for vulval condylomata and vulval intra-epithelial
neoplasia (VIN) (Boshart et al, 1984; Gissmann, 1984; Ferenczy
et al, 1985).
While the viral DNA in HPV 6 and 11 lesions is in the same
state as in other papilloma virus infections, i.e. non-integrated
and circular (Lehn et al, 1984), that of types 16 and 18 in
carcinomas may be different. There is evidence for head-to-tail
tandem repeats persisting in a non-integrated and circular form,
and some integrated genomes as monomers or as head-to-tail
repeated oligomers, up to 20 per integration site (Boshart et gl,
1984; Durst et al, 1985). In another study HPV 16 DNA was
found as a single copy co-valently linked to tumour cell DNA in a
cervical carcinoma (Lehn et al, 1985). Integration of HPV 16
and 18 also occurs in some cervical cell lines (Schwarz et al,
1985; Pater and Pater, 1985; Yee et al, 1985). In contrast,
one group failed to find HPV DNA sequences in the majority of
invasive squamous cell carcinomas of the cervix (Fukushima et
al, 1985). The sensitivity of the assay system used was estimated
at one copy of viral genome per 20 cells with a homologous HPV
probe and one copy per three cells with a heterologous DNA probe.
From all this data, the consensus view is that HPV 6 and 1 1
are found most commonly in genital warts and in CIN and VIN of
low grades in an non-integrated form and that this association
is one of low malignant potential; on the other hand, HPV 16 and
18 are found most commonly in genital carcinomas in an integrated
form and have high malignant potential (Crawford, 1984). This
hypothesis remains to be fully tested and it is unlikely to be
the whole story. Various co-factors are undoubtably important
as suggested by zur Hausen (1982), such as infection with a
second virus or bacteria or even smoking. So far it has been
impossible to document if HPV plays a casual or causal role in
genital neoplasias (Singer et al, 1984) and more data is
required, particularly on what happens during progression of the
lesions.
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6. DETECTION OF HPV GENITAL INFECTIONS
These methods are wide-ranging and include gross appearance,
colposcopy, histopathology of cervical smears and biopsies,
electron microscopy, detection of HPV antigens, detection of HPV
DNA and immune responses. Each test gives valuable information
although the only reliable method of typing HPV at the present
time is by DNA hybridisation. Most reports combine more than
one technique which, perhaps, is the best policy until the
position becomes clearer and definitive reagents are available.
A. Gross appearance and colposcopy
There is little problem in identifying the classical
condyloma acuminatum by its gross appearance and a good
description is given in Woodruff et al (1958). On colposcopic
examination of the vagina and cervix, there is often a thick
%
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white epithelial focus with surface projections containing
capillary loops. Early lesions are more difficult to define and
have only small surface projections (asperities) (Meisels et al,
1979; Reid et al, 1980) .
Flat condylomata have a smooth or irregular surface, only
slightly raised from the surrounding epithelium. They exist in
both dysplastic and non-dysplastic forms. Recently, the
colposcopic appearances of HPV lesions in the cervix have been
classified as normal, mosaic, warty, leukoplakial (thickened
white epithelium) or a combination (Vatyrynen et al, 1985).
However, colposcopic approaches do not reliably detect and
separate the types and, in practice, clinicians are more
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concerned about dysplastic zones, whether koilocytic or not, and
tend to direct their attention and their biopsies to them.
Distinguishing patches of dysplasia from non-dysplastic flat
condylomata or co-incident dysplasia and koilocytosis is
unreliable colposcopically and requires histological examination
(Kirkup et al, 1982). Condylomata can be suspected if the
lesions are multiple, if they are present outside the
transformation zone and if there are dilated capillaries in the
surrounding native squamous epithelium (Meisels et al, 1977).
B. Cytology and Histopathology
There are characteristic cellular changes in Papanicolaou
smears of women with condylomata (reviewed by Meisels et al,
1984, and Syrjanen, 1984). Normally no inflammatory cells are
present, but koilocytes and dyskeratotic cells are, although not
invariably. The koilocyte is considered pathogonomic for HPV
infection. It is an intermediate or superficial squamous cell
with enlarged hyperchromatic nucleus and an area of perinuclear
clearing (see Fig. 7). The rest of the cytoplasm is thickened,
often with an amphophilic staining pattern. It may be bi- or
multi-nucleated. Dyskeratocytes are often shed singly or in
clusters. They are small keratinised squamous cells with
orangeophilic cytoplasm and large homogeneous nuclei. Sometimes
the nuclei are atypical and it is difficult to distinguish
papilloma virus infections from CIN or carcinoma in such cases.
Neoplastic cells have a well-preserved chromatin structure, defined
nuclear membranes and abnormal nucleo-cytoplasmic ratios but
these features are hard to define and sometimes characteristic
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cells are not shed from the condyloma. Colposcopically directed
cervical biopsies should be taken where there is an abnormal
Papanicolaou smear.
Some features of the histopathology of genital warts have
already been covered in Section 4. Condyloma acuminatum is
distinguished by papillomatous growth with acanthosis. There is
elongation and thickening of rete pegs and koilocytes are
prominent, often in the tips of the papillary projections. In
the flat condyloma, the most striking feature is the presence of
koilocytes in the middle and upper epithelial layers.
In some cases, the flat condylomata are found in association
with CIN, either within the pre-malignant lesion or adjacent to
it (see Fig. 8). This makes the detection of HPV infection and
the grading of the dysplasia very difficult. Fletcher (1983)
suggests a simplified and helpful scheme of reporting on the
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histopathology of cervical biopsies which is to grade the
dysplasia with and without koilocytosis and, if desired, to note
whether the koilocytes are adjacent to, remote from, or
co-incident with the dysplasia.
An attempt has been made recently to clarify this area and
to forecast which lesions might progress by reporting on the
ploidy pattern of biopsies (Fu et al, 1983). While diploidy
represents a normal cellular pattern, polyploidy is indicative of
hyperplasia and benign neoplasms, and aneuploidy of a malignancy
(Bohm and Sandritter, 1975). It is possible to quantitate
nuclear DNA in smears or tissue sections by microspectro-
photometry or computerised image analysis after Feulgen staining.
In condylomata, diploid or polyploid DNA is found, while in CIN,
persisting for a year or more, aneuploid DNA is detected; in CIN
which regressed, most nuclei are diploid or polyploid. This
technique is demanding and time-consuming, perhaps not likely to
be useful in a routine laboratory, but automated fluorescent flow
cytometry may be developed in the near future to give similar
information.
Measurement of DNA content of cells has been complemented by
observations of abnormal mitotic figures and diffuse nuclear
atypia in VIN lesions (Crum et al, 1982). In vulval
condylomata, nuclear atypia is seen in the mature epithelial
cells only and abnormal mitoses are absent. Furthermore
last year Crum et al ( 1985) showed that a distinction between HPV
types in CIN might be made histologically. Condylomatous
lesions containing koilocytic atypia and nuclear atypia in the
upper epithelial layers were infected with HPV 6 or 1? in 61% of
cases. CIN lesions in association with condylomata showing
nuclear atypia in all the epithelial layers and/or abnormal
mitoses plus koilocytic atypia were infected with HPV 16 in 82%
of cases. CIN lesions with minimal epithelial layer maturation
and nuclear atypia in all epithelial layers and/or abnormal
mitoses had evidence of HPV 16 DNA in 33% of cases and untypable
viral DNA in 22% of cases. This analysis demonstrates that very
careful histopathology may be able to pinpoint lesions containing
HPV 16 and which may have a tendency to progress. However the
CIN lesions of grades 1 and 2 in association with HPV infections
may be difficult to fit into this histological categorisation.
Furthermore, in contrast to the results of Crum et al (1985)
another study of HPV infections of condylomatous and
condylomata-like lesions of the male and female genital tract,
perianal skin and anal mucosa, concluded that histopathology was
not sufficient to predict HPV type, even taking details of the
koilocytic features into account (Gross et al, 1985b). The only
correlation found was between Bowenoid papulosis lesions
featuring severe epithelial atypia and no koilocytic cells which
contained HPV 16 DNA.
At the present time, therefore, it seems wise to
substantiate the histopathological appearance of condylomatous or
dysplastic lesions with detection of HPV by additional methods.
However, from the point of view of the patient, a very useful
grading of cervical dysplasias can be made using rapid frozen
sections which avoids the delay inevitable with paraffin
sections. The patient can therefore be advised at the time of
colposcopy and treated immediately after diagnosis (Fletcher et
al, 1985).
C. Electron microscopy
Condylomata acuminata prepared for electron microscopy by
standard procedures were first shown to contain HPV virions in
1968 in Edinburgh (Dunn and Ogilvie, 1968). The virus particles
have characteristic size and shape which make them relatively
easy to detect in cells, even at low densities. Since then
several groups have undertaken surveys of flat condylomata and
reported HPV in approximately half the biopsies screened (Reid
et al, 1980; Pilotti et al, 1981; Ferenczy et al, 1981). The
particles are always found within the nuclei of koilocytic cells
and sometimes in the superficial dyskeratotic cells but, in all
types of genital warts, are present in low numbers only. HPV
particles have never been reported in malignant squamous cell
tumours (Syrjanen and Pyrhonen 1982; Kurman et al, 1981).
It is possible to reprocess cells for electron microscopy
from Papanicolaou smears using the methods outlined in Smith and
Coleman ( 1983) . Virus particles are seen in koilocytes and
dyskeratocytes in about half the smears examined which showed
overall cytological evidence of HPV infection (Meisels et al,
1984).
While electron microscopy has provided valuable information
about productive HPV infections in genital condylomata, it is a
painstaking technique given the paucity of virus particles. It
will not distinguish different types of HPV and obviously cannot
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be used to detect HPV DNA in malignant tumours. Apart from
research purposes, it has been superceded, largely, by detection
of HPV antigens (see Section 6D). However, recently, interesting
results have been obtained on the possible latency of HPV in the
cervix by using electron microscopy. Syrjanen et al (1985)
screened punch biopsies by electron microscopy in a prospective
follow-up of women who had had abnormal smears^and reported
finding HPV particles in tissues which were colposcopically and
histologically normal. Although this work could be done by DNA
hybridisation methods as outlined in another study (Ferenczy et
al, 1985), information on the morphology and numbers of virions
and cell types infected can be obtained only from electron
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microscopy. Thus the electron microscope provides useful
additional, and sometimes, thought-provoking results.
D. Detection of HPV antigens
The method commonly employed for the detection of HPV
antigens in genital condylomata is peroxidase-antiperoxidase as
outlined by Sternberger (1979; reviewed in Meisels et al, 1984).
This procedure has the great advantage that sections of formalin-
fixed, paraffin-embedded material can be used. An antiserum
with papilloma virus genus-specificity is made by injecting
rabbits with purified disrupted HPV 1 from pooled plantar warts
or BPV 1 from bovine fibropapillomas. This antiserum binds to
viral antigens and is detected by adding a secondary antiserum
followed by a soluble complex of peroxidase-antiperoxidase which
binds to the free site of the secondary antibody. A substrate
of peroxidase and are added; in a positive test, a dark
brown staining results.
In essence, HPV antigen is detected in the nuclei of some
koilocytes and occasionally in dyskeratocytes. In some surveys
it is found more often in flat condylomata than in exophytic
lesions (Morin et al, 1981; Ferenczy et al, 1981), while in
others the reverse is found (Syrjanen et al, 1983). The degree
of positive staining is always variable although it is most
marked where the koilocytosis is most extensive, and it ranges
from abundant, patchy and sparse, to negative. Even examining
adjacent epithelial asperities in condylomata acuminata showed
great variation in staining for no known reason (Woodruff et al,
1980). Syrjanen et al (1985) found no correlation between the
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presence of HPV particles seen on electron microscopy and the
presence of viral antigens, and surmised that the genus-specific
antigen may not necessarily be expressed or exposed at the same
time as virus particles are found.
With regard to CIN and VIN, positive staining is found to be
inversely related to the degree of dysplasia and is not found,
generally, in carcinomas (Reid et al, 1982; Kurman et al, 1983;
Crum et al, 1982) .
Variations of the peroxidase-antiperoxidase method include
using biotinylated secondary antibodies with a detection system
of avidin and biotinylated horse-radish peroxidase. In a study
by Gupta et al (1983), this technique was employed to compare
positive staining for HPV antigens in Papanicolaou smears as
compared with cervical biopsies; HPV antigens were detected in
67% of smears and 62% of biopsies. Thus cervical smears may be
$
just as effective a starting material for detection of HPV
antigens as biopsies.
At the present time, as outlined in Section 2C, no
antibodies are available which can differentiate the genital HPV
types. It would be extremely useful to develop such antibodies,
either monoclonal or polyclonal, especially directed against
early viral products. Attempts are being made in this direction
and, now that the nucleotide sequences of HPV la, 6b and 16 are
known, it may be possible to create artificial oligo-peptides
with type specificity against which antibodies could be produced.
Recently Gorra et al (1985) characterised several monoclonal
antibodies to BPV 1 which could distinguish lesions induced by
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BPV 1 from BPV 2 and HPV 1, as tested by avidin-biotin
immunoperoxidase staining. BPV I was purified from bovine
fibro-papilloma, disrupted with SDS, and used to immunise mice.
Sera from the mice were tested for antibodies to papilloma virus
by immunofluoresence on acetone-fixed sections of bovine
fibro-papillomas. Mice with high antibody titres were killed
and their spleen cells fused with a non-immunoglobulin secreting
myeloma cell line. Hybridomas were screened for immunoglobulin
production, then by immunofluoresence for anti-BPV antibodies.
Any positive cultures were cloned and further tested for type
specificity. Three were found with type specificity for BPV ],
all of the IgG2a sub-class. It should be possible to make
similar monoclonal antibodies against the HPV types present in
large numbers in warts such as HPV 1, but it would be difficult
to collect sufficient purified particles in the case of genital
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warts. As there is no expression of the genus-specific antigen
in malignant genital tumours, monoclonals with type specificity
for early viral proteins may be necessary to detect and type any
HPV present in such a lesion.
Thus screening for HPV antigens using existing antibody
preparations are of use in detecting HPV productive infections,
but great advances would be made if antibodies were available
of either type specificity or directed against antigens expressed
in transformed cells.
E. Detection of HPV DNA by hybridisation
This approach is the only one to date which leads to typing
of HPV. Furthermore the state of viral DNA (whether integrated
31.
or not, whether a single copy or repeated and in what manner)
within the infected cell or tumour can be ascertained.
Hybridisation depends on single-stranded nucleic acids forming
stable duplexes under appropriate conditions if their base
sequences are sufficiently complementary. If double-stranded
nucleic acid is heated, it denatures to single strands. The
temperature at which half the double strands become
single-stranded is called the Tw, and it can be calculated for
M
any given nucleic acid:
Tw = 81.5 + 0.50 (% G+C) + 16.6 (logNa+)- 0.60% formamide.
It depends on the G+C content of the nucleic acid, the
monovalent ion concentration and the concentration of denaturing
agents like formamide.
The optimal temperature for duplex formation is 25°C below
T . At this point (high stringency) only single strands with a
J
high degree of complementarity remain as stable duplexes; if the
hybridisation temperature is lower (low stringency) then less
well matched duplexes remain together. These differential
hybridisation conditions have proved very useful in HPV studies.
Thus it is possible, first, to screen DNA from a lesion at low
stringency with an HPV DNA as probe to look for any evidence of
HPV DNA; then, if present, the conditions of stringency can be
increased with use of different types of HPV DNA as probes, and
this will specifically type the HPV DNA in the lesion (Bornkamm
et al, 1983). A temperature of T -18°C has been used forM
stringent hybridisation, and a temperature of T^-40°C for
non-stringent (Ikenberg et al, 1983; Boshart et al, 1984).
Methods of hybridisation include Southern blotting,
adaptations of dot blotting and in situ hybridisation.
In general terms, in Southern blotting, the cellular DNA
from a biopsy is extracted and cleaved with one of several
restriction endonucleases, ECoRI and BamHI being used commonly.
The digests are run on agarose gels, denatured and transferred to
nitrocellulose filters (Southern, 1975). The filters are
incubated under the appropriate hybridisation conditions with
cloned HPV DNA, labelled in vitro by nick translation, usually
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with P. Molecularly cloned HPV DNA, commonly using the
plasmid vector pBR322 in E. coli K12, is available for most HPV
types (de Villiers et al, 1981). After hybridisation, the
filters are washed under appropriate stringency conditions and
autoradiography carried out. To calibrate the system, different
genome equivalents of unlabelled HPV DNA are included in place of
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the cellular DNA; the sensitivity is of the order of 0.5 genome
equivalents per cell. An analysis of condylomata acuminata for
HPV 6 DNA by this method is outlined in Gissman et al ( 1982) and
the detection of HPV 18 in cervical carcinomas in Boshart et al
( 1984) .
Whether the viral DNA is integrated or not can be determined
by a combination of methods (Durst et al, 1985). Firstly
cellular DNA is centrifuged in a CsC1/ethidium bromide gradient
which allows a distinction to be made between supercoiled,
nicked-circular and linear DNA or DNA co-migrating with cellular
DNA. Secondly the cellular DNA is analysed by 2-D gel
electrophoresis after digesting with a restriction endonuclease
not cleaving the viral DNA. Following Southern blotting and
hybridisation under stringent conditions, a linear (integrated)
and circular (non-integrated) can be distinguished. Finally
junction fragments between viral and cellular DNA can be detected
after digestion of cellular DNA with a restriction endonuclease
cleaving at several sites within the viral genome, followed by
gel electrophoresis and hybridisation. The cleavage pattern is
altered if the viral DNA is integrated. The DNA encompassing
the junctions between the viral and cellular genome may be cloned
and used to analyse integration sites and DNA from other tumours.
Dot blotting has been tried by several groups recently,
mostly in attempts to use cervical scrapes for typing HPV without
the need for cervical biopsies. The clinical procedure is no
more demanding than collecting routine Papanicolaou smears. In
one study (Schneider et al, 1985) smears were taken with swabs
from the vagina, vulva, endo-and ecto-cervix, and the cells
suspended by mixing in buffer before filtering directly on to
nitrocellulose membranes for hybridisation without first
extracting cellular DNA. 100,000 - 500,000 cells were obtained.
Hydrodynamic filtration was tried by placing a small cup on the
abnormal area of the cervix and irrigating the surface. The same
results were obtained with both methods and showed good
correlation with Southern blotting and histology. Sometimes
infection with more than one type of HPV was detected which may
reflect the relative cell populations obtained from smears and
biopsies, and the relative sensitivities of dot blotting and
Southern blotting. HPV DNA was largely confined to the tissue
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seen to be colposcopically and cytologically abnormal but
occasionally was found in normal tissue. It is not known if
this result is due to latent HPV infections or to "false-
positive" hybridisations. Follow-up studies are required.
Another group also used cervical scrapes but the cellular
DNA in this case was extracted, put on gels, and transferred to
robust Zetaprobe nylon filters before hybridisation (Wickenden et
al, 1985). These filters can be stored and are re-hybridisable.
A check was made on the quantity of DNA extracted from the scrape
by hybridisation with an alu-repeat sequence probe. This
particular sequence is found 5 x 10"' times in human genomes, and
16% of samples had insufficient DNA. Only HPV 6 DNA was used as
a probe in this study and it will be interesting to obtain data
using a wider range of HPV DNA types.
Dot blotting has to be carefully controlled to ensure that
the probe does not bind non-specifically to the filter. The
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probes are usually labelled with P. This makes the procedure
fairly slow (autoradiography requires 1 to 6 days for adequate
exposure) and labour-intensive. Great efforts are being made to
label the probe with a substance other than a radioactive tag,
such as a fluorochrome or biotin (see below). This would
eliminate the need for radioactive substances, enable batches of
probes to be synthesised which would be stable, and reduce the
time needed to detect duplex formation.
In situ hybridisation has proved a powerful tool in locating
viral DNA or mRNA in specific cells from tumours and other
tissues. It has the advantage over other hybridisation methods
of locating specific cells within a lesion which contain viral
information. In addition paraffin sections prepared for routine
histopathology can be used. Grussendorf and zur Hausen (1979)
were the first to show which cells in plantar and finger warts
contained HPV DNA. "^H-UTP was used to label the cRNA of HPV 1
and the sensitivity was of the order of 20 viral genomes/cell.
A similar study recently located HPV 16 DNA in nuclei of tumour
cells from cervical carcinomas (Grussendorf-Conen et al, 1985).
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The viral DNA was labelled by nick translation with H-TTP.
Tritium-labelled probes need a long exposure time on
autoradiography but produce contained, localised grains after
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development. S-labelled viral probes are being tried which,
theoretically, could produce localised grains on autoradiography
in a much reduced exposure time. However high background
labelling is a problem.
HPV DNA has been labelled with biotirl in vitro instead of
with a radioactive substance. Condylomata acuminata were then
screened by in situ hybridisation (Beckmann et al, 1985).
Hybridisation was carried out under stringent and non-stringent
conditions using HPV 1, 6, 11 and 16 DNAs as probes. After
hybridisation avidin was added, followed by goat antiavidin,
biotinylated rabbit antigoat IgG, avidin-biotinylated peroxidase
and finally a substrate for peroxidase. Each of these steps
amplifies the sensitivity of the method which was estimated at
50-100 viral copies/cell genome using a reconstruction dot
blotting experiment on nitrocellulose membranes.
At the moment, the sensitivity of hybridisation using
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biotinylated probes is about a hundred times less than using
radioactive probes. However the method is an attractive one
and, hopefully, improvements such as synthesising more suitable
biotinylated nucleotides and including more amplification steps
will improve the situation.
F. Immune response
There is little information available on the immune response
to HPV infections except it is generally agreed that circulating
antibody titre is not a significant factor in predicting
regression or persistence of warts, or re-infection (Cubie, 1972;
Pfister and zur Hausen, 1978). However more sensitive methods
for measuring antibodies have been developed in the past few
years such as enzyme-linked immunosorbent assays (ELISA). One
study with disrupted BPV 1 as antigen and an ELISA test has shown
that IgG antibodies to papilloma antigens were present in 95% of
patients with anogenital warts, 60% with CIN and 93% with
cervical carcinomas. IgM antibodies were present in 54% of
patients with anogenital warts, 29% with CIN and 95% with
cervical carcinomas. Controls of children and adults without
cervical lesions were never positive (Baird, 1985). It is hard
to understand the significance of this data, both for the IgM
and the IgG results. Some corroboration is required before such
a test would be of use as a detection method for cervical
abnormalities.
Cell-mediated immune responses are thought to play a role in
regression of warts, with inflammatory cell exudates being
characteristically found (Tagami et al, 1977). It has been
suggested that the initial cells of the wart may not be
recognised by immune effector cells, perhaps because the
products of the virally infected cells are immunosuppressive
locally (Kirchner, 1984). Recently it has proved possible to
examine wart and CIN lesions from the cervix for the
distribution of such effector cells. Specific monoclonal
antibodies were used which differentiate B lymphocytes, T cells
of the helper and cytotoxic/suppressor subsets and Langerhans
cells. Langerhans cells and T lymphocytes were much depleted
in wart epithelium compared to normal epithelium, while there
was an increase in Langerhans cells and T cytotoxic/suppressor
cells together with increased stromal lymphocytes in CIN 3
(Morris et al, 1983). The Langerhans cells of the epidermis are
known to be very important in recognition and processing of
exogenous antigens within local sites, presenting antigens to
the T lymphocytes and thus playing a crucial role during viral
infection of the skin and in tumour induction (Wolff and Stingl,
1983).
Another study has characterised mononuclear cell
infiltrates in cervical biopsies of women followed for at least
12 months (Syrjanen et al, 1984). No differences were found in
the percentage of T cell subsets, B cells or mononuclear
phagocytes between lesions which remained stationary, regressed
or progressed. Progression was only related to the degree of
CIN although there was a marked reduction in Langerhans cells in
lesions which progressed compared to those which regressed or
remained stationary. The significance of this finding is not
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known. The presentation of HPV to the immune system in the
epidermis and the local immune response is a topic of great
interest, and information of diagnostic or prognostic
significance may well be forthcoming from its study.
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7. CONCLUSIONS AND FUTURE PROSPECTS
As may be seen from the previous Section, no one method is
readily available at present for detecting genital HPV
infections, although nucleic acid hybridisation, if well
controlled, gives most information about the virus. From the
point of view of the patient, assessments made at the time of
colposcopic and other examinations are most valuable, especially
if treatment is then immediate. A pathologist, working in
conjunction with a clinician, can provide information rapidly
using frozen sections of tissue. It remains to be seen whether
the majority of HPV infections can be typed correctly on the
distribution of nuclear atypia in sections. Much more requires
to be discovered about the induction of dysplasia and what
governs its progression, stationary phase or regression.
Transmission of HPV types, especially of types 16 and 18, is
important to ascertain and whether these viruses can be latent in
the genital tract of men and women.
Nucleic acid hybridisation by Southern blotting of DNA from
biopsies is a technique requiring expertise, and is expensive and
time-consuming. However, recent advances using cervical scrapes
in place of biopsies, probes labelled with biotin instead of a
radioactive tag,and dot blotting have almost brought
hybridisation into the realm of diagnostic virology. More
information should be available in the near future from
laboratories around the world about the association of HPV 6, 11,
16 and 18 with CIN, VIN and other neoplasms of the genital tract
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which should give a clearer indication of their putative role in
genital carcinomas.
While this book is devoted to the uses of monoclonal and
polyclonal antibodies in diagnosis of sexually transmitted
diseases, antibodies against HPV which are available at present
do not provide all the information required. Antibodies which
are type specific and/or which can detect early viral proteins
are necessary and it should be feasible to produce such reagents.
The only monoclonal antibodies used so far in HPV infections are
ones which distinguish mononuclear cells in sections of tissues.
This type of study is important, not so much in the context of
detection of HPV, but in understanding the local immune response
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Types of HPV and their predominant clinical lesions.
Lesion
Plantar wart
Common wart (mosaic type)
Plane wart
Palmar and plantar warts
Epidermodysplasia verruciformis (EV)
Condyloma acuminatum, flat condyloma,





Plane wart, condyloma acuminatum
Condyloma acuminatum, flat condyloma, laryngeal





Carcinoma of uterine cervix, vulva and penis,
Bowenoid papulosis, vulval intra epithelial
neoplasia grade 3, CIN 3
EV
As type 16
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SUMMARY
Cervical biopsies were taken from 79 patients with various
grades of cervical intra-epithelial neoplasia (CIN) or with
koilocytic lesions of the uterine cervix, considered
pathognomonic of human papilloma virus (HPV) infection, and from
10 women with normal cervices. The DNA content was analysed by
flow cytometry. Analysis of data obtained showed that the
biopsies from CIN and koilocytic lesions contained significantly
more cells undergoing DNA synthesis and mitosis (29.89 - 33.06%)
than those from normal cervices (21.60%). The proportion of
aneuploid samples from the group with koilocytosis only and
without CIN (18.2%) did not differ significantly from the group
with CIN III (21.2%). These results have relevance for the
postulated role of HPV in the aetiology of cervical carcinoma and
for the clinical management of patients.
INTRODUCTION
The association between human papilloma virus (HPV)
infection of the lower genital tract and intra-epithelial
neoplasia has been recognised for some time and there is an
increasing body of evidence to suggest that the association is
causal rather than casual^. The lesions caused by
papillomaviruses tend to be persistent and are characterised by
increased proliferative activity. These features, as well as
2
animal models make the viruses attractive candidates for a
possible role in human carcinogenesis.
Most human cervical carcinomas contain aneuploid cell
3
populations and a variable proportion of cases of cervical
4
intra-epithelial neoplasia (CIN) are also aneuploid . In
addition it is known that the number of proliferating cells in a
tumour increases with increasing malignancy^. Since the advent
of flow cytometry it has become possible to identify aneuploid
populations with greater accuracy and to quantify the fraction of
a cell population in each phase of the cell cycle. In this
study, we have used an EPICS flow cytometer to examine both these
aspects in CIN and in HPV infection of the cervix.
MATERIALS AND METHODS
Patients
Seventy nine patients (age range 22-47) referred to the
Elsie Inglis Colposcopy Clinic with abnormal cervical cytology or
a clinically suspicious cervix were studied. Ten women
undergoing minor gynaecological procedures (age range 25-43) with
a normal smear history were included as normal controls.
Biopsies
A cervical biopsy was taken from an area of colposcopic
abnormality within the transformation zone of each subject or
from the transformation zone of the controls. The specimen was
snap frozen on dry ice and stored at -80°C until processed
further. A single 8 mm cryostat section was taken from the
centre of each specimen and prepared for routine histopathology
using a conventional haematoxylin and eosin stain.
The remainder of the biopsy was then thawed, minced and
incubated in 3 ml 0.5% solution of pepsin (Sigma) in 0.01 M
phosphate buffered saline (PBS), with the pH adjusted to 1.5 with
HC1, at 37°C for one hour. The supernantant was drawn off and
centrifuged at 2,000 g for 10 min and the resultant pellet washed
in PBS and re-spun at 2,000 g for 10 min.
Staining procedure
The nuclear suspension thus obtained was stained using a
modification of the method of Deitch et al^. The pellet was
dispersed in 2 ml of a solution containing 50 mg/ml propidium
iodide (Sigma) in 0.01M Tris (pH 7.0) with 5mM MgCl^, 0.1% Triton
X-100 and 15 pg/ml RNase (Sigma) and incubated at 4°C for 1-24
hours. The nuclei were then centrifuged at 2,000 g for 10 min
and resuspended in PBS.
Controls for flow cytometry
Chicken red blood cells (CRBC) were run with each sample as
an internal control. Their DNA content equals 35% of the DNA
content of a human diploid cell^. They were stained using the
propidium iodide solution described above.
Human peripheral blood lymphocytes were stained and run with
CRBC as an external control at the start of each run.
Flour cytometry
The flow cytometer used was an EPICS V (Coulter) equipped
with an argon ion laser, using 200 mW and emitting light at
488 nm. Nuclei were run at a rate of 150 per second until
20,000 stained nuceli had been counted.
Analysis of data
The data obtained were subjected to parametric analysis
using the EPICS para 1 programme which determines the proportion
of nuclei in each phase of the cell cycle. Statistical
significance of each group compared to the control group, was
calculated by the Student's 't' test.
RESULTS
Cell cycle analysis
Table 1 shows that of 89 cervical biopsies examined, 10 were
classified by histopathology as normal squamous epithelium, 11 as
containing areas of koilocytosis without evidence of CIN, 14 as
CIN I, 21 as CIN II and 33 as CIN III. Koilocytosis was indicated
by the presence of balloon-shaped cells in the epithelium and is
g
considered pathognomonic of HPV infection . Four specimens
produced histograms on flow cytometry which, because of an abnormal
distribution of DNA, were unsuitable for parametric analysis and
they were omitted from this part of the study.
The table also indicates the percentage of cells in the S
phase (the phase of DNA synthesis) and in the (the post
synthetic gap) and M (mitotic) phases of the cell cycle. Fig.l
demonstrates the data obtained from one biopsy.
Traditionally, studies of cellular proliferation have
examined the S phase fraction only, as it was not possible to
quantify the cells in the + M phases using tritiated thymidine
uptake. Two of us (RH and WN) analysed the histograms
independently and found that the S + G£ + M percentage was less
subject to observer variation than was the S phase alone,
although as can be seen from Table 1 the two measurements gave
very similar results.
The S phase fraction rose from 11.97% of the total in normal
epithelium to 20.64% in epithelium containing koilocytes but no
CIN. This difference is significant (p < 0.01). The CIN
groups all contained significantly more S phase cells than the
normal group. There was no significant difference between the
koilocytosis and the CIN groups.
When the S and G£ + M phases are considered together a
similar pattern is seen. All 4 abnormal groups (Koilocytosis
alone, CIN I,II and III) contain significantly more cells in the
S + G^ + M phases than the normal group but the 4 groups do not
differ significantly from one another.
The DNA index was calculated from the ratio between the CRBC
and sample modal channel numbers versus the ratio between CRBC
and lymphocyte modal channel numbers. Thus a DNA index of 1
equals a diploid DNA content. A sample was considered to contain
an aneuploid component if the DNA index was less than 0.9 or
greater than 1.1 or if it contained a major subsidiary peak which
was distinct from the Gq/G^ (diploid) and G^ + M peaks. All 4
abnormal groups included some aneuploid samples with the
percentage ranging from 14.3% (CIN I) to 21.2% (CIN III). Of
the 15 aneuploid samples identified, 6 were hypodiploid (DNA
index < 0.9) and 9 were hyperdiploid (DNA index > 1.1). The DNA
index of hyperdiploid populations was always less than 1.5.
DISCUSSION
We have shown that it is possible to distinguish normal
cervical epithelium from epithelium containing koilocytosis and
CIN using flow cytometry. Koilocytic epithelium and CIN
differed from normal epithelium in containing a larger proportion
of proliferating (S + G2 + M phases) cells and, in some cases,
possessing an aneuploid component.
It is particularly interesting to note that specimens
containing koilocytes with no co-existent CIN differ so markedly
from normal epithelium, both in proliferative activity and in
containing some aneuploid populations (2/11 specimens). It has
been postulated that papillomavirus infected cells initially
behave as though stimulated by a non-specific mitogen and that,
in a semi-permissive epithelium, many cells remain in a prolonged
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S or G2 phase . Reid et al proposed that cumulative mitotic
errors in these stem cells might result in occasional chromosomal
mutations spawning clones of aneuploid basal cells. By
demonstrating an increased proportion of S + G2 + M phase cells
in the koilocytic group our work would support this view. The
CIN II and CIN III lesions were found to contain a smaller
proportion of proliferating cells than the koilocytic and CIN I
lesions (although the difference is not statistically
significant). This fits Reid's hypothesis with the virus
initially stimulating epithelial proliferation followed by
subsequent S phase arrest and emergence of aneuploid populations.
4 11
In contrast to the work done by other groups ' the
relative frequency of aneuploidy did not increase significantly
with increasing severity of CIN in this study. The proportion
of samples containing aneuploid populations was essentially
similar in the 4 abnormal groups including the "koilocytosis
alone" group (range 14.4% - 21.2%). To our knowledge this is
the first published report of aneuploidy in "benign" HPV
infection of the cervix and lends support to the hypothesis that
HPV does have a central role in the aetiology of cervical
carcinoma.
In addition there may be far reaching implications for the
management of patients with any evidence of genital HPV infection
or with CIN I. In many centres these women are treated
conservatively in the hope that the lesion will regress. It has
been suggested that the clinical behaviour of lesions may be
12
predicted on the basis of the ploidy level . Our data would
indicate, on the other hand, that so called benign HPV infections
and CIN III share similar DNA patterns and thus, it could be
argued, should be treated identically.
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TABLE 1.
Percentage of nuclei from cervical biopsies in various phases of the
cell cycle, and number showing aneuploidy.
Histopathology Number suitable % S phase % (S + G2 + M) Number
for parametric analysis + S.D. phase + S.D. aneuploid
Normal 10/10 11.97 + 4.00 21.60 + 4.51 0 (0%)
Koilocytosis alone 10/11 20.64 + 8.62 31.20 + 8.53 2 (18.2%)
P < 0.01 P < 0.01
CIN I 14/14 23.25 + 9.36 33.06 + 8.71 2 (14.3%)
P < 0.001 P < 0.001
CIN II 20/21 19.80 + 7.74 29.89 + 8.39 4 (19.1%)
P < 0.01 P < 0.01
CIN III 31/33 18.27 + 5.8 31.76 + 8.38 7 (21.2%)
P < 0.001 P < 0.001
p values comparing each abnormal group with the normal group were calculated by
Student's 't* test.
Legend for figure 1
Flog cytometry of mylpar HM from a cervical biopsy
Red fluorescence is plotted on an arthrimetic scale along the ordinat
and number of nuclei along the abscissa.
The Gq/Gj peak lies within the first set of cursors (a) and the +
peak set within the second set (b). The S phase fraction lies between the
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Looking back at It
At nineteen I was a Brave Old Hunchback
Climbing to tremendous heights
Preparing to swing down on my golden rope
And rescue the Accused Innoncence.
But on my swooping, downward path one day
Innocence ducked
And, I amazed at such an act, crashed into
A wall she had been building,
How silly now to think myself able to rescue anything!
iii
DECLARATION
I declare that this thesis is my own composition. With
the exception of papers A2 and A5 which describe work carried
out as part of PhD studies (Al) at Edinburgh, no part of this
thesis has previously been submitted towards a higher degree.
In papers Bl, D1, D2, D3, D10 and Fl, I was a collaborator and
not the senior author. In all the remaining papers, I was the




It is a great pleasure to acknowledge the help and interest
of my colleagues and friends. Dr Ian Sutherland, my PhD
supervisor, sent me off on a voyage of discovery while I was an
Honours student and, although I have changed direction
considerably since those distant days, I still look back on the
complex cell wall and extracellular products of bacteria with
wonder. Professor Marmion influenced the change from my being a
Bacteriologist to a Virologist and, in particular, initiated my
interest in pathogenesis and in the factors involved in
persistent viral infections. Dr Bill McBride, during numerous
lengthy "chats", finally persuaded me that it might be worthwhile
to consider some immunological mechanisms as being important in
pathogenesis and his unfailing support through bad times and good
is much appreciated. I must thank my veterinary colleagues for
stimulating various interests and widening my horizons, namely Dr
Mike Sharp, Dr Frank Scott, Dr Bill Martin, Dr Rod Else, Mr Ken
Head and Miss Jean Robb. I am greatly indebted to my present
group of colleagues, Dr Sarah Howie, Mrs Jean Maingay, Mrs
Heather Cubie, Dr Jim Ross and Dr Rhona Hughes for their hard
work, enthusiasm, good humour and for being such marvellously
supportive people. Lastly to Bill Neill, the Virus Research




It is becoming increasingly clear that there are many
viruses which are not eliminated from the body after the primary
infection and which maintain a persistent presence thereafter,
often with important consequences for the host. The exact
mechanisms of these interactions are frequently uncertain.
Most of this thesis is concerned with examining the association
of various viruses with specific cells in vitro and in vivo
which may lead to persistence, and ascertaining the outcome in
terms of viral pathogenesis and immunity.
A viral aetiology for rheumatoid arthritis has been
suggested for many years and several species, notably rubella,
adenoviruses, measles and human retroviruses have suitable
properties to make them putative candidates. Synovial material
and mononuclear cells from patients with rheumatoid arthritis
were examined for signs of virus in the form of infectious
virions, viral antigens, viral nucleic acids, specific viral
enzymes or a cell-mediated immune response, but no indication
was found to substantiate a role for any of these viruses in the
disease process. This work represents the only systematic and
relatively wide ranging study on a viral involvement in
rheumatoid arthritis.
Cytomegalovirus is known to persist in the body after the
primary infection and it has been associated with several
tumours in man, including adenocarcinoma of the colon and
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cytomegalovirus in colonic and cervical tissue and an immune
response to the virus did not substantiate this association. It
was concluded that, while cytomegalovirus was occasionally
detected in tumour material, it was not found sufficiently
frequently to merit its suggested oncogenic role. In addition
it was sometimes present in normal tissue, probably associated
with T lymphocytes.
A study has been made of primary infection by herpes simplex
virus type 1 (HSV) in a murine model. Irradiation of mice with
sub-erythemal dose of ultra-violet B (UV) light led to a
significant depression of delayed type hypersensitivity (DTH)
response to HSV challenge. The suppression was mediated by two
phenotypes of T suppressor cells. The ability of epidermal
cells to present HSV antigens in an in vitro assay was also
suppressed by UV-irradiation. The antigen presenting cells of
the epidermis were capable of directing the type of immune
response generated. These results indicate the importance of
the initial interaction of the virus with the cells of the
epidermis and how external events surrounding the infection may
influence the immune response generated. There may also be
consequences for the establishment of latency, and the frequency
and extent of reactivation. A recrudescent model of HSV
infection in the mouse has been developed. Urocanic acid
present in the stratum corneum has been suggested as a possible
photoreceptor and mediator of UV-induced suppression. Direct
evidence was obtained that the cis-isomer of urocanic acid
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induced suppression of DTH to HSV and that two subsets of T
suppressor cells are involved.
Work has begun on examining the persistent nature of
papilloma virus infections of the epidermis and the local immune
response generated. Particular attention has been paid to human
papilloma virus infections of the cervix, recently suggested as
an important factor in the aetiology of cervical intra-epithelial
neoplasia.
Studies have been made of various animal tumours, notably
sheep pulmonary adenomatosis (jaagsiekte), canine and feline
mammary carcinomas, and ovine adenocarcinoma of the small
intestine, mostly by in vitro culture, examination of surface

















Most of this thesis concerns the mechanisms whereby viruses
may cause persistent infections, how these agents accomplish a
balance with the immune response of the host and what the outcome
of such an interaction might be. However the initial research
recorded here from 1969 was as a PhD student with Dr I.W.
Sutherland, Department of Microbiology, University of Edinburgh,
in the area of the biosynthesis of extracellular polysaccharides
in bacteria. This work led to an interest in the control of
complex polymer synthesis on bacterial cell surfaces and the
implications of microbial products in pathogenesis. A short
stay in the United States at the University of Wisconsin followed
where the control of microcyst formation in Mycococcus xanthus,
at the level of RNA polymerase, was examined.
A return was made in 1972 to Edinburgh and the Department of
Bacteriology to join a research team led by Professor B.P.
Marmion and the late Dr J. MacKay which was investigating whether
any infectious agent might be involved in the aetiology of
rheumatoid arthritis. At that time, the concept that viruses
might be able to persist in the body after the initial acute or
sub-acute infection was a novel one. Techniques were becoming
available to monitor the "foot-prints" of viruses in cells
without the need for an infection to be productive before it was
apparent. In addition new information on Retroviruses had
confirmed their unique method of replication, and oncogenes were
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beginning to be discovered. The study, with Dr H. Hart and Mr W.
Neill, of material from patients with rheumatoid arthritis was
aimed at detecting viral antigens or nucleic acid in cells of the
affected joints, or an abnormal cell-mediated immune response.
In particular Retroviruses, rubella and measles, all good
candidates as persistent agents in rheumatoid arthritis, were
considered. A short sabbatical was spent in the laboratory of
Dr C. Smith and Dr D. Hamerman, Montefiore Hospital, New York, in
1976. Although no evidence was obtained to associate any of
these viruses with the initiation or continuation of the disease,
important techniques were developed for the rapid and sensitive
detection of viral information within clinical material. In
addition mechanisms of persistence of viruses within a host were
considered and possible outcomes of these interactions. During
this time, some animal models and in vitro systems were described
in the literature which showed a clear association of viruses
with tumours.
With Dr Hart and Mr Neill, and later Dr A. Grail, all these
factors led in 1978 to an examination of the association of
cytomegalovirus, another persistent human virus, with cells of
the immune system and a consideration of whether this virus might
be involved in the initiation or progression of neoplasia. In
particular cervical intra-epithelial neoplasia (CIN) and
adenocarcinoma of the colon were studied using the methods
developed during our rheumatoid arthritis project. No evidence
was found to substantiate the suggestion that cytomegalovirus has
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a role in these pre-malignant or malignant conditions.
A considerable interest was fostered in herpes virus
infections during this work and in agents, other than
cytomegalovirus, found in the cervix. In addition advances had
been made during the previous few years on the concept of the
skin acting as a major lymphoid organ of the body with its own
antigen presenting cells and responding cells of the immune
system. Thus a start was made in 1984 to look at persistent
viral infections of the epidermis, in particular to quantitate
local immune responses and their role in the progression,
recurrence or resolution of the infection. With Dr S. Howie, Dr
J. Ross and Mrs J. Maingay, a mouse model of herpes simplex virus
infection was developed. Ultra-violet light and cis-urocanic
acid were used as modulators of immune function. Human
papilloma virus infections of the cervix were also examined, with
Dr R. Hughes and Mrs H. Cubie, from the points of view of
quantitating the local immune response and associating papilloma
virus types with CIN. Part of this study was initiated while at
the University of Western Australia in the laboratory of Dr J.
Kulski and Dr E. Pixley.
Peripheral to these main lines of research have been studies
with Mr K. Head of rumen papillomas in sheep, and with Dr R. Else
of the behaviour of some canine and feline mammary carcinoma cell
lines in vivo and in vitro. Finally, with Miss J. Robb, cell
culture systems have been developed to screen for mycotoxins in
complex extracts of animal feedings stuffs contaminated with
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fungi and which may cause acute or non-acute symptoms in various
animal species.
The following discussion outlines these areas in more detail
and seeks to put the information obtained into the context of
what was known at the time.
5.
DISCUSSION
The publications which follow are divided into sections
according to the area covered. Section A deals with work on
exopolysaccharide biosynthesis in Klebsiella aerogenes. Section
B discusses results obtained by examining tissues and cells from
patients with rheumatoid arthritis for evidence of viral
infection. Section C outlines studies on cytomegalovirus and
its suggested role in adenocarcinoma of the cervix and carcinoma
of the colon. Section D contains references on various animal
tumours, sheep pulmonary adenomatosis, fibrosarcomas in mice,
adenocarcinoma of the small intestine of sheep, feline and canine
mammary carcinoma cell lines; also work on a cytotoxicity test
for mycotoxins. Section E deals with herpes simplex virus
infections in mice, and the effect of ultra-violet light and
cis-urocanic acid on the immune response, and Section F on
papilloma virus infections.
A final Section seeks to draw these areas together and to
form some conclusions regarding the importance of persistent
viral infections.
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Section A BACTERIAL EXOPOLYSACCHARIDES
It has been known for a long time that bacteria produce
polysaccharides as part of their cell walls and, in many species,
polysaccharides are also synthesised extracellularly. Both
tyes of macromolecules are important in pathogenesis and the
control of their production is not well understood. In
Klebsiella aerogenes the exopolysaccharide consists of neutral
sugars and a limited range of uronic acids arranged in repeating
units with, commonly, a single side chain. Several mutants were
isolated which varied in their ability to synthesise exopoly¬
saccharide from the parent strain (publications A1 and A2). One
was unable to form discrete capsules and only synthesised exo¬
polysaccharide as slime; the exact mutation was not determined
and, even today, the mode of linkage of the capsule to the
bacterial cell surface has not been elucidated. Another mutant
was studied which showed reduced exopolysaccharide synthesis at
low incubation temperatures and an effect on lipopolysaccharide
synthesis leading to agglutination and "roughness" of colonies.
The alteration was thought to be in an enzyme required to
synthesise UDPglucose from glucose, or in an altered regulator,
and it is still not known what controls the relative synthesis of
lipopolysaccharide and exopolysaccharide. Indeed the
distinction between the two polymers has become somewhat blurred
as components thought to be confined to the lipopolysaccharide
have been reported as integral units of exopolysaccharide.
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It is important to determine the cultural and other
conditions which favour exopolysaccharide synthesis and a study
was made to determine the specific activity of enzymes involved
in the synthesis of precursors in wild type and non-mucoid
mutants of K. aerogenes grown under different conditions (A1 and
A5). Little was known about the level of these enzymes or the
control of precursor production, and, surprisingly, it was found
that loss of ability to form exopolysaccharide or growth under
various cultural conditions had little effect on the specific
activity of enzymes tested; perhaps control then occurs at the
metabolic level rather than at the genetic level. Sugar pyro-
phosphorylases may well represent one such point as they serve as
the first stage commitment of the activated monosaccharides to
polymer synthesis.
About 1968 it was known that the peptidoglycan backbone
(Ghuysen, Tipper and Strominger, 1968) and the 0 antigen of
lipopolysaccharide (Nikaido, 1968) were synthesised by adding
monosaccharides sequentially from sugar nucleotide precursors to
a lipid carrier, isoprenoid alcohol phosphate, using membrane
bound enzymes. The same information was not available for the
synthesis of exopolysaccharides although it had been shown that a
lipid carrier stage was probably involved. Our study (A3 and
A4) showed that membrane preparations of K. aerogenes in a
cell-free system were able to transfer sugars (glucose and
galactose) from UDP derivatives to a lipid-soluble material and
to a polysaccharide-resembling material. A model for capsular
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polysaccharide synthesis was proposed whereby UDPglucose passes
through the cell membrane and is modified to form the other sugar
nucleotides which are then transferred sequentially to a lipid
carrier before polymerisation and extrusion into the surrounding
environment. The central role of the lipid carrier in bacterial
polymer synthesis was considered. Since then cell-free synthesis
of exopolysaccharide using lipid-free membrane systems and
regenerated membrane has been accomplished (Troy, Frerman and
Heath, 1971), and now cells made permeable to sugar nucleotides
by EDTA are being used. This leaves enzymes in an ordered
state so that sugars can be added sequentially. However much
remains to be answered, such as the control of the molecular
weight of exopolysaccharides and lipopolysaccharides, what
controls the relative synthesis of these polymers and how they
get transported through the bacterial cell membranes and walls.
In the past few years, there has been an upsurge of interest
in exopolysaccharides as some are now important compounds in
industry, the bacterial alginates and xanthan for example, while
the complex interaction between the surfaces of bacteria and
tissues of higher organisms in health and disease remain a
largely undiscovered and important area.
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Section B VIRUSES AND RHEUMATOID ARTHRITIS
It has been suspected for a long time that an infectious
agent may be involved in the aetiology of rheumatoid arthritis
and for the past twenty years strenuous efforts have been made to
implicate specific viruses, especially those known to cause
persistent infections in man. Our initial research sought to
examine the cytology of synovial cells derived from patients with
rheumatoid arthritis and to establish cultural conditions for
their growth in vitro (Mackay et al, 1974; Bl). Several cell
lines were found which had the properties of transformed cells
and which were thought to have arisen by co-cultivation of human
Chang liver cells and synovial cells. No virus or viral
products were detected despite using a variety of techniques
available at that time. These included electron microscopy,
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induction followed by H-uridine labelling, RNA and DNA
polymerase activities and assays of viral antigens (B4).
Methods have improved considerably since then and it would
probably be worthwhile to re-examine these cell lines for, say,
specific retroviral antigens, for viral nucleic acid and for
abnormal oncogene expression. One cell line and synovial
material from patients with rheumatoid arthritis were injected
into the synovial cavity of baboons of different ages but they
did not develop any arthritic joint symptoms despite being kept
for three years (Mackay et al, 1983).
Retroviruses became attractive candidates in the aetiology
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of rheumatoid arthritis after their unique method of replication
had been described by Temin and Mizutani (1970) and by Baltimore
(1970), and the realisation that the viruses could persist as
integrated proviruses. For the next few years, there was some
confusion about the properties of viral reverse transcriptase and
how to distinguish it from a DNA-dependent DNA polymerase found
in normal cells. Careful assays were performed directly on
synovial material from patients with rheumatoid arthritis or on
synovial cells grown in vitro from clinical material (B2 and
B3). Synthetic template/primers were used and actinomycin D was
present. No viral reverse transcriptase was found.
This approach was probably the only one available at the
time but an attempt was made later to use nucleic acid hybridi¬
sation methods (B5 and B9). As techniques of cloning viral
nucleic acids had not yet been described, four viruses, SV-40,
rubella, a baboon retroviruses RD-114 and measles, which were
thought to have suitable properties to make them possible agents
in rheumatoid arthritis, were cultured in vitro. They were
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purified and their nucleic acid labelled with I. This was
used in membrane hybridisation with DNA and RNA of rheumatoid
synovial cells and in in situ hybridisation but no positive cells
were obtained. With improvements in the preparation and labelling
of viral nucleic acids and in hybridisation techniques, the
equivalent method today would be more sensitive and would have
the potential to pick out sub-genomic quantities of viral nucleic
acid or only a few cells in a population with viral information.
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As yet, no one has reported such results using rheumatoid
material although there have been many such publications from
other areas, especially tumours.
It was suggested that the primary change in rheumatoid
arthritis is in the effector cells of the immune system and that
the rheumatoid process involves a loss of the normal immuno-
regulatory control rather than a normal immune reaction against
an altered target cell, such as a virus-infected fibroblast
(Marmion, 1978). To test this hypothesis, synovial lymphocytes
and monocyte-derived macrophages were examined for various viral
antigens and viruses, retroviruses in particular. None were
found (B7 and B8). Again no other workers have attempted this
type of study and the series of experiments described above
represent the only systematic study in the literature searching
for a variety of viruses in a variety of cells from patients with
rheumatoid arthritis.
In a review written in 1984, consideration was given to
possible interactions between viruses and the host in rheumatoid
arthritis (BIO). Thus, while selected viruses remain as
putative agents in the aetiology of rheumatoid arthritis, no
definitive evidence has been obtained to date. It is crucial to
examine material from early rheumatoid cases if an infectious
agent is suspected, and to repeat some of the work reported here
with more sensitive methods and including such viruses as the new
family of human retroviruses. Effects on oncogene expression
and better definition of any alteration in antigens on various
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synovial cells leading to novel interactions with cells of the
immune system would also make worthwhile studies.
During the course of this work, an interest was developed in
a cell line persistently infected with rubella virus (B6). At
that time there was some evidence to indicate that proviral DNA
may be important in persistent infections involving RNA viruses.
In our system, however, formation of defective interfering
particles was found to be the major factor, not a DNA
intermediate. Since then, apart from retroviruses, no RNA
viruses have been described which persist as proviruses and the
major mechanisms of persistence in vitro are defective
interfering particles described here, development of temperature
sensitive mutants and the protective effect of interferons.
Which of these is important in vivo, if any, remains unclear and
the interactions of the virus, infected cells and immune cells of
the host are of importance in the pathogenesis of many persistent
viral infections. Two such systems involving cytomegalovirus
(CMV) and herpes simplex virus (HSV) are outlined below in
Sections C and E respectively.
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Section C CYTOMEGALOVIRUS AND ONCOGENESIS
CMV is a common human pathogen, frequently infecting
children without producing clinical symptoms. Thereafter it
persists for life, reactivating on immunosuppression and at other
times. It is not clear where or how the virus persists. There
is some evidence for it being involved in some specific tumours,
namely Kaposi's sarcoma, adenocarcinoma of the colon and
carcinoma of the prostate and cervix.
Our initial study was undertaken to find the range of
interactions of CMV with various cell types. In mink lung
epithelioid cells, infection was initiated but aborted at an early
stage; rabbit lung fibroblasts allowed a low level of
replication persisting over a long time (CI). A significant
proportion of cells contained viral antigens even four weeks
after infection but extracellular virus was not demonstrable.
CMV may have become latent in some rabbit cells with only a few
cells being capable of producing infectious virus. Interferon
may be an important factor in this persistence but whether such a
model may be applied to any human cell type is not known.
The association of CMV with human mononuclear cells is of
interest and evidence was obtained to indicate that the virus
interacted specifically with T cells in vivo and in vitro
(unpublished). Peripheral blood monocytes, alveolar macrophages
and peritoneal macrophages were all resistant to infection. The
T cells may represent a possible site of latency of CMV and, if
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so, the virus-T cell balance may be crucial in reactivation and
in the regulation of the general immune response.
The role of CMV in cervical intra-epithelial neoplasia (CIN)
was examined using several approaches. Serological surveys in
the literature had given equivocal results about the levels of
antibodies to CMV in patients with CIN, depending often on the
assay used. Each serum was tested by three methods which should
detect antibodies to different CMV antigens and no correlation
was found between antibody titre and pathological diagnosis (C3).
Peripheral to this study was the finding that the frequency of
carcinoma in situ was not age-dependent, thus emphasising that a
national screening programme should include all sexually active
women. This policy is gradually being adopted.
In addition to CMV antibodies, zinc and copper levels were
measured as an indicator of the presence of a malignant tumour
and its stage; and low levels of zinc may reflect low levels of
vitamin A which had been correlated with the development of CIN.
It was concluded that zinc and copper levels could not be used as
a diagnostic aid to CIN and little support was obtained for the
proposal that low serum zinc levels are associated with CIN
except, perhaps, at the malignant stage of invasive carcinoma
(C7) .
Peripheral blood lymphocytes from CIN patients were assayed
for responsiveness to CMV antigens using a lymphocyte stimulation
test but there was no difference between patients with various
degrees of CIN and controls (C6). In addition natural killer
and killer cell activity of CIN patients did not differ from
controls, and there was no correlation between antibodies to CMV
and increased natural killer cell activity (C4). Thus no
evidence was found to support the view that patients with
cervical cancer had reduced natural killer cell activity as had
been reported previously (Pulay, Benczur and Varga, 1982).
No CMV mRNA was found in CIN biopsies by in situ
hybridization and no viral antigens by immunofluorescence.
Cultured endocervical cells were permissive for CMV if in close
contact with connective tissue fibroblasts (unpublished).
Other studies were done to clarify the role of CMV in
adenocarcinoma of the colon. No viral nucleic acid or antigens
were detected in colonic biopsies or after culture of biopsies in
vitro (C2). This was not in agreement with published results
(Huang and Roche, 1978; Hashio, Horikami and Loh, 1979) but
since then other groups have confirmed our conclusions (Brichacek
et al, 1980; Roche et al, 1981). It was thought possible that
antibodies could be present on colonic cells, thereby blocking
both antigenic sites and receptors and halting viral replication.
However, eluates from adenocarcinomatous tissues showed the same
level of antibodies to CMV as eluates from normal colonic tissues
(C5). A final publication in this area outlines the effect of
molecular binding to the cell surface on the regulation of
intra-cellular events during CMV replication in permissive cells
(C8). It was known that CMV induced Fc receptors on infected
cells which probably share some identity with the receptors for
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antibodies and concanavalin A or succinyl concanavalin A due to a
reduction in cell viability. This may have some significance
for persistence of CMV in sites such as the colon or cervix.
Our studies led to the conclusion that CMV does not play a
significant role in either of the two human malignancies
examined. Unlike most other groups, the approaches used covered
a wide range, from detection of viral nucleic acids and antigens
to serological and cell-mediated immune responses. It has been
proposed that some herpes viruses may act as mutagens by a "hit
and run" mechanism (Galloway and McDougall, 1983) and this type
of association of CMV with tumours, especially if the event
happened early in the tumour induction, cannot be excluded by our
findings. However, some specific immune response might still be
expected but this was not found. CMV was detected very
infrequently in colonic and cervical tumours during the course of
these studies but was present, on occasion, in normal tissues.
Thus CMV may persist in sites such as the cervix and colon,
perhaps associated with T lymphocytes, but not specifically in
pre-malignant or malignant tissues.
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Section D VETERINARY-RELATED STUDIES
Collaborative studies resulted in publications D1, D2 and
D3. For the first time, in 1976, sheep pulmonary adenomatosis
was produced in experimental sheep using a putative retrovirus
alone or, more efficiently, in conjunction with an ovine
herpesvirus, raising the possibility of synergism between two
viral agents (Dl). The methods of purification of the
retrovirus relied on techniques developed in the rheumatoid
arthritis project already outlined in Section B, and the presence
of the virus was assumed from its reverse transcriptase activity.
Further work has since confirmed the presence of the retrovirus
and characterised the reverse transcriptase enzyme (Herring et
al, 1983). A collaborative project is currently underway to clone
part of the viral genome coding for the major core protein and to
prepare monoclonal antibodies to this protein.
A very interesting and, at the time, unique study
demonstrated that normal human tissues contain nucleic sequences
related to Adenovirus type 2 and expressed as mRNA (D3). Using
reagents obtained from the rheumatoid arthritis project, it was
shown that these RNAs were translated into proteins which may be
important in some tissues during cell growth and differentiation.
Since then, sequences, often G-C rich, of other viruses, such as
r\ o
herpes simplex virus and CMV have been reported as normal human
tissue. If found in tumours, misleading conclusions have
sometimes been formed concerning the role of viruses in the
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aetiology of the tumour. Presumably these regions are similar
in sequence to selected sequences in human DNA and perhaps the
protein products of such regions are also similar allowing cross
reaction in immunological tests. The whole area is one of
immense interest at the present time with advances in
understanding of oncogenes, integration of viral genes and
mechanisms of cell growth.
Emphasis was placed in D2 on making sure that cells grown in
vitro and then used for in vivo tumourigenesis were free of
contamination with viruses or Mycoplasma. Such tests remain
important and are rarely undertaken.
An interest in tumour cells led to an in vitro study of
adenocarcinoma cells from the small intestine of sheep (D4).
Morphology, ultra-structure and any involvement of viruses were
noted. One cell line was obtained which was examined in detail
as a mixture of epithelial and other cell types were present
throughout many subcultures, thus mimicking the appearance of the
tumour in vivo. The epithelioid cells were separated from the
others and their properties indicated that they represented
carcinoma cells. No other ovine cell line from any tissue has
been reported since then. These results and a possible viral
aetiology in adenocarcinoma of the small intestine prompted a
subsequent investigation of ovine rumen papillomas reported below
in Section F.
Canine mammary carcinomas were examined by in vitro culture
and three epithelial cell lines were obtained which induced
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tumours in athymic nude mice (D5, D6 and D7). These lines are
the only canine ones reported and lately an equivalent feline
mammary carcinoma line has also been established (D9). The
interest in such lines lay in examining their surface properties
in vitro such as oestrogen receptors and in establishing a nude
mouse model of tumour production, in particular for experimental
hormone manipulation as an alternative to using dogs. There is
a high incidence in bitches of naturally occurring mammary
carcinomas which are similar to human tumours in their pathology
and receptor status, and thus this work was also of value in the
medical field. Tamoxifen has been used in the treatment of
breast cancer in women for several years and is thought to act at
least partly as an oestrogen antagonist, although, in some
surveys, no correlation was found between oestrogen receptor
status and response to tamoxifen treatment. One canine mammary
carcinoma cell line, REM-134, had no detectable oestrogen
receptors and induced tumours at the same rate of growth in male
and female nude mice. The effect of tamoxifen on the tumours
induced by REM-134 cells was ascertained (D8). Oral tamoxifen
reduced the rate of growth of tumours and to the same extent in
male and female mice. These results argue against tamoxifen
acting solely as an antagonist for oestrogen and in vitro studies
support this finding. Two trials are currently underway to test
the action of tamoxifen in tumour-bearing bitches and it will be
interesting to find out whether the nude mouse model is relevant
to the situation in dogs (Else and Pierrepoint, personal
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communication).
Finally in this Section, a collaboration was established as
a result of an episode of disease in broilers in 1980-81 in
Scotland (D10). This was toxin-related and a large number of
fungi of Fusarium species were isolated from mould-contaminated
maize and wheat components of the feedstuff. In the past few
years, it has been recognised that mycotoxins can be important
factors in causing episodes of sub-acute disease or occasionally
of acute disease in a variety of animal species. While some of
these mycotoxins such as aflatoxin or zearalenone have been
identified and well-studied, others remain totally uncharacterised.
The normal method of identification of mycotoxins was by
chromatography after solvent extraction of fungal mycelium or
contaminated material, and to compare the result with standards
of known and purified mycotoxins. A screening test was thus
required which would detect unknown as well as known toxic fungal
metabolites. The sensitivity of various cell lines to several
purified mycotoxins was established (Dll and D12) and it was
concluded that such a cytotoxicity test was a useful addition to
chromatography, being significantly more sensitive for the
trichothecenes in particular. It is of special use if a variety
of cell lines with different receptors and different enzymes are
employed, such as Chang liver cells for hepatotoxins or
Neuroblastoma cells for neurotoxins. Currently an examination
is being made of hydroponic barley associated with a fatal
haemorrhagic syndrome in cattle, and of malt culms associated
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with fatal neurological symptoms in sheep. The cytotoxicity
test is now employed in many laboratories screening for
mycotoxins such as the Ministry of Agriculture. It is of
particular importance as a precautionary assay in cases where
diet and weight gain are tightly controlled and where feed is
given from bulk supplies as is happening more frequently in
present day agricultural practices. It is also useful in
episodes of unexplained illness, associated with mouldy feeding
stuff.
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Section E HERPES SIMPLEX VIRUS INFECTIONS
Primary childhood infections with herpes simplex virus (HSV)
are common and, in at least 50% of cases, the virus becomes
latent, being reactivated at intervals throughout life.
Although much is known about the replication of the virus in
permissive human cells and about the humoral and cell-mediated
immune response generated by the infection, little work has been
done to examine the interaction between HSV and antigen
presenting cells (APC). These cells are recognised to be of
primary importance in generating the immune response and in
resistance to viral infections.
In the first place (El and E2) murine bone marrow cells were
cultured in vitro and underwent maturation and proliferation in
the presence of L-cell conditioned medium. When infected with
HSV, differentiated cells exhibited a cytopathic effect although
no infectious virus was produced and most were resistant to
infection. However the Major Histocompatibility (MHC) Class II
antigen expression in the culture was increased by the infection,
perhaps due to interferon production. This result may have
important implications for the generation of the local immune
response to HSV where the number or efficiency of potential APC
at a particular site may be increased by increasing the MHC Class
II antigen expression. Few groups have looked at the
association of viruses with homogeneous macrophage populations
and it would be of particular interest to examine purified
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Langerhans cells, the major APC of the skin, in this way. This
project is currently underway using fluorescent cytometry and
anti-Class II monoclonal antibodies.
Secondly a model of HSV infection was developed in C3H mice
to examine cell-mediated immune responses, in particular delayed
type hypersensitivity (DTH) which is known to be important in
viral clearance from a local site. It had been shown before
that irradiation with ultra-violet (UV) B light suppressed DTH to
contact sensitising agents (Noonan et al, 1984) and to tumour
anitgens (Fisher and Kripke, 1978). An attempt was therefore
1/
made to show the same effect with viral antigens. If the mice
were pre-irradiated with a sub-erythemal dose of UV-B between 2
and 14 days before being infected with HSV, then their DTH
response was suppressed by 60-90% (E3). The nature of the
suppression was tested by transfer of spleen cells from
UV-irradiated mice to mice previously infected by virus.
Suppression of DTH resulted and was shown to be due to T
suppressor cells in the transferred spleen population which were
of two phenotypically distinct subsets, Lyl+2 and Lyl 2+ (E5).
The ability of epidermal cells to present HSV antigen in an in
vitro assay was decreased by at least 60% if the mice were
UV-irradiated before preparing the epidermal cells (E4). It has
also been shown that epidermal cells from mice pre-irradiated
with UV induce suppression to HSV in naive mice if injected in
the same site as the virus (E8). In this case only one type of
T suppressor cell was generated and the APC were thus directing
the type of immune response. This is a new and exciting concept
that the state of the APC on first encountering the antigen can
be a major factor in the type of immune response generated.
All these results have profound significance for the nature
of the virus-host relationship. UV-irradiation in a critical
period prior to contact with HSV may determine the extent and
severity of the primary infection, which infections become latent
and which recrudesce and with what frequency and severity. The
effect of UV-irradiation on viral infections of the skin has been
reviewed in E6.
While UV-irradiation is known to cause local and systemic
effects, its mechanism of action is not clear. Urocanic acid,
found preferentially in the stratum corneum, has been suggested
as a possible photoreceptor mediator (De Fabo and Noonan, 1983),
converting from the trans to cis form on irradiation. Using the
murine model already outlined, cis-urocanic acid applied
epidermally or injected subcutaneously before sensitisation with
HSV led to the suppression of DTH response on subsequent
challenge with HSV (E7). This was the first direct evidence
that urocanic acid can induce suppression to an epidermal
antigen. The suppression was due to the induction of specific T
suppressor cells of two phenotypic subsets, likely to be the same
as those induced by UV-irradiation (E9). It is now planned to
ascertain the site and mode of action of urocanic acid.
In addition to primary HSV infections, attempts have been
made to adapt the murine model to examine recrudescent
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infections. Recently this has proved successful (manuscript in
preparation). Mice were UV-irradiated before being infected
epidermally with HSV to give visible lesions. Thus their
initial immune response was somewhat suppressed and altered by
irradiation. After two months, they were irradiated again, and
tape stripped at the site of the initial lesion. In over 80% of
mice, lesions appeared within two days either at this site or at
an adjacent site. This finding allows an examination of the
immune response surrounding recrudescence; in particular, the
role of contra-suppressor cells in latency can be tested.
Thirdly, recrudescent oral HSV infections in man are being
studied. Mononuclear cells from peripheral blood have been used
in a lymphoproliferative test with HSV as antigen. The blood
cells have been depleted of APC by glass adherence and the role
of Class II MHC antigens in antigen presentation found by
blocking studies using monoclonal antibodies to the various
regions of the Class II MHC locus. Epidermal cells from suction
blisters are being tried as APC in the lymphoproliferative test.
It is planned to include patients with eczema herpeticum in this
study. Preliminary results indicate a poor lymphoproliferative
response to HSV antigens at the time of clinical lesions with
generation of natural killer cells.
The studies outlined above represent a concerted effort to
understand the events surrounding the initial interaction of the
virus with the cells of the host. They are unique in that a
clinical isolate of HSV was used throughout and most experiments
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have involved epidermal infections. The epidermal route was
chosen deliberately as being more natural than subcutaneous,
intravenous or intra-peritoneal which are commonly used by other
investigators. The dose of UVB irradiation necessary to effect
the immunosuppression was sub-erythemal and raised questions
about the frequency of transient immunosuppression after exposure
to sunlight and the consequences for persistent viruses already
present in the body or, indeed, for any microbial pathogen
encountered for the first time during the immunosuppression.
Antigen presentation is of fundamental importance to the
generation of the immune response and it is significant to find
that the APC may be altered by external circumstances to induce
suppression instead of a positive immune response. The results
with cis-urocanic acid represent the first time that this
compound has been shown to regulate the immune response directly,
and considerable efforts are being made to pinpoint its site and
mechanism of action. If it is possible to transiently
immunosuppress by painting the skin with cis-urocanic acid, then
such a procedure may be of clinical benefit in skin grafting.
Finally development of a murine model of recrudescent HSV
infections leads to the possibility of the analysis of the local
immune response surrounding reactivation by the same techniques
as in primary infections. Contra-suppressor cells have been
implicated in maintaining local immunity while systemic
hypersensitivity is prevented. During the triggering period of
reactivation, this balance may be lost leading to a local
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suppression of immunity and allowing virus to replicate in
epidermal cells. This hypothesis is currently being examined.
Section F PAPILLOMA VIRUSES
As already outlined in Section C, several viruses have been
associated with cervical intra-epithelial neoplasia (CIN), the
latest and most convincing of which is human papilloma virus
(HPV). It is now recognised that a high proportion of patients
with CIN have evidence of infection with specific HPV types
(Gissmann, 1984). In the superficial layers of the epithelium,
HPV infection is thought to be productive with formation of
characteristic koilocytes although in the cervix, mature virus
particles are rarely detected and never in large numbers. In a
hypothesis in 1983 (Fl) the possible association of HPV with the
deep cells of the squamous cervical epithelium was considered.
If there is dysplasia in the deep layers, HPV could be non-
causative or causative of this state. In the former case, the
association between the virus and CIN is unrelated but, perhaps,
the virus becomes activated or is able to infect cells
transformed by some other means. In the latter case, the virus
is associating with the deep cells to cause dysplasia. Thus the
virus and epithelial cells are interacting in different ways
depending on the degree of differentiation of the epithelium, and
perhaps depending on other factors such as co-infection with
another virus or synergism with a carcinogen. If the deep cells
are not dysplastic, perhaps this represents an early
non-koilocytic or pre-koilocytic stage leading to death of
maturing cells and a return to normal epithelial appearances.
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This hypothesis remains to be fully tested and is of obvious
importance in resolving the causal or casual role of HPV in
genital cancers. With advances in in situ hybridization
techniques, and in vitro culture methods for cervical biopsies
and in analysing the function of regions of the HPV genome, these
interactions should become clearer.
Recently it has become possible to analyse nuclear DNA from
human material using flow cytometry. Phases of the cell cycle
and aneuploidy can be calculated. A survey was undertaken to
analyse cervical biopsies from patients with CIN and with
histopathological evidence of HPV infection without CIN (F5).
Evidence was obtained to show that HPV induced cellular
proliferation and to approximately the same extent as found in
CIN grades. The percentage of samples which were aneuploid was
the same in each CIN grade and in the HPV infection without CIN
group. Thus it appears that HPV infection induces abnormal
cellular proliferation and changes in the DNA content in a
certain proportion of cases. These results have significance
for the management of women with cervical HPV infections without
CIN or with CIN I who are often left untreated in the hope that
the lesion may spontaneously regress. This may not be a wise
policy if aneuploidy is already present and if the epidermal
cells are proliferating abnormally.
Interest in genital HPV infections has grown rapidly over
the past few years and it has become desirable not only to detect
HPV infection but also to type the virus. A chapter was
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recently written on this topic (F4) outlining various methods
available including nucleic acid hybridization with labelled HPV
DNA probes under different stringency conditions. Our
particular interest is in the local immune response to HPV
infections, especially the role of antigen presenting cells in
persistence, regression or progression of the lesion.
On a wider front, nucleic acid probes are beginning to be
used for rapid viral diagnosis and offer some advances over more
conventional methods. This topic was reviewed in F2.
Finally in this Section, reference is made to work done on
rumen papillomas in sheep (F3). It arose out of the study
described in D4 on adenocarcinoma of the small intestine in sheep
as it seemed possible that there may be a link between the
papillomas and the development of the malignancy. This has been
described for alimentary papillomas and carcinomas in cattle,
with bracken fern in the diet being an important co-factor
(Jarrett et al, 1983). It had been noted that sheep grazing on
local moorland sometimes had rumen papillomas occurring in
conjunction with adenocarcinoma of the small intestine. The
incidence of rumen papillomas was 12.5% in sheep slaughtered in
Edinburgh - a surprisingly high figure, especially as ovine
cutaneous papillomas are extremely rare. Although evidence was
obtained to indicate the infectious nature of the papillomas,
neither virus particles nor viral DNA were found and only a few
cells in the uppermost epithelial layer were expressing viral
antigens. This result is consistent with any virus producing
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cell being shed rapidly from the surface of the mucous membrane
in the rumen. There may be a similar situation in the human
uterine cervix. It would be necessary to clone an ovine
papilloma virus DNA and to use this as a probe to screen both
rumen papillomas and intestinal adenocarcinomas for viral
information. Unlike this country, cutaneous papillomas on
unwoolled areas of sheep are reported frequently in Australia
and a collaborative survey is underway with the University of
Western Australia to examine their possible conversion to
carcinomas, with UV-irradiation as a suggested co-factor.
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IN CONCLUSION
The preceeding Sections seek to discuss published and
unpublished work of the past sixteen years. It has been of
interest to see how rapidly some techniques have developed during
this time, notably in detecting viral components in infected
cells. Yet there remain many questions to be answered concerning
persistent infections. It is no longer adequate to study viral
infections of specific cells without considering the implications
for the immune response of the host; conversely, the host may
play just as important a role as the virus in creating conditions
for the persistence. What seems certain from the various
viruses studied here is that different mechanisms of interaction
may pertain in each case. With regard to tumours, a multistep
induction is most likely with viruses, perhaps, playing some role
in one or more of these stages. Other factors are probably as
important as viral infection like chemical carcinogens,
co-infections, genetic background, age and state of
differentiation of tissues. The persistent nature of most
viruses associated with tumours is recognised but this does not
rule out a "hit and run" mechanism or a specific chromosomal
translocation event directed by an integrated viral genome. It
is impossible, as yet, to detect small regions of integrated
viral nucleic acid or rearranged sequences and the interaction of
viral genes with cellular oncogenes remains to be evaluated in
most systems.
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A study of the effect of viruses on the immune response,
either direct or indirect, is important. The primary event in
the immune response occurs when the antigen is processed by the
antigen presenting cells which then present fragments of the
antigen in association with Class II MHC molecules on their
surfaces to T cells. Much remains to be found out about the
actual process of antigen presentation and the effect on the
generation of specific lymphocyte subclasses. At the present
time, as outlined in Section E, we are examining epidermal viral
infection and the role of Langherans cells, the major antigen
presenting cells of the skin. The association of viruses with
this cell type is largely unknown and how various environmental
factors may affect this interaction is being studied. Questions
remain to be answered about the individual's response to a virus,
what determines establishment of latency, what affects frequency
and extent of reactivation and if there is any association with
neoplasms or immune complex disease.
It is becoming clear that it is not unusual for many virus
species to persist in the body after the primary infection and
that they may re-appear in different guises or perhaps affect
the immune system in more subtle and, as yet, poorly defined
ways. The interface between viral pathogenesis and immunity in
persistent infections is one of interest and fascination at the
present time, not only to virologists and immunologists but also
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summary
Several mutants isolated from three Klebsiella aerogenes strains showed
characteristics differentiating them from the wild type and also from the
normal type of non-mucoid mutants. These mutants synthesize much less
polysaccharide slime or capsule than the parent bacteria at low incubation
temperature, but similar amounts at 370. The colonies are of rough appearance
at 20° and liquid cultures at this temperature autoagglutinate. At 370,
mutant and parental types are indistinguishable. The mutants show altered
phage sensitivity patterns at 20° and the yield of lipopolysaccharide appears
to be decreased at lower temperatures. Double mutants retaining certain of
these characteristics but devoid of exopolysaccharide-synthesizing activity
have also been isolated. The properties of the parent and mutant types are
compared.
introduction
In studies on polysaccharide biosynthesis, frequent use has been made of mutants
unable to synthesize the exopolysaccharide slime or capsule characteristic of the
parent organism, for example, Diplococcus pneumoniae capsular polysaccharide
(Smith, Mills & Harper, 1957), the slime polysaccharide synthesized by Escherichia
strains and by other species of the Enterobacteriaceae (Beiser & Davis, 1957). During
studies on exopolysaccharide biosynthesis by strains of Klebsiella aerogenes a number
of mutants differing from normal non-mucoid variants were isolated. The unusual
properties of these mutants and their relationship to the parent strains are reported.
methods
Bacteria and methods ofculture. Three strains of Klebsiella aerogenes have been used.
Strains A3(sl) and A4 are laboratory strains used in several earlier studies (Wilkinson,
Dudman & Aspinall, 1955; Sutherland, 1967). Strain w70 was kindly provided by
Dr D. G. McPhee, School of Biological Sciences, University of East Anglia. Strains
kpi and a4-0 are non-mucoid mutants of A3(sl) and a4, respectively, and are in¬
cluded in certain experiments for comparison. All strains were cultured routinely on
nutrient agar at 350. For production of extracellular polysaccharide, strains were
grown on a solid nitrogen-deficient medium (Sutherland & Wilkinson, 1965). A
liquid version of this medium was also used for some experiments. The minimal
medium used was that described by Davis & Mingioli (1950). Liquid cultures were
grown in Erlenmeyer flasks containing half the nominal volume and shaken at
200-300 rev./min. in an orbital incubator. Initial isolation of mutants was made on
24-2
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eosin methylene blue (EMB) agar with glucose as carbon source or on nitrogen-
deficient medium.
Bacteriophages. The phages having Klebsiella aerogenes a3 (sl) as host have been
described earlier (Sutherland, 1967). Bacteriophage active against other K. aerogenes
strains were isolated from raw sewage by the same techniques except that membrane
filtration and not chloroform was used to remove bacteria from the preparations. The
phage-induced fucosidase preparation was that used by Sutherland (1967).
Mutagenesis. 'Old cultures' were nutrient-broth tube cultures held at 350 for 10 to
20 days. Dilutions were made into sterile 0-9 % (w/v) saline and o-i ml. samples were
spread over the surface of suitable solid media. 2-Aminopurine mutagenesis was
performed on overnight nutrient broth cultures which were diluted to approximately
104 bacteria/ml. in broth containing 2-aminopurine (200 /tg./ml.), and incubated 48 hr
at 350. Samples were then spread over nitrogen-deficient solid medium.
Preparation of polysaccharides and lipopolysaccharides. The exopolysaccharides
produced by the three strains were of two types: slime or capsule. These were
isolated and purified by the techniques originally described by Wilkinson et al.
(1955). Lipopolysaccharides were extracted from lyophilized bacterial cells by the
phenol+water method using a 5 min. extraction time (Liideritz et al. 1965). After
removal of the phenol by dialysis, the extracts were concentrated under reduced
pressure and the lipopolysaccharide was freed from other material by ultracentrifuga-
tion at 100,000 g for 4 hr, then lyophilised. The supernatant fluid was also freeze-
dried and assayed for glucose as a measure of glycogen.
Microanalysis. The constituent sugars of the polysacharides and lipopolysaccharides
were identified by paper chromatography in the solvent of Fischer & Dorfel (1955),
after hydrolysis in n-H2S04. The individual sugars were determined as described
previously (Sutherland, 1967). In addition, mannose was determined by the cysteine +
sulphuric acid assay (Dische, Shettles & Osnos, 1949) and total polysaccharide by the
anthrone method. The O-acetyl groups found in two of the three exopolysaccharides
were estimated by the hydroxylamine-ferric chloride assay (Hestrin, 1949). Total
protein was assayed by the Folin technique. All colorimetric results were read in
glass cells in a Zeiss PMQI1 spectrophotometer or a Unicam SP500 instrument. These
were also used for determining the turbidity of cell suspensions and for enzyme assays.
Paper chromatography andpaper electrophoresis. Paper chromatograms on Whatman
no. 1 paper were run in ethyl acetate + acetic acid+pyridine + water (5 + 1 + 5+3, by
vol.) (Fischer & Dorfel, 1955) or ethyl acetate + acetic acid + formic acid + water
(18 + 3 + 1 +4, by vol.) (Feather & Whistler, 1962) for 24 or 40 hr respectively. Partial
acid hydrolysates (n-H2S04 for 15 min. at ioo°.) were neutralized with Ba(OH)2
solution and compared by paper electrophoresis in pyridinium acetate at pH 5-3
using the conditions previously described (Sutherland & Wilkinson, 1968), and by paper
chromatography in the acid solvent.
results
Isolation of colonies with crenated colony type (CR mutants).
The parent strains were subjected to mutagenesis and spread, after expression of
mutations, on nitrogen-deficient or EMB medium and the colonies examined for the
presence of non-mucoid types (O mutants). These occurred at low frequency and were
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slightly smaller than the wild-type colonies, lacking the mucoidness and consequent
glossy appearance. The non-mucoid cells grew in liquid culture with uniform turbidity
and had a growth rate similar to the parental type. Several hundred O mutants have
been isolated using various mutagens. During examination of colonies following
mutagenesis, another type of mutant was observed. These colonies (CR mutants) were
detected on plates incubated at 30° or 20° and had a very characteristic appearance.
They were of the same size as those of non-mucoid mutants (10 to 12 mm. diam. after
48 hr growth on nutrient agar at 20°). The outline of the colonies was irregular and the
consistency more friable than either the parental or O type, and ridges radiated from a
central apex. The CR mutants were only isolated following treatment with amino-
purine and not with other mutagens. One CR mutant was obtained as a spontaneous
mutant from an ' old culture'. From two of the CR mutants further mutagenesis with
aminopurine led to the isolation of another form which we have designated CR-O
mutants. These cultures possessed properties common to CR mutants and O mutants.
The derivation of mutants and their type is shown in Table 1. The frequency of
occurrence of either CR or CR-0 mutants was very much lower than that of the O
mutants when aminopurine was used as mutagen. Attempts to derive a CR-O mutant
from Klebsiella aerogenes W70 have been unsuccessful.
Table 1. The type and mode of isolation of the mutants used in the present study
Parent Mutant Type Mutagen
a3(sl) A3-CR CR 2-Aminopurine
A3-CR A3-CR0 CR-O 2-Aminopurine
V/70 W70-CRI CR 2-Aminopurine
W70 W70-CR2 CR 2-Spontaneous
A4 A4-CR CR 2-Aminopurine
A4-CR A4-CRO CR-O 2-Aminopurine
Cultural characteristics of CR mutants
The characteristic colonial appearance of CR mutants on solid media was only
observed following incubation at 20 to 30° for 24 to 48 hr. After longer incubation at
these temperatures some mucoidness was noticed. The colonies also become less
friable and very adhesive to the medium. Incubation at 370 led to cultures almost
indistinguishable from the wild-type strains. The CR-O mutants were recognizable as
their characteristic colonial appearance was retained on incubation at 37°. They thus
appeared to lack the ability to synthesise extracellular polysaccharide, so resembling
O mutants. Colonies on solid media were very friable.
Liquid cultures of CR mutants at 20° in all the media tested underwent auto-
agglutination and sedimentation as a granular aggregate of bacteria. At 370 liquid
cultures were indistinguishable from the wild type, being turbid and viscous due to
polysaccharide excretion. The CR-O mutants showed the same autoagglutination and
lack of polysaccharide production at all incubation temperatures. The autoagglutina¬
tion of CR or CR-O mutants in liquid defined media was unaffected by altering the
concentration of Ca2+ or Mg2+ ions between 0 and 0-5 mM and by the addition ofEDTA
up to 3 mg/ml. (w/v). Addition of Tween 80 in concentrations up to 1 % (w/v) also
failed to prevent autoagglutination. All strains grew in the same manner using
glucose, galactose, mannose or glycerol as carbon and energy source in defined
media.
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Reversion
A marked difference between CR and O mutants was in the stability of the mutation.
In the Klebsiella aerogenes a4-0 and other non-mucoid variants spontaneous
revertants were never detected despite examination of more than 10,000 colonies.
Application of various mutagens did not induce reversion. The same was true of the
CR-0 mutants. However the CR mutants reverted to the parental type with varying
frequencies. Thus a3-cr reverted to a3(sl) spontaneously with o-oi % frequency,
whereas no spontaneous revertants from a4-cr were observed. The use of acriflavin,
2-aminopurine or ethanemethanesulphonate resulted in a reversion frequency of
°'3 % to °'4 % in the mutant a4-cr. Lower frequencies were observed using other
mutagens. The mutants from w70 behaved similarly.
Table 2. The composition of slime and capsule exopolysaccharides
Growth Molar ratio
Strain Type temperature Constituents (approx.)
a4 Capsule, slime All Glc:Gal:GlcUA 1:2:1
a4-cr Capsule, slime 30 to 35° Glc:Gal:GllcUA 1:2:1
a3(si) Slime All Glc:Fuc:GlcUA: acetyl 4:2:2:1
a3-cr Slime 30 to 350 GIc: Fuc: GlcUA: acetyl 4:2:2:1
W70 Capsule, slime All Gal: Mann: GlcUA: acetyl 1:1:1:1
W70-cr2 Capsule, slime 30 to 35° Gal: Mann: GlcUA: acetyl 1:1:1:1
Exopolysaccharide synthesis
It was obvious during the initial examination of cultures that differences in exo¬
polysaccharide synthesis occurred between parent and CR strains. It was thus possible
that the mutants might synthesize polysaccharides of altered composition and struc¬
ture. The repeating unit of Klebsiella aerogenes a3 (sl) slime polysaccharide has already
been identified (Sutherland, 1967; Sutherland & Wilkinson, 1968). Hydrolysates of
A4 polysaccharide contained glucose, galactose and glucuronic acid, while acetyl and
pyruvoyl groups were absent. The capsular polysaccharide of strain w70 contained
galactose, mannose, glucuronic acid and O-acetyl groups. The composition and approx¬
imate molar ratios of the polysaccharides are shown in Table 2 together with the
composition of the material secreted by the three corresponding CR mutants when
grown at 35°. The parent and mutant strains secrete polysaccharides of the same chemo-
type with sugars present in the same molar ratio. Further proof of the similarity of the
pairs of polysaccharides was obtained by comparison of partial acid hydrolysates by
paper electrophoresis and paper chromatography. The fragments obtained were
identical for each parent and mutant strain. In addition, phage-induced fucosidases
active against a3(sl) polysaccharide yielded the same hydrolysis products from
a3 (sl) and a3-cr polysaccharides.
On nitrogen-limited defined media with glucose as carbon and energy source, the
production of polysaccharide was determined after separation from cells by the
anthrone technique. The slime or capsular material was removed by boiling and the
bacterial deposits by centrifugation. For all the strains examined, the greatest differences
between parent and mutant strains were observed at 20° at which temperature the
CR mutants produced only about 30 % that excreted by the parent in liquid medium.
Similar results were obtained for each set of mutants and values for a4, a4-cr and
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A4-CR0 are given in Table 3. The CR-0 mutants produced no polysaccharide de¬
tectable by the techniques used, and so resemble O mutants.
Lipopolysaccharides and glycogen
The occurrence of autoagglutination and 'roughness' in other species of Entero-
bacteriaceae in usually associated with the production of incomplete lipopolysac¬
charides (Liideritz, Staub & Westphal, 1966). Thus examination of the mutant lipo¬
polysaccharides might reveal loss of part of the macromolecule. An earlier study of
the A3 and a4 strains showed that they contained 17 to 23 % galactose but^only 2 %
glucose (Sutherland & Wilkinson, 1966). They thus differed from the types of polymer
common to members of the genera Salmonella, Shigella and Escherichia, which all








24 hr 48 hr 72 hr
r
48 hr 72 hr 96 hr
f
72 hr 96 hr
A4 Solid 2-8 3"5 3-0 1-6 2-0 2-8 3*7 3*7
Liquid 2-1 2-3 2-4 2-1 1-9 2-0 2-2 2-2
A4-CR Solid 3-3 2-1 2-6 1*4 2-0 2-5 1-0 0-9
Liquid 2-9 2-0 2-1 1-8 2*0 2*6 1-2 I-I
A4-CRO Solid or o-i o-i o-i o-i 0-05 0-05 0-05 0-05
liquid i
All values are given as mg. polysaccharide (glucose anthrone value)/mg. cell protein.
Table 4. The yield of lipopolysaccharides by CR and CR-0 strains
Lipopolysaccharide
Lipopoly¬ Glycogen
Growth saccharide Composition (% dry
Strain temperature (% dry cells) Glucose galactose cells)*
A3-CR0 20° MO 2-4 19-0 2-2
35° 3-10 1-2 15-0 5*5
W70-CR.2 20° 1-45 I-I 14-0 2-8
35° 5-09 1-0 16-3 i-o
A4-CR0 20° 2*57 1-6 17-9 5'4
35° 3*33 1-2 18-6 1-9
A4-CR 20° 1-2 2-5 22-5 6-6
35° 2-1 3*7 20*7 6-0
* The values for glycogen were derived by multiplying the glucose content of the ultracentrifuge
supematants by the weight of dry material.
contain approximately equal quantities of glucose and galactose in their basal
structures (Luderitz et al. 1966). The galactan nature of the lipopolysaccharide of
Klebsiella A3(sl) and another strain has been confirmed by structural studies
(Koeltzow, Epley & Conrad, 1968). Strain W70 also proved to have a similar
lipopolysaccharide.
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Several of the CR and CR-0 strains were grown in nutrient broth containing
I % (w/v) glucose in shaken culture at 200 or 350. The bacteria were harvested by centri-
fugation, washed and lyophilized. The yields of lipopolysaccharide extracted by phenol/
water and purified by ultracentrifugation are shown in Table 4. It can be seen that the
polymer yields were generally lower following incubation at 20° than those from 350.
The composition of the macromolecules as measured by their glucose and galactose
contents appeared to be constant. The yields of glycogen varied considerably and do
not show any distinct pattern.
Phage sensitivity
One of the methods used to check the identity of mutants with the wild type was to
test the sensitivity of both strains to one or more bacteriophages. The bacterial
culture was incubated in nutrient broth then spread over the surface of plates of
nutrient agar. These were, allowed to dry at room temperature for 30 min. Drops
(o*02 ml.) of bacteriophage suspensions containing approximately io8 plaque-forming
units were applied and incubation continued at varying temperatures. Initial tests
showed no difference in phage sensitivity after incubation at 20° or 370. When,
however, the parent cells were incubated through two subcultures in nutrient broth at
20° then used to seed the plate; there were several differences from the sensitivity
pattern observed at 37°. These results are shown in Table 5. It seems probable that in
Table 5. Phage sensitivity patterns ofmutant and wild-type strains
(+, Confluent lysis; —, no lysis; ±, very small numbers of plaques.)
Incubation 370, phage: Temperature 20°, phage
Host strain 31 33 36 33 38 40 41 42 31 33 36 37 38 40 41 42
A3(SI) + + + + + + — — + + + + + + — —
A3-CR + + + + + + — — + - + ± — + — —
W70-CRI — — — — — + + + — — — — — + — +
W70-CR2 — — — — — + + — — — — — — + + —
A3-CR0 — + + + + + — — + + + + + + — —




A 4-O — — — — — +
1
+ — — — — — — + + —
A4-CR — — — — — — + — — — — — — — — —
A4-CRO — — — — — + + — — — — — — + + —
Original Host A3SL ai A4 W70
certain of the mutants the phage receptor is no longer synthesized at the lower tem¬
perature or alternatively the mutants are unable to liberate mature phage. If the defect
is one of surface properties it is presumably due to a loss of carbohydrate metabolism
at a step which is also essential for exopolysaccharide synthesis. Thus strain A3-CR
was no longer susceptible to phages F33 and 38, which both acted on the parent and
on A3-CR at 370. It is interesting that in some cases the mutants are susceptible to
more phages than the mucoid parent. This is presumably due to occlusion of the bac¬
terial surface by the capsule preventing phage uptake as it is not seen in the A3
mutants where the parent strain produces slime only.
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discussion
Mutations involving exopolysaccharide biosynthesis in Klebsiella aerogenes appear
to occur in two ways. The wild-type organisms producing capsules and slime may
undergo a mutation causing loss of the ability to form a discrete capsule. Such a
slime-forming (sl type) mutants are exemplified by K. aerogenes a 3 (sl) which secretes
an exopolysaccharide identical in all respects tested with the capsular polysaccharide
synthesized by the parent cells (Dudman & Wilkinson, 1956). Either the wild type or
the sl type can undergo a mutation causing complete loss of polysaccharide-synthe-
sizing capacity. Such non-mucoid (O) mutants show no tendency to revert. Attempts
to render them mucoid by transduction were unsuccessful, although other markers
were transferred (McPhee, Sutherland & Wilkinson, 1969). Such O mutants deficient
in precursor-synthesizing or transferase activity are analagous to many of the mutants
isolated during studies on lipopolysaccharide biosynthesis (Liideritz et al. 1966). Due
to the lack of suitable selection procedures no mutants synthesizing in complete
exopolysaccharide have yet been identified. Indeed by virtue of their repeating
unit structure it is probable that the mutation is an ' all or none' phenomenon causing
complete loss of polysaccharide-synthesizing capability. Nothing analagous to the
'rough' mutants isolated in studies on lipopolysaccharide biosynthesis has yet been
found in exopolysaccharide studies.
Wild type
(capsules, slime)
SL type, / CR type
(slime only) j (conditional)
O type CR-O type
Fig. I. Scheme for mutations involving polysaccharide synthesis in the genus Klebsiella.
The second and apparently unusual form ofmutation is that involved in CR mutants.
These apparently only arise spontaneously or under the influence of aminopurine. CR
clones appear to be much less stable than O mutants. Further mutagenesis can, albeit
rarely, lead to isolation of a double mutant retaining the characteristic colonial
morphology of the CR mutant but having completely lost exopolysaccharide-
synthesizing capacity even at 370. The scheme involving such mutations is shown in
Fig. 1. The CR mutants are obviously conditional mutants and are unusual in that the
mutation appears to have two distinct effects, assuming that no double mutation has
occurred. The first effect is on exopolysaccharide synthesis, which is greatly reduced
by lower incubation temperature but returns to the level of the wild type on temperature
up-shift. The second effect is on one of the surface components of the bacterial cells,
apparently the lipopolysaccharide. This effect appears to be a quantitative one rather
than an alteration to the lipopolysaccharide structure. A consequence of the lower
lipopolysaccharide content is the agglutinability and 'roughness' of the cultures. These
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observed results from the conditional mutation are consistent with an alteration to an
enzyme involved in the formation of nucleotide precursors for the lipopolysaccharide
and the exopolysaccharide or alternatively an altered regulator. The lipopolysac-
charides of the Klebsiella strains used in this study contain galactose, heptose,
2-ketodeoxyoctonic acid and iV-acetylglucosamine (Sutherland & Wilkinson, 1965).
The sugars found in the slime or capsular polysaccharides are fucose, glucose, galactose
glucuronic acid and mannose. Thus galactose is the only sugar common to both
lipopolysaccharide and exopolysaccharide, but only in strains a 4 and W70, not in
a3(sl). We therefore conclude that the mutation occurs in the sequence of reactions.
glucose glucose-6-phosphate -> glucose-1-phosphate -> UDP-glucose
Alteration in any of the three enzymes involved, hexokinase, phosphoglucomutase or
UDP-Glc pyrophosphorylase would affect either polymer if UDP-Glc is the glucosyl
donor involved in exopolysaccharide biosynthesis. The results for glycogen yields were
not consistent enough to determine whether a significant reduction had occurred at
lower temperatures. The donor for glycogen synthesis being ADP-glucose (Gahan &
Conrad, 1968), a reduction in glycogen would favour the first two enyzmes in the
sequence as the possible sites of mutation. One similar conditional alteration in
surface property involving what is also probably a polysaccharide, has been reported
(Knolle & Orskov, 1967). The f+ antigen of Escherichia coli is lost at lowered incuba¬
tion temperature but is again formed on return of the cells to 370.
Further experiments to identify the enzyme involved in the 'CR' conditional muta¬
tion of Klebsiella aerogenes strains are proceeding.
The authors are grateful to Miss I. C. Miller for technical assistance and to the
Science Research Council for financial support.
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The Synthesis of Exopolysaccharide by Klebsiella aerogenes Membrane
Preparations and the Involvement of Lipid Intermediates
By I. W. SUTHERLAND and MARY (NERVAL*
Department of General Microbiology, University ofEdinburgh, West Mains Road, Edinburgh EH9 3JG, U.K.
(Received 20 July 1970)
1. Membrane preparations from Klebsiella aerogenes type 8 were shown to transfer
glucose and galactose from their uridine diphosphate derivatives to a lipid and to
polymer. The ratio ofglucose to galactose transfer in both cases was 1:2. This is the
same ratio in which these sugars occur in native polysaccharide. Galactose transfer
was dependent on prior glucosylation of the lipid. Mutants were obtained lacking
(a) glucosyltransferase and (6) galactosyltransferase. The transferase activities in a
number of non-mucoid mutants was examined. 2. Glucose transfer was partially
inhibited by uridine monophosphate, and incorporation ofeitherglucose or galactose
into lipid was decreased in the presence of uridine diphosphate. The sugars are
thought to be linked to a lipid through a pyrophosphate bond, and treatment of the
lipid intermediates with phenol yielded water-soluble compounds. These could be
dephosphorylated with alkaline phosphatase. Transfer ofglucuronic acid to lipid or
polymer from uridine diphosphate glucuronic acid was much lower than that of the
other two sugars. 3. The fate ofsugars incorporated into polymer was also followed.
Some conversion ofglucose into galactose and glucuronic acidoccurred. Mutants un¬
able to transfer glucose or galactose to lipid were unable to form polymer. Other
mutants capable of lipid glycosylation were in some cases unable to form polymer.
A model for capsular polysaccharide synthesis is proposed and its similarity to the
formation of other polymers outside the cell membrane is discussed.
Two polysaccharides common to most Gram-
negative bacteria, mucopeptide and lipopoly-
saccharide, both contain repeating units in their
structure. The synthesis ofeach of these compounds,
reviewed by Ghuysen, Tipper & Strominger (1969)
and by Nikaido (1968) respectively, occurs by mem¬
brane-bound enzymes. Sugars are added sequen¬
tially from sugar nucleotide precursors to a lipid
carrier. The lipid involved is apparently very similar
in each system and has been identified as a phos-
phorylated C5J-isoprenoid alcohol of the general
structure: -[CH2-C(CH3)=CH-CH2]- (Wright,
Dankert, Fennessey & Robbins, 1967; Higashi,
Strominger & Sweeley, 1967). The Gram-positive
species Micrococcus lysodeikticus similarly uses a
lipid carrier during synthesis of an extracellular
mannan (Scher, Lennarz & Sweeley, 1968).
A third type of extracellular polysaccharide
synthesized by Gram-negative bacteria, and found
also in some Gram-positive species, is capsule or
slime material. The synthesis of this has received
much less attention than that of other polymers.
Studies with Diplococcus pneumoniae showed the
requirement for particulate enzyme preparations
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and the incorporation of radioactively labelled
sugars from appropriate sugar nucleotides into
polymer (Smith, Mills & Bernheimer, 1961). More
recent work on the structure of a number ofcapsular
or slime polysaccharides from Gram-negative
bacteria showed that they are generally composed
of fairly simple repeating units composed of three
to six sugar residues (e.g. Hungerer, Jann, Jann,
0rskov & 0rskov, 1967; Conrad, Bamburg, Epley &
(Kindt, 1966; Sutherland, 1969). There is thus some
similarity between the O-antigen component of
lipopolysaccharides and the exopolysaccharides
synthesized by such species as Escherichia coli or
Klebsiella aerogenes. Both are extracellular poly¬
mers and both contain sugar repeating units of
grossly similar type. The only indication ofsimilari¬
ties in the biosynthesis of these two polysaccharides
was the report of involvement ofa lipid carrier stage
in the synthesis of capsular polysaccharide by a
K. aerogenes strain (Troy & Heath, 1968). The
component sugars of the polymer were galactose,
mannose and glucuronic acid, but no details of the
structure were given.
The strain A4 (serotype 8) of K. aerogenes has a
simple tetrasaccharide repeating unit (Fig. 1)
(Sutherland, 1970). It does not contain acetyl or




Fig. 1. Tetrasaccharide repeating unit of K. ae.roge.nes
strain A4 capsular polysaccharide.
pyruvyl groups and was chosen for its simple
structure and the ready availability of the pre¬
sumed glycosyl donors: UDP-glucose, UDP-galac-
tose and UDP-glucuronic acid. An examination of
several of the enzymes thought to be involved in
the formation of the sugar nucleotide glycosyl
donors required for exopolysaccharide synthesis has
already been made (M. Norval & I. W. Sutherland,
unpublished results) with the wild-type strain and a
number of mutants. The present study reports
the use of membrane preparations in a cell-free
system for the transfer of sugars from sugar
nucleotides to lipid-soluble material and to poly-
saccharide-resembling capsular material.
MATERIALS AND METHODS
Cultures. The wild-type strain of K. aerogenes strain A4
(serotype 8) was studied by Dudman & Wilkinson (1956)
and the structure of its exopolysaccharide capsule has
been determined (Sutherland, 1970). The isolation of
mutants from it and the contents of several of the enzymes
involved in sugar nucleotide synthesis have been ex¬
amined (M. Norval & I. W. Sutherland, unpublished work).
Bacteria were normally grown in nutrient broth or in
trypticase soy broth (Baltimore Biologicals Laboratory,
Baltimore, Md., U.S.A.) supplemented by 1% (w/v)
glucose. A number of mutants were also grown in nutrient
broth containing 1% (w/v) galactose. Cultures were
grown in 1 litre quantities in 2-litre Erlenmeyer flasks
shaken at 35°C for 15h at 200rev./min.
Analytical methods. Protein was determined by the
method of Lowry, Rosebrough, Farr & Randall (1951).
Glucose, galactose and glucuronic acid were determined as
described by Sutherland (1970).
Chemicals. Unlabelled sugar nucleotides were purchased
from Sigma (London) Chemical Co. Ltd. (London S.W.6,
U.K.) and from C. F. Boehringer und Soehne G.m.b.H.
(Mannheim, Germany). MC-labelled sugar nucleotides
(randomly labelled in the sugar moieties) were obtained
from The Radiochemical Centre (Amersham, Bucks.,
U.K.). Other chemicals and biochemicals were of the
highest grade commercially available.
Chromatography and electrophoresis. Descending paper
chromatography was performed at room temperature in
the following solvent systems with Whatman no. 1 paper:
solvent A, butan-l-ol-pyridine-water (6:4:3, by vol.)
(Whistler & Conrad, 1954); solvent B, ethyl acetate-
acetic acid-formic acid-water(18:3:l:4, by vol.) (Feather
Sc. Whistler, 1962); solvent C, ethyl acetate-pyridine-
acetie acid-water (5:5:1:3, by vol.) (Fischer & Doerfel,
1955); solvent D, ethanol-l.OM-ammonium acetate
(pH7.5) (7:3, v/v) (Paladini & Leloir, 1952). T.l.c. on
silica gel G plates was carried out in solvent E [chloroform-
methanol-water (12:6:1, by vol.)]. Paper electro¬
phoresis on Whatman no. 1 paper was performed in
pyridine-acetic acid buffer, pH5.3. Locarte paper-
electrophoresis equipment was used with a current of
90mA applied for 3h at 40V/cm. Development of
chromatograms or electrophoresis strips was carried out
with alkaline AgN03 reagent or with the phosphate
reagent of Hanes & Isherwood (1949).
Measurement of radioactivity. Radioactivity on paper
strips was located with a Tracerlab 4 pi Scanner. Because
of the low efficiency of counting, results were usually
checked by cutting out 1 cm segments and placing them
in vials with 10ml of toluene containing 0.5% of 2,5-
diphenyloxazole for scintillation counting in a Beckmann
ambient-temperature scintillation spectrometer (Lennarz
& Talamo, 1966). Lipid extracts were evaporated to
dryness at 60°C and their radioactivities counted in 10ml
of Triton scintillation fluid (Lennarz & Talamo, 1966).
Radioactivities of material from t.l.c. plates were also
counted in this fluid. For aqueous samples a dioxan-
based scintillation fluid was used [Nuclear Enterprises
(G.B.) Ltd., Edinburgh, U.K.]. The efficiency of counting
for 14C was approx. 50% for liquid samples and 30% for
paper samples determined by scintillation counting.
Preparation of membrane material. Cells from 2 litres of
culture were harvested by centrifugation at 5000g and
washed twice in 0.9% NaCl buffered to pH8.0 with
lOmn-tris. They were then resuspended in 50ml of 10 mM-
tris—HC1 buffer, pHS.O, and 10ml portions were treated
for 2min in MSE ultrasonic equipment with 100 W out¬
put. The container was cooled with an ethanol-ice mix¬
ture and the unbroken cells were removed by centrifuga¬
tion at 5000g for 20min. The supernatant fluid from this
preparation was then centrifuged at 20000g for 60min
and washed by resuspension in tris buffer. The reddish
gel of membrane material was carefully removed and
resuspended in 5 ml of water at 0°C.
Assay for lipid material. Samples (50/xl) from incuba¬
tion mixtures were added to 4ml of chloroform-methanol
(2:1, v/v) and homogenized in a vortex mixer. The tubes
were then placed in a water bath at 60°C for 5min and
again mixed. Then 1 ml of 0.9% NaCI was added and the
mixture was again homogenized. Phase separation was
achieved by centrifugation for 15min in a bench centri¬
fuge. The aqueous layer and interface were carefully
removed by using a long Pasteur pipette and gentle suc¬
tion. The chloroform layer was carefully transferred to
scintillation vials with fresh Pasteur pipettes. Zero-time
controls consistently showed radioactivities of20-25 c.p.m.
This was also true of samples of the different labelled
sugar nucleotides included to check that there was no
breakdown or carry-over of sugars with this technique.
Assay for polymer material. Samples (25 or 50fd) from
incubation mixtures were applied to Whatman no. 1 paper
as 2 cm strips. The sheets of paper were irrigated for 20 h
in solvent D to remove low-molecular-weight material.
The areas at the origin forming strips 2 cm x 1 cm were cut
out and their radioactivities determined.
RESULTS
Transfer of sugars to lipid, material. The ability
of osmotically shocked cells of K. aerogenes to
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transfer sugars from sugar nucleotides to lipid
material was observed by Troy & Heath (1968).
There are, however, considerable disadvantages in
using whole cells. In an attempt to overcome these,
membrane material was prepared as described in
the Materials and Methods section. This was then
used as a potential source of enzymes for exopoly-
saccharide synthesis. Incubation mixtures were
prepared as follows: 0.25M-tris-HCl buffer, pH8.0,
100 pi; 50 mM-magnesium chloride, 50 pi; membrane
suspension, 200pi; water, 100pi. Sugar nucleotides
were added in the same proportions as the sugars
were found in the polysaccharide, namely 400nmol
of UDP-glucose or UDP-glucuronic acid and
800nmol of UDP-galactose. Labelled nucleotides
were added asfollows:I7DP-glucose, 3.7 x 105c.p.m.;
UDP-galactose, 1.1 x 105c.p.m.; UDP-glucuronic
acid, 5.5 x 105 c.p.m. The total volume was adjusted
to 550 pi with water. The mixtures were allowed to
equilibrate to room temperature (20°C) before
addition of the sugar nucleotides and finally the
membrane.
When single nucleotides were added, with mem¬
brane from wild-type cells, there was rapid transfer
of glucose or galactose from their respective sugar
nucleotides to lipid material but no transfer of
glucuronic acid. The rate of incorporation of either
sugar was maximal over the first lOmin but con¬
tinued at a decreased rate for 30-40 min. Typical
results are shown in Fig. 2. After 30min the ratio
of glucose incorporation to galactose incorporation
was approx. 3.5:1, and no glucuronic acid was
transferred.
On the addition of all three sugar nucleotides,
each in turn being labelled, a different pattern of
incorporation was observed. Typical results (Fig. 3)
show that the amount of galactose incorporated
into lipid is approximately twice that of glucose.
Much less glucuronic acid than glucose or galactose
was transferred. As the cells contain an active UDP-
galactose 4-epimerase in the membrane fraction
(M. Nerval & I. W. Sutherland, unpublished work)
it was to be expected that some interconversion of
the sugars would occur. Such interconversion
would only be absent from epimerase-less mutants
and attempts to obtain these were unsuccessful.
The presence of a particulate UDP-glucose de¬
hydrogenase would also permit some incorporation
of glucose into U DP-glucuronic acid and hence into
lipid, but the very small extent of transfer of labelled
glucuronic acid from UDP-glucuronic acid to lipid
was unexpected. The absence of such ..transfer
activity might be due to: (i) large quantities of
membrane-bound UDP-glucuronic acid; (ii) the
addition of glucuronic acid from a precursor other
than UDP-glucuronic acid; (iii) a soluble glucu-
ronyltransferase; or (iv) the addition of glucuronic
acid at a relatively late stage in biosynthesis to a
neutral sugar 'core'. The first three of these possi¬
bilities can be excluded. Extraction of membrane
preparations with ethanol yielded only trace
amounts of UDP-glucuronic acid, identified and
determined as described by Grant, Sutherland &
Wilkinson (1970). Nor was any other glucuronic
acid-containing nucleotide detected. The addition
to the assay mixture of the 20000g supernatant
obtained during membrane preparation caused no
increase in glucuronic acid transfer to lipid.
Transfer activity. Attempts to obtain transfer
of the neutral sugars to lipid material were madewith
Time (min)
Fig. 3. Transfer of sugars from mixtures of sugar nucleo¬
tides to lipid. The standard incubation mixture contained,
in each case, all three sugar nucleotides, one of which was"
labelled with 14C in the sugar moiety. Samples were taken
periodically for chloroform-methanol extraction. •,
UDP-galactose; A, UDP-glucose;- ■, UDP-glucuronic
acid.
Time (min)
Fig. 2. Transfer of sugar from sugar nucleotides to lipid.
The standard incubation mixture was used containing a
single sugar nucleotide together with I4C-Iabelled material.
Samples (50/xl) were withdrawn at intervals and extracted
(400nmol of UDP-glucose or UDP-glucuronic acid or
800 nmol of UDP-galactose was used) with chloroform-
methanol (2:1, v/v). •, UDP-glucose; A, UDP-galactose;
■ , UDP-glucuronic acid.
a, a,
t-> a_.
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a number of cell fractions. Only a complete ultra¬
sonic lysate and the material deposited by centri-
fugation at 20000^ were active in the transfer of
glucose or galactose. On the basis ofprotein content
the membrane preparations were two to three times
as effective as an equivalent amount of whole-cell
lysate in the transfer of either sugar from the
corresponding sugar nucleotide to lipid material.
The supernatant fluid from the 20 000g centrifuga-
tion and material deposited from it by ultracentri-
fugation at lOOOOOg were completely inactive.
Normally membrane preparations were used
immediately after preparation, all stages during the
process being performed in the cold. However,
preparations held in vials completely surrounded by
ice at 0°C for up to 4 days retained 90% of their
activity. Preparations that were frozen and then
rapidly thawed at room temperature lost all
transferase activity. When thawing was carried out
slowly over a period of 4r-5 h frozen samples retained
about 80% of their activity with respect to glucose
or galactose transfer. This was true ofmaterial kept
for up to 28 days at —20°C.
A requirement for Mg2+ has been shown for
glycosyltransferase activity in other polysaecharide-
synthesizing systems, and magnesium chloride was
accordingly included in the present assay system.
Omission of Mg2+ resulted in decrease of glucose
transfer by about 25%. It is, however, difficult to
wash membrane preparations thoroughly with
water, as the presence ofmucoid material from wild-
type cells leads to a loosely packed sediment that
probably carries over ions from the original culture.
Consequently the validity of this result is difficult
to assess. Replacement of Mg2+ with other bivalent
cations was also tested. The presence of Co2+ or
Ca2+ ions resulted in the same extent of glucose
transfer but Mn2+ caused a 30% decrease. This
could be due to competition for sites normally using
Mg2+.
Transferase activity in mutants. A number of
mutants unable to synthesize capsular polysaccha¬
ride were isolated. Examination of 23 of these non-
mucoid mutants showed that when membrane
preparations were incubated with the three sugar
nucleotides transfer of glucose or galactose to lipid
was lower than in wild-typepreparations. Results are
exemplified by strains 030, 032, 034 and 036 shown
in Table 1. In all of these mutants tested, the ratio
of glucose to galactose incorporation into lipid
resembled that of wild-type material in having a
value of almost 1:2. In only two mutants (040 and
042) of this group were deletions known to occur
before the sugar nucleotide stage. These two
mutants were defective in phosphoglucomutase and
UDP-glucose pyrophosphorylase respectively (M.
Norval & I. W. Sutherland, unpublished work).
The other 21 strains had normal profiles for the
Table 1. Comparison ofsugar incorporation into lipid
material by wild-type and mutant strains
The standard incubation mixture containing UDP-
glucose, UDP-galactose and UDP-glucuronic acid was
used with either UDP-[I4C]glucose or UDP-[14C]galactose.
Samples were withdrawn at 30min intervals and extracted
with chloroform-methanol (2:1, v/v). The resultant
incorporation is based on the values obtained at 60min
after the start of incubation. ■>











037 + 038 0.009* 0.004
* Results expressed relative to total protein.
enzymes leading to sugar nucleotide formation and
modification. Four further mutants (K119, K121,
029 and 038) incorporated glucose but not galactose.
Repeated experiments confirmed this result. Two
mutants (K138 and 037) showed no incorporation
of either glucose or galactose into lipid. When
equal quantities of membrane preparations from
strain 037 and either strain 029 or strain 038 were
combined, incorporation of glucose was detected
together with some incorporation of galactose. This
indicated that some galactose transferase activity
was present in the strain-037 preparation and that
galactose transfer was dependent on prior glucose
transfer. The results for several of these strains
together with those for a normal K. aerogenes A4
preparation for comparison are shown in Table 1.
Incorporation of glucuronic acid from UDP-
glucuronic acid was too low to permit accurate assay.
The generally lower extent ofsugar transfer in the
mutant strains could be due to lowered production
of the enzymes involved, perhaps through specia¬
lized control mechanisms. To test this membrane
preparations from the phosphoglucomutase-less
strain were used. The cells were grown (a) in the
trypticase soy medium supplemented with glucose
and (6) in the same medium supplemented with
galactose. The results for sugar transfer obtained
with the two preparations are shown in Table 2. In
this strain at least there is much lower transferase
activity with membranes prepared from cells in the
glucose medium, i.e. conditions under which no
exopolysaccharide is synthesized.
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Effects ofpotential inhibitors. In other systems in
which transfer of sugars to lipid occurs a number of
inhibitors are known. Thus the detergent Triton
X-100 selectively prevents mannan synthesis from
mannolipid in M. lysodeikticus (Scher & Lennarz,
1969) and bacitracin stops phosphate release in the
final stage of mucopeptide synthesis (Siewert &
Strominger, 1967). If the process of exopoly-
saccharide synthesis is similar to these other systems
such inhibitors might also be effective. A membrane
preparation from wild-type cells was used and the
results of Triton and bacitracin on sugar transfer to
lipid are shown in Table 3. Unlike the effect on the
mannan system, Triton inhibits transfer of sugars
to lipid. Bacitracin also affects sugar transfer to
some extent, thus resembling the effect on muco¬
peptide system but differing from that on lipopoly-
saccharide biosynthesis.
The mechanism of transfer of the initial sugar in
0-antigen synthesis involves transfer of the sugar
1-phosphate together with release of the nucleo-
Table 2. Activity of membrane preparations from a
phosphoglucomutase-less mutant (strain 040) grown
in media supplemented with glucose or galactose
The standard incubation mixture with all sugar nucleo¬
tides was used. Samples were withdrawn at 30min
intervals and extracted with chloroform-methanol (2:1,
v/v).











tide phosphate. Thus, if the first step in capsule
polysaccharide formation is the transfer of glucose
1-phosphate from UDP-glucose, UMP should be
released and it should also inhibit the reaction.
Similarly subsequent sugar transfer might be
inhibited by IJDP. The standard assay system for
glucose incorporation was first used with UDP-
glucose as the only sugar nucleotide present. Simi¬
larly the effect on galactose transfer from a mixture
of UDP-glucose and UDP-galactose was also tested.
The results for these mixtures are shown in Figs.
4(a) and 4(6) respectively. Clearly the transfer of
glucose to lipid is strongly inhibited by the presence
of UMP. The effect of UDP is probably in stopping
transfer of galactose from UDP-galactose, formed
by epimerization of the UDP-glucose. The almost
complete inhibition of galactosyl transfer by UDP
Table 3. Effect of bacitracin or Triton X-100 on
sugar transfer to lipid
The incubation mixture in all experiments contained all
three sugar nucleotides together with either UDP-[14C]-
glucose or UDP-[14C]galactose. Samples were extracted
with chloroform-methanol (2:1, v/v) at 30min intervals
and the values for sugar incorporation are based on the
60min value.

















Pig. 4. Effect of UDP and UMP on sugar transfer to lipid. The incubation mixture with UDP-glucose only was
used in (a) to show the effect on glucose transfer of the addition of UDP (200nmol) or UMP (200nmol).
Samples were taken at intervals and extracted with chloroform-methanol. In (5) the effect of the same con¬
centrations of UDP or UMP on galactose transfer from a mixture ofUDP-glucose and UDP-galactose is shown.
• , Complete system; A, +UDP; a, +UMP.
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is shown in Fig. 4(b), whereas the extent of inhibition
by UMP corresponds to that expected from, the
results for UDP-glucose. As a further check on the
initial reaction, involving glucose transfer, a series
of ten standard incubation mixtures containing
UDP-glucose only was prepared. After 30min of
incubation at 20°C with K. aerogenes A4 membrane
the reactions were terminated by pouring the
suspensions into boiling ethanol. Extraction of
nucleotides was performed as described by Grant
et al. (1970). The water-soluble nucleotides were
separated by paper electrophoresis for 4h and
identified by staining with molybdate reagent
(Hanes & Isherwood, 1949). Only two major spots
were detected, corresponding in their electrophoretic
mobilities to UDP-glucose and UMP respectively.
A very small amount of material moving ahead of
UDP-glucose was possibly UDP. A control experi¬
ment in which no membrane was added to the
incubation mixture showed UDP-glucose only.
Characterization oflipid-soluble material. Attempts
to scale up the incubation mixture to obtain suffi¬
cient glyeosyl-lipid were not satisfactory. Better
results were obtained by pooling material from a
number of experiments and using the standard
incubation mixture. The chloroform-methanol-
soluble material was obtained in the normal manner
except that extraction was at room temperature for
15min. The chloroform layers were then pooled,
back-washed with water and evaporated under
reduced pressure. The residual material was
extracted into a small volume of methanol. The
recovery of radioactive material was approx.
90% of that originally present in the chloroform
layers. Such material was prepared from incuba¬
tion mixtures with either UDP-glucose as the sole
sugar nucleotide or complete mixtures with each
sugar in turn labelled. On electrophoresis in
pyridine-acetic acid buffer, pH 5.3, all radioactivity
remained at the origin. Chromatography in solvent
D or t.l.c. on silica gel yielded some separation. In
solvent D chromatograms of lipid labelled from
either UDP-glucose or UDP-galactose showed two
main areas of radioactivity. A broad band with
i?Gal 1.26-1.34 contained 70% of the radioactivity
detected. A further 15% moved with i?Gal 1.09, and
three other peaks at i?Ga, 0.65, 0.48 and 0.22
accounted for the remaining radioactivity. On the
basis of comparison with UDP-glucose or UDP-
galactose run under the same conditions, the peaks
with i?Ga[ 0.65 and 0.48 are probably cyclic phos¬
phates, which occur as artifacts under the chromato¬
graphic conditions used (Tovey & Roberts, 1970).
When UDP-[14C]glucuronic acid was used two
areas of radioactivity with i?Gal 1.26 and 0.13 were
obtained. These possibly correspond to lipid-bound
tetrasaccharide and tetrasaccharide phosphate re¬
spectively. On t.l.c. in solvent E material labelled
with glucose or galactose showed two peaks with
RF 0.63 and 0.25 respectively, about 80% of the
label'being in the slower-moving peak. This is thus
similar in its mobility to the mannolipid described
by Caccam, Jackson & Eylar (1969). Insufficient
glucuronic acid-labelled material was available to
allow accurate identification of peaks.
Phenol treatment. The pyrophosphate bridge of
sugar diphosphate-lipid complexes can be broken
by treatment with 45% (v/v) phenol at 60°C for
5min (Kent & Osborn, 1968). This method was used
to examine the sugar diphosphate-lipid complexes
formed by incubation of the sugar nucleotides with
K. aerogenes membrane preparations. The lipid
material was dissolved in 50 fd of methanol and
added to 450 [A ofwater, and 500 p.1 of aq. 90% (v/v)
phenol was added. After 5min at 60°C the mixture
was cooled and extracted twice with 2 ml portions
ofether. Aqueous layers were freeze-dried. Samples
of both organic and aqueous layers were checked
for radioactivity, which was all found in the
aqueous layers. Samples from the aqueous layers
were submitted to paper electrophoresis. Little
difference was detected in the products obtained
with UDP-[I4C]glucose or UDP-[14C]galactose in a
complete mixture of nucleotides. In each case the
only radioactive material detected moved in a broad
band with iWGlcUA 0.93-0.95 (cf. glucose 6-phos-
phate, ilfGlc„A 0.65). After treatment with alkaline
phosphate for lh at 37°C under conditions where
lmmol of glucose 1-phosphate was completely
dephosphorylated, the preparations were again
subjected to paper electrophoresis. Ail radioactivity
was now detected in three areas, MGtcUA 0.60 and
0.45 and at the origin. The electrophoretic mobili¬
ties correspond to those obtained for trisaccharides
and a tetrasaccharide obtained by partial acid
hydrolysis of K. aerogenes A4 polysaccharide and
included on the paper for comparison (Sutherland,
1970). When UDP-glucose was the sole sugar
nucleotide present and the reaction was stopped
after 30min at room temperature, the product of
phenol treatment was slightly different. Two areas
of radioactivity were detected after electrophoresis
(MGicUA 0.65 and 0.60). After phosphatase treat¬
ment all radioactivity remained at the origin.
When the products of phenol treatment were
incubated with alkaline phosphatase and applied to
chromatograms in solvent B, the results from
mixtures containing all nucleotides and labelled
with UDP-[14C]glucose or UDP-[14C]galactose were
similar. Each showed large amounts ofradioactivity
with Rclc 0.05 and 0.10, equidistant with a tri-
saccharide and a tetrasaccharide isolated previously
from K. aerogenes A4 polysaccharide by partial acid
hydrolysis (Sutherland, 1970). A small amount of
material equidistant with glucose was observed.
Another major peak of radioactivity had Rqic 0.35.
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This is probably the disaceharide 0-a-D-galaetosyl-
(l-^3)-D-glucose, as lactose and melibiose, the only
galaetosides available for comparison, had Rclc
values 0.32 and 0.30 respectively in this solvent.
The product obtained when UDP-glucose was the
sole sugar nucleotide present in the reaction
mixture revealed only radioactivity equidistant
with glucose and with the presumed disaccharide.
These results strongly suggested that the sugars
were being incorporated into the lipid in the same
configuration in which they are present in the
polysaccharide. The products from the UDP-
glucose incorporation would thus be glucose
1-phosphate and galactosylglucose 1-phosphate.
Insufficient glucuronyl-labelled material was avail¬
able to permit comparison with the other products.
• Polymeric material. No specific enzymes hydro-
lysing K. aerogenes serotype 8 exopolysaccharide
are known. Consequently assay methods for the
-polymer are very limited. That described in the
Materials and Methods section was used as a
routine for convenience, but it is non-specific. A
second, specific, method was used to confirm these
results. This utilized the observation (Sutherland,
1970) that mild acid hydrolysis (0.25H-sulphuric
acid at 100°C for 30min) of the serotype 8 poly¬
saccharide yielded a number of oligosaccharides
that could be separated by paper electrophoresis or
by chromatography in solvent B. In all cases where
polymer synthesis was shown by the first method it
was confirmed by scanning after paper electro¬
phoresis of partial acid hydrolysates. All radio¬
activity was found to coincide with the oligo¬
saccharides or with neutral material.
When wild-type membrane preparations were
incubated with UDP-glucose a small amount of
sugar was incorporated into polymer. This was to
be expected as the UDP-glucose could be converted
into UDP-galactose and UDP-glucuronic acid.
However, incubation with UDP-galaetose or
UDP-glueuronic acid failed to yield polymer. When
a complete mixture of nucleotides was incubated
with the membrane, polymer, as determined by
both assay methods, was formed. Typical results
for polymer formation, as determined by the non¬
specific assay with each sugar nucleotide in turn in
the mixture labelled, are shown in Pig. 5. It is clear
that both glucose and galactose are incorporated to a
considerable extent and that the ratio of glucose to
galactose incorporation is approx. 1:2. Much less
glucuronic acid was incorporated. The pattern is
thus very similar to that obtained for transfer of
sugar to lipid.
Examination of the various mutants showed that
in most cases little ifany polymer was formed. This
-was to be expected in those mutants from which the
enzymes responsible for lipid intermediate forma¬
tion were known to be absent or in those which were
Fig. 5. Transfer of sugars from sugar nucleotides to
polymer. The complete incubation mixture containing all
three sugar nucleotides was used with one of them labelled
.in the sugar moiety in each case. Samples (25fil) were
withdrawn at intervals and applied to a 2 cm strip on a
sheet of Whatman no. 1 paper. This was irrigated over¬
night with solvent D. The area of the origin was cut out,
placed in scintillation fluid in a counting vial and residual
radioactivity was determined. •, UDP-galactose; A,
UDP-glucose; ■, UDP-glucuronic acid.
not known to have defects in nucleotide synthesis
or in lipid transferases. In these it was inferred that
failure to synthesize capsule must be due either to
lack of glucuronic acid transfer or to some later
stage in synthesis. . However, when the mutants
lacking UDP-glucose pyrophosphorylase and phos-
phoglucomutase were examined a rather surprising
result was obtained. The pyrophosphorylase-less
mutant grown either on glucose or galactose media
formed polymer to much the same extent as the
wild-type strain. This was also true for the phos-
phoglucomutase-less strain when grown on media
containing galactose. After growth on glucose
sugar transfer to lipid occurred but no polymer was
formed. The reason for this remains unclear. It is
possible that under these conditions some acceptor
required for polymer formation is absent and syn¬
thesis thus stops at the lipid intermediate stage.
The mutant was obtained by using ethyl methane-
sulphonate as mutagen and as far as can be deter¬
mined it is not a double mutant. J <
Fate of label transferred to polymer. Polymer was
prepared from pooled incorporation experiments in
which each sugar nucleotide in turn was labelled.
The starting material-was the aqueous layer after
chloroform-methanol extraction. Exopolysaccha¬
ride was isolated eitherbyphenolextraction followed
by dialysis and ultracentrifugation to remove
sugar phosphates and lipopolysaceharide respec¬
tively, or by precipitation with 5 vol. ofcold acetone.
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Table 4. Distribution of I4C in polymer labelled with I4C-labelled sugars from sugar nucleotides
The polymeric material prepared by incubation of membrane with complex mixtures of sugar nucleotides,
one being labelled in each case, was prepared as described in the text. Hydrolysis and chromatographic separa¬
tion were then performed also as described in the text.
Distribution of radioactivity (c.p.m.)






Glucuronic acid 247 163
In either case the product was redissolved in a small
volume of water, exhaustively dialysed and freeze -
dried. The crude products in each preparation were
dissolved in water to give approx. 5000c.p.m. in
200 pi. An equal volume of M-sulphuric acid was
added and the samples were hydrolysed in sealed
tubes for 16h at 100°C. After neutralization with
saturated barium hydroxide solution, salts and
charged material were separated by paper electro¬
phoresis, each preparation being applied to a 6 cm
strip on the paper. From each paper 2 cm guide
strips were cut out and checked for radioactivity.
All radioactive material was located in each
preparation equidistant with glucuronic acid and
with the neutral material at the origin. These areas
on the remaining 4 cm strips were eluted, pooled
and re-ran on paper chromatograms in solvent A.
The areas corresponding to glucuronic acid and
lactone, glucose and galactose were cut out and
their radioactivities counted. The distribution of
radioactivity is shown in Table 4.
If the polymer is identical with serotype 8 poly¬
saccharide, the same products of partial acid
hydrolysis should be obtained. This was performed
as for the specific assay described above. After
neutralization the samples were applied to Whatman
no. 1 paper and subjected to paper electrophoresis.
The material between glucuronic acid and the
neutral material was eluted as one fraction and the
neutral material as a second. They were applied
to separate paper chromatograms run in solvents
B and A respectively. In solvent B all material
ran equidistant with the oligosaccharides isolated
earlier from serotype 8 polysaccharide (Sutherland,
1970) and used as standards. No radioactivity
equidistant with glucuronic acid was detected. This
confirms that the conditions of hydrolysis were
insufficient to hydrolyse the aldobiouronic acid
O-a-D-glucuronosyl-D-galactose. The chromato-
gram of the neutral material showed that all the
radioactivity ran equidistant with glucose and
galactose. This is also similar to the pattern with
authentic serotype 8 polysaccharide, which fails
to yield any neutral oligosaccharides on partial
acid hydrolysis.
DISCUSSION
The gross similarity in the structure of the
repeating units of exopolysaccharide capsules of
K. aerogenes and the 0-antigenic components of
lipopolysaccharides indicated a possible similarity
in their synthetic processes. The fact that both
polymers are located outside the cell membrane
also points to possible similarities in precursor
synthesis, organization, control and polymerization.
The O-antigens are synthesized by particulate
enzymes contained in the cell membrane. Sequential
transfer of sugars from sugar nucleotide precursors
to an isoprenoid alcohol phosphate acceptor occurs
(Nikaido, 1968).
The results obtained in the present study
showed that transfer of glucose from UDP-glucose
to a lipid acceptor occurs in membrane preparations
ofK. aerogenes serotype 8. The transfer of galactose
occurs similarly. The sequence is most probably
glucosyl transfer followed by galactosyl transfer.
This is indicated on the basis of two observations:
(i) although some transfer of galactose occurred in
the absence of sugar nucleotides other than UDP-
galactose, the highest yields of galactose-labelled
lipid were obtained when UDP-glucose was also
present; (ii) mutants were obtained that transferred
(a) neither glucose nor galactose and (6) glucose
only; no mutants transferring galactose only were
obtained. In the type of mutant unable to transfer
glucose galactosyltransferase activity was present.
Galactosyltransferase thus requires glucosyl transfer
as a prerequisite.
The first stage in glycosylation of the lipid is
probably similar to the first stage occurring in
the synthesis of other extracellular polymers. In
this reaction glucose 1-phosphate is transferred
from UDP-glucose to the lipid carrier together
with release of UMP. This is based on the
inhibition of glucose transfer by UMP and iden¬
tification of UMP as the major nucleotide pro¬
duct of interaction between UDP-glucose and
the membrane-bound enzyme system. The ratio
of glucose to galactose transfer in both lipid and
polymer was 1:2, the same ratio in which these
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sugars occur in the native exopolysaccharide.
Although not conclusive, this suggests that the
system is in fact one concerned with exopoly¬
saccharide synthesis and not with some other poly¬
mer such as lipopolysaccharide from which glucose
is essentially absent (Sutherland & Wilkinson,
1966). Those mutants unable to transfer glucose or
galactose to lipid did not form polysaccharide,
indicating that the glycosylated lipids are inter¬
mediates in exopolysaccharide formation. Further,
in following the fate of the labelled sugars, radio¬
active material corresponding in electrophoretic
and chromatographic properties to characteristic
oligosaccharide components of the exopolysaccha¬
ride (Sutherland, 1970) was shown.
The lipid acceptor has not yet been characterized.
Initial experiments indicated that glycosyl-labelled
lipid had several properties common to the iso-
prenoid intermediates known to occur in the syn¬
thesis of three polysaccharides discovered outwith
the bacterial cell: lipopolysaccharide (Wright et al.
1967), mucopeptide (Higashi et al. 1967) and
mannan (Scher et al. 1968). Chromatographic
results also compared well with those for a similar
exopolysaccharide system studied by Troy &
Heath (1968; F. C. Troy, personal communication).
If the lipid is indeed an isoprenoid alcohol such
compounds appear to be involved generally in the
synthesis ofpolysaccharides outside cell membranes.
This activity has also been noted in kidney cells
synthesizing mannose-containing glycoproteins
(Caccam et al. 1969). They are thus not confined to
procaryotic cells in this function.
Interchangeability of lipid acceptors between
mannan and exopolysaccharide systems (F.
Frerman, E. C. Heath, M. Lahav, T. C. Chiu & W. J.
Lennarz, unpublished work, cited by Lahav, Chiu &
Lennarz, 1969) has been reported. It is not clear
whether the lipids are identical in these and similar
systems or merely show sufficient similarity to func¬
tion in either system. If the former, the cell must
possess suitable control mechanisms whereby lipid
is allocated to the biosynthetic processes requiring
it. It is perhaps significant that in K. aerogenes
both UDP-galactose 4-epimerase and TJDP-glucose
dehydrogenase are membrane-bound (M. Norval &
I. W. Sutherland, unpublished work). Thus for
synthesis of polysaccharides outside the cell
membrane UDP-glucose formed intracellularly
would be passed to the modifying enzymes within
the membrane. From these it could be spatially
passed to the particle-bound enzymes and lipid
carriers for the systems requiring them: exopoly¬
saccharide with UDP-glucuronie acid and both
exopolysaccharide and lipopolysaccharide with
UDP-galactose. This is shown diagrammatically in
Scheme 1. This could explain the failure to in¬
corporate significant amounts of glucuronic acid
from TJDP-glucuronic acid. The spatial configura¬
tion of the enzymes may only accept UDP-glucose,
modify it and in this way lead to polymer synthesis.
It may also be relevant that glucuronic acid forms
short side chains in the polysaccharide and is not
part of the linear chain (Sutherland, 1970).
The formation of exopolysaccharides thus ap¬
pears to be a complex process involving a series of
reactions:
(i) formation of intermediates such as UDP-
glucose ;
(ii) modification of the sugar nucleotides to yield
UDP-glucuronic acid;
(iii) sequential transfer of the sugars to a lipid
carrier, which is probably an isoprenoid alcohol
phosphate;
(iv) polymerization and extrusion into the extra¬
cellular environment. Associated with the final
stage there must presumably be some nlechanism
of attachment to the cell surface, as it is known that
stable mutants arise yielding exopolysaccharide
slime but no discrete capsules (Wilkinson, Duguid &
Edmunds, 1954; M. Norval & I. W. Sutherland,












Scheme 1. Postulated structural arrangement for polysaccharide synthesis. UDP-glucose passes through the
cell membrane to reach the membrane-bound dehydrogenase and epimerase enzymes. After modification by
these enzymes the sugar nucleotides so formed, UDP-glucuronic acid and UDP-galactose, are utilized by the
transferases to form precursors for capsule or in the latter case also for lipopolysaccharide. Finally, polymer is
excreted from the exterior surface of the membrane.
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requires a considerable number of enzymes and a
correspondingly large amount of genetic informa¬
tion for the synthesis of structures whose role
remains largely unknown and that in the laboratory
are not essential for cell viability.
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glucose' is now known to be a glycerylphosphoryldiglucosyl diglyceride, a new type of phospho-
glycolipid (Shaw, N., Smith, P. F. & Verheij, H. M. (1970), Biochemical Journal 120, 439). This
structure is based upon a diglucosyl diglyceride containing an additional glycerol phosphate
residue on the 6-hydroxyl of one of the glucose residues. Similar phosphoglycolipids have now
been isolated from Streptococcus lactis, Leuconostoc mesenteroides and Listeria monocytogenes.
The phosphoglycolipid from S. lactis has a similar structure to that isolated from M. laidlawii,
confirming the observations of Fischer (1970, Biochemical and Biophysical Research Communications
41. 73i). who isolated the same lipid from a different strain of S. lactis. L. mesenteroides and
L. monocytogenes both contain a glycerylphosphorylgaiactosylglucosyl diglyceride. It is significant
that the phosphoglycolipids are always structurally related to the diglycosyl diglycerides found
in the same organism. The most likely biosynthetic route would be transfer of glycerophosphate
from CDP-glycerol to the required diglycosyl diglyceride. Alternatively, phosphatidic acid may be
transferred from CDP-diglyceride, giving initially a diacyl glycerylphosphoryldiglycosyl diglyceride
which may then lose two acyl residues to give the phosphoglycolipid. Evidence for the occurrence
of more highly acylated phosphoglycolipids has now been obtained.
10. Transfer of Monosaccharides to Lipid Intermediates in the Synthesis of Klebsiella Exopoly-
saccharides. By I. W. Sutherland, Mary Norval and I. R. Poxton (Department of Micro¬
biology, Edinburgh University)
The synthesis of exopolysaccharide capsules or slime in the genus Klebsiella is now known to
proceed by stepwise addition of sugars from nucleotide diphosphosugars to a lipid which was
shown to be a C55 isoprenoid alcohol phosphate (Troy, F. A., Frerman, F. E. & Heath, E. C.
(1971), Journal ofBiological Chemistry 246, 118; Sutherland, I. W. & Norval, M. (1970), Biochemical
Journal 120, 567). The system thus resembles the synthesis of other repeating unit-containing
polymers which are found outwith the bacterial cell membrane.
In two different capsular serotypes of K. aerogenes the first sugar to be incorporated was glucose
(as glucose-i-phosphate). In strain A4 (serotype 8) the addition of glucose is followed by two
moles of galactose. Transfer of glucose to the lipid was slightly stimulated by several divalent
cations; galactose transfer required either Ca2+ or Mg2+. In both cases maximum transfer was
obtained when both these ions were present. The optimum pH value for the sugar transferases
appears to be between 7-5 and 8-o. Both glucose and galactose transfer increased with increasing
membrane protein concentration. Transfer was unaffected by various concentrations of bacitracin
but at high chloramphenicol concentrations galactose transfer was partially inhibited. In mutants
containing reduced amounts of lipids, bacitracin had an inhibitory effect provided that it was
added to growing cells. No inhibition was observed when the membrane preparations were obtained
from stationary phase bacteria. The possible exchange of lipid between various polymer-synthesizing
systems is therefore proposed.
11. The Biosynthesis of Lipid A in Pseudomonads. By G. O. Humphreys and Pauline M. Meadow
(Biochemistry Department, University College London)
The lipid A of many pseudomonads contains 2- and 3-hydroxy lauric acids (Hancock, I. C.,
Humphreys, G. O. & Meadow, P. M. (1970), Biochimica et biophysica acta 202, 389). In Fseudo-
monas alcaligenes brj/2 the sole 12-hydroxy acid is 3-hydroxy lauric acid (Key, B. A., Gray, G. W .
& Wilkinson, S. G. (1970), Biochemical Journal 120, 559).
A particulate preparation of bri/2 incorporated [i-14C]-I2:o into bound 3-OH, 12:0 from
either [i-14C]-Iauric acid with CoA or [i-14C]-lauryl CoA. The hydroxy acid formed was not
extractable by the Folch procedure and was not found in the phosphatidyl ethanolamine fraction.
The experiments suggested that 3-OH lauryl CoA was an intermediate in lipid A formation. This
ester was synthesized chemically and shown to be a substrate for the particulate system, but the
highest activity was obtained with an EDTA preparation of bri/2 (Robbins, P. W., Wright, A. &
Bellows, J. L. (1964), Proceedings of the National Academy of Sciences of the U.S.A. 52, 1302).
This preparation was inactive with laurate and lauryi CoA. Attempts to increase its activity by
adding possible acceptors were unsuccessful. >■
Radioactivity bound during incubation of [i-14C]-3-OH 12:0 CoA with the EDTA preparation
for 10 min was measured on filter-paper discs after extensive washing with chloroform/methanol
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II The Production of Enzymes Involved in Exopolysaccharide Synthesis
iC:'
. in Klebsiella aerogenes Types 1 and 8
Mary Norval and Ian W. Sutherland
Department of Microbiology, University of Edinburgh
(Received December 4, 1972/February 2, 1973)
The levels of several enzymes thought to be involved in synthesis of precursors for exopoly¬
saccharide formation in Klebsiella aerogenes have been examined in two wild-type strains and in
non-mucoid mutants. Enzymes involved in carbohydrate anabolism and catabolism, such as
hexokinase and phosphoglucose isomerase, were present at highest levels in the parent strains.
Enzymes presumed to be involved in forming precursors for several polysaccharides also had
high specific activities, whereas those involved solely in exopolysaccharide synthesis were present
at lower levels. Loss of ability to form exopolysaccharide had little effect on the specific activities
of the enzymes tested. Some non-mucoid mutants were deficient in one of the enzymes tested or
had lowered specific activity, while the specific activities of the other enzymes were unaffected.
The only enzymes whose specific activities were significantly increased under conditions favouring
exopolysaccharide synthesis were UDP-glucose pyrophosphorylase and GDP-mannose pyro-
phosphorylase. i
a' All naturally occurring strains of Klebsiella aero-
genes are mucoid and capsulate. Synthesis of the
exopolysaccharide is favoured by certain cultural
conditions, including nitrogen or phosphorus deficien¬
cy in the presence of excess utilisable carbohydrate,
high aeration and lowered incubation temperature [1].
Although it is now possible to postulate many
of the enzymes and precursors involved in exopoly¬
saccharide synthesis, little is known about the level
of the enzymes or the control of precursor production;
both enzymes and precursors may be common to
'more than one polysaccharide-synthesizing system
within the bacterial cell. In some non-capsulate
strains of Diplococcus pneumoniae, biochemical and
genetic defects have been determined [2]. More
recently, 01son et al. [3], examined a capsulate strain
of Escherichia coli K27 and non-mucoid mutants
derived from it. The activities of several enzymes
involved in synthesis of nucleoside diphosphate
8ugars were compared in the wild-type and mutant
strains. Levels of enzymes (such as hexokinase and
phosphoglucomutase) which are involved in a number
ofpathways, were much higher than those of enzymes
e-7- UDP-glucose dehydrogenase, required solely
for the synthesis of glucuronic acid in the capsule.
Lack of capsule production was not always due to
failure to synthesise nucleoside diphosphate sugars
and it was assumed that some mutations had occurr-
ed at later stages in polysaccharide synthesis.
Production of the exopolysaccharide colanic acid,
in Escherichia coli strain K12, may be controlled
through an operon. This was thought to regulate the
levels of a number of enzymes involved in synthesis
of the nucleoside diphosphate sugars required as
precursors [4,5]. Although E.coli K12 has a well-
defined genetic system, colanic acid has a complex
repeating unit structure [6] and is often only produc¬
ed in small quantities; yields of enzymes involved
are consequently often low. Higher enzyme levels
might be encountered in Klebsiella strains. Two
strains of K. aerogenes were chosen: strain A4, which
has a simple tetrasaccharide repeating unit contain¬
ing galactose, glucose and glucuronic acid [7] and
strain Al which secretes a polysaccharide containing
fucose, glucose and glucuronic acid [8]. These strains
belong to serotypes 8 and 1, respectively. Non-
mucoid mutants from both strains were isolated to
provide suitable systems for testing the control of
enzymes involved in synthesising polysaccharide
precursors; in the case of strain A4, UDP-galactose,
UDP-glucose and UDP-glucuronic acid and in strain
Al, UDP-glucose, UDP-glucuronic acid and GDP-
fucose. In both strains UDP-galactose is probably also
a precursor of lipopolysaccharide [9]. The transfer
of sugars from the sugar nucleotides, such as UDP-
glucose to lipid and to exopolysaccharide, was shown
using cell-free preparations, confirming their role
as precursors in exopolysaccharide synthesis [10].
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MATERIALS AND METHODS
BACTERIA AND METHODS OF CULTURE
K. aerogenes strains A1 and A4, described by
Dudman and Wilkinson [8], were cultured routinely
on nutrient agar at 35 °C. Bacteria were grown on
solid or liquid nitrogen-deficient medium [11] and on
minimal medium [12]. Lipid cultures were in Erlen-
meyer flasks containing half the nominal volume of
medium and shaken at 200—300 rev./min in an
orbital incubator. Initial isolation of mutants was
made on nitrogen-deficient medium or on eosin-
methylene blue agar with glucose or other sugar as
the carbon source.
MUTAGENESIS
The methods used included: 2-aminopurine,
N-methyl-N'-nitrosoguanidine, acriflavine, ethyl-
methane sulphonate, MnCl2, nitrite, ultraviolet and
y-irradiation.
PREPARATION OF BACTERIAL EXTRACTS
Cultures (1 1) were grown in nitrogen-deficient or
minimal medium at 30 °C for 16 h. The bacteria
were harvested, washed in ice-cold saline, resuspend-
ed in 10 ml cold 0.1 M Tris-HCl buffer pH 8.0 and
disrupted in an ultrasonic generator (M.S.E. Ltd.,
London) at 20 kHz for 80 s with cooling in ice. Whole
cells were removed by centrifugation twice at 2500 X g
for 15 min and the supernatant (20—30 mg protein/
ml) used as the crude enzyme fraction. The cell-
wall-membrane fraction was deposited by centrifuga¬
tion for 60 min at 30 000 X g and resuspended in cold
water. Fractions were stored at —20 °C and, when
required, thawed slowly.
ASSAY METHODS
Total polysaccharide was determined by a micro-
modification of the anthrone technique [13] and
protein by the method of Lowry et al. [14]. Enzyme
assays were performed at room temperature (21 °C),
in microcuvettes; in all cases the final volume was
3S0 pi and the change in absorbance at 340 nm was
measured. Glucose-6-phosphate dehydrogenase,
hexokinase and phosphoglucomutase were purchased
from Boehringer Mannheim GmbH (Mannheim,
Germany) and UDP-glucose dehydrogenase from
Sigma Biochemicals (London). Enzyme activity
was measured as units/mg protein, where one unit is
the amount of enzyme required to transform 1 pmol
substrate/min at 21 °C. Any activity found in the
control mixtures was subtracted from these values.
In all cases, enzymes were assayed at their optimal
pH or in systems involving several enzymes, at the
optimal pH of the rate-limiting step.
Hexokinase
Hexokinase was assayed by a modification of the
method of Slein et al. [14a]. The reaction mixture
contained 100 pi 1.0 M Tris-HCl buffer pH 7.5,
100 pi 0.1 M cysteine-NaOH pH 8.5, 30 pi 1.0 M
MgCl2, 20 pi 0.1 M ATP, 20 pi 0.02 M NADP; 30 pi
0.2 M glucose and 1 pi gIucose-6-phosphate dehydro¬
genase (0.14 unit). The final volume was adjusted
to 380 pi with water and the absorbance recorded at
30-s intervals over 30 min.
Phosphoglucomutase
This was assayed by the method of Najjar [15a],
Phosphoglucose Isomerase
The technique of Slein [15] was used. The reac¬
tion mixture contained: 100 pi 1 M Tris-HCl buffer
pH 7.5, 100 pi 0.1 M cysteine-NaOH, 10 pi 1.0 M
MgCl2, 20 pi 0.1 M fructose-6-phosphate, 20 pi 0.02 M
NADP and 1 pi glucose-6-phosphate dehydrogenase.
In the control, fructose-6-phosphate was replaced
by water.
Phosphomannose Isomerase
The method resembled that for phosphoglucose
isomerase, the fructose-6-phosphate being replaced
by mannose-6-phosphate [15]. The same reaction
mixture with glucose-1-phosphate replacing mannose-
6-phosphate was used to assay phosphoglucomutase,
readings being made for 5 min.
Glucose-6-Phosphate Dehydrogenase
This was determined by a modification of the
method of DeMoss [16] using the same reaction
mixture as the previous assays with 20 pi 0.1 M
glucose-6-phosphate as the substrate. The change in
absorbance at 340 nm was measured over 3 min.
TJDP-Glucose Pyrophosphorylase
The assay mixture contained: 100 pi 1.0 M Tris-
HCl buffer pH 7.5, 5 pi 1.0 M MgCl2, 20 pi 0.02 M
NADP, 30 pi 0.05 M sodium pyrophosphate, 20 pi
0.02 M IJDP-glucose, 1 pi glucose-6-phosphate de¬
hydrogenase and 2 pi phosphoglucomutase (0.065
unit). Two controls omitting UDP-glucose and
sodium pyrophosphate, respectively, were always
included [17]. The change in absorbance at 340 nm
was recorded over 5 min.
GDP-Mannose Pyrophosphorylase
This was determined according to Munch-Peter-
sen [18] in an assay mixture containing: 100 pi Tris-
HCl buffer pH 7.5, 50 pi 0.5 M NaF, 10 pi 0.05 M
ADP, 10 pi 0.2 M glucose, 5 pi 1.0 M MgCl^ 20 pi
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0.02 M NADP, 20 pi 0.05 M sodium pyrophosphate,
20 pi 0.01 M CDP-mannose, 2 pi hexokinase (0.54
unit) and 1 pi glucose-6-phosphate dehydrogenase.
The final volume was adjusted to 380 pi with water,
and the absorbance at 340 nm recorded over 10 min.
GDP-Fucose Synthetase
Determinations of this enzyme were made by the
method of Ginsburg [19]. The reaction mixture
(380 pi) was composed of: 100 pi Tris-HCl buffer
pH 8.0, 10 pi 0.02 M NADPH and 20 pi 0.01 M
GDP-mannose. The absorbance at 340 nm was mea¬
sured for 15 min. As for the assay of GDP-mannose
pyrophosphorylase, a control lacking GDP-mannose
was used.
TJDP-Glucose Dehydrogenase
This enzyme was assayed in a reaction mixture
[20] containing 50 pi 1.0 M glycine-NaOH buffer
pH 8.7, 5 pi 1.0 M MgCl2, 20 pi 0.02 M NAD and 20 pi
0.02 M UDP-glucose. After adjusting the volume to
380 pi with water, the absorbance at 340 nm was
recorded over 15 min. A control tube lacked UDP-
glucose.
UDP-Galactose-4-Epimerase
Determinations of this enzyme were made in a
reaction mixture containing: 50 pi glycine-NaOH
buffer pH 8.7, 5 pi 1.0 M MgCl2 20 pi 0.02 M NAD,
20 pi 0.01 M UDP-galaetose and 2 pi UDP-glucose
dehydrogenase (1 unit). The final volume was 380 pi
and the absorbance at 340 was recorded for 10 min
[21]-
Crude cell lysates were used throughout as the
"enzyme" preparations. Assays were therefore affect¬
ed by the presence of other enzymes and of endo¬
genous substrates and cofactors. However, the results
were sufficiently accurate and reproducible to de¬
termine whether a particular enzyme was present
and to give a measure of its activity. Most techniques
proved satisfactory, but assay of GDP-mannose
pyrophosphorylase depended on the presence of two
additional enzymes and activities thus determined
proved less accurate. In the assay of GDP-fucose
synthetase, the reduction of the intermediate GDP-
4-oxo-6-deoxy-mannose by NADPH was affected
by the non-specific oxidation of the NADPH. Where
doubtful results were obtained, the appearance of
fucose after hydrolysis of GDP-fucose was determined
chromatographically. Similarly, the assay procedure
forjjjUDP-glucose dehydrogenase was affected by
non-specific reduction of NAD. The reaction may
also be inhibited by the product UDP-glucuronic
acid. Doubtful results were again checked using
chromatography of nucleotide hydrolysates.
RESULTS
Isolation of Non-Mucoid Mutants
Both the Klebsiella aerogenes strains A1 (type 1)
and A4 (type 8) produced large, raised, shiny colonies
of viscous consistency, especially on nitrogen-deficient
medium. The capsules formed by strain A1 were
very large, approximately 10 pm in diameter, while
those formed by strain A4 were smaller. Occasional
spontaneous non-mucoid (0) mutants, which had lost
the ability to form exopolysaccharide, arose during
subculture of both strains. The frequency of O-mu-
tants was increased considerably by the use of muta¬
gens. In an attempt to induce mutations at different
chromosomal loci, the various mutagens fisted in the
Methods were employed. Mutants were thoroughly
checked for purity and their pattern of sensitivity
to a range of Klebsiella phages was compared to
that of the wild-type strains. One surprising feature
of the mutants was their stability. No mucoid rever-
tants were detected nor could they be induced by
further mutagenesis.
During examination of colonies following muta¬
genesis, two further types of mutation concerned
with exopolysaccharide synthesis were noted. One
type, which was apparently favoured by amino-
purine mutagenesis, was the form which we have
designated crenated (OR) mutants. These cultures
resembled the wild type on incubation at 35 °C, but
were non-mucoid and autoagglutinable at 15—20 °C.
Some properties of these conditional mutants have
already been described [22], No mutants of this type
were obtained from strain Al. The other type of
mutant with altered colonial morphology was a
slime-forming variant from strain Al. It was ana¬
logous to a similar mutant isolated earlier from
K. aerogenes type 54 in forming slime of the same
chemotype as the parent, but never forming capsules
[12]. Such slime-forming (SI) mutants have a similar
colonial appearance to the wild-type but can be
recognised among well-separated colonies by the
greater production of a polysaccharide with increased
viscosity.
Determination of Enzyme Levels
The probable enzymes involved in sugar nucleo¬
tide formation in strains Al and A4 are shown in
Big. 1. Although galactose is found in the strain A4
exopolysaccharide, it is also present in the lipopoly-
saccharides of both strains [9]. Ten of the enzymes
thought to be involved in synthesising precursors
of the capsular polysaccharides in the two strains
were assayed (see Methods).
The enzyme levels in the wild-type strains and in
the strain Al (SI) mutant are shown in Table 1.
It proved difficult to work with strain Al, as the
large amounts of capsular material present in cell
lysates made sedimentation of whole cells extremely
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GIucuronate-6-phosphate
tGlucose-6-phosphate dehydrogenase UDP-galactose-4-epimerase
Glucose >- GIucose-6-phosphate >- Glucose-1-phosphate >- UDP-glucose >- UDP-galactose
Phosphoglucomutase UDP-glucose pyrophosphorylase
I >- UDP-glucuronic acid
' Phosphoglucose isomerase UDP-glucose dehydrogenase
Fructose-6-phosphate
^ Phosphomannose isomerase
Mannose-6-phosphate >- Mannose-1-phosphate >- GDP-mannose >- GDP-fucose
Phosphomannomutase GDP-mannose pyrophosphorylase GDP-fucose synthetase
Pig. 1. Probable pathways leading to the nucleotide sugar precursors of the exopolysaccharides of K. aerogenes A1 and A4
Table 1. Specific activity of enzymes in cell-free preparations of K. aerogenes strains A1 and A4 and the mutant A1 (SI)
Bacteria were from 16-h cultures grown in nitrogen-deficient medium at 30 °C. The results represent the mean of 6, 2 and 10
separate preparations from A1 (SI), A1 and A4, respectively. The figures in brackets indicate the range of values obtained
Specific activity of
Enzyme
Mutant A1 (St) Strain A1 Strain A4
unita/mg protein
Hexokinase 15 (± 3) 43 (± 2) 43 (± 13)
Glucose-6-phosphate dehydrogenase 107 (± 28) 78 (± 10) 22 (± 7)
Phosphoglucomutase 22 (± 4) a 18 (± 3)
Phosphoglucose isomerase 100 (± 24) O00t> 19 (± 8
Phosphomannose isomerase 25 (± 5) a 3.4 (± 0.6)
UDP-glucose pyrophosphorylase 33 (± 10) a n (± 9)
GDP-mannose pyrophosphorylase 4.7 (± 1-3) a 0.02
GDP-fucose synthetase 0.12 (± 0.08) 0.38 (± 0.1) 0
UDP-glucose dehydrogenase 0.19 (± 0.1) 0.39 (± 0.2) 0.17 (± 0.11)
UDP-galactose-4-epimerase 0.06 (± 0.03) a 0.9 (± 0.34)
* Not tested.
difficult. A high initial absorbance at 340 nm was
also present. As preparations from the mutant A1
(SI) were obtained with little contaminating poly¬
saccharide, they were normally used in preference to
wild-type material. A noticeable feature was the
difference between the enzymes required for normal
metabolic function in the cell, such as phospho¬
glucose isomerase and those thought to be solely
involved in polysaccharide synthesis. Although the
exopolysaccharide of strain A1 did not contain
galactose, the enzyme UDP-galactose-4-epimerase
was present, presumably for formation of galactose
in lipopolysaccharide. No GDP-fucose synthetase
activity was found in strain A4 and negligible GDP-
mannose pyrophosphorylase. This was not unexpect¬
ed as this strain lacks mannose or fucose-containing
polymers. The cell-wall-membrane fraction was used
as a source of enzymes for cell-free synthesis of exo-
polysacchraide [10]. It was of interest to determine
which enzymic activities were associated with this
particulate fraction. Only UDP-glucose dehydro¬
genase and UDP-galactose-4-epimerase were found
in particulate material, while the other enzymes
assayed were in the supernatant.
Enzyme Levels in Non-Mucoid Mutants
The mean enzyme levels in a number of inde¬
pendently isolated mutants of strains Al, A1 (SI)
and A4 were examined (Table 2). In another four
mutants (Table 3) the levels of most enzymes were
apparently normal, but the level of a single enzyme
in each strain was reduced. Most non-mucoid mutants
thus possess normal enzyme levels even for those
enzymes thought to be solely involved in the synthe¬
sis of precursors for capsular polysaccharide forma¬
tion.
Two further mutants from strain A4 isolated
during attempts to obtain colonies unable to utilise
galactose were non-mucoid on minimal medium
containing glucose but mucoid on minimal medium
supplemented with galactose. One mutant, 039,
apparently lacked phosphoglucomutase while other
enzymes were present at near normal levels (Table 4).
This strain could be grown on two alternative carbon
sources, glucose-6-phosphate and glucose-1-phos¬
phate. Using the first of these, good growth was
obtained but no exopolysaccharide was formed. In
media containing glucose-1-phosphate, growth was
poor but some capsular material was formed. The
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Table 2. Enzyme, levels of non-mucoid mutants of K. aerogenes strains Al, A1 (SI) and A4
Cells from 16-h cultures in nitrogen-deficient medium grown at 30 °C. The mean value obtained is shown for each enzyme and
the variations from this are given in brackets. The number of mutants for each parental type are as follows: mutant Al (SI), 9;
strain Al, 17; strain A4, 16 mutants
Enzyme levels in mutants of
Enzyme
Mutant Al (SI) Strain Al Strain a4
units units units
Hexokinase 33 (±11) 60 (± 20) 25 (± 8)
Glucose-6-phosphate dehydrogenase 62 (± 15) 66 (± 25) 40 (± 10)
Phosphoglucose isomerase 76 (± 20) 63 (± 15) 70 (± 17)
Phosphomannose isomerase 14 (± 5) 20 (± 7) 20 (± 8)
UDP-glucose pyrophosphorylase 38 (± 12) 28 (± 10) 30 (± 10)
GDP-mannose pyrophosphorylase 0.34 (± 0.12) 0.34 (± 0.14) a
GDP-fueose synthetase 0.12 (± 0.06) 0.17 (± 0.08) a
UDP-glueose dehydrogenase 0.34 (± 0.20) 0.34 (± 0.20) 0.22 (± 0.11)
UDP-galaetose-4-epimerase a a 0.90 (± 0.5)
» Not tested.
Table 3. Non-mucoid mutants of K. aerogenes A4 and Al
with lowered enzyme levels
The cell lysates were prepared from 16-h cultures grown in
nitrogen-deficient medium at 30 °C
Mutant Specific















Table 4. Levels of enzymes in 2 mutants (039,040) of K. aero¬
genes A4 compared with the parent strain
The cell lysates were prepared from 16-h cultures grown in
nitrogen-deficient medium at 30 CC. The figures represent
the mean of 3 estimations




Hexokinase 34 25 31
Phosphoglucomutase 19 0.5 19.6
UDP glucose pyrophos¬
phorylase 30 — 0.2
UDP galactose-4-epimerase 0.84 0.60 0.50
second mutant (040) appeared to lack UDP-glucose
pyrophosphorylase; the levels of other enzymes
resembled those in the parent strain. These were the
only mutants which lacked enzymes thought to be
involved in the synthesis of sugar nucleotides requir¬
ed for exopolysaccharide formation.
The Effect of Culture Medium on Enzyme Levels
Certain cultural conditions which favour poly¬
saccharide synthesis might be expected to increase
levels of enzymes responsible for precursor formation.
The enzyme levels of cells of K. aerogenes strain Al
(SI) were assayed after growth at 30 °C in a simple
synthetic medium in which the only parameters
altered were the nitrogen and carbon sources. The
basic medium contained l°/0 (w/v) Na2HP04, 0.3 °/o
(w/v) KH2P04, 0.1 °/0 (w/v) NaCl, 0.1 % (w/v) K2S04
and 0.02 °/0 (w/v) MgS04 with the following additions:
(a) 1% (NH4)2S04, 1% glucose; (b) 0.03% (NH4)2-
S04, 1 % glucose; (c) 2°/0 casamino acids or (d)
0.03 % (NH4)2S04, 1 °/0 mannose called media A, B,
C and D, respectively.
Cell protein was used as a measure of growth
and exopolysaccharide was determined by the
anthrone technique. Polysaccharide production/mg
cell protein then gave an indication of the relative
amount of polysaccharide synthesised and could be
correlated with the specific activity of the enzymes
(Table 5). Media B and D favoured exopolysaccharide
synthesis which was 4—5 times higher than in media
A and C. Despite this, the enzyme assays showed
little difference between the specific activity of the
cells from different media. The largest variations
were in the levels of GDP-mannose pyrophosphoryl¬
ase, GDP-fucose synthetase and UDP-glucose pyro¬
phosphorylase. In media B and D, the activity of
GDP-mannose pyrophosphorylase was increased by
100°/o and that of GDP-fucose synthetase by 180%.
Although these enzymes are probably concerned
solely with precursors for exopolysaecharide synthe¬
sis, the assay techniques showed some variability,
with errors in independent estimations of ± 30%
and ± 70%, respectively, (Table 1). Activity of UDP-
glucose pyrophosphorylase was also higher, but it is
also involved in formation of precursors for lipopoly-
saccharide synthesis.
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Table 5. Enzyme levels and exopolysaccharide 'production for K. aerogenes strain A1 (SI)
Cells -were grown 16 h at 30 °C in different media (see text) prior to lysis. The specific activities for each enzyme are given
Enzyme level In medium
Enzyme . ...
A B C D
units/mg protein
Hexokinase 9 14 17.9 18.5
Glucose-6-phosphate dehydrogenase 201 140 179 168
Phosphoglucose isomerase 245 174 224 174
Phosphomannose isomerase 25.8 22.5 33.6 26.3
UDP-glucose pyrophosphorylase 25 56 45 84
GDP-mannose pyrophosphorylase 1.7 3.4 1.5 3.4
UDP-glucose dehydrogenase 0.67 0.28 0.6 0.34 "J
GDP-fucose synthetase 0.06 0.17 0.6 0.17
Exopolysaccharide production in medium





The levels of several enzymes engaged in the syn¬
thesis of sugar nucleotide precursors of the exopoly-
saccharides were assayed in two strains of Klebsiella
aerogenes and in mutants derived from them. Of
48 mutants, isolated independently with different
mutagens, one was defective in phosphoglucomutase.
Another lacked UDP-glueose pyrophosphorylase.
Pour further mutants possessed lowered activity for
one of the enzymes tested and the remainder had
no detectable defects. This was surprising if it is
assumed that the mutagenic agents used caused
deletions or alterations to the DNA at different loci.
Another unexpected observation was the stability
of the mutants, no revertants being obtained. This
was also noted for mutants ofDiplococcus pneumoniae.
Three non-mucoid mutants of strain A4 lacked
enzymes responsible for transfer of glucose or galac¬
tose from their respective uridine diphosphocom-
poundsto a lipid fraction [10]. Genes controlling syn¬
thesis and production of sugar nucleotides may be less
liable to mutation than other genes involved in poly¬
saccharide production, as are the majority of rfb
mutants in Salmonella strains [23]. These mutants
synthesise the "core" lipopolysaccharide structure
and the nucleotide sugar precursors for the O-anti-
genic side chains, but are unable to attach these
sugars to the core.
Non-mucoid mutants from strains of bacteria
which normally produce extracellular polysaccharide
have provided much information about the precur¬
sors required for polysaccharide synthesis [24,25].
However, very little work on the control of the en¬
zymes responsible for sugar nucleotide formation
has been reported. The present finding that, in non-
mucoid mutants, no uniform lowering or raising of
the levels occurs on the enzymes studied, is similar
to the results of Olson et al. [3]. Mutants obtained
from a capsulate strain of Escherichia coli also failed
to show any correlation between loss of exopoly-
saccharide formation and the levels of enzymes
forming nucleotide sugar precursors. Using a smaller
number of mutants, their results did show consider¬
able fluctuations in enzyme levels among the differ¬
ent cultures. No uniform pattern in the enzyme
levels could be observed. Unlike this E. coli strain
or the two K. aerogenes strains reported here, the
synthesis of colanic acid by E. coli K12 shows a
different pattern. Investigations by Markovitz and
his colleagues [4,26—29] have shown a complex
pattern of control of the synthesis of colanic acid and
the enzymes involved. Regulator genes normally
repress the synthesis of colanic acid and the level of
several enzymes involved in the synthesis of sugar
nucleotide precursors. These enzymes included
phosphomannose isomerase, UDP-galaetose 4-epi-
merase, UDP-glucose dehydrogenase, GDP-mannose
pyrophosphorylase and GDP-fucose synthetase.
Derepression, through culture in the presence of
p-fluorophenylalanine, or through mutation in the
regulator genes, resulted in approximately three-fold
increases in enzyme levels. Attempts to show similar
derepression of capsular polysaccharide synthesis in
K. aerogenes strains were unsuccessful.
The use of various cultural conditions to cause
differences in polysaccharide production did not
cause marked differences in the specific activities of
the enzyme studied. It is thus possible that in the
K. aerogenes strains, control occurs at the metabolic
level. Accumulation of a particular intermediate may
stimulate or repress the activity of some enzyme in
the pathway of capsule synthesis. In contrast, the
colanic acid system is controlled at the genetic
level [4]. Where a nucleotide sugar is required solely
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for capsule formation, such as GDP-fucose in strain
A1 or UDP-glucuronic acid in both strains, control
could he exercised at this point through feed-back
inhibition of enzymes of the pathway. Pyrophos-
phorylases might be the most useful point for such
inhibition, as they represent the first stage in
commitment of the activated monosaccharide to '
polymer synthesis. This would account for the results ,
obtained for these enzymes. Several such systems
have been demonstrated. They include the inhibition
of TDP-glucose pyrophosphorylase by UDP-glucose
and TDP-rhamnose [30] and the inhibition of CDP-
glucose pyrophosphorylase by CDP-paratose [31].
Some type of negative control might be exercised,
by the presence of degradative enzymes breaking
down the nucleotide sugar precursors or the
cofactors involved in their synthesis. This is seen in
the sugar hydrolase studied by Ward and Glaser [32].
The two mutants lacking phosphoglucomutase
and UDP-glucose pyrophosphorylase respectively,
could both synthesise exopolysaccharide when grown
on galactose-containing media indicating a possible
similarity to other species of the Enterobacteriaceae
in galactose metabolism. In E. coli, a transport
system with high affinity for galactose has been
studied [33] and utilisation of galactose through
galactokinase and galactose-1-phosphate uridyl-
transferase has been postulated in Salmonella species
[34]. Similar mechanisms of uptake and utilisation
probably exist in Klebsiella species and thus permit
incorporation of exogenous galactose into the extra¬
cellular polysaccharide of a strain such as A4, which
synthesises galactose-containing capsular material.
The failure to obtain UDP-galactose-4-epimerase
mutants was unexpected as these should have been
obtained by the selection procedure used. It is
possible, albeit unlikely, that as the lipopolysaccha-
ride of several Klebsiella strains contains a very high
proportion of galactose [9], such mutants would be
essentially devoid of lipopolysaccharide and possess
lowered viability.
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Castor, Prince, and Dorstewitz (1961) and Neupert
and Sommer (1973) have reported the emergence of
continuous cell lines in cell cultures from rheumatoid
synovia. Hsu, Pomerat, and Moorhead (1957) noted
heteroploid transformation in an epithelial cell
derived from a culture of knee joint synovium; the
patient was stated to be free from malignant disease,
but it was not recorded whether the joint was rheu¬
matoid, arthritic, or healthy. Chessin and Hirschhorn
(1961) referred to a permanent cell line which had
been established from a normal human synovial
tissue.
Ford and Smiley (1973) found aggregations of
small round cells in relation to fibroblasts in a
synovial culture from a rheumatoid knee; these cells
grew in suspension, were not adherent to glass, and
synthesized IgG and IgM. They clearly differed from
the cells described above and were considered to be
B-immunocytes. It might be expected that the ability
to grow continuously in culture would be a reflection
of the presence of Epstein-Barr virus genome in the
cells; however, herpes-like virions were not seen in
the cells.
The other cell transformations, as distinct from
that described by Ford and Smiley (1973), were glass-
adherent cells showing many of the characteristics of
the continuous cell lines in common use. During the
course of work described in the previous two papers
in this series, we have experienced three episodes of
such apparent 'spontaneous transformations' in cell
cultures from patients with rheumatoid arthritis.
In an investigation of the possible role of viruses in
rheumatoid arthritis these observations were initially
interesting for evident reasons, namely, the known
ability of some viruses to transform cell strains of
finite life into lines with indefinite growth potential.
However, we were very aware of the results of
Gartler (1968), who showed that the majority of
continuous cell lines described in the literature as
being from different human sources probably had a
common origin in the HeLa cell. The most reasonable
explanation is laboratory contamination. Investiga¬
tion along the lines used by Gartler (1968) has shown
that the 'epithelial transformation' we have observed
in synovial cultures probably represents contamina¬
tion with Chang 'liver cells'.
Nevertheless, we record our observations for two
reasons. First, though these cells were clearly of the
Chang (HeLa) type, they differed from the Chang
cells we had in our laboratory and may have acquired
additional characteristics by virtue of accidental
co-cultivation with rheumatoid cells. Secondly, we
draw attention again to the dangers of inadvertent
contamination with cells, this time in the particular
context of cell culture applied to rheumatology.
Materials and methods
Synovial fluid cultures were prepared as previously
described (Mackay, Panayi, Neill, Robinson, Smith,
Marmion, and Duthie, 1974).
Chang 'liver' cells were obtained from Flow Labora¬
tories (Irvine, Scotland). These cells and the synovial
membrane cultures, were prepared or passed by trypsiniza-
tion; the same basic media were used for all cell cultures
but calf serum, rather than mixtures of horse and calf
sera, was used for the Chang cells. The general procedures
for handling cells followed the methods of Paul (1970).
Chromosome preparations were made by a technique
similar to that of McDougall (1970). Species identification
by cytotoxicity tests (Greene, Coriell, and Charney, 1964),
or by the indirect immunofluorescence reaction, was done
with a horse globulin fraction containing antibody to
human lymphocytes (a reagent kindly provided by Dr.
Keith James, Department of Surgery, University of
Edinburgh). Cells were further identified at species level
by determination of lactic acid dehydrogenase isoenzyme
patterns; the race of origin was checked by electrophoretic
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examination for the fast variant ofthe glucose-6-phosphate
dehydrogenase isoenzyme. This isoenzyme is characteristic
of many Negro populations and is present in HeLa cells,
a line derived from a cervical cancer in a Negress, and is
also present in many continuous cell lines, presumably
originating from contaminating HeLa cells (Gartler,
1968). Two techniques for isoenzyme assay were used:
first the method of de Oca, Macy, and Shannon (1969), but
without a vertical starch gel apparatus our results were
equivocal, and then the method of Ellis and Alperin (1972)
which gave reproducible patterns.
Cells were tested for ability to grow in semisolid agar
by the method of MacPherson and Montagnier (1964).
For examination in the electron microscope, cells were
grown on araldite by the method of Smith, Gray, and
MacKay (1969), fixed with 3-5% glutaraldehyde in 0-1
mol/1. sodium cacodylate buffer pH 7-2, and postfixed in
1 % osmic acid in the same buffer. They were sectioned
with an LKB/ultratome and stained with 1 % ethanolic
uranyl acetate and Reynolds's lead citrate. Immuno¬
fluorescence was by the indirect technique with fluorescein
tagged antiglobulin and human sera with antibody or
rabbit antisera to various virus antigens. For fiuoro-
chrome examination, cells were fixed in Carnoy's fluid and
stained with 1/10,000 dilution of acridine orange.
Mycoplasmas were cultured by placing cells in 'sloppy'
mycoplasma medium under microaerophilic conditions,
subculturing on solid media and identifying the species
of isolates by disc inhibition with known antisera.
For estimation of reverse transcriptase activity, cell
extracts were prepared after disruption (Coffin and
Temin, 1971) and assayed by the method of Temin and
Mizutani (1970).
Results
Apparent epithelial transformations were seen on
three occasions in a laboratory in the Department of
Bacteriology. The first change occurred in a rheuma¬
toid synovial membrane culture (Ref. no. 710025)
after 5 serial subcultures; a total of 100 days in vitro.
When first noticed in a culture held in a Roux flask,
large areas of cells of epithelial morphology were
seen in association with an intervening monolayer of
fibroblasts of the type normally present in synovial
membrane cultures prepared in this fashion. When
this flask was subcultured an obviously enhanced
growth rate was evident. In the two subsequent
instances the epithelial 'transformation' was observed
in primary synovial fluid cultures as distinct rounded
foci, just visible to the naked eye, which enlarged in
diameter and in the centres of which dense piling up
of cells occurred as incubation was continued. The
appearance is illustrated in Fig. 1. These changes were
seen after 35 days (Ref. no. 720151) and 16 days
(Ref. no. 720301) in vitro. When flasks containing
these colonies were subcultured they gave rise to
even monolayers of epithelial cells resembling those
in culture Ref. no. 710025.
Serological characterization by means of cyto¬
toxicity and immunofluorescence tests confirmed
that all three cells were ofhuman origin and isoenzyme
analysis of lactic acid dehydrogenase confirmed these
findings (Table I). At that stage there was some
fig. 1 Primary synovial fluid
culture at 45 days in vitro, Ref.
no. 720151, showing distinct
rounded foci of 'epithelial cells'
with dense central areas of
thickening
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Test with antihuman lymphocyte globulin Isoenzyme analysis
Cytotoxicity tests Immunofluorescence LDH type G6PD type
710025 -Fve -t-ve Human A
720151 -t-ve -t-ve Human A
720301 -t-ve -t-ve Human A
Chang liver cells -t-ve -t-ve Human A
WI-38 +ve +ve Human B
BHK fibroblasts —ve —ve Hamster Hamster
RK 13 —ve —ve Rabbit Rabbit
710025 RBCs ND ND ND B
720151 RBCs ND ND ND B
720301 RBCs ND ND ND B
ND ss Not done.
difficulty in obtaining reproducible glucoses-phos¬
phate dehydrogenase zymograms and, pending the
results of these, certain other features of the cell lines
from rheumatoid synovia were examined. These
features ultimately included an analysis of the karyo¬
types of the cells, determination of their ability to
form colonies in soft agar, examination of the fine
structure of the cells in the electron microscope before
and after attempts to induce virus replication by
treatment of the cells with bromodeoxyuridine
(BUDR) and iododeoxyuridine (IUDR) with di-
methylsulphoxide (DMSO) and to assist synthesis of
viral proteins by treatment of the cells with actino-
mycin D.
The problem of the origin of the epithelial cells was
finally resolved by determination of their glucose-6-
phosphate dehydrogenase isoenzyme patterns on
electrophoresis in cellulose acetate strips. A com¬
parison was made between the mobility of G6PD
extracted, on the one hand, from the cultured
epithelial cells no. 710025, 720151, and 720301, and,
on the other hand, from extracts from the erythro¬
cytes of the patients from whom the cells had
(ostensibly) come, together with rheumatoid synovial
fluid fibroblasts cultured in vitro, homogenates of
rheumatoid synovial membrane, human embryonic
cells, WI-38 human lung fibroblasts, and Chang liver
cells. The latter were included because they were the
only continuous line cells of human origin present in
the laboratory at the time when the apparent 'trans¬
formations' had taken place. Some of the results
obtained are shown in Table I. It will be seen that the
isoenzyme in the 'transformed' cells was in each
instance of the fast moving A variant, and quite
different from that found in the erythrocytes of the
donor. On the other hand, the isoenzyme was the
same as that found in the Chang cells. It was con¬
cluded that the contamination of the 710025 culture
had probably been from the Chang cells and that the
other synovial cultures had probably been con¬
taminated with this line. It is of interest in this
context that cells 710025, 720151, 720301 were all
shown to be contaminated with Mycoplasma orale,
serotype I; a species known to be present in the
Chang cells carried in the department and absent
from synovial cultures that had not yielded a 'trans¬
formed' epithelial cell.
FURTHER COMPARISONS OF THE EPITHELIAL
CELL ISOLATES WITH CHANG CELLS
Although the G6PD isoenzyme analysis eventually
clearly showed that cell line 710025 was a contaminant
and identified its possible subclones (720151 and
720301), other investigations revealed certain dif¬
ferences between it and the Chang cells.
Karyotype analysis
The frequency distribution of chromosome numbers
in cells of 710025 and cells of the Chang cell line is
given in Table II. It will be seen that the mean
number and standard deviation suggest that the
karyotypes of the two populations of cells are
different, but both are markedly aneuploid. In
addition to these numerical differences, a small
submetacentric satellite chromosome was present in
116 out of 200 (58%) metaphase plates of 710025
cells, but was not seen in any of 200 Chang cells
(Fig. 2). A similar chromosome was present in 720301
preparations.
GROWTH OF CELLS IN SEMISOLID AGAR
Cell lines 710025, 720151, and Chang were seeded at
a density of 102, 103, and 105 cells/Petri dish in
semisolid agar and incubated in 5 % carbon dioxide
in air. Colonies had developed after 7 days' incuba¬
tion of the plates inoculated with 103 cells of 710025
and 720151, and these eventually reached a size of
0-2-0-5 mm diameter by 14 days. There were no
colonies in the plates inoculated with 105 Chang cells
after 14 days' incubation. The colonies in 103/710025
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Table II Frequency distribution ofchromosome numbers in 100 cells ofepithelial isolate 710025from a patient
with rheumatoid arthritis and in 100 cells of the Chang liver continuous cell line
Cell Number ofcells with chromosome number of Mean SD
<63 63 64 65 66 67 68 69 70 71 72 73 74 75 76 >76
710025 — — 1 — 1 443 13 8 14 31 9 8 22 71-84 ±2-38
Chang liver 4 7 7 17 25 12 13 3 22 2 — — — — 6 66-00 ±2-89
KARYOTYPE OF 7IOQ.25 Q.ELLS
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fig. 2 Karyotype of710025 cells
illustrating small submetacentric
satellite chromosome
were picked and subcultured in a small Falcon flask
and then replated in agar where they again formed
colonies.
ultrastructural studies
Examination of thin sections of all three cell lines
showed that approximately 30% of the cells in the
culture had surface 'blebs'—that is, distortions of the
cytoplasmic membrane with underlying collections
of beaded strands of material (Figs 3a and 3b). The
beaded appearance may have been produced by the
section of tubules, short lengths of which were
present in most areas. The outer margins of these
structures were electron dense and they varied in
diameter from 20 to 25 nm. Collections of this
material were also seen within the cell causing severe
distortion of the normal cell architecture with
displacement of ribosomes, endoplasmic reticulum,
and other organelles of the cell (Fig. 3a). These
collections were not bounded by membrane and were
variable in size. In addition to this material, in a
small proportion of the cells there occurred areas of
fibrillary material with a more definite outline (Fig.
3a). This sometimes occurred in cells without blebs.
The strands were longer and narrower (approxi¬
mately 15 nm) and arranged in a concentric fashion.
Neither type of inclusion was seen in preparations of
Chang cells. Because the structures in the cytoplasmic
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fig . 3 (a) Low power view of 710025 cell showing surface
blebs and submembrane collections of fibrillary material
with distortion of cytoplasmic organelles. Note heavier
fibres at x. x 1,500; (b) high power view of 710025 cell
showing beaded strands of material which may represent
tubules in cross-section; (c) normal Chang cells for com¬
parison with (a); mycoplasmal forms are evident at the
ceil membrane. See text, x 1,500
blebs resembled the nucleocapsids of certain viruses,
notably those of a myxovirus or a paramyxovirus,
attempts were made to 'induce' the cells to produce
vegetative virus. Treatment with either BUDR or
IUDR apparently increased the number of cells with
blebs.
Cells were treated with actinomycin D (Sigma) to
see if bleb formation and filaments were dependent
on a transcription of DNA and also if suppression
of cellular mRNA would increase the amount of
material. The number of blebs was assessed in
preparations stained with acridine orange and by
electron microscopy.
Treatment with actinomycin D increased the
number of blebs seen in acridine orange preparations
and also increased the amount of red cytoplasmic
fluorescence. The nucleic acid present was identified
as RNA by the use of RNA'ase and DNA'ase
treatment.
The treatment with nucleic acid base analogues
and with actinomycin D did not lead to the detection,
by thin section or negative contrast electron micros¬
copy, of structures resembling complete virus
virions, nor did co-cultivation or cell fusion experi¬
ments (with lysolecithin as a fusing agent) with these
cells and rabbit kidney cells (RK13), human fibro¬
blasts (WI-38), and human glioma transformed by
Rous sarcoma virus (118 MG-EH cells) yield virus
as judged by cytopathic changes.
In attempts to detect the presence ofnoncytopathic
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or incomplete virions, 3H-uridine was added (5
/iCi/'ml for 24 hours) to the culture medium of 710025
or 720301 cells previously treated with BUDR
(20 yUg/ml for 2-3 days). The cells were washed with
PBS, harvested, and lysed with distilled water and
the cytoplasmic contents fractionated on caesium
chloride and sucrose gradients in combination with
caesium chloride in the ultracentrifuge (Compans
and Choppin, 1967; Yeh and Iwasaki, 1972).
Fractions were collected and any fraction forming a
peak was examined by negative contrast staining; no
structures resembling virions or nucleocapsids were
seen.
Incubation at 37°C for 20 mins with 01 % trypsin
removed some labelled material from the cells, but
this again had no viral structure either before or
after treatment with ether. In addition, lysis of the
cells followed by assays for RNA polymerase after
sucrose density gradient centrifugation failed to
reveal any activity in the appropriate fraction for a
paramyxo-like virus (Caliguiri and Tamm, 1970;
Compans and Caliguiri, 1973).
There was evidence of reverse transcriptase activity
in Chang cells and 710025 and 720301 cells: 720151
were lost due to contamination and therefore were
not available for this purpose. The activity was
completely dependent on the presence of RNA as
shown by the sensitivity of the reaction to pre¬
incubation with RNA'ase. There were no apparent
differences in activity between the three cell lines.
Discussion
Cross-contamination of cells in culture has been
described from time to time, but the extent of the
hazard is probably less appreciated than the more
easily detected contaminations with bacteria, myco¬
plasmas, or viruses.
In none of the published work on cell lines from
human synovial sources is there any evidence of the
species of origin of the cells apart from chromosome
studies. Chessin and Hirschhom (1961) observed
aneuploidy in the synovial cell line they used. They
pointed out that such an appearance could be
produced by breakage at the centromeres as was
suggested by the high number of telocentric chromo¬
somes. If the karyograms were constructed by re¬
assembly of the separated chromosome arms then
somewhere near the normal human diploid number
of46 could be arrived at. Neupert and Sommer (1973)
stressed that their cells diverged in karyotype from
other human permanent cell lines. They considered
that breakage at the centromeric region may occur
during preparation of the chromosome spreads. In a
similar fashion to Chessin and Hirschhorn, they
constructed karyograms by re-assembly to reach the
human diploid karyotype. Neupert and Sommer
discarded the simpler explanation that cellular
contamination 'specially by L cells' had taken place
because continuously propagated cell lines of
animal or human origin were not being cultured in
their laboratory during this period.
We have been unable to trace the original descrip¬
tion of the McCoy cell whose derivation is listed in
the Flow Laboratories* catalogue as human synovial,
but in correspondence with Dr. Kathleen Cartwright
of Flow Laboratories it was pointed out that these
cells were still available provided that the customer is
fully aware that they are no longer of human origin
but have been contaminated with a mouse cell strain.
There are no McCoy cells available which are of
completely human origin.
The human synovial cell line described by Hsu
and others (1957) was lost as a result of yeast con¬
tamination and is therefore not available for further
analysis. Castor and others' (1961) strain was
destroyed in a laboratory accident (C. W. Castor,
personal communication, 1973).
Intraspecies contamination may be much more
difficult to detect. It has been shown, on the basis of
isoenzyme studies, that many of the 'transformed'
cell lines of human origin reported between 1952 and
1957 may in fact represent contamination with HeLa
cells. 24 human heteroploid cell lines were shown to
possess the A variant G6PD isoenzyme found only
in some Negroes. Furthermore, the phosphogluco-
mutase (PGM) phenotypes of 20 of the commonly
used cell lines (including Chang liver), were the same
as that of the HeLa cell (Gartler, 1968).
Chang liver cells were probably the source of the
contamination of the rheumatoid synovial culture
yielding the epithelial cell line 710025. After this
experience, special precautions were taken to avoid
contamination of primary rheumatoid materials,
including separate cell culture hoods solely for
primary cultures. Despite these precautions, con¬
tamination occurred on two further occasions and
it is reasonable to suppose either that the source was
the Chang cells or the modified line represented by
710025.
It is probable that if the G6PD isoenzyme analyses
of the epithelial isolates had worked efficiently at the
outset we would have accepted at once the obvious
interpretation of cellular contamination and not have
examined them further. However, all three rheuma¬
toid cell lines were shown to have other characteristics
which were not present in the Chang cells, the
probable source of the contamination. It must be
admitted that we have no means of ruling out the
possibility that the other two rheumatoid lines
(720151, 720301) may represent contamination from
710025 cells, and the presence of the marker chromo¬
some in both 710025 and 720301 preparations would
suggest this.
The published reports of the isolation of epithelial
* Victoria Park, Heatherhouse Road, Irvine, Scotland KA12 8NB.
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cell lines from synovia have sometimes referred to
the possibility of cell contamination but have
excluded it on the grounds of quantitative karyotypic
differences or because no continuous cell lines were
being handled in the laboratory. Our experience
suggests that the epidemiology of these contamina¬
tions is obscure and that all apparent cell trans¬
formation should be examined for isoenzyme patterns
before it is concluded that transformation of donor's
cells has in fact taken place.
Apart from some differences in karyotype and
ability to grow in semisolid agar, the most striking
feature distinguishing the 710025 epithelial cell line
from its presumed parent, the Chang cell, is the
presence of blebs and the collections of fibrillary
material under the cell membrane and within the cell.
The acquisition of these properties is of interest
from several points of view. First, they bear some
resemblance to the nucleocapsids of paramyxovirus
and certain other RNA viruses. Secondly, they recall
the virus-like structures seen in vascular endothelium
of the kidney, muscle, skin, and other organs in
systemic lupus erythematosis (SLE) (Norton, 1969;
Gyorkey, Min, Sincovics, and Gyorkey, 1969;
Kawano, Miller, and Kimmelstiel, 1969; Schu¬
macher, 1970; Hashimoto and Chandler, 1972).
The actual content of the inclusions in 710025 cells
is very similar to that seen in the SLE material. The
cytoplasmic inclusions are, however, more numerous.
Surface blebs are not a feature of SLE tissue in
section, but a recent report (Silverman, Chandler,
Nieland, and Hashimoto, 1972) mentioned apparent
buds of cell membrane containing inclusions which
were noted more frequently in SLE cells maintained
in culture. The similarity of the tubular inclusions in
cultured SLE cells to those in our material is
strikingly illustrated in fig. 9 of Hashimoto and
Chandler's (1972) paper.
The occurrence of reverse transcriptase activity
was not apparently related to the presence of the
'blebs' in 720301 and 710025 cells, but it is neverthe¬
less of interest in view of the recent demonstration by
Bykovsky, Miller, Yershov, Ilyin, and Zhdanov
(1973) of similar activity in human cancer cell lines.
In our case, however, we were unable to find morpho¬
logical evidence of B-type particles in the cells.
References
Preliminary investigations suggest that 710025
cells have a surface antigen that differs from those on
Chang cells and is stained in membrane immuno¬
fluorescence tests with sera from certain patients with
rheumatoid arthritis (J. N. McCormick, and others,
unpublished data). Both 710025 and Chang cells
react with a variety of animal sera containing anti¬
body to paramyxoviruses and other viruses. Adsorp¬
tion experiments suggest that the antibodies con¬
cerned are not directed to viruses but may be part of
the T-agglutinin-agglutinogen systems (J. N. McCor¬
mick, and others, unpublished data).
There is no explanation at present of the nature of
the change produced in Chang cells to give the 710025
cell. This is constantly present on subculture, and is
clearly hereditable. A defective viral genome acquired
from co-cultivation with the rheumatoid synovial
cells is the simplest explanation. It is also possible
that actual cell fusion may have occurred since poly-
karyocytosis is a prominent feature of such synovial
cultures.
Summary
On three occasions during the course of culturing
cells from synovial membranes and fluids of patients
with rheumatoid arthritis the appearance of appar¬
ently 'transformed' epithelial cells was observed.
When these isolates were characterized by isoenzyme
analysis they were found to resemble HeLa cells
rather than the cells of the patients from whom the
cultures were supposedly derived. Thus, they
probably arose as a result of laboratory contamination
and attention is drawn to this hazard. The only
human cell line in the laboratory at the time the
incidents occurred was the Chang liver cell. When the
karyological and ultrastructural characteristics of
the rheumatoid and Chang cells were examined they
were found to differ. In particular, the rheumatoid-
associated cells showed accumulations of beaded
strands in the cytoplasm and in bleb-like projections
of the cytoplasmic membrane. The possibility must
be considered that these differences may have arisen
as a result ofco-cultivation ofChang with rheumatoid
cells, albeit accidental.
Bykovsky, A. F., Miller, G. G., Yershov, F. I., Ilytn, K. V., and Zhdanov, V. M. (1973) Arch. ges. Virusforsch.,
42, 21 (B type oncornaviruses isolated from continuous human cancer cell lines)
Caliguiri, L. A., and Tamm, I. (1970) Virology, 42, 100 (The role of cytoplasmic membranes in poliovirus
biosynthesis) '•
Castor, C. W., Prince, R. K., and Dorstewitz, E. L. (1961) Proc. Soc. exp. Biol. {N. Y.), 108, 574 (Epithelial
transformation of human synovial connective tissue cells: cytologic and biochemical consequences)
Chessin, L. N., and Hirschhorn, K. (1961) Exp. Cell Res., 23, 138 (Virus resistance and sensitivity in cultured
human synovial cells as a possible genetic marker)
Coffin, J. M., and Temin, H. M. (1971) J. Virol., 7, 625 (Comparison of Rous sarcoma virus-specific deoxyribo¬
nucleic acid polymerases in virions of Rous sarcoma virus and in Rous sarcoma virus-infected chicken cells)
460 Annals of the Rheumatic Diseases
Compans, R. W., and Caliguiri, L. A. (1973) J. Virol., 11, 441 (Isolation and properties of an RNA polymerase
from influenza virus infected cells)
, and Choppin, P. W. (1967) Proc. nat. Acad. Sci. U.S.A., 57, 949 (Isolation and properties of the helical
nucleocapsid of the parainfluenza virus SV5)
Ellis, N., and Alperin, J. P. (1972) Amer. J. clin. Path., 57, 534 (A rapid method for electrophoresis of erythrocyte
glucose-6-phosphate dehydrogenase on cellulose acetate plates)
Ford, D. K., and Smiley, J. D. (1973) Arthr. and Rheum., 16, 341 (Continuous culture of a B-immunocyte from
rheumatoid synovium)
Gartler, S. M. (1968) Nature (Lond.), 217, 750 (Apparent HeLa cell contamination of human heteroploid cell lines)
Greene, A. E., Coriell, L. L., and Charney, J. (1964) J. nat. Cancer Inst., 32, 779 (A rapid cytotoxic antibody test
to determine species of cell cultures)
Gyorkey, F., Min, K. W., Sincovics, J. G., and Gyorkey, P. (1969) New Engl. J. Med., 280, 333 (Systemic lupus
erythematosus and myxovirus)
Hashimoto, K., and Chandler, R. W. (1972) Acta derm.-venereol. (Stockh.), 52, 263 (Paramyxovirus-like inclusions
in systemic lupus erythematosus)
Hsu, T. C., Pomerat, C. M., and Moorhead, P. S. (1957) J. nat. Cancer Inst., 19, 867 (Mammalian chromosomes
in vitro. VIII. Heteroploid transformation in the human cell strain Mayes)
Kawano, K., Miller, L., and Kimmelstiel, P. (1969) New Engl. J. Med., 281, 1228 (Virus-like structures in lupus
erythematosus)
McDougall, J. K. (1970) Nature (Lond.), 225, 456 (Effects of adenoviruses on the chromosomes of normal human
cells and cells trisomic for an E chromosome)
Mackay, J. M. K., Panayi, G., Neill, W. A., Robinson, A., Smith, W., Marmion, B. P., and Duthie, J. J. R.
(1974) Ann. rheum. Dis. 33, 225 (Cytology of rheumatoid synovial cells in culture. I. Composition and sequence
of cell populations in cultures of rheumatoid synovial fluid)
MacPherson, I., and Montagnier, L. (1964) Virology, 23, 291 (Agar suspension culture (sloppy agar) for the
selective assay of cells transformed by polyoma virus)
Neupert, G., and Sommer, K. (1973) Exp. Path., 8, 98 (Two new established cell lines derived from human synovial
tissue of rheumatoid arthritis patients)
Norton, W. L. (1969) J. Lab. clin. Med., 74, 369 (Endothelial inclusions in active lesions of systemic lupus
erythematosus)
Oca, F. M. de, Macy, M. L., and Shannon, J. E. (1969) Proc. Soc. exp. Biol. (N. Y.), 132, 462 (Isoenzyme
characterization of animal cell cultures)
Paul, J. (1970) In 'Cell and Tissue Culture', 4th ed., p. 86. Churchill Livingstone, Edinburgh and London
Schumacher, H. R. (1970) Ann. rheum. Dis., 29, 445 (Tubular paramyxovirus-like structures in synovial vascular
endothelium)
Silverman, H. A., Chandler, R. W., Nieland, N., and Hashimoto, J. (1972) Arthr. and Rheum., 15, 454
(Demonstration of microtubular inclusions in cell cultures of systemic lupus erythematosus (SLE) skin)
Smith, W., Gray, E. W., and Mackay, J. M. K. (1969) J. Microscopy, 89, 359 (A sandwich embedding technique
for monolayers of cells cultured on Araldite)
Temin, H. M., and Mizutani, S. (1970) Nature {Lond.), 226, 1211 (RNA-dependent DNA polymerase in virions of
Rous sarcoma virus)
Yeh, J., and Iwasaki, Y. (1972) J. Virol., 10, 1220 (Isolation and characterization of subacute sclerosing panen¬
cephalitis virus nucleocapsids)
 
Ann. rheum. Dis. (1975), 34, 205
DNA polymerase activity in rheumatoid
synovial membranes
MARY NORVAL, MARIE M. OGILVIE, AND B. P. MARMION
From the Department ofBacteriology, Edinburgh University Medical School, Teviot Place,
Edinburgh EH8 9AG
Norval, M., Ogilvie, M. M., and Marmion, B. P. (1975). Annals ofthe Rheumatic Diseases,
34,205-212. DNA polymerase activity in rheumatoid synovial membranes. RNase-sensitive
DNA polymerase activity was demonstrated in synovial membrane preparations from 23
out of 25 rheumatoid arthritis patients. Control groups consisted of twelve patients with
osteoarthrosis, four with secondary osteoarthrosis, and twelve with other conditions. The
last group showed no activity, while the results with the other two groups were varied.
The properties of the polymerase enzyme, such as its stimulation by synthetic templates
and inhibition by actinomycin D, were not consistent with it being associated with an on¬
cogenic virus; it seems to be more like that found in stimulated normal human lymphocytes,
described as an RNA-primed DNA-directed DNA polymerase.
The view that an infective agent provides the initiating
stimulus for the complex immunological and inflam¬
matory process in the rheumatoid joint is attractive,
but little or no definitive evidence has yet been pro¬
duced to implicate either procaryotes or viruses.
Several workers have failed to find either a cytopathic
virus in synovial cells or evidence ofa substantial, pro¬
ductive, noncytopathic virus infection (reviewed by
Marmion, 1975). The remaining possibilities for per¬
sistent viral infection of the synovium include a de¬
fective, nonproductive, cytoplasmic infection, pro¬
bably with an RNA virus, accompanied by formation
of viral gene products that give a new antigenicity to
the host cell. Alternatively, there might be integration
of viral DNA into the host cell genome, again with
expression of some genes giving rise to host cell
modification. Such an integrated viral genome might
originate directly from a DNA virus or be copied
from an RNA template belonging to an oncorna or
leucovirus by virus-coded RNA-dependent DNA
polymerase (reverse transcriptase) (Baltimore, 1970;
Temin and Mizutani, 1970).
Reverse transcriptase can be measured by the in¬
corporation of 3H-thymidine triphosphate into an
acid-insoluble product that can be shown to be an
RNA-DNA hybrid sensitive to DNase. The template
for the enzyme has a characteristic buoyant density
and is sensitive to RNase. The DNA product of the
reaction can be extracted and analysed by equilibrium
density centrifugation. It is complementary to the
template RNA extracted from purified virions, if
these are available (Sarngadharan, Sarin, Reitz, and
Gallo, 1972).
Accepted for publication October 24, 1974.
These discoveries have opened up new possibilities
for the detection of oncorna virus genes in cells.
Apart from this approach, general methods of dem¬
onstrating an oncorna virus include the visualization
of C-type particles in thin sections of cells or tissues in
the electron microscope, showing interspecies gs
antigen in cells or virions, and the growth of virus or
rescue of genetic markers in cell culture.
The present unavailability of an accepted human
oncorna virus and lack of knowledge of the cell types
that would support its multiplication restrict the dif¬
ferent lines of investigation needed to detect and vali¬
date oncorna viruses as possible aetiological agents
in rheumatoid arthritis (RA). However, morphologi¬
cal studies, examination for gs antigen, and assay for
reverse transcriptase might be used to obtain at least
preliminary indications ofviral activity. Various mam¬
malian cell lines and human neoplasias have recently
been investigated in this way (Spiegelman, Kufe,
Hehlmann, and Peters, 1973).
Schumacher (1973) and Neumark, Hollos, and
Farkas (1973) have reported the presence of C-type
particles in thin sections of synovial membrane cells
of patients with RA. Palmer and Myers (1973) at¬
tempted to show reverse transcriptase activity in a
rheumatoid cell line with a questionable result due
to the probable presence of a nuclease. However.
Spruance, Richards, Ward, and Smith (1974) showed
reverse transcriptase activity in cultured rheumatoid
synovial cell strains and also found it in normal syno¬
vial cell strains.
In general, the demonstration of enzyme activity
resembling that of a reverse transcriptase, unsup¬
ported by other evidence, cannot be taken as definitive
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Table I Clinical and laboratory details ofpatients with arthritis






1 72 F RA for 6 years —
2 67 F „ 15 „ +
3 60 F „ 10 „ + +
4 58 F „ n „ +
5 67 F „ 13 „ — +
6 59 F 4 „ +
7 61 F 2 „ —
8 54 F 5 „ +
9 59 F 6 „ +
10 60 M „ 10 „ +
11 30 F „ 10 „ _
12 54 F 5 „ —
13 36 M 3 „ + — +
14 78 F „ 17 „ —
15 47 F + +
16 66 F „ 33 „ +
17 68 F „ 13 „ + + +
18 58 F „ 10 „ + — +
19 64 F „ 19 „ +
20 50 M „ 10 „ +
21 77 F „ 14 „ +
22 56 M 5 „ + + —
23 59 F >, 12 „ — — —
24 75 F „ 25 „ +
25 24 F 5 „ + + —
Osteoarthrosis (OA)
26 58 F OA for 6 years — — —
27 52 M 2 „
28 78 F 6 „ — — —
29 62 F » 7 » — — —
30 61 F OA now ? RA for 2 years —
31 70 F OA for 10 years
32 69 F 5 „
33 77 F
34 ' 83 M 5 „
35 78 F 2 „ —
36 74 F 9 „ — — —
37 70 F ii 13 jt — — —
'Secondary'
38 43 M Rotation injury, early OA — — —
39 47 M OA for 18 years now ? RA — — —
40 22 M Kienbock's disease, secon¬ — — —
dary OA
41 54 M OA after injury and — — —
arthrodesis
'Other conditions'
42 34 M Injury 1 year ago — — —
43 25 M „ 1 „ — — —
44 28 M
45 20 F 2 „ — — —
46 20 M 2 „
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47 20 M 1
48 33 M „ 19 — — —
49 28 M 2
50 38 M — — —
51 29 M
. » 3 „ — — —
52 47 M 2 — — —
53 57 M 2 «•
* SSCT (sensitized sheep cell test) = agglutination of sheep red cells coated with specific rabbit antibody,
t Latex test = agglutination of latex particles coated with IgG globulin,
j ANF = antinuclear factor.
+ Indicates a titre of Ss 128 on one or more occasions.
.. Indicates that the serum was not available.
evidence of oncorna virus activity. Cell polymerases
will synthesize DNA on some synthetic RNA or
mixed RNA/DNA templates giving rise to erroneous
conclusions. In addition, another DNA polymerase,
primed by RNA, has been shown in stimulated,
normal human lymphocytes; this can be distinguished
from viral reverse transcriptase in several of its pro¬
perties—in particular its inability to transcribe the
heteropolymeric regions of 70S RNA tumour viruses
(Bobrow, Smith, Reitz, and Gallo, 1972).
An investigation of the nucleic acid polymerase
activity of synovial membranes from patients with
RA, degenerative arthritis, and other conditions has
been undertaken to explore these problems and
potential artefacts in a search for oncorna virus
in RA.
Materials and methods
CLINICAL POPULATION (TABLE i)
The synovial membranes from 25 RA patients under¬
going synovectomy were used. Controls comprised
membranes from 3 groups of patients. The first group
of twelve had osteoarthrosis and the second group
of four had secondary osteoarthritis. The remaining
group, 'other conditions', contained twelve patients
requiring arthrotomy after injury, 11 of these having torn
menisci.
ENZYME EXTRACTS
Within 2 hours ofoperation the synovial lining membranes
were dissected from the bulk of surrounding fibrous and
fatty tissue and cut into very small pieces. The wet weight
of the tissue varied from 0-2-5 g, and it was homogenized
by hand or with a Potter-EIvehjem homogenizer in a small
volume of 0-01 mol/1 Tris-HCl buffer pH 8-0, containing
0-001 mol/1 EDTA and 0-25 mol/1 sucrose. These extracts
were frozen and stored at —70°C. The cells were disrupted
with Nonidet P-40 according to the method of Coffin and
Temin (1971), and the high-speed pellet suspended in a
small volume of buffer used in the polymerase assay. Pro¬
tein content was estimated by the method of Lowry'
Rosebrough, Farr, and Randall (1951). The extracts were
stored in small aliquots at —70°C and were normally used
only once and not refrozen.
POLYMERASE ASSAYS
Assays were performed by the method of Temin and
Mizutani (1970) using 0-125 /imol dGTP, 0-125 /*mol
dATP, 0-125 /*mol dCTP, 2- 5/imol phospho(enol)pyruvate,
10 us pyruvate kinase (320 units/mg), 2 /imol dithiothreitol
(all from Sigma), 0-8 %Nonidet P-40,1-25 /imol MgCl2,2-5
/;moI KC1, 2-5 uCi 3H-methyl-TTP (25 Ci/^mol, Amer-
sham), 10, 20, or 40 p\ enzyme preparation, and buffer
(0-02 mol/1 Tris-HCl pH 8-0 containing 0-33 mmol/1
EDTA and 1-7 mmol/12-mercaptoethanol) to make a total
volume of 140/A. Incubation was carried out at 37°C for a
period of between 45 and 120 min. Samples of 30 fi[ were
spotted on filter paper discs at intervals of 15, 20, or 30
min. Filters were fixed in cold 10% trichloroacetic acid
(TCA), washed 5 times in cold 10%TCA and then in cold
ethanol before being air dried and counted in PPO-
toluene scintillator in a Packard Tri-Carb liquid scintilla¬
tion instrument.
For information on the nature of the primer or template,
some samples were pretreated with 10 pg pancreatic ribo-
nuclease (100 units/mg, Sigma) at 0°C for 10 min before
adding the assay constituents. Ribonuclease had pre¬
viously been heated at 70°C for 10 min to destroy any de-
oxyribonuclease activity.
The artificial templates/primers poly-deoxy-adenylic-
deoxy-thymidylic acid (poly-d(A-T)) and polyadenylic
acid decathymidylic acid (poly-A.dTio) were used at
concentrations of 0-07 OD260 units/ml (Boehringer
Corp.).
The effect of actinomycin D was found by the addition
of 50 //g/ml (Sigma) dissolved in polymerase buffer at the
start of the reaction.
PRODUCT ANALYSIS
Standard reaction mixtures as outlined above were scaled
up to 0-6 ml and were incubated at 37°C for 20 min. The
products were extracted with phenol-cresol and analysed
on Cs2S04 density gradients (Sarngadharan and others,
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Table II Polymerase activity ofsynovial membrane cells, expressed as increase in cpm incorporated into acid
insoluble material in 30 mining protein
Case no. Total Polymerase activity RNase-sensitive
polymerase activity in presence ofRNase DNA polymerase
(A) (B) (A-B)
RA group
1 4-5 0-7 3-8
2 2-1 0-7 1-4
3 1-4 0-4 1-0
4 2-3 0 2-3
5 0.7 0.5 0.2
6 1-5 1-5 0
7 0-9 0-4 0-5
8 2-7 1-4 1-3
9 0 — 0
10 7-7 3-9 3-8
11 3-4 1-9 . 1-5
12 0-4 0-2 0-2
13 2-2 1-3 0-9
14 2-6 1-1 1-5
15 3-2 1-4 1-8
16 3-6 1-3 2-3
17 0-4 0-1 0-3
18 2-0 0-5 1-5
19 1-8 0-5 1-3
20 5-1 1-7 3-4
21 3-0 0-4 2-6
22 8-0 0 8-0
23 3-0 1-0 2-0
24 0-8 0-4 0-4
25 0-8 0-3 0-5
OA group
26 1-1 0-8 0-3
27 0-5 0-5 0
28 0 — 0
29 1-9 M 0-7
30 0-5 0-5 0
31 3-6 1-4 2-2
32 0 _0
33 0 — 0
34 0-7 0-4 0-3
35 0 — 0
36 0 — 0
37 0-6 0-4 0-2
'Secondary' group
38 2-0 0-8 1-2
39 6-0 3-3 2-7
40 1-1 0-9 0-2
41 0 — 0
'Other conditions'
42 0 — 0
43 0-6 0-6 0
44 0 — 0
45 0 _0
46 0 — 0
47 0 — 0
48 0 — 0
49 0 — 0
50 0 — v 0
51 0 — 0
52 0 — 0
53 0 — 0
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1972) or glycerol gradients (Gulati, Axel, and Spiegelman,
1972).
Results
The crude enzyme extracts prepared by high-speed
centrifugation were assayed for the presence of endo¬
genous RNase-sensitive DNA polymerase. Table II
shows the result of the assays done, first without ribo-
nuclease, then after preincubation with this enzyme.
The activities of the membranes are expressed as an
increase in acid-precipitable counts per minute over
the first 30 min of the incubation per mg protein.
Normally the mean value from two enzyme concen¬
trations was recorded. With some membranes the in¬
corporation of labelled nucleic acid precursors into
acid-insoluble material was not a linear function of
time after about 30 min. Fig. 1 shows the assay of
membrane of Case 16, an RA patient. Some mem¬
branes, particularly from the patients without ar¬
thritis, showed no increase in acid-precipitable
counts over the normal incubation period. In these
cases, 40 /A samples of enzyme extract were used and
the incubation continued over 2 hours, still with no de¬
monstrable activity.
It may be seen from Table II that there is some poly-
10 20 30 40 50
MINUTES
fig 1 Endogenous DNA polymerase activity ofRA syno¬
vial membrane from Case 16. Assay conditions as in
Methods, using 20 pi crude enzyme preparation •, 40 pi k,
and 20 pi after preincubation with RNase Q
merase activity not dependent on RNA as template.
This is presumably due to the presence of some
cellular DNA polymerases in the crude enzyme
preparation. In the final column in Table II, the poly¬
merase activity dependent on RNA is obtained by
subtracting the activity after preincubation with
RNase from that without RNase treatment. This is
taken as being endogenous RNase-sensitive DNA
polymerase activity.
The presence of this activity was of interest as a
possible marker of oncorna virus, particularly as
there was a clear-cut difference between the four
groups. The mean activity for the RA group was 1 -7,
for osteoarthrosis 0-3, for 'secondary' 1-0, and for
'other conditions' 0. However, there are obvious
differences between RA synovial membrane on the one
hand and the controls on the other. The former is
characterized by massive proliferation of lining cells
and extensive infiltration with cells of the lymphocyte
series. As these cells have an RNA-primed DNA
polymerase (Bobrow and others, 1972), it was neces¬
sary to determine whether the activity in the RA
membranes (in particular) was of this type or was a
true viral RNA-dependent DNA polymerase.
It is known that crude preparations of viral poly¬
merases prefer hybrid synthetic template/primers
such as poly-A. d(T)io to double-stranded DNA
synthetic templates such as poly-d(A-T), while this is
not true of the cellular polymerases (Goodman and
Spiegelman, 1971). The activity of some membranes
was therefore determined in the presence of these two
synthetic templates and, as shown in Table III, poly-
d(A-T) at least doubled DNA synthesis, whereas
poly-A. d(T)10 had no effect.
High concentrations of actinomycin D inhibit
DNA-directed DNA synthesis but do not affect the
first step of viral reverse transcriptase activity, which
is the synthesis of an RNA-DNA hybrid (McDonnell,
Quintrell, Garapin, Fanshier, Levinson, and Bishop,
Table HI Effect ofartificial templates on polymerase
activity ofsynovial membranes, expressed as a ratio of
endogenous activity to activity in the presence ofpoly-
d(A-T) andpoly-A ,d(T)l0
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fi g. 2 Effect ofactinomycin D on endogenous DNA poly¬
merase activityofsynovial membrane ofCase 39from'secon¬
dary' group. Actinomycin D (50 pgjm! dissolved in poly¬
merase buffer) was added to assay mixture • or polymerase
buffer alone O
1970). Actinomycin D was therefore added to the
assay mixture of several membranes and samples
taken at 7,15,30, and 45 min. Even at 7 min there was
marked inhibition of incorporation into acid-in-
soluble product and this is illustrated for one mem¬
brane (Case 39) from the 'secondary' group in Fig. 2.
Table IV shows the inhibition in the 11 membranes
tested.
Finally, an attempt was made to analyse the endo¬
genous product of the polymerase system of Cs2S04
and glycerol gradients. It proved difficult to obtain a
membrane preparation of sufficient size and activity
to do this satisfactorily. However, with the few mem¬
branes tried there was never any suggestion of the for¬
mation of an intermediate RNA-DNA hybrid. This
should band at a density ofabout 1 -66 g/ml on Cs2S04
equilibrium density centrifugation (Sarngadharan
and others, 1972) and have sedimentation coefficient
of70 S on a glycerol gradient (Gulati and others, 1972).
All the radioactivity banded in the DNA region, that
is with density around 1-41 on Cs2S04 equilibrium
density centrifugation and near the top of the
glycerol gradient.
As the above results were not indicative of a viral
RNA-dependent DNA polymerase, it was thought
necessary to check the assay conditions using a known
positive control. Use was made of a human glioma
cell line transformed with Rous sarcoma virus, 118
MG-EH (Ponten and Macintyre, 1968) (kindly pro¬
vided by Dr. Jan Ponten). A pellet was prepared from
cell lysates as described for the synovial membrane
cells. In this case there was stimulation of incorpora¬
tion into acid insoluble material by at least fifteenfold
in the presence of poly-d(A-T), and in addition poly-
A. d(T)i0 stimulated the activity by at least threefold.
There was still incorporation of 3H-TMP into acid-
insoluble product over the first part of the incubation
period in the presence of actinomycin D, although it
eventually caused about 40% inhibition of activity.
As with the membrane preparations, it was difficult
to obtain sufficient product to analyse it on Cs2S04
and glycerol gradients, though evidence suggested
that a labelled intermediate RNA-DNA hybrid was
being formed.
Discussion
It may be seen from Table II that 23 out of the 25
synovial membrane preparations from patients with
RA had endogenous DNA polymerase activity. Al¬
though the dependence of the activity on RNA as
shown by the sensitivity of the reaction to preincuba¬
tion with RNase was variable, in most specimens it
was substantial and in marked contrast to membranes
from osteoarthrotic patients or traumatized joints.
Thus, none of the membranes from the nonarthritic
group showed any endogenous RNase-sensitive DNA
polymerase activity. Of the osteoarthrotic patients
the results were more varied; seven had no activity
and the remaining five had some. In the group of
patients with secondary osteoarthritis, three out of
the four showed activity. The residual activity, after
RNase treatment, is presumably due to cellular DNA-
dependent DNA polymerases present in the crude
enzyme preparations.
The difference between RA membranes and con¬
trols could be explained in various ways. One of the
characteristic features of the former is the prolifera¬
tion of the synovial membrane and it is obviously
difficult to obtain adequate control material in terms
ofcellular composition for comparative observations.
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Table IV Effect of actinomycin D (Act D) on polymerase activity of synovial membranes, expressed as
increase in cpm 3H-TMP incorporated into acid-insoluble material after 30-min incubation
Case no. Polymerase Polymerase Activity with Act D
activity activity in %
presence ofAct D Activity without Act D
RA group
16-712 48 8
19 290 25 8-6
20 680 53 7-5
21 200 15 7-5
22 230 13 5-7
25 35 0 0
OA group
19-031 42 8
34 40 4 10-0
37 70 0 0
'Secondary' group
15-038 33 5
39 195 12 6-2
Membranes from patients in 3 other categories have
been used: those with osteoarthrosis, those requiring
arthrotomy following injury, and those from a small
group with secondary osteoarthritis. These control
membranes, particularly those from patients without
arthritis, were quite different in morphology and in
size from the rheumatoid membranes. It should be
noted that, in addition to the variation in morphology
of the synovial membranes in the different groups,
they were not matched for age and sex; for instance,
the RA patients tended to be female with average age
of 58 years, whereas the nonarthritic patients tended
to be male with average age of 32.
Apart from proliferation of synovial lining cells,
RA membranes are frequently infiltrated with large
numbers of mononuclear cells of the lymphoid series,
usually in excess of any inflammatory exudate found
in degenerative or traumatic arthritis.
It is therefore necessary to consider whether the
RNase-sensitive DNA polymerase activity found in
RA synovial membranes is the product of an oncorna
virus or if it is associated with the presence of a RNA-
primed DNA polymerase of the type found in stimu¬
lated normal human lymphocytes (Bobrow and
others, 1972). Several characteristics of the membrane
enzyme suggest that, in fact, it is more likely to be
from lymphocytes than virus. Thus, activity of the
enzyme was not stimulated by poly-A. d(T)10, which
is reported to increase DNA synthesis by viral reverse
transcriptase, and actinomycin D inhibited the
enzyme. These findings are the reverse of those
described for viral enzyme and in line with our own
control experiments with extracts from a human
glioma cell line (118 MG-EH) containing the Rous
sarcoma virus genome. Finally, although it was
difficult to obtain satisfactory quantities of the nucleic
acid product of the polymerase reactions given the
low levels of enzyme activity in the membranes (com¬
pared with those in the virions) ultracentrifugal analy¬
sis of phenol extracts of the synthesized material on
glycerol and caesium sulphate gradients did not re¬
veal a RNA-DNA hybrid, only DNA of small sedi¬
mentation constants.
We were unable, therefore, to find evidence of the
presence of an oncorna virus in RA synovial mem¬
branes in terms ofRNA-dependent DNA polymerase.
This observation agrees with limited attempts by
Grayzel (1973), who used cultured rheumatoid
synovial cells and was unable to show incorporation
of isotopically labelled uridine into particles ofcharac¬
teristicbuoyant density on sucrose gradients; a marker
for liberation of virus from cells.
It is not clear, however, from the literature whether
failure to show reverse transcriptase is equable with
the absence of an oncorna virus genome, or part of
it, from a cell. The 118 MG-EH cell line and a ham¬
ster cell line, HT-1, transformed by murine sarcoma
virus (Karpas, Cawley, Tuckerman, Flemans, and
Hayhoe, 1971) both had viral reverse transcriptase.
Although the former contains gs antigen, it is ap¬
parently free from virus particles (Macintyre, Grimes,
and Vatter, 1969), and neither virions nor gs antigen
have been shown in the latter (Karpas and others,
1971). On the other hand, Holder, Robey, and Vande
Woude (1974) have shown with HBT-3 cells (suppo¬
sedly a human breast tumour cell but with HeLa cell
chromosomes) that reverse transcriptase activity is
low except in cells treated with hormones and indu¬
cers; so perhaps the viral genes for the enzyme may
not always be expressed and further experiments with
rheumatoid synovial membranes and fibroblasts are
necessary before final conclusions can be drawn.
This work was supported by a grant from the Nuffield
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A. Karpas. We wish to acknowledge the help of the con¬
sultant surgeons at the Princess Margaret Rose Hospital,
Edinburgh, for providing synovial membrane specimens.
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Attempts to identify viruses in rheumatoid synovial cells. Synovial fibroblast cell strains
derived from the synovial membranes of 7 patients with rheumatoid arthritis were
examined for the presence of viruses, in particular leucoviruses. Seven similar synovial
strains derived from patients with other arthritic conditions were used as a control
group. Evidence of the presence of a virus or a viral genome was looked for by several
methods of induction followed by 3H-uridine labelling of the cultures. In addition, the
culture supernatant, after induction and after the synovial strains had been co-cultivated
with a variety of cell lines from several species, was assayed for the presence of viral
RNA-dependent DNA polymerase activity. The DNA-polymerase activity of the
synovial cells themselves was also determined. No evidence was found by any of these
techniques to indicate the presence of virus or viral information within the synovial
fibroblasts.
Some simple methods have been developed to grow
synovial cells from rheumatoid and nonrheumatoid
synovial membranes (Castor and Fries, 1961). These
cells can be passed by trypsinization and propagated
through at least 15 subcultures. Various workers have
looked at these cultures to find differences between
the rheumatoid and nonrheumatoid cells which
could indicate some abnormality in the rheumatoid
cells (Bartfield, 1965; Smith, 1971; Phillips, 1971;
Smith and Hamerman, 1969) and in particular some
evidence of viral infection.
Generally the rheumatoid cultures grew more
quickly but could not be subcultured as many times
as the nonrheumatoid cultures. At the ultrastructural
level no differences could be detected (Wynne-
Roberts and Castor, 1972). No nuclear bodies were
seen and no cytopathic effect on prolonged co-
cultivation. However, there were various biochemical
differences in the cultures, such as increased hyaluro¬
nic acid content of rheumatoid cells and increased
acid phosphatase activity. It is known that some
viruses can interact with the host cell to alter some
cellular metabolic activities; for example, avian
sarcoma viruses induce increased hyaluronic acid
production in infected chick embryo fibroblasts
(Ishimoto, Temin, and Strominger, 1966).
Using conventional virological techniques on
rheumatoid synovial fibroblasts, no virus has been
Accepted for publication November 1, 1975.
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isolated after co-cultivation or by Sendai-induced
cell fusion, nor did the cells show haemadsorption or
haemagglutinins and there was no interference with
VSV or ECHO-11 replication (Phillips, 1971). Ford
and Oh (1965) reported no virus in the culture
supernatant after prolonged incubation and no
difference in NDV susceptibility. Smith and Hamer¬
man (1969) also failed to isolate a virus from these
cells although they showed a resistance to infection
with rubella and NDV in the case of the rheumatoid
cells. This has been attributed to the increased
hyaluronic acid content of the rheumatoid cells
compared to the nonrheumatoid (Clarris, Fraser, and
Rodda, 1974; Patterson and others, 1975). However,
it has also been shown that two means of transferring
this resistance to rubella are by intra-articular
injection into rabbit joints whereby the rabbit
synovial membrane cells become resistant 2 to 6
months later (Smith and others, 1974), and by
Sendai-virus induced cell fusion of these cells with
normal rabbit synovial cells (Smith and Hamerman,
1974). No virus was released from these cultures.
It is possible that, should a virus be concerned in
the aetiology of rheumatoid arthritis, the infection
may be a nonlytic one and thus would not be detect¬
able by normal techniques. There are several possi¬
bilities for a persistent viral infection of this kind.
The virus might be produced in small numbers and
be noncytopathic. Alternatively there might be a
defective nonproductive cytoplasmic infection with
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formation of new viral-coded antigens on the cell
surface. As a third possibility, the viral genome might
be integrated into the host cell genome with some
accompanying changes in the cell. In the case of DNA
viruses this integration can occur directly; with some
RNA viruses, as shown with leucoviruses, a DNA
copy of the RNA is made first using RNA-dependent
DNA polymerase (reverse transcriptase) before
integration occurs. Recently some of the techniques
used in leucovirus work have been applied to synovial
membranes and strains to ascertain if a virus of this
type is present (Norval, Ogilvie, and Marmion, 1975;
Spruance and others, 1975).
Person, Sharp, and Rawls (1973) have studied cell
cultures from synovial fluids and membranes after
co-cultivation with Vero cells and after induction
with 5-iododeoxyuridine (IUDR.) 3H-uridine or
3H-thymidine was added and the culture supernatant
subsequently examined by sucrose and caesium
chloride density gradient centrifugation to isolate
labelled particles. No virus was found. Grayzel
(1973) has also described the result of adding
3H-uridine to the medium of cultured rheuma¬
toid cells with and without pretreatment with
5-bromodeoxyuridine (BUDR) and actinomycin D.
There was no evidence of virus particles being
released from the cells or of viral-specific RNA
being synthesized within the cells.
In this paper we describe the properties of a
collection of synovial fibroblast cell strains from
rheumatoid arthritis patients. Strains from other
arthritic conditions were included as controls.
Evidence of the presence of a virus or viral informa¬
tion was sought by several methods of induction
followed by 3H-uridine labelling and by assaying the
culture supernatant for reverse transcriptase activity.
In addition, various techniques of co-cultivation were
tried in an attempt to rescue a defective virus. The
DNA polymerase activity of the synovial cells was
also assayed.
Materials and methods
SOURCE OF CELL STRAINS
The lining cells from synovial membranes obtained at
synovectomy were dissected out and cut into small pieces.
These were trypsinized (0-25% trypsin in Dulbecco's
solution) overnight at 37°C and the free cells removed
into Eagle's complete medium containing 10% fetal calf
serum. Monolayers of fibroblasts were passed by trypsini-
zation. In addition, 4 strains grown out from explants of
synovial tissue were received from Dr. D. Hamerman
(A, B, C, and D). The synovial fibroblast strains used and
the diagnosis of the patients from whom the specimens
came are shown in Table I. The cell strains were tested at
intervals for the presence of mycoplasmas as described
previously (Mackay and others, 1974).
ULTRASTRUCTURE
Cells were harvested using glass beads and prepared for
electron microscopy. In addition, cells were regrown for













L Osteoarthrosis and Paget's disease
M RA
N Osteoarthrosis
3 days after storage in liquid nitrogen before being
harvested for electron microscopy. The special glycogen
stain of De Bruijin (1973) and Schaff, Barry, and Grimley
(1973) was used on cell strain B. The blocks were sectioned
on an LKB Ultratome 11 and the sections viewed on a
Hitachi HU11A electron microscope.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE
ISOENZYME
The method of Ellis and Alperin (1972) was used.
ATTEMPTS TO INDUCE VIRUS PRODUCTION
(A) Induction followed by 3H-uridine labelling
Some of the cell strains were incubated in the presence of
BUDR (20 ^g/ml) for 3 days (Lowry and others, 1971),
IUDR (20 /ig/ml) for 3 days followed by dimethylsulph-
oxide (DMSO) (2%) for 4 days (Stewart and others,
1972), cycloheximide (10 //g/ml) for 16 hours (Aaronson
and Dunn, 1974), or with mitomycin C (1 /ig/ml) for
18 hours in the dark (Weiss and others, 1971).
The medium was replaced with the minimal volume of
Eagle's medium containing 1% fetal calf serum and
(5-3H) uridine (2-5 /iCi/ml, Amersham) and incubation
continued for a further 24 hours. Ammonium sulphate
precipitation of the culture supernatant was carried out
according to the method of Grayzel (1973). The precipitate
was dissolved in 1 ml 0 01 mol/1 TRIS-HC1, 1 mmol/1
EDTA pH 7-1, layered on the top of a linear sucrose
gradient of 20 to 70% (w/v) sucrose in buffer, and spun at
24000 r.p.m. for 18 hours at 4°C in a SW 40 rotor. Frac¬
tions of about 0-5 ml were collected from the bottom and
their refractive index measured. 1 ml cold 10% trichlor¬
acetic acid and 50 //I 0-2% bovine serum albumin were
added to each fraction and after at least 20 minutes at
4°C the precipitate was collected on glass fibre filter paper
discs (Whatman GF/A), washed extensively with cold
10% TCA, followed by cold ethanol. They were air-dried
and counted in PPO-toluene scintillator in a Packard
Tri-Carb liquid scintillation instrument.
(B) Induction with testosterone and IUDR
The procedure of Holder, Robey, and Vande Woude
(1974) was used. The cultures were incubated in the
presence of testosterone acetate (5 //g/ml) for 8 weeks,
being split as necessary, usually once every 2 weeks. The
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medium was changed weekly. The supernatant was
collected at 2-week intervals and assayed for reverse
transcriptase activity using the method of Lieber and
others (1973). Finally 1UDR (100 /ig/ml) was added for
1 day before the final supernatant sample was collected.
co-cultivation
(A) XCtest
The procedure of Rowe, Pugh, and Hartley (1970) was
used.
(B) With various cell lines
The procedure outlined by Benveniste and others (1974)
for inducing C-type virus from baboon placenta was used.
The cell lines tried were LLC-MK2 (monkey kidney cells),
D-17 (dog fibrosarcoma cells), XC (rat tumour cells
transformed by Prague strain of Rous sarcoma virus),
118 MG-EH (human glioma cells transformed by murine
sarcoma virus), HT-1 (hamster cells transformed by
murine sarcoma virus), and human fetal skin fibroblasts.
6 x 105 cells were seeded in a medical flat, incubated
overnight, and induced with 30 t/g/ml 1UDR for 24 hours.
1 x 105 cells of the various lines were added and incubation
continued for 8 weeks. Culture medium was changed
weekly and the cultures were split at fortnightly intervals.
The supernatant was assayed every 2 weeks for the presence
of reverse transcriptase activity using the method of
Lieber and others (1973).
transfection
DNA was extracted from the cells using the method of
Karpas and Milstein (1973) and Karpas and Tuckerman
(1974). Human fetal skin fibroblasts were subsequently
exposed to it. The cells were cultured in Eagle's medium




Induction with BUDR or testosterone of the synovial cell
strains was carried out as indicated previously, and 20 ml
culture fluid prepared and assayed according to the
method of Lieber and others (1973).
(B) Cells
Synovial fibroblasts, grown in 4 or 5 Roux flasks, were
washed in medium and prepared as outlined by Coffin
and Temin (1971). Protein content was estimated by the
method of Lowry and others (1951). Assays were carried
out using the conditions in Norval and others (1975). The
polymerase activity after preincubation with RNase, and
its sensitivity to actinomycin D was determined.
Results
Of the 14 fibroblast cell strains used in the course of
this work, all were free of mycoplasma contamination
except cultures A and C which were found to contain
Mycoplasma ovale 1. Testing for the isoenzyme
glucose-6-phosphate dehydrogenase showed that all
cell strains possessed the slow (B) type compared to
HeLa cells which have a fast (A) type.
ultra structure
Ultrathin sections of the cells showed highly vacuo¬
lated cells with dilated endoplasmic reticulum, shown
in Fig. 1. Synovial fibroblasts from rheumatoid
sources could not be distinguished from the non-
rheumatoid synovial fibroblasts. The cells had an
increased lipid content after storage in liquid nitrogen
for a period of time in medium containing 10%
dimethylsulphoxide, followed by regrowth in normal
medium; otherwise no difference in structure or
growth could be detected. The only strain showing
any abnormality was B and, in this case, the cells
contained considerable deposits of glycogen granules
(Fig. 2). These were identified using the special
glycogen strain of De Bruijin (1973) at the electron
microscope level and could be removed by preincuba¬
tion with diastase. This material appeared to be very
similar to that described previously in what was
presumed to be a culture arising from accidental
co-cultivation of Chang and synovial cells (Mackay
and others, 1974). Strain B grew very slowly compared
to the other cultures, although the rate could be
increased by the addition of hyaluronidase (80
units/ml) to the culture medium.
induction
Several methods were tried to induce an RNA virus,
should it be present, from the integrated state. These
fig . 1 Ultrathin section ofsynovial fibroblast from strain
I. (x3 900)
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A, D, F, I, and N. This was followed by assay of the
culture supernatant for reverse transcriptase activity
which would indicate release of leucovirus particles.
Testosterone has been reported to induce C-type
virus from the human carcinoma cell line HBT-3
after pretreatment with 1UDR (Holder and others,
1974). With the synovial cells, testosterone was
found to inhibit the growth of all the strains to some
extent. The level used proved toxic for strain I, but
the others were carried for the full 8-week period and
showed no change in morphology as seen in the light
microscope. At no time, except in the case of strain
A, did the culture supernatant show any sign of DNA
polymerase activity. With A, there was a small
increase in acid-precipitable counts over the 2-hour
incubation period but this is probably accounted for
by cell lysis and release of cellular DNA polymerase.
Induction of strains E, F, K, and N with BUDR
was also carried out, followed by assays of the culture
supernatant for the presence of reverse transcriptase.
Again no activity was detected.
CO-CULTIVATION
As an alternative to and in addition to induction of
the synovial fibroblasts, various methods of co-
cultivation were tried. Cell lines from several sources
were used in an attempt to discover one which may
be permissive for a defective virus. In the first place
an XC test was tried with synovial strains A, D, F,
I, and N. It has been shown that plaques are formed
when XC cells are placed in contact with cells infected
with laboratory or field isolates of murine leukaemia
virus (Rowe and others, 1970). However, when the
synovial cells were tried in this test, no giant cells,
syncytia, or plaques were formed in the cell sheet as
demonstrable by light microscopy or haematoxylin
staining.
In the second place, the method of Benveniste and
others (1974) by which C-type particles were induced
from baboon placenta was tried. In this case the
synovial cells from strains A, D, F, I, and N were
induced for 24 hours with IUDR and co-cultivated
with LLC-MK2, D-17, XC, 118 MG-EH, HT-1, and
human fetal skin fibroblasts. These cell lines were also
cultured alone. The culture supernatants were assayed
for the presence of reverse transcriptase enzyme.
After incubation for 1 week, the cell lines added to
the synovial fibroblast cultures were the dominant
cells in the co-cultivation. The assays for reverse
transcriptase of both the co-cultivated cells and the
cell lines showed a slight increase in acid-precipitable
counts over the 2-hour incubation period but this is
probably due to the presence of DNA polymerase
released by cell lysis. The rate of incorporation of the
supernatant from the cell lines alone was always the
same as that when co-cultivated with the synovial
fibroblasts. It was therefore concluded that no C-type
particles had been induced by this method, or that
the cell lines chosen were not permissive for such a
virus.
DNA POLYMERASE ACTIVITY
In addition to assaying the culture supernatant for
reverse transcriptase activity, the synovial fibroblasts
themselves were assayed. The sensitivity of the
reaction to preincubation with RNase was deter¬
mined. Also it is necessary, as has been pointed out
previously (Norval and others, 1975), to distinguish
viral reverse transcriptase within the cells from
normal RNA-primed but DNA-directed DNA
polymerase. Here the distinction was made on the
basis of sensitivity to actinomycin D as viral reverse
transcriptase is unaffected by the presence of this
antibiotic, while cellular DNA polymerase is
inhibited (McDonnell and others, 1970). The strains
used and the results obtained are shown in Table III.
It may be seen that all strains showed endogenous
DNA polymerase activity. This is expressed as an
increase in acid-precipitable counts per minute over
the first 30 minutes of the incubation per pg protein.
An enzyme concentration which gives a linear
incorporation over this period was chosen. There
did not appear to be a noticeable difference in the
level of this enzyme in the rheumatoid cells compared
to the nonrheumatoid. The activity in all strains was
dependent to a large extent on the presence of RNA
as shown by the sensitivity of the reaction to pre¬
incubation with RNase. However, the activity was
severely inhibited by actinomycin D in all cases,
which may indicate that the polymerase is RNA-
primed rather than RNA-directed and hence not
viral in origin.
TRANSFECTION
As a final attempt to extract a possible viral genome
from the synovial cells, a transfection experiment
was carried out. DNA was extracted from strains C
and F and was used to 'infect' human fetal skin
fibroblasts at a low pass. The cultures were split at
about 10-day intervals and kept until the cells began
Table III DNA polymerase activity of synovial
strains
Strain Polymerase activity Activity after Activity in
(increase acid- preincubation presence of
insoluble cpm in with RNase actinomycin D
30 miningprotein)
A 4-0 10 0
D 4-3 0-3 0-3
E 9-6 0-25 —.
F 2-2 0 0
H 0-9 0 —
J 1-8 0 0-4
K 5-6 0-25 —
L 1-7 0 0-2
M 1-6 0 0
N 4-8 0 0
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fig. 2 Ultrathin section of synovial fibroblast from
strain B. (x660)
methods depended on the use of various nucleic acid
analogues such as IUDR, or protein inhibitors such
as cycloheximide. Addition of the inducer to the
medium was followed by labelling with 3H-uridine,
which will be incorporated into the RNA of any
virus being synthesized. The medium was then
concentrated by ammonium sulphate precipitation
and fractionation carried out by sucrose density
gradient centrifugation. Leucoviruses typically have
a density of IT6-1 -18 g/cm3 under such conditions
(Robinson, 1967), while that of mycoplasmas is
around 1-22 (Todaro, Aaronson, and Rands, 1971).
Table II shows the cell strains which were induced
and the agents used.
In all cases there was no radioactivity in the region
of the gradient where leucoviruses band. Fig. 3
Table II Methods of induction ofsynovial strains
Strain Induction
B, E, F, K, N BUDR
A, C, F, I, N IUDR + DMSO
D, E Cycloheximide
F, I, N Mitomycin C
A, C, F, I, N Testosterone
fig. 4 Strain A, pass 12 (induced with IUDR and
DMSO and labelled with 2H-uridine): acid-insoluble cpm
in fractions from sucrose gradient
5 10 15 20
FRACTION NUMBER
fig. 3 Strain F, pass 1 (induced with mitomycin C and
labelled with 3H-uridine): acid-insoluble cpm in fractions
from sucrose gradient
shows this result with strain F induced with mito¬
mycin C. With strains A and C induced with 1UJL)R
and DMSO, there was a peak of radioactivity at a
density of 1-22, as shown in Fig. 4. As these cultures
are known to be contaminated with mycoplasmas
which have this particular density, the incorporation
of 3H-uridine into acid-insoluble material seems
likely to be into mycoplasma particles. As a positive
control for this method of detecting RNA viruses, a
culture of feline embryonic amniotic cells chronically
infected with feline leukaemia virus was used. The
virus particles had the appropriate density of IT7
on the sucrose density gradient used.
In addition to the above methods, induction with
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An alternative approach is to look for viral-coded
antigens on the cell surface and now the synovial
strains are being examined for leucovirus group-
specific and interspecies antigens. Apart from
infection with leucoviruses, the methods used would
have detected a productive infection with rubella
virus. In view of the results of Patterson, Howard,
and Deinhardt (1973), the synovial fibroblast strains
have also been examined for rubella virus antigens
by immunofluorescence and by radioimmunoassay
but with negative results so far (H. Hart and B. P.
Marmion, unpublished).
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to die after about 8 months. There was no sign of
transformation and no change in cell shape or growth
in the DNA-infected cultures compared to the
controls.
Discussion
The synovial fibroblasts described in this work were
all used at as low a subculture as possible and
normally under pass 12. They began to die out around
pass 18. No difference could be detected in gross
morphology between strains from rheumatoid and
nonrheumatoid sources or in growth rate, except that
the rheumatoid cells tended to be more spaced out,
perhaps due to their increased hyaluronic acid content.
Also, ultrastructural studies showed no apparent
differences apart from one rheumatoid strain .which
had significant accumulations of glycogen granules.
This strain grew very slowly compared with the
others and the deposits may reflect some altered
cellular metabolism, although it is interesting that
such deposits have been reported in a line of hamster
cells (HT-1) transformed by murine sarcoma virus
(Karpas and others, 1971). They have also been
shown in what was presumed to be a culture arising
from accidental co-cultivation of Chang and synovial
cells and details of this will shortly be published
(M. Norval, A. Graham, and B. P. Marmion,
unpublished).
Various attempts were made to rescue a defective
or integrated RNA virus which might be present
within the rheumatoid synovial cells and, in par¬
ticular, techniques developed for leucovirus detection
were used. Induction methods included addition of
IUDR, a nucleic acid analogue; cycloheximide, a
protein inhibitor; mitomycin C, a DNA inhibitor;
and the hormone testosterone. After treatment with
these compounds for varying lengths of time, the
culture supernatant was tested for the presence of
RNA viruses by 3H-uridine labelling, or for leuco-
viruses by reverse transcriptase assays. The culture
supernatant from at least 5 x 106 synovial cells was
used in the labelling experiments and was concen¬
trated by ammonium sulphate precipitation before
being layered on a sucrose density gradient. 20 ml of
culture supernatant was used in the reverse trans¬
criptase assays and concentrated first by centrifuga-
tion through 20 % glycerol according to the method
of Lieber and others (1973). Sensitivity of the reaction
was increased by the addition of polyadenylic acid-
decathymidylic acid to the assay mixture. No
positive results were obtained with any technique.
In addition to inducing the synovial fibroblasts,
co-cultivation with a variety of cell lines was tried.
It has been shown recently by Todaro and others
(1974) that C-type viruses can be induced from
several normal baboon tissues by co-cultivation with
permissive host cell lines derived from a variety of
mammalian species. They were not infectious for
several baboon cell cultures. Thus it was decided to
try co-cultivation of synovial fibroblasts with five cell
lines from species other than man, plus human fetal
skin fibroblasts. Some of the cell lines already
contained part of a viral genome within the cells,
such as the HT-1 cell line which consists of hamster
cells transformed by murine sarcoma virus. It was
thought that these might complement any viral
information within the synovial cells. However all
the co-cultivation methods failed to show the
presence of a leucovirus or a cytopathic virus. Of
course this does not mean that such a virus is definitely
not present in an integrated form within the synovial
cells as the methods of induction and co-cultivation
may not be suitable for its expression, or the cell lines
chosen may not be permissive.
Assays for DNA polymerase activity in the synovial
cells failed to show the presence of viral reverse
transcriptase. There was endogenous DNA poly¬
merase activity which was shown to be RNase
sensitive. However, it was strongly inhibited by
actinomycin D which probably means that the
enzyme is not viral in origin but is cellular RNA-
primed DNA-directed polymerase. The cell lysate is
a relatively crude preparation and it was found
difficult to obtain sufficient cells at a low pass to try
further experiments, such as the effect of various
synthetic templates. However, the results obtained
do corroborate the recent report of Spruance and
others (1975) where cultured synovial cells from 8
patients with RA and 7 controls were examined for
reverse transcriptase. On the basis of ability to utilize
various synthetic templates, it was concluded that
there was no viral reverse transcriptase present in
any strain, and all the activity was due to DNA-
directed polymerase. They reported a slightly
increased level of cellular DNA polymerase in the
rheumatoid cells compared to the nonrheumatoids.
This was not found under the conditions used to
assay this series of synovial strains, where no exo¬
genous template was added. Again, finding no
reverse transcriptase enzyme does not exclude the
presence of a leucovirus genome from the synovial
cells as this enzyme may not always be expressed or
may not be detectable under the assay conditions
used.
In a final attempt to rescue a leucovirus genome,
the nuclear DNA from a rheumatoid and a non-
rheumatoid strain was extracted and used in a
transfection experiment with human fetal skin
fibroblasts. Recently it has been shown that cellular
transformation can be induced by viral-coded DNA,
in particular DNA extracted from human rhabdo¬
myosarcoma cells caused transformation of fetal
skin fibroblasts (Karpas and Tuckerman, 1974).
However, no transformation or change in cellular
morphology took place over an 8-month period.
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of cell lines cocultivated with rheumatoid synovial cells. A previous report described a cell
isolate presumed to have arisen by accidental cocultivation (contamination) of the
Chang 'liver' cell line and rheumatoid synovial cells. This cell isolate had the same
glucose-6-phosphate dehydrogenase isoenzyme as the Chang cell and also some shared
antigens. It clearly differed in its karyotype, its ability to grow in semisolid agar, and in
the possession of bleb-like projections of the cytoplasmic membrane filled with col¬
lections of beaded or granular material. In addition, it had a novel antigen(s) not
present in the Chang cell.
As these properties might have been acquired from the synovial cells and because
the bleb structures resembled those seen in some cell lines transformed by leucovirus the
cell isolate has been further studied. Cytochemical methods at the light and electron
microscope level showed that the granular material was polysaccharide in nature, prob¬
ably glycogen. No evidence was found of the presence of a virus or a viral genome
using a variety of techniques including attempted induction followed by 3H-uridine
labelling of the cultures, and assay of the supernatant fluid from the culture for viral
RNA-dependent DNA polymerase. In addition, cell extracts were not found to contain
viral RNA-dependent DNA polymerase or RNA-dependent RNA polymerase. No
rubella virus or leucovirus interspecies antigens were detected on the cell membranes.
Mackay and others (1974) and Mackay, Marmion,
and McCormick (1975) reported the isolation of an
epithelial cell line, 710025, which had apparently
arisen from a culture of rheumatoid synovial cells
and gave reasons for concluding that it was probably
the result of a laboratory contamination of the
synovial culture with Chang 'liver' cells. However,
the cell line from this unintentional cocultivation
had features that differed from the presumed parent,
the Chang cells. First, there was a difference in
karyotype, in particular the presence of an additional
satellite chromosome in the 710025 cells. Second,
the 710025 cells were able to form small colonies in
semisolid agar whereas the Chang cells did not.
Third, sera from a proportion of patients with
rheumatoid or nonrheumatoid arthritis reacted by
membrane immunofluorescence with Chang and
710025 or equivalent cells but absorption analysis
indicated that the latter had additional, unique,
antigens to those shared with Chang cells; this point
has been substantiated by antigenic analysis with
antisera prepared in rabbits rendered tolerant to
Chang cells (J. N. McCormick, personal com¬
munication). Finally, ultrastructional examination
of the cells showed bleb-like projections of the
cytoplasmic membrane—not seen in the Chang
cells—and in some of the cells there were extensive
collections of beaded or pseudofilamentous struc¬
tures, either deep in the cytoplasm or in the blebs,
or in both places.
Two additional cell lines, 720151 and 720301,
with essentially similar characteristics were isolated
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shortly afterwards, presumably again from con¬
tamination, this time with 710025 cells. Since this
period, with added precautions against contamin¬
ation, some 150 synovial membranes or exudates
from rheumatoid or nonrheumatoid patients have
been examined in culture without isolation of any
'transformed' cell lines. Efforts to reproduce the
phenomenon by deliberate cocultivation of freshly
taken synovial exudates and Chang cells were un¬
successful (Mackay and others, 1975); in many
instances the Chang cells were eliminated by macro¬
phages in the cultures and the survivors did not
show the blebs or fibrillary material.
The epithelial cell isolates, typified by 720301
cells, required further investigation for a number of
reasons. The cytoplasmic fibrillary material super¬
ficially resembled paramyxovirus nucleocapsids, or,
alternatively, glycogen, and it was important to
establish its nature. The bizarre morphology of
720301, and the related cell lines, resembled similar
cytology in human pleural mesotheliomas (Davis,
1974), and that in a variety of tumour or trans¬
formed cells resulting from infection with avian or
murine leucoviruses. Thus, for example, surface
blebs and accumulations of glycogen, together with
distinctive, additional, marker chromosomes, have
been observed in a line of hamster cells (HT-1)
transformed by murine sarcoma virus (Karpas and
others, 1971); virus particles and murine leukaemia
group antigen were not detected in those cells.
This paper reports the results of investigations
designed to define the nature of the beaded or
pseudofilamentous structures in the cocultivated
cells, and attempts to detect the genome or gene
products of rubella, paramyxovirus or leucovirus.
Materials and methods
CULTURE METHODS
Cell lines were grown in Eagle's complete medium (1959
modification) containing 5% calf serum normally in
Roux bottles or on cover-slips in tubes at a temperature
of 37°. They were passed by trypsinization.
CYTOCHEMISTRY
For light microscopy, 720301 and Chang cells were
removed from Roux flasks using glass beads, pelleted in
Difco agar (cooled to 48°) and fixed in Bouin's fixative
(Gurr, 1957). Paraffin sections were prepared, some
being treated with 1 % diastase (BDH) for 1 hour at 37°.
The sections were stained with Schiff (Gurr, 1957) and
Best's Carmine (Gurr, 1957). Cells grown on cover-slips
were also stained similarly.
For electron microscopy, 720301 and Chang cells
were removed from Roux flasks with glass beads. They
were stained specifically for polysaccharides according
to the methods of De Bruijin (1973) and SchafF, Barry,
and Grimley (1973). The blocks were sectioned on an
LKB Ultratome 11 and the sections viewed on a Hitachi
HU11A electron microscope. Some preparations were
stained by the ruthenium red method (Vorbrodt and
Kroprowski, 1969) to detect differences in surface
carbohydrate 'coat'.
Chang and 720301 cells were also examined for content
of carbohydrate by growth for 24 hours in Eagle's
medium containing either no glucose or increasing con¬
centrations of 1 mmol/1, 5 mmol/1, and 10 mmol/1
glucose. They were then harvested, solubilized with 30%
potassium hydroxide, and the polysaccharide con¬
centration of the cell-free extracts determined colori-
metrically by the anthrone-sulphuric acid method of
Shetlar (1952).
ATTEMPTS TO INDUCE CELLS TO PRODUCE VIRUS
(а) In various regimens 720301 cells were cultured in
medium containing BUDR 20 p.g/ml for 3 days; or
IUDR 20 p.g/ml for 3 days (Lowry and others, 1971); or
IUDR 20 [xg/ml for 3 days followed by DMSO (2%) for
4 days (Stewart and others, 1972); or in medium without
arginine for 4 days (Kaplan, Wilbert, and Black, 1972).
Cells were removed with glass beads, fixed in Karnosky's
fixative, embedded in Araldite, and the sections examined
in the electron microscope. In addition, washed cells
were lysed by freezing and thawing and the lysates used
to inoculate BHK-12, RKia and Vero cells growing on
cover-slips. Cover-slips were stained with Giemsa after
4 and 11 days' incubation.
(б) 720301 and Chang cells of various passage levels, in
the former ranging from 7 to 28 passages, were incubated
in the presence of BUDR 20 fxg/ml for 3 days; or IUDR
20 pg/ml for 4 days; or IUDR 20 p.g/ml for 3 days
followed by DMSO 2% for 3 days; or puromycin
10 pg/ml for 1 day (Aaronson and Dunn, 1974); or
testosterone acetate 5 p.g/ml for 3 days (Holder, Robey,
and Vande Woude, 1974); or mitomycin C 1 pg/ml for
18 hours in the dark (Weiss and others, 1971). The
attempted induction was followed by 3H-uridine labelling
as outlined by Norval and Marmion (1976). For one
experiment, after treatment with testosterone, 720301
cells were incubated in medium containing 2-5 p.Ci/ml
(methyl-3H) thymidine and 0-4 p.Ci (2-14C) uridine
(Amersham).
DNA POLYMERASE ACTIVITY
(a) Preparation of ceils and polymerase assay
720301 and Chang cells were washed in medium and
prepared as outlined by Norval, Ogilvie, and Marmion
(1975).
(b) Preparation of culture supernatants and polymerase
assay
20 ml of culture supernatant from confluent 720301 and
Chang cultures, either before or after attempted in¬
duction with BUDR and testosterone acetate were
prepared according to the method of Lieber and others
(1973), and the sedimented pellet resuspended in 0-1 ml
polymerase buffer as used in (a). To this was added
double quantities of the assay constituents and incubation
carried out at 37° for 2 hours. Samples of 50 ji.1 were
spotted on filter paper discs at 30-minute intervals and
acid-precipitation and counting performed as above.
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MEMBRANE ANTIGENS
720301 and Chang cells were examined for interspecies
antigens associated with mammalian leucoviruses by
membrane immunofluorescence following the method of
Yoshiki and others (1974). The antisera used were rabbit
antifeline leukaemia virus, HCl-guanidine disrupted
(kindly provided by Dr. O. Jarrett), goat antifeline
leukaemia virus p27 and pl2, and goat anti-Mason
Pfizer monkey virus p27 and plO-12 (kindly provided by
the National Cancer Institute). The cells were also
examined for rubella antigens using the method described
by Hart and Marmion (1976).
Results
PSEUDOFILAMENTOUS CELLULAR INCLUSIONS
Cytochemical techniques were used in attempts to
identify the material within the bleb-like structures
and to distinguish glycogen granules and nucleo-
capsids of incomplete viral structures containing
nucleic acid. Most of the experiments with Chang
and 720301 cells were done with cultures infected
with Mycoplasma orale 1 (Mackay and others, 1974).
However, a subline of 720301 cells which had been
freed of mycoplasmas by 'pulse' treatment with
sodium aurothiomalate and M. orale 1 antiserum
and complement was used in ultrastructural studies.
Paraffin sections of pellets of 720301 cells, stained
for polysaccharide, showed Schiflf-positive material
occurring in large particulate areas in the cytoplasm.
There were also masses of this material outside the
cells. On the other hand, Chang cells only occasion¬
ally showed traces of Schiff-positive material and
small amounts extracellularly. Best's carmine
staining of paraffin sections gave less striking
results but the majority of 720301 cells seemed to
have some glycogen, whereas very few Chang cells
contained glycogen.
On the other hand cover-slip cultures of 270301
cells in monolayer showed much less Schiff-positive
material in the form of discrete inclusions. Thus the
difference in polysaccharide content with Chang and
720301 cells was less marked in cover-slips than in
the paraffin sections, even so there were more
Schiff-positive 720301 cells than Chang cells.
The results of the tests at the light microscope
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The results with the technique of De Bruijin (1973)
with K3Fe(CN)"6 are illustrated in Fig. 1 a and 1 b.
Approximately 70% of the 720301 cells showed large
stained areas in the cytoplasm which were removed
after incubation with diastase, but not if the enzyme
had been inactivated first by boiling. The same
result was obtained after the 720301 cells had been
freed of Mycoplasma contamination. The stained
areas in the Chang cells were much smaller and were
found in only about 40% of the cells. Finally,
chemical analysis of cell lysate showed consistently
higher levels of glycogen in 720301 cells compared
with Chang cells, although in each instance higher
levels of storage were attained if the concentrations
of glucose in the culture medium was increased
(Table). Ruthenium red staining did not show a
difference in cell 'coat' between Chang and 720301
cells.
Table Analysis of glycogen content (estimated as
glucose in hydrolysed cell lysate) of 720301 and Chang
cells grown in Eagle's medium with varying content of
glucose
Cell Glucose content y.g glycogen/
ofmedium (mmofl) mg protein
720301









INVESTIGATION FOR INFECTIVE VIRUS OR
VIRAL GENE PRODUCTS
(a) Infection with cytoplasmic DNA viruses and RNA
viruses, other than leucoviruses
As previously reported (Mackay and others, 1974)
paramyxovirus (measles, mumps, and parain¬
fluenza) antigens were not detected in cell lysates of
720301 by complement fixation reactions with
known antisera. Rubella antigen was not detected
by membrane or other immunofluorescence with
rabbit antisera that reacted satisfactorily with
LLC-MK2 cells chronologically infected with rubella
virus (Hart and Marmion, 1976). In addition immu¬
nization of rabbits with cell suspensions did not
stimulate viral antibodies.
Lysates of 720301 and Chang cells were also
assayed for RNA-dependent RNA polymerase using
the method of Scholtissk and Rott (1969). Results
were negative but activity was detected in the cor¬
responding lysates from LLC-MK2 cells chronically
infected with rubella and PK15 and MDBK cells
chronically infected with Newcastle Disease virus
(kindly provided by Mr. E. Gowans).
(b) Infection with leucoviruses
In view of the striking blebs and glycogen accumu¬
lation and the observations that cells with leucovirus
genomes sometimes exhibit such morphological
changes, extensive attempts have been made to
induce the 720301 cells to form complete virions or
gene products such as RNA-dependent DNA
polymerase or to show interspecies antigens char¬
acteristic of the mammalian leucoviruses.
INDUCTION EXPERIMENTS
Many methods have been described in recent years
whereby viruses have been induced from an in¬
tegrated state to form complete virions. In par¬
ticular, activation of RNA-tumour viruses in
various situations including cell lines from human
sources has been reported (Stewart and others,
1972; Holder and others, 1974; Bykovsky and
others, 1973). RNA tumour viruses thus produced
have a density of 1 • 16-1 • 18 g/cm3 (Robinson, 1967)
on sucrose gradient equilibrium centrifugation,
while Mycoplasmas have a density around 1-22
g/cm3 (Todaro, Aaronson, and Rands, 1971).
Attempts were made to induce the 720301 cells
by several methods, including BUDR, IUDR, IUDR
followed by DMSO, puromycin, and testosterone
acetate. In the first instance ultrathin sections were
examined in the electron microscope. The presence
of the inducers had a general harmful effect on
various cell structures except where DMSO was
used in addition to IUDR. Puromycin caused an
inhibitory effect with cessation of growth and
rounding of cells. Testosterone had an even more
toxic effect with much of the cell sheet detaching
from the glass over the 3-day incubation period.
No virus particles were seen and the bleb-like areas
did not alter in shape and frequency. The Chang
cells were noticeably less affected with all treatments
including testosterone.
In addition, washed cells after induction were
lysed by freezing and thawing, and the effect of the
lysates on BHK-21, RKi3 and Vero cells growing on
cover-slips found. There was no indication of virus
infection as demonstrable by Giemsa staining.
As an alternative method for the detection of
RNA virus virions, the cultures were labelled with
tritiated uridine and the labelled constituents of the
concentrated culture supernate separated by sucrose
gradient equilibrium centrifugation. As a positive
control for these experiments feline leukaemia virus
(FeLV-B) grown in feline embryo cells was labelled
with 10 (TCi/ml of 3H-uridine. This had a density of
1 • 16—1 -17 g/cm3 after sucrose gradient density
centrifugation as outlined in Methods.
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f i g . 3 Acid-insoluble cpm in sucrose density gradient
fractions from 720301 ( ) and Chang (••••) culture





















FIG. 2 Acid-insoluble cpm in sucrose density gradient
fractions from 720301 culture supernatant, labelled with
3H-uridine as in Methods
A double-labelling experiment after testosterone
induction using 3H-thymidine and 14C-uridine
showed that the peak at density around 1-21 con¬
tained both DNA and RNA (Fig. 4). Mycoplasma
orale 1 was cultured on cell-free medium from an
equivalent fraction containing this material. Thus it
seems that the 720301 cells are not producing an
RNA virus even after induction, and that the
incorporation of labelled uridine and thymidine
into cellular material is into Mycoplasmas.
When 720301 cells were treated similarly, there
was a small peak of radioactivity around density
1 ■ 22, but no evidence of any incorporation of
3H-uridine at density 1-16-1-18 (Fig. 2). This peak
was enlarged by the presence of any of the inducers
listed in the Methods but particularly by treatment
with testosterone acetate (Fig. 3). On the other
hand, the Chang cells showed no incorporation at








fig . 4 Acid-insoluble cpm in sucrose density gradient
fractions from 720301 culture supernatant, induced with
testosterone before double labelling with 3H-thymidine






302 Annals of the Rheumatic Diseases
ASSAY FOR RNA-DEPENDENT DNA POLYMERASE
AS AN INDICATOR OF LEUCOVIRUSES
Enzyme extracts were prepared from lysed cells and
tested for the presence of endogenous RNase-
sensitive DNA polymerase. Fig. 5 shows a typical
result using 10 jfI of Chang and 720301 preparations.
The enzyme activities may be expressed as an
increase in acid-precipitable counts/min over the
first 30 minutes of the incubation per peg protein.
For 720301 cells the result is 6 -1; for Chang cells 7-6.
20 40
minutes
fig. 5 Endogenous DNA polymerase activity of 720301
and Chang cells. Assay conditions as in Methods, using
10 [xl crude enzyme preparation
The product of the reaction was completely
sensitive to DNase in both cases as shown by the
reduction in acid-insoluble counts to background
level after treatment with DNase at the end of the
fig. 6 Effect ofpreincubation with RNase (♦) and post-
incubation with DNase on endogenous DNA polymerase
activity of 720301 cells. Assay conditions as in Methods
using 10 fx/ crude enzyme preparation and 10 |xl after
preincubation with RNase. DNase was added {arrow)
incubation period (Fig. 6; 720301 cells). The
dependence of the polymerase activity on the
presence of endogenous RNA is shown by pre¬
incubation of the enzyme preparation with RNase
(Fig. 6).
Various methods have been described, such as by
Norval and others (1975) to distinguish the RNA-
dependent DNA polymerase characteristic of
leucoviruses from other cellular polymerases, in
particular the DNA polymerase primed by RNA but
directed by DNA, found in normal stimulated
human lymphocytes (Bobrow and others, 1972).
Thus, the sensitivity of the enzyme from the Chang
and 720301 cells to actinomycin D was ascertained.
The result (Fig. 7) for 720301, and the Chang enzyme
was the same. The antibiotic inhibited the reaction
by over 90% even for the first sample taken 5
minutes after the start of the incubation period.
Secondly, the ability of the polymerase to utilize the
synthetic templates poly-d(A-T) and poly-A-d(T)10
was determined. It was found that poly-d(A-T)
stimulated the activity over 15-fold while poly-














f i g . 7 Effect of actinomycin D on endogenous DNA
polymerase activity of 720301 cells. Actinomycin D (50
[Xg/ml) dissolved in polymerase buffer was added to the
assay mixture (♦) or polymerase buffer alone (•).
Attempts were also made to analyse the product
of the endogenous reaction in caesium sulphate and
glycerol gradients. All the radioactivity was at the
appropriate density for DNA, that is around 1 -41
on Cs2S04 equilibrium density centrifugation and
near the top of the glycerol gradient. There was
never any evidence of the formation of a labelled
RNA-DNA hybrid which should band to a density
of around 1-66 g/cm3 on Cs2S04 (Sarngadharan
and others, 1972), and have sedimentation coefficient
of 70S on a glycerol gradient (Gulati, Axel, and
Spiegelman, 1972).
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The results therefore do not indicate the presence
of a viral RNA-dependent DNA polymerase in the
cell lysates. As a positive control in these experiments,
use was made of the cell line 118MG-EH containing
the Rous sarcoma virus genome with expression of
reverse transcriptase activity (Norval and others
1975).
Also assay of the culture supernatants of Chang
and 720301 cells did not indicate the presence of a
viral reverse transcriptase. There was a very slight
increase in acid-precipitable counts over the 2-hour
incubation period in the case of the 720301 cells.
This was not increased after induction with BUDR
but did increase slightly after treatment with
testosterone. The raised activity is probably due to
the release of DNA polymerase by cell lysis or
death and is certainly not sufficiently high to
indicate budding of RNA tumour virus into the
culture medium as shown by Lieber and others
(1973), even in the presence of poly-A-d (T)10 in the
assay mixture.
LEUCOVIRUS ANTIGENS
Although mature leucovirus particles may never be
formed by an infected cell line, there may still be
expression of some viral antigens in the cell, such as
the interspecies antigen associated with the major
core protein p27 of the virus. These interspecies
antigens were thus looked for in 720301 and Chang
cells by immunofluorescence (Yoshiki and others,
1974) using antiserum prepared against HC1-
guanidine disrupted feline leukaemia virus. In
addition, antisera prepared against p27 and pi2
proteins of feline leukaemia virus and Mason-Pfizer
monkey virus were tried. There was no staining of
either cell line with any of the antisera.
TRANSFECTION AND XC TEST
Two final experiments were tried in an attempt to
show leucovirus information within the cells. It has
been reported that DNA extracted from a human
rhabdomyosarcoma cell line caused transformation
of human fetal fibroblasts (Karpas and Tuckerman,
1974). Nuclear DNA was therefore extracted from
the 720301 and Chang cells and used to 'infect' fetal
skin fibroblasts which were split at intervals until
they began to die out after about 8 months. There
was no change in cell shape, growth, or other
evidence of transformation.
Lastly an XC test was carried out. It has been
shown that, when cells containing murine leukaemia
virus genomes were overlaid with XC cells, syncytia
and plaques developed in the cell sheet (Rowe,
Pugh, and Hartley, 1970). No effect of this nature
was observed in the case of the 720301 or Chang
cell lines.
Discussion
The cell lines described in this paper were assumed
to have arisen by accidental cocultivation of the
Chang cell line with synovial fluid cells. As viruses
have been proposed as infective agents in rheumatoid
arthritis it was therefore of interest to discover if
the unusual characteristics of these cells could be
attributed to a viral infection of some kind—either
productive and noncytopathic, or defective in some
way, or integrated.
One of the most striking features of these cells was
the bleb-like projections of the cytoplasmic mem¬
brane with associated accumulations of granular
material in the cytoplasm. Originally it was though
that this material might be nucleocapsid in origin at
occurs during chronic infection of cells with News
castle disease virus (Mackay and others, 1974), but
subsequently the results of various staining methods
at the light and electron microscope level showed
that the material was polysaccharide, probably
glycogen. This was interesting as glycogen can
accumulate in cells infected with either Myco¬
plasmas or Ieucoviruses. To resolve this difficulty,
the cell line 720301 was cleared of Mycoplasma
contamination by pulse treatment with sodium
aurothiomalate and M. orale 1 antiserum plus
complement. No Mycoplasmas were obtained on
subsequent subculture and immunofluorescence
using goat anti-M. orale serum was negative. How¬
ever after this treatment the cells were shown to
contain glycogen accumulations by electron micro¬
scopy.
No virus particles have been seen budding from
the cell membrane or associated with the cell, and
there was no evidence of a productive viral in¬
fection of any kind. Paramyxovirus antigens were
not detected in cell lysates nor rubella antigens at
the cell surface. It is known that leucoviruses can
exist in an integrated state within the host cell's
DNA, and may express some of their viral genes by
the synthesis of RNA-dependent DNA polymerase
or viral-coded antigens. Some may be induced by a
variety of agents to complete the replicative cycle
and to bud from the cell membrane into the culture
supernatant. Several different inducers were there¬
fore tried and the effect of these found by electron
microscopy, by treatment of other cell lines with
cell lysates, and by labelling with 3H-uridine and
thymidine followed by sucrose gradient centrifug-
ation. With the latter method, the results were
complicated by the presence of Mycoplasmas which
seemed to be released from the cell membrane after
induction. However, they could be separated from
leucoviruses as Mycoplasmas have a higher density
and could be labelled with both radioactive uridine
and thymidine. No peak of radioactivity with density
appropriate for a leucovirus was found. The number
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of Mycoplasmas in the culture supernatant appeared
to be increased by treatment with inducers, or
perhaps more are liberated from the cell by membrane
effects, particularly with testosterone. The Chang
cell line seemed to be much more stable than the
720301 cells in all respects, and despite containing
Mycoplasma orale 1, did not release it in detectable
quantities into the medium, even after induction.
This may also be a reflection of relative population
numbers.
The culture supernatant was examined for the
presence of RNA-dependent DNA polymerase but
none was found, even after induction with BUDR
or testosterone acetate. The endogenous DNA poly¬
merase within the cells was shown to have the
characteristics of a DNA-directed and not RNA-
directed enzyme. In addition no leucovirus inter¬
species antigen was detected on the cell membrane.
Both a transfection experiment and an XC test
were not successful.
With regard to RNA viruses other than leuco-
viruses, no RNA-dependent RNA polymerase was
found in cell lysates, and tests for rubella specific
antigens on the cell surface were negative.
Thus by all the techniques mentioned above, no
evidence was obtained that there was a viral genome,
in particular a leucovirus, present in the 'coculti-
vated' cell lines. The accumulation of glycogen
granules remains to be explained, although it is still
possible that such a genome is there but is not
expressed as mature virus particles, or even as new
viral-coded membrane antigens or polymerase
enzymes necessary for viral replication.
We thank Dr. Barbara Marczynska for helpful dis¬
cussion regarding the morphology of leucovirus-
transformed cell lines. This work was supported by a
grant from the Nuffield Foundation.
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summary DNA and RNA were extracted from synovial membranes, synovial fibroblast cells,
peripheral blood lymphocytes, and synovial fibroblast cells strains derived from patients with
rheumatoid arthritis and other joint conditions. They were hybridised after immobilisation on
nitrocellulose filters with iodinated viral nucleic acids extracted from measles, rubella virus, SV-40,
and a retrovirus, RD-114. In addition, in-situ hybridisation was carried out on sections of synovial
membranes by means of iodinated measles and rubella virus RNA. In no case did any hybridisation
occur. Positive control systems included synovial fibroblast strains transformed with SV-40, LLC-
MK2 cells chronically infected with rubella virus and RD cells infected with RD-114. It was con¬
cluded that the synovial cells did not contain viral genomes of measles, rubella virus, SV-40, or
RD-114, or at least at a level equivalent to the positive control cells.
In recent years many attempts have been made to
isolate a virus from tissues of rheumatoid patients
and there have been no positive results; for reviews
see Marmion and Mackay (1977) and Hamerman
(1975). However, the immunological abnormalities
apparent in this disease could be associated with a
virus which is not fully expressed and which therefore
would not be detectable by virus culture methods.
Such a virus might be present within the cells of the
synovial membrane or synovial fluid and might
alter the surface properties of these cells. Some work
has been done lately to examine this possibility and
again the results are predominantly negative.
Hart and Marmion (1977) studied fibroblast
strains which grew in culture from synovial mem¬
branes or synovial fluids for retroviral and rubella
viral antigens by immunofluorescence and radio¬
immunoassay and none were found, though there is
evidence from Patterson et al. (1973) that by means of
a cytotoxic assay the rheumatoid cells may be shown
to contain rubella virus membrane antigens. Similarly
the lymphocytes from rheumatoid synovial fluids
and cells in sections of synovial membranes showed
no sign of possessing retroviral or rubella viral
antigens by immunofluorescence, immunoperoxi-
dase, and radioimmunoassay (Hart and Marmion,
1977).
Attempts to rescue viruses from synovial fibroblast
strains by such procedures as chemical induction
and cocultivation were not successful (Norval and
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Marmion, 1976). Recently synovial lymphocytes
were fused and cocultivated with cell lines permissive
for primate retrovirus but with no virus being
induced (Norval et al., 1978, to be published).
Thus in the aetiology of rheumatoid arthritis
there is little to implicate viruses, whether being
produced from infected cells or even in a non¬
productive form so far. However, consideration
should be given to those viruses which may be
present within cells and which may alter cell function
or induce new proteins at the cell surface. Such
hypotheses, among others, have been reviewed
recently by Marmion and Mackay (1977). For
example, adenovirus may be considered as an
oncogenic virus in a transforming situation where a
part of the viral genome may integrate into the
host cell chromosome. This cannot be recovered as
infectious virus and will be detectable only by
nucleic acid hybridisation or perhaps by synthesis
of a few early proteins like T-antigen, although in
some cell lines even these may not be expressed;
for review, see Flint (1977).
We decided therefore to examine nucleic acids
from rheumatoid and nonrheumatoid sources for
homology with various viral nucleic acids. DNA and
RNA were extracted from synovial membranes,
synovial fluid cells, peripheral blood lymphocytes,
and synovial fibroblasts grown in culture. These were
hybridised with iodinated viral nucleic acids from
measles, rubella, SV-40, and RD-114, an endogenous
feline retrovirus, which is antigenically related to
viruses from certain nonhuman primates, by a
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Specimens from synovectomies were received in the
laboratory less than 2 hours after operations. The
synovial membranes were dissected out and cut into
small pieces (2-5 mm). They were disaggregated in
serum-free medium either with trypsin or with a
mixture of collagenase (1 mg/ml) and hyaluronidase
(80 units/ml) at 37°C for 3 hours with stirring.
The dispersed cells were washed in serum-free
medium (Earles-based Eagles), then in extraction
buffer (0-15M NaCl, 0-1M EDTA in 0-1M Tris,
pH 8-0).
Synovial fluids, removed by syringe from various
effusions, were treated with hyaluronidase (80 units/
ml) for 30 mins at 37°. The cells were deposited by
centrifugation and washed in serum-free medium,
then in extraction buffer.
Peripheral blood lymphocytes were prepared from
100 ml heparinised blood by separation on Triosil-
Ficoll gradients. They were washed in serum-free
medium, then in extraction buffer.
Synovial fibroblast strains, grown in culture
(Norval and Marmion, 1976) were harvested by
trypsinisation and washed in extraction buffer.
These were normally around pass 5.
In all cases a minimum of 2 x 107 cells were
obtained.
Nucleic acid was extracted by the method outlined
in Simpson and Iinuma (1975), a 10% solution of
sodium dodecyl sulphate (SDS) in extraction buffer
being added to make the final concentration 1 %.
The precipitated nucleic acid after chloroform/
isoamyl alcohol extraction was treated with RNase
(50 ug/ml, pretreated at 80° for 10 min, Sigma) for
DNA preparations or with DNase (20 ug/ml, Sigma)
for RNA preparations. The final precipitation of
nucleic acid was with ethanol, and it was dissolved
in SSC buffer (0-15M NaCl, 0 015 M Na citrate).
The ratio of absorbance at 260 to 280 nm was at
least 1 -85, and from 108 cells the yield varied from
around 100 p.g in the case of synovial membrane
cells to around 500 ug from cultured synovial cells.
The nucleic acid was stored at —70°C until use.
In addition RNA and DNA were extracted from
BHK-21 cells 3 days after infection with rubella
virus (Thomas strain), and from LLC-MK2 cells
chronically infected with rubella virus (Hart and
Marmion, 1977). DNA was extracted from RD
virus and RD cells chronically infected with RD-114
(McAllister et al., 1972). Also DNA was extracted
from synovial fibroblast strains, 2 rheumatoid and
1 non-rheumatoid, transformed by SV-40. This
transformation was achieved by pretreating the cells
with hyaluronidase (1 mg/ml) for 1 h at 37 °C, then
infecting with virus at a multiplicity of 100:1 or
300:1. Transformation became apparent by mor¬
phological changes after 4 to 16 weeks, and the
presence of T antigen was confirmed by immuno¬
fluorescence.
PREPARATION OF VIRUSES AND VIRAL
NUCLEIC ACID
Purified SV-40 virus was a kind gift from Dr Ching-
Juh Lai (National Cancer Institute).
Measles virus (Schwartz strain) was grown in
Vero cells in roller bottles. The medium was Earles-
based Eagles containing 2% calf serum and 100
IU/ml penicillin and 100 fxg/ml streptomycin. The
culture supernatant (3 litres) was harvested 3 days
after infection and clarified The virus was concen¬
trated by centrifugation at 30 000 r.p.m. for 1 hour
in a SW 40 rotor, and resuspended in 0-01 M Tris-
HC1, 1 mM EDTA, pH 7-1 buffer (Grayzel, 1973).
It was layered on to sucrose density gradients (20 %
and 70%) and centrifuged at 25 000 r.p.m. for 18
hours in a SW 40 rotor. Drops were collected from
the base of the tube, and fractions with density 1-19
to 1-23 g/cm3 were pooled and pelleted at 40 000
r.p.m. for 1 hour in an SW 50 1 rotor. The pellet
was suspended in 3 ml SSC and stored at —70°C.
Rubella virus (Thomas strain) was also grown in
Vero cells in roller bottles. The culture supernatant
(2 litres) was harvested after 5 days and 8 days and
clarified. It was purified as for measles except that
the 1-18 to 1-21 g/cm3 band was taken from the
sucrose density gradients.
RD cells chronically infected with RD-114 virus
were grown in roller bottles in Eagles medium
containing 5 % fetal calf serum. Culture supernatants
were harvested every second day (2 litres) and clari¬
fied. The virus was purified as for measles except that
the 1-15 to 1-17 g/cm3 band was taken from the
sucrose density gradients.
The nucleic acid was then extracted from each
virus preparation. The volume was made up to
10 ml in TNES buffer (0-1M Tris pH 9-0, 0-1M
NaCl, ImM EDTA, and 0 • 1 % SDS) and extracted 3
times with TNE (0-1M Tris pH 9-0, 0-1M NaCl,
ImM EDTA)-saturated phenol containing 10%
chloroform. The nucleic acid was precipitated with
ethanol and the final precipitate dissolved in 0 • 3 ml
sterile SSC and stored at —70°C.
IODINATION OF VIRAL NUCLEIC ACIDS
200 ug measles RNA, 50 u.g SV-40 DNA, 200 ug
rubella RNA, and 280 jxg RD-114 RNA were
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iodinated by modification of the method of Com-
merford (1971). DNA, when used, was heated at
80°C for 20 min just before iodination. A mixture
was made of 0-3 ml of 0-5 M Na acetate buffer,
pH 5 • 0; 0 • 3 ml SSC containing the nucleic acid to be
iodinated; 0 • 3 ml thallic chloride, 2 • 5 mM in 0 • 1 M
acetate buffer, pH 5 0; and 0-3 ml potassium iodide
0-125 mM, which had previously been added to
600 p.Ci125I. It was incubated at 60° for 1 hour, then
cooled to room temperature. The labelled nucleic
acid and 125I were separated on Sephadex G50.
The nucleic acid peak was dialysed exhaustively
against SSC buffer. The specific activity obtained was
6 X 104 counts per minute (cpm) per ug nucleic
acid for measles RNA, 3 x 105 for SV—40 DNA, 3 x
104 for rubella RNA, and 6 x 104 for RD-114 RNA.
FILTER HYBRIDISATION
Essentially the method of Gillespie and Spieglemann
(1965) was used in which the cellular nucleic acid
derived from the synovial membranes, synovial
fluid cells, peripheral blood lymphocytes, synovial
fibroblasts, and various cell lines plus calf thymus
DNA were immobilised on Millipore nitrocellulose
filter discs. The filters each contained 20 [xg nucleic
acid. Hybridisation was carried out in small sealed
vials containing iodinated viral nucleic acid (in the
case of viral DNA it was preheated for 15 min at
80°C), 20 p.1 5% SDS, and 4 fxg cold carrier DNA
(calf thymus DNA, except for calf thymus control
vial in which 4 jxg human DNA was used as carrier),
and 3 x SSC to make the final volume 1 ml. The
vials contained up to 5 filters with nucleic acid plus
2 blanks. Incubation was carried out at 62°C for 22
hours. The filters were washed in 3 x SSC with several
changes of buffer, digested with Sj nuclease (Bio-
chemicals Inc.) to remove unhybridised nucleic acid,
and rewashed. They were counted in a Wallace-
LKB gamma counter.
10X acetate buffer (3M NaCl, 0-1 M Na acetate,
pH 5), and 80 p.1 iodinated viral nucleic acid (about
25 000 cpm) or SSC (control). Hybridisation was
carried out at 46°C for 22 hours under cover-slips
sealed with Cowgum. The slides were washed in
acetate buffer, treated with Sx nuclease for 1 hour at
37°C, rewashed, dehydrated in ethanol, and covered
with Uford K2 emulsion. They were developed with
Kodak D 19 after periods of 4 to 8 weeks.
Results
sv-40
1-7 [ig (500 000 cpm) iodinated SV-40 DNA was
used in hybridisation with nitrocellulose filters
containing 20 peg DNA from calf thymus, from
peripheral blood lymphocytes of 4 normal people,
from 2 rheumatoid synovial membranes, and from
2 rheumatoid synovial fibroblast strains. As a
positive control for the method DNA was extracted
from 2 rheumatoid synovial strains and 1 non-
rheumatoid strain transformed by SV-40. These
should contain an integrated copy (or copies) of the
viral genome. The cpm of the filters after treatment
with Sx nuclease are shown in Table 1. These
represent an average of 2 to 4 determinations done
within 4 weeks of iodinating SV-A0.
It can be seen that the cpm of the filters contain¬
ing DNA from the SV-40 transformed synovial
cells are 2 to 3 times more than the other synovial
preparations. The latter were considered therefore
not to contain SV-40 viral sequences.
MEASLES
0-45 fxg (27 000 cpm) and 0-045 u.g (2700 cpm)
iodinated measles RNA were used in hybridisation
with nitrocellulose filters containing 20 ug DNA from
calf thymus, from 3 synovial membranes of RA
IN-SITU HYBRIDISATION
The method of Pardue and Gall (1975) was followed
in outline. Frozen sections were prepared of synovial
membranes, and various cell lines were grown on
glass slides until semiconfluent. Two methods of
fixation were used: (1) 0 -1 % Glutaraldehyde at 4°C
for 30 min followed by dehydration in 50%, 70%,
90%, and 100% ethanol. (2) Acetic acid: ethanol,
1:3 for 2 min, followed by dehydration in 95%
ethanol. These slides were treated with 200 |xl
pancreatic RNase (100 ug/ml in 2 X SSC, Sigma)
for 1 hour at 37 °C, washed in~2 X SSC, then de¬
hydrated again. They were denatured1 in 0-07N
NaOH for 2-3 min'and dehydrated.
With all slides 10 ptl hybridisation mix was added
which consisted of 100 p.1 42% formamide, 20 p.1
Table 1 Hybridisation of SV-40 125I-DNA with cellular
DNA
cpm per filter
No nucleic acid 238
Calf thymus DNA 275
Peripheral blood lymphocytes, 2 199
Peripheral blood lymphocytes, 3 194
Peripheral blood lymphocytes, 4 188
Peripheral blood lymphocytes, 5 186
Rheumatoid synovial membrane, 1 220
RJieumatoid synovial membrane, 8 202
Rheumatoid synovial fibroblast strain, 2 263
Rheumatoid synovial fibroblast strain, 7 222
SV-40 transformed rheumatoid synovial fibroblast
strain, 5 442
SV—40 transformed rheumatoid synovial fibroblast
strain, 7 408
SV-40 transformed non-rheumatoid synovial
fibroblast strain, 10 666
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patients and 1 juvenile RA, from 1 synovial mem¬
brane of an OA patient, and from 1 synovial fluid
from an RA patient. The results can be seen in Table
2; they represent an average of 2 determinations.
The counts obtained were all lower than the filter
with no nucleic acid or with DNA from calf thymus,
and it was concluded that no hybridisation had taken
place.
Moreover, in-situ hybridisation was carried out on
frozen sections cut from 4 synovial membranes.
These came from 2 patients with RA and 1 each
with OA and a popliteal cyst. The sections were all
fixed in acetic acid/ethanol and treated with RNase
before denaturing the DNA. After 4 and 8 weeks
the slides were developed and did not contain more
grains over the cells than the control slides.
These hybridisations were set up to detect measles-
specific DNA in synovial cells, and no positive
control was included for this system. Some evidence
has been produced to suggest that measles in a
chronic type of infection of chick embryo fibro¬
blasts goes through a DNA proviral stage (Zhdanov,
1975), but this has not been substantiated subse¬
quently by Holland et al. (1976) using hybridisation
techniques and transfection.
RUBELLA
2 fxg (60 000 cpm) and 0-2 fxg (6000 cpm) iodinated
rubella RNA were used in hybridisation with DNA
and RNA from 10 synovial sources as listed in
Table 3. No sample was considered to show hybrid¬
isation. DNA and RNA were extracted from
BHK-21 cells lytically infected with rubella and
from LLC-MK2 cells chronically infected with
rubella to act as controls for the system. These
results are shown in Table 4. It may be seen that
there are higher counts associated with RNA from
both the chronically infected and lytically infected
cells as compared to the RNA form the uninfected
cells, while the DNA does not show this. This is
perhaps surprising as rubella is a positive strand
RNA virus, and one would imagine only small
quantities of the negative strand being present in the
infected cells at any one time. Also from this there
is no evidence for a DNA intermediate in the
replication, even in a chronic infection, as has been
postulated recently by Sato et al. (1977) Work is
continuing on this chronically infected cell line and
will be published shortly (Norval, 1978, to be pub¬
lished).
In-situ hybridisation was also carried out with
Table 2 Hybridisation of measles lisI-RNA with cellular nucleic acid
Nucleic acid Specimen Diagnosis cpm per filter
0-45 \ig ™I-RNA 0-045 ixg mi-RNA
None 1906 303
DNA Calf thymus 2570 373
DNA Synovial membrane A Rheumatoid arthritis 1683 258
DNA Synovial membrane B Rheumatoid arthritis 1610 234
DNA Synovial membrane C Rheumatoid arthritis 1467 280
DNA Synovial membrane D Juvenile rheumatoid arthritis — 257
DNA Synovial membrane E Osteoarthrosis 1960 —
DNA Synovial fluid F Rheumatoid arthritis 2065 272
A dash means not done.
Table 3 Hybridisation of rubella virus 12iI-RNA with cellular nucleic acid
Nucleic acid Specimen Diagnosis cpm per filter
2 \xg 12SI-RNA 0-2 ng l25I-RNA
None 3035 315
DNA Calf thymus 4644 438
DNA Synovial membrane A Rheumatoid arthritis 2428 283
DNA Synovial membrane B Rheumatoid arthritis 2086 261
DNA Synovial membrane C Rheumatoid arthritis 3192 360
DNA Synovial membrane E Osteoarthrosis 3225 291
DNA Synovial fluid F Rheumatoid arthritis 3530 350
RNA Synovial membrane G Rheumatoid arthritis __ 386
RNA Synovial fluid H Reiter's disease _ 404
RNA Synovial fluid I Polyarthritis after rubella — 216
RNA Synovial fibroblast strain J
derived from synovial membrane Osteoarthrosis 3626
RNA Synovial fibroblast strain K
derived from synovial membrane Rheumatoid arthritis 2979 —
A dash means not done.
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Table 4 Hybridisation of rubella 12iI-RNA with
cellular nucleic acid
cpm per filter
2\xg 0-4 \xg 0-2 \ig
™I-RNA 12SI-RNA ™I-RNA
No nucleic acid 2168 476 347
DNA from BHK cells 2425 462 265
DNA from BHK cells lyrically
infected with rubella virus 2005 495 283
RNA from BHK cells 2709 630 394
RNA from BHK cells lyrically
infected with rubella virus 4242 1065 467
DNA from LLC-mk2 cells 1586 456 281
DNA from LLC-MK2 cells
chronically infected with
rubella virus 1313 410 371
RNA from LLC-MK2 cells 2075 474 347
RNA from LLC-MK2 cells
chronically infected with
rubella virus 2961 797 538
synovial membrane sections from the same patients
as in the measles experiments above, except that
these were fixed and pretreated in 2 ways, firstly,
to degrade RNA and denature DNA, and, secondly,
to leave the RNA intact. They were developed after
4 and 8 weeks and showed no more grains over the
cells than the control slides. In a similar manner
LLC-MK2 cells and LLC-MK, cells chronically
infected with rubella were grown on glass slides and
fixed by the 2 methods. The ones treated with
RNase and denatured did not contain more grains
after an 8-week exposure than the control slides.
The results for the set fixed in glutaraldehyde are
shown in Table 5.
It may be seen that there are more grains per cell
in the LLC-MK, cells chronically infected with
rubella virus and hybridised with 125I-rubelIa RNA
than in the uninfected cells. Thus it may be assumed
that the synovial cells contain either no rubella
nucleic acid or less than is synthesised in the chron¬
ically infected system used here as a control for the
method.
rd-114
As with the other viral nucleic acids, 1 - 5 jxg (40 000
cpm) iodinated RD-114 RNA was used in filter
Table 5 Hybridisation of rubella uiI-RNA in situ
Average number of
grains per cell (20 cells
counted)
LLC-MK2 cells hybridised with
SSC buffer 9
LLC-MK2 cells hybridised with
125/-rubella virus RNA 8
LLC-MK2 cells chronically infected
with rubella virus and hybridised
with SSC buffer 14
LLC-MK2 cells chronically infected
with rubella virus and hybridised
with 125I-rubella virus RNA 46
hybridisation with DNA from various synovial
sources. The results are shown in Table 6, and each
count represents an average of 3 determinations.
In addition DNA extracted from RD cells and RD
infected with RD-114 were used, and the results
given in Table 6. None of the filters containing
nucleic acid from synovial cells was thought to
show hybridisation to the viral probe, but the counts
on the RD-114 DNA filter were about twice that
of the RD filter, demonstrating that the RD cells
infected with RD-114 contained viral sequence(s)
in the DNA.
Discussion
Molecular hybridisation has been widely used as a
tool in recent years to probe for viral nucleic acid
sequences in human tissues, especially in various
malignancies such as lymphomas (Hehlmann et al.,
1972) and leukaemias (Larsen, et al., 1975). These
experiments are difficult to do satisfactorily, being
dependent, among other things, on obtaining nucleic
acid preparations that are pure enough plus good
control material, and on labelling the viral nucleic
acid sufficiently. Despite these inherent difficulties it
seemed worthwhile in view of the negative results
from virus isolations and in screening for viral
antigens on synovial cells to look for viral nucleic
acid sequences in rheumatoid material.
The method used here was a simple one which
consisted of immobilising the denatured cellular
Table 6 Hybridisation of RD-114 125I-RNA to cellular DNA
Nucleic acid Specimen Diagnosis cpm per filter
None 492
DNA Synovial membrane B Rheumatoid arthritis 349
DNA Synovial membrane C Rheumatoid arthritis 346
DNA Synovial membrane L Rheumatoid arthritis 493
DNA Synovial fluid F Rheumatoid arthritis 478
DNA Synovial fluid M Rheumatoid arthritis 348
DNA Synovial fluid N Inflammatory polyarthritis 489
DNA RD cells 473
DNA RD cells infected with RD-114 835
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DNA on nitrocellulose filter discs and then hybrid¬
ising in solution with iodinated viral nucleic acids
from 4 viruses—SV-40, measles, rubella, and
RD-114. Owing to the relative scarcity of clinical
material, especially of non-RA control material, the
kinetics of hybridisation were not measured. A
comparison was made between the counts on filters
containing nucleic acid from RA patients with those
from non-RA patients at one time. In addition,
the technique of iodination should give ideally a
specific activity of around 107 cpm/ug nucleic acid
but, here, only about 105 was achieved, and this will
obviously lead to a distinct loss in sensitivity.
However, the control systems used, which were
synovial fibroblasts transformed with SV^tO, LLC-
MK2 cells chronically infected with rubella virus
V and RD cells infected with RD-114 virus, were all
positive by the methods used. Various alternative
methods of labelling the viral nucleic acid were tried.
These included adding 3H-uridine during measles
infection of Vero cells, but the specific activity of the
extracted nucleic acid was not as high as with
iodination. Further, a 3H-cDNA was made to
RD-114 by the method of Rothenberg and Baltimore
(1976), but again the extracted and purified cDNA
was not labelled sufficiently. It would have been
preferable to use cDNA, as it will hybridise to viral
mRNA in cells containing the viral genome, and in
most cases this will amplify the viral information
within the cells and allow easier detection by
hybridisation.
Thus, despite these reservations about the hybrid¬
isation assay, it proved sufficiently sensitive to
detect viral sequences in the control cells. The
negative results obtained with the rheumatoid cells
are valid at this level of sensitivity, that is, they
would have to contain at least the same number of
genome equivalents as in the positive control
systems. If, on the other hand, only a few cells from
the population of synovial cells contain viral
information, such as a certain class of lymphocytes
perhaps, then this would probably not be detectable
in the assay system used. Nucleic acids were extracted
from synovial membranes, which consist of a
mixed population of cells, mostly synovial cells lining
with some lymphocytes, polymorphs, monocytes,
and macrophages, and from synovial fluids, which
again consist of a mixture of cells, largely polymorphs
with some lymphocytes, monocytes, macrophages,
and a few lining cells. As these specimens came
directly from the patient without prior culturing, it
was hoped that the total mass would contain the
relevant population of cells. All the nucleic acids
extracted from these different sources, however,
showed no homology with the viral probes prepared
from SV-40, measles, rubella, and RD-114.
Another method tried for measles and rubella
probes, in addition to filter hybridisation, was in-
situ hybridisation, but, again, no homology was
found with the nucleic acids in synovial membrane
sections from RA patients and patients with other
conditions. This technique has been used successfully
to detect viral nucleic acids in several systems, such
as viral mRNA in adeno infected and transformed
cells (Moar and Jones, 1975). One clinical situation
of interest in this context is that of detecting viral
DNA in sheep with visna (Haase et al., 1977).
Sections of choroid plexus were taken, and, while
only 0-025 % cells showed the presence of membrane
p30 antigen by immunofluorescence, 18% contained
viral DNA by in-situ hybridisation using 3H-cDNA
of visna virus as probe. It was calculated from the
number of grains over the nucleus that there were
100-200 copies of the viral genome per cell, which
is a high level of gene reiteration and very helpful,
obviously, in detection.
The 4 viruses used here as probes were selected for
various reasons. SV-40 can be a transforming virus,
and other closely related members of the same
genus, Polyomavirus, have been described in human
beings, especially when immunosuppressed. RD-114
is an endogenous cat retrovirus which has a very
close relationship to the baboon endogenous virus,
and it was hoped that it would also show some
homology with a putative human retrovirus. In
systemic lupus erythematosus (SLE) an antigen
cross-reacting to a retrovirus, SP104, has been
described on blood lymphocytes of human and
canine cases (Schwartz, 1975). SP104 was first
produced by mouse tumour cells in culture after
the tumour was induced by a cell free filtrate of
canine SLE spleen. However, very recently Quimby
et al. (1978) have reported that there is no homology
using techniques of competitive hybridisation bet¬
ween the cDNA of this virus and RNA from ceils
of dogs and human beings with SLE. Measles was
chosen because of its association with subacute
sclerosing panencephalitis in man, a slow chronic
progressive condition (Hall and ter Meulen, 1976),
and also structures like paramyxovirus nucleo-
capsids have been described in synovial lympho-
reticular cells in rheumatoid arthritis (Neumark and
Farkas, 1973). Finally rubella was selected for the
reasons outlined in Hart and Marmion (1977) and
McCormick et al. (1978).
We are continuing this study by using adeno-2
DNA as a probe and looking at in-situ hybridisation
to RNA in sections of synovial membranes and
synovial fibroblasts grown on slides. Also the kinetics
of hybridisation to RNA extracted from rheumatoid
membranes and from rheumatoid and non-rheum¬
atoid synovial fibroblasts are being examined.
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SUMMARY
LLC-MK2 cells chronically infected with two strains of rubella virus, HPV-77
and Thomas, have been examined over several months to find out the mechanism
of persistence. Evidence is given for the presence of defective particles in these
cultures by finding virion RNA which sedimented at 12S instead of the 40S
typical of the fully infectious virus. A 'provirus' DNA copy of the rubella virus
genome was not detected by methods which included filter hybridization and
in situ hybridization, or by treatment of the chronically infected cells with mito¬
mycin C, actinomycin D or 5-bromodeoxyuridine. In addition, the chronically
infected cells contained RNA-dependent RNA polymerase activity, but no RNA-
dependent DNA polymerase activity.
INTRODUCTION
Many animal viruses seem to persist in natural infections and in various cell cultures
in vitro and the mechanism by which this occurs has been the subject of some research
in the past few years, having obvious implications in 'inapparent' infections, slow virus
diseases and latency. Not much is known about how the genome of RNA animal viruses
persist, apart from retroviruses, but several cell cultures have been established which are
chronically infected with various RNA viruses and these should give some insight into
the mechanism.
Evidence has been gathered, on the one hand, to indicate that a proviral DNA form
may be important. The work of Furman & Hallum (1973) and Preble & Youngner (1973)
on mouse L cells persistently infected with a temperature sensitive (tt) mutant to Newcastle
disease virus and that of Simpson & Iinuma (1975) on bovine embryonic kidney cells
persistently infected with a ts mutant of respiratory syncytial virus, may be cited as
examples. Zhdanov (1975) described similar results in three systems of chronic infection
in which low titres of infectious virus were being produced. Finally Sato et al. (1976)
have established a cell line, BHK 2I/WI-2, persistently infected with rubella virus which
releases a latent virus and a ts variant of rubella virus with reverse transcriptase activity.
They subsequently provided evidence, from treatment of the cultures with various chemicals,
that rubella virus may persist in a proviral form within these cells (Sato et al. 1977).
On the other hand, there is also evidence to suggest that proviral DNA may not be a
necessary stage in persistent infection with RNA viruses. Thus Holland et al. (1976) found
that BHK-21 cells persistently infected with vesicular stomatitis virus (VSV) and shedding
low levels of infectious virus over 2 years did not contain proviral DNA by hybridization
or by transfection. Similar results were described for other persistent infections with various
negative-strand RNA viruses like measles, mumps, influenza, LCM and rabies. Defective
interfering particles were found to be a major factor in establishment and maintenance of
0022-1317/79/0000-3416 $02.00 © 1979 SGM
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the chronically-infected state and temperature sensitivity of the shed virus was also
important.
A line of LLC-MK, cells has been described which can be persistently infected with
rubella virus and which grew for at least 50 subcultures with no loss of ability to liberate
infectious virus (Maassab et al. 1964). A similar line was established in our laboratory
several months ago (Hart & Marmion, 1977) and has been studied subsequently to try to
find out how the virus persists in this situation.
METHODS
The conditions used to initiate and maintain a persistent infection of LLC-MK, cells
(American Cell Culture Type Collection) with HPV-77 rubella virus, vaccine strain and
an isolate Thomas have been described previously (Hart & Marmion, 1977). The presence
of rubella virus was confirmed by indirect immunofluorescence (Lennette et al. 1967) and
by labelling with 3H-uridine as outlined below. Preparation of antisera to HPV-77 and
indirect immunofluorescence techniques have also been described by Hart & Marmion
(1977)-
In addition, for lytic infections, BHK-21 or Vero cells were used. They were grown in
Earle's based Eagle's medium containing penicillin and streptomycin plus 2 or 5 % foetal
calf serum.
Curing of cells was performed as outlined by Holland et al. (1976) and growth in semi¬
solid agar as described by Macpherson & Montagnier (1964).
Purification of rubella virus and characterization of virus RNA. Rubella virus from Vero
cells infected 4 days previously and from chronically infected LLC-MK2 cells, was labelled
with 3H-uridine (2-5/rCi/mI, Radiochemical Centre, Amersham) for 24 h. The culture
supernatant was clarified at 10000g for 10 min and then either precipitated with an equal
vol. of cold saturated fNH4),S04 or centrifuged at 30000 rev/min for 1 h in an SW40 rotor.
The deposit was suspended in a small vol. of buffer, o-oi M-tris-HCI, 1 mM-EDTA, pH 7-1
(Grayzel, 1973). It was layered on to sucrose density gradients (20 to 70 %) and centrifuged
at 25000 rev/min for 18 h in an SW40 rotor. Fractions were collected from the base of the
tube, precipitated with cold io%TCA and counted after filtration through glass fibre
discs (Norval & Marmion, 1976). Under these conditions rubella virus has a density of
1-19 g/ml.
To characterize rubella virus RNA, the band of density 1 • 18 to 1 -20 g/ml was taken
frcm the sucrose density gradients and the virus pelleted. RNA was extracted and charac¬
terized by the methods outlined in Hovi & Vaheri (1970).
Treatment with chemicals. The chronically infected cells were cultured in medium con¬
taining the following substances, and then labelled with 3H-uridine for 24 h and separated
on sucrose density gradients as described above to establish the quantity of rubella virus
being released: (1) BrdUrd (Sigma), 20/tg/ml for 3 days; (2) actinomycin D (Boehringer),
o-i /rg/ml for 24 h or 5/ig/ml for 3 h followed by incubation for 1 or 3 days in medium
without actinomycin D; (3) mitomycin C (Sigma), 0-5 /ig/ml for 7 h, followed by incubation
for 3 days in medium without mitomycin C; (4) poly(I). poly(C) (Biochemicals Inc.),
10 Ag/ml for 1 h.
Extraction of cellular RNA and DNA. DNA and RNA were extracted from BHK cells,
3 days after infection with rubella virus, from uninfected BHK cells, from chronically
infected LLC-MK2 cells and from uninfected LLC-MK, cells using the method of Simpson
& Iinuma (1975). The precipitated nucleic acids after chloroform/isoamyl alcohol extraction
were treated with RNase (50/ig/ml, pre-treated at 80 °C for 10 min, Sigma) for DNA
preparations, or with DNase (20/ig/ml, Sigma) for RNA preparations. The final pre-
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cipitation was with ethanol and the nucleic acid was dissolved in SSC buffer (0-15 M-NaCl,
0-015 M-sodium citrate). The ratio of absorbance at 260 to 280 nm was at least 1-85, and
generally around io8 cells were used for extraction. The nucleic acid was stored at —70 °C
until use.
Preparation of virus nucleic acid and iodination. Rubella virus was grown in Vero cells in
roller bottles. It was purified by banding on sucrose density gradients as described above.
RNA was extracted from the concentrated virus preparation. The vol. was made up to
10 ml in TNES buffer (o-l M-tris, pH 9-0, o-i M-NaCl, 1 mM-EDTA and o-i % SDS) and
extracted three times with TNE (o-i M-tris, pH 9-0, o-i M-NaCl, 1 mM-EDTA)-saturated
phenol containing 10 % chloroform. The virus nucleic acid was precipitated with ethanol
and the final precipitate dissolved in 0-3 ml sterile SSC.
Rubella RNA (200 pg) was iodinated using a modification of the method of Commerford
(1971). A mixture was made of 0-3 ml 0-5 M-sodium acetate buffer, pH 5-0; 0-3 ml SSC
containing the rubella RNA; 0-3 ml thallic chloride, 2-5 mM in o-i M-acetate buffer, pH 5-0;
and 0-3 ml potassium iodide, 0-125 mM> which had previously been added to 600 pC\ 125I.
It was incubated for 1 h at 60 °C and the iodinated RNA separated on Sephadex G 50.
The nucleic acid was dialysed exhaustively against SSC buffer and stored at —70 °C. The
sp. act. obtained was 3 x io4 ct/min//ig nucleic acid.
Filter hybridization. Essentially the method of Gillespie & Spiegelman (1965) was used
where the cellular nucleic acid was immobilized on Millipore nitrocellulose filter discs.
The filters each contained 20 pg nucleic acid. Hybridization was carried out in small
sealed vials containing iodinated rubella RNA, 20 p\ 5 % SDS, 4 pg cold carrier calf
thymus DNA and 3 x SSC to make the final vol. 1 ml. The vials contained up to five
filters with nucleic acid plus two blanks. Incubation was carried out at 62 °C for 22 h. The
filters were washed in 3 x SSC with several changes of buffer, digested with Sx nuclease
(Biochemicals Inc.) to remove unhybridized nucleic acid and re-washed. They were counted
in a Wallac-LKB gamma counter.
In situ hybridization. The method of Pardue & Gall (1975) was followed in outline.
Chronically infected LLC-MK, cells and uninfected cells were grown on glass slides until
semi-confluent. Two methods of fixation were used. (a) o-i % glutaraldehyde at 4 °C for
30 min, followed by dehydration in 50, 70, 90 and 100 % ethanol. (b) Acetic acid:ethanol,
1:3, for 2 min, followed by dehydration in 95% ethanol. These slides were treated with
200 p\ pancreatic RNase (100 pg/m\, in 2 x SSC, Sigma) for 1 h at 37 °C, washed in 2 x SSC,
then dehydrated again. They were denatured in 0-07 M-NaOH for 2 to 3 min, then
dehydrated.
With all slides, 10 p\ hybridization mix was added which consisted of 100 p\ 42 % forma-
mide, 20 p\ 10 x acetate buffer (3 M-NaCl, o-i M-Na acetate, pH 5-0) and 80 p\ rubella
125I-RNA or SSC (control). Hybridization was carried out at 46 °C for 22 h under cover-
slips sealed with cowgum. The slides were washed in acetate buffer, treated with Si nuclease
for 1 h at 37 °C, re-washed, dehydrated in ethanol and covered with Ilford K.2 emulsion.
They were developed using Kodak D 19 after periods of 4 to 8 weeks.
Polymerase assays
RNA-dependent RNA polymerase. Vero cells lytically infected with rubella virus 5 days
previously, chronically infected LLC-MK, cells and uninfected cells were harvested with
glass beads, washed in cold o-i M-tris buffer, pH 8-0, and lysed with Nonidet P-40, added
at a final concentration of o-i %. The nuclei were removed by spinning at 2000 g for 15 min
at 4 °C and the supernatant assayed for RNA-dependent RNA polymerase activity using
a modification of the method of Scholtissek & Rott (1969). Assay mixtures contained
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I /tmol each of ATP, GTP and CTP, 3-6 //mol MgCL, 4"5/<mol dithiothreitol, 30 /<moI
tris buffer, pH 8-o, and 2-5/iCi 3H-UTP (10 to 30 Ci/mol, Radiochemical Centre, Amer-
sham) and cell Iysate in a total vol. of 200 /tl. Incubation was carried out at 37 °C and
samples of 40//I were spotted on filter paper discs at intervals of 15 min. Filters were
fixed in cold 10 % trichloroacetic acid (TCA), washed five times in cold 10 % TCA before
being air-dried and counted in PPO-toluene scintillator in a Packard Tri-Carb liquid
scintillation counter. Protein content was estimated by the method of Lowry et al. (1951).
RNA-dependent DNA polymerase. Culture supernatants from Vero cells, lytically
infected with rubella virus 5 days previously, and chronically infected LLC-MK2 cells
were precipitated by polyethylene glycol (Bronson et al. 1975). They were assayed for
RNA-dependent DNA polymerase (reverse transcriptase) activity using the method of Lieber
et al. (1973), whereby the incorporation of 3H-methyl TTP (25 Ci//<mol, Radiochemical
Centre, Amersham) into acid-insoluble material was measured in the presence of the
artificial template/primer polyadenylic acid decathymidylic acid (poly(dA).poly(dT)10,
Boehringer Corp.). Protein content was estimated by the method of Lowry et al. (1951).
RESULTS
Persistent infection ofLLC-MK2 cells
Persistent infection of LLC-MK2 cells with either HPV-77 or Thomas strains of rubella
virus could be achieved quite easily by infecting the cells and leaving them for a period
of 3 weeks before subculturing. Only a few cells survived at this stage but they gradually
grew until they formed patchy cell sheets. The cells divided more slowly than the uninfected
cells thereafter and were irregular in shape and size. They consistently liberated small
amounts of virus over at least 40 subcultures and a period of 2 years. The presence of
rubella was detected in two ways, either by labelling with 3H-uridine or by indirect immuno¬
fluorescence.
A typical result from labelling a chronically infected LLC-MK, culture is shown in
Fig. 1 and a very similar picture was obtained from labelling Vero cells 4 days after infection
with rubella virus. McCombs & Rawls (1968) found that the density of rubella was 1-19 g/ml
and it may be seen that there was a peak of incorporation into acid-insoluble material at
this density with a spread on either side. The amount varied with the number of days
after trypsinization, most being liberated within 2 days of subculturing or after recovery
from storage in liquid nitrogen, but the quantity did not decrease much with passage over
the 2 year period.
A description of the immunofluorescent results has already been given by Hart &
Marmion (1977). Briefly, acetone-fixed cells chronically infected with rubella showed a
granular cytoplasmic staining which was apparent at early subcultures in about 80 % of
the cells. This percentage declined with passage to about 5 % at the 36th subculture, in
the case of cells chronically infected with HPV strain, and to about 50% at the 15th
subculture of cells chronically infected with Thomas strain. There was only weak, or no,
membrane staining when using unfixed chronically infected cells, while BHK cells lytically
infected with rubella showed both cytoplasmic and membrane staining.
Virus RNA
Culture supernatants from Vero cells infected 3 days previously with rubella virus and
from chronically infected LLC-MK2 cells (r20 and 240 ml respectively) were harvested
after labelling with 3H-uridine. The virus was purified on sucrose density gradients and
pelleted. It was Iysed in a buffer containing SDS and the virus RNA characterized on a
*5 t0 3° % sucrose density gradient as outlined by Hovi & Vaheri (1970). The result may
be seen in Fig. 2. An 18S marker of mouse ribosomal RNA, kindly supplied by Dr Keith
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Fraction number
Fig. I. Acid-insoluble ct/min in sucrose density gradient fractions from culture supernatants of
LLC-MK, cells persistently infected with rubella virus HPV-77 strain and labelled with 3H-uridine.
James, was run at the same time. The sedimentation coefficients were calculated using
the tables of McEwan (1967). RNA from rubella produced by lytically infected Vero cells
was of two sizes, 40S and around 12S, in the ratio of about 2:1. The RNA from rubella
produced by chronically infected LLC-MK, cells, was also of two sizes 40S and around
12S, with the ratio this time being about 114.
Growth at different temperatures and cloning
The results of Preble & Youngner (1973), Simpson & Iinuma (1975) and Sato et al.
(1976) indicate that ts variants of NDV, RSV and rubella virus are important in persistent
infections. Thus when LLC-MK, cells chronically infected with Thomas strain were
cultured at 43, 40 and 31-5 °C they did not survive at 43 °C. At 40 °C the cells became
rather rounded and did not remain attached to the glass surface after a period of 3 days.
Cells were also cultured at 31-5 °C for 3 weeks during which they had a normal appearance
although they grew much more slowly and were more spaced out than at 37 °C. They were
subcultured on to coverslips which were subsequently examined by indirect immuno¬
fluorescence. The percentage which contained rubella antigen was not noticeably different
from cells maintained under the same conditions at 37 °C.
Holland et al. (1976) have observed curing of BHK-21 cells persistently infected with
VSV by cloning or by prolonged antibody treatment of a lightly seeded monolayer. The
former was tried using 60 mm Petri dishes seeded with 250, 500 and 1000 LLC-MK2 cells
chronically infected with either HPV-77 or Thomas strains which were then left for 6 weeks
at 37 °C with weekly changes of medium. At the highest cell concentration, three clones
grew on different plates which were examined by indirect immunofluorescence after sub-
culturing to coverslips. In all cases the cells showed the same staining pattern as the
chronically infected LLC-MK, cells with no difference in the percentage of cells infected
'is compared to that observed before cloning. In addition, an attempt was made to clone
me cells in semi-solid agar where io3, io4 or io5 LLC-MK, cells chronically infected
with HPV-77 at subculture 2 and 43 were placed in Petri dishes. These were observed over
a 6 week incubation period but no colonies were seen in any plate.. Occasionally clumps




Fig. 2. Acid-insoluble ct/min in sucrose density gradient fractions of rubella virus RNA purified
from culture supernatants of LLC-MK, cells chronically infected with rubella virus (• •)
and Vero cells lyrically infected with rubella virus (# •) and labelled with 3H-uridine.
Effect of various chemicals
Following the methods of Sato et al. (1976), LLC-MK, cells persistently infected with
HPV-77 or Thomas strains were treated with actinomycin D (5 /tg/ml) for 3 h. The cultures
were immediately labelled with 3H-uridine or were left for 1 or 3 days before labelling.
It was found that this level of actinomycin D was quite toxic causing the death of almost
all cells in 3 days. Labelling immediately after actinomycin D treatment indicated no
decrease in the acid-insoluble counts at density 1-19 but the viability of the cells decreased
by 50 % over this period, thus making it difficult to quantify this experiment. Actinomycin
D added at a concentration of o-i fig/ml (Woods & Robbins, 1968) followed by labelling
with 3H-uridine had no effect on the release of rubella virus.
Treatment with BrdUrd enhanced rubella virus production by twofold as measured
by the quantity of acid-insoluble counts at density 1-19, while mitomycin C seemed to
have little or no effect. These results are shown in Fig. 3. Poly(I). poly(C) treatment of the
infected cells, which should induce interferon production, reduced the quantity of labelling
at density 1-19 by 50 %.
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Fig. 3. Acid-insoluble ct/min in sucrose density gradient fractions from culture supernatants of
LLC-MK2 cells persistently infected with rubella virus HPV-77 strain and labelled with 3H-uridine:
(a) control, (b) treated with mitomycin C, or (c) treated with BrdUrd.
Table 1. Polymerase activities in rubella infected cells
RNA-dependent RNA-dependent
RNA polymerase DNA polymerase
activity* of cell activityf of culture
Cells lysates supematants
Lytically infected Vero 10-7 0
Uninfected Vero 0 0
Chronically infected LLC-MK2 8-0 0
Uninfected LL(S-MK2 0 0
* Activity measured as increase in incorporation (ct/min) of 3H-UTP into acid-insoluble material in
1 h per /ig protein.
t Activity measured as increase in incorporation (ct/min) of 3H-TTP into acid-insoluble material in I h
per /ig protein.
Polymerase activity
RNA-dependent RNA polymerase is present in negative-strand RNA viruses and is
synthesized in infected cells by positive-strand RNA viruses, while RNA-dependent DNA
polymerase is associated with retroviruses and their replication. To obtain some information
about the transcription of rubella virus RNA in the chronic and lytic states, infected cells
were lysed and assayed for RNA-dependent RNA polymerase and the culture supernatants,
after concentration, were assayed for RNA-dependent DNA polymerase. As controls the
uninfected LLC-MK2 and Vero cultures were used. The results are shown in Table 1.
There was no RNA-dependent DNA polymerase activity demonstrable in any sample,
while both the chronically infected LLC-MK, cells and the lytically infected Vero cells
showed RNA-dependent RNA polymerase activity.
Hybridization
Holland et al. (1976) have studied BHK cells persistently infected with VSV and, by
b bridization in solution of a 3H-cDNA of VSV RNA to cellular DNA, were unable to
detect virus DNA. The sensitivity was calculated to be at the level of 1 virus genome per
40 cells or i/40th virus genome per cell.
In the present work RNA and DNA were extracted from BHK-21 cells lytically infected
with rubella virus, from LLC-MK, cells chronically infected with rubella virus and from
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Table 2. Hybridization of rubella virus 12bI-RNA with cellular nucleic acid
I25I (ct/min/filter; average
of 2 determinations)
Nucleic acid 2/ig 0-4 PS 0*2 /ig
None 2168 476 347
DNA from BHK cells 2425 462 265
DNA from BHK cells lytically infected 2005 495 283
with rubella virus
RNA from BHK cells 2709 630 394
RNA from BHK cells lytically infected 4242 1065 467
with rubella virus
DNA from LLC-MK, cells 1586 456 281
DNA from LLC-MK, chronically 1313 410 371
infected with rubella virus
RNA from LLC-MK, cells 2075 474 347
RNA from LLC-MK2 chronically 2961 797 538
infected with rubella virus
Table 3. Results of in situ hybridization of rubella virus 125I-RNA to LLC-MK„ cells
chronically infected with rubella virus after an 8 week exposure
Average number of grains per cell
(20 cells counted)
LLC-MK, cells












their uninfected control cells. Two pg (60000 ct/min), 0-4 pg (12000 ct/min) and 0-2 pg
(6000 ct/min) iodinated rubella virus RNA were used in hybridization with filters to
which had been attached 20 pg cellular DNA or RNA. The results may be seen in Table 2.
Each count represents an average of two determinations which were found to be very
consistent. It may be seen that there are higher counts associated with RNA from both
the chronically and lytically infected cells as compared to the RNA from the uninfected
cells, while the DNA does not show this.
In situ hybridization was also carried out using LLC-MK2 cells chronically infected
with rubella virus and uninfected cells grown on glass slides and fixed in two ways, firstly
to degrade RNA and denature DNA and secondly to leave the RNA intact. The slides
were developed after 4 and 8 weeks. The first set where the RNA was degraded showed
the same number of grains over the uninfected cells as the cells chronically infected with
rubella. However, the result from the second set is shown in Table 3. There seemed to be
a small amount of hybridization of rubella virus 125I-RNA to the chronically infected
LLC-MK2 cells.
DISCUSSION
As already indicated in this paper, there have been various reports in the literature in
the last few years outlining mechanisms whereby RNA viruses may persist and cause
chronic infections in cell culture. Some systems investigated indicate that a DNA proviral
form may exist like that described in the replication of retroviruses, while others do not
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'indicate such an intermediate and suggest that defective interfering particles may be
important. Of particular interest in the present context is the work of Sato's group (Sato
'let al. 1976, 1977) on a persistent infection of BHK-21/WI-2 cells by rubella virus. Variants
of the wild type virus were produced which were thought to be hybrids between rubella
and the latent virus of BHK-21/WI-2 cells. They were temperature sensitive at 39-5 °C,
possessed reverse transcriptase activity and could be induced by BrdUrd or mitomycin C,
being blocked by actinomycin D. It was concluded that a DNA intermediate was involved
in the replication of rubella virus in the persistently infected cells.
A similar investigation has been carried out here using LLC-MK2 cells chronically
infected with rubella virus and the evidence gathered does not implicate a DNA intermediate
in this system. BrdUrd and mitomycin C had little or no effect on the quantity of virus
released while actinomycin D affected the viability of the cells so badly that it could not
be used at the concentration outlined by Sato et al. (1977). When actinomycin D was
added at a much lower concentration, as used by Woods & Robbins (1968), there was no
effect on the amount of virus released. These results do not support the involvement of a
DNA intermediate in this chronic infection. Infectivity titres were not measured, the
quantity of virus released being assayed by incorporation of 3H-uridine into particles of
density 1-19.
RNA polymerase assays of the infected cells showed RNA-dependent RNA polymerase
activity in both the lytic and chronic infections. Virus purified from both types of infection
did not show any RNA-dependent DNA polymerase activity. In addition, the results from
hybridization did not indicate that a DNA form was involved in the chronic infection,
although the specific activity of the probe, 125I-rubella RNA, was not as high as desirable,
hence reducing the sensitivity of the assay.
Attempts to cure the chronically infected cells by cloning, as have been described by
Holland et al. (1976) for the VSV system, failed. However, results from characterizing the
extracted virus RNA on sucrose density gradients were of interest as two peaks were
found, one of 40S, which is the sedimentation coefficient described by Hovi & Vaheri
(1970) for rubella virus RNA, and one much smaller, around 12S, which is presumably
not infectious. This is present in a much larger proportion in the virus population released
from the chronically infected cells, so that defective particles without the full complement
of virus RNA may be present in considerable numbers in this situation.
It is not really possible to say whether a ts mutant is involved as virus release was not
assayed by infectivity or plaquing at any stage but certainly the pattern of immuno¬
fluorescence observed in chronically infected cells did not change markedly between
31-5 and 37 °C and the infection did not become lytic.
The results would indicate no DNA intermediate but probably the presence of defective
interfering particles as a major factor in the maintenance of chronic infection by rubella
virus in LLC-MK, cells.
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Viruses and lymphocytes in rheumatoid arthritis.
I. Studies on cultured rheumatoid lymphocytes
MARY NORVAL, HELENA HART, AND B. P. MARMION
From the Department ofBacteriology, University ofEdinburgh Medical School, Edinburgh
summary Synovial fluid lymphocytes from patients with rheumatoid arthritis have been examined
for evidence of a productive infection with retroviruses by electron microscopy, labelling with
3H-uridine, growth in soft agar, and culturing in conditioned medium. No such viruses were detected.
In addition, the synovial lymphocytes were activated before fusion and cocultivation with several cell
lines which have proved permissive for primate retroviruses. Monitoring these cultures subsequently
by reverse transcriptase assay, labelling with 3H-uridine, and membrane immunofluorescence gave
no indication that retroviruses were present.
A possible viral aetiology for rheumatoid arthritis
(RA) has been much canvassed and investigated
during the last 10 years but with negative results so
far. Much of the search has concentrated on the
fibroblast-like cells cultured from the RA synovial
membrane or synovial fluid effusions and thought
to be derived from type B or C lining cells (Smith
and Hamerman, 1969). However, there is little
evidence for viral genomes, productive viral in¬
fection, or neoantigens in such cells. For summaries
and reviews see Hamerman (1975), Marmion and
Mackay (1977), and Marmion (in press).
Less attention has been paid in RA to the possible
production of disease as a result of the interaction
of virus with cells of the immune and immuno-
regulatory system (Denman, 1975; Talal, 1977;
Marmion and Mackay, 1977; Marmion, in press).
Reports on the relative proportion and classes of
lymphocytes in rheumatoid synovial fluid and
peripheral blood vary. Several investigations record
an increase in T-cell numbers, a decrease in B-cell
numbers (Froland et al., 1973; Holborow et al.,
1975), and the presence of a population of null cells,
up to 32% (Winchester et al., 1974). Others have
found an increase in B-cells (Mellbye et al., 1972).
The lymphocytes in RA synovial membranes, as
distinct from the synovial fluid, are predominantly
T-cells (Loewi, 1975).
There may be a marked diminution in responsive¬
ness of synovial lymphocytes of RA patients to
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various mitogens, especially PHA (Stratton and
Peter, 1972; Panayi, 1973; Holborow et al., 1975)
but reports are not consistent. Also the reactivity of
peripheral blood lymphocytes in mixed lumphocyte
culture may be depressed (Astorga and Williams,
1969). It is possible that the cells may already be
activated or that the receptor sites for the antigen
may be blocked; such effects might be virally induced.
In view of these pointers to disordered lymphocyte
function in RA we decided to investigate RA
synovial and peripheral blood lymphocytes for
evidence of viral infection or of viral gene products.
We were particularly interested in the association of
retroviruses (type C or oncoviruses) with lympho¬
cytes. This interaction has been well studied in
various mice strains in which the immune response
to endogenous viruses is modified by genetic factors
involved with infectivity and expression (review,
Ihle and Hanna, 1977). In human beings there have
been extensive attempts to detect retroviruses,
especially in association with leukaemia or lym¬
phoma. Several isolations have been made, one of
which was from cultured myeloid leukaemia cells.
This virus was closely related to simian sarcoma
virus and baboon endogenous virus (Reitz et al.,
1976), and it can be established as a chronic in¬
fection in various cell lines (Teich et al., 1975).
A range of different cell-virus relationships exists
with retroviruses and extends from productive in¬
fection to an integrated 'silent' genome. In addition
some viruses are unable to replicate in cells of the
same species from which they have been derived
(xenotropic viruses). During the course of this study
we used methods described by other workers for
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successful culture of several xenotropic viruses.
These involved fusing or cocultivating the lympho¬
cytes with potentially permissive cells from another
species. For example, baboon endogenous viruses
have been isolated from normal baboon tissue by
cocultivation with various permissive cell lines from
rhesus monkey lung and dog thymus (Todaro et al.,
1974). In addition cultivation of integrated and
silent retroviruses may require an activating step
often involving turnover of cellular DNA or
modification of DNA synthesis. One method of
accomplishing this with lymphocytes is by a mixed
lymphocyte reaction as demonstrated in mice
(Hirsch et al., 1972; Sherr et al., 1974).
In the present investigation we first of all examined
the synovial lymphocytes for any evidence of a
productive infection with retroviruses by electron
microscopy, scanning electron microscopy, labelling
with 3H-uridine, and culturing in conditioned
medium, which has proved successful for sustained
growth of human myelogenous leukaemia cells
(Gallagher and Gallo, 1975). In addition methods
were used to activate the lymphocytes before fusion
and cocultivation with various cell lines which have
proved permissive for primate retroviruses. The
cells were subsequently examined for virus by
labelling with 3H-uridine, the culture supernatant
being assayed for reverse transcriptase activity, and
finally for the presence of virus-coded proteins in
the cell membranes by immunofluorescence. In the
accompanying paper the results of testing lympho¬
cytes for the presence of viral antigens on their
membranes, including retrovirus antigens by
immunofluorescence and radioimmunoassay, are
described (Hart et al., 1979).
Materials and methods
SEPARATION OF LYMPHOCYTES
Specimens of paired synovial fluid and peripheral
blood were obtained from patients attending the
Northern General Hospital and were used within 2
hours of removal. Early in this study they were
heparinised immediately (10 U/ml), but later the
synovial fluid was left untreated while the peripheral
blood was defibrinated with glass beads. Synovial
fluids were treated with 80 U/ml hyaluronidase at
37°C for 30 minutes. Both were then separated on
Triosil-Ficoll gradients (24 parts 9% Ficoll mixed
with 10 parts 34% Triosil; centrifugation at 2000
r.p.m. for 20 min.). The lymphocyte-rich fraction
was washed twice in Hanks's salt solution and
counted after staining by the trypan-blue exclusion
method or a special Boullard haematoxylin stain.
LYMPHOCYTE CULTURE
(a) The lymphocytes, generally at a concentration of
around 106/ml, were routinely cultured in Earles-
based Eagles complete medium (EE medium) con¬
taining 100 jLg/ml streptomycin and 100 IU/ml
penicillin supplemented with 20% autologous human
serum. They were incubated at 37°C in 5 % C02.
(b) 3H-uridine labelling. The lymphocytes (from
2 x 106 up to 107) at a concentration of 106/ml
were incubated overnight in EE medium containing
20 % fetal calf serum or autologous serum or homo¬
logous plasma, plus (5-3H) — uridine (20 uCi/ml)
Amersham). Culture supernatants were concentrated
using (NH4)2S04 (Grayzel, 1973), and were fraction¬
ated on sucrose gradients by the method outlined in
Norval and Marmion (1976). In addition some
lymphocytes were cultured for 4 days in the presence
of phytohaemagglutinin (50 q.g/ml) before the label
was added.
(c) Cocultivation with fetal skin fibroblasts.
Approximately equal numbers of lymphocytes were
added to monolayers of human fetal skin fibro¬
blasts cultured in EE medium plus 10% fetal calf
serum. The medium was changed weekly and the
cultures split fortnightly.
(.d) Use of conditioned medium. The lymphocytes
were cultured in conditioned medium from fetal
skin fibroblasts; i.e., EE medium plus 10% fetal
calf serum which had been in contact with the cells
for about 4 days and which had been spun to
deposit any cells.
(e) Colony formation in soft agar. 8 X 104/ml
lymphocytes were mixed with complete 199 medium
containing a final concentration of 0-3% agar and
20 % human serum. In addition the lymphocytes were
grown on prepared feeder layers. These comprised
dextran separated mononuclear blood cells (106/ml)
in complete 199 medium containing 0-5% agar and
20% human serum, and irradiated at 100 rad/min
for 10 min (Goldman et al., 1974; Prival et al., 1974).
ELECTRON MICROSCOPY
Packed lymphocytes were prepared for electron
microscopy after incubation overnight. The blocks
were sectioned on a LBK Ultratome 11 and the
sections viewed on a Hitachi HU11A electron
microscope.
SCANNING ELECTRON MICROSCOPY
Lymphocytes after separation on Triosil-Ficoll
gradients were washed in serum-free medium and
prepared for scanning electron microscopy using the
method of Alexander et al. (1976). The specimens
were examined in a Cambridge stereoscan 180
microscope at 30 kV and 45° tilt.
POLYMERASE ACTIVITY
The synovial lymphocytes were assayed as described
by Norval et al. (1975).
Viruses and lymphocytes in rheumatoid arthritis 509
FUSION AND CO-CULTIVATION
(a) Stimulation of lymphocytes. Separated synovial
fluid lymphocytes were stimulated in a mixed
lymphocyte reaction (MLR). The preparation of
lymphocyte pools, as stimulators of MLR, and the
test have been described in detail by Urbaniak et al.
(1978). Synovial fluid lymphocytes and stimulators
were mixed in a 1:3 ratio. 0 ■ 5 uCi(3H-methyl)
thymidine (Amersham) was added to a test sample
in a microtitre well after 3 days' incubation for 18
hours. Only those synovial fluid lymphocytes which
showed positive MLR were used in the subsequent
fusion. The remainder of the lymphocytes was stored
in liquid nitrogen during the MLR test and used
directly in the fusion.
(b) Polyethylene glycol (PEG) fusion and co-
cultivation. Method as described by Pontecorvo
(1975) with the modification that the PEG was
drained off the cell sheet immediately. One batch of
PEG (6000-7500 mol. wt., BDH), checked for
toxicity to cultured cells, was used throughout.
Three sets of lymphocytes were prepared: (i) 10®
synovial fluid lymphocytes containing 3 x 10®
stimulators, (ii) 10® synovial fluid lymphocytes,
(iii) 3 x 10® stimulators.
(c) Sets from 7 patients with RA were used, and
these were fused with 105 cells of the following cell
lines known to support the growth of simian
sarcoma virus and the baboon endogenous virus,
which had been kindly provided byDr N. Teich: A204
(human rhabdosarcoma), 7605L (human lung fibro¬
blast), CCL64 (mink lung fibroblast) for 2 cultures;
Tb-l-Lu (bat lung epithelial), CCL64 (mink lung
fibroblast), D17 (dog fibrosarcoma) for 5 cultures.
The medium used was EE plus 2, 5, or 10% fetal
calf serum and culture was continued for a period
of 8 weeks with the medium being changed twice
weekly and the cells being split every fortnight. In
one case the synovial fluid lymphocytes were pre-
treated for 24 hours with 40 ug/ml IUDR plus
10" 6M diethylstilbestrol or IUDR plus 10_6M
hydrocortisone before fusion. After fusion cul-
turing was continued in the presence of the appro¬
priate hormone (Wu et al., 1976). At various times
the cultures were examined for evidence of retro¬
virus induction by:
(i) Assaying the reverse transcriptase activity of
the culture supernatant at 3 and 7 weeks by the
method of Dr N. Teich (personal communication).
(ii) Labelling with 3H-uridine at 7 weeks followed
by concentration of the culture supernatant and
sucrose density gradient centrifugation as outlined
by Norval and Marmion (1976).
(iii) XC test at 5 weeks (for 2 cultures only) by the
method of Rowe et al. (1970).
(iv) Immunofluorescence at 7 weeks with various
antiretrovirus antisera. Goat antisera to RD-114
(Tween-ether disrupted) and SSAV (Tween-ether
disrupted) were originally obtained from Dr J.
Gruber (National Cancer Institute), and used at
1/10 dilution in PBS, supplemented with 2% fetal
calf serum (PBS-FCS). Rabbit antisera were later
prepared to RD-114 and SSAV antigens (Hart et al.,
1979) and used at a dilution of 1/20 in indirect
immunofluorescence tests on acetone-fixed cells
grown on cover-slips (Schmidt et al., 1966; Lennette
et al., 1967). Horse anti-human lymphocyte serum
was kindly donated by Dr K. James. This serum was
absorbed with acetone dried mink liver powder to
give a working dilution of 1/4. Sheep anti-rabbit
immunoglobulin and rabbit anti-horse immuno¬
globulin, both conjugated with fluorescein isothio-
cyanate (Wellcome Reagents), were used diluted to
1/8-1/16 in PBS-FCS. Rabbit anti-goat IgG FITC




Five preparations of paired synovial fluid and peri¬
pheral blood lymphocyte from rheumatoid arthritis
patients and 2 pairs from osteoarthrosis patients
were examined after ultrathin sectioning. The
lymphocytes from all sources looked normal, with
large indented nuclei, compact chromatin, and a
group of mitochondria opposite the indentation and
a few mitochondria and ribosomes in the remaining
cytoplasm. No membrane maturing or other viral-
like structures were found. It was impossible to
distinguish whether the lymphocytes were from the
synovial fluid or the peripheral blood. Other cells
seen included macrophages, monocytes, and a
large number of platelets, particularly in the synovial
fluids.
Four pairs of synovial fluid and peripheral blood
lymphocytes from RA patients, 1 from juvenile RA,
and 1 OA were examined by scanning electron
microscopy. No surface features were found which
distinguished cells from the 2 sources. Measurement
of size showed that the lymphocytes from peripheral
blood seemed to fall into 2 groups, which may
correspond to T and B cells, while only the smaller
size was present in the synovial fluid population.
According to Polliack et al. (1973) the B cells in the
blood are slightly larger than the T cells, so the
smaller group common to both blood and synovial
fluid may be T lymphocytes.
CULTURING OF LYMPHOCYTES
Initially synovial fluid lymphocytes and peripheral
blood lymphocytes from 10 patients with RA, 1
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with juvenile RA, and 5 non-RA were incubated
overnight in medium containing 20% fetal calf
serum or autologous serum or homologous plasma,
and 20 p.Ci/ml 3H-uridine in an attempt to label any
RNA-containing virus which might be released into
the fluid phase of the culture. Sucrose density
gradient analysis of the concentrated fluid phase did
not reveal labelled material at the appropriate
density for a retrovirus. Rather more cell lysis
occurred in the synovial fluid lymphocyte cultures
than in the peripheral blood, particularly when calf
serum or autologous human serum was used. This
gave rise initially to patterns simulating virus
release but the labelled material was sensitive to
RNase and the release was less in homologous
plasma.
Three cultures of synovial fluid lymphocytes from
different patients were incubated first of all in the
presence of phytohaemagglutinin for 4 days before
adding 3H-uridine. Again no peaks of labelled
material typical of RNA viruses and retroviruses in
particular were found.
As there did not appear to be a productive
infection with an RNA virus in the synovial lympho¬
cytes, the cells were examined for their DNA
polymerase activity to determine if they contained
any RNA-dependent DNA polymerase. Synovial
fluid lymphocytes from 2 patients (1 RA and 1
possible juvenile RA) were assayed for polymerase
activity and compared to a rheumatoid lympho-
blastoid cell line kindly provided by Dr Ford (see
below). The activity in all cases was found to be
typical of that described in stimulated lymphocytes,
that is an RNA-primed DNA-directed polymerase,
not viral reverse transcriptase (Bobrow et at., 1972).
There was little stimulation by poly(rA).dT10, and
almost complete inhibition by actinomycin D.
It was noticed that if the cultures were kept for a
longer period than overnight the lymphocytes
gradually began to die, and after a month few
viable cells remained. Human serum seemed to
prolong the viability when compared to fetal calf
serum, but this was only marginal. In order to
examine the cells properly and to increase the
numbers of synovial lymphocytes from any one
patient, we tried various methods which have been
successful in other systems. For example, conditioned
medium from whole human embryo cells has been
used to sustain growth of human myelogenous
leukaemia cells in suspension culture (Gallagher
and Gallo, 1975). Therefore the synovial fluid
lymphocytes from 4 RA patients were cultured in
conditioned medium prepared from fetal skin fibro¬
blasts. The survival of viable cells was higher in this
medium than in EE medium with 10% fetal calf
serum over the first month, but subsequently they
began to die and none survived longer than 2 months.
Again, when synovial fluid lymphocytes from 4 RA
patients were cocultivated with fetal skin fibroblasts,
they survived as viable cells throughout 2 months
but were not dividing. The culture supernatant was
tested at 4 and 8 weeks for reverse transcriptase
activity and was negative in all cases.
Ford and Smiley (1973) reported the spontaneous
occurrence of a continuous line of lymphoblastoid
cells which appeared during culture of an RA
synovial membrane. These cells contain EBV
genome and synthesise IgG of the specificity of
rheumatoid factor in culture. However, attempts to
transform synovial fluid lymphocytes from 4 RA
patients with EBV by the method of Miller et al.
(1974), known to be successful with cord blood
lymphocytes, were failures.
GROWTH OF LYMPHOCYTES IN SOFT AGAR
Lymphocytes from 3 RA synovial fluid specimens
stored in liquid nitrogen and 3 normal peripheral
blood lymphocytes were cultured in soft agar with
and without a feeder layer of peripheral blood
mononuclear cells inactivated with x-rays. All
plates were viewed after 10 days. A few cells pro¬
liferated in plates without feeder layers (Table 1),
but by day 12 these were no longer detected. Sub¬
stantially more clusters were seen on the plates with
feeder layers but never any colonies. ('Clusters' were
considered to contain 10-20 cells and 'colonies'
more than 50). Also there were no differences in the
numbers of clusters formed between normal peri¬
pheral blood and rheumatoid synovial fluid lympho¬
cytes. Clusters from one synovial fluid lymphocyte
culture (number 2 in Table 1) were fixed for electron
microscopic examination. The cell type could not be
identified from the cellular debris, but no viral
particles were seen in this dividing population of
cells.
Table 1 Numbers of'clusters' of cells seen on day 10
after culturing lymphocytes in soft agar with and without
a feeder layer ofperipheral blood mononuclear cells
irradiated at 100 radlmin for 10 min
Number of'clusters' on day 10 (2 plates)
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PEG FUSION
As no proliferation or long-term culture of synovial
lymphocytes was obtained using the above methods,
it was decided to try activating the lymphocytes and
then to fuse them with cell lines which had proved
permissive for a variety of primate retroviruses.
Only those cells able to be activated by a MLR
were used for the subsequent fusion and coculti-
vation.
In the first place the efficiency of fusion when
PEG was used was determined by forming hetero-
karyons of synovial lymphocytes and CCL64 mink
cells. ' Two days after PEG treatment the cells
were stained by immunofluorescence by means
of anti-human lymphocytic serum.
Heterokaryons were frequent and were mainly
binuclear, with numerous long appendages which
were not detectable in mononuclear cells (Fig. 1).
The heterokaryons were not present at the end of
the 7-week culture.
After activation the synovial fluid lymphocytes
were fused with 3 out of a selection of 5 cell lines,
A204, 7605L, CCL64, Tb-l-Lu, and D-17, and the
cultures carried for an 8-week period with periodic
testing for evidence of retrovirus expression. In 1
instance the lymphocytes were pretreated with IUDR
and either diethylstilbestrol or hydrocortisone before
fusion. In all, synovial fluid lymphocytes from 7
patients were used. These patients had RA for
periods ranging from 1 year to 27 years, and varied
from seronegative to seropositive.
The cultures were followed using several methods.
Firstly, the supernatant was assayed for reverse
transcriptase activity, and in all cases this was
negative, indicating that the cells were not producing
retroviruses. A positive control of culture super¬
natant from RD cells infected with RD-114 virus
was always included in the samples to be assayed.
In addition labelling with 3H-uridine followed by
sucrose density gradient centrifugation did not show
any peak at the density of a retrovirus, i.e., 1 -16—
1-18 g/cm3, again indicating that there was no
productive virus infection. In some cases an XC
test was carried out. This has been used to detect
murine leukaemia virus genome in cells as these will
form plaques when placed in contact with XC cells
(rat tumour cells transformed by Rous sarcoma
virus) (Rowe et al., 1970). Plaques and syncytia were
never formed when the fused cells were cultured in
the presence of XC cells. The method was checked
by using mouse 3T3 cells infected with AKR type of
murine leukaemia virus.
The final test involved immunofluorescence on
acetone-fixed cells grown on coverslips which should
detect retrovirus membrane antigens, if these are
being expressed in the fused cells. Antisera to the
viruses RD-114 and SSAV were chosen. The first
is an endogenous cat virus with a close antigenic
relationship to the baboon endogenous virus, and
the second is a simian sarcoma virus. Both share
various antigenic determinants, such as p30 and
gp69-71, with other mammalian species and should
therefore be able to detect any retroviral antigens in
human cells. Originally goat antisera to the 2
viruses, which had been Tween-ether disrupted, were
used, but later antisera prepared in rabbits were used
(Hart et al., 1979). In no case was there any sug¬
gestion of positive immunofluorescence.
Fig. 1 Heterokaryons formed
by PEG fusion of synovial
lymphocytes with CCL 64 cells,
stained with horse anti-human
lymphocyte serum and anti-horse
FITC conjugate to demonstrate a
human nucleus within a mink lung
fibroblast and human antigens on
the cell surface.
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Discussion
In the past few years much attention in RA research
has focused on the type B synovial lining cell and its
presumed derivative in culture, the synovial fibro¬
blast. Although these cells have some abnormal
characteristics when compared to fibroblasts from
other disease conditions such as osteoarthrosis,
there is no evidence of neoantigens on the cell
surface, either virally induced or arising from
mutation.
In this paper we have attempted to look at the
lymphocytes present in the synovial fluid effusions
of patients with RA to see if they contain RNA
viral genes that might be linked with the chronic
inflammatory state of the joint.
It seemed unlikely, especially in the light of the
thorough attempts by various groups of workers to
isolate retrovirus from human leukaemia cells, that
the synovial lymphocytes would be productively
infected with a virus, and, indeed, our morpho¬
logical results after ultrathin sectioning did not
indicate any abnormalities in these cells compared
to those from the peripheral blood, and there was no
evidence of virion production. Similarly the surface
of the lymphocytes did not differ from the 2 sources
when examined by scanning electron microscopy.
Labelling with 3H-uridine also did not indicate a
productive viral infection.
We turned then to more indirect methods of
detecting viral information in RA lymphocytes. It is
of interest in this context that a retrovirus, SP104,
has been associated with canine systemic lupus
erythematosus (SLE), and by immunofluorescence
viral membrane antigens have been demonstrated on
some peripheral blood lymphocytes in human SLE
(Schwartz, 1975). In addition, an antigen, p30,
related to mammalian type C viral protein has been
localised in renal glomeruli in human SLE (Mellors
and Mellors, 1976). More recently, however, viral
mRNA of SP104 was not detected in either human
or canine SLE tissues by sensitive methods of
nucleic acid hybridisation (Quimby et al., 1978), a
result which is hard to reconcile with the previous
data. In the accompanying paper Hart et al. (1979)
describe experiments to detect retrovirus antigens on
the membranes of synovial lymphocytes by radio¬
immunoassay and immunofluorescence with uni¬
formly negative results. However, possibly it was
necessary to culture the cells to induce the virus, and
indeed, as in the case of xenotropic viruses, which
will replicate only in cells of a different species, it
might have been necessary to use methods of in¬
duction, fusion with permissive cells, and co-
cultivation before virus is isolated.
Our attempts to culture the synovial lymphocytes
were not successful, using different species of serum,
conditioned medium, cocultivation with fibroblasts,
or colony formation in soft agar. The latter would
have indicated transformation of a lymphocytic
population. Finally, then, the lymphocytes were
stimulated by an MLR and fused using PEG with a
variety of cell lines known to be permissive for
several primate retroviruses. Heterokaryons were
formed which were monitored over 8 weeks by
several methods, 3H-uridine incorporation, reverse
transcriptase activity of the culture supernatant, XC
test, and immunofluorescence with antisera to
RD-114 and SSAV, which should detect mammalian
interspecies and group antigens. All results were
negative.
Thus in this systemic study we have not been able
to detect any viral information in RA synovial
lymphocytes and very few differences in their
characteristics compared to peripheral blood lympho¬
cytes of the same patient.
We wish to thank Mrs Alexia Graham, who did the trans¬
mission and scanning electron microscopy reported in this
paper, and Miss Sheena Tuach for expert technical assistance.
The help of Mrs Leonora Hislop and the staff at the Rheu¬
matic Diseases Unit, Northern General Hospital, in
providing clinical specimens is gratefully acknowledged.
Grant support throughout this work was given by the
Nuffield Foundation.
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summary The adherent cells remaining after short-term culture of synovial fluid and synovial
membrane cells from rheumatoid and non-rheumatoid patients were examined for the presence of a
productive virus infection and for various viral antigens. Labelling was carried out with 3H-thymidine
and 3H-uridine followed by sucrose density gradient centrifugation of the culture supernatant. Only
in 1 case was there incorporation of 3H-uridine into material of density 1-21 g/cm3. Viral antigens
were tested for by indirect immunofluorescence with antisera to rubella virus, the retroviruses
RD-114 and simian sarcoma associated virus, early adenovirus type 2 antigens, late adenovirus type
2 antigens, SV-40 T antigen, and in 1 case measles virus. No cell showed immunofluorescence with
any antiserum except the early adenovirus type 2 antiserum, which stained the cytoplasm of about
half the synovial cell cultures, some from rheumatoid and some from non-rheumatoid patients.
A possible viral aetiology of rheumatoid arthritis
has been suggested (Denman, 1975; Barland, 1973;
Hamerman, 1975; Marmion and Mackay, 1977),
but it has not yet been supported by clear experi¬
mental evidence. Virological investigations until
recently have concentrated on the long-term cul-
turing of fibroblastic cells. These are derived from
synovial membranes of fluids and are thought to be
either type A or B lining cells (Smith, 1971). These
studies included attempted detection of cytopathic
and non-cytopathic viruses, viral genomes, and
neoantigens, and no evidence was found which
implicated any virus (Person et al., 1973; Grayzel,
1973; Norval and Marmion, 1976).
An alternative hypothesis (Talal, 1975; Denm'an
et al., 1976; Marmion and Mackay, 1977; Funden-
berg and Wells, 1976) suggests that the primary
and central change is in the effector cells of the im¬
mune system (T or B lymphocytes or monocyte-
derived macrophages) and that the rheumatoid
process involves a loss of the normal immuno-
regulatory control rather than a normal immune
reaction against an altered target cell such as a
virus-infected fibroblast. This loss of immuno-
regulatory control could be due to a viral infection
of the immune effector cells (Messner, 1974).
Recent virological studies on lymphocytes from
synovial fluids and membranes have included an
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examination for retroviruses, but these were not
shown to be present by methods such as nucleic acid
hybridisation, fusion, and cocultivation with cells
permissive for primate retroviruses, immuno¬
fluorescence, and radioimmunoassay (Norval et al.,
1979; Hart et al., 1979).
The other type of effector cells of the immune
system remaining to be subjected to experimental
scrutiny is the monocyte derived macrophage.
These are the adherent cells present within the first
few days of culture of synovial fluids as described by
Mackay et al., (1974) which do not seem to multiply
and cannot be subcultured. Most often they are
overgrown after variable periods of time by the
fibroblastic cells. In addition disaggregated synovial
membranes yield a heterogeneous mixture of fibro¬
blasts, macrophages, and undifferentiated esterase-
positive cells on primary cultures, and again the
fibroblasts generally overgrow the other cells.
Traycoff et al. (1976) have described methods for
identifying the various populations of synovial
mononuclear cells on the basis of morphology,
sudanophilia, and several cell markers, and they
classified such cells into synovial lining cells, mono-
cyte-derived macrophages, monocytes, lymphocytes,
and lymphoblasts.
The role of the synovial macrophages in the joint
is not clear. It has been suggested that they may be
bearing foreign antigens, as antibody dependent
lymphocyte cytotoxicity to adherent cells has been
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demonstrated in short-term cultures (Neill, personal
communication). It is of interest that macrophage-
lymphocyte clusters have been described in auto¬
logous cell mixtures obtained from the synovial
fluid of rheumatoid patients (Hepburn et al., 1974).
Webb et al. (1975) showed that such clusters could
be formed with heterologous lymphocytes also.
This suggested that there may be an antigen on the
macrophages towards which the lymphocytes are
sensitive, although there was no stimulation of the
lymphocytes in these clusters. It is possible that such
an antigen may be virally induced or coded.
Thus it was thought worthwhile to examine the
synovial macrophages for the presence ofa productive
viral infection by means of short-term cultures and
labelling with 3H-uridine and 3H-thymidine. In
addition these cells were examined for various
viral antigens by immunofluorescence.
Materials and methods
CELL CULTURE
Synovial fluids from patients with classical or definite
rheumatoid arthritis (RA), other forms of inflam¬
matory joint disease, and osteoarthrosis (OA) were
treated within 2 hours of extraction from the patient
with 80 U/ml hyaluronidase for 30 min at 37°C.
The cells were deposited by centrifugation at 800 g
for 10 min and washed once in Earles-based Eagle's
complete medium (EE). Short-term cultures were
set up using 1-2 x 107 viable cells/ml EE; 10 ml
into 100 ml flasks for labelling with 3H-thymidine
and 3H-uridine, and 1 ml into each tube containing
coverslips (22 X 6 mm) for immunofluorescence.
Flying coverslips were used to estimate the number of
adherent cells, and 1 ml cell suspension was suf¬
ficient to prepare 8 coverslips. All cultures were
incubated for 3 hours at 37°C in air containing 5 %
CO,. The non-adherent cells were removed at this
stage by washing thoroughly twice in EE.
Synovial membranes obtained at synovectomy
were disaggregated within 2 hours of the operation
as described by Abrahamsen et al. (1975), and the
single cell suspensions were then handled as above.
COUNT OF ACID ESTERASE-POSITIVE
ADHERENT CELLS
The flying coverslips were fixed in Baker's formol
calcium and the acid esterase staining procedure was
carried out as described by Mueller et al. (1975).
The adherent count (AC) was determined by counting
the acid esterase-positive cells (AEPC) on 10 mm2 of
the coverslip and calculating as follows:
AC/ml cell suspension = 10 x 13-2 x 8 X AEPC
count.
VIRUS DETECTION
After washing the cell sheet to remove the non¬
adherent cells, the flasks were labelled by adding
10 ml EE containing 5% fetal calf serum and either
(5-3H)-uridine or (methyl-3H)-thymidine (Amer-
sham), both at a final concentration of 10 [xCi/ml.
Incubation was continued for a further 20 hours at
37°C. On 3 occasions attempts were made to induce
a virus by adding cyclohexidimide (10fi.g/ml) at same
time as the radioactive medium.
Detection of virus in the culture supernatant was
performed as outlined by Norval and Marmion
(1976).
IMMUNOFLUORESCENCE
This was carried out as described previously (Hart
and Marmion, 1977) with coverslips fixed in acetone
after the 3 hour incubation. The specific antisera
used were all prepared in rabbits and have been
described before together with appropriate control
anticell sera. They were anti-rubella virus (Thomas
strain) grown in RK13 cells (Hart and Marmion,
1977); anti-RD114 grown in RK13, and anti-simian
sarcoma virus grown in KNRK cells (Hart et al.,
1979); anti-adenovirus type 2 grown in RK13 cells
treated with cytosine arabinoside (10 ,u.g/ml) and
used early in infection, and anti-adenovirus type 2
grown in RK13 cells used late in infection (Jones
etal., 1979).
In one experiment guinea-pig anti-measles serum
(Flow Laboratories) was used. A weak but definitely
positive reaction was detected specifically on measles
infected Vero cells at 1 /20 dilution. This serum was
used at 1/10 dilution for the synovial cells. A few
immunofluorescent tests also included hamster anti-
SV 40 T antigen serum kindly donated by Dr E.
Rogers.
Fluorescein-conjugated anti-rabbit Ig (Wellcome
Laboratories) was used at 1/16 dilution: fluorescein-
conjugated anti-guinea-pig and anti-hamster (Nor¬




Cells from synovial fluids or membranes of 14
patients with rheumatoid arthritis (RA), 4 with
osteoarthrosis (OA), 5 with other non-RA conditions,
and 1 undiagnosed were used and the adherent
cell population separated after culturing for 3 hours
at 37°C. The clinical details are listed in Table 1.
In cases where there were sufficient cells, the cultures
were labelled with 3H-thymidine and 3H-uridine,
and, after concentration by precipitation with
(NH4)2 S04, the culture supernatants were analysed
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by sucrose density gradient centrifugation. The acid-
insoluble counts per minute in each fraction were
determined and plotted against the density of the
sucrose to find out if there was a peak of incor¬
poration at any particular density throughout the
gradient. As may be seen from Table 1, only in one
case, 780127, was there a peak of radioactive
insoluble material after labelling with 3H-uridine,
which occurred at density 1 -21 g/cm3. This is shown
in Fig. 1. Labelling of the same culture with 3H-
thymidine did not produce such a peak, supporting
the idea that there might have been production
of an RNA-containing virus by the adherent synovial
cells from this patient. The density, 1-21 g/cm3, is
similar to that found on 3H-uridine labelling of
measles virus produced from Vero cells (Norval and
Smith, 1979).
With some synovial specimens there were not
sufficient cells to enable the labelling experiment to
be carried out, and only immunofluorescence was
done.
IMMUNOFLUORESCENCE
Coverslips containing adherent cells from all the
specimens listed in Table 1 were fixed and stained
with specific viral antisera to rubella virus, RD-114
(a feline endogenous retrovirus), SSAV (a simian
sarcoma retrovirus), and adenovirus type 2. With
the first 3 antisera no specific immunofluorescence
was seen, though occasionally there was a non¬
specific staining, but this could be easily recognised
as the control anti-cell sera reacted similarly. In
addition results with the antiserum to the late
adenovirus type 2 antigens were uniformly negative.
However, with the antiserum to the early adenovirus
type 2 antigens about half the specimens examined
showed weak uniform non-granular cytoplasmic
immunofluorescence, which was not present when
the control anti-cell serum was used. This immuno¬
fluorescence had no particular pattern being present
in the adherent cells from some synovial membranes
and some fluids, and from approximately equal
numbers of RA patients and non-RA.
Table 1 Clinical and laboratory details ofpatients whose synovial specimens were used as a source ofadherent cells.
Results indicating the count ofacid esterase positive adherent cells/ml in the population, and labelling of culture
supernatants with 3H-thymidine and '•H-uridine followed by sucrose density gradient centrifugation are shown.
In addition immunofluorescence using a variety of viral antisera was carried out on all the specimens
Case Diagnosis Tests for rheumatoid factor Specimen Count of acid esterase Labelling of culture
number positive adherent cells\ml supernatants with
SSCT Latex
3H-thymidine ^H-uridine
780103 RA 128 SM
780104 RA 1024 + + + SF —
780105 RA 32 SF
780106 OA SF
780107 RA 256 + + + SF
780108 Psoriatic
arthropathy <16 — SF —
780109 RA SM
780110 RA <16 SM
780114 RA 64 + + SF
780115 OA SM 3-2x105 _
780117 RA 16 SM _
780118 RA <16 ± SF 1•1X105
780119 Undiagnosed SF 7-5 x103
780121 Bilateral
congenital
dislocated hip SM 1-4x105
780122 OA <16 SM 4-8 x104
780123 RA <16 + + SM 1-8x104 ##
780124 Synovitis <16 — SF 1-5x104 . #




780130 RA <16 SF
780131 Psoriatic
arthropathy <16 — SF 9-1x104 ♦ ♦
780132 RA 1024 SF 6-7x104 ♦
780133 RA <16 SF 4-2x104 * ♦
* 780131 and 780133 were also treated with 10 |ig/ml cycloheximide at the same time as adding 3H-thymidine or 3H-uridine; 780132 was treated
with cycloheximide at the same time as adding 3H-uridine.
..=not tested. SM=synovial membrane. SF=synovial fluid. RA=rheumatoid arthritis. OA =osteoarthrosis. SSCT = (sensitised sheep cell
test)—agglutination of sheep red cells coated with specific rabbit antibody. Latex = agglutination of latex particles coated with IgG globulin.
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Fig. 1 Acid-insoluble counts per minute in sucrose
density gradient fractions from 780127 adherent cell
culture supernatant after labelling with 3H-thymidine
(• •) and 3H-uridine (9 #).
Three cultures, 780131, 780132, and 780133, were
also reacted with anti-SV 40 T antigen serum but
with negative results.
Finally, measles antiserum was used on adherent
cells from patient 780127 to check whether the peak
obtained on sucrose density gradients after label¬
ling with 3H-uridine represented productive measles
infection. No measles antigens were detected, and
no further identification of the material within the
radioactive peak was made.
Discussion
Very little has been published thus far on the pro¬
perties of the synovial monocyte-derived macro-
pages, though there have been suggestions that they
may express unique antigens or phagocytose specific
immune complexes and thus may account for the
immune processes seen in RA.
Rheumatoid synovial macrophages and lympho¬
cytes were shown to form rosettes or clusters in both
autologous and heterologous systems, but, as the
lymphocytes were not stimulated by this process,
there was no indication from this work that an
antigen was present on the macrophage surface
towards which the lymphocytes were sensitised
(Hepburn et al., 1974). This result was confirmed
by Runge (1976), who measured lymphocyte stimu¬
lation after culturing synovial macrophages with
autologous peripheral blood lymphocytes from RA
patients and controls. A small degree of stimulation
was observed in the rheumatoid cultures, but this
was not significantly different from that observed in
non-RA cultures. It was suggested that there may be
non-specific lymphocyte activation by immune
complexes associated with the macrophages rather
than a specific synovial antigen expressed on the
macrophages.
On the other hand the work of Neill (personal
communication) does support the idea that some
rheumatoid synovial cells at very early passes may
express unique antigens. These were detected by an
antibody-dependent cytotoxicity technique using
synovial cells of mixed types as targets and auto¬
logous serum. On subculture, which would eliminate
the macrophage population, the cytotoxicity became
negative. Other work using similar techniques and
also giving negative results has involved target
synovial cells maintained in culture through several
subcultures, so that no macrophages were likely to
be present (Griffiths et al., 1976).
In this present study an attempt was made to look
for virus production and some viral antigens on the
adherent synovial cells remaining after a short-term
culture. It was hoped in this way to examine a
macrophage-rich population of synovial cells which
are eliminated by the usual methods of in-vitro
culture. A productive virus infection was not
demonstrated apart from one instance in which
there was incorporation of 3H-uridine into material
of density 1-21 g/cm3, the same as measles virus.
However, by immunofluorescence using anti-
measles serum no measles antigens were expressed
on the adherent cells from this patient. The culture
was not analysed further.
Further, when the adherent cells were examined
by immunofluorescence for rubella virus antigens,
retrovirus antigen, SV-40 T antigen, and adeno¬
virus type 2 late antigens, they were all negative.
Thus a unique antigen, induced or coded for by these
viruses, was not expressed on the synovial macro¬
phage population. Ofcourse many other virus groups
remain, but the ones tested here represent good
candidates, being implicated in persistent infections
and tumorigenicity.
There was some immunofluorescent staining with
antiserum to early adenovirus type 2 antigens in the
cytoplasm of the adherent synovial cells from some
patients. This did not seem to correlate with the
diagnosis of the patient or the type of specimen. It
may represent expression of some adenovirus genes
in normal human tissue which has been described
recently in placentas by Jones et al. (1979), and
which is under investigation.
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We were interested in the Short Communication by Marshall, Lamey & Ferguson* which
described an autoradiography technique applicable to cover-slip cell cultures. For some
time now we have been doing in situ hybridizations using radioactively labelled viral nucleic
acids as probes on cover-slip cell cultures, followed by autoradiography. We use a method
described below which seems to eliminate several of the steps outlined by Marshall et al.
After the hybridization the cover-slips are washed thoroughly in buffer at 4°C and then
dehydrated through alcohols. They are mounted on DPX on microscope slides with the
Med lab Se: (1981) 38
LETTERS TO THE EDITOR 149
cells uppermost, and allowed to dry at room temperature overnight before being dipped
in photographic emulsion. After exposure and developing, the cover-slips are stained and
dehydrated as normal. They can be viewed directly microscopically, or protected for
long-term storage by placing another cover-slip on the top and sealing around the edge with
DPX. By this method the cover-slips are handled only at the initial stage and several can be
placed on the same slide, thus saving emulsion.
Department ofBacteriology, Mary Norval and W. A. Neill
University Medical School,
Teviot Place,
Edinburgh, EH8 9AG, Scotland.
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A Viral Etiology for
Rheumatoid Arthritis?
By Mary Norval, Ph.D.
Substantive evidence of a viral etiology for rheumatoid arthritis remains elusive, but the
possibility continues to intrigue scientists and clinicians. Features of viral infections that
might induce chronic arthritis are difficult to prove by standard techniques, but
immunological methods may provide an indirect means of seeking a viral etiology.
Dr. Norval presents virologic and immunological considerations in the continuing search
for a viral etiology and discusses specific viruses implicated in rheumatoid arthritis.
Rheumatoid arthritis (RA) is a chronic dis¬ease of joints that currently affects 1 to 2percent of the adult population. Studies
on very early RA cases are rare because of diffi¬
culties in making an accurate diagnosis and in
Dr. Norval is a lecturer, Department ofBacteriol¬
ogy, University of Edinburgh Medical School,
Edinburgh, United Kingdom.
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obtaining appropriate specimens from patients,
but histopathological observations indicate
some proliferation of synovial-lining cells, ini¬
tially with lymphocyte infiltration around syn¬
ovial vessels. Later, immunoproliferation of the
synovial membrane occurs with greatly in¬
creased local synthesis of immunoglobulins.
This immune pathogenesis has suggested the
idea of local antigenic stimulation as being cru¬
cial in the etiology of the disease. Over the past
two decades, great efforts have been made by sci-
61
Viral Etiology for RA?
entists and clinicians alike to discover such a spe¬
cific antigen or agent, but, as yet, no totally con¬
vincing evidence has been uncovered.
Theories of an infective etiology for RA have
ranged from the view that the initial event is
infection of the joint by an agent leading to either
some kind of persistent infection or some altered
immune response, or both, to the view that the
initial event is a change in immunoregulatory
control that may lead to an altered response to an
infecting agent.1 In addition, it is now recognized
that there is a genetic component in RA, with an
increased incidence of some HLA antigens, spe¬
cifically HLA-D4 and HLA-DR4, in RA patients
and in healthy persons with a strong family his¬
tory of RA.2 This has led to speculation about
these antigens and the ability of various agents,
particularly viruses, to interact with genetically
determined features of the cell surface. Alterna¬
tively, some evidence exists to support the opin¬
ion that infecting agents are not involved at all in
the initiation or progression of RA and that the
whole disease is caused by altered immune mech¬
anisms.
•In this review, current evidence is summarized
that implicates viruses as the etiologic agents in
RA; a brief overview is given of virologic and
immunological aspects, followed by a section on
general methods of study in this difficult area;
and finally, specific virus groups are detailed in
which there is interest at present.
GENERAL VIROLOGIC CONSIDERATIONS
An ideal agent in RA must be ubiquitous,
arthrotropic, and capable of altering immune
responses, e.g., causing the production of rheu¬
matoid factors, which are found in a substantial
proportion of patients. Some viruses have prop¬
erties that would make them good candidates. It
is known, for example, that infections with such
viruses as Epstein-Barr virus (EBV), coxsackie
virus B, and rubella virus can induce acute poly¬
arthritis, which persists for a long time and dur¬
ing which infectious virus also persists. The poly¬
arthritis, however, does not generally progress to
chronic destructive joint disease. If viral infec¬
tions are considered as the initial event in RA,
several scenarios are possible. First, there could
be an initial infection that is followed by elimina¬
tion of the virus but also a persisting altered
immune response. This would make a search for
the agent very difficult in established cases of
RA. Second, chronicity of the virus, either locally
in the affected joints or elsewhere in the body,
could lead to altered immune mechanisms, such
as altered "homing" properties of subpopula-
tions of lymphocytes. Some viruses have been
shown to persist for life after the primary infec¬
tion, either by a low-grade infection of a few cells
that is probably controlled by the immune
response (e.g., EBV) or by an integration of their
genomes into host-cell chromosomes, thus
becoming latent (e.g., herpes simplex virus).
Third, a primary change in the effector cells (T-
and B-lymphocytes or macrophages) of the
immune system could lead to a loss of normal
immunoregulatory control, which might also
lead to an altered response to a virus, especially a
virus capable of persisting in the body. Each of
these hypotheses has some evidence to support it
at the present time.
GENERAL IMMUNOLOGICAL CONSIDERATIONS
One of the distinguishing features of RA is the
large number of cases that are seropositive for
rheumatoid factors. Most commonly, these rheu¬
matoid factors are autoantibodies against the Fc
portion of immunoglobulin G (IgG). It is not
known whether they arise from abnormal hand¬
ling of a particular virus that may trigger the
disease by locally stimulating antiglobulin pro¬
duction, or whether there is already an
immunoregulatory defect that leads to produc¬
tion of rheumatoid factors perhaps an abnormal
response to a virus at the same time.
At the end of 1983, an interesting hypothesis
was proposed by Plotz3 that explains a role for
viruses in the pathogenesis of autoimmune dis¬
eases. Plotz speculated that antiidiotypic anti¬
bodies (i.e., antibodies directed against novel
sequences in the variable portion of immunoglo¬
bulins), directed against antibodies with specific¬
ity for viral components that bind to cell sur¬
faces, may also act as antibodies against
cell-surface components. Thus, autoantibodies in
various diseases may actually be antiidiotypic
antibodies to antiviral antibodies and have addi¬
tional properties of acting as antibodies against
various host-cell structures. The autoantibodies
so far characterized are all directed against struc¬
tures that viruses may require for nucleic-acid
replication or protein synthesis. It is tempting to
speculate that some autoantibodies in RA might
be just such antiidiotypic antibodies to an infect-
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ing virus. It will be of great interest to see what
evidence can be gathered in support of this
hypothesis.
Recently, it has been found that seronegative
RA patients have serum antibodies directed
against rheumatoid-factor idiotypes.4 It is possi¬
ble that such antibodies could lead to the elimina¬
tion or inactivation of the precursor B cells for
rheumatoid factors. Certainly, the blood of sero¬
negative patients is deficient in precursor B cells
that can be stimulated by a polyclonal activator
(e.g., EBV), lending support to this idea. It is not
known as yet whether these serum antibodies are
present in seropositive RA patients.
it is recognized that such a condition rarely pro¬
gresses to chronic erosive arthritis. Studies with
rubella virus and EBV are of particular concern
in this context.
By direct examination of diseased synovial tis¬
sue in the electron microscope, virus particles
have been seen on three occasions, and were
always present in very small numbers with differ¬
ing morphology. None of these reports have been
substantiated. Direct attempts have also been
made to isolate viruses from rheumatoid joints,
either from synovial membrane or from synovial-
fluid specimens. This approach can be taken fur¬
ther by co-cultivating or fusing synovial cells
If viral infections are considered as the initial event in RA, several scenarios
are possible. First, there could be an initial infection that is followed by
elimination of the virus but also a persisting altered immune response.
Second, chronicity of the virus, either locally in the affected joints or
elsewhere in the body, could lead to altered immune mechanisms. Third, a
primary change in the effector cells (T■ and B-lymphocytes or
macrophages) of the immune system could lead to a loss of normal
immunoregulatory control.
It is known that some autoantibodies are often
generated after viral infection. The most recent
evidence concerning these has come from a study
of reovirus infection in mice.5 Surprisingly, the
autoantibodies produced after the infection had
specificity for both infecting virus and host,
implying shared antigenic structures between
viral determinants and normal tissues, and sug¬
gesting a possible mechanism of host-cell dam¬
age. There may be a number of self-reactive B-cell
clones that are normally regulated to prevent
development of autoimmunity. The virus may
alter this balance in some way, perhaps by its
cytotoxic effect. These concepts could be applied
to the pathogenesis of RA, and further character¬
ization of the generation of autoimmunity after
viral infection may lead to fresh ideas on tissue
damage in the rheumatoid joint.
METHODS OF STUDYING VIRUSES IN RA
A combination of direct and indirect ap¬
proaches has been used to try to elucidate a
viral etiology for RA. The most obvious method,
perhaps, is to follow what happens during acute
polyarthritis caused by known viruses, although
directly from the patient with tissue-culture cells
that are known to be permissive for a particular
virus. Isolations are very rare, and, even if
viruses are found, it would not be possible to
determine whether they are initiating agents or
merely secondary invaders, perhaps resulting
from the abnormal inflammatory state of the
joint. Synovial cells or extracts of them have also
been introduced into experimental animals.
Notably, in 1984, this led to the isolation of par¬
voviruses, after injection of rheumatoid synovial
material into the brains of suckling mice.
A few studies have included detection of viral
antigens on synovial cells by immunofluores¬
cence, immunoperoxidase, or cytotoxicity tests.
Even fewer studies include detection of viral
nucleic acids by hybridization. These approaches
are of particular interest, because it is now recog¬
nized that some viruses can associate with cells
in a nonproductive manner, without causing
their death. Regrettably, such work has been pre¬
dominantly negative. If cells are already infected
by a virus, they may be resistant to superinfec¬
tion by it or a related virus. This method has also
been tried with rheumatoid material, especially
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peripheral-blood lymphocytes, without notable
success. In addition, the presence of neoantigens
on synovial cells has not been demonstrated in
cytotoxicity tests using autologous peripheral-
blood lymphocytes, and neither is it suggested
by the histopathology of early RA.
Various immunological methods, which have
been used to provide indirect evidence for viral
involvement in other diseases, have been tried in
RA. Serum antibody levels to a range of common
viruses are not generally different between RA
patients and control groups, although some
recent work with cytomegalovirus (CMV) anti¬
bodies in early RA is of interest. In addition, find¬
ing higher antibody levels to various EBV anti¬
gens in RA patients has provided the basis for
arguments advocating a role for EBV in RA.
Local synthesis of viral antibodies in the syn¬
ovium has not been found, and viral antibodies
have not been eluted from synovial tissue, where
they might reasonably expect to be bound if anti¬
gens are present. By measuring stimulation of
synovial lymphocytes by various viruses, no con¬
sistent proliferative response has been obtained,
indicating that there is probably no population
present already sensitized to the viruses used.
Experiments have been carried out on in vitro
synthesis of immunoglobulins by synovial-mem-
brane cells and on lymphocyte function in RA by
measuring, for example, delayed hypersensitiv¬
ity or nonspecific mitogen responses. No clear
results were obtained with either method. It is
now possible to analyze the lymphocyte subsets
in the rheumatoid synovium, by using such
methods as monoclonal antibodies that are spe¬
cific for subpopulations and fluorescence-acti¬
vated cell sorter, and to compare these with the
peripheral blood. Such work should yield inform¬
ative data in the near future. Also, various
groups are currently examining the antiidiotypic
hypothesis, by testing RA sera for their ability to
block or adsorb specific antiviral-antibody activ¬
ity, for example, or to block infection of normally
susceptible cells by specific viruses.
Animal models have proved generally disap¬
pointing in RA research, although, in goats,
there is chronic progressive arthritis with demy-
elinating encephalomyelitis associated with a
retrovirus that is of considerable interest.7
Transmission experiments have most often
failed, including one reported in 1983, in which
rheumatoid synovial cells were injected into
Various immunological methods that
have been used to provide indirect
evidence for viral involvement in
other diseases have been tried in FtA
Several surveys have indicated, however, that
antibodies to rubella were no more prevalent in
RA patients than in controls. Eluates from RA
synovial membranes did not contain rubella anti¬
bodies. There are few successful isolations of
rubella from RA synovial-fluid specimens, and
no rubella antigens or viral nucleic acid are
detectable in RA synovial-membrane tissue. It is
therefore possible that rubella may persist in the
joints in a latent form and that it is reactivated at
intervals by some inflammatory stimulus. Unfor¬
tunately, no good evidence exists, as yet, to sug¬
gest that it is associated with progression to a
chronic, erosive joint disease with rheumatoid
factor production.
Cytomegalovirus. CMV, a member of the her¬
pesvirus group, persists for life after the primary
infection occurs in unknown site(s) in the body,
although it can be isolated on occasion from
peripheral-blood leukocytes. CMV reactivates at
intervals and, because of these properties plus
the disturbance of T-lymphocyte subsets during
CMV mononucleosis, is worth considering in the
context of RA.
There has been only one report of isolation of
CMV from the synovial cells of an RA patient
who had no clinical signs of CMV.10 It was impos¬
sible to tell if CMV merely happened to be
present in this site, perhaps in some inflamma¬
tory cell, as has been shown in the colonic
mucosa. Circulating antibodies to early CMV
antigens have been demonstrated in 20 percent
of early RA patients but have rarely been found
in more established cases.11 This may indicate
some defect in handling CMV, but it seems more
likely that these results can be attributed to the
general immunoproliferative process of RA.
Retroviruses. There has been much curiosity
recently about this group, particularly after the
1980 discovery of the human T-cell leukemia
viruses (HTLV) and their possible association
with acquired immunodeficiency syndrome.12
HTLV can use HLA antigens as receptors to
enter host cells and can also avoid the cytotoxic
immune response by this mechanism. Further
retroviruses are able to persist in their hosts in an
integrated genomic form with little or no expres¬
sion of viral proteins. These properties make
them potential etiologic agents in RA, especially
considering the association between HLA anti¬
gens and the arthritic diseases.
Disappointingly, although there has been one
report of seeing viral particles with typical mor¬
phology of this group in rheumatoid synovial
membranes, no viral antigens, viral nucleic acid,
or reverse-transcriptase activity has been found
in rheumatoid synovial tissue. It would be inter¬
esting to repeat these studies with reagents pre¬
pared from HTLV instead of the primate
retroviruses used until now.
As already mentioned, a retrovirus, caprine
arthritis-encephalitis virus, belonging to the len-
tivirus subfamily, has been isolated from goats
with chronic progressive arthritis.7 Work is in
progress using the caprine, viral nucleic acid and
antigens as probes to determine if a lentivirus is
present in RA patients.
EBV. EBV is another herpesvirus and is the
causative agent of infectious mononucleosis. It is
ubiquitous and persists for life after the primary
infection, probably in a subpopulation of B-lym-
phocytes. EBV stimulates production of various
immunoglobulins, including rheumatoid factors
and has been suggested as an autoimmune trig¬
ger in RA.13'A study of antibody levels to various
EBV antigens in RA patients and controls indi¬
cates that there may be a more active infection in
RA or perhaps an altered immune response to the
virus. In 1976, an antibody was detected in sera
from 90 percent of RA patients directed toward
an antigen induced in lymphocytes by EBV infec-
tin.14 This was called RA-associated nuclear anti-
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gen (RANA) and was found in 15 to 56 percent of
sera from normal persons and at a lower titer
than in the RA patients. Further work to look for
. this antigen in synovial cells from RA joints was
disappointing: it was rarely found, although the
antibody was commonly present. EBV antigens
and viral nucleic acid were also not detected in
affected joints.15 Recently, RANA and the
nuclear antigen induced by EBV in infected cells
(EBNA) have been shown to be one and the same
protein; apparent differences in antibody titer in
RA sera toward RANA and EBNA perhaps
resulted from differences in avidities of the anti¬
bodies.16
Nevertheless, although localized EBV infection
of the synovium in RA cannot be demonstrated,
there are differences in lymphocyte responsive¬
ness between RA and control populations.17
When lymphocytes from EBV-infected individ¬
uals were incubated with EBV, there was an ini¬
tial increase in immunoglobulin-secreting cells,
followed by suppression by T cells. When lym¬
phocytes from RA patients were used, no sup¬
pression occurred. Thus, in RA, there may be a
defect or absence of T cells that regulates the
infected B cells, or the impaired response of rheu¬
matoid B cells to normal, regulatory T cells. EBV
may then be important in chronicity and progres¬
sion of the joint disease through increased anti¬
body production, thereby perpetuating the
inflammatory process. Analysis of T-cell subsets
in RA synovial fluid and membranes is currently
being undertaken18 and should yield significant
results, especially if specimens can be obtained
from early stages of the disease (before treatment
starts).
New theories ofautoantibody and
antiidiotypic-antibody production
following viral infection are of
particular interest in the context of HA
CONCLUSIONS
No definitive evidence has been produced so far
to show that any virus is the etiologic agent in
RA. Various findings over the years have tempo¬
rarily raised hopes, but these have not been sub¬
stantiated. Nevertheless, several viruses are
seen as potential candidates, and more informa¬
tion is becoming available about their properties
and interactions with humans using modern
techniques of molecular virology and immunol¬
ogy. New theories of autoantibody and anti¬
idiotypic-antibody production following viral
infection are of particular interest in the context
of RA. Perhaps it is too naive to think of a single
factor, such as one individual virus, causing RA,
and a combination of circumstances may be cru¬
cial (e.g., the patient's genetic background and
immune status at the time of the infection). Some
definite answer will surely be forthcoming within
the next few years. Ill
REFERENCES
1. Marmion BP Clin Rheum Dis 4:565, 1978
2. Laurent MR, Welsh KIJ Immuncgenet 10:275, 1983
3. Plotz PH Lancet ii:824, 1983
4. Pasquali J-L et al Clin Exp Immun 55:281. 1984
5. Tardieu M et al Eur J Immun 14:561. 1984
6. Simpson RW et al Science 223:1425,1984
7. Crawford TB et al Science 207:997,1980
8. Tingle AJ et al Infect Immun 40:22, 1983
9. Grahame R et al Ann Rheum Dis 42:2, 1983
10. Hamerman D et al J Rheum 9:658. 1982
11. Male D et al Clin Exp Immun 50:341, 1982
12. Marx JLSc/ence 224:475, 1984
13. DepperJM, Zvaifler NJ Arth Rheum 24:755, 1981
14. Alspaugh MA, Tan EM Al-th Rheum 19:711, 1976
15. Alspaugh MA et al Arth Rheum 26:712, 1983
16. Billings PB et al Proc Natl Acad Sci USA 80:7104, 1983
17. Crawford OH, McLachlan SM Brit J Rheum 22:129, 1983
18. Duke Oetal Ann Rheum Dis 42:357,1983
IM / Vol. 5, No. 11 / October 1984 75
 
Archives of Virology 67, 203—215 (1981)
Archives of Virology
© by Springer-Verlag 1981
Association of Human Cytomegalovirus (HCMV)
with Mink and Rabbit Lung Cells
By
Helena Hart and Mary Norval
Department of Bacteriology, University of Edinburgh Medical School,
Teviot Place, Edinburgh, Scotland
With 6 Figures
Accepted October 15, 1980
Summary
The association of human cytomegalovirus with mink and rabbit lung cells
was studied. Strain AD-169 was used which was free of Mycoplasma and other
contaminating agents. It was found to be incapable of productively infecting mink
lung cells. Infection appeared to be initiated but aborted at an early stage. This
was indicated by indirect immunofluorescence, assays of culture supernatants and
cell lysates for infectious virus, electron microscopy of ultra-thin sections of in¬
fected cells, labelling of virus and viral DNA with 3H-thymidine and assay of
virally-induced DNA polymerase at various times after infection. On the other
hand, using these methods, AD-169 was found to infect rabbit lung cells, the virus
being produced in low amounts over a period of up to one month after infection.
At this time, focal areas of infection were still apparent and 15 per cent of the cells
expressed nuclear viral antigens as shown by immunofluorescence. The viral
genome was assumed to have become latent in some rabbit cells with a few being
capable of producing infectious virus.
Introduction
Human cytomegalovirus (HCMV) normally replicates in the nuclei of human
fibroblasts, although there have been reports of other cells being susceptible to
infection. Two human systems have been described; firstly, lung epithelial cells
being productively infected with slow release of virus over several weeks and ac¬
companying cytopathic effect typical of cytomegalovirus (12); and secondly,
amnion epithelial cells being productively infected, the virus yield being lower
than from equivalent fibroblasts and the replication cycle being slower (4). In
addition, human embryonic kidney epithelial cells which are normally non-
permissive for cytomegalovirus replication can be converted into a permissive
state by treatment with iododeoxyuridine before infection (15).
0304-8608/81/0067/0203/$ 02.60
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Various non-human systems have also been described in attempts to find a
permissive cell for HCMV replication. Guinea-pig embryo cells were abortively in¬
fected, with no new virus particles being produced (5). Early virus antigens were
formed and cellular DNA synthesis stimulated. However, the DNA polymerase
activity in the infected cells did not have the properties of the enzyme induced by
HCMV in permissive cells (8). Mouse fibroblasts can also be abortively infected,
the block in replication being at the level of viral DNA synthesis (1).
In addition, Darai and Ft.ugel (2) found that epithelial-like mink lung cells
were highly susceptible for the replication of varicella-zoster and suggested that
this might be a suitable cell line for the growth of other Herpes viruses, like
Epstein-Barr virus and cytomegalovirus.
Finally Farber et al. (3) discussed the replication of HCMV in rabbit lung
fibroblasts. They noted a cytopathic effect in this system after 5 to 7 days which
increased for 2 weeks and then remained unchanged over a period of up to 28 days.
CMV antigens could be detected in the nucleus in 40 per cent of the cells by im¬
munofluorescence at this time. Although no infectious virus was detected in the
culture supernatant 3 days after infection, virus could be recovered by co-cultiva¬
tion of the rabbit lung cells with human embryo lung cells even 28 days post¬
infection.
We decided to investigate further the association of HCMV with rabbit lung
cells and to ascertain whether mink lung cells could be infected. This included an
examination of infected cells by electron microscopy, growth curves over periods
of up to 20 days, labelling with 3H-thymidine and subsequent extraction of viral
DNA, immunofluorescence over periods of 32 days and finally measurement of
DNA polymerase activity inside infected nuclei.
Materials and Methods
Cells
Rabbit lung cells were prepared by trypsinization of the lungs of a 1 year old New
Zealand White rabbit and grown in Earles based Eagles medium (MEM) containing
100 i.u./ml penicillin and 100 gg/ml streptomycin and supplemented with 2 to 5 per
cent rabbit serum. After the cells had formed monolayers they could be split 1:3
every week and were fibroblastic in appearance. They were used between pass 8 and 20.
Mink lung cells (Mv-l-Lu) were obtained from the American Type Culture Collec¬
tion, number CCL 64, and were cultured in MEM containing 2 to 5 per cent new born
calf serum and antibiotics as above. They were epithelial-like in appearance and exten¬
sive microvilli on the cell surface could be seen on electron microscopy of ultra-thin
sections.
Human embryo lung cells (HEL) were prepared as described for the rabbit lung
cells except that the medium was supplemented with 5 to 10 per cent new born calf
serum instead of rabbit serum.
Incubation of all cells was at 37° C in an atmosphere of air containing 5 per cent
CO2. All cells were free of contamination with Mycoplasma.
Virus
Human cytomegalovirus (HCMV), strain AD-169, which had been plaque purified
by Dr. J. M. DeMarchi and was free of other contaminating viruses as tested by Dr. G.
Darai, was obtained from Dr. J. Cameron, Institute of Virology, Glasgow. It was also
free of contamination with Mycoplasma species.
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Infection of Cells
Cells were infected as monolayers, allowing 1 hour for adsorption at 37° C, or in
suspension with gentle shaking for 2 hours at room temperature. The cells were washed
before maintenance medium containing 2 per cent of the appropriate serum was added.
infrastructure
Cells were harvested using glass beads and prepared for electron microscopy. The
blocks were sectioned on an LKB Ultratome 11 and the sections viewed on a Hitachi
HU 11 A electron microscope.
Immunofluorescence
An indirect immunofluorescence test was performed on acetone-fixed (10 minutes
at 4° C) cells grown on cover-slips using a variety of human convalescent sera which
had a high complement fixing titre to cytomegalovirus. Sheep anti-human immuno¬
globulin conjugated with fluorescein isothiocyanate (Wellcome Reagents) was added,
diluted 1/10 in phosphate buffered saline (0.01 m pH 7.2) containing 2 per cent foetal
calf serum to reduce non-specific staining.
Growth Curve of AD-169 in Babbit Lung, Mink Lung and HEL Cells
For this experiment, the rabbit lung cells were first adapted to grow in the presence
of new born calf serum instead of rabbit serum, as the former was found to be toxic
for HEL cells on subsequent assay.
2 x 106 cells were put into 5 mm Petri dishes (Sterilin) in 5 ml medium and incubated
overnight. They were infected at a multiplicity of 0.3, and the incubation continued
over a period of 20 days with a change in maintenance medium every 4 days. At
intervals, plates were removed, the culture supernatant was collected and the trypsin-
ised cells frozen and thawed twice followed by ultrasonication for 1 minutes to release
cell-associated virus. Both were then assayed according to the method of Hamelin
and Lussier (7) using HEL cells in Microtitre plates (Nunc).
Labelling of Virus with 3H-Thymidine
At various times after infection of colls with AD-169, the medium was replaced
with MEM containing 1 per cent serum and 2.5 gCi/ml (methyl-3H) thymidine (The
Radiochemical Centre, Amersham), and incubation continued for a further 48 hours.
The culture supernatant was harvested, clarified at 10,000 x g for 10 minutes and then
either precipitated with an equal volume of cold saturated (NH^SCL or centrifuged
at 30,000 rpm for 1 hour in an SW40 rotor The deposit was suspended in a small
volume of buffer, 0.01 M Tris-HCl, 1 mM-EDTA, pH 7.1 (6). It was layered on to
sucrose density gradients (20 to 70 per cent) and centrifuged at 25,000 rpm for 18 hours
in an SW 40 rotor. Fractions were collected from the base of the tube, precipitated
with cold 10 per cent TCA and counted after filtration through glass fibre discs (14).
Under these conditions HCMV has a density of 1.219 g/ml (10).
Labelling of Viral DNA with 3H- Thymidine
Cells were grown in 4 roller bottles (2 51) until almost confluent (about 2 X 107 cells
per bottle), then 2 infected with AD-169 at a multiplicity of 1, and 2 left as controls.
5 days post-infection, (methyl-3H) thymidine was added as described above. 48 hours
later, the culture supernatant was collected and cells removed with glass beads.
After clarification of the culture supernatant the virus particles were deposited by
centrifugation at 30,000 rpm in an SW 40 rotor. They were resuspendod in a small
volume of buffer and purified on a sucrose gradient as above. The cells were frozen
and thawed twice followed by ultrasonication and the cell-associated virus particles
similarly purified on sucrose density gradients. The fractions from the gradients with
density 1.20 to 1.23 g/ml were pooled, diluted and the virus particles deposited by
centrifugation at 40,000 rpm for 1 hour in an S W 50 rotor. The pellet was treated with
pronase, 2 mg/ml (Boehringer), and SDS, final concentration 1 per cent, at 37° C
for 8 hours and the viral DNA banded on a 10 to 40 per cent sucrose density gradient
(10). Fractions were collected from the base of the tube, precipitated with cold 10 per
cent TCA and counted after filtration through glass fibre discs.
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DNA Polymerase Assays
The infected cell lysates were prepared and the assay carried out according to the
method described by Hirai, Furukawa and Plotkin (8), except that activated calf
thymus DNA was used in place of salmon sperm DNA as a template, and each assay
contained 10 gCi (methyl-3H) thymidine 5'-triphosphate (30 Ci/m mole; The Radio¬
chemical Centre, Amersham). The nuclear fractions (5—30 gl) were used to assay the
Fig. 1. Thin section of AD-169 infected rabbit lung cell showing an enlarged and
involuted nucleus ( X 4800)
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DNA polymerase activity. At 15 minutes intervals during incubation, 50 [xl samples
were removed, spotted on to Whatman filter paper discs which were then fixed in
cold 10 per cent TCA washed five times in cold 10 per cent TCA then twice in cold
ethanol, before being air-dried and counted in PPO-toluene scintillator in a Packard
Tri-Carb liquid scintillation instrument. Protein content of the samples was estimated
by the method of Lowky et at. (11).
To distinguish viral DNA polymerase from cellular DNA polymerase, (NHDaSCL
at a final concentration of 54 mil was added to the assay mix (8).
ltesults
Cellular Changes After Infection
When AD-169 was used to infect rabbit and mink lung cells at a multiplicity
of infection of 0.1 to 3, there was an effect on the cells easily seen by light micro¬
scopy and appearing first 2 to 3 days post-infection. The rabbit cells became
rounded and piled up in certain areas. This effect persisted for up to 2 months.
The mink cells also became rounded although, in this case, there were no focal
areas of infection. The cells continued to divide and the effect gradually dis¬
appeared over a 3 week period.
Ultra-thin sections of both cell types were examined in the electron microscope
at 5 and 15 days post-infection. No abnormalities or viral structures could be seen
in the mink lung cells at these times. However, in the rabbit lung cells, although
no whole virus particles or dense bodies could be seen, the nucleus often looked
abberrant, being enlarged and involuted. This is illustrated in Fig. 1.
Days after infection
Fig. 2. Percentage of rabbit lung (• •) and mink lung (o o) cells showing
positive nuclear immunofluorescence at various times after infection with AD-169
Immunofluorescence
Indirect immunofluorescence was carried out on AD-169 infected rabbit and
mink lung cells at various times up to 20 days post-infection, using 3 selected
human sera which gave nuclear immunofluorescence with AD-169 infected human
embryo lung cells. The infection was at a multiplicity of 1. In the mink lung cells,
there was positive immunofluorescence showing initially as uniform nuclear stain-
15 Arch. Virol. 67/3
208 Helena Hart and Mary Norval:
ing of over half of the cells, but this number decreased rapidly and all were
negative by 6 days post-infection. In contrast, in the rabbit lung cells, positive
immunofluorescence was seen in 50 per cent of the cells 1 day after infection and.
although this number diminished, 15 per cent were still positive 20 days after in¬
fection. These results are shown in Fig. 2. The cells were not subcultured during
this time. Initially, the positive immunofluorescence was associated with in-
Fig. 3. Indirect immunofluorescence on AD-169 infected rabbit lung cells a 2 days
post-infection and b 10 days post infection
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dividual cells (Fig. 3 a) but several days post-infection the positive cells were in a
form of multinuclear giant cells (Fig. 3 b).
In addition to indirect immunofluorescence, anti-complement immunofluores¬
cence was carried out on the infected rabbit lung cells and gave the same picture,
the cells being cultured for 32 days in this case.
days after infection
Fig. 4. Assay of infectious AD-169 in culture supernatant and cell-associated at various
times after infection. (Human embryo lung cells; supernatant • • , cell-associated
o o; mink lung cells, supernatant a a. cell-associated a a; rabbit
lung cells, supernatant ■ n. cell associated a □)
Growth Curves
Culture supernatants and cell lysates of mink and rabbit lung cells were assayed
at various times post-infection with AD-169 with the result shown in Fig. 4. In¬
fected HEL cells were used as a positive control. It may be seen that, in the case
of the mink lung cells, the titres of virus in the culture supernatant and cell-
associated dropped rapidly until no infectious virus was apparent 6 days after in¬
fection. The growth curve of AD-169 in rabbit lung cells showed a different
picture. There was a fairly steady and low level of infectious virus both in the
culture supernatant and cell-associated which persisted as such over the 20 day
period of the experiment.
Labelling of Virus and Viral DNA with 3II-Thymidine
3H-thymidine was added to infected rabbit, mink and human embryo lung
cells between 5 and 7 days post-infection, with subsequent assay of the culture
15*
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supernatant by sucrose density gradient centrifugation for labelled acid-insoluble
material of the density of CMV, i. e. 1.22 g/ml. While a large peak of radioactivity
was obtained at this density in the case of the culture supernatant from infected
HEL cells, no labelling was found in the culture medium of infected mink lung
cells. With the rabbit lung cells, again there was no peak of labelling at this
density. However, the picture in this case was not entirely clear due, it is thought,
to the substantial degree of cell lysis which occurred in these cells when infected.
This resulted in some labelling at a slightly lighter density than CMV and which





To clarify this situation, the material with density 1.20 to 1.23 g/ml was taken
from these gradients and the viral nucleic acid, if any, extracted and subsequently
banded on a 10 to 40 per cent sucrose gradient. In addition to the culture super¬
natant, cell lysates were also examined in this way. The result may be seen in
Fig. 5.
Using HEL cells infected with AD-169, a peak of labelled acid-insoluble mate¬
rial with density around 1.10 g/ml was found both in the culture supernatant
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(Fig. 5a) and cell-associated (Fig. 5b), which was not present in uninfected control
cells. The same experiment using mink lung cells showed no such peak, indicating
that viral DNA was not being replicated in these cells (Figure not shown). With
the rabbit lung cells, no labelling was apparent at this density in the cell lysates
'Fig. 5d) but a small peak was seen in the material from the culture supernatant
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Fig. 5d
Fig. 5. Cells infected with AD-169 and uninfected controls were labelled with 3H-
thymidine, the virus was purified from the culture supernatants and cell lysates, its
DNA extracted and run on a sucrose density gradient. The graphs show the acid-
insoluble counts per minute (cpm) of the fractions from the gradient a culture super¬
natants of human embryo lung cells (o o) and human embryo lung cells infected
with AD-169 (• e), b lysates of human embryo lung cells (o o) and human
embryo lung cells infected with AD-169 (• •), c culture supernatants of rabbit
lung cells (o o) and rabbit lung cells infected with AD-169 (• o), and
d lysates of rabbit lung cells (o o) and rabbit lung cells infected with AD-169
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DNA Polymerase Activity
It has been reported that DNA polymerase induced by HCMV is different
from the normal cellular DNA polymerase (8, 9). In particular, it was found to be
stimulated by concentrations of 50 to 100 mi (NH^SCki, which inhibit cellular
DNA polymerase activity.
The infected cells were harvested at various times after infection and the
nuclear fractions prepared. These were assayed with and without 54 mM (NH^SCU
and the counts per minute (cpm) of 3H-TTP incorporated into acid-soluble
material in 45 minutes per \ig protein was calculated. A typical assay curve for
HEL and mink lung cells is shown in Fig. 6 (a) and (b) and the total results are













Fig. 6. a DNA polymerase activity of nuclear fraction (90 gg protein) from AD-169
infected human embryo lung cells with (o o) and without (• •) 54 mM
(NH4)2804. b DNA polymerase activity of nuclear fraction (200 gg protein) from
AD-169 infected mink lung cells with (o o) and without (• •) 54 mM
(NH4)2S04
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Considering HEL-infected cells, there was an increase in DNA polymerase
activity 4 days post-infection by about 15-fold compared to the uninfected cells.
This enzymatic activity was stimulated over 2-fold by the presence of 54 mM
(NH4)2S04 in the assay mix while the control activity was inhibited. In infected
mink lung cells DNA polymerase activity was stimulated, a peak of 12-fold 2 days
after infection and gradually decreasing thereafter. However, this enzyme seemed
to be inhibited by (NI-D^SCD at all times. A very similar picture emerged for the
rabbit lung cells with a 2-fold increase of DNA polymerase activity 5 days post¬
infection, and there was no stimulation by (NH4)2S04.
Table 1. DNA polymerase activity of nuclear fractions of human embryo lung (HEL),
mink lung and rabbit lung cells, and after infection with AD-169
Increase activity
Increase in acid- with
Increase in acid- insoluble (NH4)2SO.
in acid- Pro¬ insoluble cpm in %
insoluble tein cpm in presence of activity
cpm in dSl 45 mins/pg (NH4)2S04 without
45 mins/pl ml protei n in 45 mins/pl (NH4)2SO
HEL cells 460 7.8 59 336 73
4 days after infection 16,200 17.8 910 33,690 208
Mink lung cells 120 2.9 41 108 90
1 day after infection 1,750 6.3 278 1,950 111
2 days after infection 3,350 6.6 508 3,240 97
5 days after infection 3,000 8.9 337 1,500 50
10 days after infection 600 5.0 120 600 100
Rabbit lung cells 250 2.6 96 175 70
2 days after infection 533 3.8 140 500 93
5 days after infection 1,000 4.8 208 1,225 109
10 days after infection 290 2.2 132 272 94
Discussion
We were interested to understand the association of AD-169 with mink and
rabbit lung cells. All experiments detailed here indicated that mink lung cells
were not capable of supporting replication or persistence of HCMV. There was an
initial toxic effect, followed by recovery of the cells within a few days. Immuno¬
fluorescence results indicated that infection was initiated but aborted at an early
stage as no positive cells remained 6 days after infection. Growth curves of virus
in the medium and the cells corroborated this. No virus or viral-induced structures
were seen on electron microscopy of ultra-thin sections and there was no induction
of viral DNA polymerase activity detectable in infected cells. In addition, no
labelling of virus or viral DNA with 3H-thymidine in infected cells was obtained.
It has been reported (3) that rabbit lung cells may be infected with AD-169,
the virus being produced for the first 3 days after infection, and not thereafter,
although it could be recovered by co-cultivation with human embryo cells even
after 28 days in culture. Immunofluorescence showed 40 per cent of the cells with
nuclear fluorescence at this time and in 10 per cent it was thought that some early
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proteins had accumulated to give large fluorescent granules, perhaps indicating a
block in replication. Our experiments would support the idea of a long-term
persistent infection of rabbit lung cells with HCMV, but in our system small
amounts of infectious virus were released from the cells at a fairly constant rate
over 4 weeks after infection. This could be measured by assay of the culture
supernatant for infectious virus, and also by assay of viral DNA in the culture
supernatant after labelling with 3H-thymidine. Measurement of DNA polymerase
activity did not indicate induction of an enzyme with the properties of HCMV
DNA polymerase. However, this is probably not a sufficiently sensitve method if
only a small number of rabbit lung cells from the culture were capable of produc¬
ing virus at any time and the block in the remainder is at or before this point.
The mechanism of the low grade persistent infection is not clear but it seems
evident that there is a restriction of viral replication in rabbit cells, as has already
been described in mouse cells (1). In addition, recent work by Mocarski and
Stinski (13) indicated that HCMV genome can persist over long periods if the
virus is used to infect human fibroblasts at high multiplicities. Non-productive
cells continued to grow and some of these spontaneously converted to productive
viral infection. It was assumed that all sequences of the viral genome remained in
the cells after infection and that viral gene expression was restricted in some way
in the non-productive cells. The same situation may apply to the rabbit lung cells.
Certainly, focal areas of infection could be seen even 28 days after infection and
infectious virus was continously being produced at low level over this time. It may
be that some host function is required to complete the viral replicative cycle
which is seldom present, perhaps only being found in the rabbit lung cells at
certain stages of the growth cycle. At other times the viral genome would become
latent. It is still expressed, however, in 15 per cent of the cells as early antigens as
shown by nuclear immunofluorescence up to one month after infection.
The question of latency of cytomegalovirus is an important one as this virus
persists in man over many years, even in the presence of the host immune response.
The cell type(s) and site(s) in the body of this persistence are uncertain but there
may be a mechanism similar to that demonstrated here for rabbit lung cells,
whereby cells are infected latently, with a small proportion of the population being
capable of productive infection at any one time. The virus so produced could in¬
fect new cells and perpetuate the chronic state.
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Lack of association of cytomegalovirus with
adenocarcinoma of the colon
HELENA HART, W A NEILL, AND MARY NORVAL*
From the Department of Bacteriology, University of Edinburgh Medical School, Edinburgh
summary Tumour specimens from patients with adenocarcinoma of the colon or rectum were
examined for the presence of cytomegalovirus (CMV), and specimens of normal mucosa from the
same patients were studied in parallel. Frozen sections of 14 specimens were made and the presence
of CMV mRNA assayed by in situ hybridisation using 3H-labelled CMV-DNA as a probe. Nine of
these sections were also tested for cytomegalovirus antigens by immunofluorescence. No viral
nucleic acids or antigens were detected. In addition to these direct approaches, the specimens were
disaggregated and 19 were successfully cultured in various media over several months without
yielding virus on any occasion. Areas containing epithelial cells were found in some cultures, foci
of bipolar cells in otheis, while, in several, fibroblastic cells predominated. To ensure that any
virus-containing cells were not lost by this method, the disaggregated tumour and normal intestinal
cells were directly co-cultivated and also fused with human embryo lung cells, which are permissive
for cytomegalovirus replication. The resulting cultures were examined over two to three months for
the presence of cytomegalovirus, and in no instance was virus found, despite attempted induction
by iododeoxyuridine. Two fusion cultures became contaminated with cytomegalovirus, strain
AD-169, which was being handled in the laboratory at the same time. The strain was identified by
the pattern of viral DNA fragments produced by restriction endonuclease cleavage. Thus the
accidental passage of virus in the heterokaryons did not alter its DNA and would further indicate
the absence of any cytomegalovirus genomes in the adenocarcinoma cells.
Two groups have presented evidence recently that
cytomegalovirus may be involved in adenocarcinoma
of the colon. In the first place, colonic tissues from
seven adenocarcinoma cases were analysed by
cRNA-DNA hybridisation and over 50% contained
more than two genome equivalents/cell.1 Most
control tissue obtained from normal colon and cases
of Crohn's disease was negative. Secondly, several
cases of adenocarcinoma of the colon were investi¬
gated by long-term culture of the tumour fragments.2
Eight cell lines grew out, consisting mainly of fibro¬
blastic cells, and cytomegalovirus was isolated from
three of these. It was identified by electron micro¬
scopy, cytology of infected cells, and by immuno¬
fluorescence.
In both these situations, it is not known whether
cytomegalovirus might be the aetiological agent or is
•Address for correspondence: Dr M Norval, Department of
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merely reactivated from a latent state. It is of interest
in this context that cytomegalovirus has been found
in the gastrointestinal tract, and is claimed to be
associated with chronic or debilitating diseases such
as ulcerative colitis or intestinal ulcers.3 Cytomegalo¬
virus was isolated from three out of six cases of
ulcerative colitis, and one out of four cases of
regional enteritis by tissue culture.4 In addition,
cytomegalovirus inclusions were reported in macro¬
phages and fibroblasts located in granulation tissues
at the base of deep ulcerations in the colon and ileum
and within endothelial cells in several cases of
ulcerative colitis.5 On the other hand, no virus was
found after culture of cells from patients with
Crohn's disease.3
Here we report our attempts to analyse further the
association of cytomegalovirus with colon adenocar¬
cinoma cells. In the first place, the results of cultuiing
the tumour cells from 19 patients are given, also the
results of co-cultivating and fusing these with human
embryo lung cells which are permissive for human
cytomegalovirus replication. The heterokaryons
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produced from the fusions were treated with
iododeoxyuridine to overcome the cellular control
which might operate in such a situation.7 The
presence of cytomegalovirus was assayed by the
observation of cytopathic effect and labelling with
3H-thymidine. The cytomegalovirus isolates obtained
were characterised by analysis of fragments produced
by the restriction endonucleases EcoRI, Bgl II, and
Hind HI.
Secondly, 14 adenocarcinoma specimens were
examined directly, as frozen sections, for cytomegalo¬
virus antigens using immunofluorescence and for
cytomegalovirus nucleic acids by in situ hybridisa¬




Surgically resected specimens of colon or rectum
were obtained from the Royal Infirmary, Edinburgh,
within a few minutes of being removed from the
patient. Control specimens included pieces of
normal colonic wall from the same patient, and
others with Crohn's disease, ulcerative colitis,
and diverticular disease. They underwent routine
pathological examination, the diagnosis being based
on this result. As soon as possible, and generally
within two hours of the operation, small pieces of
tumour (about 3 mm3) and part of the normal colon
were frozen by dropping into liquid nitrogen and
were subsequently used to prepare 5 pm-thick frozen
sections. These were stored at —20°C until required
for immunofluorescence and in situ hybiidisation
studies. In addition, for culturing, similar small
pieces were removed, finely minced and treated for
one hour at 37°C in Earle's salt-based Eagle's
medium containing 100 IU/ml gentamicin, 100
IU/ml mycostatin, 100 IU/ml penicillin, and 100
pg/ml streptomycin. Soft tumours 'spilled out' cells
during this time and these were used for culture,
fusion, and co-cultivation experiments. Hard
tumours and normal colon were digested with
collagenase/dispase according to the manufacturer's
instruction (Boehringer Mannheim) to obtain single
cells.
The separated cells were used directly for culture
in Eagle's medium containing antibiotics as above
and supplemented with 10% fetal calf serum. They
were seeded into Falcon flasks (Nunc) and observed
for any morphological change over periods of two
to three months. Latterly, a modification of this
medium was used which contained D-valine.8
The disaggregated cells were also used for co-
cultivation experiments after mixing with an equal
number of human embryo lung cells. They were
examined over the next two to three months, being
subcultured three or four times in this interval.
CELLS
Human embryo lung cells were obtained by tryp-
sinising human fetal lungs and seeding the cells
in Eagle's medium supplemented with 10% fetal
calf serum and containing 100 IU/ml penicillin
and 100 pg/ml streptomycin. Confluent fibroblastic
monolayers were passed by trypsinisation and used
between passage numbers 5-20, being grown in
Eagle's medium with 5% newborn calf serum and
being maintained in the same medium with 2%
newborn calf serum. They were free of Mycoplasma
contamination.
Two colon adenocarcinoma cell lines were
obtained. HX18 line was kindly donated by Dr
Courtenay who has described the growth and
characteristics of these cells.9 The other line came
from Dr L K Woods and Dr G E Moore and has
been described elsewhere.10 Both cell lines grew in
suspension, forming large clumps similar to those
observed in fresh specimens of colon adenocar¬
cinoma tumours. Both were grown in Eagle's
medium with 10% fetal calf serum and antibiotics
as for the human embryo lung cells above. They
were contaminated with Mycoplasma species.
FUSION USING POLYETHYLENE GLYCOL
Initially, 'spill out' cells from adenocarcinoma
specimens and disaggregated cells from normal
colon were used directly for fusion. Latterly, the
tumour cells were separated from the other cell
types and non-viable cells by gravity sedimentation
through 10 ml fetal calf serum for one hour at
room temperature before fusion. The viable tumour
cell clumps which formed were fused with human
embryo lung cells using the method of Pontecorvo11,
which was slightly modified as already described and
illustrated.12 Various numbers of tumour and normal
colonic cells were fused with 2x 106 human embyro
lung cells.
STIMULATION OF VIRUS PRODUCTION BY
IODODEOXYURIDINE
Four weeks after the fusion, in the absence of a
cytopathic effect, 20 /ig/ml iododeoxyuridine (IUDR)
was added to the medium for four days. It was then
removed and the cultures observed as below for the
presence of cytomegalovirus.
EXAMINATION OF CULTURES FOR THE
PRESENCE OF CYTOMEGALOVIRUS
Cultured, co-cultivated, and fused colonic cells
were examined over two to three months in the
following ways: (1) microscopically for changes to
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the cell sheet indicative of a cytopathic effect; (2)
by labelling with 4 pCi/ml 3H-thymidine for 48
hours and analysing the concentrated culture
supernatant by sucrose density centrifugation;13
(3) by anti-complement immunofluorescence14
(ACIF) with cytomegalovirus seropositive human
sera at a dilution of 1/20 and human complement,
seronegative for cytomegalovirus. Anti-human C3
fluorescein tagged conjugate (Hyland) was used at
1/20 dilution.
The cytomegalovirus seropositive sera were
tested by complement fixation and had titres of
2048. All contained antibodies to cytomegalovirus
early and late antigens as judged by anti-complement
immunofluorescence on human embryo lung cells
infected with AD-169 two days post-infection and
blocked with 40 pg/ml cytosine arabinoside (Sigma
Chemical Company) (early), and on human embryo




A modification of the method of Kilpatrick et al.u
and Huang (personal communication) was followed,
using the DNA from infected cells rather than
extracellular virus which may be difficult to obtain
in large quantities from clinical isolates. Briefly,
4 x 10' human embryo lung cells which had been
infected with cytomegalovirus were labelled with 32P
(as orthophosphate in aqueous solution, carrier free,
The Radiochemical Centre, Amersham) at 40
pCi/ml in low phosphate medium, supplemented
with 2% dialysed newborn calf serum. After three
days, the labelled cells were washed twice with
0-01M Tris-HCl buffered saline pH 7-4, and
digested with 1 mg/ml pronase (Boehringer Mann¬
heim) and 1 % sodium dodecyl sulphate in lysis
buffer (0-05M Tris-HCl, 0-01M EDTA, pH 8-0)
for four hours at 37°. DNA was extracted using
water-saturated phenol, precipitated with ethanol,
and redissolved in buffer. It was purified by caesium
chloride equilibrium density centrifugation. Frac¬
tions of density 1 -71—1 -73 g/m were pooled, dialysed
overnight, precipitated with 2-5 volumes ethanol,
and stored at — 20°C until required. Then they were
redissolved in 50 pi buffer containing 0-01M
Tris-HCl, 0-001M EDTA, pH 7-4. Samples
containing 10 000 counts per minute were digested
with restriction endonucleases EcoR 1, Bgl II, and
Hind III (Millipore UK Ltd) in appropriate
digestion buffers for two hours at 37°C. The
restriction endonuclease fragments so produced
were analysed on 1 % agarose gels as described
previously.13
IN SITU HYBRIDISATION
Cytomegalovirus DNA was prepared as already out¬
lined.18 Briefly, human cytomegalovirus, strain AD-
169, was grown in human embryo lung cells and,
after concentration by centrifugation of the culture
supernatant, was purified by sucrose density
gradient centrifugation. The band with density
1-20-1-23 g/ml was collected and re-purified on a
second sucrose gradient. Viral DNA was extracted
using SDS and proteinase K followed by banding in
a 10-40 % sucrose gradient. Viral DNA was extracted
twice with phenol and precipitated with ethanol. It
was finally banded by CsCl equilibrium density
centrifugation, and the fractions with density
1 -705-1 -725 g/ml pooled, dialysed overnight, and the
DNA precipitated with ethanol. The precipitate was
dissolved finally in TES buffer (0-05M Tris-HCl,
0-15M NaCl, 0-005M EDTA, pH 7-4) at a con¬
centration of 50 pg/ml.
Nick-translation was then carried out,17 the
reaction mixture containing all four nucleotide
triphosphates labelled with tritium (Amersham) and
incubation continuing for five hours. Cpm/pg
nucleic acid after separation on a Sephadex G50
column was around 107.
In situ hybridisation was carried out on frozen
sections of colon which were fixed in ethanol:
acetic acid, 3:1, for 10 minutes at — 20°C just before
use, according to the method obtained from Rapp's
laboratory.
IMMUNOFLUORESCENCE
The technique of amplified direct immuno¬
fluorescence (AMDI) as described by Schmitz and
Kampa18 was used for the detection of cytomegalo¬
virus antigens on frozen sections of tumour and
normal colons. Two human sera were selected with
antibodies to cytomegalovirus early antigens. Both
had complement fixation titres of 1024 and, by
ACIF, both stained only nuclei from cytomegalo-
virus-infected human embryo lung cells, one giving
mainly a general nuclear staining and the other show¬
ing granular staining on early-infected nuclei. No
non-specific antinuclear staining was present. These
sera were labelled with fluorescein iso-thiocyanate,
isomer I (FITC, Fluka 46952).1' For the AMDI test,
the frozen sections were pre-incubated with human
sera, negative for cytomegalovirus, at a dilution of
1/10 for one hour at room temperature. This was
followed by the FITC-labelled human sera at a
dilution of 1/100, then rabbit anti-FITC serum at a
dilution of 1/160, which had been kindly donated by
Drs Schmitz and Kampa. Finally, anti-rabbit IgG
labelled with FITC (Wellcome Laboratories) was
used at 1/16.
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Results
CULTURE OF TUMOUR CELLS
Cell cultures were set up from tumour specimens of
35 patients who were diagnosed histologically as
having adenocarcinoma of the colon or rectum.
Fig. 1 Epithelial cells obtained on culture of colonic
adenocarcinoma specimen, x 211, phase contrast. (In this
and the followingfigures original magnifications are given.)
Fig. 2 Island of epithelial cells derived from colonic
adenocarcinoma after co-cultivation with human embryo
lung cells, x 211, phase contrast.
Cell growth was obtained in 19 of these. Areas of
epithelial cells were observed in seven cultures,
occasionally only when co-cultivated with human
embryo lung cells. These are shown in Figs. 1 and
2. They appeared after two to three days in culture
and persisted for two weeks to three months,
dividing several times in this interval. However,
attempts to subculture them were always un¬
successful, so that no lines of epithelial cells derived
from adenocarcinomas have been established. The
use of medium containing D-valine did not increase
the number of epithelial cells obtained, promote their
growth, or help maintain them on subculture.
Cultures containing discrete foci of bipolar cells,
which have been described by Leibovitz et al,-° were
sometimes seen and are demonstrated in Fig. 3.
These cells also failed to grow on subculture.
Cells with characteristic fibroblastic morphology
grew out from seven specimens and are shown in
Fig. 4. These could be successfully subcultured at
Fig. 3 Bipolar cells obtained on culture of colonic adeno¬
carcinoma specimen, x 825, phase contrast.
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Fig. 4 Fibroblastic celts obtained on culture of colonic adenocarcinoma specimen, x 825, phase contrast.
two-weekly intervals for periods of up to four
months. In one case, a mixture of fibroblasts and
epithelial cells was obtained.
All cultures were observed microscopically every
week, and at no time was a cytopathic effect apparent.
In addition to culturing cells from tumour
specimens, pieces of normal intestinal mucosa from
the same patient were used. All 17 cultures set up
from this source grew as fibroblasts, identical with
those fibroblastic cells obtained from the seven
adenocarcinomas described above. Again, no
cytopathic effect was apparent over a three month
period of observation.
A summary is given in Table 1 of the types of
cells which were obtained on culture from the
carcinoma specimens, together with the degree of
differentiation of the tumour and the Dukes's stage.
Table 1 Details of cell type obtained on culture of
colonic or rectal carcinomas, degree of differentiation of








Fibroblastic 0 1 2 1 1 2
Epithelial 0 4 0 1 2 0
Bipolar 2 1 0 0 2 1
No growth 0 7 6 0 2 1
CO-CULTIVATION
Equal numbers of viable cells from adenocarcinoma
of the colon or rectum and cells from pieces of
normal colon were mixed with human embryo lung
cells and used to seed Falcon flasks. Specimens from
six patients were used, three of Dukes's stage B
moderately differentiated, one of stage B poorly
differentiated, one of stage C well differentiated, and
one of stage C moderately differentiaied.
Initially, there was a cytotoxic effect on the
human embryo lung cells, so that, after two or three
days in culture, some were detached and others more
rounded and granular than normal. The ones which
survived gradually grew out into monolayers, this
taking about a month. Some colonic cells with a
different morphology from human embryo lung cells
persisted over this time also. The cultures were split
at about monthly intervals and observed micro¬
scopically over two to three months for cytopathic
effect. None was seen, although sometimes the cells
looked granular and did not grow as quickly as
normal. Labelling of the cultures with 3H-thymidine
followed by sucrose density gradient centrifugation
of the concentrated culture supernatant did not
reveal radioactive material with the density of
cytomegalovirus.
FUSION
Paired samples of fresh tumour and normal colonic
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Table 2 Details ofspecimens used in fusion experiments, together with viable counts of tumour cells and observations of
cytopathic effect (CPE) before and after treatment with IUDR
Number Diagnosis Degree of Dukes's stage Number of viable Comments on CPE CPE after
differentiation of tumour of carcinoma cells obtained tumour cell IUDR treatment
for fusion suspension
before fusion
790004 Rectal carcinoma Moderate B T 2xl0<s 20% viable
N 2 x 106 — —
790020 Rectal carcinoma Moderate B T 4x 106 Large numbers + + O
N 4x 103 of polymorphs + + + 0
790021 Colon carcinoma Moderate with foci of B T 6x 106 10% viable + + + o
poorer differentiation N 106 — o
790028 Colon carcinoma Moderate B T 2-5x103 80% viable — —
N 106 clumps — —
790043 Colon carcinoma Moderate A T 2-4 x 103 80% viable — —
N l-5x 106 clumps — —
790046 Colon carcinoma Moderate B T 2x106 80% viable — —
N 4x 106 clumps — —
790083 Colon carcinoma Moderate B T 106 90% viable — —
N 106 — —
790088 Colon carcinoma Poor C T 5x 103 90% viable — —
N 2x 106 — —
Tumour cells from specimens 790028-790088 were purified by gravity sedimentation through fetal calf serum before fusion. T: cells from tumour.
N: cells from normal mucosa of same patient. CPE: cytopathic effect. + + +, + +, + : degrees of CPE. —: negative result. O: not done or not
tested.
mucosal cells were fused with human embryo lung
cells. The diagnosis of patients from whom the
specimens were obtained is given in Table 2.
Initially, it was found that the disaggregated tumour
contained a mixture of cells whose viability ranged
from 10-20%. Gravity sedimentation through a
layer of fetal calf serum increased the purity and
number of viable cell clumps to 80-90% and these
were used latterly for the fusion (Table 2). The
cultures of fused cells were observed for periods of
two months. On two separate occasions a cytopathic
effect was observed in the heterokaryons from two
patients—namely, 790020 and 790021—five and six
weeks respectively after the fusion.
These isolates proved to be cytomegalovirus by
anti-complement immunofluorescence and by
labelling with 3H-thymidine, followed by sucrose
density gradient centrifugation, which revealed
particles of the same density as that of cytomegalo¬
virus.
They were further analysed by restriction
endonuclease cleavage of the viral DNA. The
fragments produced showed complete identity with
AD-169 strain of cytomegalovirus (Fig. 5). The virus
labelled 790021T had an extra band of high molecular
weight which was thought to represent incomplete
digestion rather than any real difference in the
pattern. Strain AD-169 was being used in the
laboratory at the same time as these cultures. Great
care, including the use of a separate room, was taken
to handle the clinical specimens away from this
virus, but it had to be assumed that contamination
had occurred on these two occasions, as it is hardly
possible that both "strains isolated should have the
characteristics of AD-169.
No viruses were isolated from subsequent fusions.
This was judged by (1) absence of cytopathic effect
over a period of two months, even after attempted
stimulation of virus production with IUDR; (2)
labelling with 3H-thymidine two months after the
fusion to ensure that the absence of cytopathic effect
also meant the absence of productive viral infection;
and (3) anti-complement immunofluorescence which
was negative on both the unstimulated and IUDR-
stimulated heterok,aryons using three specially
selected high titre sera with antibodies to cytomegalo¬
virus early and late antigens.
In addition to the fusion attempts with freshly
isolated tumour ceils, the two adenocaicinoma cell
lines were fused with human embryo lung cells. No
virus was rescued from these even after IUDR
treatment. Also both the original colonic lines and
their heterokaryons did not express the cytomegalo¬
virus early or late antigens as tested by anti-
complement immunofluorescence.
IN SITU HYBRIDISATION
The patients from whom the specimens were obtained
for in situ hybridisation are shown in Table 3 along
with the pathological diagnosis. In each case a piece
of tumour was used to make frozen sections and also
a piece of normal intestine away from the site of the
tumour. These sections, were subjected to in situ
hybridisation to assay for cytomegalovirus mRNA
within the cells using 3H-labelled DNA of cytomega¬
lovirus as a probe. As a positive control, human
embryo lung cells were infected with cytomegalo¬
virus and fixed two days after infection. When
developed, after hybridisation and autoradiography,
the infected cells showed an average of over 100
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Fig. 5 Restriction endonuclease patterns ofDNA from cytomegalovirus strain AD-169, and cytomegalovirus passaged
in heterokaryons of human embryo lung cells fused with normal IN) and tumour (T) colonic cells ofpatient 790020, and
tumour (T) colonic cells of patient 790021. The viral DNA was digested with EcoRl, Bglll, and Hindlll endonucleases.
Table 3 Specimens usedform situ hybridisation with CMV'H-DNA asprobe, andfor amplifieddirect immunofluorescence with
human CMV antisera







790020 Rectal adenocarcinoma F 57
790082 Diverticular disease F 70
790083 Colonic adenocarcinoma F 84
790084 Colonic adenocarcinoma F 74
790111 Colonic adenocarcinoma F 73
790112 Colonic adenocarcinoma M 57
80037 Caecai adenocarcinoma M 50
80045 Colonic adenocarcinoma F 83
80046 Rectal adenocarcinoma M 76
80054 Caecai adenocarcinoma M 75
80055 Caecai adenocarcinoma F 69
80067 Colonic adenocarcinoma M 59
80084 Caecai adenocarcinoma F 63
80085 Caecai adenocarcinoma F 81
80105 Caecai adenocarcinoma M 75
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grains per cell, while the uninfected cells had less
than 2 grains per cell.
For the frozen sections, both of tumour and
normal tissue, in no case was any cell seen in which
there were more than 2 grains, and all were concluded
to be negative.
IMMUNOFLUORESCENCE
The technique of AMDI was used to examine the
sections of human tissue for cytomegalovirus
antigens as the background staining obtained by
ACIF and indirect immunofluorescence was un¬
acceptable. This might be due to complement
receptors,21 or to antibody-antigen complexes
present on the surface of the mucosal epithelial cells.
In common with many other groups, attempts to
produce animal sera with sufficient amounts of anti¬
body to early antigens were not successful. When
AMDI was used on human embryo lung cells
infected with cytomegalovirus, the pattern of im¬
munofluorescence appeared as a uniform staining of
nuclear antigens (Fig. 6).
Fig. 6 AD-169 infected human embryo lung cells (early
antigens) strained by amplified direct immunofluorescence
(AMDI) showing a uniform staining of nuclear antigens.
Frozen sections from nine paired specimens of
adenocarcinoma and normal gut mucosa were
screened by AMDI as shown in Table 3 and all were
negative. Occasionally, immunofluorescence was
seen in the normal mucosa adjacent to the tumour.
This seemed to be due to the cross-reactivity of
batches of FITC anti-rabbit IgG with human IgG,
and could be eliminated by selecting non-cross-
reactive conjugates.
Discussion
Cytomegalovirus has been isolated from several
cases of adenocarcinoma of the colon by long-term
culture of the tumour tissue.2 The cells which grew
out were fibroblastic in appearance with less than 1 %
being epithelial, these being lost on subculture.
Cytomegalovirus was not apparent until several
weeks after initiation of the culture. In the work
reported here, long-term cultures of adenocarcinoma
tissues did not yield cytomegalovirus on any
occasion. The cells which grew were sometimes
fibroblastic, although a medium containing D-valine
was used in an attempt to inhibit these.8 Small areas
containing tightly packed epithelial cells were seen
in about 30% of the cultures a few days after the
initiation; these were subsequently lost on sub¬
culture.
As cells containing cytomegalovirus might not be
the ones which survived and grew in culture, we also
used the techniques of co-cultivation and fusion with
cells permissive for cytomegalovirus replication. It
has been shown in several systems that, if a whole
viral genome is present in a transformed cell, it can
be rescued in this way. One example is the lympho-
blastoid Raji cell line which contains 50-60 copies of
Epstein Barr virus DNA but does not produce
infectious virions unless fused with D-98 (a derivative
of HeLa cells) and induced with IUDR.22
Of the Herpes viruses, the transforming ability of
cytomegalovirus is least well known, although it has
been shown to have the potential to transform in
several in vitro systems23"25. However, the low
numbers of successful examples of such transforma¬
tions might indicate that an event of tumour
promotion is required in addition to the initial viral
stimulation of cell DNA.2' It is possible, for example,
that human cytomegalovirus could be responsible
for transformation of the mucosal cells of the
epithelial lining of the large bowel and that this
process is promoted by dietary factors or bile salts.
Transformation by cytomegalovirus of epithelial
cells has not been reported in vitro. The virus seems
to undergo a low semi-permissive type of replication
in human epithelial amnion cells,27 human lung
epithelial cells,28 and human ecto- and endo-
cervical cells.39
Both co-cultivation and fusion experiments did
not yield infectious cytomegalovirus even after
prolonged culture. In addition, treatment with
IUDR, which has been shown to be necessary for
activation of cytomegalovirus from a latent state in
heterokaryons of non-permissive cells,7 did not
induce any virus. On two occasions accidental
contamination with AD-169 strain of cytomegalo¬
virus occurred, despite great care being taken in the
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handling of these long-term cultures. It was of
interest, however, that the fragments produced by
restriction endonuclease cleavage of viral DNA were
identical for the virus grown in human embryo lung
cells and that passaged in the adenocarcinoma
tumour cell-human embryo cell heterokaryons. This
does not suggest a recombination with other
cytomegalovirus genetic material which might be
present in the colonic cells.
Of course, it is possible that either the whole
genome is not present in the adenocarcinoma
cells or that it cannot be rescued by such culture
methods. The latter is true of another transforming
virus, Adeno type 12, which recently has been
shown to induce rat brain tumors in vivo and to
integrate the entire viral genome in the host cell.
However, no infectious virus could be obtained from
subsequent fusions or co-cultivations of the tumour
cells with permissive cells.30
Therefore, two more direct approaches were
used during this work—firstly, AMD I to detect
cytomegalovirus antigens on frozen sections of
adenocarcinoma and normal intestinal specimens,
and secondly in situ hybridisation to detect cyto¬
megalovirus mRNA.
Looking for viral antigens by an AMDI test
has proved a good approach where the availability
of specific animal antiviral serum is limited by the
restriction of viral replication to human cells, as is
the case with cytomegalovirus. Until a mixture of
monclonal antibodies detecting a range of early and
late cytomegalovirus antigens is available, antibody-
positive human sera are the least cross-reactive
reagents with human biopsies. No immunofluores¬
cence was found using the two human sera selected,
although they contained antibodies to early and late
cytomegalovirus antigens, and thus no cytomegalo¬
virus antigens were shown to be present in the
tumour or normal intestinal cells.
In situ hybridisation has proved a useful technique
in many systems to search for the presence of viral
nucleic acids in cells where there is no productive
infection—for example, it has been used to detect
Herpes simplex type 2 mRNA in sections prepared
from frozen biopsies of patients with cervical
dysplasia.31 This method has the considerable
advantage of picking out perhaps only one or two
cells in the section which might contain viral mRN
and, in addition, there should be amplification of
any viral information by assaying the mRNA
rather than DNA. No hybridisation was found in
the intestinal tumour or normal sections with
cytomegalovirus 3H-DNA as probe. Huang and
Roche used another hybridisation' technique—that
of membrane cRNA-DNA hybridisation, which
detects viral DNA extracted from the tumour
specimens—and found that more than 50% of
patients with adenocarcinoma of the colon had
greater than 2 genome equivalents of CMV/cell.1
However, veiy recently, this work has not been
corroborated using a DNA-DNA reassociation
kinetics test which had an estimated sensitivity
of 0-3 genomes equivalents per cell. No cytomegalo¬
virus DNA was detected in biopsy specimens from
seven patients with adenocarcinoma of the colon.32
Such a method has given positive results in examin¬
ing tumour cells of patients with Kaposi's sarcoma
cytomegalovirus genomes.33 Thus, there is con¬
siderable doubt as to whether the colonic adeno¬
carcinoma cells contain any cytomegalovirus DNA,
although it may not be possible to detect a smaller
(<0-3 genome equivalents) fragment of viral DNA.
However, a smaller fragment amplified as mRNA or
specific viral protein could be detected by in situ
hybridisation and AMDI immunofluorescence.
We conclude, therefore, that cytomegalovirus
is unlikely to contribute to the maintenance of the
transformed phenotype of the adenocarcinoma
cells and that there is no localised cytomegalovirus
reactivation contiguous to the tumour, a situation
observed in metastatic nasopharyngeal carcinoma.34
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Lack of Association of Cytomegalovirus Antibody Level
with Carcinoma of the Uterine Cervix
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Abstract. Serum samples were collected from 199 patients attending a gynaecological
clinic, colposcopy specimens being taken at the same time for routine pathology ofparaffin
sections which ranged from normal, through the degrees of dysplasia to carcinoma in situ.
Other parameters noted were age, number of pregnancies and time since last pregnancy.
When level of antibody to cytomegalovirus in each serum sample was tested by ELISA,
anti-complement immunofluorescence and neutralisation, no correlation was found be¬
tween antibody titre and pathological diagnosis. The only interdependence seen was that,
as the age of the patients increased, so did the frequency of sero-positivity to cytomegalo¬
virus. Also in the group studied the frequency of carcinoma in situ was not age depen¬
dent.
Introduction
The association of cytomegalovirus (CMV) with carcinoma of the uter¬
ine cervix has been tentatively suggested both by some sero-epidemiologi-
cal surveys and, more recently, by virus isolations. In addition, CMV has
been found in semen as well as the urogenital tract, may be associated with
venereal diseases and has been demonstrated to have oncogenic potential
[Melnick et al., 1974], Vestergaard et al. [1972] reported a significantly
higher level ofantibody to CMV in sera from patients with newly diagnosed
cervical carcinoma compared to matched controls, although this was not
found by Fuccillo et al. [1971] when looking at antibody levels in patients
prior to the development of carcinoma in situ. Pasca et al. [1975] found
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antibodies to CMV more frequently in sera of women with atypia than in
women with cervical disorders other than atypia and in controls. Lastly, in
1978, Melnick et al. isolated CMV from two cell cultures derived from
cervical biopsies of patients with advanced carcinoma.
The serological surveys mentioned above were performed using a com¬
plement fixation test and newer methods such as enzyme-linked immuno¬
sorbent assays (ELISA) and anti-complement immunofluorescence (ACIF)
known to be more sensitive [Booth et al., 1979], as well as by measuring
different classes of antibody. Thus we decided to take a group of women
with cervical disorders ranging from mild, moderate and severe dysplasia to
carcinoma in situ and to measure their circulating antibody titre to CMV,
using three methods, namely ELISA, ACIF and neutralisation. These
results were then correlated with their age, parity, time since last pregnancy
and histological diagnosis of colposcopy specimens taken on the day of
serum sampling
Materials and Methods
199 sera and colposcopy specimens were collected over a period of 2 years from
patients attending the Gynaecology Outpatients Department at the Royal Infirmary of
Edinburgh. These patients all had abnormal cervical smears and were referred for further
investigation. The colposcopy specimens were paraffin-embedded for routine pathology
examination and the patients subsequently divided into six groups on the basis of this
result, namely: (1) normal, 18 patients; (2) abnormal, but no dysplasia, 25 patients; (3) mild
dysplasia, 14 patients; (4) moderate dysplasia, 38 patients; (5) severe dysplasia, 63 patients,
and (6) carcinoma in situ, 41 patients. In cases where different degrees of dysplasia were
reported in specimens from the same patient, the most severe degree was used for place¬
ment in the group. The patients were not matched individually but additional parameters
of age, parity, date of last delivery or termination of pregnancy were noted and their
distribution compared for each group.
The tests used for detection of antibodies to CMV were ELISA, ACIF and neutralis¬
ation. These were carried out in batches of 35 samples and always included duplicates from
other batches.
ELISA
This was carried out as described by Booth et al. [1979]. Titres ranged from < 10 to
12,800.
ACIF
This was designed to detect antibodies to early CMV antigens, using the method of
Kettering et al. [1977] in outline. Human embryo fibroblasts were infected with CMV
strain AD-169, in the presence of 40pg/ml cytosine arabinoside and harvested 48 h after
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infection. 2 X 104 cells/spot were placed on multispot slides (Hendley-Essex), allowed to
dry in air and fixed in cold acetone for 10 min. Doubling dilutions of sera starting at 1/10
were allowed to react for 1 h at 37 °C, human complement (serum sero-negative for CMV)
was used at a dilution of 1/4 overnight at 4 °C, and anti-human complement C3 labelled
with FITC (Hylland Division of Travenol Laboratories) at 1/40 reacted for 1 h at 37 °C.
Titres ranged from < 10 to 160.
Neutralisation
Serum samples were inactivated at 56 °C for 30 min, then doubling dilutions were
allowed to react for 30 min at 37 ° C with equal volumes ofCMV strain AD-169 containing
50PFU/10pl. 10 pi samples were assayed for any residual viral activity using human
embryo fibroblasts grown on microtitre plates (Sterilin). The titre was expressed as the
highest dilution of serum producing a 50% or greater reduction in the plaque count and
ranged from < 2 to 128.
Statistical Analysis
This was carried out by the Statistical Unit at the Western General Hospital, Edin¬
burgh, using the Health Sciences Computing Facility of the University of California. Two-
way contingency tables of serological results by each of the three methods showed inde¬
pendence between batches of sera. Four-way contingency tables of serological results and
pathological diagnosis were drawn up, also four-way contingency tables of pathological
diagnosis, age, parity and time since last delivery or termination of pregnancy. ANOVA of
serological results by pathological diagnosis and age was calculated using no transforma¬
tion and log transformation. Three age groups were made for this, 18-27 years, 28-37 years
and over 38 years.
Results
The distribution of the patients' parameters, age, parity and time since
last delivery or termination of pregnancy was calculated in each of the six
groups. Using four-way contingency tables, there was no significant differ¬
ence between any of these factors.
Initially, the results of the three antibody tests to cytomegalovirus,
ACIF, ELISA and neutralisation were divided into positive and negative,
taking as negative titres of < 10 in the ACIF test, <100 in the ELISA
test and < 2 in the neutralisation test; titres greater than these were taken
as being positive. A four-way contingency table analysis of these results
showed independence with respect to the pathological diagnosis of the
patients. Thus, for example, there was no correlation of the presence of
CMV antibody in any of the three tests with the carcinoma group as
might have been expected if CMV was associated with this condition.
There was a strong interdependence of the three tests used so that if one
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was positive, the other two had a very significant tendency to be positive
also.
In addition to the division of serological results into positive and neg¬
ative, a comparison was made of the means of titres in the three tests for the
various groups ofpatients. For this, four groups were made: normal/abnor¬
mal but no dysplasia, mild/moderate dysplasia, severe dysplasia and lastly,
carcinoma in situ. The results are illustrated in figure 1. It may be seen that
no group had a significantly higher mean titre than any other.
Taking each of the patients' parameters in turn and correlating these
with the antibody results, the only interdependence demonstrated was the
significant increase in sero-positive patients as their age increased. An
example of this is given in table I for the ELISA results, dividing the
patients arbitrarily into four age groups.
In addition, it was also noted that, in the groups studied, there was no
increase in the frequency of cervical carcinoma as the age of the patients
increased. These results are shown in table II.
Table I. Number ofpatients, divided into groups by age, who were sero-positive for CMV
as measured by the ELISA test
Age of patient ELISA titres Sero-positive
years for CMV
>200 < 100 %
18-25 20 19 51.3
26-33 56 45 55.4
34-41 28 14 66.7
>41 15 1 93.8
Table II. Number of patients, divided into groups by age, who were diagnosed as having
carcinoma in situ
Age of patient Number with Total Carcinoma in situ
years carcinoma in situ number %
18-25 9 39 20.8
26-33 19 101 18.8
34-41 11 42 26.2
>41 2 16 12.5
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Fig. 1. Antibody titres to CMV in groups of patients with normal/abnormal but no
dysplasia, mild/moderate dysplasia, severe dysplasia and carcinoma in situ of the cervix,




Several viruses have been suggested as being implicated in the aetiol-
ogy of cervical carcinoma, the most common being Herpes simplex type 2, 4
and CMV. Thomas and Rawls [1978] using complement fixation found a
higher level ofantibodies to H. simplex in patients with carcinoma in situ or
severe dysplasia but not in milder dysplasia. More recently, McDougall et
al. [1980] failed to detect mRNA of this virus in specimens of invasive
carcinoma, although they could find it in cells undergoing pre-malignant
change. Also Fenoglio et al. [1980] were able to detect Herpes early antigens
in early cervical intraepithelial neoplasia by immunoperoxidase staining
but this was lost as the condition proceeded to carcinoma in situ. It is
obviously very difficult to differentiate an initiating agent from one which is
present, as Herpes is, in the urogenital tract in a considerable number of
people and the same applies to CMV. This virus is often found in cervical
secretions; in a study by Waner et al. [1977] about 8% of patients with
suspected venereal disease were excreting CMV and there was local produc¬
tion of antibodies to CMV in over half of them.
During the course of this work, three methods were employed to
detect antibodies to CMV. The ACIF test was designed to measure anti¬
bodies to early viral antigens, while the other two measured presumably
predominantly late antigens. The three tests were found to be interdepen¬
dent to a very large extent and not to vary significantly with batches of
sera. Of the patients' parameters, age, parity, time since last pregnancy
and pathological diagnosis of cervix, no correlation was found with anti¬
body titre to CMV, except, as the patients got older, the number who
were sero-positive increased. So, no serological evidence is available
from this study to associate CMV with carcinoma of the cervix or cervi¬
cal dysplasia. Also, there was no suggestion of differential response of
these groups to the early CMV antigens. We were interested in the num¬
ber and timing of pregnancies as CMV is well-known to reactivate during
pregnancy but there was no interdependence of this factor and antibody
titre. It was of interest that, when age and pathological diagnosis were
compared, there was a similar number of patients in the younger age
groups with cervical carcinoma as in the older age groups. The same
result was reported by Mendis et al., [1979] who found 14% of their
patients with carcinoma to be 30 years or younger, and would further
indicate that national screening programmes should include all sexually
active women over 20 years.
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In addition to the serological status of patients with cervical disorders,
we were also interested in their cell-mediated immunity to CMV and are
now measuring this additional parameter.
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Natural Killer Cell Activity in Patients with
Abnormalities of the Uterine Cervix
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Abstract. Peripheral blood lymphocytes from 105 patients with various degrees of cervical
dysplasia (normal/mild, moderate and severe) up to carcinoma in situ were assayed for natu¬
ral killer cell activity against K562 cells and Chang liver cells in vitro. No difference was found
between the natural killer cell activities of any of the groups of patients studied. In addition,
the K cell activity of the patients' lymphocytes was assayed in an antibody-dependent cellular
cytotoxicity assay on Chang liver cells with anti-Chang cell antiserum. No difference was
found between patient groups. There was no correlation between the presence of antibodies in
the patients' serum to cytomegalovirus measured by anti-complement immunofluorescence
and increased natural killer cell activity.
Introduction
While it is generally accepted that T lym¬
phocytes play a major role in specific tumour
immunity, there is now evidence that natural
killer (NK) cells may provide early resistance
against viral infections, tumour growth or
metastasis [1-3]. NK cells are lymphoid-like
cells which circulate in the peripheral blood
and possess the ability to lyse both tumour
cells and virus-infected cells spontaneously
without pre-sensitization. In that respect NK
cells differ from classical cytotoxic T lym¬
phocytes (CTL) whose killing is restricted
by the major histocompatibility complex
(MHC). NK cell activity has been assayed in
vitro by lysis of K562 cells which represent a
myeloid leukaemia cell line [4], When NK
cells were partially purified from peripheral
blood or spleen by centrifugation through
Percoll gradients, most activity was associ¬
ated with the cell population containing large
granular lymphocytes (LGL) [5].
Low or negligible NK activity was initially
demonstrated in beige (bg) mice [6] and sub¬
sequently in a number of human disease
states such as Chediak-Higashi syndrome [7],
severe combined immunodeficiency [8] and
malignancy [9-12],
Antibody-dependent cell-mediated cyto¬
toxicity (ADCC) i is mediated by killer (K)
cells, which, in common with NK cells, bear
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receptors for the Fc portion of IgG. Target
cells must be pre-coated with specific anti¬
body for induction of K cell lysis, although it
would appear that NK and K cell cytotoxicity
are both mediated by the same effector cell
via different receptors.
In this study, NK and K cell activity of
peripheral blood lymphocytes from patients
with varying degrees of cervical dysplasia up
to carcinoma in situ (CIS) were examined. In
addition, the presence of antibody against
cytomegalovirus (CMV) in these patients was
measured since CMV is one of the candidate
agents that may be implicated in the aetiol¬
ogy of carcinoma of the cervix [13].
Materials and Methods
Peripheral blood samples (10 ml) were collected in
preservative-free heparin from patients attending the
Colposcopy Clinic at Elsie Inglis Maternity Hospital,
Edinburgh. The degree of cervical dysplasia observed
in frozen sections of biopsies taken from each patient
was later confirmed histologically in paraffin sections.
Serum samples from 10 ml clotted blood were ob¬
tained at the same time and stored at -20 °C.
Effector Cell Isolation
Peripheral blood mononuclear cells were isolated
from whole blood within 3 h of removal from the
patient by centrifugation through 6 ml lymphopaque
separation medium at 1,100 g for 20 min at room
temperature. Cells harvested from the interface were
washed three times in 10 ml Eagle's MEM containing
10% newborn calf serum (Row Laboratories, Irvine,
Scotland), penicillin lOOU/ml and streptomycin
100 |ig/'ml (TCM). Cells were resuspended in TCM at
a final concentration of 1 X 106/mi. These were not
further purified.
Target Cells
Target cells for the NK assay were K562 cells, a
cell line derived from a patient with chronic myeloge¬
nous leukaemia [4] and Chang liver cells. K562 cells
were grown in suspension in TCM supplemented with
10% fetal calf serum in addition to newborn calf
serum. 1 X 106 K562 cells were resuspended in 100 pi
TCM and labelled with 100 pCi [51Cr] sodium chro-
mate (specific activity 350-600 mCi/mg Cr, Amers-
ham) for 60 min at 37 "C. These were then washed
three times with 10 ml TCM to remove excess isotope.
Cell viability was checked by trypan blue exclusion
and cells were resuspended to a final concentration of
1 X 105 viable cells/ml. Chang liver cells were main¬
tained in culture in Nunc plastic flasks in TCM. Cells
were removed from the flask with trypsin-versene
mixture and 1 X 106 cells labelled with 51Cr as above.
Labelled Chang cells were used in both NK and
ADCC assays.
Cytotoxicity Assays
NKAssay. 1 X 104 K562 cells were dispensed into
400 pi precipitin tubes (Luckham) in 100 pi volumes.
Lymphocyte suspensions (105 cells) were added in
quadruplicate and the tubes incubated at 37 °C in 5 %
CO2 atmosphere for 16-18 h. After incubation all
tubes were centrifuged at 400 g for 5 min and 100 pi
supernatant removed for counting in a gamma coun¬
ter. Controls with target cells in TCM were included to
calculate the spontaneously released isotope. Cells in¬
cubated with 2% acetic acid gave the maximum re¬
lease. Cytotoxicity was calculated as follows:
% cytotoxicity = ——— X 100,
[c-b]
where a = % test release, b = % spontaneous release, c =
% maximum release.
ADCC (K Cell Assay). Labelled Chang cells were
incubated with either 50 pi normal rabbit serum as a
control or 50 pi rabbit anti-Chang cell antiserum for
30 min at 37 °C. Both sera were heat inactivated, then
diluted 1:100 for use. Anti-Chang cell antiserum was
supplied by Dr. J. McCormick, Department of Rheu¬
matology, Northern General Hospital, Edinburgh.
Antibody-treated Chang cells were washed twice to
remove unabsorbed antibody, resuspended to 1 X 105
viable cells/ml and dispensed in 100-pl volumes.
100 pi effector cell suspension was added (1 X 106/ml)
and the tests incubated overnight as above in quadru¬
plicate. Harvesting, counting and calculation for cyto¬
toxicity were performed as above. Controls included
target cells plus TCM, target cells plus effector cells
and target cells in 2% acetic acid.
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Table I. NK and K cell cytotoxicity in patients with cervical abnormalities
Target cell Percentage mean cytotoxicity ± SD in patients with:
normal/mild moderate severe CIS
dysplasia dysplasia dysplasia
K562 NK cell assay 36.90 ±14.31 (27)' 39.68 ± 15.54 (35) 38.10± 19.50 (21) 31.19± 14.14 (22)
Chang NK cell assay 12.98 + 5.97 (20) 17.81 ±6.91 (18) 16.83 ± 7.59 (19) 13.47±6.74 (17)
Chang + anti-Chang
antibody L cell assay 21.19±8.17 (20) 26.67 ±7.97 (20) 23.53 ±6.61 (19) 24.37 ±6.60 (19)
1 Number of patients in each group.
Statistics
Significance of the differences between the values
obtained for the various groups of patients was calcu¬
lated by Student's t test.
Anti-Complement Immunofluorescence
The method of Kettering et al. [14] was used in
outline to detect antibodies to CMV antigens in the
sera of patients. Human embryo fibroblasts were in¬
fected with CMV strain AD 169 and harvested 3—4
days post-infection. 2 X 104 cells/spot were placed on
multi-spot slides (Handley-Essex), allowed to air dry
and fixed in cold acetone for 10 min. Sera diluted 1 in
10 were allowed to react for 1 h at 37 °C, human com¬
plement (serum sero-negative for CMV) was used at 1
in 4, and anti-human complement C3 labelled with
FITC (Hyland Division ofTravenol Laboratories) at a
dilution of 1 in 30.
Results
In total, peripheral blood lymphocytes
were obtained from 105 patients. Their age
and number of pregnancies were noted. They
were divided into 4 categories on the basis of
the pathology of their cervical biopsies,
namely those with normal/mild dysplasia,
moderate dysplasia, severe dysplasia and
CIS. There were roughly equal numbers of
patients in each group. Initially NK cell ac¬
tivity was measured with K562 cells as tar¬
gets but this was expanded to include Chang
cells as NK targets and also K cell activity in
studies with an ADCC test on Chang cells as
targets.
Table I shows the mean ± SD of NK and
K cell cytotoxicity values of lymphocytes
from the four grops ofpatients studied. While
there is a reduction in the mean NK value
observed within the group of patients with
CIS (31.19 ± 14.14) when compared with
the value obtained for those with nor¬
mal/mild dysplasia (36.90 ± 14.31), moder¬
ate dysplasia (39.68 ± 15.54) and severe dys¬
plasia (38.10 ± 19.50), the difference be¬
tween the means was not significant (p <
0.1). Figure 1 shows the individual results
obtained for NK cytotoxicity where there was
wide variation in NK activity within the var¬
ious patient groups, most obviously in those
patients with severe dysplasia whose NK val¬
ues ranged from 0.69 to 79.54%.
Figure 2 shows the individual results ob¬
tained for NK cytotoxicity towards Chang
cells. These values reflected the decreased
sensitivity of Chang cells to NK lysis when
compared with K562 cells. The mean values
for Chang cell NK activity shown in table I
demonstrate no significant differences be¬
tween the patient groups.
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1
2
Fig. 1. Individual results of NK cell cytotoxicity
towards K562 target cells ± SD.
Fig. 2. Individual results of NK cell cytotoxicity
towards Chang target cells ± SD.
Fig. 3. Individual results of ADCC towards Chang
target cells coated with 1:100 anti-Chang cell anti¬
body.
Table I also gives results from 78 patients
whose lymphocytes were assayed for K cell
cytotoxicity in the ADCC test. No significant
differences were found between the patient
groups. The individual results are given in
figure 3.
Effect ofAge and Number ofPregnancies
on NK Activity
No significant differences were observed
within the various groups of patients when
age and number of pregnancies were consid¬
ered (table II).
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Table II. Age and number of pregnancies in patients with cervical abnormalities
Patient group
normal/mild moderate severe CIS
dysplasia dysplasia dysplasia
Age ± SD 32.54 + 6.17 29.00±5.51 31.70±5.42 31.63±4.39
Pregnancies ± SD 2.46±2.06 1.74±1.77 2.04±1.68 2.28±1.67
CMV Antibody Data
A total of 87 sera were examined by ACIF
for antibodies to CMV. The proportion of
sera sero-positive for CMV in each group was
as follows: normal/mild 14/27; moderate
12/23; severe 16/22 and CIS 11/15. The dif¬
ference between any group when compared
with CIS failed to reach statistical signifi¬
cance by Chi-square test.
When the NK values obtained with K562
cells from sero-positive patients were com¬
pared with those sero-negative for CMV,
there was no significant difference between
the means (sero-positive 38.26 ± 16.14%;
sero-negative 37.80 ± 15.28%).
Discussion
No evidence was found in this study to
indicate any decrease in NK activity in pa¬
tients with cervical abnormalities up to CIS.
These findings are in agreement with those of
several groups who have examined patients
with localized tumours of many types [15,
16]. NK activity, however, does appear to be
decreased in cancer patients with metastasis,
untreated lymphocytic leukaemia and mela¬
nomas [9-11, 17]. Patients with carcinoma of
the cervix have been studied previously [12],
but only in advanced stages of the disease
when it had progressed from CIS to invasive
cancer. Although the number of patients in
each group in that study was not large, pro¬
gressive decrease of NK activity was demon¬
strated as the disease spread, with those in
relapse having the lowest NK activity of all.
It therefore appears that, ifNK cells possess a
role in preventing the disease from firstly
becoming established, and secondly from
progressing, it is an inefficient system which
loses much of its effectiveness when the tu¬
mour grows. On the other hand, lymphocyte
infiltration is common in tumours of patients
with CIS. It may, therefore, be argued that
the presence of NK cells or cytotoxic T lym¬
phocytes maintains the CIS status and pre¬
vents spread. It is known that patients may
remain at CIS level for many years before
progressing to invasive carcinoma so it is
apparent that some forces are acting upon the
tumour to prevent its spread.
In the present study, great variation in the
NK activity within all the groups of patients
was demonstrated so that it was not possible
on the strength of this function alone to iden¬
tify those patients with mild or moderate
dysplasia who might be likely to progress to
CIS or invasive carcinoma. Additionally, the
finding that NK cells are active in vitro
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against sensitive targets such as K562 cells
does not necessarily indicate that those same
NK cells could kill autologous tumour cells in
vitro.
CMV has been isolated from cells cultured
from cervical tumours [13] and has also been
associated with human malignancies, in par¬
ticular, Kaposi's sarcoma [18] and carcinoma
of the prostate [19]. CMV has also been
shown to be capable of transforming normal
cells into cells able to produce tumours when
injected into susceptible animals [20]. Since
NK cells are particularly active against virus-
infected targets, the CMV antibody status of
the patients in the study was examined for
any correlation with NK activity. It is as¬
sumed that CMV antibody would be in¬
creased in the presence of a 'chronic viral'
infection. No such correlation was seen either
when all patients, regardless of degree of dys¬
plasia, were divided into sero-positive or
sero-negative groups or when, for example,
CIS patients sero-positive for CMV were
compared with those sero-negative. Al¬
though the proportion of patients with CIS
who were sero-positive for CMV was greater
than the proportions of sero-positive patients
with dysplasia, the difference was not statisti¬
cally significant. A larger study had pre¬
viously shown no difference in the anti-CMV
antibody status of patients with CIS when
compared with other dysplasias [21 ], and our
results confirm this.
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summary Eluates were prepared by high salt extraction from normal colonic mucosa and
adenocarcinomatous tissue from 28 patients, eight more from unmatched colonic tissue and five
from patients with other gastrointestinal disease. Immunoglobulins were detected by ELISA:
IgG was present in 24% eluates from normal colon and 21% from carcinomas; IgA in 55%
eluates from normal colon and 39% from carcinomas; IgM in 55% from normal colon and 37%
from carcinomas. Cytomegalovirus-specific antibody was found in 15% eluates from normal
colon and in 18% carcinomas. Out of the 28 matched specimens, cytomegalovirus-specific IgG
was detected in one normal and four tumour eluates, specific IgA in two normal and four tumour
eluates, and specific IgM in two normal and two tumour eluates. In two instances
cytomegalovirus-specific antibody was present in the eluates prepared from the normal and
tumour tissue of the same patient. Of those eluates which contained cytomegalovirus-specific
antibodies by ELISA, two were positive by anti-complement immunofluorescence of human
embryo fibroblasts infected with cytomegalovirus strain AD-169. It seems possible, therefore,
that cytomegalovirus antigens on colonic cells may be masked by complexing with anti-
cytomegalovirus antibodies, and may not therefore be detected by techniques such as
immunofluorescence.
Most cytomegalovirus infections of man are asymp¬
tomatic although they can occasionally result in
congenital defects, infectious mononucleosis, inter¬
stitial pneumonia, hepatitis, and other severe dis¬
eases. 1 After the primary infection, the virus persists
in the body by unknown mechanisms and in
unknown sites, although peripheral blood leuco¬
cytes seem to represent one cell population from
which virus can be recovered on occasion.
There has been suggestive evidence that cyto¬
megalovirus may be involved in the pathogenesis of
certain types of cancer, particularly Kaposi's sarco¬
ma,2 carcinoma of the cervix3 and prostate,4 and
adenocarcinoma of the colon. Thus in 1978 Huang
and Roche5 detected cytomegalovirus-DNA by hyb¬
ridisation in four of seven patients with carcino¬
ma of the colon, while Hashiro and coworkers6
isolated cytomegalovirus from cultured tumour frag¬
ments in three of eight cases. More recently,
however, Brichacek and others7 failed to detect
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cytomegalovirus DNA, using DNA-DNA hybridisa¬
tion with an estimated sensitivity of 0-3 genome
equivalents per cell, in biopsy specimens from seven
patients with colonic carcinoma. In addition we
failed to confirm an involvement of cytomegalovirus
using hybridisation, immunofluorescence to detect
cytomegalovirus-specific antigens, and by culture of
biopsy specimens.8 Roche et af have looked again
at the role of cytomegalovirus in gastrointestinal
disease and concluded that the virus was detectable
by DNA-reassociation kinetics in a proportion of
colonic cells, including those derived from both
malignant and non-malignant tissue. It was sug¬
gested that cytomegalovirus was present in masked
or latent form, and no biopsy specimens were
positive for viral antigens by immunofluorescence.
It is possible that such antigens on the surface of
tumour cells could be blocked by complexing with
antibodies as has been suggested recently.1" Indeed
just such a situation has been described for Herpes
simplex virus-specific antibodies in squamous cell
carcinoma of the uterine cervix in the absence of
apparent infection of the tumour cells by the virus.11
Thus the present study was undertaken to identify
1054 Grail and Norval
bound immunoglobulins in normal and adenocarci-
nomatous colonic mucosa, and to identify whether
any was cytomegalovirus specific.
Methods
CLINICAL SPECIMENS
Surgically resected specimens of colon were ob¬
tained from the Royal Infirmary, Edinburgh. Diag¬
nosis and Duke's stage, where appropriate, was
based on routine pathological examination. Thirty
eight specimens of tumour and 33 of normal colonic
mucosa were collected which included 28 matched
specimens of tumour and normal colon taken from a
region of the gut uninvolved by tumour. The
remaining specimens were six unmatched carcinoma
of the colon, two normal colon mucosa, one Crohn's
disease, one benign adenoma with dysplasia, two
carcinoma of the caecum and one gastric carcinoma
leading into the bowel. All tissues were stored at
—70°C until elution was performed.
ELUTION OF ANTIBODIES
A modification of the method of Boyd and James12
was used. Portions of tissue (0-5-5 g) were finely
chopped and washed three times in 0-01M phos¬
phate buffered saline, pH 7-2 (PBS). Solid material
was further disaggregated in nine volumes of an
enzyme mixture containing 10 mg collagenase B
(Sigma) and 4 mg DNase (BDH) in 100 ml PBS for
20 min at 37°C with gentle stirring. The resulting cell
suspension was removed onto ice and the procedure
repeated twice on any solid material. Cell suspen¬
sions were washed five times in PBS and re-
suspended in 5 ml 15% NaCl (pH 7-4) before being
incubated for two hours at 37°C. The eluate was
obtained by centrifugation at 10 000 g for 10
minutes. The sediment was re-extracted with 15%
NaCl as before. Resultant eluates were pooled and
dialysed against 500 ml distilled water for 24 hours
with two changes of water. After centrifugation for
one hour at 36 000 g, the supernatant was concen¬
trated 10 times with polyethylene glycol and finally
centrifuged for 30 min at 5000 g. Eluates were stored
frozen at —20°C. Protein estimation was by the
method of Lowry with bovine serum albumin as
standard.
DETECTION OF IMMUNOGLOBULINS BY ENZYME-
LINKED IMMUNOSORBENT ASSAY (ELISA)
The procedure was a modification of the method
described by Bidwell, Bartlett, and Voller.12 The
assay was done on polystyrene, flat bottomed micro
titre plates (Sterilin). Wells were saturated with 50
Ail of 175 A^g/ml goat anti-human polyvalent im¬
munoglobulins (Sigma) diluted in 0-05M carbonate
buffer, pH 9-6, for four hours at 37°C, and then
overnight at 4°C. Plates were washed three times
with 0-05% Tween 20 containing 0-9% NaCl. Fifty
microlitres of undiluted eluate was added and the
plates incubated at room temperature for six to eight
hours. After washing again, 50 /j.\ of goat anti-
human IgA, IgG, or IgM conjugated with alkaline
phosphatase (Sigma, diluted in 0-05M PBS contain¬
ing 0-05% Tween 20 according to the manufac¬
turer's instructions) was added, and the plates
incubated at room temperature. Absorbance at 405
nm was measured with a multiscan (Titertek, Flow).
In each experiment positive controls were myeloma
sera specific for IgA, IgG, or IgM; negative control
values were obtained from the same assay system
but without the eluates (these are shown in the
Table). Values greater than the mean+standard
deviation of the control values were considered
positive. Chi-square tests were used to determine
any significant differences in the detection of im¬
munoglobulins in normal and tumour eluates and
with respect to the stage of the tumour. Wilcoxon's
rank sum tests were used to compare the concentra¬
tions of each immunoglobulin present in the 28
normal and tumour eluates, and to compare im¬
munoglobulin concentrations with respect to the
stage of the tumour.
Detection of cytomegalovirus-specific immuno¬
globulins was done in a similar manner but with
cytomegalovirus-infected cell antigen or uninfected
cell antigen (see below) as the initial coating layer.
Antigens were diluted from 400 to 1000 times in
0-05M carbonate buffer pH 9-6 for ELISA. Each
eluate was tested against control antigen and
cytomegalovirus antigen because there may be
antibodies in the eluates which cross react with
antigens from human embryonic fibroblasts. The
mean and standard deviation of eluates tested
against control human embryonic fibroblast antigen
allowed calculation of a positive reaction to cyto¬
megalovirus antigen as is shown in the legend to the
Table. Chi-square tests were used to determine any
significant differences in the detection of cytomega¬
lovirus-specific immunoglobulins in normal and
tumour eluates, and with respect to tumour stage.
There were too few eluates containing cytomegalo¬
virus-specific immunoglobulin to compare the con¬
centrations of immunoglobulins in normal and
tumour eluates or with respect to tumour stage.
CYTOMEGALOVIRUS CELL ANTIGEN PREPARATION
Human embryonic fibroblasts at pass 3 to 10 were
grown in modified Eagle's medium supplemented
with 10% fetal calf serum, 100 IU/ml penicillin and
200 Aig/ml streptomycin. When confluent some cells
were infected with cytomegalovirus, strain AD-169,
Elution of cytomegalovirus antibodies from adenocarcinoma of the colon 1055
Table Non-specific and cytomegalovirus-specific immunoglobulins as measured by ELISA (Optical Density) in eluates
from colonic adenocarcinoma (1-34), normal colonic mucosa (1-28, 35, 36), Crohn's disease (37), benign adenoma with
dysplasia (38), carcinoma of the caecum (39, 40) and gastric carcinoma (41). Cytomegalovirus-specific anti-complement
immunofluorescence of eluates is also shown (+ positive; — negative) and their protein concentration (mg/g wet weight
tissue). '
Eluates from carcinoma ofcolon Eluates from normal mucosa
Protein Non-specific CMV-specific Non-specific CMV-specific
Patient Duke's Protein
no stage >"g'g IgG IgA IgM IgG IgA IgM ACIF fg'g IgG IgA IgM IgG IgA IgM ACIF
1 B 0-29 0-84 1-17 >2 1-8 2-0 1-4 0-78 0-89 1.23 >2 0-35 0-17 0-11 —
2 C 0-64 0-72 0-74 >2 >2 0-37 0-4 - 0-2 1-03 0-85 >2 0-23 1-6 0-41 -
3 C 0-4 0-97 0-89 1-73 >2 1-41 1-82 + 0-26 0-98 0-25 1-85 >2 0-46 0-95 +
4 C 01 0-74 0-77 1-48 0-36 0-17 0-12 - 0-17 0-32 0-44 0-46 0-37 0-29 0-38 -
5 C 0-09 0-37 0-42 1-56 0-57 0-43 0-35 - 0-58 0-25 0-43 0-27 0-45 0-36 0-28 -
6 B 0-34 0-33 0-78 1-22 0-49 0-43 0-29 - 0-51 0-43 0-46 0-43 0-73 0-21 0-51 -
7 C 0-42 0-32 1-81 0-73 0-71 0-26 0-37 - 0-67 0-39 0-41 1-45 0-21 0-37 0-39 -
8 A 0-31 0-72 0-36 1-35 0-43 0-31 0-41 - 0-54 0-42 0-33 >2 0-46 0-27 0-37 -
9 B 0-26 0-77 0-79 0-34 0-35 0-25 0-29 - 0-35 0-38 0-34 0-37 0-44 0-49 0-18 -
10 C 0-35 0-37 0-9 1-76 0-68 1-4 0-47 - 0-4 0-35 0-29 1-65 0-36 0-42 0-26 -
11 A 0-42 1-14 0-41 0-32 0-89 0-4 0-37 - 0-76 0-88 0-86 1-34 0-41 0-35 0-24 -
12 C 0-33 0-34 0-92 0-35 0-46 0-39 0-27 - 1-2 0-34 1-18 0-79 0-26 0-45 0-41 -
13 C 0-42 0-42 1-49 0-27 0-27 0-71 019 - 1-2 0-27 0-79 1-36 0-14 0-36 0-13 -
14 c 0-2 0-38 0-46 1-27 0-48 0-34 0-35 - 0-52 0-26 0-79 0-37 0-69 0-23 0-18 -
15 c 0-38 0-44 0-89 0-36 0-2 0-89 0-27 - 0-45 0-24 1-52 0-78 0-38 0-19 0-46 -
16 c 0-07 0-36 0-35 0-29 0-44 0-28 0-49 - 0-7 0-44 0-43 0-47 0-53 0-62 0-26 -
17 B 0-14 0-35 0-45 0-27 0-31 0-57 0-26 - 1-1 0-4 0-98 1-23 0-43 0-56 0-18 -
18 A 0-06 0-27 0-36 0-47 0-24 0-23 0-6 - 0-4 0-45 0-87 1-39 0-46 0-32 0-29 —
19 C 0-39 0-37 0-44 0-46 0-41 0-16 0-15 - 0-2 0-39 0-47 0-46 0-73 0-77 0-61 -
20 A 0-22 0-46 0-35 0-38 0-47 0-28 0-18 - 0-31 0-42 0-87 1-83 0-49 0-42 0-25 -
21 B 0-18 0-36 0-4 0-43 0-28 0-15 0-47 - 0-29 0-38 108 1-5 0-41 0-37 0-28 -
22 B 0-08 0-28 0-42 0-38 0-23 0-14 0-39 - 0-29 0-44 0-85 1-43 0-34 0-45 0-21 -
23 B 0-18 0-4 0-37 0-42 0-41 0-17 0-12 - 0-39 106 0-8 0-38 0-16 0-36 0-44 -
24 B 0-1 0-44 0-31 0-49 0-21 0-12 0-48 - 0-27 0-39 0-39 0-37 0-25 0-29 0-3 -
25 C 0-15 0-42 0-38 0-45 0-29 0-37 0-22 - 005 0-45 0-37 0-39 0-28 0-34 0-26 -
26 C 0-34 0-31 0-42 0-5 0-64 0-28 0-33 - 0-63 0-43 1-01 0-41 0-23 0-29 0-37 -
27 B 0-03 0-44 0-45 0-35 0-56 0-72 0-18 - 109 0-38 0-87 >2 0-4 1-42 1-17 -
28 B 0-3 0-32 0-46 0-36 0-29 0-42 0-26 - 0-42 0-29 0-25 0-49 0-22 0-29 0-28 -
29 B 0-26 0-26 0-41 0-42 0-15 0-19 0-19 -
30 C 1-02 0-32 0-36 0-41 0-24 016 0-39 -
31 B 0-12 0-45 0-44 0-22 018 0-12 0-56 -
32 C 0-36 0-35 0-94 1-42 0-47 0-43 0-36 -
33 B 0-32 0-46 0-36 1-71 0-49 0-49 0-15 -
34 B 0-38 0-47 0-29 0-36 0-31 0-17 0-17 -
35 1-22 0-97 0-91 >2 0-19 0-41 0-42 -
36 0-31 0-89 0-87 0-37 1-04 0-96 0-37 —
37 0-18 0-35 0-34 0-29 0-56 0-24 0-22 -
38 0-5 0-24 0-87 0-98 0-14 0-42 0-37 - 0-63 108 0-86 0-32 0-24 0-27 0-15 —
39 0-27 0-25 0-36 0-44 0-26 0-41 0-22 -
40 0-09 0-93 0-87 1-55 1-48 0-39 0-26 -
41 0-23 0-34 0-86 0-49 0-21 013 0-24 - 1-6 0-32 0-42 0-95 0-18 0-11 0-96 -
Control values for non-specific antibodies: IgG mean 0-42 standard deviation 0-06
IgA mean 0-39 standard deviation 0-09
IgM mean 0-43 standard deviation 0-07
Control values for CMV-specific antibodies: IgG mean 0-52 standard deviation 0-22
IgA mean 0-54 standard deviation 0-25
IgM mean 0-44 standard deviation 0-18
Values greater than the mean + standard deviation were considered positive; these values are underlined.
at 1-2 plaque-forming units per cell. Infected and
uninfected cultures were maintained in medium
containing 2% fetal calf serum at 37°C until adv¬
anced cytopathic effects were observed in the
infected culture. The monolayers were washed with
cold PBS and harvested using glass beads. Cells
(5xl06) were washed three times in PBS and
resuspended in 1 ml glycine buffer (5 parts 0TM
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glycine plus 3 parts 0-lM NaOH, prepared on day of
use). They were sonicated for two minutes at 9 kc/s
and stored at —70°C until required.
C YTO M EG A LO VIRUS-SPECIFIC ANTI-COMPLEMENT
IMMUNOFLUORESCENCE TEST
Monolayers of human embryonic fibroblast cells
grown on cover slips were infected with cytomegalo¬
virus, strain AD-169, and 48 h later were fixed in
cold acetone for 10 minutes. Anticomplement im¬
munofluorescence (ACIF) was carried out by the
method of Hart et al.8
Results
Normal colonic mucosa and slices of adenocarci¬
nomas were disaggregated with collagenase and
DNase, and 71 eluates prepared from the resultant
single cell suspension after treatment with 15%
NaCl. Protein concentrations of eluates ranged from
0-07-1 mg/ml, mean value 0-48 mg/ml; for carcino¬
ma eluates a mean value of 0-28+0-19 (standard
deviation) mg/g of tissue, and for normal eluates
0-57+0-37 (standard deviation) mg/g of tissue were
found.
Using ELISA, out of 38 specimens of tumour,
IgG was detected in eight eluates, IgA in 15 and IgM
in 14 (Table). Out of 33 specimens of normal colon,
IgG was detected in eight eluates, IgA in 18 and IgM
in 18.
These results indicate that there is no significant
difference in the detection of IgG (24%), IgA (55%)
and IgM (55%) in normal eluates compared with
tumour eluates (21% contained IgG, 39% contained
IgA and 37% contained IgM (0-l<p<0-5)). There
were no significant differences in the immunoglobu¬
lin concentrations of normal and tumour eluates.
When the 28 matched pairs of normal and tumour
eluates from the same patient were compared
(shown in the Table, patients 1-28), five normal and
seven tumour eluates contained IgG, 15 normal and
11 tumour eluates contained IgA, and 15 normal
and 10 tumour eluates contained IgM. These results
also indicate that there is no significant difference in
the detection of IgG, IgA and IgM in the 28
matched eluates. In three pairs of specimens the
same immunoglobulin types were present in both
the normal and tumour eluates, and in five matched
cases no immunoglobulins were detected in eluates
from either normal or tumour tissues.
Cytomegalovirus-specific antibody as measured
by ELISA was found in seven of 38 tumour
eluates and five of 33 normal colon eluates (also
shown in the Table). Comparing the 28 matched
specimens, cytomegalovirus-specific IgG was de¬
tected in one normal and four tumour eluates,
cytomegalovirus-specific IgA in two normal and
four tumour eluates and cytomegalovirus-specific
IgM in two normal and two tumour eluates. These
results show no significant difference in the presence
of cytomegalovirus-specific IgG, IgA and IgM in
tumour eluates as compared with normal eluates
(0-l<p<0-5). In two instances, cytomegalovirus-
specific immunoglobulins were present in the elu¬
ates from both the tumour and normal tissue of the
same patient, although of the same broad immunog¬
lobulin class in only one.
The patients from whom the specimens were
obtained had colorectal adenocarcinoma for the
most part, and were grouped histologically accord¬
ing to the Duke's system of classification; a few had
other bowel disorders (Table). Four out of 34
patients with colonic carcinoma had Duke's stage A,
14 of 34 had stage B, and 16 of 34 had stage
C. Of the patients with stage A disease, two of
four carcinoma eluates contained detectable im¬
munoglobulin; this was IgG in both cases and in one
case IgA was also present. Four of 14 carcinoma
eluates from patients with Duke's stage B were
positive for immunoglobulin; IgG was present in
two eluates, IgA in three eluates and IgM in three
eluates. Eleven of 16 eluates from patients with
stage C disease contained immunoglobulin; IgG was
present in three eluates, IgA in nine eluates and IgM
in eight eluates. These results show no significant
differences in the detection of IgG (19%) (p>0-5),
IgA (56%) (0-05<p<0-1) and IgM (50%)
(0-l<p<0-5) in eluates from patients with stage C
disease compared with stage B disease (IgG was
detected in 14% and IgA and IgM were detected in
21% eluates). No significant differences in the
immunoglobulin concentrations were found with
respect to tumour stage.
Cytomegalovirus-specific immunoglobulin was
detected in one patient with Duke's stage A, one
patient with stage B and four patients with stage C.
There is no significant increase in the detection of
cytomegalovirus-immunoglobulin in eluates from
patients with stage C tumour (25%) compared to
stage B tumour (7%) (0-l<p<0-5).
Anti-complement immunofluorescence was per¬
formed using human embryonic fibroblast cells
infected with cytomegalovirus, strain AD-169, and
uninfected human embryonic fibroblasts as controls.
Eluates prepared from both normal and tumour
tissue of patient number three showed positive
immunofluorescence.
Although the eluates from the colonic tissues
contained varied amounts of protein, the nature of
these, apart from IgA, IgG, IgM and cytomegalo¬
virus-specific immunoglobulins was not determined.
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Discussion
Elution of bound immunoglobulin from normal
colonic mucosa and colorectal carcinoma was
achieved by high salt extraction. There were no
significant differences in the detection of IgG, IgA
and IgM in normal and carcinoma eluates: IgG was
present in 24% of normal mucosa eluates and 21%
of carcinoma eluates (p>0-5): IgA was present in
55% of normal eluates and 39% of carcinoma
eluates (0T<p<0-5): IgM was present in 55% of
normal eluates and 37% of carcinoma eluates
(0T<p<0-5). Detection of IgG, IgA, IgM and
cytomegalovirus-specific immunoglobulin was not
significantly different in eluates from patients with
Duke's stage C compared with eluates from stage B
disease.
MacSween and Eastwood14 found significantly
higher concentrations of IgG in eluates of colonic
carcinoma with regional metastasis than in eluates of
localised tumours. This difference was not apparent
in eluates of corresponding normal tissue, and they
suggested that the increase in IgG was associated
with the metastatic state. Also it has been proposed
that patients with colorectal carcinoma who initially
have higher serum levels of IgG and perhaps of IgA
may have a longer relapse free survival.15 More
recently, all tumours have been reported to contain
IgG and IgA, whereas only 40% contained measur¬
able amounts of IgM.16 These differences in im¬
munoglobulin detection from the present study may
reflect use of different or larger specimens from
patients or differences in the preparation of eluates.
In addition the ELISA used here employed poly¬
valent antiserum as the first layer which may have
resulted in competition for immunoglobulin binding
sites and therefore reduced detection of individual
immunoglobulins. Jones et a/16 found less IgA, IgM
and IgG in eluates from colorectal carcinoma than in
normal colonic mucosa. Also there was no associa¬
tion between immunoglobulin and the amount of
tumour tissue, necrosis, mucin production and
staging, although it was suggested that tumour
associated IgM accompanied an unfavourable prog¬
nosis. In the present study detection of IgG, IgA,
IgM and cytomegalovirus specific immunoglobulin
was not significantly different in stage C disease
compared with stage B. Further interpretation of an
association between immunoglobulins and staging is
prevented by the small number of eluates from
patients with stage A tumour.
There were no significant differences in the
detection of cytomegalovirus specific IgG, IgA and
IgM in the 28 matched samples. The presence of
cytomegalovirus specific immunoglobulin in normal
and tumour eluates suggests that some cells in the
colonic mucosa may be expressing cytomegalovirus
specific antigens on their surfaces to which the
antibodies are binding. It also implies that such
antigens will be blocked and thus escape detection
by such techniques as immunofluorescence. It is of
interest in this context that Roche et al,9 while
showing cytomegalovirus DNA in various colonic
diseases by hybridisation, were unable to show
cytomegalovirus antigens by immunofluorescence.
Only two eluates in our series were positive for
cytomegalovirus antibodies using anticomplement
immunofluorescence of AD-169 infected fibroblasts
which almost certainly reflects the greater sensitivity
of the ELISA method over anticomplement im¬
munofluorescence.
The presence of cytomegalovirus immunoglobu¬
lins in eluates from both normal and tumour
material suggests that cytomegalovirus infection is
not associated specifically with colonic adenocarci¬
nomas. Furthermore, in two cases, such antibodies
were detected in eluates from tumour and normal
colonic mucosa of the same patient. A distinction
was not made between antibody eluted from infil¬
trating lymphocytes or from epithelial cells in the
adenocarcinomatous tissue and the normal colonic
mucosa. Immunofluorescence on sections of colon
may resolve this, although recent evidence from
virus isolation and nucleic acid hybridisation would
indicate that the presence of the virus, at least, is not
solely because of infiltrating mononuclear cells
infected with cytomegalovirus.9
It is known that, after a primary infection,
cytomegalovirus persists in a latent form within
man.1 As a number of studies has shown the
presence of cytomegalovirus in the gastrointestinal
tract either in normal patients, those with chronic
diseases such as ulcerative colitis,17 or in colorectal
adenocarcinoma,5 the gastrointestinal tract has been
suggested as a possible site of latency of cytomegalo¬
virus.9 The present study, thus, would also indicate
that cytomegalovirus is found in normal colonic and
adenocarcinoma cells by the detection of cytomega¬
lovirus specific immunoglobulins in tissue eluates
from some patients. It cannot be discounted, how¬
ever, that some proportion of these cytomegalovirus
antibodies may be sticking non-specifically. Further
work is necessary to establish whether cytomegalo¬
virus is associated with transformation of normal
cells to the malignant state in the colon, whether it is
the initiating factor or a cofactor, or whether it is not
involved at all in this process.
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Cell-Mediated Immune Responses to Cytomegalovirus in Jj
Patients with Dysplasia of the Uterine Cervix
W.A. Neil!, M. Norval
Department of Bacteriology, University of Edinburgh Medical School, Edinburgh, UK
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Abstract. Peripheral blood lymphocytes from 172 women with various degrees of cervieap
dysplasia were assayed for responsiveness to cytomegalovirus-induced early and late antigensl
using lymphocyte stimulation tests. No evidence was found to suggest that any group of;
patients was specifically sensitized to either of the antigens tested. Neither was there any
difference between the patient groups in respect of mitogen-induced stimulation. The concept)
that cytomegalovirus might be involved in cervical cell transformation leading to carcinoma;
has therefore not been strengthened as a result of this study.
Introduction
The cell-mediated immune (CMI) re¬
sponse is of extreme importance in recovery
from herpesvirus infections. In particular,
patients receiving cardiac [1], renal [2] or
bone marrow [3] transplants often experience
either reactivation of endogenous cytomega¬
lovirus (CMV) or primary CMV infection
leading to high morbidity and mortality.
Such patients are generally immunosup-
pressed to minimize host versus graft re¬
sponses, and CMI responses to CMV are also
compromised, although humoral antibody;
status is unaffected. '^Jit
CMV has recently been considered as an^
agent with possible involvement in various
human neoplasms [4-6] including carcinoma
of the uterine cervix. Serological studiesJUL
patients with grades of cervical dysplasia up.
to carcinoma in situ (CIS) have been equiyo^
cal with regard to CMV antibody status [7g-
10], while CMI responses in such patient,
have not yet been examined. Jjpl
The lymphocyte stimulation (LS) fest'^:
in vitro parameter-of CMI, has been P1***
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ously used to demonstrate specific lympho-
'e responsiveness to CMV in several
'ups of patients including transplant recip-
fots [11] and individuals with acquired int¬
one deficiency syndrome (AIDS) [12], The
sent study examined the response of pe-
heral blood lymphocytes (PBL) to CMV in
tients with various grades of cervical dys¬
pasia up to CIS. Lymphocyte responsiveness
CMV was then correlated with the pres-
ce of CMV antibody in serum, measured
jy an enzyme-linked immunosorbent assay
LISA).
Materials and Methods
[Subjects and Specimens. The study population
omprised 172 women attending the Lothian Area
olposcopy Clinic, Edingburgh. Diagnosis of grade of
splasia was made on frozen sections of cervical
Sopsies and later confirmed on paraffin sections. Ten
ill peripheral blood was collected from each patient
ato 100 units of preservative-free heparin (Sigma). A
yurther sample was taken at the same time to provide
jerum for the ELISA test. The specimens arrived at
|'*e laboratory within 2 h of collection.Preparation of PBL. PBL were prepared as pre-ously described [13] and resuspended at 1 X 106
^ lls/ml in RPM1 1640 supplemented with 15% autol¬
ogous plasma, 100 units/ml penicillin and 100 pg/ml
Jtreptomycin.
Preparation of CMV Antigens. Confluent mono-
hyers of human embryo fibroblasts (HEF) were in-
^fected with CMV strain AD 169 and harvested with
jdycine buffer when an extensive cytopathic effect
.y85 seen [14], This preparation was referred to as
fMVLA. for the production of the CMV early anti-
fcn (CMVEA) preparation, HEF cells were harvested
■*4-48 h after infection. Control antigen (HEF) was
Spared in the same way from uninfected cells. Ami-
tens were stored in aliquots at -70 °C until used.
- Preparation ofMitogens. Three mitogens were em¬
ployed jn the study; these were phytohaemagglutinin
PbA, Wellcome), pokeweed mitogen (PWM, Gibco)
>n<l concanavalin A (Con A, Sigma). Dilutions of
were set up in RPMI 1640 and dose-response
curves set up as decribed below to find the optimum
concentration for routine use.
The LS Test. PBL at 1 X 106/ml were dispensed in
200-pl volumes into round-bottomed 96-well micro-
test plates (Nunc) in quadruplicate. Antigens and mi¬
togens were added at varying concentrations and the
plates incubated at 37 ° C in 5 % CO2 and 95 % humid¬
ity. On the day prior to harvesting, 0.5 pCi 3H-methyl
thymidine (Amersham) was added to each well. Cells
were harvested 24 h later onto fibre glass strips in an
automatic sample harvester (Ilacon). After drying, in¬
dividual discs were counted in PPO/POPOP toluene-
based liquid scintillator for 1 min each. LS was ex¬
pressed as the stimulation index (SI). SI = Mean
counts per minute (cpm) of PBL with CMVLA or
CMVEA + mean cpm of PBL with HEF antigen. In
tests with mitogens, SI = mean cpm of PBL with mito¬
gen + mean cpm of PBL alone. A SI value of 2.0 or
more was accepted as positive stimulation in accor¬
dance with other groups [15].
Elisa. The method used was based on that de¬
scribed by Booth et al. [14], Briefly, 96-well immuno-
plates (Nunc) were coated overnight at 4"C with
CMVLA or HEF glycine-extracted antigen at optimal
concentration (1:600) as assessed by chessboard titra¬
tion. All test sera were assayed at 1:100 dilution in
buffer containing 1 % bovine serum albumin. Alkaline
phosphatase-labelled anti-human IgG (Miles-Yeda)
was used at 1:200 dilution and phosphatase substrate
(Sigma) at 1 mg/ml. Absorbance of samples was read
in a Dynatech Microelisa Autoreader at 405 nm.
Mean ± standard deviation (SD) absorbance of each
serum was calculated and any sample giving a value
greater than that obtained for a negative control serum
with CMV antigen plus 3 X SD was considered posi¬
tive. In addition, the absorbance value obtained for
each serum sample was used as a measure of antibody
titre in calculations to correlate ELISA with SI val-
Results
Initial experiments were performed to es¬
tablish the concentrations of CMVLA and
mitogens which gave maximum lymphocyte
stimulation in 6 normal healthy women, 5 of
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Fig. 1. Stimulation index!
± SD) of PBL from grof^H
tients with grades ofcervicalc
sia towards CMVLA.
•;';3S
ment fixation test (CFT). PBL from the se¬
ronegative donor failed to reach a SI of 2.0
when incubated for 5-7 days with CMVLA at
concentrations ranging from 1:20 to 1:640.
On the other hand, the mean (± SD) SI of the
seropositive donors was 3.92 ±2.12 (range
2.77-7,71) at 1:80,4.53 ± 1.99 (range 2.62-
7.31) at 1:160 and 4.53 ± 2.36 (range 1.93-
8.34) at 1:320 concentration of CMVLA. An¬
tigen at 1:20 and 1:40 was lymphotoxic re¬
sulting in a SI of less than 1.0. The optimal
time for harvesting was after 6 days of incu¬
bation. Since the concentration of CMVLA
which resulted in maximum stimulation var¬
ied among the seropositive donors, assays on
patients' PBL were set up at all three concen¬
trations. The concentration of mitogens re¬
sulting in maximum stimulation of the test
PBL was PHA 1:160 (6 of 6 donors), PWM
1:40 (6 of 6) and Con A 0.3 jig/ml (5 of 6).
These cultures were also harvested after 6
days of incubation.
PBL were tested from a total of 172 pa
tients between the ages of 20 and 4 On
were divided into 57 patients with no u.
cal abnormality, cervicitis or mild dysplasgE
35 with moderate dysplasia, 46 with^Vpn
dysplasia and 34 with CIS. Whenever^ul
cient PLB were available, responsiveness^^
CMVLA, CMVEA and all three mfiMj
was measured.
Stimulation ofPatients' PBL with i||
CMVLA, CMVEA and Mitogens Jf
Individual responses of patients' PBL jo
CMVLA are shown in figure 1. The number;
of patients in each group with a positively
was as follows: normal/mild 25 of 57 (44%fc|
moderate dysplasia 15 of 35 (43%); se^ry
dysplasia 26 of 46 (57%); and CIS 17
(50%). The' difference in the percentage^
positive patients in any group compared witlL
any other was not statistically significant
the x2 test (X2 = 0.02; 0.90 > p > 0-8$^
'*ifa
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fig. 2. Stimulation Index (mean
$D) of PBL from groups of pa-
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(tough the mean response to CMVLA seen
«j/5v=
fthe normal/mild group of patients was
gwer than that of all other groups (fig. 1), the
[Terence was not statistically significant by
Student's t test (normal/mild versus moder-
■dysplasia, t = 1.53, 0.20 > p > 0.10;
lersus severe dysplasia, t = 1.24, 0.30 >
jfc> 0.20; versus CIS, t = 1.08, 0.30 >
Z> 0.20).
?A total of 137 patients' PBL were tested
or responsiveness towards CMVEA (fig. 2).
phere was no significant difference in either
pie percentage of positive responses in any
$roup compared with another, or the mean SI
jpalues obtained.
^- The results of patients' PBL responses to
^mitogens are shown in table I where it can be
vseen that while the mean response to both
PHA and PWM of patients within the CIS
group was lower than that of others, the dif¬
ference was not statistically significant by
Student's t test (p < 0.05).
Correlation between SI and
Antibody to CMV
Of the 172 patients whose lymphocyte
responsiveness to CMV had been measured,
ELISA was carried out on 159 correspond¬
ing sera which were available. The results of
correlation between SI and the presence of
CMV antibody are shown in table II. Corre¬
lation between positive SI induced by both
CMVLA and CMVEA and the ELISA test
for antibody was good. Of 81 tests positive
by LS with CMVLA, 66 (82%) were also
positive by ELISA. In addition, of 50 LS-
positive tests obtained with CMVEA, 42
(82%) were also positive by ELISA. Table II
also shows the correlation between ELISA
and those tests negative by LS with both
CMVLA and CMVEA. Of a total of 78 pa¬
tients' PBL which did not respond in LS
tests to CMVLA, 47 (60%) were seronega¬
tive by ELISA. Forty-two of 69 (61%) pa¬
tients whose lymphocytes did not respond
Table I. Lymphocyte responses of patients to PHA, PWM and Con A
Patient group SI to mitogens
PHA PWM Con A
Normal/mild dysplasia (n = 46)
Moderate dysplasia (n = 41)
Severe dysplasia (n = 43)





















2 X 105 PBL were incubated for 6 days with PHA, PWM and Con A at final concentrations of l:160jN$j
and 0.3 pg/ml, respectively. The mean SI + SD responses of PBL from patients with CIS were compared to those
from patients with other grades of dysplasia by Student's t test,
n = Number of patients.
Table II. Correlation between LS and ELISA to CMV antigens








































Total 66/81 (82%) 41/50 (82%) 47/78 (60%) 42/69 (61%gj
to CMVEA were also seronegative by
ELISA.
Although there was good agreement be¬
tween a positive LS result for CMI and the
presence of CMV antibody, the correlation
coefficient (r) between SI and antibody titre
as measured by absorbance was not statisti¬
cally significant (r = 0.228, t = 1.36, 0.1 >
p > 0.5).
Discussion
CMV has recently been tentatively
posed as a candidate virus implicated inj
genesis of cervical cancer. Such an assoc®^
tion was suggested because CMV has b^|
isolated from cervical secretions [ 16] and ^
vical tumour biopsies [4], In vitro transfer
tion experiments have demonstrated
Bff
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Iy of specific CMV DNA fragments, ob-
i after restriction endonuclease diges-
to induce transformation in NIH 3T3
t cells [17, 18].
irvical cancer is thought to be a multi-
iisease beginning with a mild dysplasia
progressing, usually slowly, through
irate to severe dysplasia which may, un-
-eated, advance to CIS and thereafter to
ive carcinoma. If CMV is involved in
f these stages, specific viral antigens or
y induced antigens might be expressed
rvical cells. An immune response would
ndicate involvement of the virus,
this work, a specific T-cell-mediated
me response was sought using the LS
One CMV antigen preparation con-
1 viral antigens synthesized late in a
ictive replication cycle. No group of
its exhibited an increased responsive-
o this preparation and the frequency of
ve responders did not differ within
tigens synthesized 24—48 h after infec-
>y CMV represent early, mostly non-
ural virally induced proteins. These
nclude the protein(s) expressed during
:essary for cell transformation. In these
;, however, no group of patients re¬
sponded to this second antigen preparation in
5 manner different from any other group.
H CMI responses of all these patients as
pleasured by lymphocyte responsiveness to
specific CMV antigens correlated well with
She patients' humoral antibody status dem¬
onstrated by ELISA. While there was 82%
Correlation between positive SI and the pres¬
ence of CMV antibody, there was no correla¬
tion between the magnitude of the lympho-
:fyte response and the levels of antibody in
Jj>e patients' serum. A similar lack ofcorrela-
fj°n has previously been described in a com¬
parison between LS and antibody detected by
neutralization, indirect haemagglutination
and CFTs [15].
A positive LS test depends primarily on
the presence in the blood sample of a suffi¬
cient number of T cells with memory of
CMV antigens. In vitro, these have to be pre¬
sented with the antigen on monocytes, so that
proliferation is initiated, followed by lym-
phokine production and recruitment of other
lymphocytes. A number of factors can there¬
fore influence the outcome of the LS test so
that an immune individual might respond to
the antigen preparation poorly and appear to
be negative. In this study 40% of blood sam¬
ples which were negative by LS were shown
to possess CMV antibody by ELISA. On the
other hand only 6% of those seronegative by
ELISA gave a positive LS result. As a mea¬
sure of prior exposure to CMV, therefore, the
detection of antibody is more accurate than
the demonstration of specifically sensitized
lymphocytes. However, in the compromised
host, circulating antibody does not necessar¬
ily confer immunity.
Although the present work did not dem¬
onstrate involvement of CMV in the various
groups of patients studied, lymphocyte re¬
sponses may be important in delaying the
progress of the disease. The role of natural
killer cells has already been examined [13]
and presently under investigation is the re¬
sponse of interleukin-2-generated cytotoxic T
cells towards dysplastic cells in culture.
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INTRODUCTION
A variety of studies has reported an increase in the level of
copper (Cu) in the serum of patients with malignancy. This
increase has been found in carcinomas such as gastric (1),
mammary (2), cervical (3), bladder (4) and bronchial (5); in
sarcomas (6); and in haematopoietic malignancies (7,8).
Several of these reports have suggested that the serum Cu level
is a useful indicator of disease activity, response to
treatment and recurrence of tumour.
About 90% of the Cu in serum is usually contained within the
glycoprotein ceruloplasmin. Work by hinder (9) has indicated
that increased synthesis of ceruloplasmin by the liver may be
responsible for increased concentrations of ceruloplasmin and
Cu in malignancy.
Although several of the above studies have also described
changes in serum zinc (Zn)levels in human cancer patients, the
relationship appears less straightforward than that for Cu.
Generally, subnormal Zn levels are found in patients with
malignancy and there is a return to normal values with
favourable response to therapy (7). Since it appears that the
serum Cu level is influenced by the level of Zn because these
metals are physiological antagonists (10), the Cu:Zn ratio has
been advocated as a more useful measurement of disease
activity. However, some workers have reported little or no
alteration of serum Zn in malignancy (11, 12) or increased
levels (6, 13).
Recently, there has been further indication of the potential
value of serum Cu and Zn estimations in gynaecological tumours
(12). Six cases of cervical carcinoma were included in this
study and it was suggested that low-stage malignancy could not
be diagnosed by this method. The present investigation was
undertaken to establish whether changes in Cu and Zn levels in
the serum occurred with progressive stages of cervical
dysplasia, since dysplasia is presumed to precede carcinoma-in-
situ and invasive carcinoma.
MATERIALS AND METHODS
Patients and samples
Blood samples were obtained from women attending Gynaecology
Out-Patient Departments at the Elsie Inglis Hospital and Royal
Infirmary, Edinburgh. Serum was separated and stored at
-20°C. Red cells have a high Zn content (14) > hence any
haemolysed specimens were rejected. In addition, patients
known to have liver disease (15) or those receiving oral
contraceptives (16) were excluded as this may alter serum Cu
and Zn levels. Routine pathological examination was carried
out on several sections of cervical biopsies taken at the time
of the blood sample. Twenty-one patients were classified as-
having no evidence of cervical dysplasia, 24 patients had mild
dysplasia CIN I (cervical intraepithelial neoplasia - grade 1),
21 patients had moderate dysplasia, CIN II, 65 patients had
severe dysplasia/carcinoma-in-situ, CIN III, and 9 patients had
invasive carcinoma (Table 1).
Measurement of serum Cu, Zn and ceruloplasmin
Serum Cu and Zn concentrations were determined on the SP9
atomic absorption spectrophotometer with SP9 computer (Pye
Unicam) using air-acetylene flame (17). The concentration of
Cu and Zn was determined in pooled serum by standard additions
analysis (18). To 10 ml of pooled serum 100 ul of Cu standard
solutions (5, 10, 50, 100, 250, 500 mg/ml) and 100 ul of Zn
standard solutions (5, 10, 50, 100, 300 mg/ml) were added and
thoroughly mixed. Using the values for these sets of
standards and blanks, the Cu and Zn concentrations of the
\\
pooled serum and unknown serum samples could be calculated.
All standards and sera were measured in triplicate and the mean
value estimated. An absorbance versus concentration line was
plotted; the intercept of this straight line on the
concentration axis gave the concentration of the metal in the
pooled serum used to make up the standards, and the
concentration of the metal in the test sera could then be
calculated. The stability of the system was routinely checked
after every 15 measurements. Standards were cupric nitrate
and zinc chloride standard solutions "spectrosoL" (BDH
Chemicals Ltd.). New standards were always prepared on the
day of each analysis.
Serum ceruloplasmin was estimated by determining the serum




Serum samples and cervical biopsies were obtained from 140
patients. They were not taking oral contraceptives, were not
pregnant and were apparently healthy in other respects.
Routine pathology on several paraffin sections of the biopsies
classified the patients into groups depending on the extent of
dysplasia and the presence of in-situ carcinoma and invasive
carcinoma. Where difficulty in the grading of some specimens
made the distinction between two dysplastic groups less clear-
cut, these specimens were put in the higher.. dysplastic group.
Similarly, distinction between severe dysplasia and carcinoma-
in-situ is difficult; hence these samples were classifed
together as CIN III. The age range of patients in each group
was similar, as is the mean age (shown in Table 1).
Estimation of serum Cu, Zn and ceruloplasmin
Procedures involving precipitation of serum samples, e.g. by
trichloroacetic acid and extraction of samples have been shown
to be influenced by volume errors, errors resulting from
incomplete extraction and problems of contamination (17).
Dilution methods may reduce sensitivity and precision and the
risk of contamination is increased (20). Therefore, because
the physicochemical properties of the standards are as similar
as possible to the samples (21), the method of standard
additions analysis was chosen for estimation of serum Cu and Zn
in undiluted serum (18). ... ; ■ _
The average serum Cu level in healthy females was found ta.be -
125 ug/dl (SD + 0.16). In subjects with dysplasia the mean
serum Cu level increased: CIN I 133 ug/dl (SD + 0.19) p<C0.5,
GIN II 141 ug/dl (SD +_ 0.24) p<0.02, CIN III 140 ug/dl
(SD + 0.28) p 0.05. In the 8 subjects with invasive
carcinoma the mean serum Cu also increased to 147 ug/dl (SD +
0.26) p<( 0.02. These results are shown in Fig. 1.
In general, the average serum Zn levels were decreased in
dysplasia and in invasive carcinoma when compared to the mean
serum Zn value for healthy individuals 102 ug/dl (SD + 0.34).
The mean serum Zn values were: 81 ug/dl (SD +_0.19) p<( 0.02
for CIN I; for CIN II 90 ug/dl (SD +_0.28) p< 0.5; for CIN
III 93 ug/dl (SD +_ 0.28) p<C 0.5; for invasive carcinoma 73
ug/dl (SD +_0.12) p< 0.05 (Fig. 2).
Calculation of the Cu:Zn ratio provided greater differences in
the mean values for normal and dysplastic states and invasive
carcinoma. However, increased variation within each group was
apparent. Mean Cu:Zn values were:1.36 (SD + 0.57) for healthy
individuals, 1.72 (SD +_0.44) p< 0.05 for patients with CIN I,
1.72 (SD + 0.41) p<( 0.05 for patients with CIN II, 1.61 (SD +
0.46) p< 0.1 for patients with CIN III and 2.07 (SD + 0.51
p<0.01 for invasive carcinoma (Fig. 3).
Measurement of serum ceruloplasmin showed little differences
between normal and dysplastic groups CIN II, CIN III and
invasive carcinoma. Mean ceruloplasmin values were: 0.48 (SD
+ 0.09) for healthy females, 0.49 (SD + 0.12) for patients with
CIN II, 0.5 (SD +_0.18) for patients with CIN III and 0.56 (SD
+ 0.16) for patients with invasive carcinoma. There was a
marked decrease in serum ceruloplasmin_in_patients__with CIN I,
0.4 (SD + 0.09) p < 0.01, (Fig. 4).
DISCUSSION
The literature regarding the elevation of serum Cu in
malignancy generally indicates an increase in Cu levels with
increasing disease activity, a decrease in response to
treatment and increasing levels in cases of relapse (1-8). It
has been suggested that increased serum Cu and ceruloplasmin
levels in malignancy may play a role in host defense mechanisms
(22). In addition or alternatively, Cu may be important for
increased production of essential respiratory enzymes (23).
Increased serum Cu levels were reported in women with cervical
carcinoma by O'Leary and Feldman (3) and the degree of
elevation of serum Cu was related to the stage of carcinoma.
In the present study there appeared to be a progressive
increase in the mean serum Cu value with increasing dysplasia
of the cervix and invasive carcinoma (Fig. 1). However, large
overlapping of values from all the groups makes it unlikely
that this finding will be important in early diagnosis before
there is pathological evidence of carcinoma.
Although ceruloplasmin levels generally reflected serum Cu
values, there was no significant difference between CIN II, CIN
III and invasive carcinoma and the group with no evidence of
dysplasia (Fig. 4). An unexpected finding was a decrease in
ceruloplasmin in patients with mild dysplasia, CIN I. It is
possible that the measurement of ceruloplasmin may provide a
less sensitive means of estimating Cu activity. The linear
relationship between ceruloplasmin and total serum Cu may not
always apply in particular disease states, and it remains to be
confirmed that oxidase activity and Cu concentrations are
equivalent (24).
Decreasing mean serum Zn concentrations were observed in
dysplasia and invasive carcinoma of the cervix when compared to
the control group (Fig. 2). These differences were
significant for CIN I and invasive carcinoma groups. In
general, subnormal serum Zn levels have been reported in cancer
patients and a return to normal levels has been associated with
a favourable prognosis (7). It is thought that rapidly
dividing tumour tissue has an increased demand for Zn, which is
important for nucleic acid metabolism and protein synthesis
(25). However, as there was considerable overlap between the.
Zn values in the present study, Zn estimation on its own would
not allow definition of. the malignant state.
Several studies have advocated the use of the Cu:Zn ratio in
prognosis and management of patients with malignancy (6,7).
In the present study the serum Cu:Zn ratio gave a more
significant difference between the stages of dysplasia and
invasive carcinoma and the control group than individual serum
Cu or serum Zn levels (Fig. 3). Brandes et al (12) found that
the serum Cu:Zn ratio discriminated the cancer patients from
normal individuals better than measurement of Cu or Zn alone in
their study of 25 patients with malignant gynaeological
tumours. They consider that the increased serum Cu:Zn ratio
was mainly due to increased serum Cu and, that in patients with
advanced stages of tumour, a contributory effect of a decrease
in serum Zn occurred. Similarly, in the present study
increased Cu:Zn ratios largely reflected an increase in the
serum Cu levels and the additional effect of lower Zn levels
was apparent mostly in invasive carcinoma. On the other hand,
Capel et al (26) reported no increased Cu nor decreased Zn in
sera from 11 patients with tumours of the cervix, and the mean
Cu:Zn ratio was similar to that for healthy controls. Fisher
et al (22) found that, although serum Cu levels were generally
elevated in patients with melanoma and this elevation was
related to the degree and extent of tumour activity, serum Zn
levels and hence the Cu:Zn ratio did not reflect tumour
activity.
Although it would be tempting to speculate that pre-malignant
changes in serum Cu levels were observed in the present study,
the minor differences in the pathological staging of cervical
dysplasia and the large overlapping of values in all the groups
make this unlikely. Increased serum Cu and decreased serum Zn
are not exclusive to malignant disease and can occur in acute
and chronic infections, chronic liver diseases and pregnancy
(27). Although most of these conditions were excluded in the
present study, occult infection cannot be discounted. Tissue
levels of trace metals appear to vary not only with age, sex
and other factors but particularly with the organ of origin
(28). A similar study on the levels of Cu and Zn in normal,
dysplastic and malignant cervical tissue would perhaps reveal
whether changes of Cu in the serum directly reflect tissue
alterations of the metals and precede pathological evidence of
malignant cells.
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of dysplasia 21 25-63 39
CIN I 24 24-51 .33
CIN H 21 22-49 32
CIN 111 65 22-49 35
Invasive
carcinoma 9 27-60 . 38
Table 1: Classification of patients according to pathological
resection of cervical biopsy .specimens.
LEGENDS TO THE FIGURES
Fig 1. Serum copper levels (pg/dl) in women with various
grades of~ cervical dysplasia up to invasive carcinoma.
i '
Fig 2. Serum zinc levels (pg/dl) in women with cervical
dysplasia and with invasive carcinoma.
i
1
Fig 3. Serum Cu/Zn ratios in women with-cervical dysplasia
and with invasive carcinoma.
Fig 4. Serum ceruloplasmin levels (O.D.) in women with
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Summary
In order to investigate inhibition of viral replication, human embryonic
fibroblasts infected with cytomegalovirus (CMY) were treated with 0 to
25 pg/ml concanavalin A (Con A) and 0 to 150 pg/ml succinylated Con A
(S-Con A). Alterationiin cellular morphology occurred by day 2 post infec- y *3
tion (p. i.) in culturesfreated with 10 pg/ml Con A and 25 pg/ml S-Con A.
With increasing concentrations of Con A and S-Con A there was decreased
virus production from day 4 p. i. to day 10 p. i. Increasing levels of Con A and
S-Con A also reduced the number of cells in culture. When virus titres were
corrected to take cell number into account, decreased CMV titres in Con A
and S-Con A treated cells appeared mainly to reflect decreased cell num¬
bers. In support of this finding, in comparison with untreated CMTV-infected
fibroblasts, viral DNA synthesis was reduced and acid phosphatase levels
were increased in CMV-infected cells treated with Con A or S-Con A.
Introduction
The plant lectin, concanavalin A (Con A) specifically binds to cell
surfaces containing a-D-mannopyranosyl and a-D-glucopyranosyl residues
(12, 14). However, following infection by a wide range of viruses (4, 13) or
transformation (18), the receptors are redistributed into clusters. As a result
both virus infected and transformed cells are more easily agglutinated with
Con A (9). ••... -j... ».
Succinylation of Con A converts the molecule from a tetrameric to a
dimeric form which apparently reduces the crosslinking capacity (7). Con A
and S-Con A, therefore, have different biological activities and are both
useful for investigating how cell surface related changes may influence intra¬
cellular behaviour.
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When cells are productively infected with herpes simplex virus (HSV)
(17), or cytomegalovirus (CMV) (10, 16), they develop an affinity for the Fc
portion of immunoglobulin. These Fc receptors appear to be viral gene pro¬
ducts (3). In the case of HSV-infected cells, Fc receptors share some
measure of identity with receptors for anti-HSV-antibody and Con A; inhibi¬
tion of viral replication occurred in the presence of Con A (1). In addition,
inhibition of HSV-replication in cultures treated with S-ConA has been
reported (5).
In this paper we report on the results of similar studies using CMV-
infected cells treated with Con A and S-ConA, with a view to investigating
how cell surface interactions may alter viral replication and perhaps play a
role in the latency of CMV.
Materials and Methods
Virus Growth Studies
Strain AD 169 of CMV was used throughout (8). Human embryonic fibroblasts (HEF)
at pass 3 to 10 were grown in modified Eagle's medium supplemented with 5 per cent new¬
born calf serum (NBCS), 100 i. u./ml penicillin and 200pg/ml streptomycin. When con¬
fluent, cells in 24-well culture plates (Flow Laboratories) were infected with CMV at a
multiplicity of infection of 1 to 2, at 37° C for 1 hour. The cell monolayers were washed with
phosphate-buffered saline (PBS) and maintained in medium containing 2 per cent NBCS.
Con A (Sigma) at 0, 5,10,15, 25 pg/ml or S-ConA (Sigma) at 0,10, 25, 50,100,150 pg/ml
were added to cultures at this time.
Cells were harvested at daily intervals by scraping into the medium with a rubber po¬
liceman. After freeze-thawing, and ultrasonification at 9 Kc/s for 2 minutes, the virus was
titrated in HEF cells with a 0.25 per cent agarose (Seaplaque, FMC, U.S.A.) overlay and
the titre was expressed as log10 plaque forming units (PFU)/ml. Similarly infected cultures
containing the same concentration of lectin were washed with PBS, the cells removed with
PBS containing 0.1 per cent trypsin, 0.01 per cent versene and the cell number was deter¬
mined with a haemocytometer. Corrected virus titres were expressed as log10 (PFU/108
cells).
DNA Synthesis
Confluent uninfected and AD 169-infected HEF monolayers (about 2 X 108 cells) were
incubated with 0,10, 25 pg/ml ConA or 0, 10, 25, 50 pg/ml S-ConA until the cytopathic
effect was well advanced. The medium was replaced with fresh medium containing the
same concentration of lectin and 2 pCi/ml(methyl-3H) thymidine (specific activity,
84 Ci/mmol; Amersham) and the cells incubated for a further 3 days at 37° C. Infected and
uninfected cells were harvested using glass beads. The cells were washed three times in
0.01 m Tris HC1 buffered saline pH 7.4, resuspended in 9 ml buffer and digested with 1 per
cent SDS in lysis buffer (0.05 m Tris, 0.01 m EDTA pH 8.0) containing 0.2 mg/ml protein¬
ase K (Sigma) for 4 hours at 37° C. DNA was extracted twice with redistilled phenol,
saturated with TES buffer (0.05 m Tris, 0.005 m EDTA, 0.15 m NaCl pH 7.4), and preci¬
pitated with ethanol. The sample was then redissolved in TES buffer, suspended in TES
buffered CsCl with a density of 1.72 g/m1 and centrifuged for 68 hours at 100,000 g with a
Beckman SW 50.1 rotor at 20° C. Fractions were collected, the refractive index measured
with a refractometer, and then precipitated with trichloracetic acid (TCA). The precipitate
was collected on glass fibre discs, washed with 10 per cent TCA followed by methanol, and
after drying the discs were counted in toluene-based scintillation fluid.
Acid Phosphatase Activity «"
HEF were infected with AD 169 as described previously and incubated at 37° C in the
presence of Con A at 0,10, 25 pg/ml or S-ConA at 0,10, 25, 50 pg/ml. Each concentration
was tested in four cultures for each time interval. At the indicated times postinfection, two
of the four cultures were trypsinized and the cells counted; extracts were prepared from
the other two cultures by the procedure outlined in (6). Briefly, the cell monolayers were
washed three times with PBS and suspended in 0.1 ml distilled H,0. After overnight
storage at —3CP C, the cultures were thawed and 0.3 ml 0.4 m sodium acetate buffer pH 5.0
and 0.3 ml 0.2 m B-glycerophosphate (pH 5.0) were added. Incubation was carried out at
37° C for 2 hours and the reaction stopped by the addition of 0.4 ml 20 per cent TCA. The
solution was clarified by centrifugation at 2000 X g for 10 minutes and analyzed for in¬
organic phosphate (Pi) (2). Acid phosphatase activity was corrected for cell number and
is expressed as mg Pi/108 cells. ... ... . ..■* •'
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Results
Effect of S-ConA and ConA on CMV Replication in HEF
HEF cultures were infected as described in Materials and Methods and
maintained in the presence ofS-Con A (at 0, 10, 25, 50, 100 150 pg/ml) or
ConA (at 0, 5, 10, 15, 25 pg/ml) from 1 hour post infection until the time of
harvest. The virus produced was then titrated in HEF.
The addition of S-ConA and ConA altered the morphology of the infect¬
ed cell monolayers. By two days post infection (p. i.) untreated fibroblasts
appeared virtually unaltered by the presence of virus. However, at the same
time p. i. a proportion of cells had rounded in cultures treated with 10 pg/ml
ConA and there were large gaps in the cell monolayer. This effect was
aggravated in the presence of 25 pg/ml Con A. Similar effects were observed
with S-ConA. Therefore, cell numbers were determined in cultures at each
concentration of lectin by trypsinizing and counting cells in parallel cultures
daily for 10 days p. i. Measurement of cell numbers in such a collection of cul¬
tures gives, at best, an estimation which will vary from one experiment to
another. Increasing concentrations of S-ConA and ConA reduced the num¬
ber of cells in culture; concentrations of ConA greater than 25 pg/ml and S-
Con A greater than 50 pg/ml reduced cell numbers to such an extent that
estimation of cell number over the period of infection was not reliable (data
not shown).
In cultures infected with CMV, production of virus occurred after an
eclipse period of approximately 3 days and a sharp increase in virus titre
was seen by day 4 p. i. (Figs. 1 and 2). There was another increase after day
8 presumably due to a second round of replication in the cells not infected
initially. With increasing concentrations of ConA, the eclipse period was
unchanged but the amount; of virus produced on day 4 and on subsequent
days was reduced (Fig. la).
In the S-ConA treated cultures a similar reduction in virus titre was seen
at day 4—5 p. i. compared with the control culture (Fig. 2 a). The second
burst of CMV activity was more obvious in these cultures and occurred from
day 7—9 p. i. even in the presence of S-Con A, although to a lesser extent. By
day 10 inaetivation of virus was apparent.
However, when virus titre was corrected by taking differences in cell
number attributable to ConA and S-ConA treatment into account, and
expressed as PFU/106 cells, very little effect of ConA or S-ConA on CMV
replication was apparent (Figs. 1 b and 2 b). ^
DNA Synthesis in CMV-infected HEF Treated with ConA and S-ConA
There was very little difference in the incorporation of 3H-thymidine in
uninfected cultures treated with concentrations of S-ConA ranging from 10
to 50 pg/ml or ConA from 10 to 25 pg/ml compared with untreated
fibroblasts (data not shown). In CMV-infected cultures, although treatment
with S-Con A at 10 and 25 pg/ml only slightly altered the amount ofviral and
cellular DNA, in the presence of 50 pg/ml S-ConA a much greater decrease
in incorporation of 3H-thymidine occurred (Fig. 3). There appeared to be a
'
single peak of DNA but the width and the range in density of the peak
suggests that both viral and cellular DNA was present. On the other hand,
CMV-infected cultures treated with 10 and 25 pg/ml Con A gave only one
relatively sharp peak of DNA and this was probably cellular DNA, having a











Acid Phosphatase Activity in CMV-infected Celts'Treated with
•. r ConA and S-ConA ;
'■ CMV-infected HEF were incubated with various concentrations of Con A
or S-ConA over 9 days. Extracts prepared from cultures were analyzed for
inorganic phosphate (an indirect measurement of acid phosphatase activity)
* 1 -v'Uion. OJ exu'&eeUuuU" vsrus
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and at the same time, duplicate cultures were used to estimate cell number.
Before correction for cell number, no significant differences in acid
phosphatase levels were apparent in CMV-infected cultures treated with
Con A and S-ConA (data not shown). However, when acid phosphatase
activity is expressed as mg Pi/10" cells, increasing levels were associated
with increasing concentrations of Con A and S-ConA (Figs. 5 and 6).
Increases in acid phosphatase activity occurred 3 and 7 days after infection
in S-ConA treated cells (Fig. 5), which coincided with increased virus titres
on these days (Fig. 2). Decreasing levels on day 5—6 and day 9 probably
reflect lysis of the cells. Similar increases in acid phosphatase activity




It has been suggested that binding of Con A (1) and S-ConA (5) to HSV-
infected cells inhibits production of infectious virus. This effect may provide
one method of studying mechanisms of latency of Herpes viruses by deter¬
mining how viral replication is halted. We treated CMV-infected fibroblasts
with Con A and S-ConA but found that decreased CMV titres reflected
decreased cell numbers. Alterations in cellular morphology were noticeable
even at the lower levels of lectin employed. In support of this finding similar
changes have also been reported in RK-13 cells infected with vesicular
stomatitis virus and treated with Con A (15).
Gabbity et al. (5) suggested that inhibition of viral replication in HSV-
infected cells treated with S-ConA did not occur at the level of viral DNA
synthesis. In contrast, we found a reduction in viral DNA in CMV-infected
cultures treated with S-ConA, and this reflected a decrease in the number of
viable cells capable of supporting CMV infection. The effect of Con A at
10 pg/ml was more remarkable in that viral DNA did not seem to be present
(Figs. 4 b and c). The amount of virus is reduced 30-fold (Fig. 1 a) in the
presence of 10 and 25 pg/ml Con A, compared with untreated infected cells.
If the amount ofviral DNA synthesis in untreated cells is reduced by this fac¬
tor then counts per minute in the region of 102 or lower would be expected in
the presence of Con A, and this may not be sufficient for detection. In addi¬
tion, although viral DNA synthesis was detected in the presence of50 pg/ml
S-ConA, this probably reflects 10 times more viral replication occurring in
S-ConA treated cells (Fig. 2 a) than in Con A treated cells (Fig. la).
Gabbity et al. (5) considered that decreased HSV replication in S-ConA
treated cells could be caused by destruction of virus by lysosomal enzymes,
although this could not be demonstrated in practice. However, in the CMV
system, we found that, in addition to correcting for the virus growth curve,
correction of acid phosphatase levels taking cell numbers into account,
revealed an increase in acid phosphatase activity with increasing concentra¬
tions of Con A and S-ConA. This increased activity could destroy virus
particles but presumably cell lysis occurs before infectious virus can be
produced. ' .......
Decreased synthesis of viral polypeptides may be involved in the inhibi¬
tion of HSV-replication in cells treated with S-ConA (5). On the other hand,
Khelifa and Menkes (11) concluded that Con A acted on the early stages^
of Epstein-Barr virus replication at the cell or virus surface. Their findings
suggest that inactivation of extracellular virus by Con A would decrease the
virus titre. Although CMV is very cell-associated, strain AD-169 is highly ;
tissue culture adapted, and ^-virus spreads via the medium as well as by X
cell-to-cell contact. Thus extracellular inactivation of CMV by lectins may
have occurred in our system. However, such low levels of lectin would not
saturate cellular binding sites, and it is unlikely that inhibition ofCMV repli¬
cation would mainly result from inactivation of extracellular virus or the
blocking of virus from entering cells.
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Taking together the morphological evidence, differences in cell numbers,
correction of CMV titres when cell numbers are considered, reduced viral
DNA synthesis, and increased acid phosphatase activities, decreased CMV
titres in infected cultures treated with Con A and S-ConA predominantly
reflect a reduction in cell viability and not a specific effect on any one stage
of the viral replication cycle.
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Fig. 1. Virus production in CMV-infected cultures treated with Con A. a Virus titre ex¬
pressed as logio PFU/ml. (®) 0 Con A; (□) 5 pg/ml Con A; (A) 10 pg/ml C°n A; (3) 15 pg/
ml Con A; (O) pg/ml Con A. b Virus titre corrected for cell number, symbols as for a
Fig. 2. Virus production in CMV-infected cultures treated with S-Con A. a Virus titre ex¬
pressed as logio PFU/ml. (•) 0 S-Con A; (A) 10 pg/ml S-Con A; (B) 25 pg/ml S-Con A;
(O) 50 pg/ml S-Con A; (A) 100 pg/ml S-Con A; (□) 150 pg/ml S-Con A. 6 Virus titre correct¬
ed for cell number, symbols as for a
Fig. 3. CsCl buoyant density analysis of DNA from CMV-infected cells treated with
S-Con A. (All fractions were counted but in the graphs every second fraction is represented
from areas outwith the peak fractions), a DNA from CMV-infected cells. DNA from CMV-
infected cells treated from 1 hour p. i. with: 10 pg/ml S-Con A (b); 25 pg/ml S-Con A (c);
50 pg/ml S-Con A (d)
Fig. 4. CsCl buoyant density analysis of DNA from CMV-infected cells treated with Con A.
(All fractions were counted but in the graphs everyflraction is represented from areas out-
side the peak fractions), a DNA from CMV-infected' cells. DNA from CMV-infected cells
treated from 1 hour p. i. with: 10 pg/ml Con A (b); 25 pg/ml Con A (c)
Fig. 5. Acid phosphatase levels (mg P. i./109 cells) in CMV-infected cells treated with
S-Con A. (•) 0 S-Con A; (□) 10 pg/ml S-Con A; (■) 25 pg/ml S-Con A; (O) 50 pg/ml
S-Con A
Fig. 6. Acid phosphatase levels (mg P. i./109 cells) in CMV-infected cells treated with
Con A. (•) 0 ConA; (□) 10 pg/ml Con A; (■) 25 pg/ml Con A
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Experimental production of sheep
pulmonary adenomatosis (Jaagsiekte)
Sheep pulmonary adenomatosis (SPA) or Jaagsiekte is a
contagious disease of unknown aetiology'. A herpesvirus
has been isolated from such tumours in Britain' and in
Africa3,1 but attempts to produce adenomata with this
virus have been unsuccessful (ref. 5 and G. Robin¬
son, and K.W.A., in preparation). More recently, evidence
has been presented that a type C virus with a density on a
sucrose gradient of 1.5-1.20 g ml"1, containing 60-70S RNA
and RNA-directed DNA polymerase (reverse transcriptase)
is present in the adenomatous tissue'. We wish to describe
the production of SPA tumours in sheep experimentally
infected with both agents.
Techniques1 similar to those of Perk et al.', were used to
confirm the presence of a reverse transcriptase-producing
(RTP) agent in SPA tumour tissue from Scottish sheep.
This enzyme was not detected in similar fractions from the
lungs of unaffected sheep (Table 1).
A suspension of tumour from a natural case of SPA was
subjected to equilibrium density centrifugation on a sucrose
gradient. Fractions with densities of 1.15-1.17 g ml"1 were
centrifuged at 150,000g for 60 min at 4 °C and the pellet,"
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Table 1 DNA polymerase activity of fractions of tumour or
- - unaffected lung
Reagent added to standard reaction mixture
Sheep Clinical No + Actino¬
no. state addition + Poly(A)-oligo(dT),0 mycin D
A525 Adenomatosis 60* (1 )i 930 (15) 70(1.2)
J2 Adenomatosis 150(1) 370 (2.5) 33 (0.2)
J4 Adenomatosis 40 (1) 330 (8.2) 26 (0.7)
J13 Adenomatosis 110 (1) 800 (7.3) 115 (1.1)
J14 Adenomatosis 153(1) 750(4.9) 133(0.9)
N1 Unaffected 120(1) 155 (1.3) 10(0.09) >.
N15 Unaffected • 117(1) 173 (1.5) 47 (0.4)
N16 Unaffected 170(1) 313(1.8) 93(0.6)
were minimal and present in four (13%) of a total of thirty,
one sites examined. Of the sheep given both the RTP agent
and the herpesvirus, three had definite macroscopic tumours
and one was histologically positive (Fig. 1). No adenomatous
lesions were found in any other sheep. All lungs were
assayed for particles with reverse transcriptase activity and
these were detected in lung tissue from two sheep (Table 2).°
Herpesvirus, which we have isolated from 24% of SPA
tumours over the past 5 yr, was not recovered from any lung
- "-4
'Polymerase activity of 1.15-1.17 gml"1 fraction from sucrose
density gradients of tumour or lung tissue suspensions, measured as
increase in c.p.m. 3H-TTP incorporated into acid-insoluble material
in 20 min using the methods outlined by Norvai et aV. -
{Ratio of comparative activities are given in parentheses and the
discriminatory effect of poly(A)-oligo(dT)10 and actinomycin D on
polymerase activity in the adenomata and healthy tissues are shown.
resuspended in 199 medium, was injected endobronchially
into six Cheviot sheep. Herpesvirus isolated from an SPA'
tumour and passaged four times in embryo sheep kidney
cells and once in sheep pulmonary macrophages (titre >10a T
TCDinmr') was similarly injected into four sheep. Both
the herpesvirus and the density gradient fraction, containing
the RTP agent, were injected into six more sheep. As
controls, four sheep were given a supernate of tumour
suspension and four, from the same flock, a supernatant
prepared in an identical manner from apparently normal
lung. To avoid cross infection, the groups of sheep were
housed, as in previous transmission experiments, in separate
loose boxes. •
.
Results are shown in Table 2. One sheep, given the
tumour supernatant, was clinically affected with SPA 6
months after inoculation. This diagnosis was confirmed
histologically and all sheep were killed therefore 7-8 months
after inoculation. A minimum of ten standard sites from
the lungs of each sheep were examined histologically. In
the group given the RTP agent alone, one sheep had two
small (3-5-mm) adenomata and one other, histological
evidence of adenomatous changes. Lesions in both sheep
Table 2 Evidence of pulmonary adenomata in the inoculated sheep
Histological Number with
Material No. in Macroscopic adenomatous reverse
inoculated group tumours changes transcriptase
Tumour
activity
supernatant 4 1 2 1
Herpesvirus
and reverse
transcriptase- . "C :
producing




agent 6 1 2 0
Herpesvirus 6 0 0 0
Normal lung
0supernatant 4 0 0
Suspensions of finely minced tumour or lung tissue were prepared
in Eagle's medium containing antibiotics and centrifuged at 12,000?
for 30 min at 4 °C (inocula of "tumour or normal lung supernatant").
The supernate was recentrifuged at 120.000? for 90 min and the
resulting pellet gently resuspended in 1 ml TNE buffer, layered on to
a preformed gradient of 20-70% sucrose prepared in TNE buffer
and centrifuged in a Beckman SW 40 rotor at 85,000? for 16 h at
4 °C. Fractions between densities of 1.15-1.17 g ml"1 (the density of
RNA tumour viruses) were pooled, diluted in TNE buffer and centri¬
fuged at 150,000? for 60 min at 4 °C. The pellet obtained was
suspended in 0.15 ml of TNE buffer and assayed for reverse tran¬
scriptase or further diluted for inoculation of sheep. Each inoculum
was injected endobronchially in 8-ml volumes.
Fig. 1 Focus of adenomatous change. j
" " " " . -- |
" ' - •
; - - "vr;
We can find no evidence to support the view that these
tumours arose adventitiously or were caused by myoplasma
or other cultivable microorganisms. Since some sheep in
both of the groups given the density fraction containing the
RTP agent developed adenomatous lung lesions within 8
months of inoculation, it seems certain that this agent was
involved in the production of these changes. Whether it
alone is capable of .initiating adenomatous changes or
requires the assistance of the herpesvirus is conjectural and
remains to be established. In the four affected sheep given
both herpesvirus and RTP agent, lesions were extensive,
and present in a mean of 63% of the areas of lung
examined. This may indicate that the herpesvirus was
involved in the production of these changes. The possibility
that a small number of herpesvirus particles was present
in the fraction containing the RTP agent cannot be dis¬
missed completely and such contamination would simulate,
to a lesser extent, the combined inoculum of herpesvirus
and RTP agent. It may be that both viruses act synergistic^
ally to cause oncogenic transformation of the target cells,
the type II alveolar cells or the cells of Clara in the
bronchioles", but the precise role of these viruses can only
be elucidated by further experiments with purified virus. ;jyf
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Summary.—The injection (s.c. or i.p.) of 106 live or lethally irradiated methyl-
cholanthrene-induced fibrosarcoma cells into CBA/Ca mice one or 2 days before
i.v. challenge with the same tumour inhibited the formation of artificial lung tumour
metastases. In addition, it also frequently enhanced the cytostatic effect of peritoneal
exudate cells on monolayers of the same tumour. The effects on lung tumour meta¬
stasis were not 'noted if X-irradiated tumour was injected i.v., or if s.c. admini¬
stration was delayed until one day after i.v. challenge. Similar effects on tumour
growth were also observed in C3Hf/Bu mice and (CBA/Ca x A/HeJ) Fi hybrids which
were pretreated (s.c.) with tumour shortly before i.v. challenge with the same
tumour. Further studies in CBA/Ca mice suggested that the protective effect was
tumour-specific, for the growth of i.v. injected tumour was not significantly inhibited
by pretreatment with a number of other MC-induced or spontaneous tumours from
the same and different strains.
A considerable number of investiga¬
tions undertaken during recent years
have shown that factors which suppress
the function of lymphoreticular endothe¬
lial cell may he released by or extracted
from a variety of tumours. For example,
factors have been reported which sup¬
press (a) the in vitro response of spleen
cells to mitogens and alloantigens (De
Lustro and Argyris, 1976) and sheep
erythrocytes (Wong, Mankovitz and Ken¬
nedy, 1974; Kamo et al., 1975); (b)
macrophage chemotaxis in vitro (Meltzer
and Stevenson, 1977«, />; Normann and
Sorkin, 1977; Snydermann and Pike, 1976;
Pike and Snydermann, 1976) and in vivo
(Snyderman and Pike, 1970; Pike and
Snyderman, 1976); (c) macrophage-
mediated resistance to infection (North,
Kirstein and Tuttle, 1976a, b); and (d)
the in vivo response to syngeneic (North et
al., 1976ft; Pike and Snyderman, 1976;
Nelson and Nelson, 1977) and allogeneic
(Bonmassar et al., 1973) tumour trans¬
plants. It would also appear that the
inhibitory effects observed in vivo are not
always dependent upon the presence of a
large tumour mass, for they may be
evident within 24 h of the s.c. transplanta¬
tion of JO6 tumour cells (North et al.,
1976a, b).
The observed effects on macrophage
function have led to the suggestion that
neoplastic cells may abrogate or interfere
with the early phases of immunosurveil-
lance by releasing products which modify
the localization and/or activity of macro¬
phages (Snyderman and Pike, 1976; Pike
and Snyderman, 1976; North et al.,
1976a, b; Nelson and Nelson, 1977). In
view of the above suggestions and the
observations of North et al. (1976a, b), we
thought it was important to establish
whether the injection of syngeneic tumour
cells shortly before i.v. challenge with the
same tumour cells would increase the
incidence of artificial metastases, or inter¬
fere with the capacity of macrophages to
exert a cytostatic effect on syngeneic
target cells in vitro. Contrary to expecta¬
tions we found that the injection of
syngeneic tumour cells as late as 1 day
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before i.v. challenge inhibited the develop¬
ment of artificial metastases. It had,
however, a less consistent effect upon the
cytostatic activity of peritoneal exudate
cells harvested within 2 days of tumour
injection.
MATERIALS ANI) METHODS
Mice.—Almost all the experiments were
performed in inbred CBA/Ca mice (male and
female) aged 8-12 weeks. The remaining
experiments were undertaken either in Fi
hybrids of GBA/Ca and A/HeJ mice or inbred
C3Hf/Bu mice. The CBA/Ca mice were bred
from mice obtained from the MRC Laboratory
Animals Centre, Carshalton, Surrey. The
A/HeJ mice used in the breeding of the
(CBA/Ca X A/HeJ) Fi hybrids were pur¬
chased from the Jackson Laboratories, Bar
Harbor, Maine, U.S.A. The C3Hf/Bu mice
were derived from stock originally obtained
from Baylor University, Texas, U.S.A. They
were kindly provided by Dr W. H. McBride
of the Department of Bacteriology, Univer¬
sity of Edinburgh.
Tumours.—A number of tumours were
used in these studies. They include (a) MC
fibrosarcomas from a number of strains of
mice; (b) a fibrosarcoma which had been
obtained by injecting CBA/Ca mice with
syngeneic embryo cells which had trans¬
formed in vitro; and (c) an adenocarcinoma
which had spontaneously appeared in CBA/Ca
mice. Further details on the origin, generation
number and designation of these tumours
are presented in Table I.
Cultured MC-induced CBA fibrosarcoma
cells (CCH1) were generally used for pre-
treatment and always used for challenge.
These cells had been maintained for 3-18
months in culture, as previously described
(Ghaffar et al., 1974). The T3 fibrosarcoma
cell line was also maintained in culture. All
the other tumour-cell suspensions used were
obtained by pronase digestion of freshly
excised tumour cells (Woodruff and Boak,
1966).
X-Irradiation.—Tumour cells were irradia¬
ted at a dose rate of 274 rad/min to a total
of 22,000 rad using a Westinghouse X-ray
machine operating at 220 kV and 15 mA, with
HVL of 1-2 Cu under conditions of maximum
backscatter.
In vivo experimental model.—The basic
protocol involved injecting mice s.c. with 106
syngeneic or allogeneic tumour cells 1 to 2
days before i.v. challenge with 5 x 104 tumour
cells. The mice were killed 14 days after
challenge, the lungs removed and fixed in
Bourn's solution and the number of artificial
metastases (tumour nodules) per lung
counted. Each experimental group contained
6 to 19 mice. Further details on variations in
this basic protocol are reported elsewhere in
the text or in the footnotes to the figures and
tables.
In vitro cytostatic assay.—The procedure
used has been described in greater detail
elsewhere (Ghaffar et al., 1974). In essence
it involved the addition of test effector cells
to tumour-cell monolayers in the wells of
plastic microculture plates and incubating the
plates at 37°C for 48 h. At this stage, the
culture medium (see below) was replaced by
fresh medium containing 125I-iododeoxyuri-
dine (Radiochemical Centre, Amersham,
England). The incorporation ofthis thymidine
analogue into the tumour-cell monolayer was
assessed 20 h later in an LIvB Wallac gamma
scintillometer. The spleen cells whose cyto¬
static activity was being assessed were obtain¬
ed by gentle disruption in cold medium in a
hand-operated glass homogenizer while the
peritoneal exudate cells were obtained by
washing out the peritoneal cavity with 3 ml
of medium containing 10 u of heparin/ml.
These cells were always washed X 3 before
use. Throughout these in vitro studies, the
medium used was RPMI 1640 (Gibco Biocult,
Paisley, Scotland) buffered with 20 mi
HEPES and supplemented with 10% (vol/
vol) foetal calf serum, 100 u/ml penicillin and
100 pg/ml streptomycin.
Bacteriological and virological investiga¬
tions.—A variety of standard procedures
were used to ascertain if the cultured CBA
MC fibrosarcoma cell line routinely used in
these studies (that is, CCH1) was contamina¬
ted with micro-organisms which might in¬
fluence antitumour responses. In brief these
included electronmicroscopic examination of
tumour cell sections, the screening of cells
and culture supernatants for mycoplasma
(McKay et al., 1974), reverse transcriptase
assays using the method of Dr Natalie Teich
(personal communication) and indirect im¬
munofluorescence on acetone-fixed cells (Hart
and Marmion, 1977) with antisera to
Moloney leukaemia virus and RD-114, an
endogenous feline RNA oncovirus. Finally,
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the cells were grown in the presence of
3H-uridine and the supernatant^ screened
for the presence of micro-organisms contain¬
ing RNA. Further details on the culture
procedure and the density-gradient separa¬
tion technique used in the incorporation
studies are reported elsewhere (Norval and
Marmion, 107(5).
Presentation of results.—The number of
artificial metastases observed in experimental
mice have been presented in scattergrain
form and the significance of the results has
been determined using the Wilcoxon Rank
Sum test. The in vitro cytostatic results have
been expressed as geometric means together
with the limits of one standard error from
the mean ct/min of 5 replicate samples. The
cytostatic indices (CI) have been calculated
using the following formula:
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where N represents the mean ct/min obtained
using effector cells from untreated (control)
mice, and T represents the mean ct/min
using effector cells from mice treated with
tumour cells. The significance of the cyto¬
static results has been assessed by the standard
Student's two-tail t test.
RESULTS
The effect of the preinjection of tumour cells
on the development of artificial lung
metastases
In our initial experiments, mice were
injected s.c. with 10® viable cultured
tumour cells and challenged i.v. 24 h later
with various doses of cultured syngeneic
tumour cells. The number of artificially
induced pulmonary metastases present
14 days later was determined. The results
of one such experiment are presented in
Fig. 1. It will be noted that the number of
metastases was significantly reduced in
mice which had been injected s.c. with
syngeneic tumour cells 24 h before i.v.
challenge.
These initial observations were un¬
expected in view of previous suggestions
that such pretreatment might interfere
with the antitumour activity of host















Fig. I •—The effect on the growth of i.v.
injected tumour cells of the preinjection
(s.c.) of syngeneic tumour cells. A, C—no
pretreatment; B, D—tumour cells s.c.
Mice were pretreated by s.c. injection with
10(i cultured syngeneic MC fibrosarcoma
cells (CCH1) 24h before i.v. challenge with
5 x 104 or 1 x 105 CCH1 tumour cells.
Note that 14 days after i.v. challenge the
number of lung metastases in the pretreated
groups (B and D) was significantly lower
(P<()-01) than in groups receiving no pre¬
treatment (A and C).
1976a, h). We decided therefore to perform
additional experiments to see whether the
effect observed was dependent upon the
dose and route of injection of the tumour
cells, the time they were injected in rela¬
tion to i.v. challenge, and whether or not a
similar effect could be achieved with
lethally irradiated syngeneic tumour cells
or with other syngeneic and allogeneic
tumours.
Several experiments were performed to
determine the dose dependency of the





























































Fig. 2.—The effects on the growth of i.v.
injected tumour cells of the preinjection
(s.c.) of various doses of syngeneic tumour
cells. Mice in Groups B, C and D were
injected respectively s.c. with 107, 106 and
104 cultured syngeneic MC fibrosarcoma
cells (CCH1) 24 h before i.v. challenge
with 5 x 104 CCH1 tumour cells. Group A
mice had no pretrcatment. Note that 14 days
after i.v. challenge the number of meta¬
stases in animals pretreated with 107 (B)
and 106 (C) tumour cells was significantly
lower (P<0-01) than in mice receiving no
pre treatment (A). The inhibition observed
in animals pretreated with 104 tumour
cells (D) was just significant at the 0-05 level.
effect, and the results of one of these
experiments are presented in Fig. 2. These
studies revealed that 106 tumour cells or
Fig. 3.—The effects on the growth of i.v.
injected tumour cells of the preinjection
(s.c.) of various tumour cell preparations.
All mice received i.v. challenge with 5 X 104
cultured CCHl fibrosarcoma cells. Pretreat-
ment: A—no pretreatment; B—syngeneic
MC fibrosarcoma cells Day — 1; C—
lethally irradiated syngeneic MC fibrosar¬
coma cells Day — 1; D—syngeneic MC
fibrosarcoma cells Day + 1J E—allogeneic
MC fibrosarcoma cells Day — 1. Syngeneic
MC fibrosarcoma cells were from cultured
CCHl. Allogeneic MC fibrosarcoma cells
were from freshly excised ACH3. Note that
14 days after challenge the number of
tumour metastases per lung was signifi¬
cantly lower in mice pretreated with viable
or lethally irradiated syngeneic tumour cells
(B and C, P<001). In contrast, pretreat¬
ment with allogeneic tumour cells or the
administration of tumour cells after i.v.
challenge did not inhibit tumour meta¬
stases. (For further results of a similar
nature see Figs. 5 and 7.)
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more had to be injected s.c. to ensure
effective inhibition metastasis.
Experiments were then undertaken to
see whether the protection observed
above could also be achieved by pre-
injection of X-irradiated syngeneic t umour
cells or allogeneic MO fibrosarcoma cells of
A/HeJ origin. These studies revealed that
the preinjection of X-irradiated syngeneic
tumour cells also inhibited the develop¬





























A B C D
Fig. 4.—The effects on the growth of i.v.
injected tumour cells of the preinjection
of X-irradiated syngeneic tumour cells by
different routes. Mice B-D were injected
by the route indicated with 106 lethally
irradiated cultured syngeneic MC fibro¬
sarcoma cells (CCH1) and were challenged
i.v. 2 days later with 5 X 104 CCHI
tumour cells. Note that 14 days after
challenge the number of lung metastases
in the s.c. (B) and i.p. (C) pretreated
groups were significantly lower (PcO-Ol)
than in the control group (A), while those































Fig. ,r).—The effect on the growth of i.v.
injected tumour cells of the s.c. injection
of syngeneic tumour cells. Mice in Groups
B—F were injected s.c. with 10" cultured
syngeneic MC fibrosarcoma cells (CC'Hl)
at various times (Day — 3 to Day +1
respectively) in relation to challenge i.v.
with 5 X 104 OCH1 tumour cells. Noto
that the number of tumour metastases
14 days after i.v. challenge was significantly
reduced (P<0-0I) in the pretreated groups
(B-D) but was not significantly affected in
animals injected at the same time (E)
or 24 h after i.v. challenge (F). See also
Fig. 3, (D).
challenge, whilst pretreatment with fibro¬
sarcoma cells of A/HeJ origin (designated
AGH3) was without effect. It should also
be noted that syngeneic tumour cells
failed to inhibit tumour growth if admini¬
stered after i.v. challenge. This pheno¬
menon was investigated further (see
Fig. 5).
Investigations were then made into
whether the protective effect afforded by
preinjection of syngeneic tumour cells
shortly before challenge was dependent
upon the route of administration of the
original inoculum. In this experiment














noted following preinjection by the s.c.
and i.p. routes, but not by the i.v. route
(see Fig. 4). This effect has been observed
on 3 separate occasions.
The next 2 experiments were prompted



























Fig. 6.—The effects on the growth of i.v.
injected tumour cells of the preinjection
(s.c.) of syngeneic tumour cells. Mice in
Groups B-D were injected s.c. with 106
cultured syngeneic MC fibrosarcoma cells
(CCH1) at various times (Days —14, — 7
and — 2 respectively) in relation to i.v.
challenge with 5 x 104 CCHl tumour
cells. Note that the number of tumour
metastases observed 14 days after i.v.
challenge was significantly decreased in all
pretreated groups (P<005 to P<001).
mice were injected s.c., i.p. or i.v. with
106 irradiated tumour cells. Significant
inhibition of pulmonary metastasis was
Fig. 7.—The effect on the growth of i.v.
injected MC fibrosarcoma cells of the
preinjection (s.c.) of various tumour cells.
Mice were injected s.c. with 106 viable cells
from a variety of freshly excised tumours
and challenged i.v. 48 h later with 5 X 104
cultured MC fibrosarcoma cells (CCHl).
Pretreatment: A—no pretreatment: B—
syngeneic MC fibrosarcoma (CCHl); C—
syngeneic spontaneous tumour (W54);
D—allogeneic MC fibrosarcoma (ACH3);
E—allogeneic MC fibrosarcoma (FSA).
Note that 14 days after challenge the only
significant reduction in lung metastasis was
observed in mice pretreated with CCHl
tumour (B, P<001). On this occasion
the spontaneous tumour (W54, C) also
inhibited tumour growth, though the
effect was not significant, and in the 7
additional experiments performed with
this tumour the inhibitory effects were
much less marked.
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Table I.—A Summary of the Effects of Preinjection* (s.c.) of Various Tumours on the
Growth in CBA Mice of a Syngeneic MC Fibrosarcoma (CGH I) Injected



















Genera- Strain of How induced
tion origin
Nos.
18—19 CBA/Ca With 3 methylcholanthrenej
(Woodruff, Jnchley and
Dunbar, 1972)
1-2 CBA/Ca With 3 methylcholanthrene
(Woodruff et al., 1972)
CBA/p By injection of embryo cells
spontaneously transformed
in vitro (Smith and Scott,
1972)
4—5 CBA/Ca Spontaneous origin
(Woodruff and Whitehead,
1977) (in preparation)
26 -27 A/HeJ With 3 methylcholanthrene
(Woodruff et al., 1972)
6 C3Hf/Bu With 3 methylcholanthrene











* Mice were injected s.c. with 106 viable tumour cells and 24 48 h later challenged i.v. with 5 X 104
viable CCH1 fibrosarcoma cells.
f The number of experiments in which significant inhibition (P<0-05) of lung metastases formation was
observed out of the total number of experiments performed.
f This tumour is highly immunogenic, a single inoculum of 10(' irradiated cells (22,000 rad) conferring
complete protection to mice challenged 2 weeks later with 104 viable tumour cells (Woodruff and Dunbar,
1973).
§ In all 28 experiments the growth of tumour was inhibited, but this inhibition failed to reach significant
levels in 8 experiments. On all these occasions a suspension of freshly excised tumour cells had been injected.
Maintained in culture.
Note: Significant inhibition of growth of i.v.-injected cultured CCH1 tumour cells is only achieved after
preinjection of CCH1 tumour cells.
ence of s.c. growing tumour reduced the
number of artificial pulmonary metastases
which could be induced by the i.v.
injection of syngeneic tumour cells (Milas
et al., 1974). These workers also demon¬
strated by adoptive transfer that the
resistance conferred was immunologically
mediated, protection being most effectively
transferred by cells from mice challenged
12 days previously with viable tumour
cells. We decided therefore to investigate
in more detail the development of artificial
pulmonary metastases in mice which had
been injected s.c. with syngeneic tumour
cells at various times before and after i.v.
challenge.
The initial "short-term" pretreatment
experiment involved injecting mice s.c.
with 106 viable syngeneic tumour cells on
either Day —3, —2, —1, 0 or -(-1 in
relation to i.v. challenge with 5 X 104
tumour cells, and 2 weeks after challenge
the number of lung metastases formed was
assessed. Significant suppression of meta¬
stasis was observed in all mice pretreated
with syngeneic tumour cells, but was not
achieved in mice treated after i.v. chal¬
lenge (Fig. 5), thus confirming our pre¬
liminary observation (Fig. 3).
A further experiment was performed
in which mice were injected s.c. with ]06
viable syngeneic tumour cells 14, 7 and
2 days before i.v. challenge. A significant
reduction in pulmonary metastasis was
noted following pretreatment at all these
times.
The specificity of the protection con¬
ferred was assessed by pretreating the
CBA mice with a variety of tumours of
syngeneic and allogeneic origin. The
results of one such experiment are shown
in Fig. 7. It will be observed that pretreat-
































Fig. 8.—The effect on the growth of i.v.
injected tumour cells of the preinjection
of tumour cells s.c. In these experiments
C3Hf/Bu mice were injected s.c. with 107
viable cultured syngeneic tumour cells (FSA)
and challenged i.v. 1 day later with 105 of
the same tumour cells. The (CBA/Ca x
A/HeJ) Fi hybrid mice on the other
hand were pretreated with 106 cultured
viable MC fibrosarcoma cells of CBA/Ca
origin (CCH1) and challenged i.v. J day
later with 5 X 104 CCHl tumour cells.
Note that 14 days after challenge the
number of artificial metastases in the
tumour pretreated groups (B) were signi¬
ficantly less (PcO-Ol) than in the un¬
treated controls (A).
we have failed (despite repeated testing)
to significantly inhibit the growth of the
CCH 1 fibrosarcoma by pretreatment with
other syngeneic and allogeneic MC fibro¬
sarcomas and a syngeneic tumour of
spontaneous origin.
In order to ensure that the phenomenon
observed was not unique to the CBA/
CCHl combination, experiments of a
similar nature were performed in C3H
mice with syngeneic MC fibrosarcoma
(FSA) and in (CBA/Ca X A/HeJ) Fi
hybrid mice using the CCHl tumour.
These experiments revealed (Fig. 8) that
similar effects to those noted above could
be obtained in other mouse tumour
combinations.
A number of other interesting points
emerged during the course of these studies:
(a) similar protective effects could be
achieved following pretreatment (in Day
— 2) with UV-irradiated cultured CCHl
tumour cells; (b) the tumours which
developed in protected mice were much
smaller than those observed in control
mice; (c) tumour metastases were not
observed in extrapleural sites; and (d)
preliminary studies indicated that pre¬
injection of cultured CCHl tumour cells
did not influence the clearance of 125I-
labelled PVP or 51Cr-labelled CCH 1 tumour
cells injected one or 2 days later.
Finally, an overall analysis of the effects
achieved by pretreatment with CCH I
tumour cells revealed that cultured tumour
cells were much more effective than
freshly excised tumour cells. Significant
protection was observed in all experiments
(17/17) involving pretreatment with cul¬
tured CCHl tumour cells, but in only 3/11
experiments with freshly excised CCHl
cells.
ment with only the syngeneic MC fibro¬
sarcoma (CCHl) significantly inhibited
the formation of artificial metastases
following i.v. challenge with CCHl. The
specificity of this phenomenon was further
confirmed in a whole series of experiments,
the results of which are summarized in
Table I. It should be noted that to date
The effect of preinjection of tumour cells on
the in vitro cytostatic activity of peritoneal
and other cells
In these studies mice were usually
injected s.c. with 106 cultured, syngeneic
MC-induced fibrosarcoma cells (CCHl)
and 24 or 48 h later the cytostatic effect
of their peritoneal exudate cells (PEC),
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Table II.—Effect of Preinjection (s.c.) of Untreated, or X-irradiated Syngeneic
Fibrosarcoma Cells (CCHl) on the Cytostatic Activity of Peritoneal Exudate
Cells on CCH1 Target Cells'
Mouse treatment:
(Day — 1)




































In vitro tumour control 98,093 (94,911 101,382)
* Figures in parentheses represent meani s.c.
t 2-tailed Student's t test comparison of test groups with saline control. Values of P>0-05 were con¬
sidered not significant (N"S).
Note: Increased cytostasis following injection with non-irradiated and lethally irradiated tumour cells
apparent with the 80:1 effector: target ratio.




(M ml saline s.c.
10fi Syngeneic MC fibro¬
sarcoma cells (CCHl) s.c.




















* Peritoneal exudate cells.
+ Adherent cells removed by incubating PEC in large tissue-culture flasks for 1 h.
Note: The marked reduction in the cytostatic effect of PEC on CCHl tumour monolayers after removal of
glass-adherent cells. This was apparent with PEC from both saline controls and tumour-pretreatod mice.
spleen cells etc. on monolayers of the
same tumour was assessed. In the majority
of experiments, this short-term pretreat-
ment produced a significant increase in the
cytostatic activity of peritoneal exudate
cells. Results from a typical experiment
are presented in Table II. It was generally
found that PEC from control mice express
a cytostatic effect at the higher effector-to-
target ratios and that preinjection with
tumour increases this effect. It will also be
observed that lethally irradiated tumour
cells were also capable of stimulating the
cytostatic activity of PEC. To date, no
effect on the antitumour activity of cells
from peripheral blood, spleen and lymph-
node cells has been observed using this
short-term tumour pretreatment (data
not shown).
The cytostatic component of both
normal PEC and tumour-stimulated PEC
appeared to be associated with a glass-
adherent population (Table III). This
would suggest that the effects are mediated
by macrophages but this will require
confirmation by further analysis.
Further studies revealed that the in¬
creased cytostatic activity of PEC after
injection with syngeneic tumour (CCHl)
could also be achieved using an allogeneic
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Table IV.- Effect of Preinfection (s.c.) of Various Tumours on the In vitro Cytostatic
Activity of PEC on CCH1 Tumour Monolayers
Effector: ct/min (Geom. mean of 6 replicates i s.e.)
Mouse treatment target , ^
(Day —2) ratio Expt. 1 Expt. 2
01 ml Saline s.c. 80:1 15,472 (14,274-16,771) 345 (334-356)
40: 1 42,774 (41,859-43,710) 1,975 (1,769-2,206)
20:1 39,941 (38,876-41,037) 12,888(11,625-14,288)
106 Syngeneic MC fibro¬ 80:1 565 (502-637)* 866 (691-1,086)f
sarcoma cells (CCHl) s.c. 40: 1 15,874 (15,199-16,578)* 21,927 (20,390—23,580)4
20: 1 39,173 (38,788-39,562) 39,221 (38,245-40,222)4
106 Allogeneic MC fibro¬ 80: 1 2,700 (2,305-3,163)* 434 (406-464)4
sarcoma cells (ACH3) s.c. 40: 1 33,934 (33,252-34,631)* 5,732 (4,882-6,731)4
20: 1 38,715 (38,240-39,195) 36,195 (34,183-38,326)4
106 Syngeneic spontaneous 80 :1 33,420 (32,753-34,100)t 3,055 (2,684-3,503)4
adenocarcinoma cells 40: 1 38,036 (37,515-38,564)* 28,082 (27,041-29,163)4
(W54) s.c. 20: 1 38,109 (37,401-38,830) 41,195 (39,563-42,894)4
In vitro tumour control 44,032 (43,502 44,570) 41,543
Notes: Expt. 1.—Treatment with both the syngeneic and allogeneic fibrosarcomas results in elevation of
cytostasis at the higher effector: target ratios. Treatment with spontaneous tumour abrogated the cytostatic
activity of PEC.
Expt. 2.—Marked anti-tumour effect of the saline control PEC. All tumour pre-treatments reduced this
effect, particularly noticeable at the effector: target ratios of 40:1 and 20:1. As in Expt. 1, the spontaneous
tumour was most effective in reducing the cytostatic activity of PEC.
Statistical significance: All tumour-treated groups compared with saline controls using a 2-tailed Student's
t test.
* Significantly lower (P<001) than in control group.
t Significantly greater (P<0*02) than in control group.
MO fibrosarcoma of C3H origin (Expt. 1,
Table IV). It was not observed, however,
following pretreatment with a spontaneous
syngeneic tumour (W54). On the contrary,
treatment with the spontaneous tumour
resulted in a marked decrease in cyto¬
stasis.
Abrogation or reduction of cytostasis
has also been observed in a minority of
experiments with the syngeneic and allo¬
geneic MC fibrosarcomas (Expt. 2, Table
IV) and appears to be associated with an
extremely high cytostatic activity in the
PEG of control mice. Such high levels of
activity may be due to transient infection
in the mouse colony, leading to stimulation
of the lymphoreticular system as des¬
cribed by Hibbs, Lambert and Remington
(1972) and Krahenbuhl and Remington
(1974).
Finally, it should perhaps be noted that
the marked cytotoxicity normally elicited
in PEC after i.p. C. parvum was not
affected by injecting syngeneic MC fibro¬
sarcoma cells (s.c.) one day before C.
parvum injection (data not shown).
Bacteriological and virological studies
Four separate cultures of CCHl have
been examined. Three of the preparations
were routinely used in these studies for
pretreatment and challenge and they
have been maintained in culture for 3-18
months. The remaining sample had been
cultured for only a week.
To date there has been no evidence of
contamination with micro-organisms in
any of these preparations. No bacteria,
mycoplasmas, viruses or virus-like parti¬
cles were observed on electronmicroscopy
of ultra-thin sections of tumour cells, and
no mycoplasmas or bacteria were isolated
by culture techniques. Density gradient
ultra-centrifugation of 3H-uridine-labelled
culture supernatants failed to reveal any
radioactivity banding in the positions
characteristic of bacteria, mycoplasmas
(density 1-22) lactic dehydrogenase-elevat-
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ing virus (density 1-17) or RNA oncovirus
(density 1 • 16—1 -18). Furthermore there
was no evidence of reverse-transcriptase
activity in tumour-cell-culture superna-
tants. Finally, immunofluorescence tests
with antisera to MLV and RD-114 also
proved negative.
DISCUSSION
The present experiments clearly demon¬
strate that the preinjection (s.c. or i.p.)
of live or lethally irradiated CCH1 methyl-
cholanthrene-induced tumour cells into
CBA/Ca mice shortly before challenge i.v.
with the same tumour severely impaired
the development of artificially induced
lung metastases. In addition, peritoneal
exudate cells recovered from mice in¬
jected one or 2 days previously with such
tumour cells frequently exhibited an
elevated in vitro cytostatic effect on
syngeneic MC fibrosarcoma cells. The
effects of lung metastasis were not readily
achieved when small doses of cells (i.e.
< 105) were used in the pretreatment,
when they were administered i.v., or
if they were injected the day following
antigenic challenge. The experiments also
suggest that the in vivo protective effects
are probably specific, significant protection
only being conferred when the mice were
pretreated with the same tumour as used
for challenge. Furthermore, similar pro¬
tective effects were noted in other mouse-
tumour combinations.
The present observations are similar
in certain respects to those noted in less
extensive studies from other laboratories
(Milas et al., 1974; Yuhas, Pazmino and
Wagner, 1975; McBride, personal com¬
munication). They differ, however, from
those recently reported by other investiga¬
tors in other models (North et al., 1976;
Pike and Snyderman, 1976; Nelson and
Nelson, 1977) and are difficult to reconcile
with previous suggestions that the initial
survival of tumours may be due to their
ability to suppress macrophage-mediated
surveillance mechanisms (North et al.,
1976a, b; Nelson and Nelson, 1977; Pike
and Snyderman, 1976; Snyderman and
Pike, 1976).
At the present time, the mechanism
whereby the preinjection of tumour-cells
can inhibit the growth of the same tumour
injected i.v. only one or 2 days later
remains to be established. However,
observations in other tumour systems
suggest a number of ways in which this
rapid effect might be achieved. In the
first place, the injection of various tumours
has been found to result in the appearance
within one day of suppressor T cells
(Fujimoto, Greene and Sehon, 1976), whilst
cytotoxic cell activity was apparent within
3 days of challenge (Schick and Berke,
1976). Others have also shown that the
injection of tumours or tumour-cell
extracts in rats induces within 2 days
mitosis in sinus macrophages in the
draining lymph nodes and a peripheral
blood monocytosis (Carr, Price and
Westby, 1976). Additional studies had
revealed that the ability of tumour to
produce monocytosis appears to be directly
related to its antigenicity (Eccles, Bandlow
and Alexander, 1976). Thus, in theory at
least, the effect might be due to a rapidly
induced increase in T-cell cytoxicity or
macrophage activity. Alternatively, if the
initial growth of tumours is dependent
upon immunostimulation (see Prehn,
1976) it might be due to the rapid develop¬
ment of suppressor T cells. In addition,
the possibility of a prompt effect of
natural killer (NK) cell activity cannot
be excluded.
The observation that pretreatment with
cultured tumour cells results in more
effective protection than similar pretreat¬
ment with freshly excised tumour cells
is of interest. There are several possible,
though yet untested, explanations for this
difference. For example, the normal host
response to i.v. challenge may have been
adversely influenced by any lymphoreti-
cular cells which might have been present
in freshly excised tumour cell suspensions.
Alternatively, the tumour cells may have
undergone modification during culture
and as a result become more effective at
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stimulating host defence mechanisms.
Such mechanisms might include the aqui-
sition of new tumour-specific transplant
antigens or foetal calf serum antigens
from the culture medium.
Our extensive bacteriological and viro-
logical investigations, together with the
fact that the effect can be achieved with
UV-irradiated cells, leads us to conclude
that our observations are probably not
due to contamination with micro¬
organisms such as the LI)H virus which
is known to be present in many tumours
(Riley, 1968) and has been found to
modulate the immune response of the
tumour-bearing host (Kamo, Patel and
Friedman, 1976). Jn any case it is known
that the LDH virus, which replicates in
macrophages (Kamo et al., 1976), does not
usually survive for more than 10 days in
culture. Indeed this property is exploited
to remove the virus from infected tumours
(Riley, 1968). Nevertheless, the possibility
still remains that the effect is due to
contamination with some as yet un¬
detected virus such as the minute virus of
mice which has recently been shown to be
responsible for the immunosuppressive
effects of mouse EL-4 lymphoma cells
on the mixed lymphocyte reaction (Bon-
nard et dl., 1976).
The present results are of particular
interest in view of the recent flourish of
reports indicating that tumours and
tumour-cell products may interfere with
the development and activity of cells of
the monocyte macrophage series (see
introduction and James, 1977). These
observations have led to the suggestion
that tumours may initially become estab¬
lished by suppressing macrophage-media-
ted surveillance mechanisms (North et al.,
1976a, b; Snyderman and Pike, 1976;
Pike and Snyderman, 1976; Nelson and
Nelson, 1977). The present observations,
however, emphasize that the picture is far
more complicated than suggested above,
for pretreatment with tumour may on
occasions inhibit rather than promote the
growth of tumour injected shortly after¬
wards. In addition there is also a number
of reports indicating that tumours may
actually stimulate macrophage develop¬
ment and activity, these effects being
noted within 2-3 days of tumour chal¬
lenge (James, 1977). It is obvious that the
effects of tumour on macrophage function
are complex and diverse. Indeed it has
recently been shown that short-term
pretreatment with tumour may inhibit the
chemotactic responses of peritoneal macro¬
phages whilst simultaneously enhancing
their capacity to phagocytose antibody-
coated sheep erythrocytes (Meltzer and
Stevenson, 1977a). Furthermore, it is
apparent from the present studies that
pretreatment with allogeneic tumour may
enhance the cytostatic effect of peritoneal
exudate cells without suppressing the
development of tumour metastases. It is
apparent, therefore, that further studies
will be necessary to (a) explain these
divergent effects; (b) elucidate their cellu¬
lar and molecular basis; (c) establish
their relative importance with respect to
the initial phases of tumour growth; and
(d) to identify and characterize the
tumour products which modulate the
host response to tumours. Finally it must
be emphasized that such studies should
be performed with tumours which are
free (as far as can be reasonably as¬
certained) from contamination with viruses
and other micro-organisms which are
known to influence the function of cells
of the lymphoreticular system.
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Normal human tissues contain RNA and
antigens related to infectious adenovirus type 2
K. W. Jones, J. Kinross & N. Maitland M. Norval ; ii
Institute of Animal Genetics, University of Edinburgh,
Kings Buildings, West Mains Road, Edinburgh, UK '
Department of Bacteriology, Medical School,
University of Edinburgh, Edinburgh, UK
Normal human tissues have been found to contain RNA
which hybridises with four regions of the adenovirus type 2
genome, including one which contains the transforming
gene(s) of this virus. The RNAs have also been extracted
from gorilla organs, but not from those of chickens, sug¬
gesting that they are-a feature ofall normal higher primate
tissues. Serological tests suggest that these homologous
RNAs are translated into proteins connected with essen¬
tially normal and virus-infected cell functions.
THE adenoviruses1,2 are associated with respiratory infections
in humans. Many serotypes of these viruses can induce tumours
in rodents3"6, and adenovirus type 5 transforms human cells in
culture7. During studies on human cancer, we have investigated
the possibility that human tissues might contain RNA sequences
related to human DNA viruses, using the technique of in situ
hybridisation8"10. We have found that normal human tissues
contain RNA that hybridises with four regions of the genome of
- adenovirus type 2 (Ad-2). One of these regions includes the
'■ transforming gene(s) of this virus7,11,12. This suggests either that
genes similar to viral transformation genes are present in man in
0028-0836/79/0277—0274J01.00 ) Macmillan Journals Ltd 1979
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much the same way that the avian sarc genes are homologous in
base sequence to the src (transforming) gene of the Rous
sarcoma virus13,14, or that infectiously acquired Ad-2 DNA can
persist under host control. The human cells expressing the
RNAs in greatest abundance seem to be solitary, possibly
circulating cells. Human tissue cultured cells apparently do not
contain an abundance of these RNAs, which may account for the
fact that they have not been described previously.
Hybridisation studies
In looking for possible RNA sequences related to Ad-2 viral
DNA in uninfected human organs, we initially used placenta as
the RNA source because it is available in quantity. Moreover,
fetal tissues are often associated with endogenous viral sequence
expression15"17. Total RNA was extracted by standard pro¬
cedures18 and iodinated1® with 12?I for use in hybridisation.
Equal amounts of Ad-2, human DNA and X. phage DNA or
Ad-12 DNA were denatured and spotted on nitrocellulose
strips and hybridised by the usual procedure20 (for details see
legend to Fig. 1). Escherichia coli total 125I-labelled RNA served
as an RNA control, hybridised to a parallel series of spots but
substituting E. coli DNA for phage DNA. The hybridised strips
were then treated with RNase and, after suitable washing, were
dried and autoradiographed on presensitised X-ray film (Royal
X-omat XHI Kodak) at -70 °C in cassettes fitted with intensify¬
ing screens. Such spot tests are extremely sensitive and the
amount of signal due to hybridisation or to background is
immediately visually apparent. Hybridisation can be quan-
titated if necessary by cutting out the spots and scintillation
counting. This procedure was followed as described later to
construct melting-temperature curves of the hybrids.
After autoradiographic exposure, there was no trace of
hybridisation to phage DNA. In fact, the spots containing this
DNA were, if anything, below background radioactivity levels in
some cases, suggesting that the bound DNA may have pre¬
empted potential binding sites for molecules that contribute
background. There was, as expected, very strong hybridisation
to human DNA. Ad-2 DNA showed moderate hybridisation
(Fig. la), which easily reached autoradiographic saturation on
prolonged exposure (Fig. 16). Ad-12 DNA showed a barely
detectable autoradiograph (not shown). E. coli 123I-labelled










Fig. 1 Spot tests of hybridisation of 12SI-labelled human placental
RNA to DNA of X phage, human and adenovirus type 2 (Ad-2).
The location of the negative hybridisation is shown by a dotted
circle. Hybridisation has occurred to human DNA and to a lesser,
but definite, extent to Ad-2 DNA. The conditions for hybridisation
were as follows. The DNA samples were brought to the same
concentrations, and 1-p.g aliquots bound in spots to a strip of
nitrocellulose filter by the method of Gillespie and Spiegelman20.
The filter strip was then incubated for 6 h at 68 °C in 6 x SSC
containing 0.02% each of Ficoll, bovine serum albumin (BSA) and
polyvinyl pyrollidone (PVP). It was then transferred to 3.6 ml of
this same solution containing 2 mM, EDTA, 0.5% SDS and —7 x
107 c.p.m. of placental total RNA previously prepared18 and
radiolabeled1 with 125I. The mixture was annealed at 68 °C for
15-16 h, cooled rapidly and the filter strip washed in 2xSSC,
treated with RNase (40 jig ml-1, 1 h, 37 °C in 2 x SSC), washed in
2xSSC, treated with pronase (400 u.g ml"1 in 2xSSC, 1 h),
incubated in 2 x SSC, 0.5% SDS for 6 h at 68 °C, washed exhaus¬
tively in a large volume of 2xSSC, dried in a vacuum oven and
autoradiographed for (a) 10 d,(b) 3 weeks at —70 °C using Kodak
Royal X-omat XHI X-ray film presensitised by brief exposure to
light from a calibrated masked flash gun.
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Fig. 2 Restriction digests of Ad-2 separated into fragment classes
; by electrophoresis on agarose gels stained with ethidium bromide •.
and photographed in ultraviolet light, are shown paired with
autoradiographs of 125I-labelled placental RNA hybridised to the-
same fragments after transfer to nitrocellulose filter membrane and
hybridisation as detailed in the legend to Fig. 1, and in the text. The
bands in the digests are identified by letters to the left of each gel
track. For technical reasons, the smallest restriction fragments do
not photograph satisfactorily, and some of the minor autoradio¬
graphic bands are difficult to detect consistently together in the
same autoradiograph. Because of this we have included a third
track which indicates, diagrammatically, for each enzyme digest, all
the bands to which we have obtained hybridisation in replicate
experiments. These data are also shown below the photographs in
the form of maps of the positions of the restriction fragments
obtained with each enzyme in relation to the Ad-2 DNA map,
which is divided into 100 fractions, according to the usual con¬
vention. The restriction fragments which hybridise with placental
RNA are indicated for each digest by dotted lines over the frag¬
ment concerned. From these data, the provisional assignments
have been made for the maximum limits to the Ad-2 genome
sequences which hybridise with human total RNA; these are
represented as double-ended arrows below the relevant locations.
The conditions for electrophoresis were 1% agarose gels run at
40 V for 10 h, or 80 V for 4 h, in a buffer containing 15 mM Tris,
18 mM NaH2P04, 0.5 mM EDTA, pH 7.8.
These results indicated that Ad-2 DNA contained some
sequences homologous with human RNA, although they did not
show whether these might have arisen from possible
contaminating host cell sequences. Nevertheless, the fact that
Ad-2 and Ad-12 were grown in similar human cells but behaved
differently on hybridisation with human RNA suggested that
contamination was unlikely. To investigate this point, we
hybridised the same DNAs after digestion with the restriction
endonuciease EcoRI, which cuts X and adenovirus DNAs into
small numbers of fragments; these can then be separated on
agarose gels and transferred to nitrocellulose strips by the
Southern procedure21 for subsequent hybridisation with the
same 125I-labelled human RNA probe. After autoradiographic
exposure there was hybridisation only to Ad-2 DNA and this
was limited to the EcoRl A and F fragments (Fig. 2). Separate
lots of Ad-2 DNA were then cut with three further restriction
endonucleases, BamHl, 5gill and Hindlll, which are known to
produce genomal fragments overlapping and different from
those produced by EcoRl. Hybridisation of human placental
125I-RNA to these sets of fragments, as before, yielded the
following hybridisation data (Fig. 2). ;
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The fragments that hybridised were EcoRI A and F; Hindlll
A.--B, D, FG, J and H (the latter two very faintly); Bglll A, CD
and E; and BamHl A, B, C and D. These data define the
following provisional maximum limits for the hybridising
regions. As only the A and F fragments of EcoRI hybridised, all
the observed hybridisation must lie within these limits. As
jEcoRI A, BamHI B, HindIII G and Bglll E fragments hybrid¬
ised, but Hindlll C or Bglll B did not, the left end of Hindlll C
defines the most rightward limit of the first region of hybridisa¬
tion at 7.5 units on the Ad-2 map22. This region, from 0 to 7.5, is
known to contain the transforming gene(s)23. Because the Bglll
B fragment did not hybridise, but the Bglll A fragment did, the
latter, with the other restriction enzyme fragments that overlap
it, defines the beginning (left end) of the next region of hybridis¬
ation at approximately 26 units. Hindlll I did not hybridise but
Hindlll J did, so the I fragment defines a non-hybridising gap,
and the left end of J defines the beginning of the next region of
hybridisation at approximately 37 map units, extending to
approximately 58.5 units, which is defined by the left end of
EcoRI B, which did not hybridise. By the same reasoning the
EcoRl F fragment must define the limits of the fourth region of
homology as between approximately 70.7 and 75.9 map units.
From this analysis, we presume that the doublet iTmdlll FG
concerns hybridisation only to the G fragment, but that hybrid¬
isation occurs to both fragments of the Bglll CD doublet. This
point can be finally decided when a more complete analysis of
the hybridisation patterns has been carried out. This provisional
map summarising the maximum limits within which the hybrid¬
ising regions lie is given diagrammatically in Fig. 2. "
Fig. 3 Autoradiography showing concentrations of Ad-2
complementary RNA in placenta. Ad-2 DNA labelled by the
'nick-translation' reaction with 3H, was denatured and hybridised
in situ to frozen sectioned human placenta in conditions that detect
complementary cellular RNA8"10. a, A 'solitary' cell that shows a
high concentration of label signifying a high concentration of
Ad-2-related RNA. This cell type occurs relatively infrequently
(about 2-3 per x40 objective field) and occasionally seems to be .
loosely attached to the tissue (b). This may reflect the fact that it is a
circulating cell, c, An example of a generally labelled area of
placenta, after hybridisation as above. The grain distribution in this
autoradiograph suggests that whole areas of this tissue contain
Ad-2-related RNA at a lower level than the solitary, highly
labelled, cells shown in a and b. Autoradiographic exposure 3
weeks. Controls of similarly hybridised X. phage DNA were nega¬
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Fig. 4 Thermal dissociation of hybrids formed between human
total 125I-labelled RNA and human total DNA (O), and Ad-2 ..
whole genomal DNA (•, sample 1; A, sample 2), from different
sources. The curves show similar features, with both Ad-2 DNA
samples having formed hybrids of rather higher thermal stability :
than total human DNA. Hybridisation conditions are described in -
the legend to Fig. 1. Dissociation was carried out by cutting spots of
hybridised DNA from nitrocellulose filters of spot tests that had
been shown to be positive by previous autoradiography on X-ray '
film as in Fig. 1. These were then counted by scintillation spec- -
trometry in toluene-based scintillation fluid, washed and then
treated in diethyl pyrocarbonate 0.1 inSSC(0.15 MNaCl,0.015 M •
sodium citrate, pH 7.4) for 30 min, washed in SSC, and heated for -
10 min in 1 ml 0.1 SSC and 0.1% SDS at each of the temperatures
shown. The counts released were recovered from solution by -
. trichloroacetic acid precipitation in the presence of 100 p.g BSA . -
per sample, dried by suction filtration and counted by scintillation
spectrometry. Approximately 80% of the original radioactivity
was recovered. -
This provisional map has been confirmed with a further two
independently obtained samples of Ad-2 DNA and with 10
separate samples of placentas, obtained from normal births,
from two hospitals. We have also found the same pattern in the
case of human adult liver RNA, and with liver, kidney, brain and
spleen RNA obtained from a gorilla which died from the effects
of minor surgery. The RNAs from four separate human cell lines
maintained in permanent culture gave very faint patterns of
hybridisation compared with the organ RNAs and are being
studied in more detail. RNA obtained from chickens in the same
manner as for other organs of primates did not hybridise in two
separate tests.
That human organ RNA and other higher primate RNA
contain sequences with homology to certain regions of the
genome of Ad-2, but that such RNA apparently is relatively
much less abundant in cell lines of human origin, indicated that
the distribution of cells having such an abundance was not
uniform. We investigated this aspect by hybridising 3H nick-
translated, denatured Ad-2 DNA to human placental cryostat
sections in situ using a method which permits hybridisation to
mRNAs8"10. After Si nuclease treatment and thermal rinsing to
remove unhybridised probe or poorly matched hybrids, the
preparations were autoradiographed and examined micro¬
scopically. Strong hybridisation occurred only to certain cells in
the sections. These seemed to be solitary cells, with hybridisa¬
tion to almost the entire area of the cell (Fig. 3a, b). Other areas
of the sections showed a lower level of hybridisation which was,
however, above the non-cellular background (Fig. 3c). There
was no hybridisation in the case of A. phage 3H-DNA hybridised
in identical conditions. We presume from this that the bulk of
the RNA that hybridised is contributed by a tissue cell sub-
population and that cells of this type are not among the cell lines
that we examined. . c
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Melting-temperature experiments
We carried out melting-temperature experiments to determine
the thermal stability of the the hybrids formed on nitrocellulose
between Ad-2 DNA and placental RNA. These were done by
cutting out the relevant hybridised spots from the filter and
heating them in solution at increasing temperature (see legend
to Fig. 4) to measure the loss of hybridised RNA from the filters.
Hybrids formed between human I25I-labelled total RNA and
two separate Ad-2 DNA samples and with total human DNA
were compared. As can be seen from Fig. 4, the melts of Ad-2
hybrids showed similar characteristics and similar, though
slightly higher,"Tn, values compared to the homologous hybrids,'
indicating' that the hybrids to Ad-2 were reasonably thermally
stable. This result was expected from the annealing conditions
(legend to Fig. 1) which were quite stringent and essentially
identical to those used in most published Ad-2 hybridisation
studies (see discussion). We conclude that the hybrids that we
detect between human RNA and Ad-2 DNA are at least as well
matched as those in previous transcription studies of Ad-2. We
are now investigating methods to determine the precise lengths
of the hybridised regions. However, this is complicated by the
fact that the organ RNA is to some extent degraded.
Immunological studies , - , ♦ - ....
Hybridisation between a viral DNA and human RNA from
apparently uninfected tissues suggests similar protein coding
functions in the sequences concerned. To test this hypothesis,
rabbit cells infected with a clinical isolate of Ad-2 were used to
raise antisera separately against the early-infected and late-
infected cells (see legend to Fig. 5). The antisera were then
reacted with six human cell lines (not shown) in an indirect
immunofluorescence assay. All except one cell type, a human
glioma (NG-118H) transformed by Rous sarcoma virus which
was faintly positive, were completely negative. Controls of.
Ad-2-infected HEp 2 cells were brilliantly positive (Fig. 5 a) as
were transformed rat cells containing the extreme left-hand
fragment of the Ad-2 genome12 (not shown). Placental sections
were also positive when treated with the anti-early antisera (Fig.
5 b,c), but not with anti-late-infected cell antiserum. The
fluorescence was concentrated on the surfaces of cells lining
what seemed to be channels in the tissue as well as occurring
diffusely in the cytoplasm of many areas. Some cells showed the
nuclear. fluorescence usually ~ seen in transformed ceils.
However, this was rare and not intense. Of 10 placentas tested, 8
were undoubtedly positive in these tests and 2 were judged
negative. We do not understand this variation, as all were
positive in hybridisation tests for Ad-2-related RNA; however,
it may be due to the fact that the antigens concerned are unstable
and that the variations reflected the variable storage conditions
of the tissues before we obtained them.: ... v * .
Antigens were then solubilised24 from placental tissue and
tested by gel diffusion in Ouchterlony plates against both early-
and late-infected cell antisera, using controls of Ad-2-infected
rabbit cell antigens (Fig. 6). There was no reaction with any
dilution of uninfected cell antigens (not shown). Strong pre¬
cipitin lines formed between the early-infected cell antisera and
the antigens of both early- and late-infected cells, as expected,
for both will contain the same early antigens, although presum¬
ably in different "concentrations. Weaker but quite definite
precipitin lines formed between this same antiserum and the
wells containing placental antigens, and these showed partial
identity with one of the lines originating from the early-infected
cell antigen wells but no identity with late-infection antigens.
The tests against anti-late-infected cell antisera were even more
strongly positive against the infected cell antigens, particularly
the late-infected cells. However, there were no visible precipitin
lines between this antiserum and the wells containing placental
antigens. Separate tests were then carried out in which a range of
dilutions of the placental antigens were tested against each
antiserum separately. No dilution used gave any precipitin lines
with the late-infected cell antiserum (not shown). The early-
Fig. 5 Indirect immunofluorescence tests for antigens on: a, Ad-2
early-infected human cells (HEp 2); b, c, normal human placenta
,;cryostat sections, using antiserum raised against Ad-2 early-,
infected rabbit cells (Rk-13), at a dilution of 1/40 and sheep .
anti-rabbit lgG conjugated with fluorescein isothiocyanate
'.'"(Wellcome). The rabbit cells were grown in medium 199 supple- •
' mented with 2% rabbit serum and the antisera raised in rabbits.
"
Cells were infected for 20 h in the presence of 20 pg ml"' cytosine
arabinoside. The resulting antiserum was negative for virus neu-
" tralising activity. Uninfected cell antiserum was also raised and was
..negative by immunofluorescence with these same subjects, and
;i infected cell antiserum was negative with both uninfected HEp and
,. .RK-13 cells. The infecting adenovirus was obtained from a clinical
isolate. Antiserum to late-infected cells was negative in similar
'
tests. Fluorescence in the HEp cells is mainly on nuclear structures
with some cytoplasmic fluorescence. Placental sections show
stronger fluorescence in cytoplasmic regions, especially on what
•"are apparently cells lining channels or vessels in the placenta, but
-• nuclear fluorescence is also visible. These results, which demon-
: strate the presence of cross-reacting antigens between early-
-..infected and apparently uninfected placenta, have also been
obtained with all other tissues but not with cell lines tested (see
...text), and are confirmed by Ouchterlony gel diffusion (Fig. 6 and
text). .
infected cell antiserum, however, showed a single precipitin line
that altered position between the antigen and antibody well
depending on concentration. This shift is due to antigen-anti¬
body concentration which affects the solubility and hence the
mobility of the antigen-antibody complex. The fact that there
was no precipitin line in the case of anti-late-infected cell
antiserum suggests that the concentration of the relevant anti¬
bodies to early-infected cell antigens was very low.
. ■. We conclude from these preliminary immunological experi¬
ments that rabbit cells infected with Ad-2 contain certain
antigens that are not present in uninfected rabbit, or human,
cells in culture. We further conclude that some of the Ad-2-
induced antigens are identical to tissue antigens present in most
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Fig. 6 Ouchterlony gels showing patterns of precipitation
obtained between a, anti-early Ad-2-infected Rk-13 cells, and b,
anti-late Ad-2-infected Rk-13 cell antisera. Wells are numbered
1-6 in the same manner in each case. Wells 1 and 4 contained
dilutions of . 1/50 and 1/100 of late Ad-2-infected antigens;
2 and 5 contained dilutions of 1/50 and 1/100 Ad-2 early
infection antigens; 3 and 6 contained 1/50 and 1/100 dilutions
of placental antigens. An interpretation of the pattern seen in a
is shown below it. In a, precipitin lines can be seen between both
wells containing placental antigens and the central well containing
anti-Ad-2 early-infected Rk-13 cells. In 3 there is a suggestion of
partial identity with one of the lines associated with well 2 as judged
from the single spur. There are no lines visible between the central
well and wells 3 and 6 in b, indicating absence from the late-
infected cell of antigenic components related to those of normal
placenta. Dilution experiments with this particular combination
over the. range of 1/10 to 1/1,000 of antigen concentration
revealed no precipitation (not shown); however, a similar range of
dilutions of the same combination in the case of a showed an arc of 1
precipitation spiralling out from the centre well according to the
dilution of antigen; this is shown in c, in which all wells contained
placental antigen, as follows: (1) undiluted; (2) 1/10; (3) 1/50; (4)
1/100; (5) 1/1,000; (6) saline. These data confirm that normal
human placentas express antigens that are associated with Ad-2
early infection as shown by immunofluorescence in Fig. 5. . ■
human placenta samples, concerning mainly the early proteins
of the adenovirus infectious cycle. Such antigens are not detect¬
able on cell lines of human origin by immunofluorescence but
were present in all tissues of gorilla (not shown). We are now
attempting to characterise these antigens in more detail. The
presence of antigens related to Ad-2 early function proteins in
humans and in gorilla tissues correlates with the presence in
these tissues of RNA molecules that hybridise with regions of
the Ad-2 genome involved in coding early function proteins. We
suppose from this that these RNAs code for the antigens that are
shared between apparently normal human, and other primate,
tissues. The in situ hybridisation result using Ad-2 DNA probes
suggests that certain cells, or cells in a certain transitory state,
which constitute a minor subpopulation in the placenta, contain
a high concentration of the Ad-2-related RNA. The connection
between this observation and the fact that the antigens con¬
cerned are rather ubiquitous in the tissues examined is unclear
but is discussed below. However, as there are at least four
regions of the Ad-2 genome that hybridise, it is possible that
different cell types contain different proportions, or types, of the
corresponding, homologous, RNAs, and consequently code for
different antigenic moieties.
Discussion
The present findings are unique in the sense that there have been
no previous reports of RNA sequences related to adenoviruses
in apparently uninfected human cells. These findings are parti¬
cularly intriguing as they relate to adenoviruses that are potent
transforming viruses in animal hosts3"4. Moreover, the regions
of homology include sequences in the extreme left-hand end of
the Ad-2 genome that contains transforming genes of this virus.
The consistency of the findings, there being no negative results
in the 11 human tissue samples included in this study, indicates
that the RNAs concerned may be ubiquitous in the population.
Moreover, the presence of the same RNA molecules in gorilla is
indicated from the similarity of the hybridisation patterns
obtained with RNA from kidney, liver, spleen and brain. This
suggests that the RNAs may also be common within the higher
primate group, although more examples, involving some from a
natural population, will be essential to support this. '
Our criteria for hybridisation of the RNAs to Ad-2 DNA are
those normally used in hybridisation mapping of Ad-2 (refs 25,
26) and are reasonably stringent taking the genome as a whole.
Increasing the hybridisation temperature to 75°C reduced but
did not prevent hybridisation. Moreover, the thermal stability of
the Ad-2 DNA - human RNA hybrids seems representative of
hybrids formed between human total DNA and the same human
RNAs used in this work. We conclude from this that the hybrids
are reasonably well matched. This is supported by the fact that
there'is demonstrable homology between the antigens coded
during infection by Ad-2 and those present in human placenta
and liver, and gorilla organs, which indicates similar coding
functions of the RNA produced early in Ad-2 infection and that
present in apparently normal higher primate organs. " /'
These data, although consistent, are at present limited and the
possible interpretations are, correspondingly, tentative.
However, the findings are provocative and invite some specula¬
tions as to their significance. The RNAs concerned may have
originated in either of two, not necessarily mutually exclusive,
ways. Namely, host acquisition by an infectious process or the
evolution of Ad-2 (and the C group adenoviruses) through the
acquisition of nucleotide sequences similar to those found in the
natural primate host. ... -
The facts relevant to these interpretations are that only
certain Ad-2 DNA regions are represented in human RNA.
This tends to rule out a productive Ad-2 infection as the RNA
source, as we would then expect to find RNA representative of
the whole genome. Because all individuals investigated
contained the RNAs in question, it is obvious that the mode of
transmission is very efficient. This rules out a particular defective
virus as the source unless we also assume that transmission is
vertical and widespread. In this case, it is debatable whether
such sequences belong to the host or to a virus. We cannot,
however, exclude the possibility that the sequences we detect
belong to a non-defective, incompletely Ad-2-related virus, in
our view an unlikely explanation, or that Ad-2 DNA may be
carried in the manner of Epstein-Barr virus27, • following
infectious contact and subject to specific host transcriptional
control. :- . . : ;■
. .
The second hypothesis is that Ad-2 and related strains have
evolved, or otherwise acquired, genes that are related to certain
genes of their natural hosts. As it is known that Ad-5. can
integrate with host DNA28, such evolution seems likely. Also,
RNA tumour viruses of chickens and mice contain sequences
related to their host cells. In avian sarcoma viruses the trans¬
forming gene src is related in nucleotide sequence to the host
gene sarc13. It is also known that the transforming region of a
primate virus SV40, which is totally unrelated to Ad-2, is rather
similar to Ad-2 in its transcriptional structure29, although it is
not known whether the proteins coded are functionally
analogous. Such convergent evolution might reflect the fact that
both viruses have acquired or evolved control elements con¬
cerned with the same host function, as both are primate viruses.
Presumably, the advantage of such a mode of evolution would
be that the virus would be better adapted to subvert host
functions, for example, by using the host RNA splicing systems.
Pressure to acquire control of the same system on the part of
unrelated viruses could stem from the fact that the functions
concerned are key elements in growth control. In this regard it is
known that Ad-2 replicates in human cells significantly faster
than Ad-12 (refs 30,31), which does not, as far as we can detect,
share the host-related nucleotide sequences.
Whether or not either hypothesis is wholly correct, our
findings do indicate that human cells possess transcripts, from
whatever source, closely related to DNA that maps within the
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transforming region of the adenovirus genome. This may be such synthesis implies a high content of related antigens, such a
relevant not only to how the virus itself replicates and trans- cell might be particularly at risk from an autoimmune reaction
forms,' but also to how malignant human cells may alter their directed at these common antigens.
growth patterns. Moreover, at least four regions of homology The cellular source of the cross-reacting antigens in placental
are detectable which may mean that at least four different RNAs tissue is unclear. By immunofluorescence, these antigens are
related to the viral DNA exist in human cells. In future studies widely distributed in the tissue. However, they do not appear on
these can be recovered and their corresponding genes cloned tissue-cultured cells of human origin. Moreover, the cell type
and identified. In the event that the second hypothesis is that apparently possesses the greatest amount of Ad-2-related
substantially correct, such genes may relate to important RNA as determined from in situ hybridisation, and thus is
functions connected with cell and virus growth control. A search presumably most likely to synthesise most antigen, is relatively
for similar sequences related to other DNA viruses is also rare. One possible explanation is that different RNA molecules,
suggested from the fact that, antigenic similarity has been related to different regions of the Ad-2 genome, are not equally
described between SV40-induced surface antigens and fetal abundant in all cells. Another is that the antigens or their
antigens in hamsters32. precursors circulate in blood or other body fluids and/or that
The fact that Ad-2 early function antigens cross-react their distribution is altered as a result of post-mortem changes,
immunologically with apparently ubiquitous antigens present in such as blood clotting. Such a mechanism would partly explain
the natural host, regardless of their origin, is likely to be why these antigens have not generally been found on cells in
medically significant. Bacterial pathogens that share antigens culture.
with human cells can precipitate autoimmune reactions, as in the We thank Joe Bonventre and Ashley Dunn for samples of
rheumatic disease caused by Streptococcus pyogenes infections. adenovirus type 2, Phil Gallimore for rat Ad-2-transformed cell
Persistent adenovirus infections might therefore, by analogy, lines and Ad-2 virus samples, Professor B. Marmion for dis-
precipitate similar diseases. Thus, there might be a link between cussions, Jeanette Muir for technical assistance, and Dr Bruce
other rheumatic conditions or autoimmune diseases and. the Hobson and staff at the Royal Infirmary, and the staff of the
antigens that we detect. Of particular interest here is the identity Elsie Ingles Hospital, Edinburgh, for providing placental
of the cell type that seems to synthesise a high concentration of \ samples. This work was supported by the Cancer Research
Ad-2-related RNA as determined by in situ hybridisation. If x Campaign and the Nuffield Foundation.
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Summary.—Explant cultures were initiated from adenocarcinoma of the small
intestine in sheep and from various metastases. Several cell types grew, most being
fibroblastic in nature. However, 2 cultures yielded mixed cells which arranged
themselves into areas of epithelial-like cells surrounded by fibroblast-like cells and
this pattern was consistent over 30 subcultures and several months of culturing. The
epithelial-like cells were separated from the others by the use of a modified medium
containing citrulline or by sedimentation through a bovine serum albumin solution.
Various properties, including their growth rate in 5% and 0*5% serum, the absence of
surface fibronectin and their ability to grow in semi-solid agar, indicated that they
may represent carcinoma cells. Screening for virus production from these cells and
all other explant cultures proved negative.
Adenocarcinoma of the small intestine
in sheep has been reported particularly in
older ewes in New Zealand (Simpson and
Jolly, 1974), Australia (Ross, 1980), Ice¬
land (Georgsson and Vigfusson, 1973),
Scotland (Norval, personal communica¬
tion) and Northern England (McCrea and
Head, 1978). In those parts of the world at
least this tumour is found relatively fre¬
quently, but it should be noted that pre¬
valence in abattoir surveys is controlled
not only by the number of tumours in the
sheep population of the district but also
by the age and type of sheep sent for
slaughter. Thus, in animals of about 1
year old and older (lambs and ewes) it is
given as 0-97% in Iceland (Georgsson and
Vigfusson, 1973) and 0-2% in Scotland
(Norval, personal communication). Simp¬
son (1972a) reported a range of from
0-2% to 1-58% of ewes slaughtered in 10
slaughterhouses in 7 geographic areas of
New Zealand. Abattoir prevalence figures
in New South Wales, Australia, ranged
from 0-093% to 0-487% for adult sheep
(Ross, 1980). Because there are difficulties
in ensuring that the abattoir samples are
comparable it is not certain if there is a
geographical distribution in incidence
(Head, 1967). The aetiology of the disease
is not known. Simpson (19726) demon¬
strated 16 factors were statistically asso¬
ciated with the tumour in New Zealand.
It has been suggested that exposure to
carcinogens in fodder (Georgsson and
Vigfusson, 1973) or in bracken, Pteridium
aquilinum (Evans and Mason, 1965) may
be important but other factors, in par¬
ticular viruses, may be involved. In this
context, the recent work by Jarret et al.
(1978) is of interest where a correlation
has been drawn between bovine papilloma
virus, an environmental carcinogen
thought to come from bracken and
alimentary carcinoma in cattle..
Ovine adenocarcinoma is found at any
site along the length of the jejunum and
ileum, but is not found in the duodenum.
In sheep from this country, it is usually
present as a solitary primary lesion. The
cell type involved is thought to be either
adsorptive cells or goblet cells (Simpson
and Jolly, 1974). Tumours may spead
from the intestinal site to the mesenteric
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lymph node by lymphatic permeation,
and there may be transcoelomic metastasis
leading to lesions on the surface of many
organs such as the peritoneum of the
anteroventral flanks, diaphragm and
spleen. In the final stages, a large volume
of ascitic fluid is present.
This study was undertaken to examine
the cells which grew in vitro from the
primary adenocarcinoma tissue and from
various metastases, especially to look at
their morphology, ultrastructure and
whether they were infected with viruses.
One cell line of particular interest was
obtained, ST-6, which produced a mixture
of epithelial-like and other cell types on
primary culture. The epithelial-like cells
were separated from the others using
sedimentation in bovine serum albumin
solution and growth in citrulline-contain-




Tissues from 11 sheep suspected by the meat
inspectors of being examples of adenocarcinoma
of the small intestine were obtained from the
abattoir in Edinburgh. As soon as possible after
slaughter, the primary lesion and/or any meta¬
stases were used for culturing purposes. The
specimens were also the subject of morbid
anatomical examination. Tissues were pro¬
cessed to paraffin wax, cut at 5 pm and stained
with haematoxylin and eosin; in addition,
where appropriate, Gordon and Sweet's stain
for reticulin fibres, Aleian Blue and P.A.S. for
mucin were also used.
Culture methods
(a) Primary culture of tumour cells.—The
tumour specimen was cut into small pieces
approximately 1 mm in size and several placed
beneath a glass cover-slip in a plastic Petri dish
(Sterilin). The medium used was Earles-based
Eagles' complete medium containing 200 iu/ml
penicillin, 200 /ig/ml streptomycin, 50 iu/ml
mycostatin and 100 pg/ml gentamicin, and
supplemented with 10% newborn calf serum.
All culturing was performed at 37° in 5% CO2.
Cells were subcultured using trypsin-versene.
After subculture, the gentamicin and myco¬
statin were omitted from the medium and the
serum content reduced to 5%. The cells were
tested at intervals for the presence of myco¬
plasmas as described by Mackay et al. (1974).
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(b) Citrullin medium.—ST-6 cells were cul¬
tured in Sun's modified Waymouth MB 752/1
medium containing either arginine or citrulline
and supplemented with dialysed newborn calf
serum (Sun et al., 1979).
(c) Separation of cell types using sedimentation
in bovine serum albumin (BSA).—The method
described by Moore and McBride (1980) was
used whereby cell suspensions were fractionated
by velocity sedimentation at unit gravity.
Briefly, 107 cells were sedimented for 90 min
through a 1—2% BSA gradient in Dulbecco's
solution contained in an 18cm diameter
"Staput" chamber (Johns Scientific, Toronto).
(d) Rate of growth.—The rate of growth of
ST-6 cells and its subpopulations was measured
by putting 2 x 105 cells into 50mm Petri dishes
in 5 ml Eagles' medium containing either 5%
or 0-5% newborn calf serum, and counting the
number of viable cells present, after removal
with trypsin—versene, on each day for a period
of incubation of 8 days.
(e) Growth in semi-solid agar.—The epithelial
cells derived from the ST-6 culture were cloned
in Eagles' medium with 10% newborn calf
serum and containing 0-275% agarose (LGT
pure agarose powder, 49-056, Miles Labora¬
tories), with 0-55% underlay containing 105
human embryo lung cells/ml as feeder cells. The
sheep cells were seeded at densities of 5 x 104
and 104 in 50mm Petri dishes.
Fibronectin immunofluorescence
An indirect immunofluorescence test to detect
fibronectin was carried out as described by
Chen, Gallimore and McDougall (1976), using
cells grown in monolayers and fixed with 2%
paraformaldehyde. Rabbit antiserum, specific¬
ally cross-reacting with mouse, rat and human
fibronectin (data not shown), was produced by
injecting purified human cold insoluble globulin
into rabbits, and was kindly donated by Dr J.
Kinross. It was used at a dilution of 1/40, while
the FITC anti-rabbit conjugate was used at
dilutions of 1/8-1/16.
Ultrastructure
Cells grown on plastic and glass flasks were
harvested by gentle mechanical scraping using
a rubber policeman or by enzyme digestion
using neutral protease (Dispase II, Boehringer).
Some samples were fixed for 1 h in 2-5%
glutaraldehyde before removal from flasks and
others were fixed as cell suspensions after re¬
moval. After removal and fixation, cell pellets
were formed in polyethylene conical-tipped
tubes (Azlon) by centrifuging at 3000 g for 10
min. Pellets were washed twice in 0-1 ji sodium
cacodylate buffer, post-fixed in 2% osmium
tetroxide and then embedded in Spun- resin
(EMscope Laboratories) before sectioning on an
LKB Ultratome III microtome. Sections stained
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with lead citrate and uranyl acetate were ex¬
amined in a Phillips 400 TEM at an accelerating
voltage of 100 Kv.
Eor scanning electron microscopy cells were
cultured on 10mm diameter glass cover-slips in
Petri dishes. When confluent, monolayers were
fixed in 2-5% glutaraldehyde and prepared for
scanning electron microscopy by critical-point
drying using a Polaron critical-point drying
apparatus. Samples were examined in a Cam¬
bridge Stereoscan 180 SEAT.
Chromosome analysis
Sixteen hours after subculture into 25cm2
flasks from a confluent monolayer, ST-6 cells
were pulsed with 0-2 ml 2% colchicine (BDH) in
saline, and incubated for a further 2 h at 37°.
The cells were removed from the flask by
trypsinization, and processed through hypotonic
KC1 and fixative (Hungerford, 1965). Chromo¬
some spreads were made on clean chilled slides
and stained for 10 min with a 1/20 dilution of
Giemsa.
Screening for virus production
All cell cultures at Pass 4 or 5 were labelled
with 3H-thymidine and 3H-uridine for 24^48 h
followed by concentration of the culture super¬
natant and sucrose density gradient centrifuga-
tion as outlined by Norval and Marmion (1976).
In one case, ST-4, the primary tumour dis¬
aggregated by the use of trypsin and the result¬
ing single cells cultured in the presence of 3H-
thymidine and 3H-uridine directly.
In addition, for the ST-6 cells only, the cul¬
tures at Pass 10 immediately before labelling
were induced with ITJDR (20 /rg/ml) for 3 days
followed by 2% DMSO for 3 days (Stewart et al.,
1972), mitomycin C (1 jtg/ml) for 18 h in the dark
(Weiss et al., 1971), or cycloheximide (10 jug/ml)
for 16 h (Aaronson and Dunn, 1974).
ST-1, ST-2 and ST-3 cells and cell lysates
from Pass 2 were also examined by co-cultiva¬
tion and infection of human embryo fibroblasts,
RKi3, HEp-II and Vero cells followed by
microscopic examination over a period of 4
weeks for evidence of any viral cytopathic effect.
results
Morbid anatomy and light microscopy of
tumour cases
All 11 cases of suspected adenocar¬
cinoma occurred in female sheep and they
were from a variety of breeds including
Blackface, Border Leicester and Halfbred.
Their ages by dentition and skeletal
Table I.—Source and investigation of cells cultured from explants of suspect adenocar¬











ST-1 Adult Primary I (S) A
ST-2 Adult Mesenteric lymph
node I (S) A
ST-3 Adult Primary I (S) A
ST-4 Adult Primary II (S) Fungal
contaminat
ST-5 Adult Primary I (S) No growth
ST-6 ca. 9 months Posterior mediastinal
lymph node I (S) B













ii (D) No growth
No growth
No growth






Key: A = Large fibroblast-like cells with stretched out processes; B = mixture of two sizes of epithelial-like
cells, large fibroblast-like cells with long processes and long thin fibroblasts; C = long thin fibroblasts; I = on
same day as animal's death; II = on the day following the animal's death.
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Fig. 1.—Photomicrograph of a metastasis in the subcapsular sinus of the posterior mediastinal lymph
node of ST-6. Note the acinar pattern with basal nuclei and goblet-cell formation. Paraffin wax.
H. & E. x 456.
Fig. 2.—Photomicrograph of metastatic cells in the subcapsular sinus of the posterior mediastinal
lymph node of ST-6. Note many of the cells are signet-ring cells and there is some perinodal fibrosis.
Paraffin wax. H. & E. x 380.
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development ranged from 9 months
through adult (over 4 years old) to aged
(probably 7 years old or more) (Table I).
Ten of the cases were slaughtered at the
abattoir, the eleventh died from respiratory
distress caused by metastasis to the pleura
and subsequent hydrothorax (ST-10).
Morbid anatomy and histopathology re¬
vealed 10 of the cases were typical adeno¬
carcinoma of the small intestine; in the
eleventh (ST-7) the peritoneal lesions pro¬
ved to be due to a nodular fibrous peritonitis
probably associated with migrating hel¬
minth larvae.
The tumour cases had an annular
stenosing primary lesion. The mucosal
surface was usually ulcerated and the
tumour in the mucosa formed ill-defined
tubules, the cells having lost their nuclear
polarity. The serosa at this site showed
fibrosis with few tumour cells. Lymphatic
metastases caused spread in the serosa
proximal to the tumour and also to the
drainage mesenteric lymph node. Trans-
coelomic metastases to the diaphragm
and flanks were always present and from
these sites lymphogenous involvement of
the posterior mediastinal lymph node
occurred. The peritoneal tumour sites were
mainly composed of fibrous tissue rich in
fibroblasts but showing few groups of
tumour cells which sometimes became
organized into an acinar structure with
basal nuclei. Both these cell patterns could
produce mucin either as signet-ring cells
or sometimes as mucin-producing acini.
The posterior mediastinal lymph nodes
had less perinodal and medullary fibrosis
than the mesenteric lymph nodes but both
showed isolated tumour cells and a few
well organized tumour-cell acini in the
subcapsular sinus (Figs 1 and 2). Mitotic
figures were rare in the epithelial tumour
cells and were not found in the fibroblasts.
The rumen was not always available for
inspection but, in those cases where it
was examined, half had rumen fibro-
papilloma present.
Primary culture of tumour material
At first, in addition to explant culture,
the tissues were disaggregated by the use
either of trypsin or of a mixture of colla-
genase and dispose, but it was found that
explant cultures gave more satisfactory
results with cells growing out from the
tissue fragment within a few days. The
initial cultures could be split into 2 after
2 weeks to 1 month. Thereafter, the rate of
growth increased and the cells could be
subcultured at a ratio of 1:3 every week.
jsto cells grew from the ascitic fluid of
ST-10 although initially some cells were
present which looked like macrophages.
Vigorous washing of the flank metastases
was also tried in an attempt to dislodge sur¬
face tumour cells, but this was not success¬
ful. In one case, ST-4, the cultures became
contaminated ■with fungi, and in another
2, ST-o and ST-10, no cells grew out from
the explants.
Morphology of cultured cells
The variety of cell types obtained on
culture was of great interest. Typical
fibroblasts grew from 2 specimens, ST-7
and ST-9, with long, thin, tapering mor¬
phology and which were contact-inhibited.
In 4 cases, ST-1, ST-2, ST-3 and ST-11,
the cell type which grew also looked
fibroblastic although it was shorter and
fatter than the fibroblasts already des¬
cribed. However, when the cultures were
not confluent, the morphology was quite
different. The cells were large and had
stretched-out processes (Fig. 3a). As the
cultures become more confluent, the cells
seemed to be compressed into a fibro¬
blastic shape (Fig. 3b).
The 2 remaining cultures, ST-6 and
ST-8, were very different. In both there
was a mixture of cell types which is
illustrated in Fig. 4. It may be seen that
there are patches of epithelial-like cells
surrounded by fibroblast-like cells. This
appearance was noticed in the' primary
culture from the explant (Fig. 5) and
continued as a regular pattern throughout
more than 30 subcultures which were
performed weekly at a ratio of 1:2 or 1:3.
In this respect, these cells may mimic the
behaviour of cells within the tumour mass
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Fig. 3.—Cells from culture ST-1 (a) at low density and (b) when fully confluent. Phase contrast, x
Fig. 4.—Cells from culture ST-6, Pass 3, showing mixed cell types. Phase contrast, x 75.
Fig. 5.—Explant culture of ST-6. Phase contrast, x 75. ''
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Fig. 6.—Fraction 4 cells from ST-6 after separation on BSA. Phase contrast, x 66.
Fig. 8.—ST-6 cells after 5 passages in Sun's modified medium with citrulline. Phase contrast. x 46.
Fig. 9.—Transmission electron micrograph of cell pellet from Fraction 4. (a) Typical cell; note
numerous vacuoles with osmophilic material and prominent surface villi, x 4000. (b) Close-up of
same cell showing surface villous structures. x 14,333.
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and it was decided to attempt to separate
the cell populations present within the
ST-6 culture and to study their properties
further.
Separation ofST-6 subpopulations
(a) Culture in citrulline medium.—The
first approach was to culture the cells in
a medium containing citrulline which was
designed to inhibit the growth of fibro¬
blasts as described by Sun et al. (1979).
ST-6 cells were passaged 5 times in this
medium and the appearance of the cul¬
tures compared with growth of these cells
in Eagles' medium supplemented with the
same serum.
In the modified medium with citrulline,
the fibroblast-like cells gradually dis¬
appeared with each passage until none were
seen after 5 passes. Two distinct popula¬
tions of epithelial-like cells which differed
in size remained, as shown in Eig. 8. The
fibroblast-like cells persisted in the modi¬
fied medium containing arginine and in
the original Eagles' medium. It was very
striking that, during the course of passage
in the modified medium, the ST-6 cells
seemed to rearrange themselves into cell
types and to grow in discrete areas.
(b) Sedimentation through B.S.A.—In the
second method ST-6 cells at Pass 10 were
sedimented through B.S.A. and aliquots
collected, with the result shown in Eig. 7.
Each fraction was cultured after washing
the cells. Fractions 1, 2 and 3 showed






12 16 20 24 28 32 .:
Aliquot number
Fig. 7.—Profile of cell numbers in each
aliquot after sedimentation of 107 ST-6
cells, Pass 10, through BSA solution.
Fractions for culture were made from
pooled aliquots as shown.
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fibroblast-like cells of the type already
described, i.e. they were large and spread¬
ing at low confluence with long processes.
These cell fractions were grown up separ¬
ately and then pooled for subsequent
investigations and identified as Fraction
1-3. Fraction 4, on the other hand, con¬
tained a very large percentage of epithelial-
like cells and these are illustrated in Fig. 6.
Fractions 5-8 contained a mixture of
epithelial cells and fibrobasts like the
original culture and the remaining frac¬
tions had cells of typical fibroblast appear¬
ance, no epithelial cells being present.
UUrastructure of Fraction 4 and Fraction
1-3 subpopulations of ST-6
Thin sections of Fraction 4 cell pellets
showed both individual cells and groups
of cells. The nuclei were irregular in shape
with strongly indented nuclear margins,
where the cells had remained in groups,
desmosomes were seen in tight junctional
sites. At free cell surfaces, and where cells
were loosely associated, there were pro¬
minent microvilli (Fig. 9). There were
many cytoplasmic vacuoles which were
apparently devoid of contents. At high
power many of these structures contained
sparse amounts of osmophilic material
only, whilst others contained granular,
more strongly osmophilic material. Rela¬
tively few mitochondria were present and
these were usually degenerate. Other cells
showed larger, more irregular vacut, les
containing finely particulate, weakly osmo¬
philic material characteristic of mucus.
Some of the larger structures had villus-
like cytoplasmic processes extending into
their lumina. SEM observations showed
numerous microvilli on the surface of
Fraction 4 cells (Fig. 10a).
Examination of Fraction 1-3 cells by
TEM showed cells with irregular, indented
nuclei. Cell membranes were irregular but
had markedly fewer microvilli than the
Fraction 4 cells (Fig. 11). Round, and more
irregular, vacuoles were observed in the
endoplasmic reticulum. In addition, many
cells showed accumulations of fibrillar
material. The SEM appearance of a typical
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1
Fig. 10.—Scanning electron micrographa of cultured ST-6 3ubpopulations. (a) Typical cell with
multiple villous processes on the cell surface from Fraction 4. Note apparent cell processes due to
shrinkage artefact, x 2000. (b) Typical flattened cell with long cell processes and relatively
smooth cell surface from Fraction 1—3. x 2000.
Fig. 11.—Transmission electron micrograph of cell pellet from Fraction 1-3. (a) Typical cell with
filamentous inclusions. x 5132. (b) Close-up ofsame cell showing filamentous structures. X 30,666.
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Fraction 1-3 cell is shown in Fig. 10b. No
microvilli were seen on these cells and the
cytoplasmic processes were extensive and,
clearly, not due to shrinkage artefact.
No evidence of viral particles was
observed in any of the sections examined.
Cultural characteristics of ST-6 and its
subpopulations
(a) Growth rate.—The growth rate of
Fraction 1-3, Fraction 4 and ST-6 cells
was compared in the presence of 5% and
0-5% newborn calf serum, and the time
taken for a cell division to occur was
calculated. This is shown in Table II, in
Table II.—Generation time of ST-6 cells
and its subpopulations, Fraction 4 and
Fraction 1-3 cells, in Eagles' medium
containing 5% and 0-5% newborn calf
serum
Generation Generation
time in time in
5% serum 0-5% serum
(days) (days)
ST-6 (Pass 20) 2-8 3-6
Fraction 1-3 (Pass 5) 3-0 Didnotdivide
Fraction 4 (Pass 5) 1-2 1-6
which it may be seen that Fraction 4 cells
grew about 3 times as quickly as Fraction
1-3 cells in medium containing 5%
serum. In addition, they grew well in
medium containing only 0-5% serum,
while the Fraction 1-3 cells did not divide
under these conditions.
(b) Fibronectin immunofluorescence.—In
addition to the growth rate, the presence
of fibronectin was tested by indirect
immunofluorescence on ST-6 cells and its
subpopulations. The unseparated ST-6
cells revealed a mixture of fibronectin-
positive and fibronectin-negative cells.
Fraction 4 cells had little or no fibronectin
staining, while the Fraction 1-3 cells re¬
mained strongly positive.
(c) Culture in semi-solid agar.—As a
further test of the possible tumour origin
of Fraction 4 cells, they were cloned in
semi-solid agar, being seeded at a density
of 5 x 104 and 104 per plate. These numbers
gave rise to 12 and 3 clones respectively,
giving a cloning efficiency of 2-3 cells in
104 Fraction 4 cells. The clones which
grew out contained epithelial-like cells.
(d) Chromosome analysis.—Chromosome
analysis of ST-6 cells from Pass 12 was
performed on 30 well spread cells and 25 of
these possessed 54 chromosomes, the nor¬
mal diploid number for sheep. Three cells
had 51 chromosomes, one 52 and one 53
but the same chromosome was not missing
consistently in these. Complete karyotypes
were set out on 4 of the cells containing 54
chromosomes and all were shown to be
normal (Fig. 12). No marker chromosomes
or structural abnormalities were seen in
any of the cells examined. 400 cells in
mitosis were looked at and 32% of these
possessed twice the normal diploid comp¬
lement.
Screening for virus production
All cell strains which grew from the
explant cultures (see Table I) were
examined at Pass 4 or 5 for the presence of
virus by light microscopy and electron
microscopy, and none showed any evidence
of this. In addition, 3H-thymidine and
3H-uridine were added to these cultures
at Pass 4 or 5 in an attempt to label any
virus which might be released into the
fluid phase of the culture without an appar¬
ent cytopathic effect. No labelled material
was found on subsequent sucrose gradient
centrifugation of the concentrated culture
supernatant with a density typical of virus
particles. Also, in the case of the ST-6
cells, treatment with IUDR, cyclohexi-
mide and mitomycin C before labelling
did not induce any virus. Finally, using
3 cultures, ST-1, ST-2 and ST-3, no
cytopathic effect was detected after co-
cultivation with a variety of cell lines or
infection of these with cell lysates.
No culture contained Mycoplasmas.
discussion
Explant cultures were used in an
attempt to grow tumour cells from
adenocarcinoma of the small intestine of
sheep and a variety of cell types emerged.
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Table I shows that the success of a culture
could not be correlated with the speed of
establishing the explant provided the
sheep had been slaughtered and not left
unopened for hours before postmortem
examination. Likewise, the site from which
the explant was taken did not seem to
influence the successful outgrowth of cells.
Three main cell types were found in the
cultures: typical small fibroblasts, large
fibroblast-like cells and epithelial-like
cells. The small fibroblasts were recovered
from both the non-neoplastic inflam¬
matory reaction and from the tumour
tissue. However, the fibrosis associated
with the tumour when cultured soon after
the death of the sheep often gave rise to
large fibroblast-like cells. The fact that the
most successful culture (ST-6) was ob¬
tained from a lamb might be taken to
indicate that the case was unusual because
of the age of the tumour-bearer. We do not
think that this is tenable, first, because
the other sheep to give a mixed epithelial-
like and fibroblast-like culture (ST-8) was
aged, i.e. at least 6 years old, and secondly,
occurrence in lambs, although rare, has
been previously reported; Georgsson and
Vigfusson (1973), for example, stated that
the youngest of their affected sheep was a
yearling.
It has been suggested by Simpson and
Jolly (1974) that this tumour arises from
either adsorptive or goblet cells. Recently
an ultrastructural study has been under¬
taken by Ross and Day (1979) and they
reported that the tumour cells at the
primary site, and in the metastases of the
draining lymph node, form small acini
which invade deeper tissue and provoke a
fibrotic reaction. They suggested that, as
all cell types found in the normal mucosa
are present in the tumour, the lesion
originates from undifferentiated intestinal
epithelial cells.
This was ofspecial interest in the present
study as explants from 2 adenocarcinoma
specimens gave rise to cell types of mixed
morphology which persisted as such
through several months of culture and
over 30 passages. The cells seemed to
form themselves into distinct growth
patterns on subculture with the epithelial-
like cells in discrete areas being surrounded
by fibroblast-like cells. This mimics the
appearance of the tumour in vivo. Separa¬
tion of these cell types was achieved in 2
ways using methods which may also be
applicable to other systems. The large
fibroblast-like cells (Fraction 1-3) were
observed ultrastructurally to have accu¬
mulations of fibrillar material in their
cytoplasm together with mucin-containing
vacuoles. It is not known what cell type
they represent. On ultrastructural study,
the epithelial-like cells (Fraction 4) showed
extensive microvilli and frequent desmo-
somes between adjacent cell groups. In
their cytoplasm there were vacuoles some
of which contained mucus. On SEM cells
of varying size could be seen as in the
phase contrast examination of culture
samples, but the morphology of these cells
did not allow separation into 2 clearly
defined subpopulations.
There were several factors which may
indicate the oncogenic nature of these
epithelial-like cells. In the first place, their
growth rate was high and was little affected
by reduction of the serum concentration
to 0-5%. Secondly, a correlation has been
drawn between the expression of fibro-
nectin (LETS protein) and the oncogenicity
of virus-transformed cell fines where trans¬
formed fines which produce tumours have
little or no fibronectin, while in normal
cells it is distributed over the surface
(Chen et al., 1976). An immunofluorescence
test for the presence of fibronectin on the
Fraction 4 cells showed little or no stain¬
ing, while the Fraction 1-3 cells were
strongly positive. In addition, the epi¬
thelial-like cells had the ability to form
colonies in semi-solid agar. Therefore, it
seems likely that these epithelial-like cells
may represent the undifferentiated tumour
cells described by Ross and Day (1979) and
that they can be successfully cultured in
vitro.
The original cells of this culture and all
the other cell types which grew from ex-
plants of other specimens were screened for
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virus production and all proved negative.
It is possible that a virus is not involved
in the aetiology of this tumour or, alterna¬
tively, that it may be present in a non¬
productive state, perhaps integrated into
the host cell genome. The epithelial cells
obtained here will be further studied to
examine this possibility, especially with
regard to ovine papilloma virus, in case the
same correlation may apply in sheep as
has been suggested in cattle (Jarrett et al.,
1978).
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The dog has been widely used as an
experimental animal for the assessment of
human contraceptive and related drugs,
with special reference to the relative risk
of mammary carcinogenesis from such
compounds (El Etreby & Graf, 1979). In
addition to the mammary dysplasias and
neoplasias which may be induced experi¬
mentally, the domesticated canine has a
significant incidence of naturally occurring
spontaneous mammary neoplasia (Dorn et
al., 1968; Bostock, 1975). Between 40%
(Else and Hannant, 1979a) and 60%
(Misdorp & Hart, 1976) of bitches have
malignant tumours leading to metastatic
disease with euthanasia in the majority of
cases—60% at 2 years after surgery in our
experience.
Despite these facts, there are only 3
reports of tissue-culture studies of canine
mammary carcinomas, by Cella (1967),
Owen et al. (1977) and Watrach et al.
(1978). Owen and co-workers reported the
probable establishment of 2 cell lines: one,
derived from a primary adenocarcinoma,
was fibroblastic in nature, while the
second, from a lung metastasis, was epi¬
thelial in nature.
This report describes the cultural and
other characteristics of a cell line (REM
134) derived from a spontaneous primary
canine carcinoma (Hampe & Misdorp,
1974). Representative tissue was fixed at
the time of biopsy as l-2mm cubes in 2-5%
ghParaldehyde in cacodvlate buffer and
processed for examination in the trans¬
mission electron microscope as described
previously (Else & Hannant, 19796). Sub¬
sequently the bitch was killed 1 month
after mastectomy and metastatic tumours
involving the liver, diaphragm and lungs
were seen at necropsy performed 6 h post
mortem.
The tumour was disaggregated mecha¬
nically, and the fragments pressed through
stainless steel mesh. After filtration through
gauze to remove fatty fragments and
debris, the cells were cultured using
Parker TC 199 medium with the addition
of penicillin (250 iu/ml), streptomycin
(100 pg/ml) and 15% fetal calf serum.
Cells were seeded at densities of 2-5 x
106/ml and 5-0 x 106/ml.
The cells were subcultured by trypsini-
zation and, during an initial 10-month
period, 112 passages were effected. Sub¬
sequently the medium was changed to
Earle's-based Eagle's complete medium
containing 100 iu/ml penicillin, 100 pg/ml
streptomycin, 5% newborn calf serum and
2% fetal calf serum, and a further 25
passages carried out to date. Initially the
doubling time, as estimated from total cell
counts, was 48 h and at passage 120, 24 h.
Throughout the entire culture period
the morphology of the cells was typically
epithelial (Fig. 1). Their most striking-
feature at the light microscope level was
the high number of cytoplasmic vacuoles.
Monolayer cultures were disaggregated
with dispase (Boehringer) and mechanical
scraping. After washing in 0-Im sodium
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Fig. 1.—REM 134 cells at passage 115. Phase contract, x 100.
tions of cell pellets prepared from mono¬
layers showed marked variation in cell
size with varying nuclear-cytoplasmic
ratios. Nuclei were frequently irregular
and indented but were otherwise un¬
remarkable (Fig. 2). Mitoses were often
observed. Mitochondria were often either
bizarre or apparently degenerate and
relatively few in number. Osmiophilic
round inclusion bodies were occasionally
seen but only a few cells in any one sample
showed large vacuoles with villous struc¬
tures (Fig. 3). These latter structures are
similar to intracytoplasmic duct-like
vacuoles described in some human breast-
tumour cell lines and primary tumours
(Buehring & Hackett, 1974), and this is
indicative of mammary epithelial origin.
Many cells, particularly in the later
passages, had abundant filaments of fine
type or bolder tonohbrils (Fig. 4). A
striking feature of the surfaces of cells
was the presence of numerous well-
developed microvilli (Fig. 2). These were
also seen in the primary tumour where
cells were loosely arranged. Although
normal mammary epithelial cells have
microvilli, the exaggerated formations
here may be a reflection of the degree of
cacodylate buffer, cells were fixed in 2-5%
glutaraldehyde for 2 h and pelleted by
centrifugation at 3000 rev/min for 5 min.
Cell pellets were post-fixed in 2% osmium
tetroxide and embedded in Spurr resin.
Ultrastructural examination of thin sec-
Fig. 2.—Typical REM 134 cell." x 4800.
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Fig. 3.—Vacuole-like structure with microvilli in a typical cell, x 45,000.
malignant transformation. Alternatively,
they may be related to the mechanical
nidation of metastatic cells. Cell pellets
gave no information on desmosome status;
monolayer preparations showed relatively
few desmosomes. None of the cultural
cells showed myosin bundles in their
cytoplasm. There was no evidence of
viral particles in any of the samples
examined.
Monolayers were examined in a scan¬
ning electron microscope after fixation in
2-5% glutaraldehyde, followed by dehy¬
dration with acetone and critical-point
drying. Monolayers had confluent cells
with indistinct cell borders, raised centrally
placed smooth nuclei, and prominent sur¬
face microvilli (Fig. 5) covering the
remainder of the cell surface.
Cells for chromosome analysis were
pulsed with 0-2 ml of 2% colchicine (JBDH)
in saline at 16 h after subculture from
confluent monolayers and then incubated
for a further 2 h at 37°C. The cells were
removed from flasks by trypsinization and
processed through hypotonic KC1 and
fixative (Hungerford, 1965). Chromosome
spreads were made on clean chilled slides
and stained for 10 min with 1/20 dilution
Giemsa. Chromosomal examination at
early passage level indicated a karyotype
which was typically canine, 78 chromo¬
somes per cell. However, some cells
contained irregular chromosome numbers
of 105-110. At passage 120, chromosomal
analysis showed an average of 130/cell
Fig. 4.—REM 134 cell showing prominent
fibres, x 9500.
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mM
Fig. 5.—Scanning electron micrograph of REM 134 monolayer



















Fig. 6.—Chromosomal analysis of REM 134 cell at passage 120.
(range 124-136), one karyotype being
depicted in Fig. 6.
The cells had the ability to grow in
semi-solid agar (0-275% Seaplaque aga¬
rose, Marine Colloids Div.) and formed
colonies easily visible by eye after 14
days' incubation. The cloning efficiency
was ~ 4%. Individual colonies were picked
using a micropipette and cultured sepa¬
rately; their properties are being deter¬
mined at the present time.
There have been reports of retroviruses
being associated with mouse mammary-
tumour cell lines (Fine et al., .1974),
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Fig. 7.—Typical tumour on dorsum of female
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Fig. 8.—Histological appearance of tumours: (a) primary canine carcinoma, H. & E. x 1000;
(b) "nude" mouse tumour. H. & E. x 2600.
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human breast-cell lines (McGrath et al.,
1974) and a canine mammary-cell line
(Watrach et al., 1978). Thus to check for
the presence of retroviruses in this canine
mammary-cell line, labelling with |3H]-
uridine was carried out at passage 120,
followed by concentration of the culture
supernatant and sucrose density centri-
fugation as outlined by Norval & Marmion
(1976). In addition, induction was attemp¬
ted using progesterone (1 /xg/ml, Sigma) or
luteotropic hormone (5 and 10 /xg/ml.
Sigma) for 24 h before labelling with [3H]-
uridine. Levels of progesterone higher
than 1 /xg/ml were found to be toxic for
the cells. No labelling was detected in
areas of the sucrose gradients correspond¬
ing to a density of 1-16—1-18 g/ml, the
reported density for most retroviruses.
However, further studies are currently in
progress on this question.
Cells from various passages were ino¬
culated s.c. into 4-week-old female CBA
Nu/Nu mice. Inoculation of 107 cells
produced a solid tumour of diameter 0-4
cm, easily visible within 5 days, which
continued to grow steadily until ~ 2-0 cm
in diameter, when the mice were killed
at 21 days (Fig. 7). The short latent
period of 5 days was a regular feature in
all mice inoculated and contrasts with
latency periods of g 3 weeks recorded for
heterotransplanted human mammary car¬
cinomas (Ozzello et al., 1974). Presumably
this feature is related to the highly
malignant character of the cells. Inocula¬
tion of less than 105 cells produced no
tumour.
Histologically the tumours were identical
to the original primary canine carcinoma
(Fig. 8). Some of the larger tumours in¬
duced by cells from later passages, how¬
ever, also showed foci of tumour cells
with bloated cytoplasm containing brightly
eosinophilic fibrillary^ material. At cell
junctions in these sites there was a
lamellar arrangement of the material
indicative of keratin-like formations. All
samples examined histologically showed
narrow compression capsules with sparse
numbers of fibroblasts and polymorpho-
nucleocytes migrating from adjacent blood
vessels. There was usually evidence of
local tissue infiltration by tumour cells at
21 days' growth. The largest tumours
frequently had small central foci of
necrosis. Such foci presumably reflect the
rapid growth rate since the tumours
generally had an abundant supply of thin-
walled vascular channels. There is no
evidence yet that any of the tumours
metastasized but this aspect is under
further study.
The tumours were excised, disaggre¬
gated with a mixture of collagenase and
dispase (Boehringer) and 3xl06 washed
cells injected s.c. into female "nude"
mice. Again tumours were visible within
I week and grew rapidly. Serial tumour
passage from one mouse to another was
carried out 3 times and in each case the
resulting tumours were histologically the
same and similar to the original primary
carcinoma. Culture of cells derived from
disaggregation of these tumours yielded
monolayers with the same morphology
and karyotype as the original cells. In
addition, they induced tumours when in¬
jected subsequently into female "nude"
mice after 3 passages in vitro.
In male CBA "nude" mice inoculated
with 2 x 106 cells, tumours did not appear
before 19 days. The growth rate was
estimated to be half that in the female
mice with similar numbers of cells from
the same passage. This observation may
be indicative of hormonal control of tu¬
mour growth in vivo, and the apparent
sex difference is currently under investi¬
gation.
Oestrogen-receptor assays of the primary
tumour (Hamilton et al., 1977) were posi¬
tive. However, subsequent examination
of the culture medium after growth of
REM 134 cells at passage 125, by radio¬
immunoassay for oestrone and oestradiol-
17^, indicated no production of these
steroids by the cells. In addition cultured
cells and a solid tumour induced in a
"nude" mouse showed no significant
oestrogen or progesterone receptor activity
as measured by uptake of [3H]-oestradiol
CANINE MAMMARY CARCINOMA CELL LINE 681
(Hawkins, personal communication). It
would appear, therefore, that in vitro the
cell line is neither hormone-dependent nor
capable of secreting detectable amounts
of oestrogens. It is possible that for growth
in vivo the cells may be dependent on
some other factor such as pituitary hor¬
mones which may be released in higher
amounts than the ovarian hormones.
In summary, this report describes a
long-term culture derived from a canine
mammary carcinoma which requires no
special conditions for growth and appears
to satisfy the criteria for an established
cell line. One hundred and two canine
mammary carcinomas have been cultured
in vitro by one of us (R.W.E.), epithelial
cells arising in about half this number.
Out of all these, the REM 124 cells repre¬
sent the only long-term line established
which also has tumorigenic properties in
"nude" mice. Furthermore, this cell line
may provide a useful system for in vitro
studies on mammary carcinoma cells as
an alternative to dogs, particularly with
reference to experimental hormonal mani¬
pulation.
We wish to acknowledge the assistance of Dr
R. A. Hawkins, University of Edinburgh, in per¬
forming the hormone-receptor-assay studies.
This work was supported in part by the Cancer
Research Campaign.
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Abstract—Three cells lines, REM 134, 111 and 367, have been derived from canine
mammary carcinomas and their morphological characteristics in vitro are
described. They are tumorigenic in athymic nude mice, have no demonstrable
fibronectin on their cell surfaces and exhibit a varied pattern of lectin binding.
They can be cloned in semi-solid agar. One line, REM 134, responds to oestrogen
and luteotropic hormone in vitro, although none of the three had demonstrable
oestrogen receptors.
INTRODUCTION
There is a high incidence of naturally occurring
mammary carcinomas in bitches [1], and a recent
survey of such tumours showed them to be
remarkably similar to human tumours in their
pathology and receptor status [2]. The bitch has
been used as an experimental animal for the
testing of human drugs, especially steroid
hormones which may increase the risk of
mammary carcinomas [3]. Depite this, there have
been few reports of in vitro long-term culturing of
cells from these carcinomas. Owen et al. [4]
established two cell lines, one fibroblastic in
nature, derived from a primary adenocarcinoma,
and the other epithelial, from a lung metastatis,
and described some of their properties in tissue
culture. The induction of retrovirus particles
from another canine mammary carcinoma line,
after treatment with IUDR and dexamethasone,
has also been reported [5]. Recently serial
transplantation of four canine mammary tumours
in athymic nude mice has been described [6], in
addition to a study of the oestrogen receptor status
of such experimentally induced tumours [7].
During this work, cells have been cultured from
over 130 canine mammary carcinomas using
various techniques of explantation and dis¬
aggregation. Some specimens yielded cells which
grew in vitro with epithelioid morphology but
only in three instances have cell lines been
established which have properties of tansformed
cells and which induce tumours in athymic nude
mice. These were called REM 134, 367 and 111.
The initial characterization of REM 134 cells has
already been reported [8]. This communication
compares the three lines with special regard to
their morphology at the light and electron
microscopic levels, their growth in semi-solid
agar, their surface properties such as fibronectin
content and lectin binding, assay for retroviruses
and their stimulation by various hormones. Their
tumorigenicity in athymic nude mice is reported
in the accompanying paper [9].
MATERIALS AND METHODS
Clinical specimens
Mammary carcinomas and various metastases
were routinely obtained from bitches at surgery or
within 1 hr of euthanasia. All were classified
subsequently according to the WHO Inter¬
national Histological Classification [10]. Within
1-2 hr explant cultures of small fragments, about
1 mm3, were made in Petri dishes (Sterilin), or
small pieces of tissue were disaggregated in
collagenase/dispase (Boehringer) according to
the manufacturer's instructions for 1-2 hrat37°C.
Single cells were washed and cultured in Falcon
flasks (Flow). Eagle's minimal essential medium
(EMEM) supplemented with 100 iu/ml penicillin,
200 /ug/ml streptomycin, 50 iu/ml fungizone,
100 /xg/ml gentamycin and 100% foetal calf serum
was used routinely. Incubations were carried out
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at 37°C in an atmosphere of 5% C02 in air. Once
the cells were established, gentamycin and
fungizone were omitted from the medium and the
serum changed to 5% foetal calf serum plus 5%
newborn calf serum.
Electron microscopy
Cells were harvested by gentle mechanical
scraping or by using dispase. After washing in
0.1 M sodium cacodylate buffer, they were fixed in
2.5% glutaraldehyde for 2 hr and pelleted by
centrifugation at 3000 g for 5 min. Pellets were
post-fixed in 2% osmium tetroxide and embedded
in epoxy resin prior to sectioning. Thin sections,
stained with lead citrate and uranyl acetate, were
examined in a Philips 400 TEM. For scanning
electron microscopy cells were cultured on 10-mm
diameter glass cover-slips in Petri dishes. When
confluent, monolayers were fixed in 2.5%
glutaraldehyde and prepared for scanning
electron microscopy by critical point drying.
Specimens were viewed in an ISI 60 or Philips
SEM 505.
Growth rate
Cells (4 X 105) were seeded into 50-mm Petri
dishes in 5 ml EMEM containing either 5% foetal
calf serum plus 5% newborn calf serum, or 0.5% of
each. On each day for the next 4 days the number
of viable cells present were counted after removal
with trypsin-versene.
Growth in semi-solid agar
Cells (103) were cloned in 5 ml EMEM
containing 10% foetal calf serum and 0.25%
agarose (Seaplaque, Marine Colloids Division) in
50-mm Petri dishes with 1 ml medium containing
0.55% agarose as underlay. One mililitre of fresh
medium with 0.25% agarose was added after 10
days incubation.
Fibronectin immunofluorescence
An indirect immunofluorescent test to detect
fibronectin was carried out using cells grown in
monolayers or cryostat sections of tumours which
were fixed in 2% paraformaldehyde [11]. Rabbit
antiserum was produced by injecting purified
human cold insoluble globulin into rabbits, and
was kindly donated by Dr J. Kinross. It was used at
dilutions of 1/20, 1/100 and 1/250, while the
FITC anti-rabbit conjugate (Wellcome) was used
at 1/16.
Lectin immunofluorescence
A direct immunofluorescence assessment using
FITC-labelled lectins (E-Y Laboratories,
California) was carried out on cells grown in
monolayers or cryostat sections of tumours fixed
in cold acetone for 10 min.
Induction method for retroviruses
Cell cultures were induced with luteotropic
hormone (5 yug/ml, Sigma) for 24 hr, progesterone
(1 jttg/ml, Sigma) for 24 hr and IUDR (20 gg/m\)
for 24 hr, then dexamethasone (5 /rg/ml) for 72 hr
[5]. They were labelled with [3H]-thymidine for
24-48 hr followed by concentration of the culture
supernatant and sucrose density gradient
centrifugation [12].
Effect of hormones on RNA synthesis
Cells (5 X 104) in 1.5 ml EMEM with 1%
newborn calf serum and 1 % foetal calf serum were
put into tubes containing cover-slips. In some the
medium was supplemented with luteotropic
hormone in concentrations ranging from 10"6 to
10"12 M, or oestradiol-17/3 or testosterone from 10"5
to 10"" M. Five microcuries of [3H]-uridine was
added to a duplicate set of tubes on the same day
and to equivalent sets after the tubes had been
incubated for 1, 2 and 3 days. The cover-slips were
removed 24 hr after the addition of the label,
washed in phosphate-buffered saline, fixed in
cold 10% trichloroacetic acid for 10 min, washed
in water, air-dried and counted in a PPO-toluene
scintillator. An average of the two counts (which
were always within 10% of each other) was taken.
Hormone receptors
Cultured cells of REM 134, 367 and 111 were
examined for oestrogen and progesterone receptor
activity as measured by uptake of [3H]-oestradiol.
Culture medium after growth of REM 134 cells
was measured for oestrone and oestradiol-17/3 by a
radioimmunoassay [Hawkins, personal com¬
munication]. In addition, the primary tumour of
REM 134 has been assayed previously for
oestrogen receptors [13],
Chromosome analysis
REM 134 and 111 were karyotyped using the
method outlined in [8].
RESULTS
Origin of growth of REM 134, 367 and 111 cell
lines
After explantation or disaggregation followed
by culturing, epithelioid cells from canine
mammary tumours were obtained in about
60/130 cases. In some of these the epithelial cells
persisted only a short time, a month or two in
culture, before detaching from the surface.
Sometimes they became overgrown with fibro¬
blastic cells or failed to grow on subculture.
However, in some cases epithelial cells were
obtained which could be subcultured successfully
and maintained through at least 20 passages.
Three, REM 134, 367 and 111, persisted as long-
term cultures, considered as cell lines. Tumour
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cells for REM 134 were obtained from a primary
mammary solid carcinoma as described previously
[8], Cells for 367 were cultured from a primary
papillary mammary adenocarcinoma obtained at
the time of mastectomy. Tumour cells for 111
came from a pleural effusion collected
immediately after euthanasia of a bitch with
metastatic disease, following a primary mammary
anaplastic solid carcinoma. All have been
cultured for periods in excess of 1 yr; more than
130 passages of REM 134 cells have been effected
and over 40 passages of 111. Cells of 367 exhibit a
slower growth rate but have been passaged over
30 times. From the remaining epithelial cell
cultures, two strains called A and B were used for
comparison throughout, and one with fibro¬
blastic appearance was also used.
The doubling time of REM 134 cells in 10%
serum was about 24 hr, about 48 hr for 111 and
60 hr for 367 cells. If the serum content of the
medium was reduced to 1%, the doubling time of
REM 134 and 111 cells were unchanged for two
divisions, and no growth occurred thereafter. The
367 cells grew very poorly in low serum.
The ability to form colonies in semi-solid agar
has been reported as a good general index of
transformation and subsequent tumorigenesis in
suitable experimental animals [14]. Thus the
three cell lines, as well as epithelial strains A and
B and the fibroblastic strain, were cultured in
semi-solid agar. Cells REM 134,111 and 367 were
found to form colonies visible by eye after 14 days
of incubation which were picked using micro-
pipettes and cultured separately. The cloning
efficiency was 4% in all cases. No colonies were
formed from the other cells strains.
Morphology of cell lines
The histopathological appearances of the
original primary tumours REM 134, 111 and 367
are shown in Fig. 1, together with the cells from
the pleural effusion, 111. Throughout the culture
period the morphology of the three lines was
typically epithelial (Fig. 2). REM 134 cells,
however, showed considerable variation, ranging
from polygonal to rounded. Epithelial cells from
strain A and the fibroblastic cell strain used
throughout are also shown in Fig. 2.
Marked variation in cell size was seen on thin
sections of cultured cells, especially for REM 134.
Nuclei were usually irregular, with indented
nuclear membranes and coarse granular
chromatin (Fig. 3a). Mitotic figures were common
in REM 134 and 111, but less common in 367.
Vacuole-like structures with villi were occasionally
seen in REM 134 cells but were absent in 111 and
367. Many vacuoles in REM 134 cells contained
electron-dense particles (Fig. 3b). Tonofibrils
were common in the cytoplasm but mitochondria
were relatively few and sometimes bizarre,
particularly in REM 134. There were prominent
microvilli in all three lines, but none showed
myosin bundles. No evidence was seen of virus
particles.
On examination of confluent monolayers in
the scanning electron microscope, there were
flattened cells with indistinct cell borders and
slightly raised nuclear areas. At the periphery of
confluent areas the cells were rounded and heaped
(Fig. 4). The cells from the three lines showed
prominent microvilli on their surfaces with fewer
in nuclear zones. Rounded cells had prominent
villous structures and some had bleb-like
formations (Fig. 5). REM 134 cells had elongated
villi (Fig. 6a), whilst both 367 and 111 had a
greater density of shorter formations which were
sometimes more bulbous (Fig. 6b).
The karyotype of REM 134 has already been
reported [8]. Cells 111 at passage 10 showed
marked polyploidy, with chromosome numbers
ranging fron 126 to 167.
Surface properties
In addition to the ability to grow in suspension,
most transformed cell lines exhibit a greatly
reduced content or absence of fibronectin [11].
The cell lines and strains were tested by indirect
immunofluorescence after growth on cover-slips.
The results are shown in Table 1. It may be seen
that REM 134, 367 and 111 cells had no detectable
fibronectin, while the epithelial strains A and B
and the fibroblastic strain had.
The surface of the cultured cells was also
analysed by binding of nine different lectins using
a direct immunofluorescent technique (Table2).
Wherever possible, the specificity of the binding
was demonstrated by the reduction of immuno¬
fluorescence in the presence of the sugar to which
the lectin attaches. There was no apparent pattern
of lectin binding to separate the three lines from
the other strains used.
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Table 2. Binding of FITC-lectins to cell cultures as measured by direct
immunofluorescence
Epithelial Epthelial Fibroblastic
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UEA
UAE + L-fuc
PNA, Arachis hypogaea agglutinin; BSA-II, Bandeiraea simpliciforlia agglutinin; SBA,
Glycine max agglutinin; RCA, Ricinus communis agglutinin; UEA, Ulex europaeus
agglutinin; GS-I, Bandeiraea simplicifolia agglutinin; DBA, Dolichos biflorus agglutinin;
MPA, Maclura pomifera agglutinin; WGA, Triticum vulgaris agglutinin; D-gal, D-
galactose; L-fuc, L-fucose; NAc-D-gal, IV-acetyl-D-galactosamine.
+++, ++ and + = degrees of immunofluorescence; - = no immunofluorescence.
Induction of retroviruses
There have been several reports of retroviruses
being associated with mammary carcinoma cell
lines from various species, such as human [15],
murine [16] and canine, the latter being induced
with IUDR followed by dexamethasone [5], When
such a regime was carried out on REM 134, 111
and 367 cells no virus particles were detected using
[3H]-uridine labelling. In addition, induction by
treatment with progesterone or luteotropic
hormone was not successful.
Effect of hormones on rate of growth and
hormone receptors
Oestradiol-17/I, testosterone and luteotropic
hormone at varying molarities were added to
REM 134, 367 and 111 to find out if they
stimulated the growth rate. This was measured by
the uptake of [3H]-uridine over a 4-day period
after the addition of the hormone. Cell lines 111
and 367 did not respond to any of the added
hormones at any concentration. In the case of
REM 134 there was no effect due to the addition of
testosterone, but oestradiol and luteotropic
hormone stimulated RNA synthesis 72 hr after
addition by as much as 2-3 times, as illustrated
in Fig. 7.
REM 134 and 111 cell lines were analysed for
oestrogen and progesterone receptor activity and
both were negative. In addition, the uptake of
[3H]-oestradiol (5 nM) into 5 X 108 REM 134 cells
was measured in a 1- to 2-hr period at 37°C. The
cells were washed once, incubated in oestrogen-
free buffer for 0.5 hr and then washed three times
prior to counting. Control cells were incubated
with [3H]-oestradiol plus a 500-fold excess of
diethylstilbestrol, which competes for oetrogen
binding sites and would therefore block receptor-
binding. Three per cent of the initial radioactivity
was found in the cells after incubation but the
control cells contained the same amount, thus
implying that there were no oestrogen receptors.
DISCUSSION
Three epithelial cells lines derived from canine
mammary carcinomas have been described which
show tumorigenic properties in athymic nude
mice [9]. They have varied morphology but all
contain detectable fibronectin on their cell
surfaces and have the ability to grow in semi-solid
agar, producing colonies at the same efficiency.
The clones obtained seem to have identical
morphology at the light microscopic level as the
parent cells and are presently being tested for their
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Fig. 2. Phase-contrast microscopy, X100. (a) REM 134; (6)111; (c) 367; (d) epithelial strain A; (e) fibroblastic
strain.
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Fig. 3. Transmission electron micrographs of REM 134 cells, (a ) Typical cell, XI 0,000; (b) vacuole-like
structure containing particles, X71,000.
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Fig. 4. Scanning electron micrograph (SEM) of 367 cell monolayer, showing rounding and heaping of cells at
periphery, XI850.
Canine Mammary Carcinoma Cells in Vitro 1497
Fig. 5. SEM of 111 cells showing villi and blebs on rounded cells, X4000.
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Fig. 6. SEM of villous structures on cells with elongated villi in (a) REM 134 ,and bulbous structures in(b) 367;
XI 1,200 and X7000 respectively.





















Fig. 7. Incorporation of [3H^-uridine in REM 134 cells over a
24-hr period on each of four days after the addition of
oestradiol-17/2, luteotropic hormone and testosterone.
Concentrations of hormones are in ten-fold dilutions starting
at 1(T5 or KT6 M, as shown. Controls for each day with no
added hormone are also shown.
tumorigenic properties and ultrastructure. While
the REM 134 cells grew as thick even layers of cells
after reaching confluence, 111 and 367 began to
heap up at the edges of 'islands' of cells and these
had a tendency to detach from the surface,
although still viable and capable of starting re-
growth in a new flask. The pattern of binding of
lectins to the surfaces of the cell lines was not
consistent and they could not be distinguished
from the epithelial strains on this basis.
Attempts to demonstrate productive infection
with retroviruses failed despite the same methods
of induction being used as had been reported for a
canine mammary carcinoma line [5] and for
MCF-7 cells [15]. The lines are presently being
tested with anti-gp52 of a murine mammary
tumour virus [17]. In addition, an antiserum
prepared in rabbits to the membranes of REM 134
cells is being used in Western blotting to detect
similarities and differences in polypeptides eluted
from the surface of REM 134, 367 and 111,
epithelial cell strains and mammary carcinomas
themselves.
Oestrogen receptors were detected on the
original tumour from which the REM 134 cell
line was derived [13]. The tumours which gave
rise to 111 and 367 lines were not tested in this
way. A recent survey has indicated the presence of
such receptors on 61% of canine mammary
carcinomas [2]. In vitro, no receptors were
detected on the cell lines tested. However, while
367 and 111 were not stimulated by oestrogen,
luteotropic hormone or testosterone in culture,
REM 134 cells showed an increase in [3H]-uridine
uptake in the presence of oestrogen and
luteotropic hormone at physiological levels.
Thus there seemed to be a response of REM 134
cells to female hormones, although no receptor
activity could be detected. This may be due to low
levels of such receptors and an insufficiently
sensitive assay system, or to some other reason.
The rate of growth of tumours induced by the
three lines in male and female nude mice is
reported in the accompanying paper [9]
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Abstract—Three cell lines, REM 134, 111 and 367, derived from canine mammary
carcinomas have been used to induce tumours in athymic nude mice after
subcutaneous injection. The histopathology of the tumours was compared and
each was found to resemble closely the original tumour. This did not change after
serial in vivo passage. Metastasis never occurred. Injection of REM 134 cells
intracranially resulted in a fast-growing tumour which also did not metastasize;
injection intrapleurally resulted in growths most commonly on the mediastinum
with confinement to the chest cavity. Fibronectin was present in the subcutaneous
tumours. Two of the cell lines were cloned in semi-solid agar. When tested, these
clones induced tumours identical histologically to the uncloned ones. Finally, male
and female mice were injected subcutaneously with the same number of cells from
each of the three lines but the rate of tumour growth did not differ significantly
between the two sexes.
INTRODUCTION
The origin of three epithelial cell lines, REM
134, 111 and 367, derived from canine mammary
carcinomas and their properties in vitro have been
described in a previous paper [1]. This com¬
munication deals with their tumorigenicity in
athymic nude mice. REM 134 cells have already
been reported to induce tumours in nude mice and
these could be serially transplanted [2]. There was
the suggestion of a difference in the rate of tumour
growth between male and female mice and this
has been further investigated. Recently a study
was made of four canine mammary tumours in
which fragments of tissue implanted in nude mice
induced formation of tumours which could then
be serially transplanted [3]. The oestrogen
receptors of the induced tumours were assayed [4].
MATERIALS AND METHODS
Cell lines
The origin, growth and maintenance of REM
134, 367 and 111 cell lines have already been
described [1]. For inoculation into mice the cells
were removed from the surface of the culture
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vessel with trypsin-versene, washed twice in
medium, counted and re-suspended at the
required concentration in 0.1 ml saline.
Mice
CBA athymic mice, 4-6 weeks old, were
purchased from the Clinical Research Centre,
Harrow, U.K. They were kept in an isolator with
autoclaved bedding, filtered air, sterile food and
acidified water (pH 2.8). Injections of cells were
carried out subcutaneously, intracranially and
intrapleurally. Tumour diameters in two
directions (and height in some instances) were
measured using Vernier callipers, and the mice
were weighed at weekly intervals. When the
tumours reached around 2 cm in diameter or
became necrotic the mice were killed by cervical
dislocation. The tumours were excised using an
aseptic technique and, in some instances,
disaggregated with a mixture of collagenase/
dispase (Boehringer) before re-injection into
another mouse as cell suspensions or before
culturing in vitro. Part of each was fixed for
histopathology in 10% buffered formalin,
sectioned after embedding in paraffin wax and
stained with haematoxylin and eosin. Various
organs were also prepared in the same way. Pieces
of tumour were prepared for electron microscopy
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by fixing in 2.5% gtutaraldehyde and embedding
in 'Transmit' resin (Taab Ltd).
RESULTS
Initially various numbers of cells from REM
134, 367 and 111 were inoculated subcutaneously
into female athymic nude mice. REM 134 cells
were found to be highly tumorigenic, an
inoculation of 107 cells producing a solid tumour
easily visible by eye within 5 days which
continued to grow steadily until approximately
2 cm in diameter at 21 days. If 105 cells were used,
3/4 mice developed tumours. Inoculation of less
than 105 cells produced no tumour. With regard to
the other two cell lines, 1.5 X 106 cells of 367
produced visible tumours in 3 weeks and less than
1.5 X 105 cells produced no tumour, while 106 111
cells produced visible tumours in 2-3 weeks.
Metastases were never seen macroscopically. In
addition to the three cell lines, various epithelial
cell strains derived from canine mammary
carcinomas were also tested in nude mice, plus a
fibroblastic strain. None induced tumours when
injected subcutaneously at 107 cells per mouse.
Hamsters, five male and six female, injected
subcutaneously on the day of birth with 2 X 106
REM 134 cells did not develop tumours.
Subcutaneous inoculations of REM 134 cells in
nude mice produced solid-type carcinoma
formations as sub-epidermal or dermal nodules.
There was extensive cellular pleomorphism in
tumours with varying cell size and indistinct cell
outlines. Some cells stained more deeply than
others and some pyknotic cells were seen. Nuclei
were often variable in size and bizarre shapes were
seen; mitoses were commonly observed. A striking
feature was the presence of squamous metaplasia
in many parts of the tumour nodules (Fig. 1).
Central areas of larger tumours were sometimes
necrotic, with pyknotic cells sandwiched between
necrotic and viable zones. The borders of
neoplasms were irregular but well-demarcated;
however, there was no well-recognisable complete
compression capsule. In some sites the tumour
cells infiltrated into surrounding muscle or
connective tissue. Part of this effect may have been
related to the relative depth of initial sub¬
cutaneous inoculation of cells. In some tumours
there was evidence of satellite tumour nodules in
connective or muscle tissue and, not uncommonly,
tumour cells impinged on capillaries at the
periphery of tumour foci. The cells were equally
undifferentiated in both female and male nude
mice.
In some mice inoculated with REM 134 cells the
tumours invaded into the lumbar musculature
and at autopsy were found to have tumour masses
encroaching on the peritoneal cavity. In none of
these mice, howver, was there evidence of spread
of tumour to abdominal or other body organs,
either continuously or by metastasis.
Tumours induced by 111 cells were solid
aggregations of epithelial cells (Fig. 2). Although
tumour foci were well-demarcated there was only
thin and incomplete compression capsule
formation. The tumour cells did not appear to
infiltrate the surrounding tissues but the
peripheral connective tissue was well-vascularised.
In contrast to REM 134, there was no evidence of
squamous metaplasia, although areas of central
necrosis were a regular feature with the same
pyknotic cell interfaces as described above.
Cellular pleomorphism was observed but, com¬
pared with REM 134-induced tumours, cells were
more uniform. Typically, they had indistinct cell
borders with large pale, but regularly ovoid,
nuclei. Mitotic figures were common. Male and
female tumours were similar.
Murine tumours produced by inoculation of
367 cells contrasted markedly with REM 134 and
111 tumours (Fig. 3a). Tumour architecture was
typically well-organised tubular or papillary
adenocarcinoma (Fig. 3b). This appearance, as in
the case of REM 134 and 111 tumours, resembled
closely the original canine tumours. Larger
tumours exhibited central foci of necrosis and
aggregations of pyknotic cells were present at the
interface between necrotic and viable tumour
zones. Sometimes macrophage-like cells were
seen. Tumour borders were fairly well circum¬
scribed by compression capsules but the tumours
induced in male mice had less prominent
encapsulation than in females. Tumour cells had
large pale-staining ovoid nuclei with sparse
cytoplasm and indistinct cell membranes.
Mitoses were less commonly observed than in
REM 134 and 111 tumours. An interesting feature
was the fact that 367 tumours in male mice were
apparantly more differentiated and organised as
tubular elements than in female mice.
Frozen sections of tumours induced by REM
134, 367 and 111 were shown to contain
fibronectin as measured by indirect immuno¬
fluorescence (Table 1), despite the cells not
synthesising it in detectable amounts in vitro [1].
Fibronectin was also present in three canine
mammary carcinomas tested. Serial tumour
passage from one mouse to another was carried
out three times using tumours induced by REM
134, 367 and 111 cells which were excised,
disaggregated with collagenase/dispase and re¬
injected subcutaneously. In each case the
resulting tumours were the same as regards gross
morphology and histopathology as the originals.
Cell cultures derived from the disaggregated
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Fig. 1. Histopathology of tumour induced by REM 134 cells in athymic nude mouse (X160; H and E).
Fig. 2. Flistopathology of tumour induced by 111 cells in athymic nude mouse (XI60; H and E).
Fig. 3. Histopathology of tumour induced by 367 cells in athymic nude mouse (a; X160 ; H and E), showing (b)
the well-organised tubular adenocarcinoma structure (X320).
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Fig. 4. Histopathology of tumours induced by two clones of 367 cells in athymic nude mice (a, X320; b, X160
both H and E).
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Table 1. Presence of fibronectin as measured by




Mouse tumour induced by REM 134 cells +++ ++ „
Mouse tumour induced by 367 cells ++ - -
Mouse tumour induced by 111 cells +++ ++ -
Mammary carcinoma A +++ ++ +
Mammary carcinoma B ++ ++ +
Mammary carcinoma C ++ + -
+++, ++, + — degrees of immunofluorescence; - = no
immunofluorescence.
tumours yielded monolayers with the same
properties as the parent cells.
It has been reported that injection of MCF-7
mammary carcinoma cells in different sites in
athymic mice may lead to development of
tumours with different rates of proliferation and
invasiveness [5], Thus 1.5 X 106 REM 134 cells
were injected intracranially and 5 X 105
intrapleurally. A tumour was visible in the first
case on the head of the mouse within 4 days. It was
killed after 11 days, when the tumour measured
8 mm. Histological examination showed ex¬
tensive invasion of tumour cells around and below
the meninges into the brain and cranially into the
ethmoid and frontal regions of the head. The
neoplasia was anaplastic carcinoma with
squamous metaplastic foci, as observed in the
original canine tumour and the subcutaneous
murine lesions described above. Although there
was intra-cerebral growth of tumour cells, there
was no evidence of metastases elsewhere in the
mouse.
After intrapleural injection the mice were kept
for 1 month and then killed. In the case of REM
134 there was copious pleural fluid when the
mouse was opened. This was cultured in vitro and
within 48 hr there was a good growth of cells with
typical REM 134 morphology. Macroscopically,
mice inoculated intrapleurally showed friable
white nodular growths on the mediastinum and
parietal pleura, and frequently on the diaphragm.
The neoplasia appeared to originate commonly
on the mediastinum. Gross sectioning of lung
tissue showed no obvious tumour involvement of
the parenchyma or pleural surfaces.
Histologically, tumour tissue showed typical
REM 134 morphology with a marked degree of
pleomorphism, high mitotic index and bizarre
nuclei, together with early squamous metaplasia.
Where parietal pleural nidation was observed
there was neoplastic infiltration of adjacent
musculature. Tumour growth was confined to the
chest cavity macroscopically, and histological
examination of other selected organs showed no
tumour metastases.
Intrapleural inoculation of 367 and 111 cells
resulted in similar localised tumour growth
patterns but no evidence of metastatic disease was
observed. In each case the tumours induced were
characteristic of the original subcutaneous
lesions.
REM 134 and 367 cells were cultured in semi¬
solid agar and several clones grown up
individually [1]. Four REM 134 clones (2 X 105
cells of each) and three 367 (2 X 106 cells of each)
were then tested for their tumorigenicity in nude
mice by subcutaneous injection. In all cases
tumours were induced but their rate of growth
varied, a property which correlated with their in
vitro rate of growth. Histologically, the tumours
induced in mice by different clones of REM 134
were identical and similar in type to the initial
subcutaneous uncloned mouse tumours; for
example, the histopathology of two tumours
induced by two such clones is depicted in Fig. 4(a
and b).
There was some preliminary evidence to
suggest that REM 134 cells induced a slower rate
of tumour growth in male mice than in females
[2]. In addition, a response to oestrogen had been
noted with these cells in vitro, a property not
shared by the 367 and 111 cell lines [1], Thus three
male and three female mice of the same age were
injected subcutaneously with 5 X 105 REM 134
and 367 and 106 111 cells. The mice were weighed
weekly and the dimensions of any tumour formed
measured.
The area of each tumour was calculated by
multiplying the diameter measurements together.
Height was not included as it was only possible to
measure this dimension when the tumour was
large. Figure 5(a, b and c) depicts the results
obtained for male and female mice injected with
REM 134, 367 and 111 respectively. Regression
coefficients were calculated using the area of the
tumour as the dependent variable and days post-
injection as the independent. All regressions were
significant. Weighted T tests were performed with
these coefficients as independent variables
weighted by the reciprocal of the estimated
variance of each coefficient. The weighted means
for the male mice were tested against those of the
female for each of the three cell lines, giving the
results of T4 = 1.6 for REM 134, T4 = 0.33 for 111
and T4 = 0.54 for 367. None of these was
significant.
The regressions were repeated using various log
transformations (log area vs day, log area vs log
day, area vs log day) which produced improved
fits for some mice, notably two females injected
with REM 134, although for most mice the
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Fig. 5. Rate of growth of tumours in male (X X) and female (• •) athymic nude mice induced by (a)
REM 134, (b) 367 and (c) 111 cells.
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original regression gave the best fit. Thus the
weighted T test was calculated on the transformed
(log area) data for REM 134, giving T4 = 2.05,
0.1 <P<0.2. This was considered of marginal
significance only.
Calculation of the regression coefficients from
an analysis of weight of mice on days post¬
infection did not suggest any relationship with
the growth rate of tumours (data not shown).
DISCUSSION
Cell suspensions from three canine mammary
carcinoma cell lines were found to induce
tumours when inoculated subcutaneously in
athymic nude mice. These tumours were similar
in general histological type to their canine
originals, and could be passaged as cell
suspensions from one mouse to another directly
or as in vitro tissue cultures.
An interesting feature of the lines was that 367
appeared to be less aggressive, with a greater
number of cells required to induce tumour
growth subcutaneously. Morphologically, 367
tumours were better differentiated tubular or
papillary carcinomas, as opposed to the anaplastic
epithelial neoplasms induced by REM 134 and
111 cells. In all the mice inoculated, however,
there was no gross or microscopic evidence of
metastatic disease with any of the tumour types.
Some tumours induced by REM 134 showed early
infiltration of adjacent musculature but, in
common with all the subcutaneous neoplasms,
the cells were well-circumscribed by a compression
pseudo-capsule. In some cases with 134 and 111
cells there was evidence of 'pushing' expansion of
tumours but capillaries at the edge of tumours
showed no convincing evidence of tumour cells
within their lumens, as might have been expected
in early metastasis. One possible explanation for
apparent tumour-to-muscle infiltration may be
related to site of original cell inoculation such as
inadvertently seeding cells into muscular tissue
rather than subdermal areolar connective tissue.
The lack of metastasis agrees with most other
studies [3, 6, 7], although Ozzello and Sordat
report that some human mammary cell lines do
metastasize at variable frequency [8]. It might be
worthwhile allowing tumours to remain 'in situ'
for longer periods or to 'trigger' any metastatic
potential by use of agents such as collagenase.
Attempts were made to induce metastatic
disease by inoculating cells intracranially in the
case of REM 134, and intrapleurally for all three
lines. Florrid tumour growth occurred but there
was still no induction of metastatic disease.
Examination of clones of 134 and 367 prepared
by growth of colonies in semi-solid agar showed
differences in rates of growth in mice but
histologically the tumours induced had no well-
defined differences from the originals. Ultra-
structural examinations have so far yielded no
further explanation for the different growth rates.
Initial studies [1] showed that the cell lines
exhibit no hormone receptors when subjected to
standard receptor assay; this is in contrast to the
findings of Thomas et al. [4], who reported the
presence of oestrogen receptors in four solid cell
lines which grew in nude mice. In vitro studies for
REM 134 cells indicated an increased growth rate
in the presence of oestrogen and luteotropic
hormone [1], and some preliminary work showed
that there may be a difference in growth rate of
tumours induced by REM 134 cells in male and
female mice [2]. However, the present results,
using larger numbers of mice and statistical
analysis, showed that there was no significant
difference in growth rate between males and
females. It is possible that any hormone receptors
present on the original canine tumours from
which the cell lines were derived may have been
masked or lost during passage, and the apparent
response of REM 134 cells in vitro due to some
other factor. To clarify this matter, we are
currently testing the effect of tamoxifen, an anti-
oestrogenic agent, on growth rate of REM 134
cells in vitro and tumour induction in male and
female nude mice.
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SUMMARY
Tumours were induced in CBA athymic nude mice by subcutaneous
injection of REM 134 cells. These cells were from a continuous line
derived from a canine mammary carcinoma and have no detectable
oestrogen receptors. In vitro, the anti-oestrogen tamoxifen was
_6 _g
growth inhibitory at a concentration of 10 M and adding 10 M
oestradiol-17|> did not reverse this effect. The relative rate of
growth of the tumours induced by the cultured cells was the same in
male and female mice. Oral tamoxifen at a dose of 1 mg/mouse/week
suppressed the growth rate significantly and to the same extent in
male and female mice; subcutaneous tamoxifen at 2 mg/mouse/week had
no significant effect. These results argue against tamoxifen acting
solely as an antagonist for oestrogen.
INTRODUCTION
Tamoxifen, one of the synthetic triphenyl-ethylene compounds,
has been used as a specific anti-oestrogen for the past 10 years in
the treatment of both locally advanced and disseminated breast cancer
in post-menopausal women (Mourisden et al,1979). More recently a
trial was undertaken to study the effect of tamoxifen in all women
undergoing mastectomy for early breast cancer (Nolvadex Adjuvant
Trial Organization, 1983). A significantly prolonged disease-free
interval and survival was found in both pre- and post-menopausal
women and in cases with and without lymph node metastasis. It is
thought that tamoxifen exhibits its anti-tumour activity through
binding to the specific oestrogen receptor protein (ER) in the
cytoplasm of some breast tumour cells (Furr et al, 1979)although the
exact mode of action is unknown. Originally in several surveys,
mostly involving small numbers of patients, it was found that 47% of
ER-negative tumours responded completely or partially to tamoxifen
treatment (reviewed in Patterson et al, 1982). This latter figure
casts some doubts on the ER hypothesis,.and in the Nolvadex Trial
mentioned already, no correlation was found between ER status and
response to tamoxifen treatment.
Tamoxifen studies in various animal species show that its effect
varies from species to species; in mice it is thought to be a full
oestrogen agonist (reviewed in Patterson, 1981).
In dogs there is little recorded information as to the action of
tamoxifen in normal or tumour-bearing bitches. In a pilot study
carried out by one of the authors (RWE, unpublished results) the use
of oral tamoxifen was found to be useful in bitches with ER-positive
tumours but a major disadvantage was the production of endometrial
hyperplasia with vaginal discharge in entire females. Another study
on the use of tamoxifen for post-mastectomy therapy in bitches is
currently in progress in South Wales (Pierrepoint, personal
communication).
A cell line, REM 134, derived from a spontaneous primary
canine mammary carcinoma has been described (Else, Norval and Neill,
1982). Its in vitro properties have been investigated (Norval,
Maingay and Else, 1984a) and its ability to induce tumours in athymic
nude mice (Norval, Maingay and Else, 1984b). The cells had no
demonstrable oestrogen receptors, and the rate of tumour growth did
not differ between male and female nude mice. An investigation was
undertaken to ascertain the effect of tamoxifen and the mode of
administration on tumour growth in this system in the hope of
elucidating the mechanism of action of tamoxifen in vivo.
MATERIALS AND METHODS
Mice
CBA athymic nude mice, 4-6 weeks old, were purchased from the
Clinical Research Centre, Harrow. The mice were kept in an isolator
with autoclaved bedding, filtered air, sterile food and acidified
water (pH 2.8). Cells were injected subcutaneously into the centre
of the back. Tumour diameters in 2 directions were measured using
vernier callipers. The mice were weighed weekly. When the tumours
became necrotic or reached around 2 cms in diameter, the mice were
killed by cervical dislocation. Tumour tissues were weighed and fixed
for histopathology in 10% buffered formalin, together with selected
organs prior to processing as paraffin and resin block sections.
Tamoxifen
This was a gift from ICI Ltd., Alderley Park. Just before use,
it was weighed and suspended with Vortex mixing in 10% w/v sucrose in
0.01M phosphate buffered saline, pH 7.2 (PBS) at a concentration of
0.5, 1 or 2 mg/O.lml. 0.1ml was injected into the mice
subcutaneously or given orally, by introduction into the back of the
throat using a small canula, once per week.
Cells
REM 134 cell line was derived, cultured and maintained as
already described (Else, Norval and Neill, 1982). For inoculation
into mice, the cells were prepared as outlined in Norval, Maingay
and Else, 1984b. To measure the effect of tamoxifen in vitro, 5 x
3
10 cells were inoculated into wells of 96-well microtitre plates
(Nunc) in 0.2 ml medium containing 1% foetal calf serum. Tamoxifen,
dissolved in ethanol at a concentration of 1 mg/ml, then diluted in
medium, was added to give final concentrations of 10 10 ^ and
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10 M. One pCh H-thymidine (Amersham) was added to 12 wells of
each concentration of tamoxifen and 12 wells containing no
tamoxifen. The plates were incubated at 37°C in 5% humidified
atmosphere. Twenty four-hours later the cells were harvested using
an Ilacon Harvester on to glass fibre discs which were washed in
water, cold 10% trichloroacetic acid, and ethanol before being
counted in PPO-toluene scintillator in a Packard scintillator
3
counter. H-thymidine was added to further sets of wells after 1,2,3
and 4 days and the cells harvested after 24 hours. In addition,
_8
10 M oestradiol-17jj was added to 1 set of wells in the presence of
0
10 M tamoxifen. The mean of the 12 counts was taken for each time
point, the standard error of the mean being within 10% of the mean in
all cases.
RESULTS
The response of REM 134 cells in vitro to tamoxifen was first
ascertained in case the cells were resistant to the drug. It was
found that growth of REM 134 cells was inhibited by 10 ^M tamoxifen as
3 -7
measured by the uptake of H-thymidine. At 10 M growth was slowed,
and at lower concentrations no difference was found when compared to
_8
cultures without tamoxifen. Adding 10 M oestrogen-17p did not alter
__6
the response to 10 M tamoxifen. These results are shown in Fig.l.
It was not possible to measure cell growth by counting numbers of
viable cells as the REM 134 cells clumped together after removal from
the culture vessel, even in the presence of 0.1% trypsin.
From previous experiments it was already known that REM 134
cells at numbers over 10^ induced subcutaneous solid-type carcinoma
tumours in CBA nude mice and the rate of tumour growth in 3 male and
3 female mice did not differ significantly (Norval, Maingay and Else,
1984b).
In the first experiment, 11 male and 10 female CBA nude mice
were injected subcutaneously with 5 x 10^ REM 134 cells. Five days
later 1 group of 3 or 4 mice of each sex was treated orally with 0.5
mg tamoxifen, another group with 1 mg and the third was given no
tamoxifen. Tamoxifen was given weekly thereafter, to appropriate
groups, and tumour dimensions were measured twice weekly starting on
day 20 and finishing on day 76. The results are shown in Fig. 2a, b
and c, the area of the tumours being calculated by multiplying the
two diameter measurements together.
From inspection of the graphs, it may be seen that growth rate of
tumours was depressed in the group of mice given 1 mg tamoxifen weekly
by the oral route while 0.5 mg tamoxifen had an equivocal effect.
There was rather a widespread response by the group of control mice
which made statistical analysis of these results unsatisfactory. It
was possible to determine the effect of sex on the growth rate of
tumours using regression coefficients calculated with days
post-injection as an independent variable and area of tumour as a
dependent variable and performing an analysis of variance. No
significant difference was found between the sexes. The weights of
the male and female mice in the tamoxifen groups were the same as in
the control group throughout the period of the experiment (data not
shown).
A second experiment was completed in which 12 CBA male and 12
female mice were injected subcutaneously with 2.5 x 10^ REM 134
cells. Starting 4 days later, 1 group of 4 mice of each sex was
treated orally with 1 mg tamoxifen per week, a second with 2 mg
injected subcutaneously, and a third was given no tamoxifen. Tumour
measurements were started on day 11 and then weekly till day 36. The
results are depicted in Table 1.
Coefficients were calculated from individual regressions of days
post-injection against area of tumour (with zero intercept). They
were used as independent variables in analyses of variance with 2
grouping factors, treatment and sex. The first analysis compared
the control group and 1 mg oral dose group and the second the control
group and 2 mg subcutaneous group. The results show that sex was not
a factor in determining growth rate of tumours, as had already been
found in the first experiment. Analysis of the control group and 1
mg oral dose group show a difference just below significance between
the means of the 2 groups (F value 3.97; probability 0.087). There
was no significant difference between the means of the control group
and the 2 mg subcutaneous dose group (F value 0.51; probability 0.49).
Thus, bearing in mind the difficulty in finding a regression
formula which adequately described the growth of tumours in all the
mice and the rather variable growth responses in the control group, a
dose of 1 mg tamoxifen given orally was considered to reduce the
growth rate of the tumours to a significant extent. Weights of mice
in both tamoxifen groups did not differ from the control mice.
Histopathological examination was made of haematoxylin and eosin
stained tumour sections from mice treated with tamoxifen and compared
with sections from control tumour-bearing mice. In addition,
selected organ sections (liver, kidney, spleen, lungs, brains,
ovaries and uterus) were compared. There was variation in degrees
of central necrosis in all groups depending on the size of the tumour
mass, but there was no obvious difference in tumour morphology or
body distribution between tamoxifen treated groups and controls.
Similarly, siting of tumour borders below the epidermis relative to
the superficial dermal muscle bundles varied amongst individuals
within each treatment group but not between groups. This variation
was probably directly attributable to the site of the original
inoculation.
In none of the treatment groups was inflammatory cellular
infiltration a feature. Tumour borders were usually well-defined by
a compression pseudo-capsule except in some large control tumours
which had become ulcerated. There was no evidence of capillary or
lymphatic permeation by tumour cells in the area surrounding tumours,
and no change in vascularity of tumours in treated and control
groups. A difference in tumour cell morphology was not noticed
between groups. Cellular pleomorphism was equally marked in all
groups and the mitiotic index of tumours was similar.
Examination of sections of organs showed no evidence of
metastatic tumours in either control or treated mice. Some
variation in ovarian and uterine histology was seen in different
treatment groups; these results are to be reported elsewhere.
DISCUSSION
In recent months it has been a matter of some debate whether
tamoxifen acts solely through binding to cytoplasmic oestrogen
receptors or whether it may have additional targets (Baum, 1984).
This is of importance when considering treatment of patients who have
breast cancer and who have differing menopausal, nodal and ER status.
Apart from acting as an oestrogen antagonist, several other theories
have been advanced to explain the mechanism of action of tamoxifen,
especially in women who are ER negative. In the first place, an
anti-oestrogen binding protein has been described in human tissues
which is larger than ER and ubiquitous, unlike ER (Sutherland et al,
1980). This protein binds tamoxifen with high affinity, while
oestradiol competes weakly for the same site. A similar
anti-oestrogen binding site distinct from the oestrogen receptor has
also ' been identified in rat tissue (Sudo,Monsma and
Katzenellenbogen, 1983). It is present in the microsomal fraction
and distributed widely, its level not ' paralleling that of the
oestrogen receptor. Secondly it is possible that growth factor
activity may be altered by tamoxifen binding, as suggested by Baum
(1984). The cell membrane may be changed, thus influencing the
ability of the cells to respond to other hormones like insulin,
pituitary hormone, growth hormone and, perhaps most significantly,
prostaglandins. Tamoxifen inhibits synthesis of prostaglandins in
vitro (Ritchie, 1978) and less prostaglandin may inhibit growth of
tumour cells in vivo while increasing the immune response.
Only a few reports on the oestrogen receptor status of primary
mammary tumours in dogs have been published (Hamilton, Else and
Forshaw, 1977; D'Arville and Pierrepoint, 1979;- MacEwen, Patnaik,
Harvey et al, 1982). These studies have confirmed that between 50-60
per cent of primary tumours are ER-positive and that the majority of
such tumours are histologically benign although the correlation
between ER-positivity, tumour type and survival is not clear-cut.
Virtually nothing is known concerning the effects and mode of action
of tamoxifen in tumour-bearer or post-mastectomy bitches.
In this study, a canine mammary carcinoma cell line REM 134,
which has been well characterized has been used to examine the effect
of tamoxifen on tumour growth in athymic nude mice. Addition of
tamoxifen at a concentration of 10 ^M to REM 134 cells cultured in
vitro had a growth inhibitory effect. At 10 ^M it was cytotoxic and
this was not reversed by.oestradiol-17p> . Human mammary carcinoma
cell line, MCF-7, has been shown to respond to tamoxifen in several
ways. At low concentrations there was evidence of oestrogen agonism
but at higher concentrations tamoxifen suppressed progesterone
receptor synthesis and cell growth and behaved as an oestrogen
antagonist (Horwitz, Koseki and McGuire, 1978). In this respect our
observation that tamoxifen in bitches may produce an exaggerated
progesterone-like effect culminating in endometrial hyperplasia is
relevant. Other groups have also showed suppression of MCF-7 cell
growth, reduction of plasminogen activator activity and suppression
of progesterone receptor levels (Coezy, Borgna and Rochefort, 1982;
Katzenellanbogen et al, 1984). MCF-7 cells contain ER, but REM 134
cells have no detectable ER or progesterone receptors. While it is
possible that these receptors may be present at a level below the
sensitivity limit of the assay system, it seems more probable that
tamoxifen is acting by some other mechanism in the REM 134 cells.
In vivo REM 134 cells v induced tumours when injected
subcutaneously into athymic nude mice. These tumours were solid
type carcinomas formed as sub-epidermal or dermal nodules, were
undifferentiated and did not metastasise (Norval, Maingay and Else,
1984b). No difference in growth rate was found between male and
female mice, thus indicating that oestrogen receptors are probably
not important in this system. Tamoxifen given orally at a dose of 1
mg/week reduced the growth rate of tumours; 0.5 mg/week had no
effect, nor did 2 mg/week administered by subcutaneous injection.
Both sexes gave the same results.
Thus we have shown that oral tamoxifen inhibits growth of mammary
tumour cells in athymic nude mice, and that the mechanism of action is
unlikely to be by tamoxifen acting as an oestrogen antagonist. The
route of administration of the drug appears to be important and
subcutaneous injection presumably does not allow circulation to organs
or to the tumour site where tamoxifen exerts its effect. These
results may have some significance for the treatment of women with
breast cancer and lend some further support to the concept that
tamoxifen may act both in vivo and in vitro by more than one
mechanism.
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TABLE 1. Area of tumours (cm x 10 ) induced by REM 134 cells
in athymic mice treated with tamoxifen.
Days post-injection
11 18 25 32 36
23 64 106 171 204
Male mice 29 69 109 161 202
22 38 75 165 169
21 43 76 164 198
No
tamoxifen
18 43 48 74 130
Female mice 22 61 88 103 122
22 49 80 136 156
32 78 138 267 440
17 37 61 106 119
Male mice 17 48
14 28 81 95 110
1 mg tamoxifen 22 37 78 119 116
weekly,
given orally
17822 41 97 147
Female mice 14 25 25 44 44
12 28 50 62 77
18 40 67 106 110
18 64 99 154 156
Male mice 10 24 33 58 59
19 49 94 126 167
2 mg tamoxifen 23 57 82 139 137
weekly,
given sub-
cutaneously 18 62 102 151 172
Female mice 18 46 96 193 233
15 48 52 100 133
14 56 81 121 126
FIGURE LEGENDS
Fig 1. Mean counts per minute incorporated into REM 134 cells
during incubation in the presence of 10 ^M tamoxifen (• • ),
—6 —8 —7
10 M tamoxifen and 10 M oestradiol-17 p> (o——-o), 10 M
—8
tamoxifen (A -A), 10 M tamoxifen (A A), and no tamoxifen
3
H-thymidine was added on day 0, 1, 2, 3 and 4 and
cells were harvested 24 hours later.
Fig 2. Area of tumour at various times after subcutaneous injection
with REM 134 cells; (a) no tamoxifen given, (b) 0.5 mg
tamoxifen weekly given orally, (c) 1 mg tamoxifen weekly given
orally.
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Characteristics of a feline mammary carcinoma cell line
M. NORVAL, J. MAINGAY, Department of Bacteriology, University of Edinburgh, Medical School,
Teviot Place, Edinburgh EH8 9AG, R. W. ELSE, Department of Veterinary Pathology, Royal (Dick)
School of Veterinary Studies, Summerha/I, Edinburgh QEH9 IQH
The establishment of an epithelial cell line, jm, from a
feline mammary adenocarcinoma is described. In
vitro, the morphological and cultural properties of
these ceils, their surface features such as lectin
binding and their response to hormones were ascer¬
tained. In vivo, they are tumorigenic in athymic nude
mice inducing tumour nodules composed of epithelia-
like cells.
STUDIES have been made on cell lines derived from
mammary carcinomas in several species, such as
mouse (Owens and Hackett 1972), dog (Owen et al
1977) and man (Soule et ai 1973). Such cells have been
investigated morphologically and their response to
various hormones, hormone receptor status and
tumorigenicity in experimental animals assayed.
These cells may provide 'in vitro' models for testing
steroid hormone and other related drugs used in
treatment of mammary carcinomas.
With regard to the cat, Dorn et al (1968) stated that
mammary tumours were the third commonest of all
feline neoplasms. In a comparative review of
mammary neoplasia, Hamilton (1974) found that
these tumours occurred in domestic cats half as often
as in bitches. Most female cats, in Britain at least, are
subjected to ovariohysterectomy at, or soon after,
puberty (five to six months old), thereby minimising
any ovarian influence on mammary tissue. However,
Hamilton et al (1976) reported that the majority of
feline mammary carcinomas showed no demonstrable
oestrogen receptor activity.
Nearly all mammary tumours in the cat are
carcinomas (80 per cent, R W. Else, personal observa¬
tions) and the most common type is the adeno¬
carcinoma (Havden and Neilsen 1971). The
carcinomas resemble those occurring in women in
being highly aggressive. They rapidly metastasise to
multiple visceral sites and, although bone metastases
are unusual (Kas et al 1970), Weijer et al (1972) have
suggested that feline mammary carcinoma is a
valuable comparative intermediate model between
mouse and man. Little recent work, however, has
been, done to investigate further the cat model,
particularly with regard to studies of metastasis.
In this paper, a description is given of the origin of a
cell line called jm which is derived from a feline
mammary carcinoma. Its morphological properties,
surface features, response to hormones and tumori¬
genicity in athymic nude mice are characterised.
Material and methods
Clinical material and primary culture
Pieces of mammary tumours were obtained from
cats undergoing euthanasia or surgery. Within two
hours, small fragments were disaggregated in col-
lagenase/dispase (Boehringer) for one to two hours at
37°C. The single cells were washed and suspended in
tissue culture medium. Eagle's minimal essential
medium supplemented with 100 iu ml-1 penicillin,
200 pg ml"1 streptomycin, 50 iu ml"1 fungizone,
100 jig ml"1 gentamicin and 10 per cent fetal calf
serum. Incubation was carried out at 37°C in an
atmosphere of 5 per cent carbon dioxide in air using
Falcon flasks (Flow) with loose caps. After Five days,
the medium was changed. If the culture became
confluent, the cells were passaged using trypsin-
versene. Gentamicin and fungizone were then omitted
from the medium.
In vitro properties of jm line
Specimens were prepared for transmission electron
microscopy and chromosome spreads made as out¬
lined by Else et al (1982). Doubling time and colony
formation in semi-solid agar were also performed as
described by Else et al (1982). Fibronectin content,
binding of lectins labelled with fitc, induction of
retrovirus and response to stimulation by various
hormones were all measured as outlined by Norval et
al (1984a).
For transfection experiments, high molecular
weight dna was prepared from jm cells using the
method of Balmain and Pragnell (1983). Transfection
of NIH3T3 and C-127 cells with dna at concentra¬
tions of 30 jig ml-1 and 10 jig ml-1 was carried out,
whereby 1 ml of dna-calcium chloride coprecipitate
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TABLE 1: Binding of FITC-lectins to cell cultures as measured
by direct immunofluorescence
Epithelial Epithelial
jm cells cells A cells B
pna -
gs-i + +
gs-l + D-gal —
8sa-ii + + +
oba + +






rca -r D-gal -
wga + + +
uea
uea -i- L-fuc -
Con A + + +
Con A + D-man +
Con A + D-glc +
lpa +
pna Arachis hypogaea agglutinin
3sa-ii Bandeiraea simplicifolia agglutinin
s8a Glycine max agglutinin
rca Ricinus communis agglutinin
uea Ulex europaeus agglutinin
gs-i Bandeirea simplicifolia agglutinin
dba Dolichos biflorus agglutinin
mpa Madura pomifera agglutinin
wga Triticum vulgaris agglutinin
Con A Concanavalia ensiformis agglutinin








. + + and + Degrees of immunofluorescence
were induced as measured by incorporation of 3H-
uridine into particles with the density of l-16tol-18g
ml"'. Recently, many cell cultures derived from
tumours have been tested for the presence of onco¬
genes by the ability of their dna to transform N1H3T3
cells or C-127 cells (Pulciani et ai I9S2). However,
using dna purified from jm cells at pass 8, no foci of
transformed cells was obtained and thus no evidence
of oncogene involvement found.
The athymic nude mouse has proved an excellent
experimental model for the induction of tumours and
has been used, for example, in studies on the onco¬
genicity of various canine mammary tumour cell lines
(Norval et al 1984b). Cells from jm cultures were
inoculated subcutaneously into four-week-old cba
Nu/Nu mice. In three out of three mice inoculation of
3X106 cells produced tumours of about 0-4 cm
diameter within two weeks which continued to grow
steadily until the mice were killed a month later. An
inoculum of 106 cells led to the formation of a visible
tumour in one out of two mice in one month. 107 cells
of epithelial strain A or B injected subcutaneously
into two mice each did not produce visible tumours
and subsequent histological examination when the
mice were killed two months later was negative for
neoplasia.
Paraffin wax and plastic resin sections of tumours
induced by jm cells showed tumour nodules
composed of epithelia-like cells. The borders of the
tumours were completely circumscribed by compres¬
sion pseudocapsules but, in several sites, there was
evidence of infiltration of cells into adjacent sub-
dermal musculature (Fig 5a). In general the tumour
cells were characteristically anaplastic (Fig 5b),
although some sites showed differentiation into
tubular elements (Fig 5c) which closely resembled the
original feline tumour.
Discussion
Out of 30 pieces of tumour obtained from feline
mammary carcinomas, one yielded cells on culture
which had the characteristics of transformed cells.
These cells were epithelial in morphology at the light
and electron microscope level, and sometimes formed
into acinar arrangements as though mimicking their
in vivo growth properties. The karyotype did not
show any consistent abnormality such as in chromo¬
some number or translocation. The jm cells had the
ability to grow in semi-solid agar which has been
suggested as a reliable characteristic of most tumori-
genic ceils (Chen et al 1976). Clones produced by this
method had the same morphology as the parent cells.
Lectins labelled with fitc were used to examine the
quantity and type of glycoproteins on the surface of
jm cells and to compare these with two epithelial cell
strains also derived from feline mammary
carcinomas. Three differences in binding were
detected. The significance of this finding will have to
await the isolation of more tumorigenic feline cell
lines, and an analysis of antigens on the surface of jm
ceils, both of which are being undertaken by the
authors.
No retrovirus-like particles were observed on
electron microscopy or after attempted induction
with several agents. In addition no oncogenes were
detected using the NIH3T3 and C-127 transformation
systems. There have been reports of retroviruses
being associated with mammary carcinomas cultured
from various species, such as murine (Fine et al 1974),
canine (Watrach et al 1978) and human (McGrath et
al 1974). However, apart from the first example where
murine mammary tumour virus is well established as
the aetiological agent of the carcinoma, consistent
evidence has not been produced to support the
involvement of retroviruses in the other species. In
addition, oncogenes have not been demonstrated in
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FIG 5: Histopathology of tumour induced by JM cells in an athymic nude mouse
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FIG 1: Macroscopic (above) and histological (H&E x 400) (below) appearance of feline mammary tumour from which JM cell
line was derived
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FIG 2: Phase contrast microscopy of JM cells in vitro at passage 6. x 100
was added to 15 ml medium for a 75 cm2 flask contain¬
ing 3 x10s actively growing recipient cells (Campo
and Spandidos 1983). dna prepared from SV-40 was
used as a positive control and salmon sperm dna as a
negative control. The cultures were observed for three
weeks, changing the medium every third day.
Mice
Female cba athymic mice, four to six weeks old,
were purchased from the Clinical Research Centre,
Harrow. They were kept in an isolator with auto-
claved bedding, filtered air, sterile food and acidified
water (pH 2-8). Injections were carried out sub-
cutaneously. When the tumours reached around 2 cm
in diameter, the mice were killed by cervical disloca¬
tion. Tumours were excised and part of each fixed for
histopathology in 10 per cent buffered formalin,
sectioned after embedding in paraffin wax and
stained with haematoxylin and eosin.
Results
Tissue from mammary carcinomas of 30 cats
undergoing euthanasia or surgery was disaggregated
and put into culture. In most cases, there was some
cell attachment and growth initially but confluent
monolayers did not form and the cells eventually
rounded, detaching from the surface. However with
four tumours this did not happen; the cells grew well
and could be passaged. Two cultures yielded cell
strains with epithelioid morphology called A and B,
and one with Fibroblastic morphology, all of which
were used for comparison throughout. The fourth
culture yielded the cell line jm which was derived from
a highly malignant tubular adenocarcinoma (Fig 1).
with Fibroblastic morphology, all of which were used
for comparison throughout. The fourth culture
yielded the cell line jm which was derived from a
highly malignant tubular adenocarcinoma (Fig 1).
Histologically, the tumour was poorly circumscribed
with Fibrosis around neoplastic tubular formations
and aggregations of macrophages with sparse
numbers of lymphocytes and plasma cells were
observed frequently at the borders of tumour lobules.
In vitro, jm cells formed distinct epithelial islands
(Fig 2). They were passaged over 30 times with no
change in morphology. On transmission electron
microscopy they showed epithelia-Iike cell mor¬
phology (Fig 3a) with irregular nuclear outlines,
some lipid accumulations and vacuole structures
(Fig 3b). One clump of cells showed an acinar
arrangement with small villiform processes projecting
into the lumen (Fig 3c) but this was not a common
feature. The cell surfaces exhibited only sparse
numbers of short microvilli. No viral particles were
observed.
Chromosome preparations were made of jm cells at
passage 5. They contained 38 to 42 chromosomes with
abnormalities including translocations, dicentrics and
fragments. One karyotype, depicted in Fig 4, had 39
chromosomes including one abnormal chromosome
and an additional fragment.
The doubling time of jm cells in 10 per cent serum
A7. Norval, 7. Maingay, R. W. Else
(b)
FIG 3: Transmission electron micrographs of JM cells at passage 6
(a) Typical cells, x 3500
(b) Internal vacuole structure, x 23,100
(c) Acinar arrangement of cells, x 34,400
(c)
Feline mammary carcinoma cell line 161
Ubchr
at ill S § $ a £ s § A-1
B - 2 (lAbchr)
'-.ft ■ • t - 2
'
lui IS li u * i F ♦ 2
♦ Frog
. c D ' ■
♦ Frag
fit «t I« •• M « a





fig 4: Karyotype of a jm cell showing 39 chromosomes
was 48 hours, and 96 hours in 1 per cent serum. These
times remained unaltered throughout 30 passages in
vitro. jm cells were also tested for their ability to form
colonies in semi-solid agar. Cells from passage 4 were
suspended in medium containing 0-25 per cent
agarose. Colonies were formed, visible by eye, after
21 days incubation at a cloning efficiency of 4 per
cent. Epithelial strain A and the fibroblastic strain did
not form colonies, while epithelial strain B formed
very small colonies at an efficiency of less than 1 per
cent, just visible by eye after 21 days. The jm clones
were picked using a micropipette and cultured
separately. At the light microscope level and from
measuring rate of growth, they did not differ from the
parent cells.
The cell surfaces were examined for fibronectin
content using an indirect immunofluorescence tech¬
nique (Norval et al 1984a). jm cells showed positive
immunofluorescence as did the two epithelial cell
strains, fibronectin being present in about the same
quantity as measured by dilution of the antiserum to
fibronectin. Sugars on the cell surface were studied
using a direct immunofluorescence test with 11 lectins
labelled with fitc (Norval et al 1984a). Wherever
possible the specificity of the binding was demon¬
strated by a reduction of immunofluorescence in the
presence of the sugar to which the lectin binds. The
results are shown in Table 1 where it may be seen that
jm cells were generally the same as for the two epi¬
thelial cell strains with three exceptions, in two cases,
sba and dba, both of which have specificity for
N-acetyl D-galactosamine, the lectin was bound to jm
cells and not to the two epithelial cell strains, while
with rca-i which has specificity for B-linked
D-galactose, the converse was true.
If the jm cells were treated with 5-iodo-2'-deoxy-
uridine followed by dexamethasone, with proges¬
terone or with luteotropic hormone, no retroviruses
NIH3T3 system while they are present in some human
carcinomas of the colon, lung and pancreas (Pulciani
et al 1982).
The jm- cells were tumorigenic in cba athymic
nude mice, the tumours produced being similar in
histopathology to the original feline tumour. If such
tumours were excised, disaggregated with col-
Iagenase/dispase and cultured in vitro, they pro¬
duced cells with the same morphology and pattern of
growth as the original jm cells. It will be interesting to
look at hormone receptors in these cells, tumour
induction in male nude mice and to study the effects
of antioestrogenic compounds like tamoxifen.
As far as the authors know, this is the first tumori¬
genic feline mammary cell line to be described and, in
view of the similarities in the nature and biological
behaviour of feline and human breast carcinomas,
further study of these cells should yield information
of comparative significance.
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Association of toxin-producing fungi with
disease in broilers
J. ROBB. MSc. East of Scotland College ofAgriculture. Kings Buildings. West Mains Road. Edinburgh. K. S. KIRKPATRICK,
MRCVS. BVMS. D. B. Marshall (Newbridge) Ltd. Newbridge. Midlothian. M. NORVAL. PhD. BSc. Department of Bacteriologyr
University of Edinburgh Medical School. Tcviot Place. Edinburgh
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An episode of suboptimal growth, poor feathering and
behavioural abnormalities in broilers in Scotland during the
winter of 1980-81 is described. This was considered to be
associated with mould-contaminated maize and wheat com¬
ponents of the feed, from which fusaria were isolated in
persistently high numbers. Four species. Fusarium culmorum,
F tricinctum. F nivale and F moniliforme, were identified.
Chloroform extracts of the raw materials and of an artificial
medium in which three of the Fusarium species were cultured
proved toxic to tissue cultures of a human epithelial cell line
(HEp II). Specific identification by thin layer chromatography
of the mycotoxins deoxynivalenol, zearalenone and diacetoxy-
scirpenol was achieved in some extracts. In addition, several
other areas of the chromatograms were found to be toxic in the
HEp II cell system and these may contain toxins for which
standards were not available or, alternatively, previously un-
characterised fungal metabolites. It was concluded that the
toxins produced by the fusaria were major contributing factors
to the disease symptoms shown by the birds.
IN 1960 there was an outbreak of aflatoxicosis (turkey X
disease) in poultry in Britain (Butler 1973). Thousands of
turkeys died after eating rations containing groundnut meal
contaminated by Aspergillus flavus which had produced
aflatoxin. Since then no mycotoxin-associated disease episode
in any animal species has been described, despite these meta¬
bolites being present in some types of animal feedstuffs
(Roberts and others 1975). However, it has been reported that
mycotoxins of the trichothecenes group, which are produced
by various Fusarium species, may be involved in altered
feathering and reduced growth in poultry (Wvatt and others
1973). There is. therefore, the potential for these compounds
to affect bird performance, especially where dietary para¬
meters are closely controlled.
An episode of toxin-related disease seen in broilers in
Scotland during the winter of 1980-81 is reported here. The
subsequent investigation indicated that the presence of
mycotoxins in some components of the feedstuffs may have
been the major contributing factor.
Clinical symptoms
In general, the flocks were kept in groups of 18.000 in houses
of approximately 10.000 square feet floor area. All were warm
air brooded in part of the house only (3500 square feet) and
were fed standard broiler diets supplied from one mill.
The time of onset of clinical signs varied but on several
occasions was in five-dav-old chicks. Affected chicks showed a
high level of excitability, excessive activity, high pitched
chirping and wall-pecking. There was a tendency for birds to
stand in groups and some individuals within groups stood
passively allowing their toes to be pecked. Examination
revealed that a number of these birds were suffering from
varying degrees of vasoconstrictive damage to one or more
toes, with well defined dry necrosis being evident in most
cases. Ultimately, sloughing of the affected toes took place.
There was a general lack of interest in food within these
groups and selective feeding was evident. Small birds and toe
damaged birds were the least inclined to eat and therefore the
size distribution of birds within the house widened. Mortality
in the first and second weeks was 1 per cent and 0-5 per cent
respectively above normal levels, and post mortem examina¬
tions revealed dehydrated birds with slightly enlarged livers
and grossly distended gall bladders. A variety of colours was
present in the livers but no significant or characteristic
histopathological feature was present.
During the second to fourth week of life, uneven growth was
apparent within the affected flocks and up to 10 per cent of
small poorly feathered birds were detected. These birds were
well muscled with pendulous abdomens; feather growth was
slow and feather quality poor. On culling and post mortem
examination, the only regular finding was an obvious thicken¬
ing of the cartilage growth plates, particularly in the long bones
of the legs. The birds appeared rickety but this was not
confirmed histologically.
Individual birds with nervous involvement associated with
head tremors were detected in several flocks and, on two
occasions, about 10 per cent of two. four-week-old flocks
suffered acute incoordination and collapse with loss of the
righting reflex. The episode occurred four to six hours after the
introduction of a new batch of feed. Gradual recovery of
affected birds took place over 12 hours with very limited
mortality being recorded.
Periods of excessive thirst, soft dropping and an increase in
the level of faecal fat excretion were seen in all affected groups.
Between five-and-a-half and eight weeks of age. some degree
of compensatory growth occurred in most flocks. However,
the variability in bird size with unacceptably high food con¬
sumption continued to be apparent at the end of growout.
In a comparative feed trial using known toxic feed and a
normal research diet of similar nutrient specification, the
weight achievement of test chicks to 14 days of age was 56 per
cent that of the control group.
Microbiological tests
No pathogenic bacteria were isolated from the necrotic toe
lesions, from the small culled chickens or from the feed. In
addition, the disease could not be reproduced by taking whole
intestines and contents from affected birds and inoculating a
homogenate of these into the crops of one-dav-old broiler
chicks using the method described by Kouwenhoven and
others (1978). Nor did the disease appear to have the charac¬
teristics of horizontal spread caused by an infectious agent.
Its geographical distribution and speed of onset seemed to
indicate that it was feed associated.
Feed from affected houses was examined for the presence of
fungi. Samples were diluted with Ringer's solution and surface
plated on potato dextrose agar, malt extract agar and half
strength trvptone soya agar supplemented with casein hydro-
lysate. Incubation temperatures were 25°C, 37°C and 55°C
respectively.
Fusarium species, between 105 and 10h/g, were isolated; the
normal numbers found in this part of Britain are about 10" to
104/g. Four species were identified: Fusarium culmorum, F
tricinctum. F nivale and F moniliforme. with the latter pre¬
dominating. It is known that many Fusarium species have the
ability to produce various toxic metabolites and therefore the
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presence of an abnormally large population of these organisms
indicated the potential for the production of significant toxins.
Mycotoxin testing
Feedstuffs
Feedstuffs and their individual components were examined
for the presence of toxins and for toxigenic capacity. In all the
analyses. 25 g samples were extracted according to the method
of Patterson and Roberts (1979) and the concentrated chloro¬
form and aqueous extracts were analysed by thin layer chroma¬
tography using Patterson and Roberts' standards plus deoxyni-
valenol. The trichothecenes diacetoxyscirpenol and deoxy-
nivalenol were positively identified in the maize and wheat
components of the feedstuff. This was later confirmed by gas-
liquid chromatography.
In addition, biological assay of the extracts using a human
epithelial cell line (HEp II) as an indicator system was
performed, in a similar manner to that described by Saito and
others (1971). The cells were grown on coverslips in 1 ml
Earles-based Eagle's complete medium supplemented with
5 per cent new born calf serum. 200 iu/ml penicillin and 200
/xg/ml streptomycin until semiconfluent. Thereafter small
aliquots (0.5, 1 and 2 fx 1) of the chloroform and aqueous
extracts were added. After 48 hours incubation at 37°C the
coverslips were removed from the medium, the cells fixed in
ethanol and stained by Giemsa. and examined microscopically
to assess the cytotoxic effect.
Of the 18 standard mvcotoxins available, it was found that 10
were toxic in such a test, namely ochratoxin A, diacetoxy¬
scirpenol. T-2 toxin. T-2 triol, PR-toxin, T-2 tetraol, roridin,
deoxynivalenol. verrucarin A and HT-2 toxin. A clear cyto¬
toxic effect on the HEp II cells was observed with the chloro¬
form extracts of the feedstuffs (Figs 1 and 2). No such effect
was seen in cells incubated with the aqueous extracts or with
chloroform extracts from batches of feedstuffs not producing
adverse symptoms in birds.
Fusaria
The four Fusarium species were cultured in 50 ml liquid
potato dextrose medium for 10 days at 25°C, followed by two
weeks at 10°C. This procedure was considered to maximise
toxin production from several Fusarium species (J. Robb and
M. Marsh, unpublished data). The medium was then extracted
as described and on bioassay it was found that the chloroform
extracts of Fculmorum, Fmonilifortne (Fig 3) and Ftricinctum
contained compounds toxic to the HEp II cells. Zearalenone
was identified in the F culmorum extract and diacetoxyscir¬
penol in the Fmoniliforme extract by thin layer chromatogra¬
phy and confirmed by gas-liquid chromatography.
In addition, several spots were seen on the thin layer
chromatograms, plus the track from the F tricinctum extract.
FIG 1: HEp 11 cells (Giemsa x 117)
% <
* >
FIG 3: HEp II cells after incubation for 48 hours with 1 yul chloroform
extract of Fmoniliforme (Giemsa x 117)
which did not correspond to the available standards. When
eluted. some of these areas were toxic in the HEp II test; these
may represent additional (as yet) unidentified mycotoxins.
Growing the individual Fusarium species on sterilised grain
at 25°C for 10 days, then at 10°C for two weeks, produced
extracts with similar characteristics to those observed in the
extracts of the culture media described above.
Conclusions
The feedstuffs associated with disease symptoms in broilers
contained higher than normal numbers of Fusarium species, |
and several of these species were capable of producing toxic
metabolites when cultured on a medium or on sterilised grain.
The commercial diets contained similar toxic compounds. It is
therefore concluded that their presence in the feed was an
important contributory factor in the disease episode described.
We urge consideration of mycotoxins as factors in animal
diseases, especially where diet and weight gain are tightly
controlled and where feed is mixed and given continuously
from bulk supplies.
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Thirty-three standard mycotoxins were assayed by thin-layer chromatography
and by cytotoxicity in HEp-2 and Chang cells. Various levels of detection were
found. The cytotoxicity test was significantly more sensitive than thin-layer
chromatography for the trichothecenes and should be useful for screening extracts
from animal feedstuffs for the presence of unknown mycotoxins.
It has become increasingly obvious in recent
years that outbreaks of disease may occur in
farm animals in Britain owing to the ingestion of
various mycotoxins in feedstuffs. In 1960, an
episode of aflatoxicosis (Turkey X disease) oc¬
curred when many thousands of turkeys died
after eating rations containing groundnut meal
contaminated by Aspergillus flavus which had
produced aflatoxin (reviewed in reference 1).
More recently, toxins elaborated by various
species of Fusarittm in the maize and wheat
components of the feed were implicated in an
outbreak of suboptimal growth in broiler chick¬
ens (8). It is thus of importance to be able to
screen various animal feedstuffs for the presence
of mycotoxins and to assay for these compounds
in outbreaks of disease of unknown etiology. A
multimycotoxin-screening procedure has been
described by Patterson and Roberts (7) and
involves extraction of the feedstuff with organic
solvents followed by thin-layer chromatography
(TLC) and identification by comparison, with
mycotoxin standards. This screen is therefore
confined to the identification of known toxins
and, in addition, is relatively insensitive for the
detection of some compounds.
Various biological methods have been de¬
scribed for the assay of mycotoxins, ranging
from whole animals such as brine shrimp (3) and
chicken embryos (5) to in vitro tissue culture
systems such as human embryo fibroblasts (2),
rabbit reticulocytes (4), and HeLa cells (9). The
range of mycotoxins which may be detected by a
given assay has been rarely characterized; also,
the relative sensitivities of the various systems
have not been compared. Therefore, it was
thought useful to develop a standard biological
assay which could be carried out routinely with
ease and to compare the sensitivity and range of
mycotoxins detected with a conventional assay
employing TLC.
There were 33 standard preparations of myco¬
toxins available which had been tested for purity
and identity by nuclear magnetic resonance
spectroscopy. The sources of these were afla¬
toxin Gi, cytochalasin B and D, scopoletin, and
T-2 toxin from Sigma Chemical Co.; afiatoxins
Bj, B2, G2, and Mlt citrinin, diacetoxyscirpenol,
HT-2 toxin, luteoskyrin, 5-methoxysterigmato-
cystin, O-methyl sterigmatocystin, ochratoxin
A, patulin, penicillic acid, PR toxin, rubratoxin
B, sterigmatocystin, T-2 tetraol, and zearalen-
one from Makor Chemicals, Israel; roridin, T-2
triol, verrucarin A, and verrucarol from Cam¬
bridge Research Biochemicals Ltd.; 4-acetoxy-
3,15-scirpendiol, 15-acetoxy-3,4-scirpendiol,
scirpentriol, triacetoxyscirpene isolated from
Fusarium sulphurium (10), and moniliformin iso¬
lated from Fusarium monoliforme, all kindly
donated by P. S. Steyn; and deoxynivalenol
kindly donated by M. Shepherd. Each was dis¬
solved in acetone at 1 mg/ml, and 10-fold serial
dilutions were made in acetone. Controls con¬
tained acetone alone.
For the TLC, plates (Merck art. 5554 DC-
Alufolien Kieselgel 60F 254 and art. 5553 DC-
Alufolien Kieselgel 60) were spotted with 5p.l
samples of each standard or dilution of standard,
run in toluene-ethyl acetate-formic acid
(60:30:10), and sprayed with 50% aqueous
H2S04 when necessary, before viewing in a UV
cabinet (shortwave, 254 nm; longwave, 366 nm).
Rf values are noted in Table 1. The lowest
dilution at which spots could be detected by eye
was noted.
For the biological assays, two cell lines were
used, HEp-2 cells and Chang cells, both human
epithelial type, the latter of liver origin. These
were maintained on Earles-based Eagles medi¬
um supplemented with 5% newborn calf serum,
200 IU of penicillin per ml, and 200 p.g of
streptomycin per ml, and subcultured by tryp-
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4-Acetoxy-3,15-scirpendiol 100 10 50 0.14
15-Acetoxy-3,4-scirpendiol 100 10 500 0.09
Affatoxin Bt 100 100 0.5 0.17
Aflatoxin B2 100 100 0.5 0.13
Aflatoxin Gj ND" ND 0.5 0.14
Aflatoxin G2 1,000 100 0.5 0.11
Aflatoxin 10 10 0.5 0.0
Citrinin 10 100 0.05 0.42
Cytochalasin B ND ND 500 0.3
Cytochalasin D 10 10 50 0.17
Deoxynivalenol 100 100 500 0.0
Diacetoxyscirpenol 1 10 500 0.23
HT-2 toxin 10 1 500 0.18
Luteoskyrin ND ND 500 0.38
5-Methoxysterigmatocystin Not done ND 5,000 0.66
O-Methyl sterigmatocystin 100 10 5,000 0.32
Moniliformin ND ND 5,000 0.0
Ochratoxin A ND ND 0.05 0.45
Patuiin 100 100 500 0.32
Penicillic acid 1,000 1 50 0.35
PR toxin 1 100 50 0.44
Roridin A 0.0001 0.1 500 0.26
Rubratoxin B ND ND ND 0.22
Scirpentriol 100 10 50 0.04
Scopoletin ND ND 0.5 0.27
Sterigmatocystin 100 10 5,000 0.56
T-2 tetraol 10 100 500 0.04
T-2 toxin 10 0.01 500 0.26
Triacetoxyscirpene 10 10 500 0.38
T-2 triol 100 100 500 0.1
Vemrcarin A 0.1 0.1 5,000 0.35
Verrucarol 1,000 1,000 50 0.15
Zearalenone 100 100 50 0.55
" ND, Not detected at 1,000 ng.
sinization when confluent. In the test, they were
cultured on cover slips in 1 ml of medium until
semiconfluent. One microliter of each standard
or dilution of standard was added, and after 48 h
of incubation at 37°C, the cover slips were
removed, the cells were fixed in ethanol, stained
with Giemsa stain, and examined microscopical¬
ly to assess the cytotoxic effect, if any. The
lowest dilution at which a cytocidal effect was
apparent was noted, i.e., marked inhibition of
growth, cell rounding, and detachment from the
surface. Each observation was made in tripli¬
cate, and cytotoxic levels were found to vary by
a maximum of 1 dilution. The results are given in
Table 1.
It may be seen that there was great variation
in the level at which the standard mycotoxins
were detected in the assay systems used, from
no effect at 1,000 ng to visible spots at 0.05 ng in
the TLC for citrinin and ochratoxin A, and
cytotoxicity at 0.0001 ng for roridin A in HEp-2
cells. Although the TLC method detected almost
all of the compounds used, it was not as sensi¬
tive as the cytotoxic assay for at least 13 of the
33 mycotoxins tested. This difference in sensi¬
tivity was most striking for the trichothecenes,
for example, T-2 toxin and verrucarin. The
cytotoxic test did not detect eight compounds
with either Chang or HEp-2 cells, and generally
there was some difference in the level of sensi¬
tivity between the two lines. Lompe and Milc-
zewski (6) described the effect of 16 mycotoxins
on three human and two porcine cell lines and
found various levels of sensitivity, suggesting
the use of more than one line of different origin
in screening. The level of sensitivity of HEp-2
cells to roridin A was higher than expected but
was reproducible in three separate series of
dilutions and cytotoxic tests.
Thus, when screening for mycotoxins in such
materials as animal feedstuffs, it would be ad¬
vantageous to use a cytotoxic assay system in
950 NOTES Appl. Environ. Microbiol.
addition to TLC. Apart from the increased sensi¬
tivity for the trichothecene group, the cytotoxic
method has a good chance of picking up un¬
known toxins which may be present in samples
of feedstuff associated with outbreaks of disease
and for which there are no standards available.
We thank T. J. Simpson for supplying some of the mycotox-
ins used in this work and for helpful discussions.
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CHAPTER 35
The use of a cytotoxicity test as
a screening test for mycotoxins
Jean Robb and Mary Norval
INTRODUCTION
The ability of fungi to produce mycotoxins in forages and stored feedingstuffs
is well known. As a result of this potential hazard, or because of specific
disease problems or sub-optimal performance in poultry and animals, animal
feedingstuffs are routinely screened for mycotoxins. Usually solvent extracts
of feedingstuffs are subjected to a clean-up stage and then analysed by
thin-layer, gas-liquid or high-pressure liquid chromatography. In many
instances multimycotoxin methods (Gorst-Allman et al., 1979) are used,
making it possible to extract several mycotoxins of different chemical
structures in the one procedure. These methods are often relatively insensi¬
tive, particularly for trichothecene toxins, and are only able to detect
compounds Of known chemical composition providing the necessary stan¬
dards are available.
It is possible therefore that animals may eat feeds containing mycotoxins
which routine laboratory methods cannot detect. Such a situation occurred in
Scotland during the winter of 1980-81 when sub-optimal growth, poor
feathering and behavioural abnormalities were seen in broilers (Robb et al.,
1982). Examination of poultry meal extracts by thin-layer chromatography
(Patterson and Roberts, 1979) failed to demonstrate mycotoxins but bioassay
with a tissue culture of HEpII cells enabled identification of the toxic
component of the feed. Since then the sensitivities of the cytotoxicity and
thin-layer chromatography methods have been compared using toxin stan¬
dards and extracts from feedingstuffs. This chapter describes the results of
these experiments.
METHODS
Thirty-three standard preparations of mycotoxins were used; they were
aflatoxin G1; cytochalasin B and D, scopoletin (Sigma), aflatoxin B,, B2, G2
375
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and M1; citrinin, diacetoxyscirpenol, HT-2 toxin, luteoskyrin, 5-
methoxysterigmatocystin, O-methyl sterigmatocystin, ochratoxin A, patulin,
penicillic acid, PR-toxin, rubratoxin B, sterigmatocystin, T-2 tetraol, T-2
toxin and zearalenone (Makor Chemicals, Israel), roridin, T-2 triol, verrucar-
in A and verrucarol (Cambridge Research Biochemicals Ltd), 4-acetoxy-3,15-
scirpendiol, 15-acetoxy-3,4-scirpendiol, scirpentriol, triacetoxyscirpene and
moniliformin (all kindly donated by Dr P. S. Steyn) and deoxynivalenol
(kindly donated by Dr M. Shepherd). Each was dissolved in acetone at 1
mg/ml and 10-fold serial dilutions made in acetone.
Animal feedingstuffs were extracted with acetonitrile, iso-octane and
chloroform and then examined by thin-layer chromatography (Patterson and
Roberts, 1979; Figure 1).
For TLC, plates (Merck Art 5554 DC-Alufolien Kieselgel 60F 254 and Art
5553 DC-Alufolien Kieselogel 60) were spotted with 5 pi samples of each
concentration, run in toluene : ethyl acetate : formic acid 60 : 30: 10, and
sprayed with 50% aqueous H2S04 where necessary, before viewing in a UV
cabinet (short-wave 254 nm, long-wave 366 nm). The lowest dilution at which
spots could be detected visually was noted.
For biological assay, HEpII cells were used. The cells were maintained on
coverslips in 1 ml Earles-based Eagles medium supplemented with 5%
newborn calf serum, 200 i.u./ml penicillin and 20 pg/ml streptomycin, and
subcultured by trypsinization when confluent. In the test, they were cultured
on coverslips in 1 mi medium until semi-confluent. One microlitre (1 pi) of
each dilution of the standard or 1 pi of feedingstuff extract was added and,
after 48 hours incubation at 37 °C, the coverslips were removed, the cells fixed
in ethanol, stained by Giemsa's and examined microscopically to assess
cytotoxicity. The lowest dilution at which a cytocidal effect, i.e. marked
inhibition of growth, cell-rounding and detachment from the surface, was
apparent was noted. Observations were made in triplicate and cytotoxic levels
were found to vary by a maximum of 1 dilution.
RESULTS
Table 1 shows that there was much variation in the level at which the standard
mycotoxins were detected in the assay systems employed, from undetectable
at 1000 ng to visible spots at 0.05 mg in TLC of citrinin and ochratoxin A
respectively or cytotoxicity to HEpII cells at only 0.0001 ng of roridin A.
While the TLC method detected most compounds, it was less sensitive than
the cytotoxic assay for at least 13 of the 33 tested. This difference in sensitivity
was most striking for the trichothecenes, e.g. T-2 toxin and verrucarin A.
The results in Table 2 show that, apart from the turkey feeds and the
tapioca, no individual feedingstuff was consistently toxic to HEpII cells.
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Figure 1 Extraction and clean-up procedure for the detection of mycotoxins in
animal feeds.
However, few of these were tested, and these were directly related to a
disease problem so that the results may not be representative. A supplement
used in the poultry feeds was consistently toxic, but its effects in the final feed
were diluted.
A CYTOTOXICITY TEST TO SCREEN FOR MYCOTOXINS 377
25 g sample
Extract with 90 ml acetonitrile
10 ml 4% potassium chloride
50 ml filtrate





Add 12.5 ml water and extract







Add I ml 1.0 N HCI
and extract with







O.I ml for TLC
(EXTRACT II)
Transfer to dialysis
tubing with I ml
acetonitrile and
equilibrate against
25 ml 30% acetone
Aqueous acetone fraction
Extract with











Figure 1 Extraction and clean-up procedure for the detection of mycotoxins in
animal feeds.
However, few of these were tested, and these were directly related to a
disease problem so that the results may not be representative. A supplement
used in the poultry feeds was consistently toxic, but its effects in the final feed
were diluted.




extract I extract II
Feed type +ve —ve +ve —ve
Barley 1 5 0 6
Wheat 7 14 1 20
Starter pellets 33 20 7 46
Maize 8 18 3 23
Starter crumbs 22 7 11 18
Broiler finisher 9 1 3 7
Turkey feed 2 0 2 0
Soya 6 5 3 8
Fat 1 2 1 2
Soffe 0 1 0 1
Supplement 3 0 1 2
Tapioca 1 0 0 1
Silage 6 18 0 22
Cattle cake 2 17 0 19
Grass 0 4 0 4
Sow mix 2 12 0 14
Potatoes 0 4 0 4
Draff 6 15 1 20
Oats 1 10 0 11
Straw 0 6 0 6
feedingstuff may be responsible for the toxicity. Untreated cereals or forages
are less likely to contain interfering compounds. Apart from demonstrating
sensitivity to the trichothecenes, the test will also indicate the presence of
other mycotoxins, known and unknown, which are not included in the routine
standards used for TLC or GLC analysis.
Lompe and Milezewski (1979) described the effect of 16 mycotoxins on
three human and two porcine cell lines and found varying levels of sensitivity,
suggesting that several cell lines of different origin might be used in screening.
If extracts were passed through a clean-up cartridge such as Sep-Pak and
aliquots tested against various cell lines, feedingstuffs which gave positive
results could be re-extracted and analysed by the most sensitive chemical
method available for the types of toxic compounds indicated by the cytotoxic¬
ity tests.
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335. Interactions between herpes simplex type I and murine bone
marrow macrophages
Sarah Howie, Mary Norval, and J. Maingay
The association of a cloned clinical isolate of herpes simplex tvpe I (HSV-I) with bone
marrow derived macrophages from C3HfBu/Kam mice has been investigated. The bone
marrow cells were prepared from the femurs of 6-8 week old mice and cultured in L-ceilconditioned medium. On davs 0. 2, 4, 6 and 8 thev were infected with HSV-I at a multiplicityoil, and the outcome was followed in various ways. Infectious centre assavs were performedand infectious virus present in the culture supernatant and cell-associated at 1 day and 3 davs
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post-infection was measured by a plaque assay. The number of cells expressing viral antigens
was estimated bv indirect immunofluorescence at the same times after infection. In addition
the uptake of 3H-thvmidine into the infected cells over a 24-hour period after infection was
compared with uninfected controls. Finally the Fc receptor avidity of adherent cells, and the
expression of cell surface class II MHC antigens were measured at 1 and 3 days post infection.
In uninfected cultures the number of adherent cells with high avidity Fc receptors increased
from 15% on day 1 to 70% on day 3, and greater than 90% after further incubation. In
infected cultures 3 davs post-infection, greater than 90 % of the surviving cells had high avidity
Fc receptors, although there were onlv 10% of the cells remaining compared to uninfected
controls. This suggests that the cells which can survive such an infection are a subpopulation of
mature macrophages. Throughout the culture period, a small percentage of cells (0.2%)
permissive for HSV replication and expressing viral antigens were present and these increased
6-8 days after the culture had been initiated. DNA synthesis was inhibited by 50 % in infected
cultures suggesting that, even in non-permissive cells, host macro-molecular synthesis may be
inhibited bv the virus. Similar experiments using bone marrow derived macrophages from
neonatal mice are presently being undertaken. These macrophages represent one class ot
antigen presenting cell, and a study of their interactions with HSV may clarify the types of
immune responses generated by different antigen presenting cells during infection.
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Summary
Macrophages from murine bone marrow (strain C3Hf Bu/Kam) were
cultured in vitro in L-cell conditioned medium. After 0, 2,4, 6, 8 and 10 days,
they were infected with a clinical strain of herpes simplex virus type 1 and
the outcome followed morphologically, by phagocytic index, infectious virus
yields, immunofluorescence, expression of Fc receptors and major histo¬
compatibility complex (MHC) Class II antigens. At a multiplicity of infection
of 1—5, little morphological difference was apparent between infected and
uninfected cultures at early stages in vitro but marked changes occurred
later with reduction in cell numbers in the infected cultures. Indirect
immunofluorescence failed to detect cells expressing early viral antigens,
and yields of infectious virus indicated that permissive infection was not
taking place. While phagocytic index and Fc receptor expression did not
change 24 hours post-infection, MHC Class II antigen expression was
increased. Thus, although the bone marrow macrophages seem predominantly
resistant to infection with HSV-1, they may be modified by the presence of
the virus. Since macrophages may act as antigen presenting cells for the
immune system, this type of mechanism may be important in the generation
of local immune responses.
Introduction
Macrophages play a crucial role in the generation of both humoral and
cell-mediated immune responses acting as antigen presenting cells, and are
* Present address: Department of Radiation Oncology, UCLA Centre for Health
Sciences, Los Angeles.
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recognised to be of primary importance in resistance to viral infections.
Several studies have indicated that they are necessary for resistance to
herpes simplex virus (HSV) infections in mice; if macrophages are depleted
or immature, then resistance to HSV is dimished and, conversely, agents
which stimulate macrophages increase resistance (3, 5, 19). Most work on
the function of macrophages in viral infection has involved peritoneal cells
and this subject has been reviewed recently by Morahan (12).
It was reported in 1971 that peritoneal macrophages can be abortively
infected with HSV type 1 (HSV-1) with a possible block at the stage of
virion assembly (17). While peritoneal macrophages are generally considered
non-permissive for HSV replication unless stimulated in vivo by agents such
as thioglycollate, they can be made permissive by pre-culture in vitro for
3 to 4 days before infection (9). Recently, several strains of HSV-1 were
found to replicate to different extents in peritoneal macrophages after they
had been aged in vitro or thioglycollate stimulated. This ability could not
be correlated with pathogenicity in mice (2). Different results were reported
by Brucher et al. (1) who showed an association between the permissive¬
ness of peritoneal macrophages to HSV-1 and in vivo susceptibility to
infection. Macrophages from resistant strains of mice produced more inter¬
feron post-infection than macrophages from more sensitive strains, suggesting
a possible mechanism of selective resistance.
Macrophages are morphologically and functionally diverse. They are
thought to originate from precursor monoblasts and promonocytes in the
bone marrow. If bone marrow cells are cultured in vitro, in the presence
of L-cell conditioned medium which contains "macrophage colony stimu¬
lating factor", they are stimulated to differentiate and divide, and have
been shown by morphology, esterase staining and phagocytosis to provide
a culture of virtually pure macrophages (6). Thus these cells provide a
convenient model system for studying the association of HSV with macro¬
phages of different maturation states. This may help to clarify the types of
immune responses generated by antigen presenting cells during the course
of a viral infection.
Bone marrow macrophages were obtained from mice and infected with
HSV-1 after various periods in culture. The outcome of the infection was
followed morphologically, by phagocytic index, infectious virus yields,
immunofluorescence, and by expression of Fc receptors and major histo¬
compatibility complex (MHC) Class II antigens.
Materials and Methods
Bone Marrow Cultures
Femurs from 6—8 week old female mice (C3Hf Bu/Kam strain, bred and main¬
tained in the Departmental Animal House) were collected and bone marrow cells
prepared by cutting off the ends and flushing aseptically with medium, the yield
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being about 107 cells per femur. The cells were washed and cultured at various
densities as described below. The medium used throughout was RPMI 1640 (Imperial
Laboratories) supplemented with 10 to 30 per cent L-cell conditioned medium
(depending on the batch used), 5 per cent foetal calf serum, 2 mM L-glutamine,
5x10~5m 2-mercaptoethanol, lOOIU/ml penicillin, 200 gg/ml streptomycin and
100 (J.g/ml gentamicin. The conditioned medium was prepared from pooled 24-hour
supernatants from confluent L-cell cultures which were filter sterilized, titrated to
find the optimal concentration for growth of bone marrow macrophages and stored
at —70° C until use.
During the culture period, the percentage of adherent macrophages present was
determined by a non-specific esterase strain (18) and by phagocytosis of sensitized
calf red blood cells.
Virus and Viral Infections
HSV-1 was isolated from a clinical case and was plaque-purified in Vero cells.
These cells were cultured in Eagle's minimal essential medium (Northumbria Bio-
logicals Ltd.) supplemented with 2 to 5 per cent new born calf serum, 2 mM L-
glutamine and antibiotics as above. Plaque assays for infectious virus were performed
using Vero cells in microtitre plates with 0.25 per cent Seaplaque agarose (FMC
Corporation) in the overlay. After incubation for 3 days, the cells were fixed in formyl
saline and stained with Giemsa before counting the plaques using a low power micro¬
scope. The same batch of virus stock was used throughout, and it contained 1010
plaque forming units (PEU) per ml.
On day 0, for all the tests, bone marrow cells were infected as monolayers with
the same amount of virus. HSV-1 was allowed to adsorb for 1 hour at 37° C before
washing the cell sheets 3 times and putting on fresh medium. All incubations were
carried out at 37° C in an atmosphere of air with 5 per cent CO2 in a humidified
incubator.
Virus Yields
Bone marrow cells were seeded at a density of 106 in 1 ml volumes in 24-well
Costar plates. At 1 and 24 hours post-infection, the cells were scraped off duplicate
wells, using small rubber policemen, into the culture supernatant. All samples were
stored at —70° C, then ultra-sonicated for 1 minute before being assayed for PFU on
Vero cells in microtitre plates, in quadruplicate. The mean of the number of plaques
at suitable dilutions was taken.
In addition, on every second day, cells were scraped off 3 wells and counted to
give an average number present per well. Cell counts were also performed 24 and
72 hours post-infection.
Immunofluorescence
The bone marrow cells were seeded at a density of 2 X 10r> in 1 ml volumes in
tubes containing coverslips. The coverslips were fixed at 0, 1, 4, and 24 hours post¬
infection in 2 per cent paraformaldehyde in 0.28 M Na cacodylate buffer, pH 6.9, for
10 minutes at room temperature. They were treated with 0.05 per cent Triton X-100
in 0.01 m phosphate buffered saline (PBS), pH 7.2, for 5 minutes at room temperature,
then washed in the same buffer.
Two antibody preparations were employed in indirect immunofluorescence. The
first was a mouse monoclonal antibody T181 (used undiluted), directed against an
early viral nuclear antigen and kindly donated by Chan (7). It was followed by a
rabbit anti-mouse antiserum used at a dilution of 1/50 (4), then a sheep anti-rabbit
FITC conjugate at 1/20 (Wellcome). The second antibody preparation was an anti¬
serum raised in a New Zealand rabbit by 3 subcutaneous injections of 2x 10° RK13
cells harvested 4 hours after infection with HSV-1 at a multiplicity of 5. The first
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injection was in Fround's complete adjuvant and was followed at fortnightly intervals
by injections in Freund's incomplete adjuvant. The rabbit was bled 2 weeks later.
The serum was used at a dilution of 1/20, followed by sheep anti-rabbit FITC conju¬
gate as before.
Fc Receptor Assays
Bone marrow cells were seeded at a density of 3 x 105 in 1 ml volumes in 24-well
Costar plates. Fc receptor expression was measured 2-1 hours post-infection as de¬
scribed previously (10). Briefly 5 per cent (v/v) calf reel blood cells (CRI3C) in PBS
were mixed with an equal volume of a 1/32 dilution of hyperimmune rabbit anti-
CRBC serum, incubated at 37° C for 1 hour and washed extensively with PBS.
Cultures of bone marrow cells were washed and overlaid with 0.3 ml 2.5 per cent (v/v)
suspensions of the sensitized red cells and incubated for 1 hour at room temperature.
The wells were washed very gently four times with PBS to remove non-adherent
erythrocytes. The percentage of bone marrow cells binding 3 or more erythrocytes at
the cell surface was determined using an inverted microscope and counting at least
200 cells from each of 4 wells for each time point.
MHC Glass II Antigens
Bone marrow cells were seeded at a density of 2 x 106 in 1 ml volumes in tubes
containing coverslips. The coverslips were fixed in 2 per cent paraformaldehyde in
0.28 m Na cacodylate buffer, pH 6.9, for 10 minutes, 24 hours post-infection with
HSV. The immunoperoxidase method of Ritchie etal. (14) was used with a mouse
anti-class II (Iak) monoclonal antibody [4TB 93 from the American Type Culture
Collection (13)]. At least 500 cells were examined on each coverslip and the number
showing positive immunoperoxidase staining was noted.
Results
Morphological Characteristics
Initially the bone marrow cultures consisted of a mixed population of
adherent and non-adherent cells (Fig. la). During in vitro culture, macro-
phage-like cells began to grow out and by the fourth day micro-colonies
were beginning to form which are illustrated in Fig. lb. The cell numbers
decreased from an initial 106 per well to 2 X 105 during the first 4 days but
thereafter the number remained static. Using a non-specific esterase strain,
43 per cent adherent cells showed staining characteristic of macrophages
after 3 days in vitro, and this number rose to over 99 per cent by 6 clays.
Using sensitized CRBC, 10 per cent of the bone marrow cells were phagocytic
after 1 day in vitro. This increased to 36 per cent after 3 clays, and 84 per
cent after 7 days (see below and Fig. 2). Thus by these criteria, the bone
marrow cells represent a culture of relatively pure macrophages which
undergo maturation and proliferation in vitro in the presence of L-cell
conditioned medium.
After 0, 2, 4, 6, 8 and 10 clays in vitro, the cultures were infected with
HSV-1. Cells from the earlier times (0 and 2 clays) showed little morphological
change from uninfected controls, but cells from 4 days onwards showed
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marked changes (Fig. lc). There was a reduction in cell numbers to around
105 per well 24 hours post-infection and this dropped further to around
8 X 104 per well 72 hours post-infection. If incubated for longer than 72 hours,
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Days of culture
Fig. 2. Percentage phagocytic cells in bone marrow cultures incubated for 0, 2, 6 and
8 days in vitro before infecting with HSV-1 and assayed 24 hours later (a -a
infected with HSV; • • mock-infected controls)
These studies were all done using the same amount of virus per well
which gave a multiplicity of infection of 1 on day 0 and about 5 at other
time points. Infection with one-tenth this quantity of virus did not result
in any morphological differences over 7 days compared to uninfected
cultures.
Phagocytosis
At 24 hours post-infection, at least 100 cells in each of 4 wells were
counted to find the percentage capable of phagocytosing sensitized CRBC.
I'lie results are shown in Fig. 2. No difference was apparent between infected
and uninfected cultures at any time.
Virus Yields
These are illustrated in Fig. 3. There was no indication of productive
infection at any time. The experiment was repeated 3 times with the same
result. Infection at a multiplicity of 0.1 instead of 1 gave virus yields
consistently one-tenth that normally produced.
Immunofluorescence
The monoclonal antibody, T181, and the polyclonal rabbit antiserum
were able to detect HSV antigens in Vero cells from 2 hours post-infection.
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The fluorescence in both cases was predominantly in the form of nuclear
granules. By 6 hours post-infection, there was overall nuclear fluorescence
and by 24 hours the whole cell was fluorescent.
The antibody preparations were used on the bone marrow cells after
they had been in culture for 0 to 8 days and had been fixed at 0, 1,4 and
24 hours post-infection. No viral antigens were detected at any time.
DAY OF CULTURE
Fig. 3. Number of plaque-forming units/cell in bone marrow cultures infected with
HSV-1 after being in culture for 0, 2, 4, 6, 8 and 10 days (• • at 1 hour post¬
infection; a a at 24 hours post-infection)
An infectious centre assay indicated that only 0.2 per cent bone marrow
cells adsorbed HSV-1 on day 0. This rose to a level of 1 per cent after the
cells had been in culture for 6 days (data not shown).
Fc Receptor Assays
The percentage of cells with Fc receptors was assayed during 7 days
of in vitro culturing and the effect of HSV-1 measured 24 hours post¬
infection. This was repeated 3 times and the results of 1 representative
experiment are shown in Fig. 4. The standard error for each point was less
than 5 per cent of the mean, except for the first point. The cells obviously
underwent differentiation during culture; no difference was found in Fc
receptor expression between infected and uninfected cells. In one case cells
were trypsinized (0.1 per cent trypsin for 30 minutes at 37° C) immediately
before analysis to determine whether any virally induced trypsin-sensitive
Fc receptors were present, but none was found.
MHC Class II Antigens
The final analysis was of MHC Class II antigen expression during the
culture period and the effect of HSV-1 on this measured 24 hours post-
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Fig. 4. Percentage Fc receptor-positive cells in bone marrow cultures incubated for
0, 2, 4, 6 and 8 days in vitro before infecting with HSV-1 and assayed 24 hours later
(a a infected with HSV; • • mock-infected controls)
Fig. 5. Percentage MHO class II-positive cells in bone marrow cultures incubated for
0, 2, 4, 6 and 8 days in vitro before infecting with HSV-1 and assayed 24 hours later
(a a infected with HSV; • • mock-infected controls)
infection. The experiment was repeated 3 times and at least 500 cells were
examined on each coverslip. The percentage showing positive staining from
one representative experiment is shown in Fig. 5. The standard error for
each point was less than 5 per cent of the mean. Initially the bone marrow
cells had no detectable MHC Class II antigens but these were generated
during culture until 50 per cent were positive. When the cells were infected
with HSV-1, a consistently higher level of expression was seen compared
to the uninfected cultures.
7„ Fc-receptor positive cells
100
°/o class II-positive cells
Discussion
By nonspecific esterase staining, Fc receptor expression and phagocytic
ability, the bone marrow cells used here represent a culture of relatively
pure macrophages which undergo maturation and proliferation in vitro in
the presence of L-cell conditioned medium. Bone marrow derived macro¬
phages are more homogeneous than peritoneal exudate cells and recently
have been used as targets for the replication of mouse hepatitis virus type 3
(15). It was of interest to find out if HSV-1 had the same kind of interaction
with these cells as has been found for peritoneal macrophages and whether
this association changed with maturation during in vitro culturing. It has
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already been reported that bone marrow macrojhrages from susceptible
DBA/2 mice were able to support replication of HSV-1 after preculturing
for 7 days, but to a lesser extent (one-tenth) than peritoneal macrophages
from the same source (1). Morahan et al. (12), using DNA hybridization
techniques, recently showed that viral DNA synthesis occurred in infected
bone marrow macrophage cultures but no evidence of infectious virus
production was obtained. The cells showed marked cytopathic effects.
In this study bone marrow macrophages from C3Hf Bu/Karn mice were
cultured in vitro and infected with a clinical strain of HSV-1. This strain of
mouse is relatively resistant to infection with the HSV-1 strain used, 107 PFU
being required to induce paralysis and subsequent death in 90 per cent of
female animals (aged 6—8 weeks) injected intraperitoneally. Injections of
3 X 106 PFU killed 1 out of 10 6—8 week old mice but 5 out of 5, 16 day old
mice. Resistance to HSV-1 in various strains of mice is thought to be
immunologically mediated and is not coded for in the major histocompatibility
region (8).
The morphology of the bone marrow cells, which had been in culture
for more than 2 days altered after infection with HSV-1. However yields
of infectious virus indicated that the cells were not permissive. Indirect
immunofluorescence using antibodies capable of detecting viral antigens
induced 2 hours post-infection was negative, and an infectious centre assay
showed adsorption of virus to only a few cells in the cultures. It is possible
that these represent a small subpopulation of macrophages, below the limit
of detection by immunofluorescence, which are capable of, at least, abortive
infection. Subpopulations of peritoneal macrophages separated on the basis
of size have not shown preferential permissiveness for HSV-1 replication,
thus far (2, 11). However in the study here the majority of the bone marrow
cells were found to be resistant to infection and the morphological changes
noted may have been due to some modifying effect of the virus preparation.
The stock of virus used probably includes non-infectious virus particles as
well as infectious virus which could affect, for example, cell membranes,
especially as the macrophages become more differentiated. In support of
this, the adherent cells remaining 72 hours after infection began to grow
and divide, and secondly, infecting at a multiplicity one-tenth lower than
standard removed most of the differences noted between infected and
uninfected cultures.
Three parameters, phagocytic ability, Fc receptor expression and MHC
Class II expression were examined 24 hours post-infection. The first two
were unaltered compared to the uninfected controls, but MHC Class II
expression was increased at all time points. MHC Class II antigen expression
at the cell surface is directly implicated in antigen presentation by non-
lymphoid cells to specific T lymphocytes of the helper/inducer subsets. Thus
a cell which does not express such antigens cannot act as an antigen presenting
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cell during the immune response. It is known that MHC Class II antigen
expression 011 macrophages can be modulated by several factors including
activation state and interferon (16).
It is possible that the presence of HSV may induce interferon production
in the bone marrow cultures which would increase expression of MHC
Class II antigens on the cell surface. This hypothesis is currently being
tested. In vivo this may have wide implications for the generation of immune
responses to HSV, particularly at local sites of infection. Here high levels
of immunity are thought to be important for viral clearance, and these may
be induced by increasing the number of potential antigen presenting cells
at the site by increasing MHC Class II antigen expression.
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Exposure to Low-Dose Ultraviolet Radiation
Suppresses Delayed-Type Hypersensitivity to Herpes
Simplex Virus in Mice
Sarah Howie, Ph.D., Mary Norval, Ph.D., and Jean Maingay, B.A.
Department of Bacteriology, University of Edinburgh Medical School, Edinburgh, Scotland
Ultraviolet B (UVB) radiation is reported to induce a defect
in epidermal antigen presentation which leads to specific
suppression of the delayed-type hypersensitivity (DTH)
response to trinitrochlorobenzene. We have used a similar
system to examine the murine DTH response to herpes
simplex virus type 1 (HSV-1). Mice irradiated with 96
mj/cm2 UVB on shaved dorsal skin 3 days before s.c.
injection of live HSV-1 in the flank showed 54—92% sup¬
pressed DTH responses to challenge with inactivated virus
compared with nonirradiated control animals. If irradiation
When herpes simplex virus (HSV) is inoculated s.c.into mice, the virus replicates locally reaching itshighest titers between days 2-6 and is undetect¬able 10 days later [1]. HSV may then invade thesensory nerve endings in the local neuroder-
matome and establish latency in the sensory ganglia [2], A de¬
layed-type hypersensitivity (DTH) response can be detected by
injection of virus or viral antigen into the ear pinna with mea¬
surement of ear swelling 24—18 h later. Delayed-type hypersen¬
sitivity is found 4 days after a primary infection, reaches a max¬
imum at 8 days, and lasts for the lifetime of the animal [2], It is
inder the control of the I region of the H-2 complex and plays
a role in recovery from infection [3,4]. B cells that suppress the
DTH response are found in the draining lymph node from 16
days onward [5], The control of primary HSV infections is com¬
plex, but T cells seem to be important in early events, with
evidence for both cytotoxic and DTH-mediating T cells being
involved (reviewed in [6]).
Several groups, using a variety of systems, have shown that
UV irradiation in vivo has a selective suppressive effect on the
immune system [7,8]. Epidermal [9,10] and spleen [11] cells from
UV-irradiated animals are deficient in antigen-presenting ability
and antigen-specific T-suppressor lymphocytes may be generated
is a result of this. UV radiation does not penetrate the skin and
suppression is not due to local effects on the skin [12]. Although
irradiation is known to affect the numbers and morphology of
Langerhans cells, and to lead to increased production ofepidermal
:ell-derived activating factor (ETAF) by keratinocytes, it has been
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took place 7 days before inoculation with virus, some
suppression of DTH occurred; if 14 days before, no
suppression was found. The transient nature of the UVB
response is further illustrated by the observation that ir¬
radiation with the same dose of UVB 5 h before, or 3 days
after, inoculation with virus had no effect on DTH. Once
induced, some degree of UVB suppression was found to
persist for at least 3 months after irradiation. J Invest Der¬
matol 86:125-128, 1986
shown recently that maximum suppression of DTH occurs at a
different wavelength from the one directly affecting the Langer¬
hans cells [13]. Thus, there may be release of an UV-induced
photoproduct by epidermal cells which then interacts with Lan¬
gerhans cells and suppresses their capacity to present antigen.
In the study reported here, infection with an epidermal patho¬
gen, HSV-1, has been used in a mouse model. Measurement has
been made of the DTH response to this virus and the effect of
UV radiation on this parameter quantitated.
MATERIALS AND METHODS
Animals Female C3HfBu/Kam mice, bred and maintained in
the departmental animal house, were used when 10—16 weeks
old.
UVB Irradiation Mice were irradiated under a bank of 2 Phil¬
ips TL20W/12 sunlamps at a distance of 30 cm. These bulbs had
an output in the UVB range between 270-350 nm with a peak
output at 310 nm. Measurement of output was made inside the
perspex box, described below, using an Industrial Light Research
Radiometer IL700A with an actinic optical assembly. The output
was 0.8 J/m2/s. Before irradiation, mice were shaved dorsally and
their ears protected by black electrical tape [13]. When tested, this
tape did not allow any penetration of UVB radiation. Mice were
irradiated in a 5-chambered perspex box with deep walls and no
lid, such that they could not turn around or over.
Virus The virus used was a plaque-purified clinical isolate of
HSV-1, the DNA of which has been analyzed using 3 restriction
endonucleases. The virus was passaged in vitro in Vero cells.
Aliquots were stored at — 70°C and sonicated for 60 s in an ul-
trasonicating water bath immediately before use. The number of
plaque-forming units (pfu) of infectious virus present per milliliter
of cell suspension was determined on Vero monolayers with 0.25%
sea plaque agarose (FMC Corporation) in the overlay. Infectious
virus was inactivated by UVB irradiation for 60 min. The stock
preparation of virus used throughout had a titer of 10'° pfu/ml
which was equivalent to 103 pfu per Vero cell. In mice, an i.p.
injection of 107 ptu of this virus strain induced paralysis and death
in 90% of animals.
l-chloro-2,4,6-Trinitrobenzene l-chloro-2,4,6-Trinitro-
benzene, obtained from BDH Chemicals Ltd., Poole, England,
was made up to 5% (w/v) in acetone immediately before use.
0022-202X/86/S03.50 Copyright © 1986 by The Society for Investigative Dermatology, Inc.
126 HOWIE, NORVAL, AND MAINGAY THE JOURNAL OF INVESTIGATIVE DERMATOLOG'
DTH Assay The principle of the assay was identical whether
HSV-1 or TNCB was used as the sensitizing agent.
TNCB Assay: The abdomens of mice were shaved and then
painted with 0.1 ml 5% TNCB in acetone or with acetone alone.
Five to 8 days later, the mice were individually marked and their
ear thicknesses were measured using a micrometer gauge (Draper
Precision Instruments, Japan). They were then challenged by
painting 15 yul of 5% TNCB in acetone onto both sides of each
ear pinna. Twenty-four hours later, the ear thicknesses were again
measured and the increase in ear thickness calculated. A mean of
the 2 measurements from each mouse was taken before the mean
and SE for each experimental group was calculated.
HSV-1 Assay: Mice were inoculated s.c. in the flank with 107
pfu of infectious virus or 104 uninfected sonicated Vero cells in
phosphate-buffered saline (PBS). Eight days later, they were in¬
dividually marked and their ear thicknesses were measured as
above. They were then injected with 10 /xl of PBS containing 106
pfu UV-inactivated HSV-1 in both ear pinnae. Twenty-four hours
later, the ear thicknesses were again measured and the increase in
ear thickness calculated. A mean of the 2 measurements from each
mouse was taken before the mean and SE for each experimental
group were calculated.
UVB-Induced Suppression of DTH To determine the sup¬
pressive effect of UVB on generation of DTH, mice were irra¬
diated as described above 3 days prior to initial sensitization with
TNCB or HSV-1 [13]. The net increase in ear thickness ofcontrol
and UVB-irradiated mice was taken as the difference between the
mean ear swelling ofsensitized and unsensitized mice. Percentage
suppression was calculated according to the formula:
% suppression =
100 X net increase in UV-irradiated mice
10° r— : : :
Net increase in control mice
as described by Noonan et al [13].
RESULTS
Calibration of the Suppressive Effect of UVB on DTH
Responses Mice were irradiated with increasing amounts of
UVB 3 days prior to sensitization with TNCB (UV experimental
group) or acetone alone (UV control group) and were compared
with control and experimental groups that had not been exposed
to UVB. Table I shows that 20-min irradiation with UVB (equiv¬
alent to 96mJ/crrr) caused 60% suppression ofthe DTH response.
This dose of UVB did not give rise to any observable burning
of the skin. Mice irradiated for 30 min did demonstrate burning
on the skin of their backs and the decreased suppression of the
DTH response seen in this group may be explained by an ov¬
erriding generalized inflammatory reaction to the epidermal dam¬
age. For this reason, it was decided to use 20-min irradiation with
UVB in all subsequent experiments.
Table I. UVB-Induced Suppression of DTH to TNCB
24-h Increase in Ear
Thickness
Sensitized UVB (units X lO2 mm % Suppression
with Irradiation ± SEM") of DTH
Acetone Nil 8.2 ± 1.14
TNCB Nil 27.3 ± 2.01 —
TNCB 10 min 20.2 ± 1.74* 37
TNCB 20 min 15.8 ± 0.84* 60
- TNCB 30 min 19.0 ± 1.94* 44
All mice were challenged with 15 /zl TNCB in acetone on both sides of both ear
pinnae.
JFive mice per group.
''Significantly different from the experimental group sensitized with TNCB with¬
out prior UVB exposure, p < 0.001 in all cases (Student's /-test).
Induction of Specific DTH to HSV-1 Mice were inoculatei
with live HSV-1 or an equivalent amount ofuninfected Vero cell
s.c. in the flank. As described in Materials and Methods, the 24-1
DTH response was determined after challenge with inactivatei
virus (cultured in Vero cells) on day 8. The induction of DTF
to HSV-1 is shown in Table II, which also indicates that the DTF
to the virus is specific in nature and directed against HSV-1 an
tigens rather than Vero cell antigens.
DTH to HSV-1 is Suppressed by UVB Treatment To ex
amine the effect of UVB pretreatment on the generation of DTF
to HSV-1, mice were shaved dorsally and UV-irradiated for 0 o
20 min as above. Three days later, they were inoculated witl
either 104 sonicated Vero cells or 107 pfu of HSV-1 as above. Thi
24-h DTH response to challenge 8 days later with 106 UV-in
activated pfu of HSV-1 was determined as above. Table III show
that this single exposure to a suberythemal dose of UVB irra
diation induced 54—92% suppression of the DTH response tc
HSV-1
UVB-Induced Alteration in the Generation of DTH i:
Transient and Short-Term in Nature To determine the re¬
lationship between the time of exposure to UVB and the time o
sensitization with virus, mice were irradiated at several time point:
before and after infection with HSV-1. Fig 1 shows that micf
irradiated 14 days before sensitization to virus demonstrated nc
suppression of DTH, whereas mice irradiated 7, 3, and 2 day:
before sensitization were suppressed by 40, 70, and 82%, re¬
spectively. Irradiation on the same day as (5 h before) or 3 day:
after, sensitization to virus had no effect on DTH responses. Thi:
indicates that the UVB-induced generation of DTH suppressior
is transient, short-term in nature, and that it takes up to 2 day:
to be effective.
However, in contrast to this result, mice that had been UVE
suppressed for DTH to HSV-1 remained suppressed for as long
as tested. This was up to 3 months after UV-induced DTF-
suppression had been demonstrated (data not shown). Thus chi
suppressed state, once generated, is not transient.
DISCUSSION
3
Knowledge of the immunologic mechanisms that control HSV
infections is crucial to an understanding of HSV pathogenesis.
This is important both for the prevention of spread of primary
disease and for attempts to modify the pattern of subsequeni
episodes of epidermal recrudescence.
We have examined how a well-characterized in -vivo immuni
response, DTH. to experimental HSV-1 infection [4,-5,14] is al¬
tered by UV irradiation, a stimulus known to affect both vira
pathogenesis [15] and the correct functioning of the immune sys¬
tem itself [9,13],
Table II. Induction and Specificity of DTH to HSV-1
Increase in Ear Thickness
(units X 10~2 mm
Sensitized with Challenged with ± SEM)
Vero HSV-1 6.8 ± 0.92 (n = 5)"
HSV-1 HSV-1 17.7 ± 0.5 (n = 5)
Vero TNCB 9.5 ± 0.92 (n = 5)
HSV-1 TNCB 8.1 ± 0.42 (n = 5)
Acetone TNCB 9.3 ± 1.0 (n = 5)
TNCB TNCB 23.7 ± 0.68 (n = 6)
Acetone HSV-1 4.9 ± 0.52 (n = 5)
TNCB HSV-1 5.4 ± 0.76 (n = 5)
Mice sensitized on day 0 with 0.1 ml 5% TNCB in acetone, acetone alone. 1'
pfu infectious HSV-1 grown in Vero cells or 104 Vero cells alone (see Materials ai
Methods for inoculation details).
Mice challenged on day 8 with either 15 ^tl 5% TNCB in acetone on both sidi
of each ear pinna or by injection of 10* pfu UV-inactivatcd HSV-1 into each e.
pinna.
Jn = Number of mice.
VOL. 86, NO. 2 FEBRUARY 1986 UVB IRRADIATION SUPPRESSES DTH TO HSV-1 IN MICE 127





Increase in Ear Thickness (units x 10~3 mm ± SEM)










3.4 ± 0.7 (n = 5)"
13.31 ± 0.84 (n = 5)
1.45 ± 0.65 (n = 5)
2.2 ± 1.02 (n = 5)
92%
3.53 ± 0.36 (n = 8)
9.3 ± 0.73 (n = 5)
3.75 ± 0.53 (n = 6)
4.4 ± 0.47 (n = 6)
88%
2.9 ± 0.51 (n = 5)
14.0 ± 0.90 (n = 6)
3.5 ± 0.65 (n = 8)
8.6 ± 0.92 (n = 5)
54%
All mice challenged on day 8 (after sensitization) with I0h UV-inactivated pfu HSV-1 in both ear pinnae.
Jn = Number of mice.
The results described demonstrate that exposure to a single
suberythemal dose of 96 mj/cm2 UVB irradiation at a critical
time (2-7 days) prior to s.c. inoculation with infectious virus
suppressed the DTH response to HSV-1. Significant suppression
persisted for as long as tested (1 month) after UVB irradiation.
No suppression was generated if virus was injected immediately,
or 3 days prior to irradiation with the same dose of UVB. This
;uggests that skin exposed to UVB is altered over a period of
time such that immune responses against antigens encountered
up to 7 days subsequently, do not follow the "normal" pattern.
UVB irradiation is known to affect the antigen-presenting ca¬
pacity of the skin [9,10] and other organs [11], It also causes an
alteration in antigen handling such that foreign antigens subse¬
quently encountered induce the systemic generation of specific
suppressor cells. This phenomenon has been described for contact
sensitizing agents [13] and also for tumor antigens [7]. The murine
skin is reported to contain 2 functional sets of antigen-presenting
cells (APC), one sensitive to UVB irradiation and inducing pos-
:tive immunity, and the other resistant to UVB and inducing
pecific suppressor cells [16], The balance between these sets must
be delicately controlled and any factor that alters this will have
far-reaching effects on the immune response to antigens subse¬
quently encountered. Recently, it has been reported that antibody
responses to topically applied antigens are also suppressed by UV
irradiation; in this case, failure to prime due to a defect in antigen
presentation was the main mechanism postulated [17]. The effects
of UV irradiation on the antibody responses to HSV-1 are cur¬
rently being investigated.
As suppression was found to be long-lasting, it is unlikely to
be due to a loss of APC from the epidermis as it is known that
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Time of UV-B irradiation (days) with sensitization at time0(*)
Hgure 1. Kinetics of UVB induction of DTH suppression. HSV-1 (107
pfu) was used for sensitization and challenge was 8 days later with 106
UV-inactivated pfu HSV-1 in both ear pinnae. At least 5 mice were present
■ each group and SEM for each point are shown. (The increase in ear
ckness of an equivalent group of nonirradiated mice is shown, O).
within 24—48 h [18] and that animals first exposed to an antigen
2 weeks after UVB irradiation have normal DTH responses [19].
Adoptive transfer experiments are in progress to characterize
any population of immune cells induced by UVB irradiation. In
addition, the effect of irradiation on the function of epidermal
cells and other APC after HSV-1 infection is being investigated.
The authors are indebted to Drs. E. de Fabo and M. Fisher for their detailed
advice about the UVB irradiations.
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SUMMARY
In order to investigate the cellular interactions involved in the immune response to herpes simplex
virus type 1 (HSV-1) in a murine model, an in vitro antibody induction system was developed. This
comprised HSV-1-primed T cells from infected mice, trinitrophenol (TNP)-primed B cells from mice
primed with TNP-coupled calf erythrocytes, and TNP-HSV-1 as antigen. When antigen-presenting
cells (APC) were removed from the assay system, the induced antibody response disappeared but
could be reconstituted by the addition of APC derived from the peritoneal cavity or skin of normal
mice. Since HSV-1 is an epidermal pathogen, it was decided to investigate the role of skin APC in
HSV-1 immunity. Skin APC from mice irradiated 3 days previously with a suberythemal dose of
ultraviolet (UV)-B were found to have a decreased capacity to present HSV-1 antigen in vitro.
However, the APC capacity of their peritoneal cells was unaffected. The reduction in APC capacity is
not only a local effect at the irradiated site, as APC from mice exposed to UV-B with one ear protected
by black electrical tape were equally affected in both ears.
INTRODUCTION
(erpes simplex virus type 1 (HSV-1) is usually first encountered
l childhood when it causes an epidermal infection of the mouth
rea with mild fever which is often not noticed. The virus
tplicates and is thought to travel up the sensory neurones to the
igeminal ganglion where it remains latent. In some individuals
te virus is reactivated at intervals throughout life and may
;crudesce causing a lesion (cold sore) at the epidermal site of
te original infection. Recrudescence has been shown to be
•iggered by a variety of stimuli, including colds, fever, sunlight,
tenstruation, physical trauma and stress (reviewed in Mims &
Vhite, 1984).
The importance of the immune system in controlling
rimary and latent HSV-1 infection has been demonstrated
oth experimentally and in natural infections, and has been
ecently extensively reviewed (Rouse & Lopez, 1984; Wildy &
fell, 1985). However, the relative roles of the various facets of
Abbreviations: APC, antigen-presenting cells. BBS, borate-bulfered
dine; C, complement; CRBC, calf erythrocytes; EBM, Eagle's based
tedium; ESC, ear skin cells; FCS, fetal calf serum: HSV-1, herpes
implex virus type 1: LC, Langerhans cells, NCS, newborn calf serum;
1W. nylon wool passed; PBS. 0-01 M phosphate-buffered saline, pH 7-2;
C, peritoneal cells; PEC. plaque-forming cell; PFU. plaque-forming
nils; SRBC, sheep erythrocytes; Th, T helper; TNBS. 2,4,6-trinitroben-
;ne sulphonic acid; TNP. trinitrophenol; UV, ultraviolet.
Correspondence: Dr S. E. M. Howie, Dept. of Bacteriology,
Iniversity of Edinburgh Medical School, Teviot Place, Edinburgh EH8
AG, U.K.
the immune response, specific and non-specific, humoral and
cell-mediated, remain unclear.
The generation of any specific immune response to a
thymus-dependent antigen such as HSV-1 (Burns, Billup &
Notkins, 1975) initially requires antigen-presenting cells (APC).
Epidermally encountered pathogens like HSV-1 are presumably
processed and presented to specific T lymphocytes on the
surface of APC, the Langerhans cells (LC), within the skin. LC
have been shown experimentally to be susceptible to modulation
by external factors such as epidermal tape stripping and UV-B
light exposure. The former depletes skin ofepidermal LC and la
immunogenicity (Streilein, Lonsberry & Bergstresser, 1982).
The latter alters APC function in the skin in such a way that
suppressive immune responses are preferentially induced to
both tumour (Fisher & Kripke, 1978) and skin-sensitizing
antigens (Noonan et al., 1984). Both epidermal tape stripping
and exposure to UV-B light are stimuli that can cause recrudes¬
cence ofHSV-1 in murine models (Harbour, Hill & Blyth, 1983).
Thus, a stimulus that affects the generation of immunity to
epidermally encountered antigens also affects the pathogenesis
of an epidermal viral infection.
We have reported elsewhere (Howie, Norval and Maingay,
1985) that UV-B light suppresses the delayed type hypersensi¬
tivity (DTH) response to HSV-1 in a mouse model. In order to
investigate further the role of epidermal APC in HSV-1
infections, an in vitro assay for antibody production has been
developed. This is based on a system described previously for
measuring responses to tumour-specific antigens (Howie &
McBride, 1982), and allows examination of the roles of APC
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and virus-specific T helper (Th) cells in the generation of
antibody production.
Using this system in the study of the immune response in
mice after infection with HSV-1, it has been possible to
characterize virus-specific Th cells and APC from several sites
and to examine the effect of UV-B light on APC capacity. The
implications of the results obtained for understanding patho¬
genic mechanisms in HSV infections are discussed.
MATERIALS AND METHODS
Mice
C3HfBu/Kam(H-2-A) female mice aged between 8 weeks and 20
weeks were used throughout. The mice were bred and main¬
tained in the departmental animal house.
Reagents
2,4,6-Trinitrobenzene sulphonic acid (TNBS), glycyl glycine
and DNase were purchased from Sigma Chemical Co., Poole,
Dorset; Percoll from Pharmacia, Uppsala, Sweden; fetal calf
serum (FCS) from Gibco Biocult Ltd, Paisley, Renfrewshire;
RPMI-1640 from Flow Laboratories Ltd, Irvine, Ayrshire;
10 x Eagle's Basal Medium with Earle's salts (EBM), newborn
calf serum (NCS), L-glutamine and trypsin from Imperial
Laboratories Ltd, Salisbury, Wiltshire.
Sera
Monoclonal rat anti-Thy 1-2 (30-HT2) antibody was the kind
gift of Dr H. S. Micklem, Department ofZoology, University of
Edinburgh; monoclonal anti-Iak (TIB 93) (Oi et al., 1978) was
obtained from the ATCC; monoclonal anti-H-2Kk (HB5) was
the generous gift of Dr W. H. McBride, Department of
Radiation Oncology, UCLA Centre for Health Sciences, Los
Angeles, CA; monoclonal antibody YE236 against HLA-DR
which cross-reacts with Iarf but not IaA (Brickel et al., 1981) was
the kind gift of Professor I. McConnell. Department of
Veterinary Pathology, Edinburgh University; ATH anti-ATL
(anti-IaA) serum was purchased from Mercia Brocades Ltd,
Weybridge, Surrey; rabbit anti-mouse IgG enhancing serum
was prepared by repeatedly immunising a rabbit with purified
mouse immunoglobulin as described previously (Howie &
McBride, 1982).
Complement
Serum from normal outbred guinea-pigs as a source of comple¬
ment was absorbed with either sheep erythrocytes (for PFC
assays) or mouse spleen cells (for cytotoxicity).
Erythrocytes
Sheep erythrocytes (SRBC) from sheep No. R207 were the kind
gift of Mr C. Burrells, Moredun Research Institute, Edinburgh.
Calf erythrocytes (CRBC) were purchased from Tissue Culture
Services, Slough, Berks.
Virus
A clinical isolate of HSV-1 which had been plaque-purified and
whose DNA had been analysed by restriction enzymes was used
throughout. The virus was passaged in vitro in Vero cells grown
in EBM containing 5% NBS, 100 i.u./ml penicillin, 200 /(g/ml
streptomycin and 2 mM L-glutamine (complete EBM). Infei
tious virus was titrated as plaque-forming units (PFU) o
monolayers of Vero cells overlaid with complete EBM contaii
ing 0-25% Seaplaque agarose (FMC Corporation).
Trinitrophenylation of HSV-1
Virus, grown in Vero cells, was harvested from the cultui
supernatant when the cytopathic effect was well advanced an
concentrated by precipitation with 50% saturated (NH4)2S04.
was purified by caesium chloride density gradient centrifug;
tion, pooling the fractions with density 1-27-1-295 g/ml. Th
purified virus was dialysed for 48 hr against borate-buffere
saline, pH 8, (BBS) at 4°. The protein content of the viri
solution was determined by the Lowry technique. A solution c
15 mg/ml TNBS in BBS was prepared and was added to th
virus solution at a concentration of 25 pg/mg protein. Th
mixture was stirred for 1 h at room temperature in the dark an
then dialysed for 24 hr at 4° against several changes i
Dulbecco's phosphate-buffered saline, pH 7-2 (PBS). Th
trinitrophenylated virus particles were examined under th
electron microscope and seen to be still enveloped. One hundre
/rg/ml virus protein was estimated to be roughly equal to 1(
virus particles per ml.
Trinitrophenylation of erythrocytes
Trinitrophenylated SRBC and CRBC (TNP-SRBC and TNF
CRBC) were prepared as previously described (Howie I
McBride, 1982).
Immunization of mice
TNP priming. Mice were injected intraperitoneal^ with 0-
ml of 0-5% TNP-CRBC on two occasions at least 4 weeks apart
Spleens were used as a source of TNP-primed B cells at least
weeks after the last injection.
Virus inoculation. Mice were immunized with a variety o
PFU of live HSV-1 by a variety of parenteral routes (see Tabl
2). When given an initial intraperitoneal dose of I07 PFl
infectious virus, approximately 90% of C3HfBu/K.am mice agei
5-6 weeks developed neurological symptoms within 5 days am
subsequently died.
UV-B treatment
Mice were exposed to 96 mj/cm2 UV-B irradiation. This was ;
suberythemal dose and was equivalent to 20 min under tw<
Philips TL20W/12 bulbs in the UV-B apparatus in the depart
ment animal house.
Cell preparations
Peritoneal cells were obtained by lavage of the peritoneal cavit;
with 5 ml PBS.
Ear cells were prepared by a modification of the method o
Stingl et al. (1978). Ears from normal or UV-B-exposed mio
were split and incubated in 0-5% trypsin for 1 hr at 37°. The;
were removed from the trypsin, washed by immersion in PB1
and vigorously mixed on a rotamixer in PBS containing 0-051);
DNase. The resulting cell suspension was layered onto a 20/50/;
discontinuous Percoll gradient and spun at 400 g for 20 min
Subcellular debris floated on top of the 20% layer and cells wert
found at the 50% interface and in the pellet. The cells in tht
starting population were 1-3% Ia + ve by immunoperoxidasi
staining and 3-5% Fc receptor +ve by rosette formation witl
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ntibody-coated CRBC. The cells on the 50% interface (25% of
te total cells) were 10-17% Ia + ve and 15-20% Fc receptor
- ve, while the cells in the pellet had only background levels of
oth Ia + ve and Fc receptor + vc cells (< 1%). The 50% Percoll
iterface yielded 1-5 x 105 cells per mouse ear and was used as
te source of ear antigen-presenting cells.
Spleen cells were prepared by homogenization of aseptically
:moved spleens. Viable cells were determined by trypan blue
^elusion. Various subpopulations of spleen cells were separ-
ted out: (i) spleen cells were enriched for T cells by passage over
ylon wool columns (Julius, Simpson & Herzenberg, 1973); (ii)
tleen cells were depleted ofT cells by treatment with anti-Thy-1
nd complement, leaving a population of B cells and APC; (iii)
'-depleted spleen cells were incubated with carbonyl iron to
jnctionally remove APC as described previously (Howie &
'eldmann, 1978). Cells, 5 x 107, were mixed with OT g carbonyl
on at 37° for 1 hr. Cells that had taken up iron particles were
;moved from the suspension with a magnet.
Intibody-forming cell cultures
ill cultures were incubated in 200-/(1 volumes and quadrupli-
ated in 96-well microtitre plates. The medium used throughout
/as RPM1-1640 containing 5% FCS. 5 x 10 5 m 2-mercaptoeth-
nol, 100 i.u/ml penicillin, 200 /(g/ml streptomycin and 2 mm l-
lutamine (complete RPMI). Anti-Thy-1 and complement-
reated spleen cells, or the same depleted of APC, were plated at
concentration of 5 x 105 viable cells per well in the presence of 3
ig/ml TNP-HSV or 2 x 107 TNP-CRBC as antigen. Th, 5 x 10J
>er well from appropriate sources, were added, and APC as
equired. The cultures were incubated for 4 days at 37° in a
lumidified 5% C02 incubator. At the end of this time, the
[uadruplicate cultures were harvested, pooled, washed and the
lumber of direct and indirect PFC in the cultures determined by
Cunningham plaque-forming cell (Cunningham & Szenburg,
968) assay in the presence of complement and enhancing
erum. The results were calculated as the number of PFC
ounted with SRBC as indicator cells subtracted from those
ounted using TNP-CRBC and are expressed as the number of
'FC/KP input TNP-primed spleen cells.
RESULTS
rNP-HSV-1 acts as antigen in vitro
vlice were inoculated with 1(P PFU HSV-1 in the ear pinna, and
1 weeks later with 107 PFU intraperitoneal^. Eight weeks after
he second injection, spleens were removed, homogenized and
tassed over nylon wool columns to yield a population of T
ymphocytes (>95% Thy-1 +ve by immunofluorescence). The
r cells from the HSV-1-infected mice were mixed in a 1:10 ratio
vith anti-Thy-1 and complement-treated spleen cells from mice
trimed with TNP-CRBC. A range of doses ofTNP-HSV-1 were
itrated into the cell mixtures as antigen. It can be seen from Fig.
that TNP-HSV-1 induced good PFC responses at 1-10 /(g/ml
>f culture. In all subsequent experiments 3 /(g TNP-HSV-1 per
nl of culture were used.
fhe helper cells found in HSV-1-primed spleens are specific T cells
fable 1 demonstrates that the helper cells involved in generating
.nti-TNP PFC in the presence of TNP-HSV were found in
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Figure 1. Trinitrophenylated HSV-1 stimulates antibody formation by
T-cell depleted TNP-CRBC-primed spleen cells in the presence of nylon
wool-passed spleen cells from HSV-1-infected mice. For culture condi¬
tions, see 'Materials and Methods'. (O O) PFC in the presence of
nylon wool-passed HSV-1-primed spleen cells plus anti-Thy-1 and C-
trealed TNP-CRBC-primed spleen cells and TNP-HSV-1 as antigen.
(• •) PFC generated by anti-Thy-1 and C-treated TNP-CRBC-
primed spleen cells in the presence of TNP-HSV-1 as antigen.
Table 1. HSV-1 helper cells are T cells and antigen-
specific
Antigen Helper cell source PFC/10" cells*
None None 80
TNP-CRBC None 120
TNP-CRBC NW TNP-CRBC spleen 1300
TNP-CRBC NW HSV-1 spleenf 150
TNP-HSV-1 None 60
TNP-HSV-1 NW TNP-CRBC spleen 10
TNP-HSV-1 Whole HSV-1 spleen 860
TNP-HSV-1 NW HSV-1 spleen 1520
TNP-HSV-1 Anti-Thy-1 and C-treated
HSV-1 spleen 190
* Number of PFC generated by 2-5 x Kb/ml TNP-
CRBC primed, anti-Thy-1 and C-treated spleen cells
reconstituted with 2-5 x 105/ml helper cells as shown in
the presence of either 107/ml TNP-CRBC or 3 /(g/ml
TNP-HSV-1 as a source of antigen.
t Mice inoculated with 106 PFU infectious HSV-1
into the ear pinna 4 months previously and with 107 PFU
3 months previously.
anti-Thy-1 and complement-treated spleen cells of HSV-1-
infected mice. The cells did not act as helper cells when TNP-
CRBC was used as antigen. Thus, HSV-1-specific Th cells (Th-
HSV-1) were present in the spleens of HSV-1-infected mice.
HSV-l-specific Th cells are present in the spleens of mice
inoculated with a variety of doses of virus by a variety of
parenteral routes
Table 2 shows that mice inoculated with a variety of doses of
HSV-1 by a variety of parenteral routes had good levels of Th-
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Table 2. HSV-1-specific T-helper cells are found in the spleens of mice infected by
different routes
HSV-1 infections (PFU infectious virus injected)
PFC without PFC with
1st inj. Interval 2nd inj. Interval until use T,,HSV-1 * T„HSV-lt
10® ear pinna 24 days 10' i.p. 59 days 10 1970
10® ear pinna 24 days 10' ear pinna 83 days 60 1520
5x10® s.c. flank 20 days 5 x 10' i.p. 17 days 70 1450
3 x 10Jear pinna 8 days 10® UVJ ear
pinna 9 days 80 1250
10® i.p. — — 31 days 30 910
* Number of PFC generated by 2-5 x 106/mlTNP-CRBC primed, anti-Thy-1 and C-
treated spleen cells in the presence of 3 /rg/ml TNP-HSV-1 as a source of antigen.
t As above, but with the addition of 2-5 x 105/ml nylon wool-passed spleen cells
from HSV-1-infected mice.
% UV-B inactivated (1 hr exposure) virus used.
HSV-1 in their spleens as long as 4 months after initial exposure
to virus. In all cases, the Th were antigen-specific (data not
shown).
The antibody response to TNP-HSV can be APC-depleted and
reconstituted with APC from the peritoneal cavity and ear skin
It can be seen in Table 3 that incubation of anti-Thy-1 and
complement-treated TNP-primed spleen cells with carbon;
iron depleted the response to TNP-HSV in the presence of Ti
HSV-1. The antibody response was restored by the addition c
APC derived from the peritoneal cavity or from ear skin. Thi
restoration can be blocked by pretreatment of the APC wit
either polyclonal or monoclonal anti-IaA, but not by monoclor
al anti-H-2KA antibody or monoclonal anti-la1' antibody.
Table 3. APC-depleted spleen cells can be reconstituted by cells derived from the peritoneal cavity
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* APC from normal mice.
t APC were incubated at 10®/ml with the stated final concentrations of antibodies for 2 hr at 4 .
The cells were then washed three times with 20 ml PBS and added to APC-depleted cultures. For
details of antibodies, see 'Materials and Methods'.
t All cultures (except controls) consisted of 2-5 x 106/ml APC and T-cell depleted TNP-CRBC
primed spleen cells+ 3 /rg/ml TNP-HSV-1 +2-5 x 107ml nylon wool-passed HSV-1-primed spleen
cells.
§ PFC/10® cells expressed as a percentage of the number obtained in non-APC-depleted cultures
(see controls).
c PC, peritoneal cells.
** ND, not determined,
ft ESC, ear skin cells.
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ie APC function of ear skin cells but not of peritoneal cavity cells
diminished by in vivo exposure to UV-B light
was previously shown that UV irradiation of mice with a
berythemal dose of 96 mJ/cm2 3 days before (but not 5 hr
•fore or 3 days after) inoculation with live HSV-1 suppressed
e DTH response to HSV-1 (Howie, Norval & Maingay, 1985).
order to examine this further, the APC function of ear skin
lis that had been pre-exposed to UV-B 3 days before use in
tro was tested and compared with the APC function of
iritoneal cells from the same animals. The results of three
parate experiments are shown in Fig. 2. At the level of 10% ear
Table 4. Reduction in APC capacity of ear skin cells


















Ear skin cells '
10% 1%
1—Peritoneal—1
gure 2. All cultures consisted of 2-5 x lO'/ml APC and T-cell depleted
NP-CRBC-primed spleen cells + 3 ng/ml TNP-HSV-1 +2-5 x 105/ml
/Ion wool-passed HSV-1 -primed spleen cells. APC were obtained from
ormal (•) mice or mice UV-irradiated 3 days before use in vitro (O).
he percentage reconstitution was calculated as the number of PFC/106
ills expressed as a percentage number obtained in non-APC-depleted
lltures as detailed in Table 3. Each point represents one experiment.
PFC/10" cellst
APC source (% reconstitution)J
None 40 (3)
Normal PC 10% 1320 (87)
Normal PC 3% 1170 (77)
Normal PC 1% 930 (62)
UV-B PC 10% 1280 (85)
UV-B PC 3% 1180 (78)
UV-B PC 1% 860 (57)
Normal ESC 10% 1530 (100)
Normal ESC 3% 1470 (97)
Normal ESC 1% 1060 (70)
UV-B ESC taped 10% 1140 (75)
UV-B ESC taped 3% 490 (32)
UV-B ESC taped 1% 270(18)
UV-B ESC untaped 10% 990 (66)
UV-B ESC untaped 3% 500 (33)
UV-B ESC untaped 1% 320 (21)
Controls
Undepleted + TNP-HSV-1 60
Undepleted + TNP-HSV-1+Th-HSV-1 1510
* APC from peritoneal cavity and ear skin of normal mice
and mice irradiated in vivo with 96 mJ/m2 UV-B with one ear
protected by black electrical tape (six mice per group).
t All cultures (except controls) consisted of 2-5 x 106/ml
APC and T-cell depleted TNP-CRBC primed spleen cells + 3
/rg/ml TNP-HSV-1+2-5 x 10s nylon wool-passed HSV-1-
primed spleen cells.
t PFC/106 cells expressed as a percentage of the number
obtained in non-APC-depleted cultures (see controls).
§ Response of non-APC-depleted cultures.
cin cells in the test system, both irradiated and non-irradiated
ells could reconstitute the antibody response. However, at the
;vel of 1% and 0 1% ear skin cells in the test system, there was
iminished ability to present HSV-1 antigens if the mice had
een UV-irradiated (P= <0-001 by Student's /-test). The
jnction of the peritoneal APC was not altered by UV
radiation. This may suggest that there are fewer functional
iPCs in irradiated skin. Limiting dilution assays are being
erformed to test this.
leduction in APC capacity of ear skin cells following in vivo UV-
i light exposure is not just a local effect
Vhen mice were irradiated with UV-B light as above, but with
■ne ear protected by black electrical tape, the reduction in APC
apacity was found in both the taped and untaped ears. The tape
id not allow penetration of any UV light. The APC capacity of
ieritoneal cells from the same mice was unaffected. This
xperiment was performed three times with the same results, and
he data from one experiment are shown in Table 4. Taped and
intaped ears from non-UV-irradiated mice were also compared,
nd there was no difference in their ability to present antigen in
itro (data not shown).
DISCUSSION
In vivo UV-B has been shown to deplete skin of LC (Toews,
Bergstresser & Streilein, 1980) and to induce preferentially the
formation of T suppressor cells to tumour antigens (Fisher &
Kripke, 1978), contact sensitizing antigens (Noonan et at., 1984)
and photosensitizing antigens (Takigawa et at., 1984). UV-B
exposure has also been shown to deplete skin of APC function in
vivo (Perry & Greene. 1982) and in subsequent in vitro assays
(Stingl et at., 1981), and to deplete LC of their surface markers
(Aberer et at., 1981).
It has recently been shown, however, that the alterations in
epidermal density and morphology of LC after UV irradiation
occur at a different wavelength from that which induces
systemic suppression of contact hypersensitivity (Noonan et at.,
1984; Morrison, Bucana & Kripke, 1984). LC then may not be
directly responsible for the suppression but may interact in some
way with a UV-induced photoformat. Alternatively, Granstein,
Lowy & Green (1984) have recently reported a novel skin APC
in UV-B irradiated skin which is I-J + ve, UV-resistant, and
may be the APC responsible for T-suppressor cell generation.
We have previously shown that DTH responses to HSV-1 in
vivo can be suppressed by pre-exposure of mice to a suberythe-
mal dose of 96 mJ/cm2 UV-B 3 days before infection with virus.
Exposure to the same dose of UV-B immediately before or 3
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days after inoculation with live HSV-1 had no effect on DTH
(Howie, Norval & Maingay. 1985). In accordance with the work
of Noonan et al. (1984), who measured DTH to the skin-
sensitizing agent TNCB. these results suggest that there is a
critical time after exposure to UV-B light, during which the
ability of the skin to handle antigen is altered. For this reason,
we decided to investigate the effects of UV-B exposure on the
ability of skin cells to present HSV-1 antigens in more detail.
The experiments described here show: (i) that skin cells from
normal mice can present HSV-1 antigens in an in vitro antibody-
induction system, (ii) that pre-exposure to UV-B 3 days before
use in vitro diminishes the capacity of ear skin cells to present
HSV-1 antigens, but does not alter the APC capacity of
peritoneal cells from the same animals, and (iii) that the UV-B-
induced reduction in APC capacity is not local to the site of
irradiation.
Given the importance of the immune system in controlling
HSV-1 infection, any stimulus that alters the immune response
to epidermally encountered antigens may affect the pathogene¬
sis of primary and possibly of recrudescent HSV-1 infections
also. It is tempting to speculate that one factor which may
determine the outcome of primary HSV-1 infection is the initial
type of immune response generated. If the virus is encountered
at a time when the APC capacity of the epidermis has been
altered by some stimulus, the initial immune response to HSV-1
may not be wholly appropriate. It is not known what effect this
might have on the interaction of HSV-1 with the host or, indeed,
what effect this might have on the establishment of latency and
the frequency of recrudescences. We are currently investigating
these areas.
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Two phenotypically distinct T cells (Lyl+2~ and Lyl~2+)
are involved in ultraviolet-B light-induced suppression
of the efferent DTH response to HSV-1 in vivo
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SUMMARY
We have previously demonstrated that the delayed-type hypersensitivity (DTH) response to herpes
simplex virus type 1 induced by subcutaneous injection with live virus was suppressed by irradiating
mice with a low dose (96 mJ/cm2) ofultraviolet-B (UV-B) light 3 days before sensitization. In order to
determine the nature of the suppression, cells from mice irradiated with UV-B before immunization
with live virus were transferred to syngeneic animals that had been sensitized with live virus without
prior UV-B exposure. Efferent suppression of DTH to HSV-1 was shown to be due to T lymphocytes,
and two phenotypically distinct T cells were involved: an Lyl+2~ subset and an Lyl~2+ subset.
INTRODUCTION
Herpes simplex virus (HSV) is a major human epidermal
pathogen. In some individuals the virus becomes latent and may
recrudesce at varying intervals throughout life. The immune
response has been shown to be important in determining the
outcome ofboth primary and recrudescent infections, but which
arms of the response are most crucial in the various stages of the
host-virus interaction is not yet clear. It is known that cell-
mediated immunity is ofparamount importance in both clearing
viral infection and controlling recurrences (reviewed in Nash,
1985). Any environmental stimulus that transiently depresses
cell-mediated immunity generated at an epidermal site may have
profound effects upon the nature of the host-virus balance
initiated by primary exposure to the virus at around the same
time. Irradiation with UV-B light represents one such stimulus.
We have previously reported that DTH to HSV-1 in a
murine model can be suppressed by irradiation of the mice with
96 mJ/cm2 ultraviolet-B (UV-B) light 3 days before sensitization
with live virus (Howie, Norval & Maingay, 1986a). We have also
demonstrated that epidermal antigen-presenting cells (APC)
from mice similarly irradiated have a diminished ability to
present HSV-1 antigens to HSV-1 T-helper cells in vitro (Howie,
Norval & Maingay, 1986b). In order to investigate further the
cellular nature of the UV-B-induced suppression of DTH to
Abbreviations: APC, antigen-presenting cell; DTH, delayed-type
hypersensitivity; HSV-1, herpes simplex virus type 1; PBS, Dulbecco's
phosphate-buffered saline; Tdh, T effector cell for delayed-type hyper¬
sensitivity; TNCB, l-chloro-2,4,6-trinitrobenzene; Ts, T-suppressor
cell; UV-B, ultraviolet-B light.
Correspondence: Dr S. E. M. Howie, Dept. of Bacteriology,
University Medical School, Teviot Place, Edinburgh EH8 9AG, U.K.
HSV-1 a series of cell transfer experiments was performed. The
results of these experiments are presented here.
MATERIALS AND METHODS
Mice
C3Hf Bu/Kam female mice aged 10-12 weeks were used
throughout. The mice were bred and maintained in the Depart¬
ment of Bacteriology animal house.
Virus
A clinical isolate of HSV-1, the DNA of which had been
analysed using restriction endonucleases, was used throughout.
The virus was cultured in Vero cells and assayed for plaque-
forming units (p.f.u.) per ml as described previously (Howie,
Norval & Maingay, 1986c).
TNCB
l-chloro-2,4,6-trinitrobenzene, picryl chloride containing 20%
H20 was purchased from BDH Ltd, Poole, Dorset. A 2%
solution (w/v) was made up in acetone immediately before use.
Antibodies
Rat monoclonal anti-mouse Ly-1 (TIB 104) and anti-mouse Ly-
2 (TIB 105) antibodies were purchased from the American Type
Culture Collection. Rat anti-mouse Thy 1.2 (30H12) was the
kind gift of Dr H. S. Micklem, Department of Zoology,
Edinburgh University. Rabbit anti-rat IgG was purchased from
Sigma U.K. Ltd, Poole, Dorset.
DTH assay
This has been described elsewhere (Howie et al, 1986a). In brief,
mice were sensitized by subcutaneous injection in the right flank
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with 5 x 106 p.f.u. HSV-1 grown in Vero cells. Control mice were
sensitized with an equivalent number (104) of sonicated unin¬
fected Vero cells. Mice were tested for DTH to HSV-1 between 8
days and 14 days after sensitization. Before challenge, mice were
tail-marked with indelible ink and their ear thicknesses were
measured. Challenge consisted of the equivalent of 106 p.f.u. of
HSV-1, which had been inactivated by UV-B irradiation for 1
hr. The challenge was administered by injecting 10 p\ UV-
inactivated virus into each ear pinna. Twenty-four hours later,
ear thickness was again measured and the DTH calculated as the
average ear increase per mouse. In order to induce DTH to
TNCB, mice were painted with 100 ^1 of a 2% solution of picryl
chloride in acetone on shaved abdomens. Mice were challenged
by painting 10 /d of a 2% solution of picryl chloride in acetone
on both sides of the ear pinnae. Ear thickness was measured
immediately before and 24 hr after challenge, as described for
HSV-1 above.
Suppression ofDTH
In order to induce suppression of DTH to HSV-1, mice were
irradiated for 20 min under two Phillips TL20/12 bulbs, which
gave a dose of 96 mJ/cm2 on the shaved backs of the mice as
described previously (Howie et al., 1986a). Mice were irradiated
in a high-sided perspex box in which they could not turn around.
The ears of the mice were protected from UV-B irradiation by
opaque tape, which did not allow any UV-light to penetrate.
Suppression of DTH was determined by the formula:
% suppression = 100 —
100 x net increase of UV mice
net increase of control mice
as described by Noonan et al. (1984).
Cell transfers
Cells from spleens of HSV-l-sensitized mice and from mice
irradiated with UV-B 3 days before sensitization with HSV-1 or
TNCB were treated appropriately (see below) and injected
intravenously into recipient mice 24 hr before ear challenge.
Cell separations
Cells were enriched for Thy-1 + ve cells by passage over nylon-
wool columns (Julius, Simpson & Herzenberg, 1973). This ga\
a population of cells >95% Thy-1 + ve by immunofluorescence
Cells were depleted of Thy-1 + ve cells by treatment with ant
Thy 1.2 serum and guinea-pig complement. This gave
population of cells < 10% Thy-1 + ve by immunofluorescenc.
For depletion of Ly-1 and Ly-2 bearing cells, nylon-wool passe
spleen cells were treated with the appropriate monoclon;
antibodies. The rat monoclonal antibodies TIB 104 and TIB 1C
were not cytotoxic. Spleen cells were incubated with thes
antibodies for 1 hr at room temperature. They were then washe
twice with PBS and incubated for 30 min at room temperatur
with a rabbit anti-rat immunoglobulin serum (which had bee:
absorbed previously with mouse spleen cells to remove anti
mouse activity), washed twice with PBS and incubated for 1 h
at 37° in guinea-pig complement, which had been previousl-
absorbed with mouse spleen cells. Control cells for transfer wer
treated as above with anti-rat Ig and complement only.
The percentage viable cells left after killing with the variou
antisera was determined by trypan blue dye exclusion; for th
anti-Ly-1 antibody (TIB 104) plus the anti-Ly-2 antibody (TII
105) this was 48 ±4%, for the anti-Ly-1 antibody alone 37 + 3%
for the anti-Ly-2 antibody alone 24 + 2%, and for the contrc
(i.e. cells treated with anti-rat Ig and complement only) 8 + 1%
These values were averaged over all experiments performec
+ standard error.
RESULTS
DTH to HSV-1 is transferable by an Ly-1 + ve 2 —ve T cell
We have previously reported that antigen-specific DTH to
HSV-1 can be induced by subcutaneous immunization with live
virus (Howie etal., 1986a). In order to determine which cell type
was responsible for the DTH response, spleen cells from mice
sensitized 8 days previously were transferred into naive syn¬
geneic recipients. Twenty-four hours later, the ears of the
recipient mice were challenged with UV-inactivated virus and
the 24-hr DTH response measured. Table 1 shows that the cell
responsible for the DTH response is an Ly-l+2~ T cell.
Table 1. Ly phenotype of transferable Tdh
Exp. 1 Exp. 2
Nylon-wool passed
Sensitization spleen cells transferred Increase in ear thickness % maximum Increase in ear thickness % maximum
(Day 0) (Day 8) (units x 10~2 mm) response (units x mm""2) response
104 Nil 3-00 + 0-37 (n= 11) 2-00 + 0-2(71 = 6)
107 HSV-1 Nil 14-48 ±1-02 (/!= 11)5[ 100 10-90 + 0-89 (71 = 5)11 100
Nil RIG + C only" 10-90 + 0-69 (n = 5)1f 67 9-00+1-25 (71 = 5)11 76
Nil Lylt 3-37 ±0-39 (/z = 7)
'•
6 2-15 + 0-33 (TI = 5) 4
Nil Ly2f 11-17±1-25(TI = 6) 71 8-25 + 0-25 (7i = 5)1I 70
Nil Ly 1 + Ly2§ 3-89 + 0-89 (TI = 7) 11 ND ND
n = number of mice per group.
* Spleen cells from mice sensitized with HSV-1.8 days previously, passed over nylon wool and treated with anti-rat
immunoglobulin and guinea-pig complement alone (3 x 106 cells transferred per mouse). -
t Spleen cells as above but also treated with TIB 104 (3 x 106 cells transferred per mouse).
+ Spleen cells as above but also treated with TIB 105 (3 x 106 cells transferred per mouse).
§ Spleen cells as above but also treated with TIB 104 and TIB 105 (3 x 106 cells transferred per mouse). •
If Significantly different from control value (P< 0-001 by Student's /-test).
Suppression of efferent DTH response to HSV-1
Table 2. UV-B-induced suppression of DTH to HSV-1 is transferable by spleen cells
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No. spleen cells Increase in ear
UV-B irradiation Sensitization transferred i.v. thickness %
(Day —3) (Day 0) (Day 8) (units x 10~2 mm) suppression
Nil 104 Vero Nil 3-0±0-35 (n=10) —
Nil 107 HSV-1 •Nil 11-25 + 0-56 (n = 6)t —
96 mJ/cm2* 107 HSV-1 Nil 4-43+0-53 {n = 4)J 83
Nil 107 HSV-1 3x 107 5-8±0-64 (n = 5)t 66
Nil 107 HSV-1 107 6-13 ± 1 -45 (n = 5)t 62
Nil 107 HSV-1 3x 106 10-70 ± 0-95 (n = 5) 7
Nil IO7 HSV-1 106 13-0±0-87 (n = 5) —
All mice were challenged on Day 9 with 106 UV-inactivated p.f.u. HSV-1 in both
ear pinnae; n — number of mice per group.
* This group of mice provided the spleen cells used for transfer,
f Significantly different from control value (f< 0-001 by Student's /-test).
£ Significantly different from positive response (PcO-Ol by Student's (-test).
Spleen cells transfer the UV-B-induced suppression of efferent
DTH to HSV-1
We have previously reported that DTH to HSV-1 can be
specifically suppressed by irradiating dorsally shaved mice with
96 mJ/cm 2 UV-B light 3 days before sensitization with HSV-1.
This was a systemic effect that was not restricted to the
irradiated site since the ears of the mice are protected by tape
that allowed no penetration of UV-B (Howie et at., 1986a). In
order to determine which cells were responsible for the in vivo
suppression of DTH, spleen cells from UV-B-suppressed mice
were transferred to syngeneic recipients that had been sensitized
to live virus 8 days previously. Twenty-four hours later, the mice
were challenged in the ears with inactivated virus and the degree
of suppression of DTH determined. Table 2 shows that spleen
cells transfer the suppression of DTH in a titratable fashion.
The transferable UV-B-induced suppressor cell is a T cell
In order to determine which cell type was responsible for the
transferable suppression, spleen cells from UV-B-suppressed
animals were separated into T-cell enriched (nylon-wool passed)
and T-cell depleted (anti-Thy-1- and complement-treated)
populations. The separated cells were then injected intra¬
venously into syngeneic recipients that had been sensitized with
live virus 8 days previously. Twenty-four hours later, the ears
were challenged with inactivated virus. Table 3 demonstrates
that the suppressor cell is a T lymphocyte.
Ly-l+2~ and Ly-1~2+ T cells are responsible for the transfer of
UV-R-induced suppression of DTH to HSV-1
Nylon-wool passed spleen cells from UV-B-suppressed mice
Table 3. The transferable UV-B-induced suppressor of DTH to HSV-1 is a T lymphocyte
Spleen cells
UV-B irradiation Sensitization transferred Increase in ear thickness %
(Day-3) (Day 0) (Day 8) (units x 10-2 mm) suppression
Nil 104 Vero Nil 2-96 ±0-58 (/t= 10)
Nil 107 HSV-1 Nil 11-43 ±0-78 (n = 6)§ —
96 mJ/cm2 107 HSV-1 Nil 3-65 ±0-64 (n = 5)H 91
Nil 107 HSV-1 3 x 107 whole spleen* 4-97 + 0-73 (/i = 9)1f 75
Nil 107 HSV-1 107 nylon wool spleenf 4-16±0-94 (// = 6)§ 80
Nil 107 HSV-1 3 x 107 Thy-1 + C spleenf 9-00 ±0-39 (n = 8) 28
n = number of mice per group.
* Spleen cells from mice irradiated with 96 mJ/cm2 UV-B 8 on Day —3 and injected with 107
p.f.u. HSV-I.
t Spleen cells as above but passed over nylon wool (> 95% Thy-1 + ve by immunofluorescence).
J Spleen cells as above but treated with anti-Thy-1 monoclonal antibody and complement
(< 10% Thy-1 + ve by immunofluorescence).
§ Significantly different from control value (P< 0-001 by Student's /-test).
U Significantly different from positive response (P<0-01 by Student's /-test).
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(units x 10-2 mm) % suppression
Nil lO4 Vero Nil 3-00 ±0-37 (//= 11) — 1-5 ± 0-5 (n = 8) —
Nil 107 HSV-1 Nil 14-48± 1-02 (n=ll)tt 0 11-5 ± 1-3 (n = 6)ft 0
96 mJ/cm2 107 HSV-1 Nil 5-38 ±1-31 (n = 4)§§ 78 4-0 ±0-9 (n = 4)§§ 74
Nil 107 HSV-1 RIG + C onlyf 6-92±0-56(/i = 6)t+ 66 2-8 ±0-8 (n = 5)tt 84
Nil 107 HSV-1 Lyl treated§ 8-63 ±0-48 (« = 6)tJ 51 4-0 ±0-8 (n = 5)t: 74
Nil 107 HSV-1 Ly2 treated^ 6-89 ±0-94 (n = T)ii 66 4-7+1-1 (n = 5)§§ 66
Nil 107 HSV-1 Lyl + Ly2 treated** 14-25 ± 0-88 (n = 7) 9 9-0 ± 1-5 (n = 5) 30
n = number of mice per group.
* No. of cells transferred in Exp. 1 =3 x 106 per mouse,
f No. of cells transferred in Exp. 2 = 2x 107 per mouse.
X Spleen cells from mice exposed to 96 mj/cm2 UV-B 11 days previously and 107 p.f.u. HSV-1 8 days previously, nylon-wool
passed and treated with rat immunoglobulin and complement alone.
§ Spleen cells as in above but also treated with TIB 104.
1f Spleen cells as in above but also treated with TIB 105.
** Spleen cells as in above but also treated with TIB 104 and TIB 105.
ft Significantly different from control value (P < 0 001 by Student's /-test).
Significantly different from positive response (P< 0-001 by Student's /-test).
§§ Significantly different from positive response (PcO-01 by Student's /-test).
Table 5. Specificity of the UV-B-induced Ts cells
Nylon-wool passed
spleen cells
UV-B irradiation Sensitization transferred Challenge* Increase in ear thickness
(Day-3) (Day 0) (Day 8) (Day 9) (units x 10~2 mm) % suppression
Nil Nil Nil HSV-1 2-25 ± 0-70 (* = 7)
Nil Nil Nil TNCB 5-29 + 0-78 (n = 7) —
Nil 107 HSV-1 Nil HSV-1 14-53 + 0-69 (« = 9) 0
Nil 2% TNCB Nil TNCB 25-15± 1-06 (n = 5) 0
96 mJ/cm2 107 HSV-1 Nil HSV-1 8-88 ± 0-72 (n = 4) 48
96 mJ/cm2 2% TNCB Nil TNCB 16-40+1-04 (n = 5) 47
Nil 107 HSV-1 3x 107, UV-B-HSV-lf HSV-1 5-81 ±0-47 (n = 4) 71
Nil 107 HSV-1 3 x 107, UV-B-TNCBt HSV-1 16-30 ±1-20 (n = 5) 3
Nil 2% TNCB 3x 107, UV-B-HSV-1 TNCB 25-30 ± 1-24 {n = 5) 6
Nil 2% TNCB 3 x 107, UV-B-TNCB ■ TNCB 16-55 ±0-94 (n = 5) 46
Nil 107 HSV-1 3x 106, UV-B-HSV-1,
Anti-RIG + C§ HSV-1 7-15± 1-00 (zi = 5) 60
Nil 107 HSV-1 3x 106, UV-B-HSV-1, LylK HSV-1 8-00 ±1-19 (n = 5) 51
Nil 107 HSV-1 3x I06, UV-B-HSV-1, Ly2** HSV-1 7-20 ±1-00 {n = 5) 60
Nil 107 HSV-1 3 x 106, UV-B- HSV-1,
Lyl ft, Ly2 HSV-1 12-35 ± 0-73 (n = 5) 14
Nil 2% TNCB 3x 106, UV-B-HSV-1, Lyl TNCB 25-75 + 1-08 (n = 5) 5
Nil 2% TNCB 3x IO6, UV-B-HSV-1, Ly2 TNCB 24-30 ± 1-32 (n = 5) 9
n = number of mice per group.
Mice were challenged either by injecting 106 p.f.u. UV-B-inactivated HSV-I in both ear pinnae, or by painting both
ear pinnae with 15 //I 2% TNCB in acetone.
f Nylon-wool passed spleen cells from mice treated with 96 mJ/cm2 UV-B on Day —3 and HSV-1 s.c. on Day 0.
J Nylon-wool passed spleen cells from mice treated with 96 mJ/cm2 UV-B on Day —3 and 100 /d 2% TNCB in
acetone on shaved abdomen on Day 0.
§ Cells as above but treated with rabbit anti-rat Ig and complement only.
Cells as above but treated with TIB 104.
** Cells as above but treated with TIB 105.
ft Cells as above but treated with TIB 104 and TIB 105.
Suppression of efferent DTH response to HSV-1 657
/ere treated with (a) anti-Ly-1 serum, (b) anti-Ly-2 serum, (c)
nti-Ly-1 and anti-Ly-2 serum, or (d) anti-rat Ig and compo¬
nent only, as described in the Materials and Methods. The
reated cells were then transferred into syngeneic recipients that
iad been sensitized with live virus 8 days previously. After 24 hr
■Tie ears were challenged with inactivated virus and the 24-hr
DTH response determined. Table 4 shows that both Ly-l+2~
nd Ly-1"2+ T suppressor cells are involved. Suppression was
inly abrogated by treating simultaneously with anti-Ly-1 and
.nti-Ly-2 serum.
specificity of the transferable UV-B-induced T-suppressor cells of
■OTH to HSV-1
n order to determine the specificity of the transferable T-
uppressor cells, cross-over experiments were performed using
nice sensitized to either HSV-1 or TNCB. Spleens from animals
hat had been UV-B-irradiated 3 days before sensitization with
dther HSV-1 or TNCB were removed 8 days after sensitization.
The spleen cells were passed over nylon-wool columns and
reated with antibodies to Ly-1 or Ly-2 antigens. Table 5 shows
hat all the HSV-1 T-suppressor cell populations examined were
pecific, in as much as they did not suppress DTH to TNCB. The
ine specificity of the T cells in terms of their reactivity with other
'iral antigens is being examined.
DISCUSSION
Delayed-type hypersensitivity to HSV-1 has been extensively
tudied in murine model systems (Nash, Field & Quartey-
'apafio, 1980; Schrier, Pizer & Moorhead, 1983a; reviewed in
<ash, 1985). The DTH has been shown to be specific and under
he control of the I region of the H-2 complex (Nash, Phelan &
Vildy, 1981b). The DTH has been clearly demonstrated to be
mportant in viral clearance (Nash et at., 1981b). T-cell
uppression of DTH to HSV-1 has also been extensively studied
Nash, Gell & Wildey, 1981a; Shrier, Pizer & Moorhead, 1983b;
eviewed in Nash, 1985).
The DTH response may be suppressed at either the afferent
>r efferent level, or at both levels. T-suppressor cells are
esponsible for the suppression of both afferent and efferent
DTH. The suppression of DTH to HSV-1 is specific in all cases,
ihrier et al. (1983b) demonstrated that the intravenous inocula-
ion of a temperature-sensitive mutant of HSV-1 would induce
ransferable T-suppressor cells capable of suppressing both
fferent and efferent DTH to HSV-1, whereas the injection of
irally infected syngeneic spleen cells induced transferable T,
/hich would only suppress efferent DTH. Using a non-
athogenic strain of HSV-1 injected intravenously to induce
uppression of DTH to HSV-1, Nash & Gell (1983) demon-
trated that two phenotypically distinct T, cells were involved in
uppression for afferent DTH to HSV-1, one being Ly-l+2~ and
re other Ly-1~2+.
Ultraviolet-B light is an external environmental stimulus
iat has been implicated in triggering HSV-1 recrudescence
Vheeler, 1975). UV-B is also a stimulus that is well known to
lduce systemic T-suppressor cells of DTH specific for antigens
:en by the epidermis at a critical time after irradiation (Noonan
et al., 1984; Morrison, Bucana & Kripke, 1984). We have,
previously reported (Howie et al., 1986a) that irradiation of
mice with 96 mJ/cm2 UV-B 3 days before subcutaneous injection
with live pathogenic HSV-1 abrogates the DTH response
normally generated. The present report demonstrates that this
suppression is mediated by transferable T suppressor cells.,Two
phenotypically distinct Ts subsets, one Ly-1 +2" and one Ly-
1~2+, are responsible for the efferent suppression of DTH to
HSV-1. Both T, subsets are 'specific', i.e. they do not suppress
DTH to the skin-sensitizing agent, picryl chloride; our experi¬
ments to date do not, however, distinguish between a specific
effector cell reaction or a specific induction of a non-specific
event. We are examining this in greater detail.
The ability of a low (suberythemal) dose ofUV-B irradiation
to induce Ts to epidermal antigens during a period of 2-10 days
after irradiation (Howie et al., 1986a) may be of crucial
importance in determining the outcome of infection by epider¬
mal pathogens during this time. In particular, when a persistent
pathogen such as HSV-1 is involved, this may lead to a 'deviant'
immunological balance being established between the host and
the virus. Such an imbalance may be a factor in determining
whether a primary infection becomes latent or in tipping the
host-virus balance towards recrudescence of an already latent
infection. We have also previously reported (Howie et al.,
1986b) that irradiation of the epidermis with 96 mJ/cm2 UV-B
light induces an alteration in the ability of epidermal cells to
induce systemic T-suppressor cells of DTH specific for antigens
seen by the epidermis at a critical time after irradiation (Noonan
et al., 1984; Morrison et al., 1984). We have previously reported
(Howie et al., 1986a) that irradiation of mice with 96 mJ/cm2
UV-B 3 days before subcutaneous injection with live pathogenic
HSV-1 abrogates the DTH response normally generated. The
present report demonstrates that this suppression is mediated by
transferable T-suppressor cells. Two phenotypically distinct Ts
subsets, one Ly-l+2_ and one Ly-1~2+, are responsible for the
efferent suppression of DTH to HSV-1. Both Ts subsets are
'specific', i.e. they do not suppress DTH to the skin-sensitizing
agent, picryl chloride; our experiments to date do not, however,
distinguish between a specific effector cell reaction or a specific
induction of a non-specific event. We are examining this in
greater detail.
The ability of a low (suberythemal) dose ofUV-B irradiation
to induce Ts to epidermal antigens during a period of 2-10 days
after irradiation (Howie et al., 1986a) may be of crucial
importance in determining the outcome of infection by epider¬
mal pathogens during this time. In particular, when a persistent
pathogen such as HSV-1 is involved, this may lead to a 'deviant'
immunological balance being established between the host and
the virus. Such an imbalance may be a factor in determining
whether a primary infection becomes latent, or in tipping the
host-virus balance towards recrudescence of an already latent
infection. We have also previously reported (Howie et al..
1986b) that irradiation of the epidermis with 96 mJ/cm2 UV-B
light induces an alteration in the ability of epidermal cells to
present HSV-1 antigens in vitro. Skin cells from mice irradiated
with UV-B 3 days before being used as APC have a diminished
ability to present HSV-1 antigens in vitro as compared with non-
irradiated controls. The effect of this alteration in APC capacity
of the epidermis is being examined in the light of the concomi¬
tant induction of T, cells for DTH to HSV-1 in irradiated
animals.
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The effect of UV-irradiation on viral infections of the skin
M Norval,* S Howie, J Ross & J Maingay
The effect on the skin of exposure to relatively small doses of ultraviolet light has long been thought beneficial and
socially desirable, leading to a 'healthy tanHowever it is less well known that similar (ifnot smaller) doses of UV-B
radiation can have transient but profound depressive effects on the immune response to antigens or pathogens
encountered by the skin. The result of this on the immunopathology of both primary and recurrent episodes of
persistent viral infections of the epidermis is discussed.
Skin as an immunologically competent organ
In recent years, the skin has been recognized as playing
an important role in the recognition of, and response to,
foreign antigens.1-2 This immune surveillance is of
crucial importance as, throughout life, the epidermis
is constantly exposed to various insults including
mechanical injury, chemicals such as irritants and
contact sensitizing agents, physical agents like ultra¬
violet light (UV) as well as microbial pathogens.
The complexities of the interactions between the
epidermal cells, the dermis, local lymph nodes and the
peripheral immune system are beginning to be under¬
stood. Pivotal in this are the Langerhans cells (LCs) of
the epidermis, first recognized by Paul Langerhans in
1868. These cells are known to act as the antigen pre¬
senting cells (APCs) of the immune system. They
process foreign antigen and present it to T-lymphocytes
in association with Class II antigens of the Major Histo¬
compatibility Complex (MHC). LCs are dendritic in
nature, bone-marrow derived and have the ability to
move from the epidermis into the afferent lymphatics
Figure 1. Section of epidermis showing epidermal cells
becoming more keratinized as they reach the surface, a
Langerhans cell (LC), a melanocyte (M) and a lymphocyte
(Ly). In the dermis are blood vessels, stromal cells and cells of
the lymphatic system.
'"Department of Bacteriology, University of Edinburgh Medical
School, Teviot Place, Edinburgh EH8 9AG.
Received 31 January, 1986.
and so to the draining lymph nodes where they may act
as dendritic APCs.3 Epidermal keratinocytes produce
an interleukin-1 like factor called epidermal-cell-
derived thymocyte-activating factor (ETAF), which
activates T-lymphocytes in association with antigen. In
addition, they have been shown to express Class II MHC
antigens after a variety of immune stimuli and exposure
to y-interferon in both mouse and man,4-5 and may also
process antigen. Recently interleukin-I has also been
shown to be synthesized by LCs.6
There is a population of T-lymphocytes present in the
epidermis. These cells may be resident in that site or be
attracted from the lymphatics or blood vessels of the skin
by epidermal APCs. T-lymphocytes could recognize
antigen presented by LCs within the epidermis and
become effector cells locally. Alternatively, they could
be activated in the lymph nodes by APCs (which have
migrated there from the epidermis) and proliferate
before moving to the skin to effect the immune
response. In delayed type hypersensitivity (DTH)
reactions both these events are thought to occur at
different times during the development of the response.7
Finally, a population of Thy-1 positive indeterminate
cells, derived from the bone marrow, has been described
in murine epidermis, which is postulated to consist of
APCs for the induction of immunosuppression.2 Figure
1 illustrates the structure of the epidermis.
Effect of UV radiation on immune function
Many systems have been described which demonstrate
profound modulations of the immune system by UV
radiation. These effects are complex and are made even
more so by variations in the wavelength of UV light
employed, the doses of radiation administered, the
experimental animals studied and the parameters of the
immune system measured. Mice have been used
extensively as experimental models and the following
results have all been obtained in murine systems. In
essence, UV-irradiation results in the induction of
immunosuppression with the generation of specific T
suppressor (Ts) lymphocytes.
At the site of irradiation there is a local effect which is
illustrated by a specific immunological tolerance to
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heteroduplex analysis or Southern blot-hybridization.32
These methods allow the study of plasmid evolution
during an outbreak and demonstrate the presence and
frequency of transposons carrying drug-resistance deter¬
minants from plasmid to plasmid.
Conclusions
Studies of the epidemic process in S. sonnei infections
involve use of a series of microbiological methods,
including phage typing, biotyping, colicin typing, and
drug-resistance typing. They allow intraspecific sub¬
division of S. sonnei strains and provide support for
epidemiological analysis in epidemic situations. Since
phenotypic traits can experience change in the course of
strain circulation, a detailed epidemiological investi¬
gation will require, in addition, examination of genetic
relatedness between individual bacterial isolates. This is
accomplished by plasmid pattern analysis, which is a
valuable and reliable epidemiological laboratory
method.
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contact and photosensitizing agents.* It is known that
UV-irradiation of certain wavelengths reduces the
number of LCs in the epidermis in exposed areas, and
changes the morphology (and perhaps the function) of
those remaining;9 in addition, ETAF production is
markedly decreased. Recently, a new functional type of
epidermal APC has been described,"1 which, unlike the
LC, is UV-resistant and appears to induce, pre¬
ferentially, Ts cells rather than T helper (Th)
lymphocytes. Such cells could induce Ts cells either
locally or systemically, after migration from the
epidermis to lymph nodes or the spleen.
In addition to the local effect of UV-irradiation, there
is a systemic effect in which the immune response is
suppressed at unexposed sites. The exact mechanism is
not known but it is probable that several factors are
involved. It takes time, several hours at least, for the
effect to develop after the exposure. The distribution of
LCs is altered; accumulations of APCs may occur in
draining lymph nodes immediately following irradiation
and other epidermal APCs may be destroyed because of
DNA damage.11 There is a local inflammatory response,
the extent of which depends on the dose of UV-
irradiation. This may deplete T-lymphocytes specific for
DTH and suppress local graft-versus-host responses.
However, the wavelength at which the LCs are altered
(270-290 nm) can be separated from the wavelength at
which the maximum suppression at an unexposed site
occurs (320 nm),12 so some other mediators must also be
involved. The UV-spectrum is illustrated in Figure 2.
As already stated Ts cells are found following UV-
irradiation which are antigen specific and which were
first described as inducing systemic suppression in UV-
induced tumour cells.13 Presumably these are generated
systemically. UV-irradiation has poor penetrating
capacity and would only have effects on the upper cells
of the epidermis. It is possible that DNA damage in
these cells leads to the release of some chemical
mediator(s) which could either interact locally with LCs,
Alteration in
Figure 2. Wavelength of radiation and points at which various
effects occur.
or circulate to lymphoid organs and there interact with
APCs to induce the generation of Ts cells.14 Urocanic
acid as been suggested as a possible photoreceptor
mediator.15 This substance is located preferentially in
the stratum corneum and absorbs U V at the same wave¬
length at which suppression occurs. UV-irradiation
induces isomerization of urocanic acid from the trans- to
the m-form; at present no interaction of urocanic acid
with the cells of the immune system has been
demonstrated.
These various mechanisms are summarized in Table 1
and there is an excellent recent review by Kripke &
Morison.16
Table 1. Immunosuppression caused by UV-irradiation.




UV-resistant LCs (I-J ):







Ts cells induced by local effect.
Redistribution of APCs.
Chemical mediators released
by DNA damage to
epidermis or ds-isomer of
urocanic acid interacts with
APCs locally or systemically.
Herpes simplex virus UV-irradiation
So far, most studies on the modulation of the immune
response by UV-irradiation have used a high dose
(greater than 10000 J m 2) which causes a marked
erythema with extensive inflammatory changes in the
skin. Systems include prevention of immunological
rejection of skin cancers induced by UV-irradiation as
already mentioned,17 and contact hypersensitivity
studies with various chemicals like dinitrofluoro-
benzene.18 In contrast to these experiments, we wished
to establish whether UV-irradiation altered the immune
response to a viral infection of the skin and whether the
dose of UV would have an effect if reduced to sub-
erythemal levels. The virus chosen was herpes simplex
(HSV).
HSV is a complex DNA-containing virus causing an
epidermal infection of the oral or genital region. The
infection is apparent clinically as 'cold sores' or may be
subclinical. About 80% of adults have serological
evidence of having been in contact with HSV, commonly
as young children. After the primary infection, the virus
is not eliminated from the body but persists in a latent
form, probably integrated or as concatemerized viral
DNA in the neurones of the ganglion serving the area of
skin infected initially."' In about half of these cases, the
virus reactivates at intervals, travels down the axon of
the nerve and is found in the skin again. It may replicate
there to form a recrudescent lesion.2" The frequency of
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these recrudescences varies enormously from one indi¬
vidual to another, from as often as once a month to once
in a lifetime. Very often there is a recognizable trigger¬
ing factor and one of the most common for oral HSV
recrudescence is exposure to UV-light.
The importance of the immune system in controlling
primary and latent HSV infections has been demon¬
strated under both experimental and natural conditions
and has been reviewed extensively,2L22 However, the
relative roles of the various facets of the immune
response, specific and non-specific, humoral and cell-
mediated, remain unclear. It seems likely that
epidermally encountered pathogens like HSV are pro¬
cessed and presented to specific T-lymphocytes on the
surface of LCs, although whether HSV can productively
infect and destroy LCs, thus altering antigen present¬
ation in the skin, is not known.
We examined the effect of UV-irradiation on the
generation of immunity to primary HSV in a murine
model. Mice were irradiated with a suberythemal dose
of UV-B (wavelength 270-350 nm, dose 960 J m 2) on
their shaved dorsal skin 3 d before being infected sub-
cutaneously with HSV. They were challenged 8 d later
with inactivated HSV and were found to have 60-90%
suppressed DTH response compared to non-irradiated
control mice.23 DTH is particularly important in viral
clearance from a local site. Irradiation on the same day
as infection had no effect on DTH, showing that the
suppression is not immediate. However, the infection
had to take place within a limited time (14 d) after
UV-irradiation, otherwise no suppression was gen¬
erated. Once the suppression was induced, it persisted
for as long as tested (more than 30 d).
To test the nature of the suppression, spleen cells from
UV-irradiated mice were transferred to mice which had
been infected with virus 8 d before. Suppression of DTH
resulted and it was specific for HSV. The suppression
was shown to be due to Ts cells in the transferred spleen
cell population and two phenotypically distinct subsets
were involved, distinguishable on the basis of their cell
surface antigen expression (S. Howie, M. Norval, J.
Maingay and J. Ross, unpublished results).
To examine antigen presentation of HSV by
epidermal cells, an in vitro assay was set up. It was found
that UV-irradiation of mice before the epidermal cells
were collected decreased antigen presentation by at
least 60%. Interestingly, this reduction was not only a
local effect on the epidermal cells at the exposed site but
was found in epidermal cells from unexposed sites also.
However, the APC capacity of peritoneal cells was
unaffected by UV-irradiation.24 We do not know what
this defect in antigen presentation is: it may be a
functional reduction, a reduction in numbers of APCs in
the epidermis or an alteration in trafficking properties.
Preliminary experiments on the photo-isomer of
urocanic acid have proved unexpectedly exciting.
Injection of this compound subcutaneously, followed by
sensitization with HSV, led to suppression of DTH
response on subsequent challenge with HSV. This
suppression was of the same order as that induced by
UV-irradiation and experiments are in progress to
ascertain if c/s-urocanic acid affects the epidermal
function of APCs, numbers, trafficking out of the
epidermis or whether it might affect the generation of Ts
cells systemically.
Conclusions and speculations
Given the importance of the immune system in control¬
ling HSV infections, any environmental stimulus which
transiently depresses the immune response may have
profound effects on the nature of the host-virus balance,
depending on the timing of the two events. Thus UV-
irradiation in a critical period prior to contact with HSV
may determine the severity and extent of primary
infection, which infections become latent and which
recrudesce and with what frequency and severity. In our
experiments, low-dose irradiation was used. It is
probable that continuous exposure to high doses of UV,
as in tropical countries, may lead to a reduction in
immunosuppressive effect, perhaps by changes in the
permeability of the epidermis or by the synthesis of a
greater amount of melanin.
There are other epidermal viral infections, in addition
to HSV, which are of interest in the context of immuno¬
suppression. Varicella zoster causes chicken pox; the
virus becomes latent and may recrudesce to produce
shingles many years later, often when the immune
system is thought to be depressed. Skin warts are the
result of infection by several types of papilloma viruses.
Warts persist for many weeks or months, then fre¬
quently regress spontaneously. Cell-mediated immunity
is thought to be important in their control and cure, and
certainly immunosuppressed patients are recognized as
having a high incidence of papilloma infection, often of a
florid nature.25 There is growing evidence of latent
infection of epidermal cells after the wart has dis¬
appeared and the histopathological appearance is
normal. Various pox viruses, such as molluscum con-
tagiosum and orf, cause epidermal infections and the
host response to these, often persistent in nature, is not
well understood. Other viruses have epidermal phases
which can be very transient, as in rubella, or longer
lasting, as in measles. For all of these infections, the
effect of UV-irradiation around the time of the initial
contact with the virus upon severity of symptoms,
persistence of virus, latency or any second phase of
infection is not known.
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Microbe '86
XIV International Congress ofMicrobiology,
7-13 September 1986, Manchester, UK.
This important Congress will be held under the auspices of the
1UMS and under the joint sponsorship of The Royal Society of
London, The Society for General Microbiology, The Society
for Applied Bacteriology, The Society for Chemical Industry
and The British Mycological Society.
The scientific programme incorporates the Bacteriology
Division Meeting, which offers 32 symposia highlighting topics
including systematics, medicine, veterinary science, genetics,
molecular biology, ecology and industrial/applied micro¬
biology (IUMS News, May 1986). The Mycology Division
Meeting offers 10 symposia covering genetics, mycotoxins,
membranes and mycorrhiza (IUMS News, April 1986).
Details of the Social Programme (organized by Dr TA
Roberts) and the Virology Programme (Dr BWJ Mahy) will
appear in the August 1986 issue of Microbiological Sciences.
Further information can be obtained from the Secretary to
the Organizing Committee: Dr JA Cole, Department of Bio¬
chemistry, University of Birmingham, PO Box 363,
Birmingham B15 2TT, UK.
The 2nd Circular for the Congress is available from Mr AF
Yates, Trading Services, UM1ST, PO Box 88, Sackville Street,
Manchester M60 10D, UK.
Xth International Specialized Symposium on Yeast
The Xth International Specialized Symposium on Yeast
"Genetics and Molecular Biology' co-sponsored by IUMS was
organized by the Institute of Molecular Biology, Bulgarian
Academy of Sciences for the International Commission for
Yeasts at Varna, Bulgaria on 4th-9th November, 1985.
This highly successful Symposium was attended by 148 par¬
ticipants from almost all European countries, Canada, the
USA and Japan.
1UMS financial support was used to assist 17 participants, 3
from USA, 3 from USSR, 2 from The Netherlands. 2 from
Canada and 1 each from Norway, France, Switzerland,
Denmark, Japan and the UK.
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